|
5054 genotypes with 12938 annotations displayed
of selected term and subterms
|
|
Searched Term: abnormal lymphocyte morphology
|
\1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93488
|
| decreased CD8-positive, alpha-beta T cell number
|
J:93488
|
\1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk)
|
decreased NK T cell number
|
J:137009
|
\1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: FVB/N)
|
decreased gamma-delta T cell number
|
J:193548
|
| decreased T cell number
|
J:193548
|
\2310022B05Riktm1a(EUCOMM)Hmgu/\2310022B05Riktm1a(EUCOMM)Hmgu
(C57BL/6N-2310022B05Riktm1a(EUCOMM)Hmgu/H)
|
increased B cell number
|
J:165965
|
\2810408A11Riktm1a(EUCOMM)Wtsi/\2810408A11Riktm1a(EUCOMM)Wtsi
(C57BL/6N-2810408A11Riktm1a(EUCOMM)Wtsi/H)
|
decreased NK cell number
|
J:165965
|
| increased CD4-positive, alpha-beta T cell number
|
J:165965
|
| increased NK cell number
|
J:165965
|
\3425401B19Rikem2(IMPC)Ccpcz/\3425401B19Rikem2(IMPC)Ccpcz
(C57BL/6NCrl-3425401B19Rikem2(IMPC)Ccpcz/Ph)
|
increased effector memory T-helper cell number
|
J:211773
|
\5730403I07Rikem8Gpt/\5730403I07Rikem8Gpt
(involves: C57BL/6JGpt)
|
abnormal T cell number
|
J:329871
|
\9430015G10Riktm1Lex/\9430015G10Riktm1Lex
(B6;129S5-9430015G10Riktm1Lex/Mmucd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:171883
|
| increased B cell number
|
J:171883
|
\AA467197em1Nyam/\AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam)
|
decreased CD4-positive, alpha-beta T cell number
|
J:347271
|
\Abattm1c(EUCOMM)Hmgu/\Abattm1c(EUCOMM)Hmgu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:333883
|
| abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:333883
|
| abnormal T-helper 1 cell differentiation
|
J:333883
|
| abnormal T-helper 17 cell differentiation
|
J:333883
|
\Abcb1atm1Bor/\Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:102640
|
| decreased gamma-delta intraepithelial T cell number
|
J:102640
|
\Abcb1atm1Bor/\Abcb1atm1Bor
\Abcb1btm1Bor/\Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:102640
|
| decreased gamma-delta intraepithelial T cell number
|
J:102640
|
| increased double-positive T cell number
|
J:102640
|
\Abcb4em1(IMPC)H/\Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
\Abcc2tm2b(KOMP)Wtsi/\Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Abcc5em1(IMPC)H/\Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Abcc9em1(IMPC)H/\Abcc9+
(C57BL/6N-Abcc9em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Abce1tm1b(EUCOMM)Hmgu/\Abce1+
(C57BL/6N-Abce1tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
\Abcg1tm1Dgen/\Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:132952
|
| increased CD4-positive, alpha-beta T cell number
|
J:132952
|
| increased CD8-positive, alpha-beta T cell number
|
J:132952
|
\Abcg8tm1b(KOMP)Wtsi/\Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
decreased B-2 B cell number
|
J:211773
|
| decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
\Abl1m1/\Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
|
abnormal B cell differentiation
|
J:14644
|
| abnormal T cell number
|
J:14644
|
| decreased immature B cell number
|
J:14644
|
| decreased pre-B cell number
|
J:14644
|
| decreased pro-B cell number
|
J:14644
|
| decreased single-positive T cell number
|
J:14644
|
| decreased thymocyte number
|
J:14644
|
| increased single-positive T cell number
|
J:14644
|
\Abl1m1/\Abl1m1
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:28795
|
| decreased mature B cell number
|
J:28795
|
| decreased pre-B cell number
|
J:28795
|
| decreased pro-B cell number
|
J:28795
|
\Abl1m1/\Abl1m1
(involves: 129S/SvEv * C57BL/6)
|
abnormal lymphopoiesis
|
J:148105
|
| decreased pro-B cell number
|
J:148105
|
\Abl1tm1Mlg/\Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J)
|
decreased B cell number
|
J:72875
|
| decreased lymphocyte cell number
|
J:72875
|
| decreased T cell number
|
J:72875
|
| decreased thymocyte number
|
J:72875
|
\Ablim3em1(IMPC)Tcp/\Ablim3em1(IMPC)Tcp
(C57BL/6N-Ablim3em1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Acacatm1Dejs/\Acacatm1Dejs
\Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
decreased memory T cell number
|
J:209886
|
| decreased T cell number
|
J:209886
|
\Acetm6Keb/\Acetm6Keb
(involves: 129 * C57BL/6)
|
increased T cell number
|
J:122178
|
\Ackr3tm1.1Fma/\Ackr3tm1.1Fma
(involves: BALB/cJ * C57BL/6)
|
decreased marginal zone B cell number
|
J:124878
|
\Ackr4tm1.1Rjbn/\Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:166490
|
| abnormal T-helper 17 cell differentiation
|
J:166490
|
| increased T-helper 17 cell number
|
J:166490
|
\Acoxlem1(IMPC)Mbp/\Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Acp2tm1a(EUCOMM)Wtsi/\Acp2tm1a(EUCOMM)Wtsi
(C57BL/6N-Acp2tm1a(EUCOMM)Wtsi/H)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
| increased B cell number
|
J:165965
|
\Acsl3Gt(OST148301)Lex/\Acsl3Gt(OST148301)Lex
(B6;129S5-Acsl3Gt(OST148301)Lex/Orl)
|
decreased B cell number
|
J:82809
|
| increased CD4-positive, alpha-beta T cell number
|
J:82809
|
\Acss3em1(IMPC)Ccpcz/\Acss3em1(IMPC)Ccpcz
(C57BL/6NCrl-Acss3em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Acta2em1(IMPC)H/\Acta2em1(IMPC)H
(C57BL/6NTac-Acta2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Actbtm4(cre/ERT2)Npa/\Actb+
\Sgpl1tm1.1Npa/\Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6)
|
abnormal regulatory T cell number
|
J:199525
|
| decreased follicular B cell number
|
J:199525
|
| decreased marginal zone B cell number
|
J:199525
|
| decreased single-positive T cell number
|
J:199525
|
| increased thymocyte number
|
J:199525
|
\Actl6atm1.1Grc/\Actl6atm1.1Grc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
decreased B cell number
|
J:192124
|
| decreased lymphocyte cell number
|
J:192124
|
\Adatm1Mw/\Adatm1Mw
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased T cell number
|
J:25085
|
\Adatm1Mw/\Adatm1Mw
\Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-positive T cell number
|
J:73418
|
| increased double-negative T cell number
|
J:73418
|
\Adam10tm1.1Dhc/\Adam10tm1.1Dhc
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal B cell differentiation
|
J:158127
|
| absent marginal zone B cells
|
J:158127
|
| decreased transitional stage T2 B cell number
|
J:158127
|
| increased follicular B cell number
|
J:158127
|
| increased transitional stage T1 B cell number
|
J:158127
|
\Adam10tm1.1Khr/\Adam10tm1.1Khr
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)
|
abnormal T cell differentiation
|
J:179060
|
| decreased CD4-positive, alpha-beta T cell number
|
J:179060
|
| decreased CD8-positive, alpha-beta T cell number
|
J:179060
|
| decreased double-positive T cell number
|
J:179060
|
| decreased T cell number
|
J:179060
|
\Adam10tm1Zhu/\Adam10tm1.1Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
| decreased CD4-positive, alpha-beta T cell number
|
J:139042
|
| decreased double-positive T cell number
|
J:139042
|
\Adam10tm1Zhu/\Adam10tm1Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
| decreased CD4-positive, alpha-beta T cell number
|
J:139042
|
| decreased double-positive T cell number
|
J:139042
|
\Adam17tm1.2Bbl/\Adam17tm1.2Bbl
\Sox9tm3(cre)Crm/\Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased B cell number
|
J:144795
|
| decreased lymphocyte cell number
|
J:144795
|
| decreased T cell number
|
J:144795
|
\Adam17tm1.2Bbl/\Adam17tm1.2Bbl
\Sox9tm3(cre)Crm/\Sox9+
(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl)
|
increased T-helper 1 cell number
|
J:229771
|
| increased T-helper 2 cell number
|
J:229771
|
| increased T-helper 17 cell number
|
J:229771
|
\Adam28tm1.2Dica/\Adam28tm1.2Dica
(B6JRj.129-Adam28tm1.2Dica)
|
abnormal alpha-beta T cell morphology
|
J:298188
|
| abnormal lymphocyte morphology
|
J:298188
|
| decreased CD8-positive, alpha-beta T cell number
|
J:298188
|
\Adam28tm1.2Dica/\Adam28tm1.2Dica
(CJRj.129-Adam28tm1.2Dica)
|
decreased CD8-positive, alpha-beta T cell number
|
J:298188
|
\Adamts14Gt(511E11)Cmhd/\Adamts14Gt(511E11)Cmhd
\Adamts2tm1Prc/\Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:271185
|
| decreased CD8-positive, alpha-beta T cell number
|
J:271185
|
| increased CD4-positive, alpha-beta T cell number
|
J:271185
|
\Adap1tm1a(EUCOMM)Wtsi/\Adap1tm1a(EUCOMM)Wtsi
(C57BL/6N-Adap1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased memory-marker NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Adcyap1tm1Clw/\Adcyap1tm1Clw
(B6.129S4-Adcyap1tm1Clw)
|
increased T-helper 17 cell number
|
J:194151
|
\Adgrf5tm1b(KOMP)Wtsi/\Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Adgrg3tm1Zgwg/\Adgrg3tm1Zgwg
(involves: 129 * C57BL/6)
|
abnormal B cell morphology
|
J:222670
|
| decreased follicular B cell number
|
J:222670
|
| decreased mature B cell number
|
J:222670
|
| decreased transitional stage T1 B cell number
|
J:222670
|
| increased marginal zone B cell number
|
J:222670
|
| increased transitional stage T2 B cell number
|
J:222670
|
\Adipor1tm1b(EUCOMM)Hmgu/\Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Adipor2tm1b(EUCOMM)Hmgu/\Adipor2tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Admtm1Kmca/\Admtm1Kmca
(B6.129P2-Admtm1Kmca)
|
increased uterine NK cell number
|
J:201446
|
\Admtm1Unc/\Admtm1Unc
(involves: 129S6/SvEvTac)
|
decreased uterine NK cell number
|
J:201446
|
\Adora2aem1(IMPC)H/\Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Adrb3em1(IMPC)Krb/\Adrb3em1(IMPC)Krb
(C57BL/6NTac-Adrb3em1(IMPC)Krb/Krb)
|
increased CD4-negative, CD25-positive NK T cell number
|
J:211773
|
\Adrm1Gt(OST128063)Lex/\Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal single-positive T cell number
|
J:166694
|
| increased CD4-positive, alpha-beta T cell number
|
J:166694
|
| increased CD8-positive, alpha-beta T cell number
|
J:166694
|
\Afdnem1(IMPC)Mbp/\Afdn+
(C57BL/6N-Afdnem1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Aff1Rob/\Aff1+
(involves: BALB/cAnNCrl * C3H/HeN)
|
abnormal double-negative T cell morphology
|
J:82265
|
\Aff1tm1Cim/\Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal T cell differentiation
|
J:63253
|
| decreased B cell number
|
J:63253
|
| decreased double-positive T cell number
|
J:63253
|
| decreased mature B cell number
|
J:63253
|
| decreased pre-B cell number
|
J:63253
|
| decreased single-positive T cell number
|
J:63253
|
\Agkem1Qiz/\Agkem1Qiz
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:282052
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:282052
|
\Agktm1.1Smoc/\Agktm1.1Smoc
(Not Specified)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:282052
|
\Aglna/?
(C57BL/6-Aglna/Anu)
|
increased activated T cell number
|
J:169366
|
\Agtpbp1atms/\Agtpbp1atms
(MRL/Mp-Agtpbp1atms)
|
abnormal lymphocyte cell number
|
J:103944
|
| abnormal T cell differentiation
|
J:103944
|
| abnormal T cell subpopulation ratio
|
J:103944
|
| decreased B cell number
|
J:103944
|
| increased CD4-positive, alpha-beta T cell number
|
J:103944
|
| increased CD8-positive, alpha-beta T cell number
|
J:103944
|
\Ahnaktm1b(KOMP)Mbp/\Ahnak+
(C57BL/6N-Ahnaktm1b(KOMP)Mbp/H)
|
increased large unstained cell number
|
J:211773
|
\Aicdaem1Jaych/\Aicdaem1Jaych
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:305843
|
\Aicdatm1.1Fwa/\Aicdatm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:209271
|
| abnormal somatic hypermutation frequency
|
J:209271
|
\Aicdatm1b(EUCOMM)Hmgu/\Aicdatm1b(EUCOMM)Hmgu
(C57BL/6N-Aicdatm1b(EUCOMM)Hmgu/Wtsi)
|
decreased follicular B cell number
|
J:211773
|
| decreased late germinal center B cell number
|
J:211773
|
| increased early germinal center B cell number
|
J:211773
|
| increased germinal center B cell number
|
J:211773
|
\Aicdatm1Hon/\Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:136224,
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm1Hon/\Aicdatm1.1Fwa
(involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal class switch recombination
|
J:209271
|
\Aicdatm1Hon/\Aicdatm1Hon
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427,
J:73659,
J:120658
|
| abnormal somatic hypermutation frequency
|
J:136224,
J:141427
|
| increased germinal center B cell number
|
J:169227
|
\Aicdatm1Hon/\Aicdatm1Hon
\Bcl6tm1.1Jwan/\Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal somatic hypermutation frequency
|
J:190534
|
\Aicdatm1Hon/\Aicdatm1Hon
\Exo1tm1Wed/\Exo1tm1Wed
\Ightm4.1Mnz/\Igh+
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm1Hon
\Exo1tm1Wed/\Exo1tm1Wed
\Ightm4.1Mnz/\Igh+
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm1Hon
\Ightm3Mnz/\Ightm4.1Mnz
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:159173
|
\Aicdatm1Hon/\Aicdatm1Hon
\Ightm4.1Mnz/\Igh+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm1Hon
\Ightm4.1Mnz/\Igh+
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
\Aicdatm1Hon/\Aicdatm3Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm1Hon/\Aicdatm4Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm2.1Hon/\Aicdatm2.1Hon
(C57BL/6-Aicdatm2.1Hon)
|
abnormal somatic hypermutation frequency
|
J:169227
|
| increased germinal center B cell number
|
J:169227
|
\Aicdatm2.1Hon/\Aicdatm2.1Hon
(involves: BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:169227
|
\Aicdatm3.1Mnz/\Aicdatm3.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
\Aicdatm3Mnz/\Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
\Aicdatm4.1Mnz/\Aicdatm4.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
\Aicdatm4Mnz/\Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
\Aim2Gt(CSG445)Byg/\Aim2Gt(CSG445)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased NK cell number
|
J:158969
|
\Airetm1.1(cre)Ghr/\Airetm1.1(cre)Ghr
(Not Specified)
|
decreased regulatory T cell number
|
J:176844
|
\Airetm1.1Doi/\Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell number
|
J:83422
|
\Airetm1.1Doi/\Airetm1.1Doi
\Tg(Ins2-TFRC/OVA)296Wehi/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
| decreased CD4-positive, alpha-beta T cell number
|
J:135154
|
\Airetm1Mand/\Aire+
\Tg(Ins2-TFRC/OVA)296Wehi/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
\Airetm1Pltn/\Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:77873
|
\Airetm1Pltn/\Airetm1Pltn
(B6.129S4-Airetm1Pltn)
|
decreased follicular B cell number
|
J:115076
|
| increased B cell number
|
J:115076
|
| increased marginal zone B cell number
|
J:115076
|
\Ajubaem1(IMPC)H/\Ajubaem1(IMPC)H
(C57BL/6N-Ajubaem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Akap9tm1a(KOMP)Wtsi/\Akap9+
(involves: C57BL/6 * C57BL/6N)
|
decreased B cell number
|
J:213427
|
| decreased mature B cell number
|
J:213427
|
| increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased CD8-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
\Akap13tm1Segj/\Akap13+
(involves: 129)
|
decreased B cell number
|
J:181088
|
| decreased transitional stage T2 B cell number
|
J:181088
|
| increased transitional stage T1 B cell number
|
J:181088
|
\Akt1tm1Pnt/\Akt1tm1Pnt
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
\Akt3tm1Mbb/\Akt3tm1Mbb
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
| decreased double-positive T cell number
|
J:135903
|
| increased double-negative T cell number
|
J:135903
|
\Akt1tm1Pnt/\Akt1tm1Pnt
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
| decreased double-positive T cell number
|
J:135903
|
| increased double-negative T cell number
|
J:135903
|
\Akt1tm1Pnt/\Akt1tm1Pnt
\Akt3tm1Mbb/\Akt3tm1Mbb
\Tg(Lck-cre)1Cwi/0
(Not Specified)
|
decreased double-positive T cell number
|
J:135903
|
\Aldh1l2em1(IMPC)Kmpc/\Aldh1l2em1(IMPC)Kmpc
(C57BL/6NTac-Aldh1l2em1(IMPC)Kmpc/Kmpc)
|
increased B-1a cell number
|
J:211773
|
| increased CD8-positive, CD25-positive alpha-beta T cell number
|
J:211773
|
\Aldh2tm1a(EUCOMM)Wtsi/\Aldh2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh2tm1a(EUCOMM)Wtsi/Ieg)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
\Aldh2tm1a(EUCOMM)Wtsi/\Aldh2tm1a(EUCOMM)Wtsi
\Fancd2tm1Hou/\Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
abnormal lymphopoiesis
|
J:193232
|
| increased CD8-positive, alpha-beta T cell number
|
J:193232
|
| increased double-positive T cell number
|
J:193232
|
\Alg1tm1b(KOMP)Wtsi/\Alg1+
(C57BL/6N-Alg1tm1b(KOMP)Wtsi/Nju)
|
increased lymphocyte cell number
|
J:211773
|
\Altretm1.1Hbgl/\Altretm1.1Hbgl
\Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased regulatory T cell number
|
J:342907
|
| decreased T cell number
|
J:342907
|
| increased CD8-positive, alpha-beta T cell number
|
J:342907
|
| increased memory T cell number
|
J:342907
|
\Amdhd1tm2b(EUCOMM)Hmgu/\Amdhd1tm2b(EUCOMM)Hmgu
(C57BL/6N-Amdhd1tm2b(EUCOMM)Hmgu/BayMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Amelxem1(IMPC)Ccpcz/\Amelx+
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Amhr2tm3(cre)Bhr/\Amhr2+
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased uterine NK cell number
|
J:170203
|
\Amtem1(IMPC)Tcp/\Amt+
(C57BL/6N-Amtem1(IMPC)Tcp/Cmmr)
|
decreased lymphocyte cell number
|
J:211773
|
\Angtm1Dats/\Angtm1Dats
(Not Specified)
|
increased lymphocyte cell number
|
J:236081
|
\Ank1ity16/\Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased lymphocyte cell number
|
J:199427
|
\Anpeptm1.1Lsha/\Anpeptm1.1Lsha
(B6.Cg-Anpeptm1.1Lsha)
|
increased CD4-positive, alpha-beta T cell number
|
J:163945
|
\Anxa5tm1Epo/\Anxa5tm1Epo
\Anxa6tm1Moss/\Anxa6tm1Moss
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:193886
|
\Anxa5tm1Epo/\Anxa5tm1Epo
\Anxa6tm1Moss/\Anxa6tm1Moss
\Col10a1tm1Ksec/\Col10a1tm1Ksec
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased B cell number
|
J:193886
|
| increased T-helper cell number
|
J:193886
|
\Ap1g1tm1Schu/\Ap1g1+
(either: (involves: 129P2/OlaHsd * 129X1/SvJ) or (involves: 129P2/OlaHsd * C57BL/6J))
|
decreased CD4-positive, alpha-beta T cell number
|
J:53252
|
\Apbb1ipem1(IMPC)Ccpcz/\Apbb1ipem1(IMPC)Ccpcz
(C57BL/6N-Apbb1ipem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\ApcMin/\Apc+
(involves: 129 * C57BL/6)
|
decreased NK cell number
|
J:156864
|
| decreased T cell number
|
J:156864
|
\ApcMin/\Apc+
\Tg(Rorc-EGFP)1Ebe/?
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
\Apctm1Kk/\Apctm1Kk
\Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:100461
|
| arrested T cell differentiation
|
J:100461
|
| increased double-negative T cell number
|
J:100461
|
\Apctm2.1Cip/\Apc+
\Atg7tm1Tchi/\Atg7tm1Tchi
\Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:227287
|
| increased regulatory T cell number
|
J:227287
|
\Apctm2.1Cip/\Apctm2.1Cip
\Lect2tm1Ymg/\Lect2tm1Ymg
\Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
increased NK T cell number
|
J:184496
|
\Apctm2.1Cip/\Apctm2.1Cip
\Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
decreased NK T cell number
|
J:184496
|
\Apctm2Rak/\Apctm2Rak
\Tg(KRT14-cre)8Brn/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL)
|
decreased thymocyte number
|
J:114152
|
\Apex2em1(IMPC)H/\Apex2em1(IMPC)H
(C57BL/6NTac-Apex2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun)
|
decreased B cell number
|
J:95267
|
| decreased T cell number
|
J:95267
|
| decreased thymocyte number
|
J:95267
|
\AplfGt(RRF189)Byg/\AplfGt(RRF189)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:168260
|
\Apoetm1Unc/\Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:108154,
J:47027
|
| abnormal T cell number
|
J:47027
|
| decreased follicular B cell number
|
J:133606
|
| decreased marginal zone B cell number
|
J:133606
|
| increased B cell number
|
J:133606
|
| increased marginal zone B cell number
|
J:133606
|
| increased T-helper 2 cell number
|
J:47027
|
\Apoetm1Unc/\Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
increased CD4-positive, alpha-beta T cell number
|
J:125366
|
\Apoetm1Unc/\Apoetm1Unc
\Ccr5tm1Blck/\Ccr5tm1Blck
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell number
|
J:128063
|
\Apoetm1Unc/\Apoetm1Unc
\Ccr5tm1Kuz/\Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell number
|
J:128063
|
\Apoetm1Unc/\Apoetm1Unc
\Cxcl10tm1Adl/\Cxcl10tm1Adl
(B6.129-Cxcl10tm1Adl Apoetm1Unc)
|
decreased CD4-positive, alpha-beta T cell number
|
J:166204
|
\Apoetm1Unc/\Apoetm1Unc
\Faslpr/\Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:121671
|
| decreased CD8-positive, alpha-beta T cell number
|
J:121671
|
\Apoetm1Unc/\Apoetm1Unc
\Faslgld/\Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
increased T cell number
|
J:91058
|
\Aptxtm1Pmc/\Aptxtm1Pmc
\Atmtm2.1Mfgc/\Atmtm2.1Mfgc
(involves: 129 * C57BL/6)
|
abnormal CD4-positive helper T cell morphology
|
J:316365
|
| abnormal T cell differentiation
|
J:316365
|
| decreased T cell number
|
J:316365
|
| increased CD8-positive, alpha-beta T cell number
|
J:316365
|
\ArTfm/Y
(involves: STOCK EdaTa Atp7aMo-blo)
|
increased immature B cell number
|
J:110923
|
\Arb2aem2(IMPC)Ccpcz/\Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph)
|
decreased Ly6C-positive NK T cell number
|
J:211773
|
\Arfgap2tm1c(EUCOMM)Hmgu/\Arfgap2tm1c(EUCOMM)Hmgu
\Sting1em1Jmin/\Sting1em1Jmin
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:363611
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:363611
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:363611
|
| increased CD4-positive, alpha-beta T cell number
|
J:363611
|
| increased regulatory T cell number
|
J:363611
|
\Arhgap15tm1Ehi/\Arhgap15tm1Ehi
(B6.129-Arhgap15tm1Ehi)
|
decreased lymphocyte cell number
|
J:174896
|
\Arhgap17tm1b(EUCOMM)Wtsi/\Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased B-1a cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| increased transitional stage T1 B cell number
|
J:211773
|
\Arhgap45em1Ciphe/\Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe)
|
decreased B cell number
|
J:309971
|
| decreased CD4-positive, alpha-beta T cell number
|
J:309971
|
| decreased CD8-positive, alpha-beta T cell number
|
J:309971
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:309971
|
| decreased DN1 thymic pro-T cell number
|
J:309971
|
| decreased naive B cell number
|
J:309971
|
| decreased T cell number
|
J:309971
|
\Arhgdiatm1Ytk/\Arhgdiatm1Ytk
(involves: 129S/SvEv * C57BL/6 * DBA)
|
decreased T cell number
|
J:140671
|
\Arhgdiatm1Ytk/\Arhgdiatm1Ytk
\Arhgdibtm1Miyo/\Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:140671
|
| decreased follicular B cell number
|
J:140671
|
| decreased immature B cell number
|
J:140671
|
| decreased marginal zone B cell number
|
J:140671
|
| decreased mature B cell number
|
J:140671
|
| decreased pre-B cell number
|
J:140671
|
| decreased T cell number
|
J:140671
|
| decreased transitional stage B cell number
|
J:140671
|
| increased single-positive T cell number
|
J:140671
|
\Arhgdibtm1Miyo/\Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased B cell number
|
J:140671
|
| decreased T cell number
|
J:140671
|
\Arhgef1tm1.1Rmt/\Arhgef1tm1.1Rmt
(C57BL/6-Arhgef1tm1.1Rmt)
|
decreased B cell number
|
J:113295
|
| decreased B-1 B cell number
|
J:113295
|
| decreased follicular B cell number
|
J:113295
|
| decreased marginal zone B cell number
|
J:113295
|
\Arhgef1tm1a(EUCOMM)Wtsi/\Arhgef1tm1a(EUCOMM)Wtsi
(C57BL/6N-Arhgef1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased immature NK cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased marginal zone B cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker gamma-delta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased mature NK cell number
|
J:211773
|
\Arhgef1tm1Djle/\Arhgef1tm1Djle
(involves: 129S4/SvJae)
|
increased germinal center B cell number
|
J:174313
|
\Arhgef1tm1Kdf/\Arhgef1tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphocyte cell number
|
J:99463
|
| decreased B cell number
|
J:99463
|
| decreased marginal zone B cell number
|
J:99463
|
\Arhgef4tm1a(KOMP)Wtsi/\Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi)
|
decreased T cell number
|
J:165965
|
| increased mature B cell number
|
J:165965
|
\Arhgef6tm1Kdf/\Arhgef6tm1Kdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:137269
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137269
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137269
|
| decreased lymphocyte cell number
|
J:137269
|
| decreased mature B cell number
|
J:137269
|
\Arhgef6tm2e.1(EUCOMM)Wtsi/\Arhgef6tm2e.1(EUCOMM)Wtsi
(C57BL/6N-Arhgef6tm2e.1(EUCOMM)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Arid3atm1Pwt/\Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:169178
|
| abnormal class switch recombination
|
J:169178
|
| decreased B cell number
|
J:169178
|
| decreased B-1 B cell number
|
J:169178
|
| decreased B-1a cell number
|
J:169178
|
| decreased B-2 B cell number
|
J:169178
|
| decreased marginal zone B cell number
|
J:169178
|
| decreased pre-B cell number
|
J:169178
|
| decreased pro-B cell number
|
J:169178
|
| decreased transitional stage B cell number
|
J:169178
|
| decreased transitional stage T1 B cell number
|
J:169178
|
| decreased transitional stage T2 B cell number
|
J:169178
|
\Arid3btm1c(KOMP)Wtsi/\Arid3btm1c(KOMP)Wtsi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * SJL)
|
abnormal B cell differentiation
|
J:236980
|
| decreased B cell number
|
J:236980
|
| decreased B-1b cell number
|
J:236980
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236980
|
| decreased immature B cell number
|
J:236980
|
| decreased pre-B cell number
|
J:236980
|
| decreased pre-pro B cell number
|
J:236980
|
| decreased pro-B cell number
|
J:236980
|
| decreased transitional stage B cell number
|
J:236980
|
| increased B-1a cell number
|
J:236980
|
| increased follicular B cell number
|
J:236980
|
\Arid4atm1Alb/\Arid4atm1Alb
(involves: 129S7/SvEvBrd)
|
decreased B cell number
|
J:141004
|
| decreased lymphocyte cell number
|
J:141004
|
| decreased T cell number
|
J:141004
|
| increased T cell number
|
J:141004
|
\Arid4atm1Alb/\Arid4atm1Alb
\Arid4btm1Alb/\Arid4b+
(involves: 129S7/SvEvBrd)
|
decreased B cell number
|
J:141004
|
| decreased lymphocyte cell number
|
J:141004
|
| decreased T cell number
|
J:141004
|
| increased T cell number
|
J:141004
|
\Arid5atm1Rnis/\Arid5atm1Rnis
(B6.Cg-Arid5atm1Rnis)
|
decreased T-helper 17 cell number
|
J:197418
|
| increased T cell number
|
J:197418
|
\Arid5btm1Pjh/\Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c)
|
abnormal lymphopoiesis
|
J:70658
|
| decreased double-positive T cell number
|
J:70658
|
| decreased pro-B cell number
|
J:70658
|
| increased single-positive T cell number
|
J:70658
|
\Arpc1btm1a(EUCOMM)Wtsi/\Arpc1btm1a(EUCOMM)Wtsi
(C57BL/6N-Arpc1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased marginal zone precursor B cell number
|
J:211773
|
| decreased mature NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased immature NK cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
\Asah1tm1.2Geno/\Asah1tm1.2Geno
(involves: C57BL/6)
|
decreased B cell number
|
J:285931
|
| decreased CD4-positive, alpha-beta T cell number
|
J:285931
|
| decreased CD8-positive, alpha-beta T cell number
|
J:285931
|
| decreased double-positive T cell number
|
J:285931
|
| decreased lymphocyte cell number
|
J:285931
|
| decreased T cell number
|
J:285931
|
\Asb2tm2b(KOMP)Wtsi/\Asb2+
(C57BL/6N-Asb2tm2b(KOMP)Wtsi/Kmpc)
|
decreased Ly6C-positive immature NK cell number
|
J:211773
|
| increased Ly6C-positive immature NK cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
\Asb7em1(IMPC)Ccpcz/\Asb7em1(IMPC)Ccpcz
(C57BL/6N-Asb7em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Asltm1Brle/\Asltm1Brle
(involves: 129S7/SvEvBrd)
|
decreased lymphocyte cell number
|
J:180208
|
\Aspscr1em1(IMPC)Tcp/\Aspscr1em1(IMPC)Tcp
(C57BL/6NCrl-Aspscr1em1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Asxl1tm1.1Iaai/\Asxl1tm1.1Iaai
\Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
decreased mature B cell number
|
J:208092
|
\Asxl1tm1.1Iaai/\Asxl1tm1.1Iaai
\Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
decreased mature B cell number
|
J:208092
|
\Asxl1tm1.1Mjxu/\Asxl1+
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:208085
|
\Asxl1tm1.1Mjxu/\Asxl1tm1.1Mjxu
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:208085
|
| decreased lymphocyte cell number
|
J:208085
|
| increased single-positive T cell number
|
J:208085
|
\Asxl1tm1a(EUCOMM)Wtsi/\Asxl1+
(C57BL/6N-Asxl1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased B cell number
|
J:165965
|
\Asxl1tm1Bc/\Asxl1tm1Bc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal lymphopoiesis
|
J:155898
|
| decreased B cell number
|
J:155898
|
| decreased CD4-positive, alpha-beta T cell number
|
J:155898
|
| decreased pre-B cell number
|
J:155898
|
| decreased T cell number
|
J:155898
|
| increased double-negative T cell number
|
J:155898
|
\Atad2btm1b(EUCOMM)Hmgu/\Atad2btm1b(EUCOMM)Hmgu
(C57BL/6N-Atad2btm1b(EUCOMM)Hmgu/Ics)
|
decreased NK T cell number
|
J:211773
|
\Atf2Tg(Gzma-Klra1)7Wum/\Atf2+
(involves: C57BL/6)
|
decreased NK cell number
|
J:61178
|
| decreased NK T cell number
|
J:61178
|
\Atg3tm1.1Ywh/\Atg3tm1.1Ywh
\Fnip1m1Btlr/\Fnip1m1Btlr
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
absent B cells
|
J:234285
|
\Atg3tm1.1Ywh/\Atg3tm1.1Ywh
\Gt(ROSA)26Sortm1(cre/ERT)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
abnormal T cell morphology
|
J:172749
|
\Atg3tm1.1Ywh/\Atg3tm1.1Ywh
\Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal T cell morphology
|
J:172749
|
| decreased CD4-positive, alpha-beta T cell number
|
J:172749
|
| decreased CD8-positive, alpha-beta T cell number
|
J:172749
|
\Atg4btm1b(EUCOMM)Hmgu/\Atg4btm1b(EUCOMM)Hmgu
(C57BL/6N-Atg4btm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Atg5tm1Myok/\Atg5tm1Myok
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased lymphocyte cell number
|
J:235399
|
\Atg5tm1Nmz/\Atg5tm1Nmz
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell morphology
|
J:211733
|
| abnormal T cell subpopulation ratio
|
J:211733
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211733
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211733
|
| decreased T cell number
|
J:211733
|
\Atg7tm1Tchi/\Atg7tm1Tchi
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
decreased B cell number
|
J:176843
|
| decreased NK cell number
|
J:176843
|
| decreased T cell number
|
J:176843
|
\Atg7tm1Tchi/\Atg7tm1Tchi
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
increased lymphocyte cell number
|
J:235399
|
\Atg16l2m1Anu/\Atg16l2m1Anu
(C57BL/6NCrlAnu-Atg16l2m1Anu)
|
decreased lymphocyte cell number
|
J:104190
|
\Atl2tm2b(EUCOMM)Hmgu/\Atl2+
(C57BL/6N-Atl2tm2b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Atmm1Btlr/\Atmm1Btlr
(C57BL/6J-Atmm1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265252
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265252
|
| decreased single-positive T cell number
|
J:265252
|
| decreased T cell number
|
J:265252
|
\Atmm2Btlr/\Atmm2Btlr
(C57BL/6J-Atmm2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265253
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265253
|
| decreased single-positive T cell number
|
J:265253
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265253
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265253
|
\Atmm3Btlr/\Atmm3Btlr
(C57BL/6J-Atmm3Btlr)
|
increased B-1a cell number
|
J:272820
|
\AtmM4Btlr/\AtmM4Btlr
(C57BL/6J-AtmM4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272821
|
\Atmm5Btlr/\Atmm5Btlr
(C57BL/6J-Atmm5Btlr)
|
abnormal lymphocyte morphology
|
J:272824
|
| increased B-1 B cell number
|
J:272824
|
\Atmm6Btlr/\Atmm6Btlr
(C57BL/6J-Atmm6Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274964
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274964
|
| abnormal T cell differentiation
|
J:274964
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274964
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274964
|
| decreased T cell number
|
J:274964
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:274964
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274964
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274964
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274964
|
\Atmtm1.1Mmpl/\Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)
|
decreased T cell number
|
J:226414
|
| increased B cell number
|
J:226414
|
\Atmtm1Awb/\Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
decreased activated T cell number
|
J:34193
|
| decreased double-positive T cell number
|
J:34193
|
| decreased T cell number
|
J:34193
|
| increased double-positive T cell number
|
J:34193
|
\Atmtm1Awb/\Atmtm1Awb
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150435
|
| decreased CD4-positive, alpha-beta T cell number
|
J:90941
|
| decreased CD8-positive, alpha-beta T cell number
|
J:90941
|
\Atmtm1Awb/\Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J)
|
decreased single-positive T cell number
|
J:226414
|
| decreased T cell number
|
J:226414
|
| increased B cell number
|
J:226414
|
| increased double-positive T cell number
|
J:226414
|
\Atmtm1Awb/\Atmtm1Awb
\Paxxem1Spj/\Paxxem1Spj
(involves: A/J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:236776
|
| decreased B cell number
|
J:236776
|
| decreased T cell number
|
J:236776
|
\Atmtm1Awb/\Atmtm1Awb
\Rad52tm1Aps/\Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:90941
|
| decreased CD8-positive, alpha-beta T cell number
|
J:90941
|
\Atmtm1Bal/\Atmtm1Bal
(involves: 129S4/SvJae)
|
decreased pre-B cell number
|
J:35914
|
| decreased thymocyte number
|
J:35914
|
\Atmtm1Fwa/\Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6)
|
decreased immature B cell number
|
J:61201
|
| decreased lymphocyte cell number
|
J:61201
|
| decreased pre-B cell number
|
J:61201
|
| decreased T cell number
|
J:61201
|
| decreased thymocyte number
|
J:61201
|
\Atmtm1Fwa/\Atmtm1Fwa
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:191288
|
\Atmtm1Led/\Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal T cell differentiation
|
J:36561
|
| decreased CD4-positive, alpha-beta T cell number
|
J:36561
|
| increased double-positive T cell number
|
J:36561
|
\Atmtm1Mfl/\Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal T cell differentiation
|
J:69726
|
| decreased thymocyte number
|
J:69726
|
| increased double-negative T cell number
|
J:69726
|
| increased single-positive T cell number
|
J:69726
|
\Atmtm1Shzh/\Atmtm2.1Fwa
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:191288
|
\Atmtm2.1Fwa/\Atmtm2.1Fwa
\Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac)
|
decreased B cell number
|
J:277750
|
| decreased T cell number
|
J:277750
|
| decreased thymocyte number
|
J:277750
|
\Atmtm2.1Mfgc/\Atmtm2.1Mfgc
(C57BL/6-Atmtm2.1Mfgc)
|
abnormal T cell differentiation
|
J:316365
|
| decreased T cell number
|
J:316365
|
\Atmintm1.1Jhh/\Atmintm1.1Jhh
\Cd79atm1(cre)Reth/\Cd79a+
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh)
|
decreased B cell number
|
J:230105
|
| decreased immature B cell number
|
J:230105
|
\Atmintm1.1Jhh/\Atmintm1.1Jhh
\Cd79atm1(cre)Reth/\Cd79a+
\Tg(IghMyc)22Bri/0
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri)
|
decreased B cell number
|
J:230105
|
| decreased immature B cell number
|
J:230105
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased B cell number
|
J:191832
|
| increased immature B cell number
|
J:191832
|
| increased pre-B cell number
|
J:191832
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:191832
|
| decreased immature B cell number
|
J:191832
|
| decreased mature B cell number
|
J:191832
|
| decreased pre-B cell number
|
J:191832
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:191832
|
| decreased lymphocyte cell number
|
J:191832
|
| decreased mature B cell number
|
J:191832
|
| decreased pre-B cell number
|
J:191832
|
\Atmintm1.2Jhh/\Atmintm1.2Jhh
\Trp53tm1Brn/\Trp53tm1Brn
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased B cell number
|
J:191832
|
| decreased immature B cell number
|
J:191832
|
\Atn1tm1b(EUCOMM)Wtsi/\Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased lymphocyte cell number
|
J:211773
|
\Atp6v0a2tm1Kdb/\Atp6v0a2tm1Kdb
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:274048
|
| decreased alpha-beta T cell number
|
J:274048
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274048
|
| decreased T cell number
|
J:274048
|
\Atp6v0d1tm1b(EUCOMM)Hmgu/\Atp6v0d1+
(C57BL/6N-Atp6v0d1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Atp11cambr/Y
(C57BL/6-Atp11cambr)
|
abnormal B cell differentiation
|
J:171924
|
| decreased B cell number
|
J:171924
|
| decreased B-1 B cell number
|
J:171924
|
| decreased B-1a cell number
|
J:171924
|
| decreased B-1b cell number
|
J:171924
|
| decreased B-2 B cell number
|
J:171924
|
| decreased follicular B cell number
|
J:171924
|
| decreased immature B cell number
|
J:171924
|
| decreased lymphocyte cell number
|
J:171924
|
| decreased mature B cell number
|
J:171924
|
| decreased pre-B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
| decreased T cell number
|
J:171924
|
\Atp11cambr/Y
\Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6 * C57BL/6JApb * DBA/2)
|
decreased B cell number
|
J:171924
|
\Atp11cambr/Y
\Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6JApb)
|
decreased immature B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
\Atp11cambr/Y
\Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6 * C57BL/6J * C57BL/6JApb)
|
decreased B cell number
|
J:171924
|
| decreased immature B cell number
|
J:171924
|
| decreased pre-B cell number
|
J:171924
|
\Atp11cm1Btlr/Y
(involves: C57BL/6J)
|
absent follicular B cells
|
J:171925
|
| arrested B cell differentiation
|
J:171925
|
| decreased B cell number
|
J:185495,
J:171925
|
| decreased B-1 B cell number
|
J:171925
|
| decreased B-2 B cell number
|
J:171925
|
| decreased immature B cell number
|
J:171925
|
| decreased transitional stage B cell number
|
J:171925
|
| decreased transitional stage T1 B cell number
|
J:171925
|
| decreased transitional stage T2 B cell number
|
J:171925
|
| decreased transitional stage T3 B cell number
|
J:171925
|
\Atp11cm1Btlr/Y
\Tg(BCL2)22Wehi/0
(involves: C57BL/6J * C57BL/6JWehi * SJL/Wehi)
|
decreased B cell number
|
J:171925
|
| decreased follicular B cell number
|
J:171925
|
| decreased mature B cell number
|
J:171925
|
| increased marginal zone B cell number
|
J:171925
|
\Atp11cm1Btlr/Y
\Tg(IghmHyHEL10,IgkHyHEL10)4Ccg/0
(involves: C57BL/6 * C57BL/6J * C57BL/6JSfdAnu)
|
decreased B cell number
|
J:171925
|
\Atp11cm1Btlr/\Atp11cm1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:185495
|
\Atp11cm1Btlr/\Atp11cm2Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:171925
|
\Atp11cm2Anu/Y
(C57BL/6JAnu-Atp11cm2Anu/AnuApb)
|
decreased B cell number
|
J:171924
|
\Atp11cm2Btlr/Y
(involves: C57BL/6J)
|
decreased B cell number
|
J:185495,
J:171925
|
\Atp11cm2Btlr/\Atp11cm2Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:185495
|
\Atp13a5tm1Lex/\Atp13a5tm1Lex
(B6;129S5-Atp13a5tm1Lex/Mmucd)
|
decreased NK cell number
|
J:171883
|
\Atrtm1Bal/\Atrtm2Bal
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:123200
|
\Avptm1b(EUCOMM)Wtsi/\Avp+
(C57BL/6N-Avptm1b(EUCOMM)Wtsi/H)
|
decreased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Avpr1atm1Sbhu/\Avpr1atm1Sbhu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:105892
|
| increased B-1a cell number
|
J:105892
|
\Axltm1Grl/\Axltm1Grl
\Mertktm1Grl/\Mertktm1Grl
\Tyro3tm1Grl/\Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased lymphocyte cell number
|
J:70420
|
\B2mtm1Jae/\B2mtm1Jae
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:80910
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80910,
J:744
|
| increased gamma-delta intraepithelial T cell number
|
J:744
|
| increased gamma-delta T cell number
|
J:744
|
\B2mtm1Jae/\B2mtm1Jae
(involves: 129S2/SvPas)
|
decreased CD8-positive, alpha-beta T cell number
|
J:166104
|
\B2mtm1Jae/\B2mtm1Jae
\Cd4tm1Jrp/\Cd4tm1Jrp
(involves: 129S2/SvPas * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:45168
|
\B2mtm1Jae/\B2mtm1Jae
\Foxp3sf\Otcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
increased CD4-positive, alpha-beta T cell number
|
J:20865
|
| increased plasma cell number
|
J:20865
|
\B2mtm1Jae/\B2mtm1Jae
\Rr94tm3.2Litt/\Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
\B2mtm1Jae/\B2mtm1Jae
\Rr96tm1.1Yzo/\Rr96tm1.1Yzo
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
\B2mtm1Jae/\B2mtm1Jae
\Tg(H2-K-Cd86)27All/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
absent B cells
|
J:112475
|
\B2mtm1Jae/\B2mtm1Jae
\Tg(LckNotch1)9Erob/?
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
increased CD8-positive, alpha-beta T cell number
|
J:93005
|
\B2mtm1Jae/\B2mtm1Jae
\Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:151075
|
\B2mtm1Jae/\B2mtm1Jae
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S6/SvEvTac * 129S2/SvPas)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:131287
|
\B2mtm1Jae/\B2mtm1Jae
\Zbtb7btm1Litt/\Zbtb7btm1.2Litt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
| abnormal double-positive T cell morphology
|
J:141144
|
\B2mtm1Unc/\B2m+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:64451
|
\B2mtm1Unc/\B2mtm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell number
|
J:113083
|
| absent CD8-positive, alpha-beta T cells
|
J:64451
|
\B2mtm1Unc/\B2mtm1Unc
(NOD.129P2-B2mtm1Unc)
|
absent CD8-positive, alpha-beta T cells
|
J:121685
|
\B2mtm1Unc/\B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
|
decreased CD8-positive, alpha-beta T cell number
|
J:123934
|
| increased T-helper 1 cell number
|
J:123934
|
\B2mtm1Unc/\B2mtm1Unc
\Ciitatm1Ccum/\Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum)
|
decreased single-positive T cell number
|
J:107051
|
\B2mtm1Unc/\B2mtm1Unc
\H2-Ab1b-tm1Doi/\H2-Ab1b-tm1Doi
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
absent CD4-positive, alpha-beta T cells
|
J:77098
|
| absent CD8-positive, alpha-beta T cells
|
J:77098
|
\B2mtm1Unc/\B2mtm1Unc
\H2-D1b-tm1Bpe/\H2-D1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:41077
|
\B2mtm1Unc/\B2mtm1Unc
\Il2tm1Hor/\Il2tm1Hor
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:39981
|
| abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:39981
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:51450
|
| abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:39981
|
\B2mtm1Unc/\B2mtm1Unc
\Il2rgtm1.1Asin/\Il2rgtm1Wjl
\Tg(Cd8a*-cre)B8Asin/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\B2mtm1Unc/\B2mtm1Unc
\Il7rtm1.1Asin/\Il7rtm1Imx
\Tg(Cd8a*-cre)B8Asin/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\B2mtm1Unc/\B2mtm1Unc
\Prkdcscid/\Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid)
|
absent lymphocyte
|
J:102141
|
| arrested B cell differentiation
|
J:102141
|
| arrested T cell differentiation
|
J:102141
|
\B2mtm1Unc/\B2mtm1Unc
\Rr381em2Kap/\Rr381em2Kap
(involves: 129P2/OlaHsd * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
\B2mtm1Unc/\B2mtm1Unc
\Tespa1tm1Smoc/\Tespa1tm1Smoc
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:186446
|
\B2mtm1Unc/\B2mtm1Unc
\Tg(GFAP-B2m)9Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)
|
absent CD8-positive, alpha-beta T cells
|
J:135214
|
\B2mtm1Unc/\B2mtm1Unc
\Tg(GFAP-B2m)#Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)
|
absent CD8-positive, alpha-beta T cells
|
J:135214
|
\B2mtm1Unc/\B2mtm1Unc
\Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)
|
decreased CD8-positive, alpha-beta T cell number
|
J:121685
|
\B2mtm1Unc/\B2mtm1Unc
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:93553
|
\B2mtm1Unc/\B2mtm1Unc
\Zbtb7btm4.1Itan/\Zbtb7btm4.1Itan
(involves: 129P2/OlaHsd)
|
increased CD8-positive, alpha-beta T cell number
|
J:193321
|
\B3galt2tm1.1(KOMP)Vlcg/\B3galt2+
(C57BL/6N-B3galt2tm1.1(KOMP)Vlcg/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\B3gnt5tm1Big/\B3gnt5tm1Big
(C57BL/6-B3gnt5tm1Big)
|
decreased B cell number
|
J:166763
|
\B3gnt5tm1Nari/\B3gnt5tm1Nari
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:161366
|
\B3gnt5tm2.1Big/\B3gnt5tm2.1Big
(involves: 129/Sv * C57BL/6 * FVB/N)
|
decreased B cell number
|
J:166763
|
\B3gnt6tm1Lx/\B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J)
|
increased T cell number
|
J:123826
|
\B4galnt2tm1Jbl/\B4galnt2tm1Jbl
(involves: 129S1/Sv)
|
abnormal B cell number
|
J:217719
|
\B4galnt3tm1a(EUCOMM)Wtsi/\B4galnt3tm1a(EUCOMM)Wtsi
(C57BL/6N-B4galnt3tm1a(EUCOMM)Wtsi/Ics)
|
increased CD8-positive, alpha-beta T cell number
|
J:165965
|
\B4galt1tm1Yiw/\B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased lymphocyte cell number
|
J:106669
|
\B4galt3em1Masn/\B4galt3em1Masn
(C57BL/6-B4galt3em1Masn)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:343168
|
| decreased regulatory T cell number
|
J:343168
|
| increased CD8-positive, alpha-beta T cell number
|
J:343168
|
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased regulatory T cell number
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:123547
|
| abnormal T-helper 17 cell differentiation
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
| decreased T-helper 17 cell number
|
J:169839
|
| increased regulatory T cell number
|
J:169839
|
| increased T-helper 1 cell number
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\B9d2+
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased regulatory T cell number
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\B9d2+
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:169839
|
\B9d2/Tgfb1tm1Flv/\B9d2+
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
| decreased T-helper 17 cell number
|
J:169839
|
| increased regulatory T cell number
|
J:169839
|
| increased T-helper 1 cell number
|
J:169839
|
\Babam1em1(IMPC)Ccpcz/\Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
\Bach2M1Btlr/\Bach2M1Btlr
(C57BL/6J-Bach2M1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:272023
|
| increased B-1 B cell number
|
J:272023
|
\Bach2m1Ccg/\Bach2m1Ccg
(C57BL/6-Bach2m1Ccg)
|
decreased B cell number
|
J:94077
|
| decreased marginal zone B cell number
|
J:94077
|
\Bach2m2Anu/\Bach2m2Anu
(C57BL/6NCrlAnu-Bach2m2Anu)
|
decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
\Bach2tm1a(EUCOMM)Wtsi/\Bach2tm1a(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased immature B cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-negative NK T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive gamma-delta T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Bach2tm1b(EUCOMM)Wtsi/\Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased B cell number
|
J:211773
|
| decreased B-1a cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased marginal zone B cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased transitional stage B cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
\Bach2tm1Igar/\Bach2tm1Igar
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:91110
|
| abnormal class switch recombination
|
J:91110
|
| abnormal somatic hypermutation frequency
|
J:91110
|
| absent germinal center B cells
|
J:91110
|
| decreased B cell number
|
J:91110
|
| decreased mature B cell number
|
J:91110
|
\Badtm1Meg/\Badtm1Meg
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:88139
|
| abnormal T cell differentiation
|
J:88139
|
| decreased mature B cell number
|
J:88139
|
| decreased pro-B cell number
|
J:88139
|
\Bag3tm1.1Jhl/\Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased lymphocyte cell number
|
J:144416
|
\Bahd1tm2b(KOMP)Wtsi/\Bahd1+
(C57BL/6N-Bahd1tm2b(KOMP)Wtsi/Ics)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
\Bak1tm1Thsn/\Bak1tm1Thsn
\Baxtm1Sjk/\Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)
|
abnormal B cell morphology
|
J:66872
|
| abnormal T cell morphology
|
J:66872
|
| increased lymphocyte cell number
|
J:66872
|
\Bak1tm1Thsn/\Bak1tm1Thsn
\Baxtm1Sjk/\Baxtm2Sjk
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell number
|
J:100463
|
| decreased marginal zone B cell number
|
J:100463
|
| increased B cell number
|
J:100463
|
| increased B-2 B cell number
|
J:100463
|
| increased follicular B cell number
|
J:100463
|
| increased pre-B cell number
|
J:100463
|
| increased pro-B cell number
|
J:100463
|
| increased transitional stage B cell number
|
J:100463
|
\Bak1tm1Thsn/\Bak1tm1Thsn
\Baxtm1Sjk/\Baxtm2Sjk
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:100463
|
| increased B cell number
|
J:100463
|
| increased lymphocyte cell number
|
J:100463
|
\Bak1tm1Thsn/\Bak1tm1Thsn
\Baxtm2Sjk/\Baxtm2Sjk
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased regulatory T cell number
|
J:208318
|
\Bank1tm1Kuro/\Bank1tm1Kuro
(Not Specified)
|
increased B-1a cell number
|
J:113321
|
| increased mature B cell number
|
J:113321
|
\Batf3tm1Kmm/\Batf3tm1Kmm
(involves: 129S6/SvEvTac * BALB/cJ)
|
decreased memory T cell number
|
J:141064
|
\Batftm1.1Ejt/\Batftm1.1Ejt
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:160935
|
| abnormal T-helper 2 cell differentiation
|
J:160935
|
| absent germinal center B cells
|
J:160935
|
| decreased CD4-positive, alpha-beta T cell number
|
J:160935
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:160935
|
| decreased T follicular helper cell number
|
J:160935
|
| decreased T-helper 17 cell number
|
J:160935
|
\Batftm1.1Kmm/\Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm)
|
abnormal CD4-positive T cell differentiation
|
J:150643
|
\Baxtm1Sjk/\Baxtm1Sjk
(involves: 129X1/SvJ)
|
increased B cell number
|
J:29253
|
| increased thymocyte number
|
J:29253
|
\Bbc3tm1Ast/\Bbc3tm1Ast
(involves: C57BL/6 * NZB)
|
increased CD8-positive, alpha-beta T cell number
|
J:132819
|
\Bbc3tm1Gpz/\Bbc3tm1Gpz
\Trp53tm1Brd/\Trp53tm8Xu
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:170216
|
\Bbs5tm1b(EUCOMM)Wtsi/\Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Bcap31tm1.1Bwang/\Bcap31tm1.1Bwang
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:274469
|
| decreased single-positive T cell number
|
J:274469
|
| decreased thymocyte number
|
J:274469
|
| increased effector memory T-helper cell number
|
J:274469
|
\Bckdhaem1(IMPC)Tcp/\Bckdha+
(C57BL/6NCrl-Bckdhaem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Bcl2tm1Dlo/\Bcl2tm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:73660
|
| decreased CD8-positive, alpha-beta T cell number
|
J:73660
|
| decreased lymphocyte cell number
|
J:73660
|
| decreased mature B cell number
|
J:73660
|
| decreased pre-B cell number
|
J:73660
|
| decreased thymocyte number
|
J:73660
|
\Bcl2tm1Lbox/\Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell differentiation
|
J:114637
|
| decreased B cell number
|
J:114637
|
| decreased immature B cell number
|
J:114637
|
| decreased mature B cell number
|
J:114637
|
| decreased pre-B cell number
|
J:114637
|
\Bcl2tm1Sjk/\Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:15224
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:15224
|
| decreased B cell number
|
J:15224
|
| decreased double-positive T cell number
|
J:15224
|
| decreased lymphocyte cell number
|
J:15224
|
| decreased T cell number
|
J:15224
|
| increased double-negative T cell number
|
J:15224
|
\Bcl2tm1Tsu/\Bcl2tm1Tsu
(involves: 129P2/OlaHsd * ICR)
|
abnormal lymphocyte morphology
|
J:22391
|
\Bcl2tm2.1Lbox/\Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell number
|
J:175730
|
| increased immature B cell number
|
J:175730
|
| increased mature B cell number
|
J:175730
|
| increased pre-B cell number
|
J:175730
|
\Bcl2tm2.1Lbox/\Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell number
|
J:175730
|
| increased immature B cell number
|
J:175730
|
| increased mature B cell number
|
J:175730
|
| increased pre-B cell number
|
J:175730
|
\Bcl2a1atm1.1Tac/\Bcl2a1atm1.1Tac
\Bcl2a1btm1.1Tac/\Bcl2a1btm1.1Tac
\Bcl2a1dtm1.1Tac/\Bcl2a1dtm1.1Tac
(involves: BALB/cJ * C57BL/6NTac)
|
decreased CD4-positive, alpha-beta memory T cell number
|
J:258915
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:258915
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:258915
|
| decreased gamma-delta T cell number
|
J:258915
|
| decreased regulatory T cell number
|
J:258915
|
\Bcl2l1tm1Cant/\Bcl2l1tm1Cant
(involves: 129S6/SvEvTac)
|
decreased memory T cell number
|
J:77507
|
\Bcl2l1tm1Ywh/\Bcl2l1tm1Ywh
\Mcl1tm1Ywh/\Mcl1tm1Ywh
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
absent CD4-positive, alpha-beta T cells
|
J:137400
|
| absent CD8-positive, alpha-beta T cells
|
J:137400
|
| decreased double-positive T cell number
|
J:137400
|
\Bcl2l1tm1Ywh/\Bcl2l1tm1Ywh
\Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:99012
|
| decreased thymocyte number
|
J:99012
|
\Bcl2l11em1(IMPC)H/\Bcl2l11em1(IMPC)H
(C57BL/6NTac-Bcl2l11em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Bcl2l11tm1.1Ast/\Bcl2l11+
\Ptentm1Hwu/\Pten+
\Tg(CD2-icre)4Kio/0
(involves: 129S1/Sv * 129S4/SvJae * C57BL/10 * CBA/Ca)
|
abnormal T cell number
|
J:133215
|
| increased germinal center B cell number
|
J:133215
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
abnormal plasma cell morphology
|
J:58641
|
| decreased double-positive T cell number
|
J:58641
|
| increased B cell number
|
J:58641
|
| increased CD4-positive, alpha-beta T cell number
|
J:58641
|
| increased CD8-positive, alpha-beta T cell number
|
J:58641
|
| increased double-negative T cell number
|
J:58641
|
| increased follicular B cell number
|
J:132217
|
| increased immature B cell number
|
J:132217
|
| increased marginal zone B cell number
|
J:132217
|
| increased T cell number
|
J:58641
|
| increased transitional stage B cell number
|
J:132217
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
abnormal B cell morphology
|
J:133084
|
| abnormal NK cell morphology
|
J:123409
|
| increased immature B cell number
|
J:133084
|
| increased mature B cell number
|
J:133084
|
| increased NK cell number
|
J:123409
|
| increased regulatory T cell number
|
J:208318
|
| increased transitional stage B cell number
|
J:133084
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(B6.129-Bcl2l11tm1.1Ast/J)
|
decreased lymphocyte cell number
|
J:137609
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(involves: 129S1/Sv)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:132819
|
| increased B cell number
|
J:132819
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast/J)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Biktm1Ast/\Biktm1Ast
(B6.Cg-Bcl2l11tm1.1Ast Biktm1Ast)
|
abnormal B cell differentiation
|
J:103605
|
| abnormal T cell differentiation
|
J:103605
|
| decreased immature B cell number
|
J:103605
|
| decreased pre-B cell number
|
J:103605
|
| decreased pro-B cell number
|
J:103605
|
| increased B cell number
|
J:103605
|
| increased mature B cell number
|
J:103605
|
| increased T cell number
|
J:103605
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bmftm1Rjd/\Bmftm1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
| increased thymocyte number
|
J:153652
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bmftm2.1Rjd/\Bmftm2.1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm2.1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bnip3lGt(XT0573)Wtsi/\Bnip3lGt(XT0573)Wtsi
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:137609
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S1/Sv * BALB/c)
|
decreased B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Faslpr/\Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
|
abnormal effector T cell morphology
|
J:132217
|
| abnormal T cell number
|
J:132217
|
| abnormal T cell subpopulation ratio
|
J:132217
|
| decreased B cell number
|
J:132217
|
| increased follicular B cell number
|
J:132217
|
| increased immature B cell number
|
J:132217
|
| increased marginal zone B cell number
|
J:132217
|
| increased memory T cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased NK T cell number
|
J:203157
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Pmaip1tm1Ast/\Pmaip1tm1Ast
(involves: 129S1/Sv * C57BL/6)
|
abnormal NK cell morphology
|
J:123409
|
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Zbtb1m1Btlr/\Zbtb1m1Btlr
(involves: 129S1/Sv * C3H/HeN * C57BL/6 * C57BL/6J)
|
absent T cells
|
J:178820
|
\Bcl2l11tm1Ast/\Bcl2l11tm1Ast
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Aicdatm1(cre)Njen/\Aicda+
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:181782
|
| decreased germinal center B cell number
|
J:181782
|
| decreased plasma cell number
|
J:181782
|
\Bcl2l11tm1Sjk/\Bcl2l11tm1Sjk
(involves: 129X1/SvJ)
|
increased B cell number
|
J:100463
|
| increased B-2 B cell number
|
J:100463
|
| increased follicular B cell number
|
J:100463
|
| increased transitional stage B cell number
|
J:100463
|
\Bcl2l11tm3Rjd/\Bcl2l11tm3Rjd
(B6.129S6-Bcl2l11tm3Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
\Bcl2l11tm3Rjd/\Bcl2l11tm3Rjd
\Bmftm3.1Rjd/\Bmftm3.1Rjd
(B6.129S6-Bcl2l11tm3Rjd Bmftm3.1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD4-positive, alpha-beta T cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
\Bcl2l11tm6.1Boui/\Bcl2l11tm6.1Boui
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased regulatory T cell number
|
J:208318
|
\Bcl3m1Btlr/\Bcl3+
(C57BL/6J-Bcl3m1Btlr)
|
decreased B cell number
|
J:255184
|
| decreased B-1b cell number
|
J:255184
|
| increased CD8-positive, alpha-beta T cell number
|
J:255184
|
\Bcl3m1Btlr/\Bcl3m1Btlr
(C57BL/6J-Bcl3m1Btlr)
|
decreased B cell number
|
J:255184
|
| decreased B-1b cell number
|
J:255184
|
| increased B-1 B cell number
|
J:255184
|
| increased CD8-positive, alpha-beta T cell number
|
J:255184
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:255184
|
\Bcl3m2Btlr/\Bcl3m2Btlr
(C57BL/6J-Bcl3m2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:264818
|
| increased B-1 B cell number
|
J:264818
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:264818
|
\Bcl3m3Btlr/\Bcl3m3Btlr
(C57BL/6J-Bcl3m3Btlr)
|
decreased central memory CD8 positive, alpha-beta T cell number
|
J:274858
|
\Bcl3tm1Rie/\Bcl3tm1Rie
(involves: 129)
|
decreased B cell number
|
J:77049
|
\Bcl3tm1Sbn/\Bcl3tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:39747
|
| abnormal class switch recombination
|
J:39747
|
| abnormal lymphocyte morphology
|
J:39747
|
| decreased B cell number
|
J:39747
|
\Bcl3tm1Sbn/\Bcl3tm1Sbn
(involves: 129S4/SvJae)
|
decreased follicular B cell number
|
J:207111
|
| decreased transitional stage T1 B cell number
|
J:207111
|
| decreased transitional stage T2 B cell number
|
J:207111
|
| increased marginal zone B cell number
|
J:207111
|
\Bcl6tm1.1Dent/\Bcl6tm1.1Dent
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T follicular helper cell differentiation
|
J:202372
|
| decreased germinal center B cell number
|
J:202372
|
| decreased T follicular helper cell number
|
J:202372
|
\Bcl6tm1.1Jwan/\Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac)
|
abnormal somatic hypermutation frequency
|
J:190534
|
\Bcl6tm1.1Meln/\Bcl6tm1.1Meln
(involves: 129 * C57BL/6 * FVB/N)
|
decreased T follicular helper cell number
|
J:194821
|
\Bcl6tm1.1Mtto/\Bcl6tm1.1Mtto
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6 * C57BL/6JJcl)
|
abnormal memory B cell morphology
|
J:190943
|
| abnormal somatic hypermutation frequency
|
J:190943
|
| decreased germinal center B cell number
|
J:190943
|
\Bcl6tm1.1Mtto/\Bcl6tm1.1Mtto
\Cd79atm1(cre)Reth/\Cd79a+
\Tg(Cd4-cre)1Cwi/0
(involves: BALB/c * C57BL/6 * C57BL/6JJcl * DBA/2)
|
decreased germinal center B cell number
|
J:190943
|
\Bcl6tm1.1Mtto/\Bcl6tm1.1Mtto
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JJcl)
|
decreased germinal center B cell number
|
J:190943
|
\Bcl6tm1.1Mtto/\Bcl6tm1.1Mtto
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2)
|
abnormal somatic hypermutation frequency
|
J:190943
|
| absent germinal center B cells
|
J:190943
|
| decreased germinal center B cell number
|
J:190943
|
| decreased T follicular helper cell number
|
J:190943
|
\Bcl6tm1.1Toka/\Bcl6tm1.1Toka
(involves: C57BL/6 * NZB)
|
decreased germinal center B cell number
|
J:174014
|
| decreased T follicular helper cell number
|
J:174014
|
\Bcl6btm1Dtf/\Bcl6btm1Dtf
(involves: 129P2/OlaHsd)
|
decreased memory T cell number
|
J:99818
|
\Bcl6btm1Tto/\Bcl6btm1Tto
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93656
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:93656
|
\Bcl6btm2Dent/\Bcl6btm2Dent
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
decreased lymphocyte cell number
|
J:123621
|
\Bcl10m1Btlr/\Bcl10m1Btlr
(C57BL/6J-Bcl10m1Btlr)
|
decreased B-1 B cell number
|
J:265122
|
| increased CD4-positive, alpha-beta T cell number
|
J:265122
|
| increased single-positive T cell number
|
J:265122
|
| increased T cell number
|
J:265122
|
\Bcl10tm1Mak/\Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:67297
|
| decreased activated T cell number
|
J:67297
|
| decreased double-positive T cell number
|
J:67297
|
| decreased thymocyte number
|
J:67297
|
| increased double-negative T cell number
|
J:67297
|
\Bcl10tm1Swm/\Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:85147
|
| decreased B cell number
|
J:85147
|
| decreased B-1 B cell number
|
J:85147
|
| decreased follicular B cell number
|
J:85147
|
| decreased marginal zone B cell number
|
J:85147
|
| decreased mature B cell number
|
J:85147
|
\Bcl11atm1Ngc/\Bcl11a+
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
| decreased DN2 thymocyte number
|
J:194616
|
| decreased lymphocyte cell number
|
J:207383
|
\Bcl11atm1Ngc/\Bcl11atm1Ngc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:83646
|
| absent B cells
|
J:207383,
J:83646
|
| absent CD4-positive, alpha-beta T cells
|
J:83646
|
| absent lymphocyte
|
J:207383
|
| decreased T cell number
|
J:83646
|
| increased CD8-positive, alpha-beta T cell number
|
J:83646
|
| increased double-negative T cell number
|
J:83646
|
| increased gamma-delta T cell number
|
J:83646
|
\Bcl11atm1Pwt/\Bcl11atm1Pwt
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:207383
|
\Bcl11atm1Pwt/\Bcl11atm1Pwt
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased B cell number
|
J:207383
|
\Bcl11atm2.1Peli/\Bcl11atm2.1Peli
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
| decreased B cell number
|
J:194616
|
| decreased DN2 thymocyte number
|
J:194616
|
| decreased immature B cell number
|
J:194616
|
| decreased pre-B cell number
|
J:194616
|
| decreased pro-B cell number
|
J:194616
|
\Bcl11btm1.2Leid/\Bcl11btm1.2Leid
(involves: C57BL/6 * SJL)
|
absent T cells
|
J:147182
|
\Bcl11btm1Avram/\Bcl11btm1Avram
\Tcratm1Mom/\Tcratm1Mom
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
\Bcl11btm1Avram/\Bcl11btm1Avram
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:128515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:128515
|
| decreased double-negative T cell number
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
| increased B cell number
|
J:128515
|
| increased gamma-delta T cell number
|
J:128515
|
| increased NK cell number
|
J:128515
|
\Bcl11btm1Avram/\Bcl11btm1Avram
\Tg(Cd4-cre)1Cwi/?
\Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:128515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
\Bcl11btm1Jpk/\Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:83651
|
| abnormal T cell morphology
|
J:83651
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:83651
|
| decreased double-positive T cell number
|
J:83651
|
| increased CD8-positive, alpha-beta T cell number
|
J:83651
|
| increased double-negative T cell number
|
J:83651
|
\Bcl11btm1Peli/\Bcl11btm1Peli
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)
|
abnormal NK cell differentiation
|
J:161373
|
\Bcl11btm2.1Jpk/\Bcl11b+
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
abnormal T cell number
|
J:210122
|
| decreased CD4-positive, alpha-beta T cell number
|
J:210122
|
| decreased CD8-positive, alpha-beta T cell number
|
J:210122
|
| decreased double-positive T cell number
|
J:210122
|
| decreased thymocyte number
|
J:210122
|
| increased double-negative T cell number
|
J:210122
|
\Bclaf1tm1Raz/\Bclaf1tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:158087
|
| increased B cell number
|
J:158087
|
\Bcrtm1(BCR/ABL)Tsr/\Bcr+
\Runx1tm3Dow/\Runx1+
\Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:203111
|
\Bdp1em1(IMPC)Tcp/\Bdp1+
(C57BL/6N-Bdp1em1(IMPC)Tcp/Cmmr)
|
increased lymphocyte cell number
|
J:211773
|
\Bean1em1(IMPC)H/\Bean1em1(IMPC)H
(C57BL/6N-Bean1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Becn1tm1.1Bflu/\Becn1tm1.1Bflu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203090
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203090
|
\Becn1tm1Ebr/\Becn1tm1Ebr
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd)
|
increased lymphocyte cell number
|
J:235399
|
\Bhlhe40tm1Tan/\Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal CD4-positive T cell differentiation
|
J:72651
|
| decreased double-positive T cell number
|
J:72651
|
| increased CD4-positive, alpha-beta T cell number
|
J:72651
|
| increased CD8-positive, alpha-beta T cell number
|
J:72651
|
| increased double-negative T cell number
|
J:72651
|
\Bhlhe41tm1.2Cdon/\Bhlhe41tm1.2Cdon
(B6.129S6-Bhlhe41tm1.2Cdon)
|
abnormal lymphocyte cell number
|
J:157740
|
| abnormal T-helper 2 cell differentiation
|
J:157740
|
\Birc2tm1Jda/\Birc2tm1Jda
(B6.129P2-Birc2tm1Jda)
|
decreased lymphocyte cell number
|
J:97656
|
\Birc2tm1Rbr/\Birc2tm1Rbr
\Birc3tm1.1Rbr/\Birc3tm1.1Rbr
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
decreased germinal center B cell number
|
J:172843
|
| increased B cell number
|
J:172843
|
| increased follicular B cell number
|
J:172843
|
| increased marginal zone B cell number
|
J:172843
|
\Birc3tm1Jda/\Birc3tm1Jda
(B6.Cg-Birc3tm1Jda)
|
abnormal lymphocyte cell number
|
J:166899
|
| decreased follicular B cell number
|
J:166899
|
| decreased immature B cell number
|
J:166899
|
| increased B cell number
|
J:166899
|
| increased marginal zone B cell number
|
J:166899
|
| increased T cell number
|
J:166899
|
\Birc5tm1Mak/\Birc5tm1Mak
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd)
|
abnormal T cell morphology
|
J:90892
|
| decreased double-negative T cell number
|
J:90892
|
| decreased thymocyte number
|
J:90892
|
\Birc5tm1Wnt/\Birc5tm1Emc
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:87435
|
\Birc5tm1Wnt/\Birc5tm1Emc
\Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:87435
|
| decreased T cell number
|
J:87435
|
| increased double-negative T cell number
|
J:87435
|
\Blktm1Tara/\Blktm1Tara
\Fyntm1Sor/\Fyntm1Sor
\Lyntm1Ard/\Lyntm1Ard
(either: B6.129-Lyntm1Ard Fyntm1Sor Blktm1Tara or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6))
|
abnormal B cell differentiation
|
J:115080
|
| abnormal pro-B cell differentiation
|
J:115080
|
| arrested B cell differentiation
|
J:115080
|
| decreased B cell number
|
J:115080
|
| decreased immature B cell number
|
J:115080
|
| decreased pre-B cell number
|
J:115080
|
\Blmtm4Ches/\Blmtm4Ches
\Cd19tm1(cre)Cgn/\Cd19+
\Nsmce2tm2.1Ofc/\Nsmce2tm2.1Ofc
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal B cell morphology
|
J:227197
|
| decreased B cell number
|
J:227197
|
\Blmtm4Ches/\Blmtm4Ches
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:194603
|
\Blnkem1(IMPC)H/\Blnkem1(IMPC)H
(C57BL/6N-Blnkem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Blnkm1Btlr/\Blnkm1Btlr
(C57BL/6J-Blnkm1Btlr)
|
arrested B cell differentiation
|
J:159439
|
| decreased mature B cell number
|
J:159439
|
| increased CD4-positive, alpha-beta T cell number
|
J:159439
|
| increased CD8-positive, alpha-beta T cell number
|
J:159439
|
\Blnkm1Btlr/\Blnkm1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
\Blnktm1Achn/\Blnktm1Achn
(involves: 129X1/SvJ)
|
abnormal B cell differentiation
|
J:58805
|
| abnormal mature B cell morphology
|
J:58805
|
| absent B-1b cells
|
J:58805
|
| arrested B cell differentiation
|
J:58805
|
| decreased B-1a cell number
|
J:58805
|
| decreased mature B cell number
|
J:58805
|
| increased pro-B cell number
|
J:58805
|
\Blnktm1Dkit/\Blnktm1Dkit
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:84040
|
| abnormal immature B cell morphology
|
J:94297
|
| abnormal plasma cell differentiation
|
J:143854
|
| abnormal pre-B cell morphology
|
J:84040
|
| arrested B cell differentiation
|
J:143854
|
| decreased follicular B cell number
|
J:143854
|
| decreased immature B cell number
|
J:84040
|
| decreased marginal zone B cell number
|
J:143854
|
| decreased mature B cell number
|
J:84040
|
| decreased transitional stage B cell number
|
J:143854
|
\Blnktm1Dkit/\Blnktm1Dkit
\Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal pre-B cell morphology
|
J:84040
|
| absent immature B cells
|
J:84040
|
| absent mature B cells
|
J:84040
|
| arrested B cell differentiation
|
J:84040
|
| decreased pre-B cell number
|
J:84040
|
\Blnktm1Dkit/\Blnktm1Dkit
\Igh-Jtm1(3H9-VDJ)Mwg/\Igh-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
\Blnktm1Dkit/\Blnktm1Dkit
\Igh-Jtm1(3H9-VDJ)Mwg/\Igh-J+
\Igk-Jtm1Mwg/\Igk-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
\Blnktm1Dkit/\Blnktm1Dkit
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal plasma cell differentiation
|
J:143854
|
| arrested B cell differentiation
|
J:143854
|
| decreased B-1 B cell number
|
J:143854
|
| decreased B-2 B cell number
|
J:143854
|
| decreased follicular B cell number
|
J:143854
|
| decreased marginal zone B cell number
|
J:143854
|
\Blnktm1Kplm/\Blnktm1Kplm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:61130,
J:131161
|
| absent B-1a cells
|
J:61130
|
| decreased B cell number
|
J:61130,
J:131161
|
| decreased immature B cell number
|
J:61130
|
| decreased mature B cell number
|
J:61130
|
| decreased pre-B cell number
|
J:61130,
J:120460
|
| increased pro-B cell number
|
J:61130,
J:131161
|
\Blnktm1Kplm/\Blnktm1Kplm
\Ightm4Cgn/\Igh+
\Igktm1Rsky/\Igk+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:120460
|
| decreased B cell number
|
J:120460
|
| increased pre-B cell number
|
J:120460
|
| increased transitional stage B cell number
|
J:120460
|
\Blnktm1Kplm/\Blnktm1Kplm
\Plcg2tm1.1Kuro/\Plcg2+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:131161
|
\Blnktm1Kplm/\Blnktm1Kplm
\Plcg2tm1.1Kuro/\Plcg2tm1.1Kuro
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:131161
|
\Blnktm1Pjln/\Blnktm1Pjln
(involves: BALB/c)
|
abnormal pre-B cell morphology
|
J:58740
|
| arrested B cell differentiation
|
J:58740
|
| decreased mature B cell number
|
J:58740
|
| increased mature B cell number
|
J:157575
|
| increased pre-B cell number
|
J:58740,
J:80332
|
\Blnktm1Pjln/\Blnktm1Pjln
\Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:94768
|
| decreased immature B cell number
|
J:94768
|
| decreased mature B cell number
|
J:94768
|
\Blnktm1Pjln/\Blnktm1Pjln
\Btktm1Gsv/Y
\Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB)
|
abnormal B cell differentiation
|
J:94768
|
\Blnktm1Pjln/\Blnktm1Pjln
\Btktm1Wk/\Btktm1Wk
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:70406
|
\Bmal1tm1Bra/\Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
decreased lymphocyte cell number
|
J:110697
|
| increased lymphocyte cell number
|
J:191844
|
\Bmal1tm1Bra/\Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:118522
|
| abnormal T cell subpopulation ratio
|
J:118522
|
| decreased B cell number
|
J:135933,
J:118522
|
| decreased follicular B cell number
|
J:118522
|
| decreased lymphocyte cell number
|
J:135933,
J:118522
|
| decreased transitional stage B cell number
|
J:118522
|
\Bmftm1.1Ast/\Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst)
|
abnormal B cell morphology
|
J:133084
|
| increased follicular B cell number
|
J:133084
|
| increased immature B cell number
|
J:133084
|
| increased mature B cell number
|
J:133084
|
| increased pre-B cell number
|
J:133084
|
| increased transitional stage B cell number
|
J:133084
|
\Bmftm1Rjd/\Bmftm1Rjd
(B6.129S6-Bmftm1Rjd)
|
increased B cell number
|
J:153652
|
| increased CD8-positive, alpha-beta T cell number
|
J:153652
|
\Bmftm3.1Rjd/\Bmftm3.1Rjd
(B6.129S6-Bmftm3.1Rjd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:153652
|
\Bmi1tm1Brn/\Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
abnormal double-negative T cell morphology
|
J:17712
|
| decreased immature B cell number
|
J:17712
|
| decreased mature B cell number
|
J:17712
|
| decreased thymocyte number
|
J:17712
|
\Bmi1tm1Brn/\Bmi1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:134271
|
\Bmi1tm1Brn/\Bmi1tm1Brn
\E2f6tm1Lees/\E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:134271
|
\Bmi1tm1Sgon/\Bmi1tm1Sgon
\Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:221849
|
| decreased T cell number
|
J:221849
|
\Bmi1tm1Sgon/\Bmi1tm1Sgon
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/?
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased lymphocyte cell number
|
J:221849
|
\Bnc1em1(IMPC)H/\Bnc1em1(IMPC)H
(C57BL/6NTac-Bnc1em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
\Bod1lem1Bltn/\Bod1lem1Bltn
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:337726
|
\Bomb1NSF/N/\Bomb1NSF/N
(involves: NFS/N * SL/Kh)
|
increased pre-B cell number
|
J:55364
|
\Bomb1SL/Kh/\Bomb1SL/Kh
(involves: NFS/N * SL/Kh)
|
increased pre-B cell number
|
J:55364
|
\Bpitm1.1Buls/\Bpitm1.1Buls
(involves: BALB/cJ * C57BL/6J)
|
increased T cell number
|
J:346703
|
\Braftm1Bbd/\Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased thymocyte number
|
J:170095
|
\Braftm1Bbd/\Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
decreased thymocyte number
|
J:170095
|
\Braftm1Bbd/\Braf+
(B6.129-Braftm1Bbd)
|
decreased thymocyte number
|
J:170095
|
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Shld1em1Nus/\Shld1em1Nus
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:307190
|
\Brca1tm2Mak/\Brca1tm2Mak
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:63282
|
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell number
|
J:63282
|
| decreased double-positive T cell number
|
J:63282
|
| decreased single-positive T cell number
|
J:63282
|
| decreased thymocyte number
|
J:63282
|
| increased double-negative T cell number
|
J:63282
|
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
\Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell number
|
J:63282
|
| decreased double-positive T cell number
|
J:63282
|
| decreased thymocyte number
|
J:63282
|
| increased double-negative T cell number
|
J:63282
|
\Brca2tm1Mak/\Brca2tm2Mak
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased activated T cell number
|
J:79697
|
\Brd2em1(IMPC)Wtsi/\Brd2+
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
\Brpf1tm1a(EUCOMM)Wtsi/\Brpf1+
(Not Specified)
|
decreased T cell number
|
J:165965
|
\Bscl2tm1b(EUCOMM)Hmgu/\Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
increased large unstained cell number
|
J:211773
|
\Bsgtm1.1Znc/\Bsgtm1.1Znc
\Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased double-positive T cell number
|
J:207886
|
| decreased single-positive T cell number
|
J:207886
|
| decreased thymocyte number
|
J:207886
|
\Bsgtm1Tmu/\Bsgtm1Tmu
(involves: 129S2/SvPas)
|
increased T-helper 17 cell number
|
J:287636
|
\Bst1tm1Thir/\Bst1tm1Thir
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:111424
|
| decreased immature B cell number
|
J:111424
|
| increased B cell number
|
J:111424
|
\Btbd1tm1a(KOMP)Wtsi/\Btbd1tm1a(KOMP)Wtsi
(C57BL/6N-Btbd1tm1a(KOMP)Wtsi/Wtsi)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Btbd3tm1b(EUCOMM)Hmgu/\Btbd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Btbd3tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased CD8-positive, CD25-positive alpha-beta T cell number
|
J:211773
|
\Btf3em1(IMPC)Tcp/\Btf3+
(C57BL/6NCrl-Btf3em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Btg1em1(IMPC)Mbp/\Btg1em1(IMPC)Mbp
(C57BL/6NCrl-Btg1em1(IMPC)Mbp/Mmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Btkm1Anu/\Btkm1Anu
(involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)
|
decreased B cell number
|
J:104190
|
\Btkm1Anu/\Btkm1Anu
X/\Yaa
(involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)
|
decreased B cell number
|
J:104190
|
\Btkm2Anu/\Btkm2Anu
(C57BL/6NCrlAnu-Btkm2Anu)
|
increased immature B cell number
|
J:104190
|
\Btktm1a(EUCOMM)Hmgu/Y
(C57BL/6N-Btktm1a(EUCOMM)Hmgu/Ics)
|
increased CD4-positive, alpha-beta T cell number
|
J:165965
|
\Btktm1Gsv/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:35769
|
| absent B-1a cells
|
J:35769
|
| absent mature B cells
|
J:35769
|
| decreased B cell number
|
J:35769
|
| decreased immature B cell number
|
J:35769
|
\Btktm1Gsv/Y
\Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal lymphocyte cell number
|
J:120989
|
| abnormal pre-B cell morphology
|
J:120989
|
| absent B-1a cells
|
J:120989
|
| decreased B cell number
|
J:120989
|
\Btktm1Gsv/\Btk+
(involves: 129P2/OlaHsd * C57BL/6)
|
absent B-1a cells
|
J:35769
|
| decreased B cell number
|
J:35769
|
| decreased mature B cell number
|
J:35769
|
\Btktm1Wk/\Btktm1Wk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:28968
|
| decreased mature B cell number
|
J:28968,
J:82298
|
| increased pro-B cell number
|
J:28968
|
\Btktm1Wk/\Btktm1Wk
\Cd40tm1Geha/\Cd40tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:82298
|
| decreased mature B cell number
|
J:82298
|
\Btktm1Wk/\Btktm1Wk
\Tectm1Welm/\Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:66080
|
| decreased B cell number
|
J:66080
|
| increased pre-B cell number
|
J:66080
|
\Btkvila/\Btkvila
(C57BL/6JAnu-Btkvila/AnuApb)
|
decreased B cell number
|
J:104190
|
\Btkxid/Y
(CBA/HN-Btkxid)
|
decreased B cell number
|
J:81429
|
\Btkxid/Y
(involves: CBA/HN * DBA/2N)
|
decreased B cell number
|
J:81429
|
\Btkxid/?
(involves: BALB/c * CBA/N)
|
decreased B-1 B cell number
|
J:108696
|
| decreased mature B cell number
|
J:108696
|
\Btkxid/Y
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * CBA/CaHN)
|
decreased follicular B cell number
|
J:69477
|
\Btkxid/?
\Tg(IGH-Btk)1Witt/0
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B-1 B cell number
|
J:108696
|
\Btkxid/?
\Tg(IGH-Btk)1Witt/\Tg(IGH-Btk)1Witt
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B-1 B cell number
|
J:108696
|
\Btkxid/\Btkxid
(CBA/CaHN-Btkxid/J)
|
decreased follicular B cell number
|
J:69477
|
\Btkxid/\Btkxid
(involves: CBA/HN * DBA/2N)
|
decreased B cell number
|
J:81429
|
\Btkxid/\Btkxid
(CBA/HN-Btkxid)
|
abnormal lymphopoiesis
|
J:7981
|
| abnormal pre-B cell morphology
|
J:7981
|
| decreased B cell number
|
J:81429
|
\Btkxid/\Btkxid
(B6.CBA-Btkxid)
|
decreased transitional stage B cell number
|
J:145687
|
\Btkxid/\Btkxid
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * CBA/CaHN)
|
decreased follicular B cell number
|
J:69477
|
\Btnl1em1Ahay/\Btnl1em1Ahay
(Not Specified)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:236526
|
| decreased gamma-delta intraepithelial T cell number
|
J:236526
|
\Btnl1tm1(KOMP)Mbp/\Btnl1tm1(KOMP)Mbp
(C57BL/6N-Btnl1tm1(KOMP)Mbp)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:236526
|
| decreased gamma-delta intraepithelial T cell number
|
J:236526
|
\Btnl1tm1(KOMP)Mbp/\Btnl1tm1(KOMP)Mbp
\Foxn1nu/\Foxn1nu
(involves: albino stock * C57BL/6N)
|
decreased gamma-delta intraepithelial T cell number
|
J:236526
|
\Btnl1tm1(KOMP)Mbp/\Btnl1tm1(KOMP)Mbp
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/0
\Tg(tetO-Btnl1)#Ahay/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N)
|
decreased gamma-delta intraepithelial T cell number
|
J:236526
|
\Btnl1tm1(KOMP)Mbp/\Btnl1tm1(KOMP)Mbp
\Tg(tetO-Btnl1)#Ahay/0
\Tg(Vil-rtTA2*M2)1Rsmi/0
(involves: C57BL/6N * FVB/N)
|
decreased gamma-delta intraepithelial T cell number
|
J:236526
|
\Btnl2em1Wche/\Btnl2em1Wche
(C57BL/6-Btnl2em1Wche)
|
abnormal gamma-delta T cell morphology
|
J:321348
|
\Btnl6em1.1Ahay/\Btnl6em1.1Ahay
(Not Specified)
|
decreased CD4-positive, gamma-delta intraepithelial T cell number
|
J:291989
|
\Btnl6em1Ahay/\Btnl6em1Ahay
\Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, gamma-delta intraepithelial T cell number
|
J:291989
|
\Btrctm1Kin/\Btrctm1Kin
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:84639
|
\Bud13em1(IMPC)Ccpcz/\Bud13+
(C57BL/6NCrl-Bud13em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\C1ql3em1(IMPC)H/\C1ql3em1(IMPC)H
(C57BL/6NTac-C1ql3em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\C1ql4tm1Lex/\C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex)
|
decreased lymphocyte cell number
|
J:344722
|
\C1qtnf6tm1Yiw/\C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
|
increased B cell number
|
J:227217
|
\C2cd3em1(IMPC)Tcp/\C2cd3+
(C57BL/6N-C2cd3em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\C3ar1tm1Raw/\C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
abnormal T-helper 2 cell differentiation
|
J:80071
|
| decreased lymphocyte cell number
|
J:80071
|
\C8atm1b(EUCOMM)Hmgu/\C8atm1b(EUCOMM)Hmgu
(C57BL/6N-C8atm1b(EUCOMM)Hmgu/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\C9orf72tm1.1Eggn/\C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
abnormal lymphocyte morphology
|
J:240357
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:240357
|
\C9orf72tm1Eggn/\C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
|
abnormal lymphocyte morphology
|
J:240357
|
\C9orf72tm1Lagi/\C9orf72tm1Lagi
(involves: C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:232242
|
\Cab39em1(IMPC)Tcp/\Cab39+
(C57BL/6NCrl-Cab39em1(IMPC)Tcp/Cmmr)
|
decreased lymphocyte cell number
|
J:211773
|
\Cabp1tm1b(EUCOMM)Wtsi/\Cabp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cabp1tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Cacnb4lh/\Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
decreased double-positive T cell number
|
J:115345
|
| decreased lymphocyte cell number
|
J:5281
|
\CacybpGT(OST39970)Lex/\CacybpGT(OST39970)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell morphology
|
J:110899
|
| decreased thymocyte number
|
J:110899
|
\Cadm1Gt(Ayu21-W34)Imeg/\Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj)
|
abnormal T cell differentiation
|
J:178612
|
| abnormal T cell receptor V(D)J recombination
|
J:178612
|
| decreased CD4-positive, alpha-beta T cell number
|
J:178612
|
| decreased CD8-positive, alpha-beta T cell number
|
J:178612
|
| increased double-positive T cell number
|
J:178612
|
\Calcrltm1Kmca/\Calcrltm1Kmca
(involves: 129S6/SvEvTac)
|
decreased uterine NK cell number
|
J:201446
|
\Camltm1Rjb/\Camltm2Rjb
\Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased single-positive T cell number
|
J:100536
|
| decreased thymocyte number
|
J:100536
|
\Camltm1Rjb/\Camltm2Rjb
\Tg(Lck-cre)1Cwi/0
\Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:100536
|
| abnormal positive T cell selection
|
J:100536
|
| decreased thymocyte number
|
J:100536
|
\Camsap3tm1a(EUCOMM)Wtsi/\Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased gamma-delta T cell number
|
J:211773
|
\Capza1em1(IMPC)Tcp/\Capza1em1(IMPC)Tcp
(C57BL/6NCrl-Capza1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Car6em1(IMPC)Ccpcz/\Car6em1(IMPC)Ccpcz
(C57BL/6NCrl-Car6em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
\Car9tm1Lex/\Car9tm1Lex
(B6;129S5-Car9tm1Lex/Mmucd)
|
increased mature B cell number
|
J:171883
|
\Card11em1(IMPC)Ccpcz/\Card11em1(IMPC)Ccpcz
(C57BL/6NCrl-Card11em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Card11em1Welu/\Card11+
(involves: C57BL/6)
|
decreased marginal zone B cell number
|
J:292926
|
| decreased transitional stage T1 B cell number
|
J:292926
|
| decreased transitional stage T3 B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
\Card11em1Welu/\Card11em1Welu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:292926
|
| abnormal germinal center B cell morphology
|
J:292926
|
| abnormal plasma cell differentiation
|
J:292926
|
| decreased B-1 B cell number
|
J:292926
|
| decreased B-1a cell number
|
J:292926
|
| decreased germinal center B cell number
|
J:292926
|
| decreased marginal zone B cell number
|
J:292926
|
| decreased pre-B cell number
|
J:292926
|
| decreased transitional stage T1 B cell number
|
J:292926
|
| decreased transitional stage T3 B cell number
|
J:292926
|
| increased follicular B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
\Card11em2Welu/\Card11+
(involves: C57BL/6)
|
increased B-1 B cell number
|
J:292926
|
| increased marginal zone B cell number
|
J:292926
|
\Card11em2Welu/\Card11em2Welu
(involves: C57BL/6)
|
abnormal plasma cell differentiation
|
J:292926
|
| decreased mature B cell number
|
J:292926
|
| increased B-1a cell number
|
J:292926
|
| increased B-1b cell number
|
J:292926
|
| increased germinal center B cell number
|
J:292926
|
| increased marginal zone B cell number
|
J:292926
|
| increased pre-B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
\Card11em3Welu/\Card11em3Welu
(Not Specified)
|
decreased B-1 B cell number
|
J:292926
|
| decreased marginal zone B cell number
|
J:292926
|
\Card11m1Btlr/\Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:149767
|
| abnormal double-negative T cell morphology
|
J:149767,
J:139069
|
| decreased B-1 B cell number
|
J:149767,
J:139069
|
| decreased gamma-delta T cell number
|
J:149767,
J:139069
|
| decreased mature B cell number
|
J:149767,
J:139069
|
| decreased memory T cell number
|
J:149767,
J:139069
|
| decreased NK cell number
|
J:149767,
J:139069
|
| decreased NK T cell number
|
J:149767,
J:139069
|
| decreased regulatory T cell number
|
J:149767
|
\Card11m3Btlr/\Card11m3Btlr
(C57BL/6J-Card11m3Btlr)
|
increased B-1a cell number
|
J:221487
|
\Card11M4Btlr/\Card11+
(C57BL/6J-Card11M4Btlr)
|
decreased B-1a cell number
|
J:254856
|
| increased B-1b cell number
|
J:254856
|
\Card11M4Btlr/\Card11M4Btlr
(C57BL/6J-Card11M4Btlr)
|
decreased B-1a cell number
|
J:254856
|
| increased B-1b cell number
|
J:254856
|
\Card11M5Btlr/\Card11+
(C57BL/6J-Card11M5Btlr)
|
increased B-1 B cell number
|
J:254879
|
| increased B-1a cell number
|
J:254879
|
\Card11M5Btlr/\Card11M5Btlr
(C57BL/6J-Card11M5Btlr)
|
increased B-1 B cell number
|
J:254879
|
| increased B-1a cell number
|
J:254879
|
\Card11M6Btlr/\Card11M6Btlr
(C57BL/6J-Card11M6Btlr)
|
increased alpha-beta T cell number
|
J:272116
|
\Card11M7Btlr/\Card11M7Btlr
(C57BL/6J-Card11M7Btlr)
|
abnormal T cell differentiation
|
J:274762
|
| decreased B cell number
|
J:274762
|
| decreased B-1 B cell number
|
J:274762
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:274762
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:274762
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:274762
|
| increased CD4-positive, alpha-beta T cell number
|
J:274762
|
| increased CD8-positive, alpha-beta T cell number
|
J:274762
|
| increased T cell number
|
J:274762
|
\Card11m8Btlr/\Card11m8Btlr
(C57BL/6J-Card11m8Btlr)
|
abnormal B cell differentiation
|
J:274940
|
| decreased B cell number
|
J:274940
|
| decreased B-1a cell number
|
J:274940
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:274940
|
| increased B-1b cell number
|
J:274940
|
| increased CD4-positive, alpha-beta T cell number
|
J:274940
|
| increased CD8-positive, alpha-beta T cell number
|
J:274940
|
| increased NK T cell number
|
J:274940
|
| increased T cell number
|
J:274940
|
\Card11tm1Litt/\Card11tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal double-negative T cell morphology
|
J:89322
|
| abnormal T cell differentiation
|
J:89322
|
| absent B-1a cells
|
J:89322
|
\Card11tm1Pngr/\Card11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:84036
|
| abnormal lymphocyte morphology
|
J:84036
|
| absent B-1a cells
|
J:84036
|
| decreased NK cell number
|
J:84036
|
\Card11tm1Vmd/\Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N)
|
absent immature B cells
|
J:95800
|
\Card11tm1Xav/\Card11tm1Xav
(involves: 129 * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:132226
|
| increased CD4-positive, alpha-beta T cell number
|
J:132226
|
| increased CD8-positive, alpha-beta T cell number
|
J:132226
|
\Card11unm/\Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
|
abnormal B cell differentiation
|
J:84042
|
| decreased B-1 B cell number
|
J:84042
|
\Card14em2Tshu/\Card14+
(involves: C57BL/6)
|
abnormal gamma-delta T cell number
|
J:289239
|
| increased alpha-beta T cell number
|
J:289239
|
\Card19tm1Rwen/\Card19tm1Rwen
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)
|
decreased B cell number
|
J:336763
|
| increased B cell number
|
J:336763
|
\Carm1tm1b(EUCOMM)Hmgu/\Carm1+
(C57BL/6N-Carm1tm1b(EUCOMM)Hmgu/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
\Carm1tm1Mtb/\Carm1tm1Mtb
(involves: 129S6/SvEvTac)
|
arrested T cell differentiation
|
J:159958
|
\Carm1tm2.1Mtb/\Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)
|
arrested T cell differentiation
|
J:159958
|
\Carmil2bas/\Carmil2bas
(involves: C3HeB/FeJ * C57BL/6)
|
decreased regulatory T cell number
|
J:205441
|
\Carmil2bas/\Carmil2tm1a(KOMP)Mbp
(involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)
|
decreased regulatory T cell number
|
J:205441
|
\Casp3tm1Flv/\Casp3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased thymocyte number
|
J:36821
|
\Casp3tm1Flv/\Casp3tm1Flv
\Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:100854
|
\Casp3tm1Mak/\Casp3tm1Mak
\Tg(TcrLCMV)327Sdz/0
(B6.Cg-Casp3tm1Mak Tg(TcrLCMV)327Sdz)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:97650
|
\Casp8em1Hbz/\Casp8em1Hbz
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:342732
|
\Casp8em1Hbz/\Casp8em1Hbz
\Mlklem1Hbz/\Mlklem1Hbz
(involves: C57BL/6)
|
decreased B cell number
|
J:342732
|
| decreased lymphocyte cell number
|
J:342732
|
| decreased mature B cell number
|
J:342732
|
| decreased T cell number
|
J:342732
|
\Casp8em1Hbz/\Casp8em1Hbz
\Ripk1em1Hbz/\Ripk1em1Hbz
\Ripk3tm1Xidw/\Ripk3tm1Xidw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased lymphocyte cell number
|
J:342732
|
| decreased mature B cell number
|
J:342732
|
| decreased T cell number
|
J:342732
|
\Casp8em1Hbz/\Casp8em1Hbz
\Ripk3tm1Xidw/\Ripk3tm1Xidw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:342732
|
| decreased lymphocyte cell number
|
J:342732
|
| decreased mature B cell number
|
J:342732
|
| decreased T cell number
|
J:342732
|
\Casp8m1Btlr/\Casp8m1Btlr
(C57BL/6J-Casp8m1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:255007
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:255007
|
| decreased T cell number
|
J:255007
|
| increased CD8-positive, alpha-beta T cell number
|
J:255007
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:255007
|
\Casp8M2Btlr/\Casp8M2Btlr
(C57BL/6J-Casp8M2Btlr)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:272851
|
\Casp8tm1.1Raz/\Casp8tm1.1Raz
\Ripk3tm1Vmd/\Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased B cell number
|
J:170815
|
| increased T cell number
|
J:170815,
J:170814
|
\Casp8tm1.1Vmd/\Casp8tm1.1Vmd
\Ripk3tm2Vmd/\Ripk3tm2Vmd
(involves: C57BL/6N)
|
increased T cell number
|
J:209137
|
\Casp8tm1Hed/\Casp8tm1Hed
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:116713
|
| decreased B-1 B cell number
|
J:116713
|
| decreased marginal zone B cell number
|
J:116713
|
\Casp8tm1Raz/\Casp8tm1Raz
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal lymphocyte morphology
|
J:107455
|
| abnormal T cell morphology
|
J:82759
|
| abnormal T cell subpopulation ratio
|
J:107455,
J:82759
|
| decreased CD4-positive, alpha-beta T cell number
|
J:82759
|
| decreased CD8-positive, alpha-beta T cell number
|
J:82759
|
| decreased T cell number
|
J:82759
|
| increased B cell number
|
J:107455
|
| increased lymphocyte cell number
|
J:107455
|
| increased T cell number
|
J:107455
|
\Cbfa2t3tm1.1Swh/\Cbfa2t3tm1.1Swh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased immature B cell number
|
J:140967
|
\Cbfbtm1Itan/\Cbfbtm1Itan
\Rr94tm3.1Litt/\Rr94tm3.1Litt
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal double-positive T cell morphology
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
| increased double-positive T cell number
|
J:158962
|
\Cbfbtm1Itan/\Cbfbtm1Itan
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:158962,
J:125953
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:125953
|
| abnormal T cell differentiation
|
J:125953
|
| abnormal T-helper 1 cell differentiation
|
J:125953
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158962
|
| increased double-positive T cell number
|
J:158962
|
\Cbfbtm1Itan/\Cbfbtm1Itan
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive T cell differentiation
|
J:125953
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
| abnormal double-positive T cell morphology
|
J:125953
|
| abnormal T-helper 1 cell differentiation
|
J:125953
|
| decreased thymocyte number
|
J:125953
|
\Cbfbtm1Itan/\Cbfbtm1Itan
\Zbtb7btm2Litt/\Zbtb7b+
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
\Cbfbtm1Itan/\Cbfbtm1Itan
\Zbtb7btm2Litt/\Zbtb7btm1.2Litt
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
\Cbfbtm1Spe/\Cbfbtm1Spe
\Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))
|
increased CD4-positive, alpha-beta T cell number
|
J:80670
|
\Cbfbtm1Spe/\Cbfbtm1Spe
\Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))
|
increased CD4-positive, alpha-beta T cell number
|
J:80670
|
\Cbfbtm1Spe/\Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
| decreased double-positive T cell number
|
J:124224
|
| increased CD4-positive, alpha-beta T cell number
|
J:124224
|
\Cbfbtm1Tok/\Cbfbtm1Tok
\Tg(Gata1-Cbfb)1Tok/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent T cells
|
J:80668
|
| decreased lymphocyte cell number
|
J:80668
|
\Cbfbtm2.1Spe/\Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
| decreased double-positive T cell number
|
J:124224
|
| increased CD4-positive, alpha-beta T cell number
|
J:124224
|
\Cbfbtm6Ppl/\Cbfb+
(involves: 129S/SvEv * C57BL/6)
|
decreased B cell number
|
J:252447
|
\Cbltm1.1Hua/\Cbltm1.1Hua
\Lattm1Les/\Lattm1Les
(involves: 129P2/OlaHsd)
|
increased CD4-positive, alpha-beta T cell number
|
J:91369
|
\Cbltm1.1Hua/\Cbltm1.1Hua
\Lcp2tm1Gak/\Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
| increased CD4-positive, alpha-beta T cell number
|
J:91369
|
\Cbltm1.1Hua/\Cbltm1.1Hua
\Lcp2tm1Gak/\Lcp2tm1Gak
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
\Cbltm1Ddlb/\Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:103366
|
| abnormal T cell differentiation
|
J:103366
|
| decreased single-positive T cell number
|
J:103366
|
\Cbltm2Hua/\Cbltm2Hua
\Cblbtm1Hua/\Cblbtm1Hua
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal T cell morphology
|
J:80427
|
\Cblbtm1Pngr/\Cblbtm1Pngr
\Itktm1Litt/\Itktm1Litt
(B6.129-Itktm1Litt Cblbtm1Pngr)
|
abnormal T cell morphology
|
J:141390
|
| abnormal T-helper 2 cell differentiation
|
J:141390
|
| decreased T cell number
|
J:141390
|
\Cbliftm1a(KOMP)Wtsi/\Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
increased CD4-positive, alpha-beta T cell number
|
J:236022
|
| increased T cell number
|
J:236022
|
\Cbstm1Unc/\Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent uterine NK cells
|
J:190486
|
| decreased uterine NK cell number
|
J:190486
|
\Cbx2tm1Cim/\Cbx2tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:38487
|
\Cbx4tm1.1Gxu/\Cbx4tm1.2Gxu
\Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal lymphopoiesis
|
J:194053
|
| decreased double-positive T cell number
|
J:194053
|
| decreased T cell number
|
J:194053
|
\Ccdc86tm1Hfuj/\Ccdc86+
(involves: C57BL/6NTac)
|
abnormal T cell morphology
|
J:151722
|
\Ccdc88bem1(IMPC)Tcp/\Ccdc88bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc88bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Ccdc88bm1Pgrs/\Ccdc88bm1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:230618
|
\Ccdc171m1Anu/\Ccdc171+
(C57BL/NCrlAnu-Ccdc171m1Anu/Anu)
|
decreased mature B cell number
|
J:104190
|
\Ccdc171m1Anu/\Ccdc171m1Anu
(C57BL/NCrlAnu-Ccdc171m1Anu/Anu)
|
decreased mature B cell number
|
J:104190
|
\Ccl2tm1Rol/\Ccl2tm1Rol
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:147697
|
\Ccl2tm1Rol/\Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
increased CD4-positive, alpha-beta T cell number
|
J:68145
|
\Ccl5tm1Hso/\Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:75842
|
\Ccl19tm1Cys/\Ccl19tm1Cys
(B6.129X1-Ccl19tm1Cys)
|
decreased T cell number
|
J:126345
|
\Ccl21atm1Yout/\Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal negative T cell selection
|
J:244640
|
| decreased alpha-beta T cell number
|
J:244640
|
| decreased B cell number
|
J:244640
|
| decreased thymocyte number
|
J:244640
|
\Ccl25tm1.1Mal/\Ccl25tm1.1Mal
(B6.129S2-Ccl25tm1.1Mal)
|
abnormal gamma-delta T cell number
|
J:136944
|
| abnormal T cell subpopulation ratio
|
J:136944
|
| decreased gamma-delta intraepithelial T cell number
|
J:136944
|
\Ccl25tm1.1Mal/\Ccl25tm1.1Mal
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:136667
|
| abnormal T cell subpopulation ratio
|
J:136667
|
| decreased gamma-delta intraepithelial T cell number
|
J:136667
|
\Ccl27atm1.1(KOMP)Vlcg/\Ccl27atm1.1(KOMP)Vlcg
(C57BL/6N-Ccl27atm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased regulatory T cell number
|
J:330550
|
\Ccnb2tm1Thnt/\Ccnb2tm1Thnt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:47430
|
\Ccnd1tm1Dsn/\Ccnd1tm1Dsn
\Ccnd2tm1Wbg/\Ccnd2tm1Wbg
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:92563
|
\Ccnd3tm1.1(Ccnd2)Iaai/\Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
decreased double-positive T cell number
|
J:192031
|
| decreased pre-B cell number
|
J:192031
|
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(Not Specified)
|
decreased double-positive T cell number
|
J:88120,
J:192031
|
| decreased lymphocyte cell number
|
J:88120
|
| decreased pre-B cell number
|
J:192031
|
| increased double-negative T cell number
|
J:88120
|
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
decreased double-positive T cell number
|
J:192031
|
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192031
|
\Ccnd3tm2.1Pisc/\Ccnd3tm2.1Pisc
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192032
|
\Ccr1tm1Cge/\Ccr1tm1Cge
(C.129S4-Ccr1tm1Cge)
|
decreased CD4-positive, alpha-beta T cell number
|
J:95242
|
| decreased CD8-positive, alpha-beta T cell number
|
J:95242
|
\Ccr2em1(IMPC)H/\Ccr2em1(IMPC)H
(C57BL/6N-Ccr2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Ccr2tm1Blck/\Ccr2tm1Blck
\Faslpr/\Faslpr
(MRL.Cg-Ccr2tm1Blck Faslpr)
|
abnormal lymphocyte cell number
|
J:113343
|
\Ccr2tm1Mae/\Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:110814
|
| increased B cell number
|
J:110814
|
| increased CD8-positive, alpha-beta T cell number
|
J:110814
|
\Ccr4tm1Pwr/\Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:70088
|
\Ccr4tm1Pwr/\Ccr4tm1Pwr
(B6.129P2-Ccr4tm1Pwr)
|
increased CD8-positive, alpha-beta T cell number
|
J:95239
|
| increased NK T cell number
|
J:95239
|
\Ccr5tm1Kuz/\Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:110814
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:110814
|
| decreased NK cell number
|
J:135308
|
| increased NK T cell number
|
J:110814
|
\Ccr6tm1(EGFP)Irw/\Ccr6tm1(EGFP)Irw
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:85086
|
| abnormal CD4-positive, alpha-beta intraepithelial T cell morphology
|
J:85086
|
| abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:85086
|
| decreased B cell number
|
J:120122
|
\Ccr6tm1Gma/\Ccr6tm1Gma
\Tg(Rorc-EGFP)1Ebe/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
\Ccr6tm1Lira/\Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:148286
|
| abnormal intraepithelial T cell number
|
J:76461
|
| abnormal lymphocyte morphology
|
J:148286
|
| decreased B cell number
|
J:148286
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148286
|
| decreased CD8-positive, alpha-beta T cell number
|
J:148286
|
| increased activated T cell number
|
J:76461
|
| increased B-1 B cell number
|
J:124358
|
| increased double-positive T cell number
|
J:76461
|
| increased T cell number
|
J:76461
|
\Ccr7m1Btlr/\Ccr7m1Btlr
(C57BL/6J-Ccr7m1Btlr)
|
increased single-positive T cell number
|
J:221477
|
\Ccr7tm1Rfor/\Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal class switch recombination
|
J:57976
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57976
|
| decreased T cell number
|
J:57976
|
| increased CD4-positive, alpha-beta T cell number
|
J:57976
|
| increased T cell number
|
J:57976
|
\Ccr9tm1.1Mal/\Ccr9tm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:72386
|
| decreased double-positive T cell number
|
J:72386
|
| decreased pro-B cell number
|
J:72386
|
| decreased T cell number
|
J:72386
|
| increased T cell number
|
J:72386
|
\Ccr9tm1.1Mal/\Ccr9tm1.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell number
|
J:136944
|
| abnormal T cell subpopulation ratio
|
J:136944
|
| decreased gamma-delta intraepithelial T cell number
|
J:136944
|
\Ccr9tm1.1Mal/\Ccr9tm1.1Mal
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:136667
|
| abnormal T cell subpopulation ratio
|
J:136667
|
| decreased gamma-delta intraepithelial T cell number
|
J:136667
|
\Ccr9tm1Ccb/\Ccr9tm1Ccb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:94596
|
| decreased thymocyte number
|
J:94596
|
\Ccr9tm1Lov/\Ccr9tm1Lov
(involves: 129)
|
abnormal gamma-delta intraepithelial T cell morphology
|
J:110846
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:110846
|
| decreased lymphocyte cell number
|
J:110846
|
| increased gamma-delta T cell number
|
J:110846
|
\Ccr10tm1.1Nax/\Ccr10tm1.1Nax
(B6.129S4(Cg)-Ccr10tm1.1Nax)
|
decreased gamma-delta intraepithelial T cell number
|
J:165323
|
\Ccr10tm1Cge/\Ccr10tm1Cge
(C.129S4-Ccr10tm1Cge)
|
abnormal plasma cell morphology
|
J:140728
|
\Cd1tm1Gru/\Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
absent NK T cells
|
J:47769
|
| decreased CD4-positive, alpha-beta T cell number
|
J:126220
|
\Cd1d1tm1.1Aben/\Cd1d1tm1.1Aben
\Tg(Cd4-cre)1Cwi/0
(B6.Cg-Cd1d1tm1.1Aben Tg(Cd4-cre)1Cwi)
|
decreased NK T cell number
|
J:183087
|
\Cd1d1tm1.1Boes/\Cd1d1tm1.1Boes
(involves: C57BL/6)
|
abnormal NK T cell morphology
|
J:151699
|
| decreased NK T cell number
|
J:151699
|
\Cd1d1tm1.2Aben/\Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
abnormal CD4-positive T cell differentiation
|
J:177038
|
\Cd1d1tm1Crw/\Cd1d1tm1Crw
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:76976
|
\Cd1d1tm1Luc/\Cd1d1tm1Luc
(B6.129S6-Cd1d1tm1Luc)
|
decreased regulatory T cell number
|
J:122245
|
\Cd1d1tm1Luc/\Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested T cell differentiation
|
J:125679
|
| decreased NK T cell number
|
J:39748
|
\Cd1d1tm1Luc/\Cd1d1tm1Luc
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt)
|
decreased NK cell number
|
J:129712
|
\Cd1d1tm2Aben/\Cd1d1tm2Aben
(B6.129P2-Cd1d1tm2Aben)
|
decreased NK T cell number
|
J:174337
|
\Cd1d1tm2Aben/\Cd1d1tm2Aben
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased NK T cell number
|
J:174337
|
\Cd3dtm1Kap/\Cd3dtm1Kap
(C57BL/6-Cd3dtm1Kap)
|
arrested T cell differentiation
|
J:39925
|
| decreased CD4-positive, alpha-beta T cell number
|
J:39925
|
| decreased CD8-positive, alpha-beta T cell number
|
J:39925
|
\Cd3em1Btlr/\Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
absent T cells
|
J:132486
|
| arrested T cell differentiation
|
J:132486
|
\Cd3em1Btlr/\Cd3em1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd3em2Btlr/\Cd3em2Btlr
(C57BL/6J-Cd3em2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274934
|
| abnormal T cell differentiation
|
J:274934
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274934
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274934
|
| increased CD8-positive, alpha-beta T cell number
|
J:274934
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274934
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:192604
|
| abnormal T cell differentiation
|
J:192604
|
| abnormal T cell number
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:192604
|
| abnormal positive T cell selection
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno
\Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive T cell differentiation
|
J:192604
|
| abnormal positive T cell selection
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Geno/\Cd3etm1.1Geno
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:192604
|
| abnormal T cell differentiation
|
J:192604
|
| decreased double-positive T cell number
|
J:192604
|
| decreased T cell number
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
\Cd3etm1.1Lov/\Cd3etm1.1Lov
(Not Specified)
|
abnormal T cell morphology
|
J:72144
|
| arrested T cell differentiation
|
J:72144
|
| decreased double-positive T cell number
|
J:72144
|
| increased double-negative T cell number
|
J:72144
|
\Cd3etm1.1Lov/\Cd3etm1.1Lov
\Trdctm1Mal/\Trdctm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
\Cd3etm1Cpt/\Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
absent T cells
|
J:54756
|
| decreased double-positive T cell number
|
J:54756
|
\Cd3etm1Cpt/\Cd3etm1Cpt
\Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:54756
|
| decreased T cell number
|
J:54756
|
\Cd3etm1Lov/\Cd3etm1Lov
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell morphology
|
J:72144
|
| arrested T cell differentiation
|
J:72144
|
| decreased double-positive T cell number
|
J:72144
|
| increased double-negative T cell number
|
J:72144
|
\Cd3etm1Mal/\Cd3etm1Mal
(involves: C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:77098
|
| absent CD8-positive, alpha-beta T cells
|
J:77098
|
| arrested T cell differentiation
|
J:77098
|
\Cd3etm1Mal/\Cd3etm1Mal
(C57BL/6-Cd3etm1Mal)
|
abnormal B cell morphology
|
J:81133
|
| abnormal double-negative T cell morphology
|
J:81133
|
| absent T cells
|
J:131351
|
| arrested T cell differentiation
|
J:81133
|
\Cd3etm1Mal/\Cd3etm1Mal
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:77098
|
| absent CD8-positive, alpha-beta T cells
|
J:77098
|
| arrested T cell differentiation
|
J:77098
|
\Cd3gtm1.1Cage/\Cd3gtm1.1Cage
(B6.129P2-Cd3gtm1.1Cage)
|
decreased CD8-positive, alpha-beta T cell number
|
J:153813
|
| decreased thymocyte number
|
J:153813
|
\Cd3gtm1Amk/\Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77504
|
| decreased thymocyte number
|
J:114561
|
\Cd3gtm1Amk/\Cd3gtm1Amk
\Tg(Igh-Pim1)1Brn/0
(involves: 129P2/OlaHsd * C57BL/6LiA * CBA)
|
decreased thymocyte number
|
J:114561
|
\Cd4del/\Cd4del
(C57BR/cdJ-Cd4del)
|
absent CD4-positive, alpha-beta T cells
|
J:46692
|
| increased CD8-positive, alpha-beta T cell number
|
J:46692
|
\Cd4em1Litt/\Cd4em1Litt
\Rr386em1Pdi/\Rr386em1Pdi
(involves: C57BL/6J)
|
decreased T helper 1 cell number
|
J:333574
|
\Cd4m1Btlr/\Cd4m1Btlr
(C57BL/6J-Cd4m1Btlr)
|
absent CD4-positive, alpha-beta T cells
|
J:212900
|
\Cd4maat/\Cd4maat
(C57BL/6JAnu-Cd4maat/Apb)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal double-positive T cell morphology
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
| increased CD8-positive, alpha-beta T cell number
|
J:104190
|
\Cd4sesh/\Cd4sesh
(C57BL/6JAnu-Cd4sesh/AnuApb)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal double-positive T cell morphology
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Cd4thth/\Cd4thth
(C57BL/6JSfdAnu-Cd4thth)
|
absent CD4-positive, alpha-beta T cells
|
J:104190
|
\Cd4tm1(cre/ERT2)Thbu/\Cd4+
\Gfm1tm1c(EUCOMM)Wtsi/\Gfm1tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal T-helper 17 cell differentiation
|
J:302272
|
| increased CD8-positive, alpha-beta T cell number
|
J:302272
|
| increased single-positive T cell number
|
J:302272
|
\Cd4tm1(cre/ERT2)Thbu/\Cd4+
\Tgfbr2tm1Karl/\Tgfbr2tm1Karl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased memory T cell number
|
J:204579
|
| increased regulatory T cell number
|
J:204579
|
\Cd4tm1Doi/\Cd4tm1Doi
\Lag3tm1Doi/\Lag3tm1Doi
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
\Cd4tm1Doi/\Cd4tm1Litt
\Lag3tm1Doi/\Lag3+
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
\Cd4tm1Jrp/\Cd4tm1Jrp
(either: B6.129S2-Cd4tm1Jrp or B10.Cg-Cd4tm1Jrp)
|
abnormal T cell differentiation
|
J:45168
|
| decreased CD4-positive, alpha-beta T cell number
|
J:45168
|
| decreased double-positive T cell number
|
J:45168
|
| increased CD8-positive, alpha-beta T cell number
|
J:45168
|
\Cd4tm1Jrp/\Cd4tm1Jrp
\Tg(TcrAND)53Hed/0
(either: (involves: 129S2/SvPas * C57BL/6 * SJL) or (involves: 129S2/SvPas * C57BL/6 * C57BL/10 * SJL))
|
abnormal T cell number
|
J:45168
|
\Cd4tm1Knw/\Cd4tm1Knw
(B6.129S-Cd4tm1Knw/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:87828
|
| increased CD8-positive, alpha-beta T cell number
|
J:87828
|
\Cd4tm1Litt/\Cd4tm1Litt
(involves: 129S2/SvPas)
|
absent CD4-positive, alpha-beta T cells
|
J:50435
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962,
J:50435
|
\Cd4tm1Litt/\Cd4tm1Litt
\Foxp3sf\Otcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:20865
|
\Cd4tm1Litt/\Cd4tm1Nik
\Tg(Lck-cre)3785Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:73479
|
| increased CD8-positive, alpha-beta T cell number
|
J:73479
|
\Cd4tm1Mak/\Cd4tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:68957
|
\Cd4tm1Mak/\Cd4tm1Mak
(B6.129S2-Cd4tm1Mak/J)
|
absent plasma cells
|
J:133047
|
\Cd4tm1Mak/\Cd4tm1Mak
\Cd8atm1Mak/\Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal double-negative T cell morphology
|
J:12572
|
| abnormal gamma-delta T cell number
|
J:12572
|
| abnormal T cell differentiation
|
J:12572
|
| abnormal T cell number
|
J:12572
|
| decreased double-positive T cell number
|
J:12572
|
\Cd4ts1BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd4ts2DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd4ts3BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd4ts4C3H/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd4ts5BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd4ts5C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
\Cd4ts6DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd4vts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd5tm1.1Chra/\Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
|
decreased B cell number
|
J:189919
|
| decreased CD4-positive, alpha-beta T cell number
|
J:189919
|
| decreased double-positive T cell number
|
J:189919
|
| decreased follicular B cell number
|
J:189919
|
| decreased T-helper 17 cell number
|
J:189919
|
| increased double-negative T cell number
|
J:189919
|
\Cd5tm1.1Chra/\Cd5tm1.1Chra
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6 * FVB/N)
|
decreased T helper 1 cell number
|
J:189919
|
\Cd5tm1Cgn/\Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn)
|
increased regulatory T cell number
|
J:189919
|
\Cd5ltm1Nto/\Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:52195
|
| decreased thymocyte number
|
J:52195
|
\Cd6tm1Linf/\Cd6tm1Linf
(D1.Cg-Cd6tm1Linf)
|
decreased B-1 B cell number
|
J:238478
|
| decreased B-1a cell number
|
J:238478
|
| increased B-1a cell number
|
J:238478
|
| increased B-1b cell number
|
J:238478
|
\Cd7tm1Bfh/\Cd7tm1Bfh
(involves: 129 * C57BL/6)
|
increased double-positive T cell number
|
J:48758
|
| increased thymocyte number
|
J:48758
|
\Cd7tm1Bfh/\Cd7tm1Bfh
(B6.129-Cd7tm1Bfh)
|
increased double-positive T cell number
|
J:48758
|
| increased thymocyte number
|
J:48758
|
\Cd8am1Btlr/\Cd8am1Btlr
(C57BL/6J-Cd8am1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221492
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221492
|
\Cd8atm1.1(cre)Koni/\Cd8atm1.1(cre)Koni
(involves: C57BL/6J * C57BL/6NHsd * SJL)
|
decreased CD8-positive, alpha-beta T cell number
|
J:177182
|
\Cd8atm1.1Kio/\Cd8atm1.1Kio
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive T cell differentiation
|
J:76799
|
\Cd8atm1.1Litt/\Cd8atm1.1Litt
(either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:50624
|
\Cd8atm1Asin/\Cd8atm1Asin
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal double-positive T cell morphology
|
J:126026
|
\Cd8atm1Asin/\Cd8atm1Asin
\Cd8b1tm1Litt/\Cd8b1tm1Litt
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(involves: 129 * FVB/N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
\Cd8atm1Asin/\Cd8atm1Asin
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
\Cd8atm1Asin/\Cd8atm1Asin
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
| decreased CD4-positive, alpha-beta T cell number
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
\Cd8atm1Asin/\Cd8atm1Mak
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
| abnormal T cell subpopulation ratio
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
\Cd8atm1Mak/\Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
absent CD8-positive, alpha-beta T cells
|
J:68956
|
\Cd8atm1Mak/\Cd8atm1Mak
\Zbtb7bhd/\Zbtb7bhd
(involves: B6.129S2-Cd8atm1Mak * B6.Cg-Thpokhd)
|
absent CD4-positive, alpha-beta T cells
|
J:95867
|
\Cd8b1M1Btlr/\Cd8b1+
(C57BL/6J-Cd8b1M1Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:255009
|
| increased CD4-positive, alpha-beta T cell number
|
J:255009
|
\Cd8b1M1Btlr/\Cd8b1M1Btlr
(C57BL/6J-Cd8b1M1Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:255009
|
| increased CD4-positive, alpha-beta T cell number
|
J:255009
|
\Cd8b1m2Btlr/\Cd8b1m2Btlr
(C57BL/6J-Cd8b1m2Btlr)
|
abnormal B cell differentiation
|
J:274761
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274761
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274761
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274761
|
| decreased T cell number
|
J:274761
|
| increased CD4-positive, alpha-beta T cell number
|
J:274761
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274761
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274761
|
\Cd8b1tm1Litt/\Cd8b1+
\Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell subpopulation ratio
|
J:110916
|
| decreased T cell number
|
J:110916
|
| decreased thymocyte number
|
J:110916
|
\Cd8b1tm1Litt/\Cd8b1+
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
decreased double-positive T cell number
|
J:112551
|
\Cd8b1tm1Litt/\Cd8b1tm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal T cell subpopulation ratio
|
J:110916
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112551,
J:110916
|
| decreased thymocyte number
|
J:110916
|
\Cd8b1tm1Litt/\Cd8b1tm1Litt
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
abnormal negative T cell selection
|
J:112551
|
| abnormal positive T cell selection
|
J:112551
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112551
|
| increased CD4-positive, alpha-beta T cell number
|
J:112551
|
\Cd8b1tm1Wpfl/\Cd8b1tm1Wpfl
(involves: 129S2/SvPas)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:19928
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:19928
|
| abnormal T cell subpopulation ratio
|
J:19928
|
| decreased CD8-positive, alpha-beta T cell number
|
J:19928
|
| decreased thymocyte number
|
J:19928
|
\Cd8mts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
\Cd8mts2BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
\Cd8mts3C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
\Cd8mts4DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
\Cd8mts5BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd8mts5C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased memory T cell number
|
J:83220
|
\Cd8mts6C3H/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
\Cd8ts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
\Cd8ts2C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
\Cd8ts3C3H/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
\Cd8ts3DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Cd19em2(IMPC)Ics/\Cd19em2(IMPC)Ics
(C57BL/6N-Cd19em2(IMPC)Ics/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Cd19tm1(cre)Cgn/?
\Gt(ROSA)26Sortm1(HBEGF)Awai/\Gt(ROSA)26Sortm1(HBEGF)Awai
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:131076
|
| abnormal lymphocyte cell number
|
J:131076
|
| abnormal lymphocyte morphology
|
J:131076
|
| absent immature B cells
|
J:131076
|
| absent mature B cells
|
J:131076
|
\Cd19tm1(cre)Cgn/\Cd19+
\Cxcr4tm1Tng/\Cxcr4tm2Tng
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased plasma cell number
|
J:109147
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ell2tm1.1Cmil/\Ell2tm1.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased mature B cell number
|
J:234692
|
| decreased plasma cell number
|
J:234692
|
| decreased transitional stage T1 B cell number
|
J:234692
|
| decreased transitional stage T2 B cell number
|
J:234692
|
| decreased transitional stage T3 B cell number
|
J:234692
|
| increased follicular B cell number
|
J:234692
|
| increased immature B cell number
|
J:234692
|
| increased pre-B cell number
|
J:234692
|
| increased pro-B cell number
|
J:234692
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ell2tm2.1Cmil/\Ell2tm2.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased mature B cell number
|
J:234692
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ep300tm2Reck/\Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:147840
|
| abnormal transitional stage B cell morphology
|
J:147840
|
| decreased marginal zone B cell number
|
J:147840
|
| increased activated T cell number
|
J:147840
|
| increased B cell number
|
J:147840
|
\Cd19tm1(cre)Cgn/\Cd19+
\Faslpr/\Fastm1Cgn
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
\Cd19tm1(cre)Cgn/\Cd19+
\Fastm1Ach/\Fastm1Ach
(involves: 129P2/OlaHsd * BALB/c)
|
increased lymphocyte cell number
|
J:123556
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gna12tm1Citb/\Gna12tm1Citb
\Gna13tm2.1Soff/\Gna13tm2.1Soff
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N)
|
decreased marginal zone B cell number
|
J:117663
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm1(DTA)Riet/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:92789
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
abnormal plasmablast number
|
J:228288
|
| increased B cell number
|
J:228288
|
| increased plasma cell number
|
J:228288
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:113365
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm5(Map3k14)Rsky/\Gt(ROSA)26Sortm5(Map3k14)Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
increased marginal zone B cell number
|
J:139293
|
| increased mature B cell number
|
J:139293
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm5(Map3k14)Rsky/\Gt(ROSA)26Sortm5(Map3k14)Rsky
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:139293
|
| decreased mature B cell number
|
J:139293
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm6(Map3k14*)Rsky/\Gt(ROSA)26Sortm6(Map3k14*)Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:139293
|
| increased mature B cell number
|
J:139293
|
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm6(Map3k14*)Rsky/\Gt(ROSA)26Sortm6(Map3k14*)Rsky
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:139293
|
| increased mature B cell number
|
J:139293
|
\Cd19tm1(cre)Cgn/\Cd19+
\Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:74619
|
| decreased B cell number
|
J:74619
|
| decreased follicular B cell number
|
J:74619
|
| decreased pre-B cell number
|
J:74619
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkbtm1Cgn/\Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:79132
|
| decreased follicular B cell number
|
J:79132
|
| decreased immature B cell number
|
J:79132
|
| decreased marginal zone B cell number
|
J:79132
|
| decreased mature B cell number
|
J:79132
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkbtm2Cgn/\Ikbkbtm2.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:79132
|
| decreased follicular B cell number
|
J:79132
|
| decreased marginal zone B cell number
|
J:79132
|
| decreased mature B cell number
|
J:79132
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkbtm2Mka/\Ikbkbtm2Mka
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:82995
|
| decreased B-1 B cell number
|
J:82995
|
| decreased marginal zone B cell number
|
J:82995
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:79132
|
| decreased follicular B cell number
|
J:79132
|
| decreased immature B cell number
|
J:79132
|
| decreased marginal zone B cell number
|
J:79132
|
| decreased mature B cell number
|
J:79132
|
\Cd19tm1(cre)Cgn/\Cd19+
\Il10tm1Roer/\Il10tm1Roer
(involves: 129P2/OlaHsd)
|
increased B cell number
|
J:151551
|
| increased CD4-positive, alpha-beta T cell number
|
J:151551
|
| increased plasma cell number
|
J:151551
|
\Cd19tm1(cre)Cgn/\Cd19+
\Inpp5dtm1Rav/\Inpp5dtm1Rav
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell morphology
|
J:166155
|
| decreased B cell number
|
J:166155
|
| increased B cell number
|
J:166155
|
\Cd19tm1(cre)Cgn/\Cd19+
\Irf8tm1.1Hm/\Irf8tm1.1Hm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased follicular B cell number
|
J:168923
|
| increased B cell number
|
J:168923
|
| increased B-2 B cell number
|
J:168923
|
| increased follicular B cell number
|
J:168923
|
| increased marginal zone B cell number
|
J:168923
|
| increased transitional stage B cell number
|
J:168923
|
\Cd19tm1(cre)Cgn/\Cd19+
\Klhl6tm2Sato/\Klhl6tm2Sato
(either: (involves: 129P2/OlaHsd * 129T2/SvEms) or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal B cell differentiation
|
J:101363
|
| decreased B cell number
|
J:101363
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ltbtm1Avt/\Ltbtm1Avt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased marginal zone B cell number
|
J:79129
|
\Cd19tm1(cre)Cgn/\Cd19+
\Map3k7tm1Aki/\Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:112597
|
\Cd19tm1(cre)Cgn/\Cd19+
\Mcl1tm2Sjk/\Mcl1tm3Sjk
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:86906
|
| absent early pro-B cells
|
J:86906
|
| absent late pro-B cells
|
J:86906
|
| absent pre-B cells
|
J:86906
|
| arrested B cell differentiation
|
J:86906
|
| decreased B cell number
|
J:86906
|
\Cd19tm1(cre)Cgn/\Cd19+
\Mirc30tm1.1Rdf/\Mirc30tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
\Cd19tm1(cre)Cgn/\Cd19+
\Myd88em1.1Rsky/\Myd88+
(involves: C57BL/6NTac)
|
increased germinal center B cell number
|
J:308792
|
| increased plasma cell number
|
J:308792
|
\Cd19tm1(cre)Cgn/\Cd19+
\Notch2tm1.1Hhi/\Notch2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased marginal zone B cell number
|
J:83476
|
\Cd19tm1(cre)Cgn/\Cd19+
\Notch2tm2Hhi/\Notch2tm1.1Hhi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent marginal zone B cells
|
J:83476
|
| decreased transitional stage B cell number
|
J:83476
|
\Cd19tm1(cre)Cgn/\Cd19+
\Pax5tm1Mbu/\Pax5tm3Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal B cell differentiation
|
J:75504
|
| abnormal class switch recombination
|
J:75504
|
| decreased immature B cell number
|
J:75504
|
| decreased mature B cell number
|
J:75504
|
| decreased pre-B cell number
|
J:75504
|
\Cd19tm1(cre)Cgn/\Cd19+
\Prdm1tm1Clme/\Prdm1tm1Clme
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:101890
|
| abnormal memory B cell number
|
J:101890
|
| abnormal plasma cell differentiation
|
J:101890
|
| abnormal plasma cell morphology
|
J:101890,
J:114881
|
| decreased plasma cell number
|
J:101890
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell negative selection
|
J:155314
|
| abnormal class switch recombination
|
J:114881
|
| abnormal plasma cell morphology
|
J:114881
|
| increased B cell number
|
J:83213
|
| increased B-1 B cell number
|
J:83213
|
| increased marginal zone B cell number
|
J:83213
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ptpn6tm1Rsky/\Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased follicular B cell number
|
J:123568
|
| decreased marginal zone B cell number
|
J:123568
|
| increased B cell number
|
J:123568
|
| increased B-1a cell number
|
J:123568
|
| increased plasma cell number
|
J:123568
|
| increased T cell number
|
J:123568
|
\Cd19tm1(cre)Cgn/\Cd19+
\Rac1tm1Tyb/\Rac1tm1Tyb
\Rac2tm1Mddw/\Rac2tm1Mddw
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:86765
|
| decreased B cell number
|
J:86765
|
| decreased B-1 B cell number
|
J:86765
|
| decreased follicular B cell number
|
J:86765
|
| decreased marginal zone B cell number
|
J:86765
|
| decreased transitional stage B cell number
|
J:86765
|
\Cd19tm1(cre)Cgn/\Cd19+
\Rbpjtm1Hon/\Rbpjtm1Hon
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76240
|
| decreased marginal zone B cell number
|
J:121523,
J:76240
|
| increased follicular B cell number
|
J:121523,
J:76240
|
\Cd19tm1(cre)Cgn/\Cd19+
\Rbpjtm1Hon/\Rbpjtm1Hon
\Spentm2.1Hon/\Spentm2.1Hon
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased marginal zone B cell number
|
J:121523
|
| increased follicular B cell number
|
J:121523
|
\Cd19tm1(cre)Cgn/\Cd19+
\Slc3a2tm1.1Mgin/\Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:148000
|
| abnormal plasma cell differentiation
|
J:148000
|
| decreased germinal center B cell number
|
J:148000
|
\Cd19tm1(cre)Cgn/\Cd19+
\Spentm2.1Hon/\Spentm2.1Hon
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased follicular B cell number
|
J:121523
|
| increased marginal zone B cell number
|
J:121523
|
\Cd19tm1(cre)Cgn/\Cd19+
\Srsf3tm1Pjln/\Srsf3tm1Pjln
(involves: 129P2/OlaHsd * BALB/c)
|
decreased B cell number
|
J:113645
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tbl1xr1tm1c(EUCOMM)Hmgu/\Tbl1xr1tm1c(EUCOMM)Hmgu
\Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
abnormal B cell differentiation
|
J:292118
|
| abnormal lymphocyte morphology
|
J:292118
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tcf3tm1Mbu/\Tcf3tm1.2Mbu
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased B cell number
|
J:137719
|
| decreased immature B cell number
|
J:137719
|
| decreased mature B cell number
|
J:137719
|
| decreased pre-B cell number
|
J:137719
|
| decreased pro-B cell number
|
J:137719
|
| decreased transitional stage B cell number
|
J:137719
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tcf3tm1Mbu/\Tcf3tm1.2Mbu
\Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
decreased pre-B cell number
|
J:137719
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tgfbr2tm1Roes/\Tgfbr2tm1Roes
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B-1 B cell morphology
|
J:90558
|
| abnormal B-1 B cell number
|
J:90558
|
| absent plasma cells
|
J:90558
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfaip3tm1.1Awai/\Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd)
|
decreased B-1a cell number
|
J:175422
|
| decreased B-1b cell number
|
J:175422
|
| decreased marginal zone B cell number
|
J:175422
|
| decreased mature B cell number
|
J:175422
|
| increased B cell number
|
J:175422
|
| increased follicular B cell number
|
J:175422
|
| increased germinal center B cell number
|
J:175422
|
| increased T cell number
|
J:175422
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfaip3tm2Ama/\Tnfaip3+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased germinal center B cell number
|
J:163917
|
| increased plasma cell number
|
J:163917
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:172843
|
\Cd19tm1(cre)Cgn/\Cd19+
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
\Traf2tm1Rbr/\Traf2tm1Rbr
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased follicular B cell number
|
J:132877
|
| increased marginal zone B cell number
|
J:132877
|
\Cd19tm1(cre)Cgn/\Cd19+
\Traf2tm1Rbr/\Traf2tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6)
|
increased follicular B cell number
|
J:132877
|
| increased marginal zone B cell number
|
J:132877
|
\Cd19tm1(cre)Cgn/\Cd19+
\Traf2tm1Rbr/\Traf2tm1Rbr
\Traf3tm1Rbr/\Traf3tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased marginal zone B cell number
|
J:132877
|
\Cd19tm1(cre)Cgn/\Cd19+
\Traf3tm1Rbr/\Traf3tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased follicular B cell number
|
J:132877
|
| increased marginal zone B cell number
|
J:132877
|
\Cd19tm1(cre)Cgn/\Cd19+
\Ube2ntm1Aki/\Ube2ntm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:112287
|
| decreased marginal zone B cell number
|
J:112287
|
\Cd19tm1(cre)Cgn/\Cd19+
\Wacem2Cya/\Wacem2Cya
(B6.Cg-Cd19tm1(cre)Cgn Wacem2Cya)
|
abnormal plasma cell differentiation
|
J:345327
|
| decreased plasma cell number
|
J:345327
|
\Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:27463
|
| decreased B-1 B cell number
|
J:83213,
J:27463
|
\Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:155314
|
\Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:155314
|
\Cd19tm1(cre/ERT2)Rsky/\Cd19+
\Myd88em1.1Rsky/\Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
increased plasma cell number
|
J:308792
|
\Cd19tm1Tft/\Cd19tm1Tft
(Not Specified)
|
decreased B cell number
|
J:27236
|
| decreased B-1 B cell number
|
J:27236
|
\Cd19tm1Tft/\Cd19tm1Tft
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:71174
|
| decreased B-1 B cell number
|
J:71174
|
\Cd19tm1Tft/\Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
increased CD8-positive, alpha-beta T cell number
|
J:106487
|
\Cd19tm1Tft/\Cd19tm1Tft
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell number
|
J:71174
|
| decreased B-1 B cell number
|
J:71174
|
| decreased mature B cell number
|
J:71174
|
\Cd22m1Anu/\Cd22m1Anu
(C57BL/6JAnu-Cd22m1Anu/AnuApb)
|
arrested B cell differentiation
|
J:104190
|
| decreased B cell number
|
J:104190
|
\Cd22m1Btlr/\Cd22m1Btlr
(C57BL/6J-Cd22m1Btlr)
|
abnormal B cell differentiation
|
J:173079
|
\Cd22m1Btlr/\Cd22m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
\Cd22m2Btlr/\Cd22m2Btlr
(C57BL/6J-Cd22m2Btlr)
|
abnormal B cell differentiation
|
J:215821
|
\Cd22m3Btlr/\Cd22m3Btlr
(C57BL/6J-Cd22m3Btlr)
|
decreased B cell number
|
J:220066
|
| increased B-1a cell number
|
J:220066
|
\Cd22m4Btlr/\Cd22m4Btlr
(C57BL/6J-Cd22m4Btlr)
|
decreased B cell number
|
J:224660
|
| decreased B-2 B cell number
|
J:224660
|
| decreased memory B cell number
|
J:224660
|
| increased B-1a cell number
|
J:224660
|
\Cd22m5Btlr/\Cd22m5Btlr
(C57BL/6J-Cd22m5Btlr)
|
decreased B cell number
|
J:254827
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254827
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254827
|
\Cd22tm1.1(CD22)Lnit/\Cd22tm1.1(CD22)Lnit
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:189017
|
| decreased marginal zone B cell number
|
J:189017
|
| decreased transitional stage T1 B cell number
|
J:189017
|
| decreased transitional stage T2 B cell number
|
J:189017
|
\Cd22tm1Eac/\Cd22+
\Lyntm1Ard/\Lyn+
\Ptpn6me-v/\Ptpn6+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
\Cd22tm1Eac/\Cd22+
\Lyntm1Ard/\Lyn+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
\Cd22tm1Eac/\Cd22+
\Ptpn6me-v/\Ptpn6+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
\Cd22tm1Eac/\Cd22+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
\Cd22tm1Eac/\Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:37451
|
| abnormal transitional stage B cell morphology
|
J:132991
|
| decreased marginal zone B cell number
|
J:132991
|
| decreased mature B cell number
|
J:37451,
J:132991
|
| decreased memory B cell number
|
J:37451
|
\Cd22tm1Lam/\Cd22tm1Lam
(involves: 129 * C57BL/6)
|
decreased marginal zone B cell number
|
J:125719
|
| decreased mature B cell number
|
J:125719
|
\Cd22tm1Lam/\Cd22tm1Lam
\Ightm1.2Rsky/\Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
\Cd22tm1Lam/\Cd22tm1Lam
\Ightm1.2Rsky/\Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
decreased B-1a cell number
|
J:125719
|
\Cd22tm1Lnit/\Cd22tm1Lnit
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased marginal zone B cell number
|
J:198790
|
\Cd22tm1Msn/\Cd22tm1Msn
(either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))
|
abnormal mature B cell morphology
|
J:76974
|
| increased B-1 B cell number
|
J:76974
|
\Cd22tm1Tft/\Cd22tm1Tft
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:92736
|
| decreased marginal zone B cell number
|
J:92736
|
| decreased mature B cell number
|
J:92736
|
\Cd22tm2Lnit/\Cd22tm2Lnit
(involves: 129P2/OlaHsd * C57BL/6)
|
absent mature B cells
|
J:198790
|
| decreased marginal zone B cell number
|
J:198790
|
\Cd22tm2Tft/\Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell number
|
J:92736
|
\Cd22tm2Tft/\Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:208364
|
\Cd22tm3Lnit/\Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
absent mature B cells
|
J:198790
|
| decreased B cell number
|
J:198790
|
| decreased marginal zone B cell number
|
J:198790
|
| decreased transitional stage B cell number
|
J:198790
|
\Cd22tm3Tft/\Cd22tm3Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell number
|
J:92736
|
\Cd24atm1Pjln/\Cd24atm1Pjln
(C57BL/6-Cd24atm1Pjln)
|
abnormal B cell differentiation
|
J:76695
|
| decreased immature B cell number
|
J:76695
|
| decreased pre-B cell number
|
J:76695
|
\Cd27em1(IMPC)Ccpcz/\Cd27em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd27em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Cd27tm1Jbo/\Cd27tm1Jbo
(B6.129P2-Cd27tm1Jbo)
|
decreased regulatory T cell number
|
J:198200
|
\Cd28tm1.1Huen/\Cd28tm1.1Huen
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
decreased regulatory T cell number
|
J:191101
|
\Cd28tm1a(EUCOMM)Hmgu/\Cd28tm1a(EUCOMM)Hmgu
(C57BL/6N-Cd28tm1a(EUCOMM)Hmgu/H)
|
decreased T cell number
|
J:165965
|
| increased CD4-positive, alpha-beta T cell number
|
J:165965
|
\Cd28tm1Jmg/\Cd28tm1Jmg
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
\Cd28tm1Jmg/\Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
\Cd28tm1Ltu/\Cd28tm1Ltu
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased regulatory T cell number
|
J:194503
|
| increased activated T cell number
|
J:194503
|
| increased B cell number
|
J:194503
|
\Cd28tm1Mak/\Cd28+
\Cd5tm1Cgn/\Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal class switch recombination
|
J:14194
|
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:123989
|
| decreased regulatory T cell number
|
J:191101,
J:205441
|
\Cd28tm1Mak/\Cd28tm1Mak
\Cd5tm1Cgn/\Cd5+
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd28tm1Mak/\Cd28tm1Mak
\Cd5tm1Cgn/\Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
| increased CD4-positive, alpha-beta T cell number
|
J:110925
|
| increased CD8-positive, alpha-beta T cell number
|
J:110925
|
\Cd28tm1Mak/\Cd28tm1Mak
\Cd40lgtm1Flv/\Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak)
|
decreased regulatory T cell number
|
J:93421
|
\Cd28tm1Mak/\Cd28tm1Mak
\Tg(Cd4-cre)1Cwi/?
\Traf6tm2Ywc/\Traf6tm2Ywc
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:130882
|
| increased memory T cell number
|
J:130882
|
\Cd28tm1Mak/\Cd28tm1Mak
\Tg(H2-K-Cd86)7All/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:112266
|
\Cd28tm1Pjl/\Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:83722
|
\Cd28tm1Pjl/\Cd28tm1Pjl
\Tg(H2-K-Cd86)27All/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased B cell number
|
J:112475
|
\Cd28tm1Pjl/\Cd28tm1Pjl
\Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
abnormal class switch recombination
|
J:83722
|
\Cd28tm1Shr/\Cd28tm1Shr
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:68642
|
\Cd28tm1Shr/\Cd28tm1Shr
\Ctla4tm1Shr/\Ctla4+
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
\Cd28tm1Shr/\Cd28tm1Shr
\Ctla4tm1Shr/\Ctla4tm1Shr
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:68642
|
\Cd36tm1Mfe/\Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal B cell morphology
|
J:130897
|
| abnormal plasma cell differentiation
|
J:130897
|
| increased transitional stage B cell number
|
J:130897
|
\Cd37tm1Hor/\Cd37tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:63315
|
\Cd38em1(IMPC)Ccpcz/\Cd38em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd38em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Cd40tm1Kik/\Cd40+
\Mir146tm1.1Lfl/\Mir146tm1.1Lfl
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T follicular helper cell number
|
J:266124
|
\Cd40tm1Kik/\Cd40tm1Kik
(involves: 129P2/OlaHsd)
|
absent germinal center B cells
|
J:190943
|
| decreased B cell number
|
J:190943
|
\Cd40tm1Kik/\Cd40tm1Kik
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
| increased marginal zone B cell number
|
J:113556
|
\Cd40tm1Kik/\Cd40tm1Kik
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(involves: 129 * 129P2/OlaHsd * BALB/c)
|
increased follicular B cell number
|
J:138560
|
| increased marginal zone B cell number
|
J:138560
|
| increased transitional stage B cell number
|
J:138560
|
\Cd40lgm1Btlr/Y
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd40lgm1Btlr/\Cd40lgm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Cd40lgtm1Flv/\Cd40lgtm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:25010
|
| abnormal T cell differentiation
|
J:25010
|
| decreased double-positive T cell number
|
J:25010
|
| increased CD4-positive, alpha-beta T cell number
|
J:25010
|
\Cd40lgtm1Flv/\Cd40lgtm1Flv
(NOD.129S2-Cd40lgtm1Flv)
|
decreased regulatory T cell number
|
J:93421
|
\Cd40lgtm1Imx/Y
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:21137
|
\Cd40lgtm1Imx/\Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6J * BALB/c)
|
abnormal T cell clonal deletion
|
J:110925
|
\Cd44M1Btlr/\Cd44M1Btlr
(C57BL/6J-Cd44M1Btlr)
|
decreased alpha-beta T cell number
|
J:267483
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267483
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267483
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:267483
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:267483
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:267483
|
\Cd44tm1Hbg/\Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68069
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:68069
|
\Cd47tm1Fpl/\Cd47tm1Fpl
(involves: 129S7/SvEvBrd)
|
decreased T cell number
|
J:36489
|
\Cd48tm1Rsr/\Cd48tm1Rsr
(B6.129S4-Cd48tm1Rsr)
|
increased CD4-positive, alpha-beta T cell number
|
J:53718
|
\Cd52em1(IMPC)Ccpcz/\Cd52em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd52em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
\Cd59atm1Bpm/\Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
decreased plasma cell number
|
J:119703
|
| increased CD4-positive, alpha-beta T cell number
|
J:123582
|
| increased double-positive T cell number
|
J:123582
|
\Cd69tm1Fsm/\Cd69tm1Fsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:61329
|
| increased immature B cell number
|
J:61329
|
| increased pre-B cell number
|
J:61329
|
\Cd69tm1Naka/\Cd69tm1Naka
(B6.129P2-Cd69tm1Naka)
|
decreased CD4-positive, alpha-beta T cell number
|
J:184704
|
\Cd70tm1(cre)Jbo/\Cd70tm1(cre)Jbo
(B6.129P2-Cd70tm1(cre)Jbo)
|
decreased regulatory T cell number
|
J:198200
|
\Cd70tm1.1Jda/\Cd70tm1.1Jda
(B6.Cg-Cd70tm1.1Jda)
|
decreased CD8-positive, alpha-beta T cell number
|
J:193042
|
\Cd72b/\Cd72b
\Faslpr/\Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
abnormal B cell number
|
J:204782
|
| abnormal T cell number
|
J:204782
|
\Cd72c/\Cd72c
\Faslpr/\Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
abnormal B cell number
|
J:204782
|
| abnormal T cell number
|
J:204782
|
\Cd72tm1Jrp/\Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal B cell differentiation
|
J:76990
|
| decreased B cell number
|
J:76990
|
| decreased B-2 B cell number
|
J:76990
|
| decreased follicular B cell number
|
J:76990
|
| decreased mature B cell number
|
J:76990
|
| increased B-1 B cell number
|
J:76990
|
| increased B-1a cell number
|
J:76990
|
| increased immature B cell number
|
J:76990
|
| increased marginal zone B cell number
|
J:76990
|
| increased pre-B cell number
|
J:76990
|
| increased pro-B cell number
|
J:76990
|
\Cd72tm1Jrp/\Cd72tm1Jrp
\Tg(BCL2)22Wehi/0
(either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))
|
decreased mature B cell number
|
J:76990
|
| increased immature B cell number
|
J:76990
|
\Cd72tm1Tsub/\Cd72tm1Tsub
\Faslpr/\Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)
|
abnormal B cell number
|
J:204782
|
| abnormal T cell number
|
J:204782
|
\Cd74em1(IMPC)H/\Cd74em1(IMPC)H
(C57BL/6N-Cd74em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Cd74tm1Doi/\Cd74tm1Doi
(either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6))
|
decreased CD4-positive, alpha-beta T cell number
|
J:4119,
J:45185
|
| increased CD8-positive, alpha-beta T cell number
|
J:4119
|
\Cd74tm1Doi/\Cd74tm1Doi
\H2-DMatm1Doi/\H2-DMatm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:42482
|
| increased CD8-positive, alpha-beta T cell number
|
J:42482
|
\Cd74tm1Doi/\Cd74tm1Doi
\Tap1tm1Arp/\Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell number
|
J:113083
|
\Cd74tm1Eae/\Cd74tm1Eae
(involves: 129S2/SvPas)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113050
|
\Cd74tm1Eae/\Cd74tm1Eae
(B6.129S2-Cd74tm1Eae)
|
arrested B cell differentiation
|
J:112084
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:65918
|
\Cd74tm1Liz/\Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:28966
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * BALB/cAn)
|
abnormal B cell differentiation
|
J:110927
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110927,
J:113714
|
| increased immature B cell number
|
J:110927
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
\Cd74tm1Liz/\Cd74tm1Liz
(involves: 129S/SvEv)
|
abnormal positive T cell selection
|
J:125548
|
\Cd74tm1Liz/\Cd74tm1Liz
(B6.129S-Cd74tm1Liz/J)
|
decreased B cell number
|
J:194664
|
\Cd74tm1Liz/\Cd74tm1Liz
\H2-DMatm1Liz/\H2-DMatm1Liz
(involves: 129S/SvEv * BALB/c)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113714
|
\Cd74tm1Liz/\Cd74tm1Liz
\H2-DMatm1Luc/\H2-DMatm1Luc
\Tg(CD74)AR194Ayr/?
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:88717
|
\Cd74tm1Liz/\Cd74tm1Liz
\H2-DMatm1Luc/\H2-DMatm1Luc
\Tg(CD74*)1Ayr/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:88717
|
\Cd74tm1Liz/\Cd74tm1Liz
\Sppl2atm1Basc/\Sppl2atm1Basc
(B6.129-Sppl2atm1Basc Cd74tm1Liz)
|
decreased B cell number
|
J:194664
|
\Cd74tm1Liz/\Cd74tm1Liz
\Sppl2atm1Dgen/\Sppl2atm1Dgen
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased follicular B cell number
|
J:194595
|
\Cd79am1Anu/\Cd79am1Anu
(involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)
|
absent pre-B cells
|
J:104190
|
\Cd79am1Anu/\Cd79am1Anu
(C57BL/6-Cd79am1Anu)
|
absent pre-B cells
|
J:171924
|
\Cd79am1Btlr/\Cd79am1Btlr
(involves: C57BL/6J * C57BL/10J)
|
decreased B cell number
|
J:174338
|
\Cd79am1Btlr/\Cd79am1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
\Cd79am2Btlr/\Cd79am2Btlr
(C57BL/6J-Cd79am2Btlr)
|
decreased B-1 B cell number
|
J:254836
|
\Cd79atm1(cre)Reth/\Cd79a+
\Commd3tm1.1Ksuz/\Commd3tm1.1Ksuz
(involves: BALB/c * C57BL/6NSlc * SJL)
|
abnormal plasmablast number
|
J:278399
|
| decreased follicular B cell number
|
J:278399
|
| decreased mature B cell number
|
J:278399
|
\Cd79atm1(cre)Reth/\Cd79a+
\Commd8tm1.1Ksuz/\Commd8tm1.1Ksuz
(involves: BALB/c * C57BL/6NSlc * SJL)
|
abnormal plasmablast number
|
J:278399
|
| decreased follicular B cell number
|
J:278399
|
| decreased mature B cell number
|
J:278399
|
\Cd79atm1(cre)Reth/\Cd79a+
\Ctnnbl1tm1.1Crad/\Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:232010
|
\Cd79atm1(cre)Reth/\Cd79a+
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Tg(BCL2)22Wehi/0
(involves: BALB/c * C57BL/6JWehi * SJL/JWehi)
|
decreased B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
\Cd79atm1(cre)Reth/\Cd79a+
\Dynll1tm1.1Jhh/\Dynll1tm1.1Jhh
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth)
|
abnormal B cell morphology
|
J:230105
|
| decreased immature B cell number
|
J:230105
|
| decreased mature B cell number
|
J:230105
|
| decreased pre-B cell number
|
J:230105
|
\Cd79atm1(cre)Reth/\Cd79a+
\Dynll1tm1.1Jhh/\Dynll1tm1.1Jhh
\Tg(IghMyc)22Bri/0
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth Tg(IghMyc)22Bri)
|
decreased immature B cell number
|
J:230105
|
\Cd79atm1(cre)Reth/\Cd79a+
\Eif4a1tm1.1Bea/\Eif4a1tm1.1Bea
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased B cell number
|
J:344730
|
| decreased pro-B cell number
|
J:344730
|
\Cd79atm1(cre)Reth/\Cd79a+
\Eif4btm1.1Tnr/\Eif4btm1.1Tnr
\Eif4htm1c(EUCOMM)Wtsi/\Eif4htm1c(EUCOMM)Wtsi
(involves: BALB/c * C57BL/6 * C57BL/6N)
|
decreased mature B cell number
|
J:344730
|
\Cd79atm1(cre)Reth/\Cd79a+
\Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
abnormal B cell differentiation
|
J:181705
|
| abnormal class switch recombination
|
J:181705
|
| absent B-1a cells
|
J:181705
|
| decreased follicular B cell number
|
J:181705
|
| decreased marginal zone B cell number
|
J:181705
|
| decreased mature B cell number
|
J:181705
|
| decreased pre-B cell number
|
J:181705
|
| decreased transitional stage B cell number
|
J:181705
|
\Cd79atm1(cre)Reth/\Cd79a+
\Huwe1tm1.1Mak/Y
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:181705
|
| absent B-1a cells
|
J:181705
|
\Cd79atm1(cre)Reth/\Cd79a+
\Ikzf1tm3.1Mbu/\Ikzf1tm3.1Mbu
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:209928
|
| abnormal B cell number
|
J:209928
|
| decreased pre-B cell number
|
J:209928
|
| increased pro-B cell number
|
J:209928
|
\Cd79atm1(cre)Reth/\Cd79a+
\Phf5atm1.1Oux/\Phf5atm1.1Oux
(involves: BALB/c * C57BL/6J)
|
abnormal B cell receptor editing
|
J:345807
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:345807
|
| decreased B cell number
|
J:345807
|
| decreased early pro-B cell number
|
J:345807
|
| decreased immature B cell number
|
J:345807
|
| decreased late pro-B cell number
|
J:345807
|
| decreased mature B cell number
|
J:345807
|
| decreased pre-B cell number
|
J:345807
|
| increased pre-pro B cell number
|
J:345807
|
\Cd79atm1(cre)Reth/\Cd79a+
\Phf5atm1.1Oux/\Phf5atm1.1Oux
\Tg(IghelMD4)4Ccg/0
(involves: BALB/c * C57BL/6 * C57BL/6J)
|
abnormal B cell number
|
J:345807
|
\Cd79atm1(cre)Reth/\Cd79a+
\Slc39a10tm1.1Tfk/\Slc39a10tm1.1Tfk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
decreased B cell number
|
J:213935
|
| decreased pro-B cell number
|
J:213935
|
\Cd79atm1(cre)Reth/\Cd79a+
\Wastm1.1Ldn/Y
(involves: BALB/c * C57BL/6)
|
decreased B cell number
|
J:182528
|
| decreased follicular B cell number
|
J:182528
|
| decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
\Cd79atm1(cre)Reth/\Cd79a+
\Wastm1.1Ldn/\Was+
(involves: BALB/c * C57BL/6)
|
abnormal B cell number
|
J:182528
|
\Cd79atm1(cre)Reth/\Cd79a+
\Wastm1.1Ldn/\Wastm1.1Ldn
(involves: BALB/c * C57BL/6)
|
decreased B cell number
|
J:182528
|
| decreased follicular B cell number
|
J:182528
|
| decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
\Cd79atm1(cre)Reth/\Cd79atm1(cre)Reth
\Mzb1tm1.1Rug/\Mzb1tm1.1Rug
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal B cell number
|
J:211639
|
| decreased pre-B cell number
|
J:211639
|
| increased late pro-B cell number
|
J:211639
|
| increased pro-B cell number
|
J:211639
|
\Cd79atm1.1Cgn/\Cd79a+
\Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:179254
|
| decreased pre-B cell number
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn
(involves: 129P2/OlaHsd)
|
decreased B-1a cell number
|
J:124400
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:71100
|
| decreased marginal zone B cell number
|
J:71100
|
| decreased mature B cell number
|
J:71100
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn
\Cd79btm1Gzmn/\Cd79b+
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:179254
|
| decreased pre-B cell number
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn
\Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:124400
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn
\Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:179254
|
| absent pre-B cells
|
J:179254
|
| decreased B cell number
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
\Cd79atm1.1Cgn/\Cd79atm1.1Cgn
\Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
absent mature B cells
|
J:71100
|
| arrested B cell differentiation
|
J:71100
|
\Cd79atm1.1Rsky/\Cd79atm1.1Rsky
(involves: C57BL/6)
|
decreased marginal zone B cell number
|
J:179254
|
| decreased mature B cell number
|
J:179254
|
| increased immature B cell number
|
J:179254
|
| increased pre-B cell number
|
J:179254
|
| increased transitional stage B cell number
|
J:179254
|
| increased transitional stage T1 B cell number
|
J:179254
|
| increased transitional stage T2 B cell number
|
J:179254
|
| increased transitional stage T3 B cell number
|
J:179254
|
\Cd79atm2(cre/Esr1*)Reth/\Cd79a+
\Rag1tm1.1Sadu/\Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
\Cd79atm2Cgn/\Cd79atm2Cgn
(involves: C57BL/6 * C.B-20)
|
decreased B cell number
|
J:80885
|
| decreased mature B cell number
|
J:80885
|
\Cd79atm2Cgn/\Cd79atm2Cgn
(involves: C57BL/6)
|
decreased mature B cell number
|
J:71100,
J:66840
|
| decreased pre-B cell number
|
J:71100,
J:66840
|
| increased pro-B cell number
|
J:66840
|
\Cd79atm2Cgn/\Cd79atm2Cgn
\Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
| decreased transitional stage B cell number
|
J:66840
|
\Cd79atm2Pld/\Cd79atm2Pld
(BALB/c-Cd79atm2Pld)
|
abnormal B cell differentiation
|
J:87492
|
| abnormal T cell differentiation
|
J:87492
|
| absent mature B cells
|
J:87492
|
| decreased double-positive T cell number
|
J:87492
|
\Cd79atm2Pld/\Cd79atm2Pld
\Cd79btm1Mnz/\Cd79btm1Mnz
(involves: 129S1/Sv * BALB/c)
|
absent pre-B cells
|
J:87492
|
\Cd79atm3Cgn/\Cd79atm3Cgn
\Tg(Mx1-cre)1Cgn/?
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:88620
|
\Cd79atm4.1Cgn/\Cd79atm4.1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
\Cd79atm4.1Cgn/\Cd79atm4.1Cgn
\Ightm1.2Rsky/\Igh+
(involves: BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:125719
|
\Cd79atm4Cgn/\Cd79atm4.1Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:91091
|
\Cd79atm4Cgn/\Cd79atm4.1Cgn
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
| arrested B cell differentiation
|
J:91091
|
| decreased B cell number
|
J:91091
|
| decreased follicular B cell number
|
J:91091
|
| decreased marginal zone B cell number
|
J:91091
|
\Cd79atm5.1Cgn/\Cd79a+
\Ightm1.2Rsky/\Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn
(involves: 129 * C57BL/6)
|
abnormal B cell morphology
|
J:125719
|
| decreased B-1a cell number
|
J:125719
|
| decreased immature B cell number
|
J:125719
|
| decreased mature B cell number
|
J:125719
|
| decreased pre-B cell number
|
J:125719
|
| decreased T cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn
\Ightm1.2Rsky/\Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
\Cd79atm5.1Cgn/\Cd79atm5.1Cgn
\Ightm1.2Rsky/\Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
abnormal B cell morphology
|
J:125719
|
| abnormal class switch recombination
|
J:125719
|
| decreased immature B cell number
|
J:125719
|
| decreased mature B cell number
|
J:125719
|
| decreased pre-B cell number
|
J:125719
|
| decreased T cell number
|
J:125719
|
| increased B-1b cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
\Cd79atm5Cgn/\Cd79atm5.1Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:91091
|
\Cd79atm5Cgn/\Cd79atm5.1Cgn
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
| arrested B cell differentiation
|
J:91091
|
| decreased B cell number
|
J:91091
|
\Cd79atm6Cgn/\Cd79atm6Cgn
(involves: C57BL/6)
|
abnormal B cell number
|
J:113407
|
| decreased B-1a cell number
|
J:113407
|
| increased transitional stage B cell number
|
J:113407
|
\Cd79bm1Btlr/\Cd79bm1Btlr
(C57BL/6J-Cd79bm1Btlr)
|
decreased B cell number
|
J:267537
|
| decreased B-1 B cell number
|
J:267537
|
| decreased NK cell number
|
J:267537
|
| increased alpha-beta T cell number
|
J:267537
|
| increased CD4-positive, alpha-beta T cell number
|
J:267537
|
| increased CD8-positive, alpha-beta T cell number
|
J:267537
|
\Cd79bm1Ghost/\Cd79bm1Ghost
(B10.Cg-Ptprca Cd79bm1Ghost H2a)
|
abnormal B cell differentiation
|
J:157450
|
| absent B cells
|
J:157450
|
| arrested B cell differentiation
|
J:157450
|
\Cd79bM2Btlr/\Cd79bM2Btlr
(C57BL/6J-Cd79bM2Btlr)
|
abnormal lymphocyte morphology
|
J:272863
|
| decreased B cell number
|
J:272863
|
| decreased B-1 B cell number
|
J:272863
|
\Cd79btm1Gzmn/\Cd79btm1Gzmn
(involves: 129/Sv * C57BL/6)
|
decreased B-1a cell number
|
J:124400
|
\Cd79btm1Mnz/\Cd79btm1Mnz
(involves: 129S1/Sv)
|
abnormal pro-B cell differentiation
|
J:78601
|
| abnormal pro-B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz
\Tg(BCL2)22Wehi/0
\Tg(IghelMD4)4Ccg/0
\Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz
\Tg(BCL2)22Wehi/0
\Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz
\Tg(IghelMD4)4Ccg/0
\Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
\Cd79btm1Mnz/\Cd79btm1Mnz
\Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv)
|
abnormal pre-B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
\Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129 * C57BL/6)
|
decreased mature B cell number
|
J:71100
|
\Cd79btm2.1Mnz/\Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
| decreased mature B cell number
|
J:66840
|
| decreased pre-B cell number
|
J:66840
|
| decreased transitional stage B cell number
|
J:66840
|
| increased pro-B cell number
|
J:66840
|
\Cd79btm3Mnz/\Cd79btm3Mnz
(involves: 129/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:128768
|
| decreased B cell number
|
J:128768
|
| decreased B-1a cell number
|
J:128768
|
| decreased immature B cell number
|
J:128768
|
| decreased mature B cell number
|
J:128768
|
| increased marginal zone B cell number
|
J:128768
|
| increased pro-B cell number
|
J:128768
|
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae)
|
decreased regulatory T cell number
|
J:205441,
J:113109
|
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell number
|
J:112266
|
| decreased double-positive T cell number
|
J:112266
|
\Cd80tm1Shr/\Cd80tm1Shr
\Cd86tm2Shr/\Cd86tm2Shr
\Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: 129S4/SvJae * FVB/N * NOD)
|
decreased regulatory T cell number
|
J:113109
|
\Cd81tm1Geha/\Cd81tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell morphology
|
J:43975
|
| decreased B-1 B cell number
|
J:43975
|
| decreased B-1a cell number
|
J:43975
|
\Cd81tm1Lvy/\Cd81tm1Lvy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell morphology
|
J:40394
|
\Cd81tm1Tmiy/\Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:41830
|
| decreased B-1 B cell number
|
J:41830
|
\Cd83anu/\Cd83anu
(involves: C57BL/6JAnu * CBA/CaJAnu)
|
abnormal B cell morphology
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
\Cd83lcd4/\Cd83lcd4
(involves: C57BL/6J)
|
abnormal CD4-positive T cell differentiation
|
J:92721
|
\Cd83tm1.1Lnjt/\Cd83tm1.1Lnjt
(involves: C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236611
|
\Cd83tm1.1Lnjt/\Cd83tm1.1Lnjt
\Marchf1tm1.1Sish/\Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236611
|
\Cd83tm1Tft/\Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75700
|
| arrested T cell differentiation
|
J:75700
|
| decreased CD4-positive, alpha-beta T cell number
|
J:75700
|
\Cd84tm1Pls/\Cd84tm1Pls
(C57BL/6J-Cd84tm1Pls)
|
abnormal long lived plasma cell morphology
|
J:157915
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157915
|
| decreased germinal center B cell number
|
J:157915
|
\Cd86tm1Shr/\Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
decreased regulatory T cell number
|
J:93421
|
\Cd180tm1Kmiy/\Cd180tm1Kmiy
\Faslpr/\Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
decreased B cell number
|
J:137066
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137066
|
| increased double-negative T cell number
|
J:137066
|
\Cd209atm1.1Cfg/\Cd209atm1.1Cfg
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:217719
|
| increased mature B cell number
|
J:217719
|
| increased plasma cell number
|
J:217719
|
\Cd209btm1.1Cfg/\Cd209btm1.1Cfg
(involves: C57BL/6)
|
decreased mature B cell number
|
J:217719
|
\Cd209dtm1.1Cfg/\Cd209dtm1.1Cfg
(involves: C57BL/6)
|
increased B cell number
|
J:217719
|
\Cd247tm1Lov/\Cd247tm1Lov
(involves: 129S4/SvJae)
|
abnormal single-positive T cell number
|
J:14170
|
| abnormal T-helper 1 cell morphology
|
J:14170
|
| absent gamma-delta intraepithelial T cell
|
J:46914
|
| decreased CD4-positive, alpha-beta T cell number
|
J:14170
|
| decreased double-positive T cell number
|
J:14170
|
| decreased thymocyte number
|
J:14170
|
\Cd247tm1Lov/\Cd247tm1Lov
\Fcer1gtm1Rav/\Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal effector T cell morphology
|
J:46914
|
| absent gamma-delta intraepithelial T cell
|
J:46914
|
| decreased thymocyte number
|
J:46914
|
\Cd247tm1Mal/\Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6))
|
abnormal intraepithelial T cell morphology
|
J:15272
|
| abnormal T cell differentiation
|
J:15272
|
| decreased CD4-positive, alpha-beta T cell number
|
J:15272
|
| decreased CD8-positive, alpha-beta T cell number
|
J:15272
|
| decreased double-positive T cell number
|
J:15272
|
| decreased single-positive T cell number
|
J:15272
|
| decreased thymocyte number
|
J:15272
|
| increased double-negative T cell number
|
J:15272
|
\Cd247tm1Mal/\Cd247tm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112990,
J:110847
|
| abnormal T cell differentiation
|
J:112990
|
| abnormal T cell morphology
|
J:110847
|
| decreased double-positive T cell number
|
J:110847
|
\Cd247tm1Mal/\Cd247tm1Mal
\Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:110847
|
| abnormal T cell differentiation
|
J:110847
|
| abnormal T cell morphology
|
J:110847
|
| decreased double-positive T cell number
|
J:110847
|
\Cd247tm1Mhu/\Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:15579
|
| decreased CD4-positive, alpha-beta T cell number
|
J:15579
|
| decreased CD8-positive, alpha-beta T cell number
|
J:15579
|
| decreased double-positive T cell number
|
J:15579
|
| decreased thymocyte number
|
J:15579
|
| increased double-negative T cell number
|
J:15579
|
\Cd247tm1Mhu/\Cd247tm1Mhu
\Fcer1gtm1Rav/\Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
\Cd247tm1Tks/\Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:15271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:15271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:15271
|
| decreased double-positive T cell number
|
J:15271
|
| decreased single-positive T cell number
|
J:15271
|
| decreased thymocyte number
|
J:15271
|
\Cd247tm1Tks/\Cd247tm1Tks
(B6.129P2-Cd247tm1Tks)
|
abnormal NK cell morphology
|
J:66403
|
| decreased NK T cell number
|
J:28282
|
\Cd247tm2.1Lov/\Cd247tm2.1Lov
(Not Specified)
|
abnormal gamma-delta T cell differentiation
|
J:192915
|
| abnormal NK T cell morphology
|
J:192915
|
| abnormal T cell differentiation
|
J:192915
|
| abnormal T-helper 1 cell differentiation
|
J:192915
|
| decreased CD4-positive, alpha-beta T cell number
|
J:192915
|
| decreased CD8-positive, alpha-beta T cell number
|
J:192915
|
| decreased thymocyte number
|
J:192915
|
| increased regulatory T cell number
|
J:192915
|
\Cd247tm2.1Lov/\Cd247tm2.1Lov
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:192915
|
\Cd274tm1.1Lex/\Cd274tm1.1Lex
(involves: 129S5/SvEvBrd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126829
|
\Cd274tm1Lpc/\Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc)
|
increased activated T cell number
|
J:89781
|
| increased CD8-positive, alpha-beta T cell number
|
J:89781
|
\Cd274tm1Lpc/\Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell morphology
|
J:136330
|
| abnormal T-helper 1 cell differentiation
|
J:162539
|
| decreased T helper 1 cell number
|
J:162539
|
| increased CD8-positive, alpha-beta T cell number
|
J:152305
|
| increased T cell number
|
J:142815
|
\Cd274tm1Lpc/\Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
|
decreased germinal center B cell number
|
J:165841
|
| decreased plasma cell number
|
J:165841
|
| decreased T-helper 17 cell number
|
J:165841
|
\Cd274tm1Shr/\Cd274tm1Shr
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:91480
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:91480
|
\Cdc7tm1.1(KOMP)Vlcg/\Cdc7+
(C57BL/6N-Cdc7tm1.1(KOMP)Vlcg/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Cdc42tm1b(EUCOMM)Hmgu/\Cdc42+
(C57BL/6N-Cdc42tm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Cdh10tm2b(KOMP)Wtsi/\Cdh10tm2b(KOMP)Wtsi
(C57BL/6N-Cdh10tm2b(KOMP)Wtsi/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Cdh17tm1Ohn/\Cdh17tm1Ohn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:96738
|
| decreased B-1a cell number
|
J:96738
|
| decreased germinal center B cell number
|
J:96738
|
| decreased marginal zone B cell number
|
J:96738
|
| decreased mature B cell number
|
J:96738
|
| increased pre-B cell number
|
J:96738
|
| increased pro-B cell number
|
J:96738
|
\Cdhr3em1(IMPC)Wtsi/\Cdhr3em1(IMPC)Wtsi
(C57BL/6NCrl-Cdhr3em1(IMPC)Wtsi/Wtsi)
|
decreased lymphocyte cell number
|
J:211773
|
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased single-positive T cell number
|
J:92529
|
\Cdk6tm1Phin/\Cdk6tm1Phin
(involves: 129S4/SvJae)
|
abnormal lymphopoiesis
|
J:144975
|
| abnormal T cell differentiation
|
J:144975
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144975
|
| decreased double-negative T cell number
|
J:144975
|
| decreased double-positive T cell number
|
J:144975
|
| decreased thymocyte number
|
J:144975
|
\Cdk6tm1Phin/\Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
\Cdk6tm1Phin/\Cdk6tm1Phin
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:144975
|
\Cdk6tm2.1Phin/\Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased DN4 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| decreased thymocyte number
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
| increased double-negative T cell number
|
J:174697
|
\Cdk6tm2.1Phin/\Cdk6tm2.1Phin
\Il2ratm1Dw/\Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
\Cdk6tm3.1Phin/\Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased DN1 thymic pro-T cell number
|
J:174697
|
| increased thymocyte number
|
J:174697
|
\Cdk6tm4.1Phin/\Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased DN4 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| decreased thymocyte number
|
J:174697
|
| increased CD4-positive, alpha-beta T cell number
|
J:174697
|
| increased CD8-positive, alpha-beta T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
\Cdkn1atm1Led/\Cdkn1atm1Led
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
| decreased lymphocyte cell number
|
J:76041
|
\Cdkn1atm1Led/\Cdkn1atm1Led
\Zbtb17tm1Cksn/\Zbtb17tm1Cksn
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zbtb17tm1Cksn Cdkn1atm1Led Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:60292
|
| increased B cell number
|
J:60292
|
| increased memory T cell number
|
J:60292
|
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6)
|
increased thymocyte number
|
J:33401
|
\Cdkn1btm1Kin/\Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell number
|
J:33402
|
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Nop53tm2.1Asuz/\Nop53tm2.1Asuz
\Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:71394
|
| increased CD8-positive, alpha-beta T cell number
|
J:71394
|
| increased double-positive T cell number
|
J:71394
|
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
abnormal lymphocyte morphology
|
J:63299
|
| increased mature B cell number
|
J:63299
|
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
abnormal lymphocyte morphology
|
J:63299
|
\Cdkn2ctm1Yxi/\Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased B cell number
|
J:50053
|
| increased T cell number
|
J:50053
|
\Cds2Gt(OST184358)Lex/\Cds2+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:103485
|
| increased T cell number
|
J:103485
|
\Cebpbtm1Vpo/\Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal plasma cell morphology
|
J:25215
|
\Cebpetm1Kgx/\Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
increased plasma cell number
|
J:76024
|
\Cebpetm1Kgx/\Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
increased plasma cell number
|
J:76024
|
\Cflartm1.1Pope/\Cflartm1.2Pope
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal B cell number
|
J:167430
|
| abnormal CD4-positive, alpha-beta T cell number
|
J:167430
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:167430
|
| abnormal lymphocyte cell number
|
J:167430
|
| increased CD8-positive, alpha-beta T cell number
|
J:167430
|
\Cflartm1Ywh/\Cflartm1Ywh
\Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased single-positive T cell number
|
J:100558
|
\Cgrrf1tm1b(KOMP)Wtsi/\Cgrrf1tm1b(KOMP)Wtsi
(C57BL/6N-Cgrrf1tm1b(KOMP)Wtsi/Wtsi)
|
increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
\Chd2Gt(RRBO46)Byg/\Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:146176
|
| increased CD4-positive, alpha-beta T cell number
|
J:146176
|
\Chd4tm1.1Kge/\Chd4tm1.1Kge
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:109547
|
| arrested T cell differentiation
|
J:109547
|
| decreased double-positive T cell number
|
J:109547
|
| increased CD8-positive, alpha-beta T cell number
|
J:109547
|
\Chd4tm1.2Kge/\Chd4tm1.2Kge
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell differentiation
|
J:109547
|
| decreased double-positive T cell number
|
J:109547
|
| increased CD8-positive, alpha-beta T cell number
|
J:109547
|
| increased double-negative T cell number
|
J:109547
|
\Chd7tm2a(EUCOMM)Wtsi/\Chd7+
(involves: 129S5/SvEvBrd * C57BL/6N)
|
increased NK T cell number
|
J:330596
|
\Chd7Whi/\Chd7+
(C3HeB/FeJ-Chd7Whi)
|
increased NK T cell number
|
J:330596
|
\Chd8em1(IMPC)Mbp/\Chd8+
(C57BL/6N-Chd8em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Chek2tm1Mak/\Chek2+
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
| decreased double-negative T cell number
|
J:103922
|
\Chi3l1tm1Eli/\Chi3l1tm1Eli
(B6.Cg-Chi3l1tm1Eli)
|
decreased T-helper 2 cell number
|
J:148490
|
\Chi3l1tm1Eli/\Chi3l1tm1Eli
\Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * CBA)
|
abnormal T-helper 2 cell number
|
J:148490
|
\Chia1tm1.1Lof/\Chia1tm1.1Lof
(C57BL/6-Chia1tm1.1Lof)
|
increased lymphocyte cell number
|
J:257728
|
\Chordc1em1(IMPC)Mbp/\Chordc1+
(C57BL/6N-Chordc1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Chrna5em1(IMPC)H/\Chrna5em1(IMPC)H
(C57BL/6N-Chrna5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Chrna7tm1Bay/\Chrna7tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased lymphocyte cell number
|
J:140280
|
\Chrnb2tm1Jpc/\Chrnb2tm1Jpc
(B6.129P2-Chrnb2tm1Jpc)
|
decreased B cell number
|
J:112766
|
\Chrnb2tm1Jpc/\Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:103908
|
\Chst1tm1(KOMP)Vlcg/\Chst1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased B cell number
|
J:204813
|
| increased T cell number
|
J:204813
|
\Chst3tm1Tmu/\Chst3tm1Tmu
(involves: 129S2/SvPas * 129X1/SvJ)
|
decreased T cell number
|
J:73698
|
\Chuktm2Mka/\Chuktm2Mka
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma)
|
decreased marginal zone B cell number
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
\Chuktm2Yhu/\Chuktm2Yhu
\Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:197037
|
| increased CD8-positive, alpha-beta T cell number
|
J:197037
|
\Churc1tm1b(EUCOMM)Wtsi/\Churc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Churc1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
\Cigs2tm1.1Anse/\Cigs2tm1.1Anse
(involves: BALB/cJ * C57BL/6)
|
abnormal class switch recombination
|
J:181313
|
\Ciitam1Btlr/\Ciitam1Btlr
(C57BL/6J-Ciitam1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221483
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221483
|
\Ciitatm1.1Dim/\Ciitatm1.1Dim
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:51885
|
\Ciitatm1Ccum/\Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal T cell differentiation
|
J:64283
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31601
|
| increased CD4-positive, alpha-beta T cell number
|
J:64283
|
| increased CD8-positive, alpha-beta T cell number
|
J:64283
|
\Ciitatm1Ccum/\Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
abnormal T cell differentiation
|
J:106081
|
| decreased CD4-positive, alpha-beta T cell number
|
J:106081
|
| increased CD8-positive, alpha-beta T cell number
|
J:106081
|
\Ciitatm1Jpyt/\Ciitatm1Jpyt
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell subpopulation ratio
|
J:57100
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57100
|
| increased CD8-positive, alpha-beta T cell number
|
J:57100
|
| increased double-positive T cell number
|
J:57100
|
\Ciitatm1Wrth/\Ciitatm1Wrth
(involves: 129P2/OlaHsd * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:233241
|
\Ciitatm2Wrth/\Ciitatm2Wrth
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92170
|
\Cimap2Retro/\Cimap2+
(involves: C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:223336
|
\Cimap2Retro/\Cimap2Retro
(involves: C57BL/6J)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:223336
|
| increased activated T cell number
|
J:223336
|
| increased CD8-positive, alpha-beta T cell number
|
J:223336
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:223336
|
\Cimap2tm1a(KOMP)Wtsi/\Cimap2+
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:223336
|
\Cishtm1.1Cdon/\Cishtm1.1Cdon
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:204829
|
\Cishtm1.2Cdon/\Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
| abnormal T-helper 2 cell differentiation
|
J:204829
|
| increased lymphocyte cell number
|
J:204829
|
\Ckbtm1.1(KOMP)Wtsi/\Ckbtm1.1(KOMP)Wtsi
(C57BL/6N-Ckbtm1.1(KOMP)Wtsi/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Cks1btm1Sir/\Cks1btm1Sir
\Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
decreased lymphocyte cell number
|
J:121564
|
\Clcnkbem1(IMPC)Mbp/\Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Cldn3em1(IMPC)H/\Cldn3em1(IMPC)H
(C57BL/6N-Cldn3em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Clec4a2tm1Yiw/\Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased single-positive T cell number
|
J:217720
|
\Clec4dtm1.1Cfg/\Clec4dtm1.1Cfg
(involves: C57BL/6)
|
increased B cell number
|
J:217719
|
| increased mature B cell number
|
J:217719
|
\Clec4etm1.1Cfg/\Clec4etm1.1Cfg
(B6.Cg-Clec4etm1.1Cfg)
|
decreased lymphocyte cell number
|
J:136334
|
\Clec4gtm1.1Cfg/\Clec4gtm1.1Cfg
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:217719
|
\Clec4gtm1.1Fhe/\Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
|
increased activated T cell number
|
J:200968
|
| increased CD4-positive, alpha-beta T cell number
|
J:200968
|
| increased CD8-positive, alpha-beta T cell number
|
J:200968,
J:194891
|
\Clec4ntm1Yiw/\Clec4ntm1Yiw
(B6.129P2-Clec4ntm1Yiw)
|
abnormal CD4-positive T cell differentiation
|
J:160680
|
\Clec10atm1Hed/\Clec10a+
\St3gal1tm1Jxm/\St3gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:78035
|
\Clec10atm1Hed/\Clec10atm1Hed
\St3gal1tm1Jxm/\St3gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:78035
|
\Clip2em1(IMPC)Ccpcz/\Clip2em1(IMPC)Ccpcz
(C57BL/6NCrl-Clip2em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Clnktm1Rygo/\Clnktm1Rygo
\Lcp2tm1Geha/\Lcp2tm1Geha
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c)
|
increased NK cell number
|
J:131621
|
\Clockem1(IMPC)Ccpcz/\Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Clpptm1a(EUCOMM)Wtsi/\Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased gamma-delta T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| increased B cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased mature B cell number
|
J:211773
|
\Clptm1ltm1d(EUCOMM)Wtsi/\Clptm1l+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
abnormal class switch recombination
|
J:265892
|
\Clptq1NZB/BlNJ/\Clptq1NZB/BlNJ
(B6.NZB-(D4Mit193-D4Mit33))
|
increased B-1a cell number
|
J:143646
|
| increased NK T cell number
|
J:143646
|
\Clspntm1(KOMP)Vlcg/\Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg)
|
increased B cell number
|
J:332163
|
\Cltatm1.2Fmb/\Cltatm1.2Fmb
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:235591
|
| decreased germinal center B cell number
|
J:235591
|
\Cluhem1(IMPC)Ccpcz/\Cluh+
(C57BL/6N-Cluhem1(IMPC)Ccpcz/Ccpcz)
|
increased Ly6C-positive mature NK cell number
|
J:211773
|
\Cmahtm1Avrk/\Cmahtm1Avrk
\Dock2m1Hsd/\Dock2m1Hsd
(B6NHsd.Cg-Dock2m1Hsd Cmahtm1Avrk)
|
decreased follicular B cell number
|
J:144035
|
| decreased marginal zone B cell number
|
J:144035
|
\Cmahtm1Avrk/\Cmahtm1Avrk
\Dock2m1Hsd/\Dock2m1Hsd
\Siaetm1.2Avrk/\Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd Cmahtm1Avrk)
|
decreased follicular B cell number
|
J:144035
|
| decreased marginal zone B cell number
|
J:144035
|
\Cmtm4tm1d(EUCOMM)Wtsi/\Cmtm4tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:333836
|
| increased B cell number
|
J:333836
|
\Cmtm7tm2a(EUCOMM)Hmgu/\Cmtm7+
\Rag1tm1Fwa/\Rag1tm1Fwa
(chimera involves: C57BL/6 * C57BL/6N)
|
abnormal B-1a B cell morphology
|
J:207033
|
| decreased B-1a cell number
|
J:207033
|
| decreased plasma cell number
|
J:207033
|
\Cnot4tm1b(EUCOMM)Wtsi/\Cnot4+
(C57BL/6N-Cnot4tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased KLRG1-positive NK cell number
|
J:211773
|
\Cnpy2em1(IMPC)Wtsi/\Cnpy2+
(C57BL/6N-Cnpy2em1(IMPC)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
\Coblem1(IMPC)Ccpcz/\Coblem1(IMPC)Ccpcz
(C57BL/6NCrl-Coblem1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory T-helper cell number
|
J:211773
|
\Cog6tm1a(EUCOMM)Wtsi/\Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased marginal zone B cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker gamma-delta T cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased B-2 B cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased follicular B cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
\Col1a1tm1(CAG-Ezh2*)Meln/\Col1a1+
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased germinal center B cell number
|
J:199122
|
\Col1a1tm1(tetO-Fos)Wag/\Col1a1+
\Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:201145
|
\Col1a1tm1(tetO-GFP/RNAi:Rad21)Iaai/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
\Col1a1tm1(tetO-Irf4)Sing/\Col1a1tm1(tetO-Irf4)Sing
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
\Irf4tm1Mak/\Irf4+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
| abnormal plasma cell differentiation
|
J:203903
|
\Col1a1tm1(tetO-Irf4)Sing/\Col1a1tm1(tetO-Irf4)Sing
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
\Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
| abnormal plasma cell differentiation
|
J:203903
|
\Col1a1tm1(tetO-RNAi:Rps19)Karl/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
\Col1a1tm1(tetO-RNAi:Rps19)Karl/\Col1a1tm1(tetO-RNAi:Rps19)Karl
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
\Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
\Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/\Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
\Col1a1tm2(tetO-RNAi:Rps19)Karl/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
\Col1a1tm2(tetO-RNAi:Rps19)Karl/\Col1a1tm2(tetO-RNAi:Rps19)Karl
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:179085
|
\Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:229031
|
\Col1a1tm6(tetO-MSI2)Jae/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:163322
|
\Col1a2tm1b(EUCOMM)Wtsi/\Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Col3a1m1Btlr/\Col3a1m1Btlr
(C57BL/6J-Col3a1m1Btlr)
|
increased alpha-beta T cell number
|
J:271973
|
| increased CD4-positive, alpha-beta T cell number
|
J:271973
|
| increased CD8-positive, alpha-beta T cell number
|
J:271973
|
\Col4a3tm1b(EUCOMM)Wtsi/\Col4a3tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a3tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Col4a5tm1b(EUCOMM)Wtsi/\Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
increased large unstained cell number
|
J:211773
|
\Col7a1em#Jtol/\Col7a1em#Jtol
(involves: 129S4/SvJae * BALB/c * C57BL/Ka * NOD)
|
absent B cells
|
J:280214
|
| absent NK T cells
|
J:280214
|
| absent T cells
|
J:280214
|
\Col10a1tm1Bhr/\Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased B cell number
|
J:62230
|
| decreased double-positive T cell number
|
J:62230
|
| decreased thymocyte number
|
J:62230
|
| increased CD4-positive, alpha-beta T cell number
|
J:62230
|
| increased double-negative T cell number
|
J:62230
|
| increased single-positive T cell number
|
J:62230
|
\Col10a1tm1Ksec/\Col10a1tm1Ksec
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:193886
|
| increased B cell number
|
J:193886
|
| increased T-helper cell number
|
J:193886
|
\Colgalt2tm1.1Hwei/\Colgalt2tm1.1Hwei
(involves: C57BL/6J)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:310468
|
| abnormal regulatory T cell morphology
|
J:310468
|
\Commd9tm1b(KOMP)Wtsi/\Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Commd10Tg(Vav1-icre)A2Kio/0
\Map3k7tm1.1Arte/\Map3k7tm1.1Arte
(involves: C57BL/10 * C57BL/6J * C57BL/6NTac * CBA/Ca)
|
increased B cell number
|
J:332172
|
| increased lymphocyte cell number
|
J:332172
|
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
\Zbtb11tm1.1Lieg/\Zbtb11tm1.1Lieg
(involves: C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:343208
|
\Comttm1Kara/\Comttm1Kara
(involves: 129S4/SvJaeSor)
|
increased uterine NK cell number
|
J:137276
|
\Copatm1.1Shum/\Copa+
(B6(CBA)-Copatm1.1Shum)
|
abnormal B cell morphology
|
J:288425
|
| decreased double-positive T cell number
|
J:288425
|
| increased effector memory T-helper cell number
|
J:288425
|
| increased single-positive T cell number
|
J:288425
|
\Cops5tm1Rpar/\Cops5tm1Rpar
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:132114
|
| decreased single-positive T cell number
|
J:132114
|
| decreased thymocyte number
|
J:132114
|
\Cops5tm1Rpar/\Cops5tm1Rpar
\Tg(Lck-cre)548Jxm/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
\Cops5tm1Rpar/\Cops5tm1Rpar
\Tg(Lck-cre)548Jxm/0
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129 * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:132114
|
\Cops8tm1Nwe/\Cops8tm1.1Nwe
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:126339
|
\Coro1akoy/\Coro1akoy
(C57BL/6-Coro1akoy)
|
decreased CD4-positive, alpha-beta T cell number
|
J:141431
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141431
|
| decreased thymocyte number
|
J:141431
|
\Coro1aptcd/\Coro1aptcd
(B6.CTS-Coro1aptcd)
|
abnormal effector T cell morphology
|
J:141431
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141431
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141431
|
| increased thymocyte number
|
J:141431
|
\Coro1aptcd/\Coro1atm1Achn
(B6.Cg-Coro1aptcd Coro1atm1Achn)
|
abnormal effector T cell morphology
|
J:141431
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141431
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141431
|
| increased thymocyte number
|
J:141431
|
\Coro1atm1Achn/\Coro1atm1Achn
(involves: 129X1/SvJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:111593
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111593
|
| decreased memory T cell number
|
J:111593
|
| decreased T cell number
|
J:111593
|
\Coro1atm1Achn/\Coro1atm1Achn
(B6.129X1-Coro1atm1Achn)
|
decreased thymocyte number
|
J:141431
|
\Coro1atm1Jpie/\Coro1atm1Jpie
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:133258
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133258
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133258
|
\Cpa3tm3(icre)Hrr/\Cpa3+
\Gt(ROSA)26Sortm1Hjf/?
\Notch1tm1Agt/\Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
\Cpa3tm3(icre)Hrr/\Cpa3+
\Notch1tm1Agt/\Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:143731
|
| abnormal B cell morphology
|
J:143731
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
| decreased double-negative T cell number
|
J:143731
|
| decreased double-positive T cell number
|
J:143731
|
| increased single-positive T cell number
|
J:143731
|
\Cpaptm1a(EUCOMM)Wtsi/\Cpaptm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cpaptm1a(EUCOMM)Wtsi/Wtsi)
|
increased CD8-positive, alpha-beta T cell number
|
J:194085
|
| increased T cell number
|
J:194085
|
\Cpgi5563tm1.1(NCC)Wcs/\Cpgi5563tm1.1(NCC)Wcs
(C57BL/6N-Cpgi5563tm1.1(NCC)Wcs/Wtsi)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:277622
|
| decreased CD8-positive, alpha-beta T cell number
|
J:277622
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:277622
|
| decreased gamma-delta T cell number
|
J:277622
|
\Cpmem1(IMPC)Ccpcz/\Cpmem1(IMPC)Ccpcz
(C57BL/6NCrl-Cpmem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Cps1em1(IMPC)H/\Cps1+
(C57BL/6NTac-Cps1em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
\Cr1ltm1.1Song/\Cr1ltm1.1Song
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:146538
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146538
|
| decreased lymphocyte cell number
|
J:146538
|
| increased B cell number
|
J:146538
|
\Cr1ltm1.1Song/\Cr1ltm1.1Song
\Tg(Lck-cre)548Jxm/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:146538
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146538
|
| decreased lymphocyte cell number
|
J:146538
|
| increased B cell number
|
J:146538
|
\Cr1ltm1.1Song/\Cr1ltm1.1Song
\Vsig4tm1Gne/\Vsig4tm1Gne
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6N * DBA/2 * SJL)
|
decreased lymphocyte cell number
|
J:146538
|
\Cr2tm1.1Jhws/\Cr2tm1.1Jhws
(Not Specified)
|
decreased B-1a cell number
|
J:205353
|
\Cr2tm1Crr/\Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B-1 B cell morphology
|
J:31942
|
| decreased B cell number
|
J:31942
|
| decreased B-1a cell number
|
J:69452
|
\Cr2tm1Crr/\Cr2tm1Crr
(involves: 129S7/SvEvBrd)
|
decreased follicular B cell number
|
J:69477
|
| increased marginal zone B cell number
|
J:69477
|
\Cr2tm1Hmo/\Cr2tm1Hmo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
| abnormal memory B cell differentiation
|
J:151991
|
\Cr2tm2.1(HLA-A)Crr/\Cr2tm2.1(HLA-A)Crr
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
| abnormal memory B cell differentiation
|
J:151991
|
\Crbntm1.1Ble/\Crbntm1.1Ble
(involves: C57BL/6)
|
decreased B cell number
|
J:267091
|
| decreased T cell number
|
J:267091
|
\Crebbptm1Dli/\Crebbp+
(involves: 129S6/SvEvTac * C57BL/6)
|
absent pre-B cells
|
J:60630
|
| decreased B cell number
|
J:60630
|
| decreased lymphocyte cell number
|
J:191503
|
\Crebbptm1Jvd/\Crebbptm1Jvd
\Ep300tm2Pkb/\Ep300tm2Pkb
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell number
|
J:105505
|
| decreased double-positive T cell number
|
J:105505
|
| increased double-negative T cell number
|
J:105505
|
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:105505
|
| decreased T cell number
|
J:105505
|
| decreased thymocyte number
|
J:105505
|
| increased double-positive T cell number
|
J:105505
|
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB)
|
decreased double-positive T cell number
|
J:88323
|
| increased CD8-positive, alpha-beta T cell number
|
J:88323
|
\Crebbptm1Pkb/\Crebbptm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
\Crip3tm1Mjb/\Crip3tm1Mjb
(either: (involves: 129S/Sv) or (involves: 129S/Sv * C57BL/6))
|
decreased thymocyte number
|
J:72942
|
\Crlf2tm1Wjl/\Crlf2tm1Wjl
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:108209
|
| decreased B cell number
|
J:108209
|
| decreased single-positive T cell number
|
J:108209
|
\Crtamtm1Achn/\Crtamtm1Achn
(involves: 129 * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:145314
|
| increased CD8-positive, alpha-beta T cell number
|
J:145314
|
\Crxem1(IMPC)Ccpcz/\Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
\Csf1tm1.2Sabw/\Csf1tm1.2Sabw
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell number
|
J:180199
|
| decreased lymphocyte cell number
|
J:180199
|
| increased T cell number
|
J:180199
|
\Csf1rtm1Ers/\Csf1rtm1Ers
(involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)
|
decreased lymphocyte cell number
|
J:73663
|
\Csf2raem1Szut/\Csf2raem1Szut
(C57BL/6-Csf2raem1Szut)
|
increased lymphocyte cell number
|
J:322934
|
\Csf3em1(IMPC)H/\Csf3em1(IMPC)H
(C57BL/6NTac-Csf3em1(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
\Csktm1Sor/\Csk+
\Ptprcltng/\Ptprctm1Mak
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
\Csktm1Tara/\Csktm1Tara
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:49654
|
| absent CD8-positive, alpha-beta T cells
|
J:49654
|
\CsptC57BL/6/\CsptC57BL/6
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
increased CD8-positive, alpha-beta T cell number
|
J:97046
|
\CsptC57BL/6/\CsptNOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
increased CD8-positive, alpha-beta T cell number
|
J:97046
|
\Cstbtm1b(EUCOMM)Wtsi/\Cstbtm1b(EUCOMM)Wtsi
(C57BL/6N-Cstbtm1b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
\Ctcftm2Gal/\Ctcf+
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10)
|
decreased double-positive T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
| abnormal T cell morphology
|
J:143271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
| decreased single-positive T cell number
|
J:143271
|
| increased double-negative T cell number
|
J:143271
|
| increased single-positive T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal
\Tg(Lck-cre)1Cwi/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J)
|
abnormal T cell differentiation
|
J:143271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
\Ctcftm2Gal/\Ctcftm2Gal
\Tg(Lck-cre)1Cwi/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
| decreased T cell number
|
J:143271
|
| increased double-negative T cell number
|
J:143271
|
| increased single-positive T cell number
|
J:143271
|
\Ctla4m1Btlr/\Ctla4m1Btlr
(C57BL/6J-Ctla4m1Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:265263
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265263
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265263
|
\Ctla4tm1All/\Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:42481
|
| decreased T cell number
|
J:42481
|
| increased double-negative T cell number
|
J:42481
|
\Ctla4tm1All/\Ctla4tm1All
\Tg(TcrAND)53Hed/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:119845
|
| abnormal T cell subpopulation ratio
|
J:119845
|
| increased CD4-positive, alpha-beta T cell number
|
J:119845
|
| increased CD8-positive, alpha-beta T cell number
|
J:119845
|
\Ctla4tm1All/\Ctla4tm1All
\Tg(TcraTcrb)8Rest/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:140448
|
| increased CD4-positive, alpha-beta T cell number
|
J:140448
|
\Ctla4tm1Saka/\Ctla4tm1Saka
\Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
|
increased regulatory T cell number
|
J:140085
|
\Ctla4tm1Shr/\Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal T cell differentiation
|
J:30393
|
| abnormal T cell morphology
|
J:30393
|
| decreased double-positive T cell number
|
J:30393
|
| increased double-negative T cell number
|
J:30393
|
| increased T cell number
|
J:30393
|
\Ctnnb1tm4Wbm/\Ctnnb1tm4Wbm
\Krt14tm1(cre)Wbm/\Krt14+
(involves: 129P2/OlaHsd)
|
decreased gamma-delta T cell number
|
J:202499
|
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio)
|
decreased B cell number
|
J:348981
|
| decreased double-positive T cell number
|
J:348981
|
| decreased NK cell number
|
J:348981
|
| decreased T cell number
|
J:348981
|
| increased CD4-positive, alpha-beta T cell number
|
J:348981
|
| increased CD8-positive, alpha-beta T cell number
|
J:348981
|
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Ctps2tm1c(EUCOMM)Hmgu/\Ctps2tm1c(EUCOMM)Hmgu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:348981
|
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj)
|
decreased germinal center B cell number
|
J:348981
|
| decreased lymphocyte cell number
|
J:348981
|
| decreased T follicular helper cell number
|
J:348981
|
| increased CD8-positive, alpha-beta T cell number
|
J:348981
|
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased effector memory T-helper cell number
|
J:348981
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:348981
|
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/0
\Foxp3sf/Y
\Rag1tm1Mom/\Rag1+
(mixed)
|
decreased regulatory T cell number
|
J:348981
|
\Ctsdtm1.1Thre/\Ctsdtm1.1Thre
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
decreased double-positive T cell number
|
J:227618
|
\Ctsdtm1.1Thre/\Ctsdtm1.1Thre
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased double-positive T cell number
|
J:227618
|
\Ctsdtm1Cptr/\Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
decreased double-positive T cell number
|
J:28201
|
| decreased lymphocyte cell number
|
J:28201
|
\Ctsetm1Kjy/\Ctsetm1Kjy
(involves: C57BL/6)
|
increased double-positive T cell number
|
J:108745
|
\Ctslm1Btlr/\Ctslm1Btlr
(C57BL/6J-Ctslm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272869
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:272869
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272869
|
| abnormal T cell differentiation
|
J:272869
|
| decreased alpha-beta T cell number
|
J:272869
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272869
|
| increased alpha-beta T cell number
|
J:272869
|
| increased CD8-positive, alpha-beta T cell number
|
J:272869
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272869
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272869
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272869
|
\Ctslnkt/\Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))
|
decreased CD4-positive, alpha-beta T cell number
|
J:54856
|
\Ctslnkt/\Ctslnkt
(C.Cg-Ctslnkt)
|
decreased CD4-positive, alpha-beta T cell number
|
J:99009
|
| increased CD8-positive, alpha-beta T cell number
|
J:99009
|
\Ctsltm1.2Thre/\Ctsltm1.2Thre
(involves: C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:216506
|
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased regulatory T cell number
|
J:153355
|
\Ctsltm1Cptr/\Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:153355
|
| increased regulatory T cell number
|
J:153355
|
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:216506
|
\Ctsstm1Hap/\Ctsstm1Hap
\Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:100854
|
\Cttnbp2tm1b(KOMP)Wtsi/\Cttnbp2tm1b(KOMP)Wtsi
(C57BL/6N-Cttnbp2tm1b(KOMP)Wtsi/Wtsi)
|
decreased transitional stage T1 B cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
\Cul4a/Pcid2tm2Ktc/\Cul4a/Pcid2tm2Ktc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
decreased lymphocyte cell number
|
J:138468
|
\Cul4a/Pcid2tm2Ktc/\Cul4a/Pcid2tm2Ktc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
decreased lymphocyte cell number
|
J:138468
|
\Cux1tm1Rhsc/\Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal T cell differentiation
|
J:100055
|
| decreased B cell number
|
J:100055
|
| decreased double-positive T cell number
|
J:100055
|
| decreased thymocyte number
|
J:100055
|
\Cx3cr1tm1Litt/\Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
decreased NK cell number
|
J:129712
|
\Cxadrtm1.1Ics/\Cxadrtm1.1Ics
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
increased thymocyte number
|
J:174138
|
\Cxcl9tm1b(EUCOMM)Wtsi/\Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Cxcl10tm1Adl/\Cxcl10tm1Adl
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:75584
|
\Cxcl11em1Groj/\Cxcl11em1Groj
(C57BL/6J-Cxcl11em1Groj)
|
abnormal B cell morphology
|
J:345391
|
| increased CD8-positive, alpha-beta T cell number
|
J:345391
|
\Cxcl12tm1.1Sjm/\Cxcl12tm1.1Sjm
\Ndor1Tg(UBC-cre/ERT2)1Ejb/?
(involves: 129S/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:194748
|
\Cxcl12tm1.1Sjm/\Cxcl12tm1.1Sjm
\Tg(Prrx1-cre)1Cjt/?
(involves: C57BL/6 * SJL/J)
|
abnormal B cell differentiation
|
J:194748
|
\Cxcl12tm1.1Ystz/\Cxcl12tm1.2Ystz
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased pro-B cell number
|
J:168434
|
\Cxcl12tm1Tng/\Cxcl12tm1.1Link
\Tg(BGLAP-cre)1Clem/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * FVB/N)
|
decreased B cell number
|
J:193594
|
\Cxcl12tm1Tng/\Cxcl12tm1.1Link
\Tg(Prrx1-cre)1Cjt/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL/J)
|
decreased B cell number
|
J:193594
|
| decreased pre-pro B cell number
|
J:193594
|
\Cxcl12tm1Tng/\Cxcl12tm1.1Link
\Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N)
|
decreased B cell number
|
J:193594
|
| decreased pre-pro B cell number
|
J:193594
|
\Cxcl12tm1Tng/\Cxcl12tm1Tng
(involves: 129P2/OlaHsd)
|
decreased pre-B cell number
|
J:34750
|
| decreased pro-B cell number
|
J:34750
|
\Cxcl12tm3.1(HBEGF/EGFP)Tng/\Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng)
|
decreased pro-B cell number
|
J:164657
|
\Cxcl13em2(IMPC)H/\Cxcl13em2(IMPC)H
(C57BL/6NTac-Cxcl13em2(IMPC)H/H)
|
increased lymphocyte cell number
|
J:211773
|
\Cxcl13m1Btlr/\Cxcl13m1Btlr
(C57BL/6J-Cxcl13m1Btlr)
|
increased B-1 B cell number
|
J:221480
|
\Cxcl16tm1Syon/\Cxcl16tm1Syon
(B6.129P2-Cxcl16tm1Syon)
|
decreased NK T cell number
|
J:155199
|
\Cxcr2tm1a(EUCOMM)Wtsi/\Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased immature B cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased pre-B cell number
|
J:211773
|
| decreased pre-pro B cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1+ CD4 alpha-beta T cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
\Cxcr2tm1Mwm/\Cxcr2tm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
increased B cell number
|
J:19570
|
\Cxcr4em1(IMPC)Mbp/\Cxcr4+
(C57BL/6NCrl-Cxcr4em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Cxcr4tm1.1Bala/\Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:186735
|
| decreased B cell number
|
J:186735
|
| decreased immature B cell number
|
J:186735
|
| decreased NK cell number
|
J:178789
|
| decreased T cell number
|
J:186735
|
| increased mature B cell number
|
J:186735
|
| increased NK cell number
|
J:178789
|
\Cxcr4tm1Qma/\Cxcr4tm1Qma
(involves: 129X1/SvJ)
|
decreased pro-B cell number
|
J:49070
|
\Cxcr4tm1Tng/\Cxcr4tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:69256
|
\Cxcr4tm1Tng/\Cxcr4tm1Tng
(B6.Cg-Cxcr4tm1Tng)
|
abnormal T cell differentiation
|
J:82996
|
| decreased double-positive T cell number
|
J:82996
|
\Cxcr4tm1Yiw/\Cxcr4tm1Yiw
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:164872
|
\Cxcr4tm1Yzo/\Cxcr4tm1Yzo
(Not Specified)
|
abnormal B cell differentiation
|
J:167314
|
| abnormal lymphopoiesis
|
J:69255
|
\Cxcr4tm2Yzo/\Cxcr4tm2Yzo
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:94911
|
| decreased B-1 B cell number
|
J:94911
|
| decreased B-2 B cell number
|
J:94911
|
| decreased mature B cell number
|
J:94911
|
| decreased plasma cell number
|
J:94911
|
\Cxcr4tm2Yzo/\Cxcr4tm2Yzo
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:217569
|
\Cxcr4tm2Yzo/\Cxcr4tm2Yzo
\Tg(Fabp4-cre)1Rev/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:217569
|
| decreased CD4-positive, alpha-beta T cell number
|
J:217569
|
| increased CD8-positive, alpha-beta T cell number
|
J:217569
|
\Cxcr4tm2Yzo/\Cxcr4tm3.1Yzo
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:167314
|
\Cxcr4tm3.1Yzo/\Cxcr4tm3.1Yzo
(Not Specified)
|
decreased pro-B cell number
|
J:167314
|
\Cxcr5tm1Lipp/\Cxcr5tm1Lipp
(involves: 129S2/SvPas * CD-1)
|
increased B cell number
|
J:37126
|
\Cybbtm1Din/\Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
increased lymphocyte cell number
|
J:235399
|
\Cycstm1Mak/\Cycstm1Mak
(involves: C57BL/6)
|
absent pre-B cells
|
J:98949
|
| decreased B cell number
|
J:98949
|
| decreased T cell number
|
J:98949
|
\Cyldtm1.1Awai/\Cyldtm1.1Awai
(Not Specified)
|
abnormal B cell differentiation
|
J:126113
|
| abnormal B cell morphology
|
J:126113
|
| abnormal class switch recombination
|
J:126113
|
| decreased B-1 B cell number
|
J:126113
|
| decreased immature B cell number
|
J:126113
|
| increased B cell number
|
J:126113
|
| increased follicular B cell number
|
J:126113
|
| increased marginal zone B cell number
|
J:126113
|
| increased pro-B cell number
|
J:126113
|
\Cyldtm1Awai/\Cyldtm1Awai
\Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
abnormal mature B cell morphology
|
J:126113
|
| decreased B-1 B cell number
|
J:126113
|
| decreased immature B cell number
|
J:126113
|
| increased B cell number
|
J:126113
|
\Cyldtm1Scs/\Cyldtm1Scs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112392
|
| abnormal T cell number
|
J:112392
|
| decreased CD4-positive, alpha-beta T cell number
|
J:112392
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112392
|
| increased double-positive T cell number
|
J:112392
|
\Cyp1a1tm1.1Dwn/\Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
|
decreased lymphocyte cell number
|
J:163973
|
\Cyp1a1tm4.1Dwn/\Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
|
decreased lymphocyte cell number
|
J:163973
|
\Cyp19a1tm1b(EUCOMM)Hmgu/\Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Cyp19a1tm1Esi/\Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased B cell number
|
J:92438
|
| increased lymphocyte cell number
|
J:92438
|
| increased mature B cell number
|
J:92438
|
\Cyp27b1tm1b(EUCOMM)Hmgu/\Cyp27b1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp27b1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Cyp27b1tm1Dgo/\Cyp27b1tm1Dgo
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased T cell number
|
J:70030
|
\Cyrenem1Vokh/\Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
abnormal class switch recombination
|
J:306598
|
\Cyrentm1.1(KOMP)Vlcg/\Cyrentm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal class switch recombination
|
J:265834
|
\Cytiptm1Tes/\Cytiptm1Tes
(involves: 129S1/Sv * FVB/N)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:110320
|
| decreased lymphocyte cell number
|
J:110320
|
\D6Wsu163etm1b(EUCOMM)Wtsi/\D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Daam2tm1b(KOMP)Wtsi/\Daam2tm1b(KOMP)Wtsi
(C57BL/6N-Daam2tm1b(KOMP)Wtsi/Wtsi)
|
increased large unstained cell number
|
J:211773
|
\Dapp1tm1Mnz/\Dapp1tm1Mnz
(B6.129P2-Dapp1tm1Mnz)
|
decreased B-1a cell number
|
J:86182
|
\Dbn1tm1b(KOMP)Wtsi/\Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Wtsi)
|
increased CD8-positive, alpha-beta T cell number
|
J:211773
|
\Dbr1Gt(YTA280)Byg/\Dbr1+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:223318
|
\Dcaf5em1(IMPC)Ccpcz/\Dcaf5em1(IMPC)Ccpcz
(C57BL/6NCrl-Dcaf5em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Dcaf12em1(IMPC)Ccpcz/\Dcaf12em1(IMPC)Ccpcz
(C57BL/6N-Dcaf12em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Dcaf15tm1a(EUCOMM)Hmgu/\Dcaf15tm1a(EUCOMM)Hmgu
(C57BL/6NCrl-Dcaf15tm1a(EUCOMM)Hmgu/Ccpcz)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Dckm1Btlr/\Dck+
(C57BL/6J-Dckm1Btlr)
|
decreased B cell number
|
J:236696
|
\Dckm1Btlr/\Dckm1Btlr
(C57BL/6J-Dckm1Btlr)
|
decreased B cell number
|
J:236696
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236696
|
| increased CD8-positive, alpha-beta T cell number
|
J:236696
|
\Dckmemi/\Dckmemi
(C57BL/6J-Dckmemi)
|
abnormal T cell differentiation
|
J:184080
|
| decreased B cell number
|
J:184080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184080
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:184080
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:184080
|
\Dcktm1.1Radu/\Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal double-negative T cell morphology
|
J:158373
|
| abnormal T cell differentiation
|
J:158373
|
| decreased B cell number
|
J:158373
|
| decreased double-positive T cell number
|
J:158373
|
| decreased pre-B cell number
|
J:158373
|
| decreased T cell number
|
J:158373
|
| increased double-negative T cell number
|
J:158373
|
| increased pro-B cell number
|
J:158373
|
\Dclre1cm1Brck/\Dclre1cm1Brck
(involves: C3H * C57BL/6)
|
absent B cells
|
J:207533
|
| absent T cells
|
J:207533
|
\Dclre1cm1Brck/\Dclre1cm1Brck
(involves: C57BL/6)
|
absent B cells
|
J:207533
|
| absent CD4-positive, alpha-beta T cells
|
J:207533
|
| absent CD8-positive, alpha-beta T cells
|
J:207533
|
| decreased DN1 thymic pro-T cell number
|
J:207533
|
| decreased DN4 thymocyte number
|
J:207533
|
| decreased double-positive T cell number
|
J:207533
|
| decreased pre-B cell number
|
J:207533
|
\Dclre1cm1Btlr/\Dclre1cm1Btlr
(C57BL/6J-Dclre1cm1Btlr)
|
decreased B cell number
|
J:217790
|
| decreased single-positive T cell number
|
J:217790
|
| decreased T cell number
|
J:217790
|
| increased NK cell number
|
J:217790
|
\Dclre1cM2Btlr/\Dclre1cM2Btlr
(C57BL/6J-Dclre1cM2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265131
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265131
|
| decreased single-positive T cell number
|
J:265131
|
| decreased T cell number
|
J:265131
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265131
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265131
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265131
|
\Dclre1cm3Btlr/\Dclre1cm3Btlr
(C57BL/6J-Dclre1cm3Btlr)
|
decreased B cell number
|
J:265132
|
| decreased B-1 B cell number
|
J:265132
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265132
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265132
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265132
|
| decreased NK T cell number
|
J:265132
|
| decreased single-positive T cell number
|
J:265132
|
| decreased T cell number
|
J:265132
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265132
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265132
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265132
|
\Dclre1ctm1.1Fwa/\Dclre1ctm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:80995
|
| arrested T cell differentiation
|
J:80995
|
\Dclre1ctm1.1Jpdv/\Dclre1ctm1.1Jpdv
(involves: 129P1/ReJ)
|
abnormal B cell differentiation
|
J:137743
|
| abnormal T cell receptor V(D)J recombination
|
J:194422
|
| arrested T cell differentiation
|
J:137712
|
\Dclre1ctm1Fwa/\Dclre1ctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
absent immature B cells
|
J:80995
|
| arrested B cell differentiation
|
J:80995
|
| arrested T cell differentiation
|
J:80995
|
| decreased thymocyte number
|
J:80995
|
\Dclre1ctm1Fwa/\Dclre1ctm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
| absent B cells
|
J:147864
|
| arrested B cell differentiation
|
J:147864
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147864
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147864
|
| decreased double-positive T cell number
|
J:147864
|
| decreased thymocyte number
|
J:147864
|
\Dclre1ctm1Jsek/\Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:147864
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
| decreased B cell number
|
J:147864
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147864
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147864
|
| decreased double-positive T cell number
|
J:147864
|
| decreased pre-B cell number
|
J:147864
|
| decreased thymocyte number
|
J:147864
|
| increased pro-B cell number
|
J:147864
|
\Dclre1ctm2.1Jpdv/\Dclre1ctm2.2Jpdv
\Tg(Cr2-cre)3Cgn/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:153841
|
\Dclre1ctm2.2Jpdv/\Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv)
|
absent immature B cells
|
J:153841
|
| arrested B cell differentiation
|
J:153841
|
| arrested T cell differentiation
|
J:153841
|
| decreased CD4-positive, alpha-beta T cell number
|
J:153841
|
| decreased CD8-positive, alpha-beta T cell number
|
J:153841
|
| decreased double-positive T cell number
|
J:153841
|
| decreased mature B cell number
|
J:153841
|
| decreased thymocyte number
|
J:153841
|
\Dclre1ctm2Mcow/\Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:96535
|
| arrested T cell differentiation
|
J:96535
|
| decreased lymphocyte cell number
|
J:96535
|
| decreased thymocyte number
|
J:96535
|
\Ddit3tm2.1Dron/\Ddit3tm2.1Dron
(B6.129S(Cg)-Ddit3tm2.1Dron/J)
|
abnormal T cell morphology
|
J:214136
|
\Ddrgk1tm1c(EUCOMM)Hmgu/\Ddrgk1tm1c(EUCOMM)Hmgu
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:231701
|
\Ddx52tm1a(EUCOMM)Wtsi/\Ddx52+
(C57BL/6N-Ddx52tm1a(EUCOMM)Wtsi/Ics)
|
decreased NK cell number
|
J:165965
|
\Def6Gt(OST307148)Lex/\Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased immature B cell number
|
J:106469
|
| increased memory T cell number
|
J:106469
|
| increased T cell number
|
J:106469
|
\Del(3Cd1d2-Cd1d1)1Crw/\Del(3Cd1d2-Cd1d1)1Crw
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:174337
|
| decreased NK T cell number
|
J:112657,
J:174337,
J:39749,
J:76976
|
\Del(3Cd1d2-Cd1d1)1Crw/\Del(3Cd1d2-Cd1d1)1Crw
\TcraLn1Ogu/\Tcra+
(involves: 129/Sv * C57BL/6)
|
abnormal NK T cell morphology
|
J:152041
|
\Del(3Cd1d2-Cd1d1)1Crw/\Del(3Cd1d2-Cd1d1)1Crw
\Tg(TcraAV19AJ33)1Shima/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK T cell morphology
|
J:112657
|
\Del(3Cd1d2-Cd1d1)1Sbp/\Del(3Cd1d2-Cd1d1)1Sbp
(involves: 129S6/SvEvTac)
|
decreased NK T cell number
|
J:151699
|
\Del(6Gimap5-Gimap3)1Yout/\Del(6Gimap5-Gimap3)1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased B cell number
|
J:209926
|
| decreased NK cell number
|
J:209926
|
| decreased T cell number
|
J:209926
|
\Del(9Cd3g-Cd3d)1Cpt/\Del(9Cd3g-Cd3d)1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
absent gamma-delta T cells
|
J:76991
|
| arrested T cell differentiation
|
J:76991
|
| decreased alpha-beta T cell number
|
J:76991
|
\Del(11Stat5a-Stat5b)1Mam/\Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
absent gamma-delta T cells
|
J:122463
|
| arrested B cell differentiation
|
J:122463
|
| decreased B cell number
|
J:122463
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122463
|
\Del(14Trim13-Dleu2)4Rdf/\Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
\Del(14Trim13-Rnaseh2b)6Rdf/\+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
| increased B cell number
|
J:179879
|
\Del(15Rr316124-Rr313939)2Fsp/\+
\Myctm1Atp/\Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:257739
|
\Del(15Rr316124-Rr313939)2Fsp/\+
\Rr331em1Fsp/\Rr331+
(involves: C57BL/6)
|
decreased B cell number
|
J:257739
|
| increased pre-B cell number
|
J:257739
|
\Del(15Rr316124-Rr313939)2Fsp/\+
\Rr307328em1Fsp/\Rr307328+
(involves: C57BL/6)
|
decreased B cell number
|
J:257739
|
| increased pre-B cell number
|
J:257739
|
\Del(15Rr316124-Rr313939)2Fsp/\Del(15Rr316124-Rr313939)2Fsp
(Not Specified)
|
decreased B cell number
|
J:257739
|
\Del(17Btnl1-Btnl6)1Ahay/\Del(17Btnl1-Btnl6)1Ahay
(involves: BALB/c * C57BL/6J)
|
decreased CD4-positive, gamma-delta intraepithelial T cell number
|
J:291989
|
\Dennd1btm1.2Achn/\Dennd1btm1.2Achn
(involves: C57BL/6)
|
abnormal T cell number
|
J:229307
|
\Dennd5bem1(IMPC)Tcp/\Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Dffbtm1Osa/\Dffbtm1Osa
\Dnase2atm1Osa/\Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:81474
|
| decreased double-positive T cell number
|
J:81474
|
| increased double-negative T cell number
|
J:81474
|
\Dgkatm1Xpz/\Dgkatm1Xpz
(involves: 129 * C57BL/6)
|
increased T cell number
|
J:113564
|
\Dgkatm1Xpz/\Dgkatm1Xpz
\Dgkztm1Gak/\Dgkztm1Gak
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:113564
|
\Dgkztm1Gak/\Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85149
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85149
|
| increased B cell number
|
J:85149
|
\Dgkztm1Gak/\Dgkztm1Gak
(B6.129X1-Dgkztm1Gak)
|
increased T cell number
|
J:113564
|
\Dh/\Dh+
(Not Specified)
|
increased lymphocyte cell number
|
J:30753
|
\Dh/\Dh+
(B6.CBA-Dh)
|
abnormal T cell differentiation
|
J:5834
|
\Dhx9Tn(pb-Act-RFP)1.071225026-HRAZhu/\Dhx9+
\Igs12tm1Zhu/\Igs12tm1Zhu
\Ptprca/\Ptprcb
\Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/NJ * SJL/J)
|
abnormal T cell differentiation
|
J:207361
|
\Dhx15tm1c(EUCOMM)Wtsi/\Dhx15tm1c(EUCOMM)Wtsi
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N)
|
abnormal B cell differentiation
|
J:284624
|
| decreased B cell number
|
J:284624
|
| decreased pre-B cell number
|
J:284624
|
\Dhx15tm1c(EUCOMM)Wtsi/\Dhx15tm1c(EUCOMM)Wtsi
\Tg(Cd4-cre)1Cwi/0
(involves: C3H * C57BL/6N * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:284624
|
| decreased CD8-positive, alpha-beta T cell number
|
J:284624
|
\Diaph1M1Btlr/\Diaph1+
(C57BL/6J-Diaph1M1Btlr)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:254820
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254820
|
\Diaph1M1Btlr/\Diaph1M1Btlr
(C57BL/6J-Diaph1M1Btlr)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:254820
|
| abnormal CD8-positive, alpha-beta T cell number
|
J:254820
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254820
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254820
|
\Diaph1M2Btlr/\Diaph1+
(C57BL/6J-Diaph1M2Btlr)
|
decreased B-1 B cell number
|
J:254819
|
\Diaph1M2Btlr/\Diaph1M2Btlr
(C57BL/6J-Diaph1M2Btlr)
|
decreased B-1 B cell number
|
J:254819
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:254819
|
\Diaph1m3Btlr/\Diaph1m3Btlr
(C57BL/6J-Diaph1m3Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254818
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254818
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254818
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254818
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254818
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254818
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254818
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:254818
|
\Diaph1tm1.1Sna/\Diaph1tm1.1Sna
(B6.Cg-Diaph1tm1.1Sna)
|
decreased CD4-positive, alpha-beta T cell number
|
J:126090
|
| decreased CD8-positive, alpha-beta T cell number
|
J:126090
|
| decreased T cell number
|
J:126090
|
| increased single-positive T cell number
|
J:126090
|
\Diaph1tm1Asal/\Diaph1tm1Asal
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:124319
|
\Dicer1m1Btlr/\Dicer1m1Btlr
(C57BL/6J-Dicer1m1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265172
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265172
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265172
|
| decreased single-positive T cell number
|
J:265172
|
| decreased T cell number
|
J:265172
|
| increased B-1 B cell number
|
J:265172
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265172
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265172
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265172
|
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Aicdatm1(cre)Njen/\Aicda+
(involves: 129 * C57BL/6)
|
absent memory B cells
|
J:181782
|
| absent plasma cells
|
J:181782
|
| decreased germinal center B cell number
|
J:181782
|
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased regulatory T cell number
|
J:138683
|
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\Tg(Foxp3-EGFP/icre)1aJbs/0
(involves: 129 * NOD/ShiLt)
|
abnormal effector T cell morphology
|
J:138808
|
| abnormal regulatory T cell morphology
|
J:138808
|
| decreased regulatory T cell number
|
J:138808
|
\Dicer1tm1Dli/\Dicer1tm1Dli
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:100546
|
\Dicer1tm1Mmk/\Dicer1tm1.1Mmk
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
abnormal immunoglobulin V(D)J recombination
|
J:135783
|
| decreased B cell number
|
J:135783
|
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
arrested B cell differentiation
|
J:135783
|
| decreased immature B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
| decreased pre-B cell number
|
J:135783
|
| increased pro-B cell number
|
J:135783
|
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Tg(IghelMD4)4Ccg/0
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
decreased B cell number
|
J:135783
|
| decreased mature B cell number
|
J:135783
|
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell number
|
J:98192
|
| decreased thymocyte number
|
J:98192
|
| increased gamma-delta T cell number
|
J:98192
|
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
decreased B cell number
|
J:158901
|
\Dicer1tm1Tara/\Dicer1tm1Tara
\Foxn1tm3(cre)Nrm/\Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
abnormal positive T cell selection
|
J:180783
|
| decreased CD4-positive, alpha-beta T cell number
|
J:180783
|
| decreased CD8-positive, alpha-beta T cell number
|
J:180783
|
\Dis3tm1.1Uba/\Dis3tm1.1Uba
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal B cell morphology
|
J:302856
|
| abnormal class switch recombination
|
J:302856
|
\Dkc1tm1.1Pjma/Y
(B6.129X1(FVB)-Dkc1tm1.1Pjma)
|
decreased B cell number
|
J:217050
|
| decreased T cell number
|
J:217050
|
\Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
|
decreased B cell number
|
J:81054
|
| decreased lymphocyte cell number
|
J:81054
|
| decreased pre-B cell number
|
J:81054
|
\Dkk3tm1Cni/\Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6)
|
decreased NK cell number
|
J:106922
|
\Dlgap2em1(IMPC)Mhzh/\Dlgap2em1(IMPC)Mhzh
(C57BL/6N-Dlgap2em1(IMPC)Mhzh/Mhzh)
|
decreased lymphocyte cell number
|
J:211773
|
\Dlk1tm1Srba/\Dlk1tm1Srba
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell number
|
J:145076
|
| decreased immature B cell number
|
J:145076
|
| decreased mature B cell number
|
J:145076
|
| increased immature B cell number
|
J:145076
|
| increased marginal zone B cell number
|
J:145076
|
| increased transitional stage B cell number
|
J:145076
|
\Dll1tm1Gos/\Dll1+
(C3Fe.129-Dll1tm1Gos)
|
decreased B-1 B cell number
|
J:150183
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150183
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150183
|
| increased B cell number
|
J:150183
|
| increased CD8-positive, alpha-beta T cell number
|
J:150183
|
\Dll1tm1Gos/\Dll1+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased CD4-positive, alpha-beta T cell number
|
J:150183
|
| increased B cell number
|
J:150183
|
\Dll1tm1Mjo/\Dll1tm1Mjo
\Tg(Mx1-cre)1Cgn/?
(involves: 129 * C57BL/6 * CBA)
|
absent marginal zone B cells
|
J:90630
|
\Dll4tm1Frad/\Dll4tm1Frad
\Foxn1tm3(cre)Nrm/\Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm)
|
abnormal T cell differentiation
|
J:143472
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143472
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143472
|
| decreased double-positive T cell number
|
J:143472
|
| decreased thymocyte number
|
J:143472
|
| increased immature B cell number
|
J:143472
|
\Dll4tm1Kaho/\Dll4tm1Kaho
\Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymphopoiesis
|
J:143473
|
| absent CD4-positive, alpha-beta T cells
|
J:143473
|
| absent CD8-positive, alpha-beta T cells
|
J:143473
|
| decreased double-positive T cell number
|
J:143473
|
\Dmdmdx/Y
\Spp1tm1Blh/\Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
decreased T cell number
|
J:150572
|
| increased regulatory T cell number
|
J:150572
|
| increased T cell number
|
J:150572
|
\Dmdmdx/\Dmdmdx
\Prkdcscid/\Prkdcscid
(involves: BALB/c * C57BL/10ScSn * C57BL/Ka)
|
absent CD4-positive, alpha-beta T cells
|
J:125527
|
| absent CD8-positive, alpha-beta T cells
|
J:125527
|
| decreased B cell number
|
J:125527
|
\Dmdmdx/\Dmdmdx
\Spp1tm1Blh/\Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
decreased T cell number
|
J:150572
|
| increased regulatory T cell number
|
J:150572
|
| increased T cell number
|
J:150572
|
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:63444
|
\Dnajc3m1Btlr/\Dnajc3m1Btlr
(C57BL/6J-Dnajc3m1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:265248
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265248
|
| increased single-positive T cell number
|
J:265248
|
| increased T cell number
|
J:265248
|
\Dnajc11spc/\Dnajc11spc
(B6.Cg-Dnajc11spc)
|
decreased B cell number
|
J:221543
|
| decreased double-positive T cell number
|
J:221543
|
| increased CD4-positive, alpha-beta T cell number
|
J:221543
|
| increased CD8-positive, alpha-beta T cell number
|
J:221543
|
| increased DN1 thymic pro-T cell number
|
J:221543
|
| increased double-negative T cell number
|
J:221543
|
\Dnajc15Gt(RRN226)Byg/\Dnajc15Gt(RRN226)Byg
(B6.129P2-Dnajc15Gt(RRN226)Byg)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:204025
|
\Dnmt1tm2Jae/\Dnmt1tm2Jae
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113645
|
| decreased pro-B cell number
|
J:113645
|
\Dnmt3btm1Enl/\Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
\Dnmt3btm1Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:106540
|
| decreased thymocyte number
|
J:106540
|
| increased double-negative T cell number
|
J:106540
|
\Dnmt3btm6Enl/\Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
\Dnmt3btm6Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
\Dnmt3btm7Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte number
|
J:106540
|
\Dntttm1Gfn/\Dntttm1Gfn
\Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
\Dntttm1Tok/\Dntttm1Tok
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:61801
|
| abnormal T cell morphology
|
J:61801
|
| decreased gamma-delta T cell number
|
J:61801
|
\Dock2m1Anu/\Dock2m1Anu
(C57BL/6JAnu-Dock2m1Anu)
|
decreased B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Dock2m1Btlr/\Dock2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:173592
|
| abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
\Dock2m1Hsd/\Dock2m1Hsd
\Irf5tm1Ttg/\Irf5tm1Ttg
(B6NHsd.Cg-Irf5tm1Ttg Dock2m1Hsd)
|
abnormal B cell differentiation
|
J:182658
|
| absent marginal zone B cells
|
J:182658
|
| decreased follicular B cell number
|
J:182658
|
| increased B cell number
|
J:182658
|
| increased immature B cell number
|
J:182658
|
\Dock2m1Hsd/\Dock2m1Hsd
\Siaetm1.2Avrk/\Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
|
decreased B-1a cell number
|
J:144035
|
| decreased follicular B cell number
|
J:144035
|
| decreased marginal zone B cell number
|
J:231437,
J:144035
|
| decreased T cell number
|
J:144035
|
| increased B-1b cell number
|
J:144035
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:231437
|
\Dock2m2Anu/\Dock2m2Anu
(C57BL/6JAnu-Dock2m2Anu)
|
abnormal T cell morphology
|
J:104190
|
| decreased mature B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Dock2m2Btlr/\Dock2m2Btlr
(C57BL/6J-Dock2m2Btlr)
|
decreased B cell number
|
J:173670
|
| decreased CD4-positive, alpha-beta T cell number
|
J:173670
|
| decreased CD8-positive, alpha-beta T cell number
|
J:173670
|
\Dock2m2Btlr/\Dock2m2Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
| abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
\Dock2m3Anu/\Dock2m3Anu
(C57BL/6NCrlAnu-Dock2m3Anu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
\Dock2m3Btlr/\Dock2m3Btlr
(C57BL/6J-Dock2m3Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:191187
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:191187
|
| decreased CD4-positive, alpha-beta T cell number
|
J:191187
|
| decreased CD8-positive, alpha-beta T cell number
|
J:191187
|
\Dock2m4Btlr/\Dock2m4Btlr
(C57BL/6J-Dock2m4Btlr)
|
abnormal B cell differentiation
|
J:221486
|
| abnormal CD4-positive T cell differentiation
|
J:221486
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221486
|
\Dock2m5Btlr/\Dock2+
(C57BL/6J-Dock2m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:225938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
| decreased CD4-positive, alpha-beta T cell number
|
J:225938
|
| decreased single-positive T cell number
|
J:225938
|
| increased CD8-positive, alpha-beta T cell number
|
J:225938
|
| increased single-positive T cell number
|
J:225938
|
\Dock2m5Btlr/\Dock2m5Btlr
(C57BL/6J-Dock2m5Btlr)
|
abnormal B cell differentiation
|
J:225938
|
| abnormal CD4-positive T cell differentiation
|
J:225938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
| decreased CD4-positive, alpha-beta T cell number
|
J:225938
|
| decreased single-positive T cell number
|
J:225938
|
| increased B cell number
|
J:225938
|
| increased CD8-positive, alpha-beta T cell number
|
J:225938
|
| increased single-positive T cell number
|
J:225938
|
\Dock2m7Btlr/\Dock2+
(C57BL/6J-Dock2m7Btlr)
|
decreased B cell number
|
J:255181
|
\Dock2m7Btlr/\Dock2m7Btlr
(C57BL/6J-Dock2m7Btlr)
|
decreased B cell number
|
J:255181
|
| increased NK cell number
|
J:255181
|
\Dock2m8Btlr/\Dock2m8Btlr
(C57BL/6J-Dock2m8Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:272402
|
| increased CD8-positive, alpha-beta T cell number
|
J:272402
|
\Dock2M9Btlr/\Dock2M9Btlr
(C57BL/6J-Dock2M9Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:272403
|
\Dock2m10Btlr/\Dock2m10Btlr
(C57BL/6J-Dock2m10Btlr)
|
decreased B-1b cell number
|
J:272404
|
| increased NK cell number
|
J:272404
|
\Dock2m11Btlr/\Dock2m11Btlr
(C57BL/6J-Dock2m11Btlr)
|
abnormal B cell differentiation
|
J:272405
|
| abnormal CD4-positive T cell differentiation
|
J:272405
|
| abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:272405
|
| decreased B cell number
|
J:272405
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272405
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272405
|
| decreased NK cell number
|
J:272405
|
| increased B-1 B cell number
|
J:272405
|
| increased CD8-positive, alpha-beta T cell number
|
J:272405
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272405
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272405
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272405
|
\Dock2M12Btlr/\Dock2M12Btlr
(C57BL/6J-Dock2M12Btlr)
|
decreased B-1a cell number
|
J:272406
|
\Dock2m13Btlr/\Dock2m13Btlr
(C57BL/6J-Dock2m13Btlr)
|
increased alpha-beta T cell number
|
J:272437
|
| increased CD8-positive, alpha-beta T cell number
|
J:272437
|
\Dock2M14Btlr/\Dock2M14Btlr
(C57BL/6J-Dock2M14Btlr)
|
abnormal lymphocyte morphology
|
J:272438
|
| increased CD8-positive, alpha-beta T cell number
|
J:272438
|
\Dock2m15Btlr/\Dock2m15Btlr
(C57BL/6J-Dock2m15Btlr)
|
decreased B cell number
|
J:274942
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274942
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274942
|
| decreased T cell number
|
J:274942
|
| increased B-1 B cell number
|
J:274942
|
| increased CD8-positive, alpha-beta T cell number
|
J:274942
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274942
|
| increased NK cell number
|
J:274942
|
\Dock2M16Btlr/\Dock2M16Btlr
(C57BL/6J-Dock2M16Btlr)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:274971
|
\Dock2tm1Tsas/\Dock2tm1Tsas
(involves: C57BL/6)
|
decreased marginal zone B cell number
|
J:71005
|
\Dock2tm1Tsas/\Dock2tm1Tsas
(B6.Cg-Dock2tm1Tsas)
|
decreased lymphocyte cell number
|
J:130919
|
| decreased mature B cell number
|
J:130919
|
| decreased T cell number
|
J:130919
|
\Dock2tm1Tsas/\Dock2tm1Tsas
\Tg(Tcra2B4)1Mmd/?
\Tg(Tcrb2B4)1Mmd/?
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:84581
|
| decreased double-positive T cell number
|
J:84581
|
\Dock8cpm/\Dock8cpm
(C57BL/6JSfdAnu-Dock8cpm)
|
decreased marginal zone B cell number
|
J:155516
|
| decreased T cell number
|
J:155516
|
\Dock8cpm/\Dock8pri
(C57BL/6J-Dock8cpm/Dock8pri)
|
decreased marginal zone B cell number
|
J:155516
|
| decreased T cell number
|
J:155516
|
\Dock8m1Anu/\Dock8m1Anu
(C57BL/6NCrlAnu-Dock8m1Anu)
|
decreased activated T cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Dock8m2Anu/\Dock8m2Anu
(C57BL/6NCrlAnu-Dock8m2Anu)
|
absent marginal zone B cells
|
J:104190
|
| decreased activated T cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Dock8M2Btlr/\Dock8M2Btlr
(C57BL/6J-Dock8M2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272530
|
\Dock8m4Btlr/\Dock8m4Btlr
(C57BL/6J-Dock8m4Btlr)
|
abnormal B cell differentiation
|
J:274856
|
| abnormal CD4-positive T cell differentiation
|
J:274856
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274856
|
| abnormal T cell differentiation
|
J:274856
|
| decreased B-1 B cell number
|
J:274856
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274856
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274856
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274856
|
| decreased T cell number
|
J:274856
|
| increased CD4-positive, alpha-beta T cell number
|
J:274856
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274856
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274856
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274856
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274856
|
\Dock8pri/\Dock8pri
(C57BL/6JAnu-Dock8pri)
|
decreased B-1 B cell number
|
J:155516
|
| decreased germinal center B cell number
|
J:155516
|
| decreased marginal zone B cell number
|
J:155516
|
| decreased T cell number
|
J:155516
|
\Dock8tm1Ysfk/\Dock8tm1Ysfk
(B6.Cg-Dock8tm1Ysfk)
|
decreased CD4-positive, alpha-beta T cell number
|
J:185165
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185165
|
| decreased marginal zone B cell number
|
J:185165
|
\Dock10tm1a(EUCOMM)Hmgu/\Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg)
|
arrested B cell differentiation
|
J:236911
|
| decreased B cell number
|
J:236911
|
| decreased follicular B cell number
|
J:236911
|
| decreased marginal zone B cell number
|
J:236911
|
| increased single-positive T cell number
|
J:236911
|
| increased T cell number
|
J:236911
|
\Dock10tm1Thar/\Dock10tm1Thar
(involves: C57BL/6)
|
decreased B cell number
|
J:300632
|
\Dock11tm1.1Mmar/\Dock11tm1.1Mmar
(Not Specified)
|
decreased marginal zone B cell number
|
J:238172
|
\Dok7tm1.1(KOMP)Vlcg/\Dok7+
(C57BL/6N-Dok7tm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Dot1ltm1.1Saam/\Dot1ltm1.1Saam
\Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:193161
|
\Dph6tm1a(KOMP)Wtsi/\Dph6tm1a(KOMP)Wtsi
(C57BL/6N-Dph6tm1a(KOMP)Wtsi/Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased marginal zone B cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased plasma cell number
|
J:211773
|
\Dpp4em1Rba/\Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba)
|
decreased lymphocyte cell number
|
J:279723
|
\Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased CD4-positive, alpha-beta T cell number
|
J:238079
|
| increased CD8-positive, alpha-beta T cell number
|
J:238079
|
\Dpp4tm1b(EUCOMM)Wtsi/\Dpp4tm1b(EUCOMM)Wtsi
(C57BL/6N-Dpp4tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Droshatm1Litt/\Droshatm1.1Litt
\Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased CD8-positive, alpha-beta T cell number
|
J:138683
|
\Droshatm1Litt/\Droshatm1.1Litt
\Foxp3tm4(YFP/icre)Ayr/\Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal regulatory T cell morphology
|
J:138683
|
| increased CD8-positive, alpha-beta T cell number
|
J:138683
|
\Droshatm1Litt/\Droshatm1.1Litt
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:138683
|
| decreased double-positive T cell number
|
J:138683
|
| decreased lymphocyte cell number
|
J:138683
|
| decreased regulatory T cell number
|
J:138683
|
| decreased thymocyte number
|
J:138683
|
| increased activated T cell number
|
J:138683
|
| increased gamma-delta T cell number
|
J:138683
|
\Dsg3sqk/\Dsg3sqk
(C57BL/6-Dsg3sqk)
|
decreased B cell number
|
J:219200
|
| decreased double-positive T cell number
|
J:219200
|
| decreased immature B cell number
|
J:219200
|
| decreased lymphocyte cell number
|
J:219200
|
| decreased pre-B cell number
|
J:219200
|
| decreased single-positive T cell number
|
J:219200
|
| decreased transitional stage B cell number
|
J:219200
|
\Dsg4hage/\Dsg4hage
\Faslpr/\Faslpr
X/\Yaa
(EOD-Dsg4hage)
|
abnormal effector T cell morphology
|
J:140028
|
\Dtnbp1tm1b(EUCOMM)Hmgu/\Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Dtx1tm1.2Mzl/\Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
|
abnormal lymphocyte morphology
|
J:151605
|
| decreased marginal zone B cell number
|
J:151605
|
\Duox2em1(IMPC)Mbp/\Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Duoxa2tm1b(KOMP)Wtsi/\Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
| decreased immature B cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased memory-marker gamma-delta T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased transitional stage T1 B cell number
|
J:211773
|
| increased alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Dusp4Gt(XG164)Byg/\Dusp4Gt(XG164)Byg
(B6.129P2-Dusp4Gt(XG164)Byg)
|
increased CD4-positive, alpha-beta T cell number
|
J:180366
|
\Dusp5tm1.1Achn/\Dusp5tm1.1Achn
(involves: C57BL/6NCrl)
|
increased thymocyte number
|
J:218203
|
\Dusp5tm1a(KOMP)Wtsi/\Dusp5tm1a(KOMP)Wtsi
(C57BL/6-Dusp5tm1a(KOMP)Wtsi)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:240637
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:240637
|
\Dusp10tm1Flv/\Dusp10tm1Flv
(involves: 129S6/SvEvTac)
|
increased activated T cell number
|
J:92104
|
\Dusp14Gt(OST210117)Lex/\Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex)
|
increased T-helper 1 cell number
|
J:209403
|
| increased T-helper 17 cell number
|
J:209403
|
\Dyrk1atm1Jdc/\Dyrk1atm1Jdc
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)
|
decreased B cell number
|
J:223138
|
| decreased double-positive T cell number
|
J:223138
|
| decreased immature B cell number
|
J:223138
|
| decreased mature B cell number
|
J:223138
|
| decreased pre-B cell number
|
J:223138
|
| decreased thymocyte number
|
J:223138
|
\Dyrk1btm1b(EUCOMM)Wtsi/\Dyrk1b+
(C57BL/6N-Dyrk1btm1b(EUCOMM)Wtsi/Ics)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Dyrk2em1(IMPC)Ics/\Dyrk2+
(C57BL/6N-Dyrk2em1(IMPC)Ics/Ics)
|
decreased large unstained cell number
|
J:211773
|
\E2f1tm1Meg/\E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
abnormal double-positive T cell morphology
|
J:33100
|
| increased CD4-positive, alpha-beta T cell number
|
J:33100
|
| increased CD8-positive, alpha-beta T cell number
|
J:33100
|
| increased thymocyte number
|
J:33100
|
\E2f1tm1Meg/\E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93708
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:93708
|
| abnormal double-positive T cell morphology
|
J:93708
|
| decreased double-positive T cell number
|
J:93708
|
| decreased regulatory T cell number
|
J:93708
|
| increased T cell number
|
J:93708
|
| increased thymocyte number
|
J:93708
|
\E2f2tm1Zubi/\E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:76318
|
| abnormal T cell subpopulation ratio
|
J:76318
|
| increased memory T cell number
|
J:76318
|
\E2f2tm1Zubi/\E2f2tm1Zubi
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased CD8-positive, alpha-beta T cell number
|
J:76318
|
\E2f4tm1Jrn/\E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:64192
|
| decreased thymocyte number
|
J:64192
|
| increased double-negative T cell number
|
J:64192
|
| increased NK cell number
|
J:64192
|
\Ebag9tm1Rehm/\Ebag9tm1Rehm
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:152534
|
\Ebf1m1Btlr/\Ebf1m1Btlr
(C57BL/6J-Ebf1m1Btlr)
|
decreased B cell number
|
J:265157
|
| increased CD4-positive, alpha-beta T cell number
|
J:265157
|
| increased single-positive T cell number
|
J:265157
|
| increased T cell number
|
J:265157
|
\Ebf1m2Btlr/\Ebf1m2Btlr
(C57BL/6J-Ebf1m2Btlr)
|
decreased B cell number
|
J:265158
|
| decreased B-1 B cell number
|
J:265158
|
| decreased B-2 B cell number
|
J:265158
|
| increased B-1a cell number
|
J:265158
|
| increased B-1b cell number
|
J:265158
|
| increased CD4-positive, alpha-beta T cell number
|
J:265158
|
| increased single-positive T cell number
|
J:265158
|
| increased T cell number
|
J:265158
|
\Ebf1M3Btlr/\Ebf1M3Btlr
(C57BL/6J-Ebf1M3Btlr)
|
decreased B-1 B cell number
|
J:265160
|
| increased CD4-positive, alpha-beta T cell number
|
J:265160
|
| increased single-positive T cell number
|
J:265160
|
| increased T cell number
|
J:265160
|
\Ebf1M4Btlr/\Ebf1M4Btlr
(C57BL/6J-Ebf1M4Btlr)
|
decreased B cell number
|
J:267560
|
| decreased NK cell number
|
J:267560
|
| increased alpha-beta T cell number
|
J:267560
|
| increased CD4-positive, alpha-beta T cell number
|
J:267560
|
| increased CD8-positive, alpha-beta T cell number
|
J:267560
|
\Ebf1M5Btlr/\Ebf1M5Btlr
(C57BL/6J-Ebf1M5Btlr)
|
abnormal lymphocyte morphology
|
J:272841
|
| decreased B cell number
|
J:272841
|
| decreased B-1 B cell number
|
J:272841
|
\Ebf1m6Btlr/\Ebf1m6Btlr
(C57BL/6J-Ebf1m6Btlr)
|
abnormal lymphocyte morphology
|
J:272842
|
| decreased B cell number
|
J:272842
|
| decreased B-1 B cell number
|
J:272842
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:272842
|
| increased alpha-beta T cell number
|
J:272842
|
| increased CD4-positive, alpha-beta T cell number
|
J:272842
|
| increased CD8-positive, alpha-beta T cell number
|
J:272842
|
\Ebf1Serv/\Ebf1+
(C57BL/6JAnu-Ebf1Serv)
|
decreased B cell number
|
J:104190
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased B-1 B cell number
|
J:182210
|
| decreased marginal zone B cell number
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased germinal center B cell number
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Polr2atm1(cre/ERT2)Bbd/\Polr2a+
(involves: C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
| decreased germinal center B cell number
|
J:182210
|
| decreased immature B cell number
|
J:182210
|
| decreased marginal zone B cell number
|
J:182210
|
| decreased pre-B cell number
|
J:182210
|
| decreased transitional stage B cell number
|
J:182210
|
| increased B cell number
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Polr2atm1(cre/ERT2)Bbd/\Polr2a+
\Tg(BCL2)#Wehi/0
(involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi)
|
decreased immature B cell number
|
J:182210
|
| decreased pre-B cell number
|
J:182210
|
\Ebf1tm1.1Rug/\Ebf1tm1.1Rug
\Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6 * SJL)
|
decreased B-1 B cell number
|
J:182210
|
| decreased marginal zone B cell number
|
J:182210
|
\Ebf1tm1Rug/\Ebf1tm1Rug
(involves: 129S2/SvPas)
|
abnormal B cell morphology
|
J:52607
|
| absent B-1 B cells
|
J:52607
|
| absent mature B cells
|
J:52607
|
| arrested B cell differentiation
|
J:52607
|
| decreased pro-B cell number
|
J:52607
|
\Ebi3Gt716Lex/\Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:286951
|
| increased CD8-positive, alpha-beta T cell number
|
J:286951
|
\Ebi3Gt716Lex/\Ebi3Gt716Lex
\Tg(DO11.10)10Dlo/0
(involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:134148
|
\Ebi3tm1Rsb/\Ebi3tm1Rsb
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T-helper 1 cell morphology
|
J:97822
|
| abnormal T-helper 2 cell morphology
|
J:97822
|
| decreased NK cell number
|
J:81014
|
| decreased T-helper 2 cell number
|
J:81014
|
\Ecrg4tm1b(EUCOMM)Hmgu/\Ecrg4tm1b(EUCOMM)Hmgu
(C57BL/6N-Ecrg4tm1b(EUCOMM)Hmgu/Orl)
|
decreased large unstained cell number
|
J:211773
|
\Ednrbtm1Nrd/\Ednrbtm1Nrd
\Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/\Gt(ROSA)26Sor+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)
|
abnormal mature B cell number
|
J:233811
|
| decreased B cell number
|
J:233811
|
| decreased germinal center B cell number
|
J:233811
|
| decreased marginal zone B cell number
|
J:233811
|
\Eef1a1tm2Arge/\Eef1a1+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal double-positive T cell morphology
|
J:197167
|
\Eef1a2wst/\Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
|
decreased plasma cell number
|
J:7903
|
\Efhd2tm1(KOMP)Vlcg/\Efhd2tm1(KOMP)Vlcg
(C57BL/6-Efhd2tm1(KOMP)Vlcg)
|
increased germinal center B cell number
|
J:228565
|
| increased plasma cell number
|
J:228565
|
\Efnb1tm1.1Jwu/\Efnb1tm1.1Jwu
\Efnb2tm1.1Jwu/\Efnb2tm1.1Jwu
\Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
abnormal T cell differentiation
|
J:178148
|
| abnormal T-helper 1 cell differentiation
|
J:178148
|
| abnormal T-helper 17 cell differentiation
|
J:178148
|
| decreased CD4-positive, alpha-beta T cell number
|
J:178148
|
| decreased CD8-positive, alpha-beta T cell number
|
J:178148
|
| decreased DN4 thymocyte number
|
J:178148
|
| decreased double-positive T cell number
|
J:178148
|
| decreased T cell number
|
J:178148
|
| increased DN3 thymocyte number
|
J:178148
|
| increased double-negative T cell number
|
J:178148
|
\Eftud2tm1b(KOMP)Wtsi/\Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Egfrtm1Dwt/\Egfrtm1Dwt
\Sox9tm3(cre)Crm/\Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased T-helper 1 cell number
|
J:229771
|
| increased T-helper 2 cell number
|
J:229771
|
| increased T-helper 17 cell number
|
J:229771
|
\Egln1tm1.1Brei/\Egln1tm1.1Brei
\Tg(CD68-icre)1Bwlx/0
(involves: C57BL/6)
|
abnormal lymphocyte cell number
|
J:194598
|
\Egr1tm1b(NCOM)Mfgc/\Egr1+
(C57BL/6N-Egr1tm1b(NCOM)Mfgc/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Egr1tm1Jmi/\Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
increased lymphocyte cell number
|
J:123870
|
\Eif1adtm1b(EUCOMM)Hmgu/\Eif1ad+
(C57BL/6N-Eif1adtm1b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
\Eif2ak2em1Btlr/\Eif2ak2em1Btlr
\Zfp574em1Btlr/\Zfp574em1Btlr
(C57BL/6J-Zfp574em1Btlr Eif2ak2em1Btlr)
|
abnormal class switch recombination
|
J:354285
|
| decreased lymphocyte cell number
|
J:354285
|
\Eif4a1tm1.1Bea/\Eif4a1tm1.1Bea
\Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased germinal center B cell number
|
J:344730
|
\Eif4btm1.1Smoc/\Eif4btm1.1Smoc
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
(involves: 129 * C57BL/6)
|
decreased lymphocyte cell number
|
J:311140
|
| decreased NK cell number
|
J:311140
|
\Elapor1tm1b(EUCOMM)Hmgu/\Elapor1+
(C57BL/6N-Elapor1tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Elavl1tm1.1Atas/\Elavl1tm1.1Atas
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6)
|
decreased T-helper 17 cell number
|
J:207013
|
\Elavl1tm1Dkon/\Elavl1tm1Dkon
\Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm)
|
abnormal positive T cell selection
|
J:148866
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148866
|
| decreased CD8-positive, alpha-beta T cell number
|
J:148866
|
| increased double-negative T cell number
|
J:148866
|
| increased double-positive T cell number
|
J:148866
|
| increased single-positive T cell number
|
J:148866
|
\Elavl1tm1Dkon/\Elavl1tm1Dkon
\Tg(Lck-cre)I57Jxm/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)
|
abnormal negative T cell selection
|
J:148866
|
| increased thymocyte number
|
J:148866
|
\Elavl1tm1Thla/\Elavl1tm1Thla
\Gt(ROSA)26Sortm1(cre/ERT2)Alj/\Gt(ROSA)26Sor+
(involves: 129)
|
decreased double-positive T cell number
|
J:155109
|
\Elf1tm1Jml/\Elf1tm1Jml
(Not Specified)
|
abnormal B cell differentiation
|
J:100734
|
\Elf4em1Hdu/\Elf4em1Hdu
(C57BL/6-Elf4em1Hdu)
|
abnormal CD4-positive T cell differentiation
|
J:328935
|
\Elf4tm1Nim/\Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
|
abnormal lymphocyte morphology
|
J:79568
|
| abnormal T cell differentiation
|
J:79568
|
| decreased NK cell number
|
J:79568
|
| decreased NK T cell number
|
J:79568
|
| increased B cell number
|
J:79568
|
\Elk4tm1a(EUCOMM)Wtsi/\Elk4tm1a(EUCOMM)Wtsi
(C57BL/6N-Elk4tm1a(EUCOMM)Wtsi/H)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased mature B cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
| increased B cell number
|
J:165965
|
| increased T cell number
|
J:165965
|
\Elk4tm1Rtr/\Elk4tm1Rtr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal positive T cell selection
|
J:88515
|
| abnormal T cell selection
|
J:88515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:88515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:88515
|
| decreased single-positive T cell number
|
J:88515
|
| decreased T cell number
|
J:88515
|
| decreased thymocyte number
|
J:88515
|
\Elk4tm1Rtr/\Elk4tm1Rtr
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129/Sv * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:88515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:88515
|
\Elk4tm1Rtr/\Elk4tm1Rtr
\Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * C57BL/6)
|
abnormal positive T cell selection
|
J:88515
|
| decreased CD4-positive, alpha-beta T cell number
|
J:88515
|
\Elk4tm1Rtr/\Elk4tm1Rtr
\Tg(TcrLCMV)327Sdz/?
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:88515
|
| decreased CD8-positive, alpha-beta T cell number
|
J:88515
|
\Elmo1M1Btlr/\Elmo1M1Btlr
(C57BL/6J-Elmo1M1Btlr)
|
decreased B cell number
|
J:265231
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265231
|
| increased B-1 B cell number
|
J:265231
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265231
|
\Elmo1m2Btlr/\Elmo1m2Btlr
(C57BL/6J-Elmo1m2Btlr)
|
decreased B cell number
|
J:265232
|
\Elmo1m3Btlr/\Elmo1m3Btlr
(C57BL/6J-Elmo1m3Btlr)
|
decreased central memory CD8 positive, alpha-beta T cell number
|
J:271894
|
| decreased NK cell number
|
J:271894
|
| increased CD8-positive, alpha-beta T cell number
|
J:271894
|
\Elmo1M4Btlr/\Elmo1M4Btlr
(C57BL/6J-Elmo1M4Btlr)
|
abnormal B cell morphology
|
J:271969
|
| abnormal T cell morphology
|
J:271969
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271969
|
| increased B-1 B cell number
|
J:271969
|
| increased CD8-positive, alpha-beta T cell number
|
J:271969
|
\Elmod1tm1a(EUCOMM)Hmgu/\Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased B cell number
|
J:165965
|
\Elmod1tm1b(EUCOMM)Hmgu/\Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Emp2tm1.1Tac/\Emp2tm1.1Tac
\Tg(Zp3-cre)93Knw/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
increased uterine NK cell number
|
J:243365
|
\Emsyem1(IMPC)Ccpcz/\Emsy+
(C57BL/6NCrl-Emsyem1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
\Emv72b/\Emv72b
(CAnNCr.B6NCr-Emv72b)
|
abnormal T cell morphology
|
J:194735
|
\Entpd1tm1a(EUCOMM)Wtsi/\Entpd1tm1a(EUCOMM)Wtsi
(C57BL/6N-Entpd1tm1a(EUCOMM)Wtsi/Ieg)
|
increased T cell number
|
J:165965
|
\Entpd7tm1Ktak/\Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:191188
|
| increased T-helper 17 cell number
|
J:191188
|
\Eomestm1.1Bflu/\Eomestm1.1Bflu
\Tbx21tm1Glm/\Tbx21tm1Glm
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:163822
|
| decreased CD8-positive, alpha-beta T cell number
|
J:163822
|
| decreased memory T cell number
|
J:163822
|
\Eomestm1.1Bflu/\Eomestm1.1Bflu
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased memory T cell number
|
J:163822
|
\Eomestm1.1Twa/?
\Il15tm1Imx/\Il15tm1Imx
(involves: C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1.1Twa/?
\Tbx21tm1Glm/\Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1.1Twa/?
\Tg(CD2-Tbx21)#Staka/?
(involves: C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1.1Twa/?
\Tg(Itgax-TGFBR2)1Flv/?
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
\Eomestm1Apr/\Eomes+
(involves: C57BL/6)
|
decreased memory T cell number
|
J:112679
|
| decreased NK cell number
|
J:112679
|
\Eomestm1Apr/\Eomes+
\Tbx21tm1Srnr/\Tbx21tm1Srnr
(involves: C57BL/6)
|
decreased memory T cell number
|
J:112679
|
| decreased NK cell number
|
J:112679
|
| decreased NK T cell number
|
J:112679
|
\Eomestm1Srnr/\Eomestm1Srnr
\Tbx21tm1Srnr/\Tbx21tm1Srnr
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:137655
|
| abnormal T cell morphology
|
J:137655
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137655
|
| decreased memory T cell number
|
J:137655
|
\Eomestm1Srnr/\Eomestm1Srnr
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased memory T cell number
|
J:137655
|
\Ep300Plt6/\Ep300Plt6
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:140200
|
| decreased lymphocyte cell number
|
J:140200
|
\Ep300tm1Pkb/\Ep300+
\Mybtm1Ssp/\Myb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
\Ep300tm1Pkb/\Ep300tm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:98329
|
\Ep300tm2Pkb/\Ep300tm2Pkb
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased single-positive T cell number
|
J:105505
|
| decreased thymocyte number
|
J:105505
|
| increased double-positive T cell number
|
J:105505
|
\Epas1tm1.1Fsl/\Epas1+
(involves: C57BL/6 * C57BL/6NTac)
|
increased lymphocyte cell number
|
J:199595
|
\Epdr1tm1b(NCOM)Mfgc/\Epdr1tm1b(NCOM)Mfgc
(C57BL/6N-Epdr1tm1b(NCOM)Mfgc/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Epg5em1(IMPC)H/\Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\epi/?
(involves: CBA/J)
|
decreased lymphocyte cell number
|
J:27487
|
\Epm2aTg(TcraK,TcrbK)TG-BFlv/\Epm2a+
(involves: C57BL/6J * CBA/J)
|
increased CD8-positive, alpha-beta T cell number
|
J:107545
|
\Eps8l2tm1b(EUCOMM)Wtsi/\Eps8l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eps8l2tm1b(EUCOMM)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
\Eps15tm1Noff/\Eps15tm1Noff
(B6.129-Eps15tm1Noff)
|
decreased B cell number
|
J:195689
|
| decreased lymphocyte cell number
|
J:195689
|
| increased marginal zone B cell number
|
J:195689
|
\Eps15tm1Noff/\Eps15tm1Noff
(involves: 129 * C57BL/6)
|
abnormal marginal zone B cell morphology
|
J:195689
|
| increased marginal zone B cell number
|
J:195689
|
| increased transitional stage T1 B cell number
|
J:195689
|
\Ercc1tm1Jhjh/\Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:92471
|
\Ercc6l2em1Mengf/\Ercc6l2em1Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
| decreased T cell number
|
J:311900
|
\Ercc6l2em1Mengf/\Ercc6l2em1Mengf
\Nhej1em1Mengf/\Nhej1em1Mengf
(Not Specified)
|
abnormal T cell receptor V(D)J recombination
|
J:311900
|
\Ercc6l2em2Mengf/\Ercc6l2em2Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
\Ergmld2/\Erg+
(involves: 129S1/Sv * C57BL/6)
|
decreased transitional stage B cell number
|
J:137835
|
\Ern1tm1Rjk/\Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal pro-B cell morphology
|
J:106975
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell number
|
J:82423
|
| abnormal class switch recombination
|
J:82423
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110416
|
| decreased CD8-positive, alpha-beta T cell number
|
J:110416
|
| increased double-positive T cell number
|
J:110416
|
| increased plasma cell number
|
J:88156
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:110923
|
| decreased mature B cell number
|
J:110923
|
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal B cell differentiation
|
J:63462
|
| decreased B cell number
|
J:63462
|
| decreased immature B cell number
|
J:63462
|
| decreased mature B cell number
|
J:63462
|
| decreased thymocyte number
|
J:111590
|
\Esr1tm1Ksk/\Esr1tm1Ksk
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell number
|
J:82423
|
| abnormal class switch recombination
|
J:82423
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110416
|
| decreased CD8-positive, alpha-beta T cell number
|
J:110416
|
| increased double-positive T cell number
|
J:110416
|
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell number
|
J:82423
|
| abnormal lymphopoiesis
|
J:83617
|
| increased pre-B cell number
|
J:83617
|
| increased pro-B cell number
|
J:83617
|
\Ess2tm1.1Nbioc/\Ess2tm1.1Nbioc
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6N * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:339504
|
| decreased CD8-positive, alpha-beta T cell number
|
J:339504
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:339504
|
| decreased memory T cell number
|
J:339504
|
| increased gamma-delta T cell number
|
J:339504
|
| increased NK T cell number
|
J:339504
|
\Ets1tm1.1Dds/\Ets1+
(129S6/SvEvTac-Ets1tm1.1Dds)
|
decreased memory T cell number
|
J:121460
|
\Ets1tm1.1Dds/\Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:121460
|
| abnormal lymphopoiesis
|
J:121460
|
| decreased B cell number
|
J:121460
|
| decreased CD4-positive, alpha-beta T cell number
|
J:121460
|
| decreased memory T cell number
|
J:121460
|
| increased double-positive T cell number
|
J:121460
|
\Ets1tm1Fwa/\Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa)
|
abnormal B cell differentiation
|
J:93845
|
| absent B-1a cells
|
J:93845
|
| decreased B cell number
|
J:93845
|
| decreased mature B cell number
|
J:93845
|
| decreased pro-B cell number
|
J:93845
|
| increased pro-B cell number
|
J:93845
|
\Ets1tm1Jml/\Ets1tm1Jml
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125056
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125056
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125056
|
| increased double-negative T cell number
|
J:125056
|
\Ets1tm1Jml/\Ets1tm1Jml
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:125056
|
| increased double-negative T cell number
|
J:125056
|
\Ets1tm2Jml/\Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:50627
|
| decreased NK cell number
|
J:50627
|
| decreased T cell number
|
J:50627
|
| decreased thymocyte number
|
J:50627
|
| increased plasma cell number
|
J:50627
|
\Etv6em1(IMPC)Rbrc/\Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc)
|
increased large unstained cell number
|
J:211773
|
\Etv6em3Knic/\Etv6+
(involves: C57BL/6J)
|
abnormal B cell number
|
J:342774
|
\Etv6tm1(RUNX1)Haho/\Etv6+
\Tg(Gata1-cre)1Sho/0
(involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)
|
abnormal B cell differentiation
|
J:151639
|
\Etv6tm1(RUNX1)Haho/\Etv6+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:151639
|
| decreased B cell number
|
J:151639
|
| decreased lymphocyte cell number
|
J:151639
|
\Etv6tm1(RUNX1)Haho/\Etv6+
\Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:151639
|
| decreased B cell number
|
J:151639
|
| decreased pre-B cell number
|
J:151639
|
| decreased pro-B cell number
|
J:151639
|
\Ewsr1tm1(ERG)Thr/\Ewsr1+
\Rag1tm1(cre)Thr/\Rag1+
(involves: 129S/SvEv)
|
increased lymphocyte cell number
|
J:98679
|
\Ewsr1tm1b(EUCOMM)Wtsi/\Ewsr1+
(C57BL/6N-Ewsr1tm1b(EUCOMM)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Ewsr1tm1Sblee/\Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased double-positive T cell number
|
J:122058
|
| decreased immature B cell number
|
J:122058
|
| decreased mature B cell number
|
J:122058
|
| decreased pre-B cell number
|
J:122058
|
\Exo1tm2Wed/\Exo1tm2Wed
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:198719
|
| abnormal somatic hypermutation frequency
|
J:198719
|
\Extl1em1Caox/\Extl1em1Caox
\Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA)
|
abnormal regulatory T cell morphology
|
J:333437
|
| decreased T helper 1 cell number
|
J:333437
|
| increased B cell number
|
J:333437
|
| increased T cell number
|
J:333437
|
| increased T-helper 17 cell number
|
J:333437
|
\Ezh1tm1Sgon/\Ezh1tm1Sgon
\Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:193722
|
| decreased immature B cell number
|
J:193722
|
| decreased pro-B cell number
|
J:193722
|
\Ezh2tm1Tara/\Ezh2tm1Tara
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd)
|
decreased germinal center B cell number
|
J:199122
|
\Ezh2tm1Tara/\Ezh2tm1Tara
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:83216
|
| abnormal immunoglobulin V(D)J recombination
|
J:83216
|
| abnormal pro-B cell morphology
|
J:83216
|
| decreased immature B cell number
|
J:83216
|
| decreased pre-B cell number
|
J:83216
|
\Ezh2tm2Sho/\Ezh2tm2.1Sho
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
| decreased thymocyte number
|
J:182211
|
| increased double-negative T cell number
|
J:182211
|
\Ezh2tm2Sho/\Ezh2tm2Sho
\Pgrtm2(cre)Lyd/\Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased uterine NK cell number
|
J:290765
|
\Ezh2tm2Sho/\Ezh2tm2Sho
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
| decreased thymocyte number
|
J:182211
|
| increased double-negative T cell number
|
J:182211
|
\F3tm1.1Dwr/\F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
decreased B cell number
|
J:91165
|
\Fabp1tm1b(EUCOMM)Hmgu/\Fabp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fabp1tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd)33Wnt/0
\Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR)
|
abnormal T cell differentiation
|
J:69617
|
| decreased CD4-positive, alpha-beta T cell number
|
J:69617
|
| decreased CD8-positive, alpha-beta T cell number
|
J:69617
|
| decreased double-positive T cell number
|
J:69617
|
| increased B cell number
|
J:69617
|
| increased double-negative T cell number
|
J:69617
|
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd)33Wnt/0
\Tg(Lck-cre)I57Jxm/0
\Tg(Tcra2C,Tcrb2C)1Dlo/0
(involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)
|
increased double-negative T cell number
|
J:69617
|
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd/EGFP)#Jizh/?
\Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased activated T cell number
|
J:113207
|
| decreased single-positive T cell number
|
J:113207
|
| increased B cell number
|
J:113207
|
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd/EGFP)#Jizh/?
\Tg(Lck-cre)1Cwi/?
(involves: 129S4/SvJae)
|
decreased activated T cell number
|
J:113207
|
| decreased single-positive T cell number
|
J:113207
|
| increased B cell number
|
J:113207
|
\Faddtm2.1Wnt/\Faddtm2.1Wnt
\Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
abnormal T cell subpopulation ratio
|
J:162312
|
| increased B cell number
|
J:162312
|
\Fads1Gt(IST11525H2)Tigm/\Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
decreased regulatory T cell number
|
J:186265
|
\Fam3aem1Cya/\Fam3aem1Cya
(involves: C57BL/6)
|
increased NK T cell number
|
J:295206
|
| increased T cell number
|
J:295206
|
\Fam72atm1.1(KOMP)Vlcg/\Fam72atm1.1(KOMP)Vlcg
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
| increased germinal center B cell number
|
J:326431
|
\Fam72atm1.1(KOMP)Vlcg/\Fam72atm1.1(KOMP)Vlcg
\Msh2tm1Mak/\Msh2tm1Mak
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
\Fam76bGt(IST14004H1)Tigm/\Fam76bGt(IST14004H1)Tigm
(C57BL/6-Fam76bGt(IST14004H1)Tigm)
|
decreased B cell number
|
J:358021
|
\Fam83hem1(IMPC)Ccpcz/\Fam83hem1(IMPC)Ccpcz
(C57BL/6N-Fam83hem1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Fam110btm1a(EUCOMM)Wtsi/\Fam110b+
(C57BL/6N-Fam110btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased mature B cell number
|
J:165965
|
\Fam120cem1(IMPC)Ccpcz/Y
(C57BL/6NCrl-Fam120cem1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
\Fam221aem1(IMPC)Ccpcz/\Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Fam234btm1a(EUCOMM)Wtsi/\Fam234btm1a(EUCOMM)Wtsi
(C57BL/6N-Fam234btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
\Fancctm1Mab/\Fancctm1Mab
\Sod1tm1Cep/\Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphocyte morphology
|
J:71134
|
| decreased lymphocyte cell number
|
J:71134
|
\Faslpr-cg/\Faslpr-cg
(CBA/KlJms-Faslpr-cg/J)
|
abnormal T cell differentiation
|
J:24805
|
\Faslpr/\Faslpr
(MRL/Mp-Faslpr)
|
abnormal B cell morphology
|
J:108760
|
| abnormal B cell receptor editing
|
J:131138
|
| abnormal marginal zone B cell morphology
|
J:131138
|
| abnormal T cell morphology
|
J:108760,
J:8267
|
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr/J)
|
decreased immature B cell number
|
J:122315
|
| decreased marginal zone B cell number
|
J:122315
|
| decreased mature B cell number
|
J:122315
|
| decreased transitional stage B cell number
|
J:122315
|
| increased plasma cell number
|
J:122315
|
\Faslpr/\Faslpr
(B6.MRL-Faslpr/J)
|
increased follicular B cell number
|
J:132217
|
| increased immature B cell number
|
J:132217
|
| increased marginal zone B cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
\Faslpr/\Faslpr
(C3.MRL-Faslpr/J)
|
abnormal T cell morphology
|
J:7454
|
\Faslpr/\Faslpr
(B6.MRL-Faslpr)
|
increased double-negative T cell number
|
J:135036
|
\Faslpr/\Faslpr
(C3.MRL-Faslpr)
|
abnormal T cell morphology
|
J:8267
|
\Faslpr/\Faslpr
(MRL/MpJ-Faslpr)
|
decreased activated T cell number
|
J:137066
|
| decreased B cell number
|
J:137066
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137066
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137066
|
| increased double-negative T cell number
|
J:137066
|
\Faslpr/\Faslpr
(involves: 129P2/OlaHsd * MRL)
|
increased double-negative T cell number
|
J:26250
|
| increased gamma-delta T cell number
|
J:26250
|
\Faslpr/\Faslpr
\Fcer1gtm1Tks/\Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
increased double-negative T cell number
|
J:106188
|
\Faslpr/\Faslpr
\Havcr1tm1Kuch/\Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr)
|
increased activated T cell number
|
J:186484
|
| increased B cell number
|
J:186484
|
| increased CD4-positive, alpha-beta T cell number
|
J:186484
|
| increased CD8-positive, alpha-beta T cell number
|
J:186484
|
| increased double-negative T cell number
|
J:186484
|
| increased T cell number
|
J:186484
|
\Faslpr/\Faslpr
\Ifngtm1Ts/\Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased double-negative T cell number
|
J:39600
|
\Faslpr/\Faslpr
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg)
|
abnormal B cell receptor editing
|
J:131138
|
| abnormal marginal zone B cell morphology
|
J:131138
|
\Faslpr/\Faslpr
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp)
|
arrested B cell differentiation
|
J:119584
|
| decreased mature B cell number
|
J:119584
|
| increased T cell number
|
J:119584
|
\Faslpr/\Faslpr
\Irf1tm1Mak/\Irf1+
(MRL.Cg-Irf1tm1Mak Faslpr)
|
increased CD4-positive, alpha-beta T cell number
|
J:114771
|
\Faslpr/\Faslpr
\Irf1tm1Mak/\Irf1tm1Mak
(MRL.Cg-Irf1tm1Mak Faslpr)
|
increased CD4-positive, alpha-beta T cell number
|
J:114771
|
\Faslpr/\Faslpr
\Itfg2Gt(OST215121)Lex/\Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
|
decreased B cell number
|
J:205951
|
| increased double-negative T cell number
|
J:205951
|
\Faslpr/\Faslpr
\Pou2af1tm1Pmt/\Pou2af1tm1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * MRL)
|
abnormal T cell number
|
J:125114
|
| decreased plasma cell number
|
J:125114
|
| increased B cell number
|
J:125114
|
\Faslpr/\Faslpr
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * MRL)
|
increased gamma-delta intraepithelial T cell number
|
J:26250
|
| increased gamma-delta T cell number
|
J:26250
|
| increased T cell number
|
J:26250
|
\Faslpr/\Faslpr
\Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
|
decreased CD4-positive, alpha-beta T cell number
|
J:122222
|
| increased double-negative T cell number
|
J:122222
|
\Faslpr/\Faslpr
\Tg(H2-K-Cd86)27All/0
(involves: C57BL/6 * CBA * MRL/MpJ)
|
decreased B cell number
|
J:112475
|
\Faslpr/\Faslpr
\Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113557
|
| decreased double-negative T cell number
|
J:113557
|
\Faslpr/\Faslpr
\Tlr9tm1Aki/\Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr)
|
increased double-negative T cell number
|
J:135036
|
\Faslpr/\Faslpr
\Tlr9tm1Aki/\Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
increased CD4-positive, alpha-beta T cell number
|
J:113557
|
| increased double-negative T cell number
|
J:113557
|
\Faslpr/\Faslpr
\Tnfrsf9tm1Byk/\Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
increased B-1 B cell number
|
J:127197
|
| increased B-2 B cell number
|
J:127197
|
| increased CD4-positive, alpha-beta T cell number
|
J:127197,
J:126929
|
| increased double-negative T cell number
|
J:127197,
J:126929
|
\Faslpr/\Faslpr
\Tnfrsf13cBcmd1/\Tnfrsf13c+
(MRL.Cg-Tnfrsf13cBcmd1 Faslpr)
|
decreased B cell number
|
J:122315
|
| decreased marginal zone B cell number
|
J:122315
|
\Faslpr/\Fastm1Cgn
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
\Fasm1Btlr/\Fasm1Btlr
(C57BL/6J-Fasm1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:216052
|
| decreased CD8-positive, alpha-beta T cell number
|
J:216052
|
| increased NK cell number
|
J:216052
|
\Fasm2Btlr/\Fasm2Btlr
(C57BL/6J-Fasm2Btlr)
|
increased central memory CD4-positive, alpha-beta T cell number
|
J:271891
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:271891
|
\Fastm1Ach/\Fastm1Ach
\Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N)
|
increased double-positive T cell number
|
J:123556
|
\Fastm1Ach/\Fastm1Ach
\Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:123556
|
\Fastm1Cgn/\Fastm1Cgn
\Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
decreased B cell number
|
J:114948
|
| decreased T cell number
|
J:114948
|
| increased activated T cell number
|
J:114948
|
| increased double-negative T cell number
|
J:114948
|
| increased memory T cell number
|
J:114948
|
\Fastm1Osa/\Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell clonal deletion
|
J:32125
|
| increased B cell number
|
J:32125
|
| increased lymphocyte cell number
|
J:64296,
J:32125
|
\Faslgld/\Faslgld
(C3H/HeJ-Faslgld/J)
|
abnormal T cell differentiation
|
J:12002,
J:8267
|
| decreased B cell number
|
J:29572
|
| increased lymphocyte cell number
|
J:7306,
J:29572
|
| increased T cell number
|
J:29572
|
\Faslgld/\Faslgld
(C3H/HeJ-Faslgld)
|
abnormal T cell morphology
|
J:8267
|
\Faslgld/\Faslgld
(involves: C3H/HeJ * C57BL/6)
|
increased T cell number
|
J:153501
|
\Fasltm1.1Cgm/\Fasltm1.1Cgm
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N)
|
increased germinal center B cell number
|
J:168406
|
| increased plasma cell number
|
J:168406
|
\Fasltm1.1Lest/\Fasltm1.1Lest
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:87990
|
\Fbn1em1(IMPC)H/\Fbn1+
(C57BL/6NTac-Fbn1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Fbn1tm2.1Hcd/\Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal T-helper 1 cell morphology
|
J:206074
|
| increased B cell number
|
J:206074
|
| increased plasma cell number
|
J:206074
|
\Fbn1tm3.1Hcd/\Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal T-helper 1 cell morphology
|
J:206074
|
| increased B cell number
|
J:206074
|
| increased plasma cell number
|
J:206074
|
\Fbn1Tsk/\Fbn1+
(B6.Cg-Fbn1Tsk)
|
abnormal uterine NK cell morphology
|
J:1377
|
\Fbxl3em1(IMPC)Ccpcz/\Fbxl3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxl3em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
\Fbxl19tm1b(EUCOMM)Wtsi/\Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
\Fbxo7tm1a(EUCOMM)Hmgu/\Fbxo7tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased pro-B cell number
|
J:183053
|
\Fbxo7tm1a(EUCOMM)Wtsi/\Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal effector T cell number
|
J:272313
|
| abnormal T cell differentiation
|
J:272313
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272313
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272313
|
| decreased T cell number
|
J:272313
|
| increased activated T cell number
|
J:272313
|
| increased double-negative T cell number
|
J:272313
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272313
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272313
|
| increased memory T cell number
|
J:272313
|
\Fbxo7tm1c(EUCOMM)Wtsi/\Fbxo7tm1c(EUCOMM)Wtsi
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6J * C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272313
|
| decreased T cell number
|
J:272313
|
\Fbxo21em1Smbk/\Fbxo21em1Smbk
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Fbxo21em1Smbk Commd10Tg(Vav1-icre)A2Kio)
|
increased T cell number
|
J:333469
|
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137138
|
| decreased double-negative T cell number
|
J:137138
|
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:200006
|
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:128523
|
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-positive T cell number
|
J:128523
|
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:128523
|
| decreased single-positive T cell number
|
J:128523
|
| increased double-positive T cell number
|
J:128523
|
\Fbxw8tm1b(EUCOMM)Hmgu/\Fbxw8+
(C57BL/6N-Fbxw8tm1b(EUCOMM)Hmgu/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
\Fbxw16em1(IMPC)Ccpcz/\Fbxw16+
(C57BL/6N-Fbxw16em1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Fbxw26tm1b(KOMP)Wtsi/\Fbxw26tm1b(KOMP)Wtsi
(C57BL/6N-Fbxw26tm1b(KOMP)Wtsi/Wtsi)
|
decreased memory-marker NK cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Fcamrtm1Shib/\Fcamrtm1Shib
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal memory B cell differentiation
|
J:150824
|
| abnormal somatic hypermutation frequency
|
J:150824
|
\Fcer1gtm1Rav/\Fcer1gtm1Rav
\Tyrobptm1.1Viv/\Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
\Fcgr2btm1Kgcs/\Fcgr2b+
(involves: C57BL/6)
|
increased germinal center B cell number
|
J:190890
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Il17atm1Yiw/\Il17a+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased plasma cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Il17atm1Yiw/\Il17atm1Yiw
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Traf3ip2tm1Sbn/\Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:191090
|
| increased double-negative T cell number
|
J:191090
|
| increased memory T cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
| increased single-positive T cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Traf3ip2tm1Sbn/\Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:191090
|
| increased double-negative T cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Traf3ip2tm2Sbn/\Traf3ip2+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
\Fcgr2btm1Ttk/\Fcgr2btm1Ttk
\Traf3ip2tm2Sbn/\Traf3ip2tm2Sbn
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:191090
|
| increased plasma cell number
|
J:191090
|
\Fcgr3tm1Jsv/\Fcgr3tm1Jsv
\Sle21129P2/Ola/\Sle21129P2/Ola
(B6.129P2-Fcgr3tm1Jsv)
|
increased activated T cell number
|
J:179175
|
| increased B cell number
|
J:179175
|
\Fcmrtm1.2Khl/\Fcmrtm1.2Khl
(involves: C57BL/6)
|
decreased B cell number
|
J:174871
|
\Fcmrtm1Ohno/\Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno)
|
abnormal B cell morphology
|
J:190117
|
| decreased marginal zone B cell number
|
J:190117
|
| increased B-1 B cell number
|
J:190117
|
| increased T cell number
|
J:190117
|
\Fcrl2tm1Lex/\Fcrl2tm1Lex
(B6;129S5-Fcrl2tm1Lex/Mmucd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:171883
|
\Fdx2em1(IMPC)Rbrc/\Fdx2em1(IMPC)Rbrc
(C57BL/6NJcl-Fdx2em1(IMPC)Rbrc/Rbrc)
|
increased large unstained cell number
|
J:211773
|
\Fen1tm3.1Bhsh/\Fen1+
(Not Specified)
|
increased plasma cell number
|
J:231218
|
\Fen1tm3.1Bhsh/\Fen1tm3.1Bhsh
(Not Specified)
|
increased plasma cell number
|
J:231218
|
\Fermt3tm2.1Ref/\Fermt3tm2.1Ref
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal effector T cell morphology
|
J:203436
|
\Festm1Mcs/\Festm1Mcs
(involves: 129X1/SvJ)
|
decreased B cell number
|
J:64748
|
\Festm2Pag/\Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased B cell number
|
J:98590
|
| increased pre-B cell number
|
J:98590
|
| increased pro-B cell number
|
J:98590
|
\Ffar2tm1Dgen/\Ffar2tm1Dgen
(involves: C57BL/6)
|
increased T cell number
|
J:153951
|
\Fgd3em1(IMPC)Ccpcz/\Fgd3em1(IMPC)Ccpcz
(C57BL/6N-Fgd3em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Fgf23tm1Tyam/\Fgf23tm1Tyam
(involves: C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:88172
|
\Fgfr2tm1Dsn/\Fgfr2tm1Dsn
\Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
increased gamma-delta T cell number
|
J:119723
|
\Fgfr4M1Btlr/\Fgfr4M1Btlr
(C57BL/6J-Fgfr4M1Btlr)
|
decreased B-1a cell number
|
J:265097
|
\Fgl1tm1b(EUCOMM)Hmgu/\Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
|
decreased B cell number
|
J:269578
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:269578
|
\Fgl2tm1Pam/\Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
increased regulatory T cell number
|
J:130895
|
\Fhip1bem1(IMPC)Tcp/\Fhip1bem1(IMPC)Tcp
(C57BL/6NCrl-Fhip1bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Fibcd1tm1Spte/\Fibcd1tm1Spte
(B6.129S1-Fibcd1tm1Spte)
|
decreased lymphocyte cell number
|
J:340107
|
\Flcntm1Baba/\Flcntm1.1Lss
\Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:189078
|
| decreased B cell number
|
J:189078
|
\Fli1tm1.1Dkw/\Fli1+
(B6.129S6-Fli1tm1.1Dkw)
|
decreased B cell number
|
J:137876
|
\Fli1tm1.1Dkw/\Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw)
|
abnormal B cell differentiation
|
J:137876
|
| abnormal class switch recombination
|
J:137876
|
| decreased B cell number
|
J:137876
|
| decreased follicular B cell number
|
J:137876
|
| increased marginal zone B cell number
|
J:137876
|
| increased transitional stage B cell number
|
J:137876
|
\Fli1tm1Ber/\Fli1tm1Ber
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))
|
decreased thymocyte number
|
J:33052
|
\Fli1tm1Morl/\Fli1tm1Morl
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
increased NK cell number
|
J:167426
|
\Flt3em1(IMPC)Ccpcz/\Flt3em1(IMPC)Ccpcz
(C57BL/6NCrl-Flt3em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
\Flt3m1Btlr/\Flt3m1Btlr
(C57BL/6J-Flt3m1Btlr)
|
decreased NK cell number
|
J:159599
|
\Flt3tm1.1Dosm/\Flt3+
(B6.129(C)-Flt3tm1.1Dosm)
|
arrested B cell differentiation
|
J:205200
|
\Flt3tm1Dgg/\Flt3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
| decreased B cell number
|
J:126003
|
| decreased mature B cell number
|
J:126003
|
| decreased T cell number
|
J:126003
|
\Flt3tm1Dgg/\Flt3tm1Dgg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
| decreased B cell number
|
J:126003
|
| decreased mature B cell number
|
J:126003
|
| decreased T cell number
|
J:126003
|
\Flt3tm1Dosm/\Flt3+
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Flt3tm1Dosm Tg(Mx1-cre)1Cgn)
|
arrested B cell differentiation
|
J:133528
|
| decreased B cell number
|
J:133528
|
| decreased lymphocyte cell number
|
J:133528
|
| decreased pre-B cell number
|
J:133528
|
| increased pro-B cell number
|
J:133528
|
\Flt3tm1Irl/\Flt3tm1Irl
(either: 129S/SvEv-Flt3tm1Irl or (involves: 129S/SvEv * C57BL/6J))
|
abnormal B cell differentiation
|
J:27238,
J:99149
|
| decreased pre-B cell number
|
J:27238
|
| decreased pro-B cell number
|
J:27238
|
\Flt3tm1Irl/\Flt3tm1Irl
\KitW/\KitW-v
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell number
|
J:27238
|
| decreased B cell number
|
J:27238
|
| decreased double-negative T cell number
|
J:27238
|
| decreased double-positive T cell number
|
J:27238
|
| decreased lymphocyte cell number
|
J:27238
|
| decreased pre-B cell number
|
J:27238
|
| decreased pro-B cell number
|
J:27238
|
\Flt3tm2.1Dosm/\Flt3+
(B6.129(C)-Flt3tm2.1Dosm)
|
abnormal B cell morphology
|
J:205200
|
| increased pre-pro B cell number
|
J:205200
|
| increased pro-B cell number
|
J:205200
|
\Flt3ltm1Imx/\Flt3ltm1Imx
(C57BL/6-Flt3ltm1Imx)
|
abnormal immature B cell morphology
|
J:62536
|
| decreased B cell number
|
J:79569
|
| decreased double-negative T cell number
|
J:79569
|
| decreased lymphocyte cell number
|
J:62536
|
| decreased NK cell number
|
J:62536
|
| decreased pre-B cell number
|
J:79569
|
| decreased pro-B cell number
|
J:79569,
J:62536
|
\Flt3ltm1Imx/\Flt3ltm1Imx
(involves: C57BL/6)
|
decreased NK cell number
|
J:189122
|
\Fndc3aem1(IMPC)Tcp/\Fndc3aem1(IMPC)Tcp
(C57BL/6N-Fndc3aem1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Fndc9tm1.1(KOMP)Vlcg/\Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Fnip1em1(IMPC)Ccpcz/\Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Fnip1Gt(RRM154)Byg/\Fnip1Gt(RRM154)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| arrested B cell differentiation
|
J:189078
|
| decreased B cell number
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| decreased mature B cell number
|
J:189078
|
| decreased pre-B cell number
|
J:189078
|
| decreased transitional stage B cell number
|
J:189078
|
| increased pro-B cell number
|
J:189078
|
\Fnip1Gt(RRM154)Byg/\Fnip1Gt(RRM154)Byg
\Ightm2Cgn/\Ightm2Cgn
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
\Fnip1Gt(RRM154)Byg/\Fnip1Gt(RRM154)Byg
\Tg(BCL2)22Wehi/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
increased B cell number
|
J:189078
|
\Fnip1Gt(RRM154)Byg/\Fnip1Gt(RRM154)Byg
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| increased immature B cell number
|
J:189078
|
\Fnip1LPAB.1/\Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
absent B cells
|
J:187318
|
| arrested B cell differentiation
|
J:187318
|
| decreased B-1 B cell number
|
J:187318
|
\Fnip1m1Btlr/\Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr)
|
absent B cells
|
J:234285
|
| decreased marginal zone B cell number
|
J:234285
|
\Fnip1m2Btlr/\Fnip1m2Btlr
(C57BL/6J-Fnip1m2Btlr)
|
decreased B cell number
|
J:265134
|
| increased B-1 B cell number
|
J:265134
|
| increased CD4-positive, alpha-beta T cell number
|
J:265134
|
| increased single-positive T cell number
|
J:265134
|
| increased T cell number
|
J:265134
|
\Fnip1M3Btlr/\Fnip1M3Btlr
(C57BL/6J-Fnip1M3Btlr)
|
abnormal B cell differentiation
|
J:272802
|
\Fnip1tm1.2Baba/\Fnip1tm1.2Baba
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| arrested B cell differentiation
|
J:189078
|
| decreased B cell number
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| decreased mature B cell number
|
J:189078
|
| decreased pre-B cell number
|
J:189078
|
| decreased transitional stage B cell number
|
J:189078
|
| increased pro-B cell number
|
J:189078
|
\Fnip1tm1.2Baba/\Fnip1tm1.2Baba
\Ightm2Cgn/\Ightm2Cgn
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
\Fnip1tm1.2Baba/\Fnip1tm1.2Baba
\Tg(BCL2)22Wehi/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased B cell number
|
J:189078
|
\Fnip1tm1.2Baba/\Fnip1tm1.2Baba
\Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
absent B cells
|
J:189078
|
| absent B-2 B cells
|
J:189078
|
| decreased B-1 B cell number
|
J:189078
|
| increased immature B cell number
|
J:189078
|
\Fostm1Pa/\Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal lymphopoiesis
|
J:3233
|
\Fostm1Wag/\Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell number
|
J:3493
|
| decreased double-positive T cell number
|
J:3493
|
| decreased thymocyte number
|
J:3493
|
| increased T cell number
|
J:3493
|
\Fostm7Wag/\Fostm7Wag
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:190150
|
\Foxn1nu-StL/\Foxn1nu-StL
(involves: C57BL/6)
|
absent T cells
|
J:63313
|
\Foxn1nu-str/\Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
decreased lymphocyte cell number
|
J:30715
|
| decreased T cell number
|
J:30715
|
\Foxn1nu-Y/\Foxn1nu-Y
(101/HY-Foxn1nu-Y)
|
absent T cells
|
J:4060
|
\Foxn1nu/\Foxn1nu
(involves: CBA)
|
decreased lymphocyte cell number
|
J:202299
|
| decreased T cell number
|
J:202808
|
\Foxn1nu/\Foxn1nu
\Map3k14aly/\Map3k14aly
(involves: BALB/cAJcl * C57BL/6J)
|
absent B cells
|
J:96579
|
| decreased gamma-delta intraepithelial T cell number
|
J:96579
|
| decreased T cell number
|
J:96579
|
\Foxn1nu/\Foxn1tm1.1Dmsu
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
decreased thymocyte number
|
J:159773
|
\Foxn1tm1.1Cbln/\Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:177992
|
| decreased single-positive T cell number
|
J:177992
|
| increased DN1 thymic pro-T cell number
|
J:177992
|
| increased double-positive T cell number
|
J:177992
|
\Foxn1tm1.1Cbln/\Foxn1tm1Tbo
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
absent T cells
|
J:177992
|
\Foxn1tm1.1Dmsu/\Foxn1tm1.1Dmsu
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:159773
|
| decreased thymocyte number
|
J:159773
|
\Foxn1tm1.1Dmsu/\Foxn1tm1.1Dmsu
\Tg(KRT5-cre/ERT2)2Ipc/0
(involves: 129/Sv * C57BL/6 * SJL)
|
decreased thymocyte number
|
J:159773
|
\Foxn1tm1Nrm/\Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:86255
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:86255
|
| abnormal T cell differentiation
|
J:86255
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86255
|
| decreased double-negative T cell number
|
J:86255
|
| decreased double-positive T cell number
|
J:86255
|
| decreased T cell number
|
J:86255
|
| decreased thymocyte number
|
J:86255
|
\Foxn1tm1Tbo/\Foxn1tm1Tbo
(involves: 129S1/Sv)
|
absent T cells
|
J:33796
|
| increased B cell number
|
J:33796
|
\Foxn1tm2Tbo/\Foxn1tm2Tbo
\Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased T cell number
|
J:110046
|
\Foxn1tm3(cre)Nrm/\Foxn1+
\Gt(ROSA)26Sortm1(Tbx1)Rche/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NHsd)
|
decreased thymocyte number
|
J:214094
|
\Foxn1tm3(cre)Nrm/\Foxn1+
\Mir205hgtm1Oers/\Mir205hgtm1Oers
(B6(Cg)-Mir205hgtm1Oers Foxn1tm3(cre)Nrm)
|
decreased thymocyte number
|
J:278363
|
\Foxn4em1(IMPC)Ccpcz/\Foxn4+
(C57BL/6NCrl-Foxn4em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Foxo1tm1.1Rdp/\Foxo1+
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv)
|
increased B cell number
|
J:157297
|
\Foxo1tm1.1Stlp/\Foxo1tm1.1Stlp
\Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
abnormal single-positive T cell number
|
J:154205
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154205
|
| decreased double-positive T cell number
|
J:154205
|
| decreased T cell number
|
J:154205
|
| increased CD4-positive, alpha-beta T cell number
|
J:154205
|
| increased CD8-positive, alpha-beta T cell number
|
J:154205
|
\Foxo1tm1Flv/\Foxo1tm1Flv
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
increased CD4-positive, alpha-beta T cell number
|
J:189962
|
| increased CD8-positive, alpha-beta T cell number
|
J:189962
|
| increased regulatory T cell number
|
J:189962
|
| increased T cell number
|
J:189962
|
\Foxo1tm1Flv/\Foxo1tm1Flv
\Ifngtm1Ts/\Ifngtm1Ts
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129S7/SvEvBrd * 129X1/SvJ)
|
increased CD4-positive, alpha-beta T cell number
|
J:189962
|
| increased CD8-positive, alpha-beta T cell number
|
J:189962
|
\Foxo1tm1Flv/\Foxo1tm1Flv
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(CD2-Il7r)1Asin/?
\Tg(Cd4-cre)1Cwi/?
\Tg(TcraTcrb)425Cbn/?
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:147057
|
\Foxo1tm1Flv/\Foxo1tm1Flv
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Cd4-cre)1Cwi/?
\Tg(TcraTcrb)425Cbn/?
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased T cell number
|
J:147057
|
\Foxo1tm1Flv/\Foxo1tm1Flv
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased single-positive T cell number
|
J:147057
|
\Foxo1tm1Rdp/\Foxo1tm1.1Rdp
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv)
|
absent marginal zone B cells
|
J:157297
|
| increased B cell number
|
J:157297
|
\Foxo3tm1Nmt/\Foxo3tm1Nmt
(B6.Cg-Foxo3tm1Nmt)
|
abnormal NK cell morphology
|
J:123409
|
| increased NK cell number
|
J:123409
|
\Foxp1tm1.1Pwt/\Foxp1tm1.1Pwt
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:156832
|
| decreased CD8-positive, alpha-beta T cell number
|
J:156832
|
\Foxp1tm1Rao/\Foxp1tm1Rao
(B6.129-Foxp1tm1Rao)
|
abnormal B cell differentiation
|
J:112644
|
| arrested B cell differentiation
|
J:112644
|
| decreased mature B cell number
|
J:112644
|
\Foxp2tm2.2Woen/\Foxp2+
(involves: C57BL/6 * C57BL/6J)
|
increased CD4-positive, alpha-beta T cell number
|
J:150425
|
| increased CD8-positive, alpha-beta T cell number
|
J:150425
|
\Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
abnormal lymphocyte morphology
|
J:11262
|
\Foxp3sf/Y
(B6.Cg-Foxp3sf)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:82560
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:82560
|
\Foxp3sf\Otcspf/Y
(involves: 129/Rl)
|
increased CD4-positive, alpha-beta T cell number
|
J:20865
|
\Foxp3sf/\Foxp3sf
\Tg(Rorc-EGFP)1Ebe/?
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
\Foxp3tm1(CD2/CD52)Shori/\Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:171378
|
\Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:82560
|
| abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:82560
|
\Foxp3tm1.1Ayr/\Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:125405
|
| decreased double-positive T cell number
|
J:125405
|
\Foxp3tm1.1Ayr/\Foxp3tm1.1Ayr
\Mir146tm1.1Bal/\Mir146tm1.1Bal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased regulatory T cell number
|
J:167922
|
\Foxp3tm1.1Mal/\Foxp3tm1.1Mal
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
decreased regulatory T cell number
|
J:131351
|
\Foxp3tm1Ayr/\Foxp3tm1Ayr
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:125405
|
| decreased double-positive T cell number
|
J:125405
|
\Foxp3tm1Flv/\Foxp3+
\B9d2/Tgfb1tm1Flv/\Tgfb1tm2Flv
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased regulatory T cell number
|
J:123547
|
\Foxp3tm1Kuch/?
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:123352
|
| increased regulatory T cell number
|
J:123352
|
\Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
|
absent regulatory T cells
|
J:117165
|
| increased activated T cell number
|
J:117165
|
| increased CD4-positive, alpha-beta T cell number
|
J:117165
|
| increased CD8-positive, alpha-beta T cell number
|
J:117165
|
| increased lymphocyte cell number
|
J:117165
|
\Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch)
|
increased lymphocyte cell number
|
J:117165
|
\Foxp3tm2.1(EGFP/cre)Shori/Y
(involves: 129 * C57BL/6)
|
decreased regulatory T cell number
|
J:234397
|
\Foxp3tm2.1(EGFP/cre)Shori/Y
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6)
|
increased effector memory T-helper cell number
|
J:234397
|
\Foxp3tm2Ayr/?
\Zap70rps/\Zap70rps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:211510
|
| abnormal double-positive T cell morphology
|
J:211510
|
| abnormal regulatory T cell number
|
J:211510
|
| abnormal T cell differentiation
|
J:211510
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211510
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211510
|
\Foxp3tm3(HBEGF/GFP)Ayr/\Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell number
|
J:117743
|
\Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:120636
|
| abnormal T cell subpopulation ratio
|
J:120636
|
\Foxp3tm3Tch/\Foxp3+
(C.129X1-Foxp3tm3Tch)
|
decreased T cell number
|
J:120636
|
| decreased thymocyte number
|
J:120636
|
\Foxp3tm4(YFP/icre)Ayr/Y
\Zfp91tm1Smoc/\Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased regulatory T cell number
|
J:306129
|
| increased CD8-positive, alpha-beta T cell number
|
J:306129
|
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
\Nr4a2tm1.1Pcn/\Nr4a2tm1.1Pcn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal regulatory T cell morphology
|
J:205658
|
\Foxp3tm4(YFP/icre)Ayr/\Foxp3tm4(YFP/icre)Ayr
\Ikzf4tm1Djr/\Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:294549
|
| increased germinal center B cell number
|
J:294549
|
| increased T cell number
|
J:294549
|
| increased T follicular helper cell number
|
J:294549
|
\Foxp3tm5.2Ayr/\Foxp3tm5.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal intraepithelial T cell morphology
|
J:156942
|
| abnormal T cell differentiation
|
J:156942
|
| decreased regulatory T cell number
|
J:156942
|
| increased T cell number
|
J:156942
|
\Foxp3tm6.2Ayr/\Foxp3tm6.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:156942
|
\Foxp3tm7.2Ayr/\Foxp3+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:156942
|
\Foxp3tm7.2Ayr/\Foxp3tm7.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal regulatory T cell morphology
|
J:156942
|
| decreased regulatory T cell number
|
J:156942
|
\Foxp3tm9(EGFP/cre/ERT2)Ayr/\Foxp3+
\Il1r2tm1.1Epi/\Il1r2tm1.1Epi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6NTac)
|
abnormal alpha-beta T cell number
|
J:347877
|
| increased CD4-positive, alpha-beta T cell number
|
J:347877
|
| increased T follicular helper cell number
|
J:347877
|
\Foxq1sa-e1/\Foxq1sa-e1
(involves: 101/Rl * C3H/Rl)
|
abnormal lymphocyte cell number
|
J:75422
|
\Fshrtm1Saco/\Fshrtm1Saco
(involves: 129)
|
increased pre-B cell number
|
J:65577
|
\Fstl1tm1b(EUCOMM)Hmgu/\Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Fts/\Fts+
(B6.Cg-Fts)
|
abnormal CD4-positive T cell differentiation
|
J:108193
|
| abnormal T cell morphology
|
J:108193
|
| increased thymocyte number
|
J:108193
|
\Fubp1tm1.1Dlev/\Fubp1tm1.1Dlev
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:229985
|
\FusGt(U3NeoSV1)HO14Ggh/\FusGt(U3NeoSV1)HO14Ggh
(B6.129S2-FusGt(U3NeoSV1)HO14Ggh)
|
decreased B cell number
|
J:60213
|
| decreased lymphocyte cell number
|
J:60213
|
\Fyb1tm1Gak/\Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte number
|
J:111368
|
\Fyntm1Rmp/\Fyntm1Rmp
(involves: 129S2/SvPas)
|
decreased gamma-delta T cell number
|
J:37062
|
| decreased T cell number
|
J:37062
|
\Fyntm1Rmp/\Fyntm1Rmp
\Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:112977
|
| abnormal NK T cell number
|
J:37940
|
| absent CD4-positive, alpha-beta T cells
|
J:37940
|
| absent CD8-positive, alpha-beta T cells
|
J:37940
|
| absent T cells
|
J:37062
|
| arrested T cell differentiation
|
J:37062,
J:37940
|
| decreased double-positive T cell number
|
J:37940
|
| decreased gamma-delta intraepithelial T cell number
|
J:112977,
J:37940
|
\Fyntm1Sor/\Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal T cell clonal deletion
|
J:2242
|
\Fyntm1Sor/\Fyntm1Sor
\Lcktm1Litt/\Lcktm1.1Litt
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S7/SvEvBrd * 129X1/SvJ)
|
decreased regulatory T cell number
|
J:152472
|
| increased regulatory T cell number
|
J:152472
|
| increased T cell number
|
J:152472
|
\Fyntm1Yik/\Fyntm1Yik
\Ptk2tm1Lfr/\Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:110771
|
| decreased double-positive T cell number
|
J:110771
|
| decreased thymocyte number
|
J:110771
|
\Fzd1em1(IMPC)Mbp/\Fzd1em1(IMPC)Mbp
(C57BL/6N-Fzd1em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Fzd9tm1Uta/\Fzd9tm1Uta
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
decreased B cell number
|
J:98133
|
| decreased pre-B cell number
|
J:98133
|
| decreased pro-B cell number
|
J:98133
|
\G6pc2tm1.1Pesa/\G6pc2tm1.1Pesa
(NOD.129S2-G6pc2tm1.1Pesa)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:160286
|
\Gab3em1Khoe/\Gab3em1Khoe
(C57BL/6-Gab3em1Khoe)
|
abnormal mature NK cell morphology
|
J:291290
|
| abnormal uterine NK cell morphology
|
J:291290
|
| decreased NK cell number
|
J:291290
|
\Gab3m1Khoe/\Gab3m1Khoe
(C57BL/6-Gab3m1Khoe)
|
abnormal mature NK cell morphology
|
J:291290
|
| abnormal uterine NK cell morphology
|
J:291290
|
| decreased NK cell number
|
J:291290
|
\Gabarapl2tm1b(EUCOMM)Hmgu/\Gabarapl2+
(C57BL/6N-Gabarapl2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\GabpaGt(XH074)Byg/\GabpaGt(XH074)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:92671
|
\Gabrb3tm2.1Geh/\Gabrb3tm2.1Geh
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:333883
|
| abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:333883
|
| abnormal T-helper 17 cell differentiation
|
J:333883
|
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
| decreased lymphocyte cell number
|
J:76041
|
| increased T cell number
|
J:76041
|
| increased thymocyte number
|
J:57882
|
\Gadd45btm1Flv/\Gadd45btm1Flv
(involves: 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
\Gadd45btm1Flv/\Gadd45btm1Flv
\Gadd45gtm1Flv/\Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
\Gadd45btm1Flv/\Gadd45btm1Flv
\Gadd45gtm1Flv/\Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
increased mature B cell number
|
J:118837
|
| increased memory T cell number
|
J:118837
|
\Gadd45gtm1Flv/\Gadd45gtm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
\Galnt1tm1.1Jxm/\Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased B cell number
|
J:128982
|
| decreased germinal center B cell number
|
J:128982
|
| decreased plasma cell number
|
J:128982
|
| decreased T cell number
|
J:128982
|
| increased lymphocyte cell number
|
J:128982
|
\Galnt18tm1b(KOMP)Wtsi/\Galnt18tm1b(KOMP)Wtsi
(C57BL/6N-Galnt18tm1b(KOMP)Wtsi/Wtsi)
|
increased NK cell number
|
J:211773
|
\Galr1em1(IMPC)H/\Galr1em1(IMPC)H
(C57BL/6N-Galr1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Galr2Gt(OST105469)Lex/\Galr2Gt(OST105469)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:103485
|
| increased T cell number
|
J:103485
|
\Gapttm1.1Wz/\Gapttm1.1Wz
(Not Specified)
|
increased marginal zone B cell number
|
J:138146
|
\Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased lymphocyte cell number
|
J:78348
|
\Gata1tm2Sho/\Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased lymphocyte cell number
|
J:78348
|
\Gata1tm6Sho/\Gata1tm6Sho
(involves: 129S1/Sv * BALB/c)
|
decreased lymphocyte cell number
|
J:115273
|
\Gata3tm1Iho/\Gata3tm1Iho
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:86996
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
\Gata3tm1Iho/\Gata3tm1Iho
\Tg(Cd4-cre)1Cwi/0
\Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
\Gata3tm1Iho/\Gata3tm1Iho
\Tg(DO11.10)10Dlo/0
\Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:86996
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
| decreased CD8-positive, alpha-beta T cell number
|
J:86996
|
| decreased double-positive T cell number
|
J:86996
|
\Gata3tm1Iho/\Gata3tm1Iho
\Tg(Lck-cre)1Cwi/0
(involves: BALB/c)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:86996
|
| abnormal T cell subpopulation ratio
|
J:86996
|
| arrested T cell differentiation
|
J:86996
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86996
|
| decreased double-positive T cell number
|
J:86996
|
| decreased thymocyte number
|
J:86996
|
\Gata3tm1Jfz/\Gata3tm1Jfz
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Cd4-cre)1Cwi/0
\Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:141145
|
\Gata3tm1Jfz/\Gata3tm1Jfz
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93538
|
| abnormal T cell differentiation
|
J:141145
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141145
|
\Gata3tm1Jfz/\Gata3tm1Jfz
\Tg(Tnfrsf4-cre)1Nik/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93538
|
| decreased T-helper 2 cell number
|
J:93538
|
| increased T-helper 1 cell number
|
J:93538
|
\Gata3tm2Jeng/\Gata3tm2Jeng
(Not Specified)
|
abnormal double-positive T cell morphology
|
J:155686
|
| abnormal T cell differentiation
|
J:155686
|
| abnormal T cell number
|
J:155686
|
| decreased double-negative T cell number
|
J:155686
|
| decreased gamma-delta T cell number
|
J:155686
|
| decreased thymocyte number
|
J:155686
|
\Gata3tm3Gsv/\Gata3tm3Gsv
\Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell number
|
J:117058
|
\Gba1tm1.1Pmis/\Gba1tm1.1Pmis
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
| decreased double-positive T cell number
|
J:167081
|
\Gba1tm1.1Pmis/\Gba1tm1.2Pmis
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
| decreased double-positive T cell number
|
J:167081
|
\Gcnt1em1(IMPC)Ccpcz/\Gcnt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Gcnt1em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Gcnt1tm1Jxm/\Gcnt1tm1Jxm
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:86387
|
\Gcnt2tm1Tmu/\Gcnt2tm1Tmu
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell number
|
J:100533
|
\Gdatm1a(KOMP)Wtsi/\Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi)
|
decreased T-helper cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Gdf5em1(IMPC)H/\Gdf5em1(IMPC)H
(C57BL/6NTac-Gdf5em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Gfi1Gen/\Gfi1+
(C57BL/6J-Gfi1Gen)
|
abnormal NK cell differentiation
|
J:182679
|
\Gfi1tm1.1Wep/\Gfi1tm1.1Wep
(B6.129-Gfi1tm1.1Wep)
|
arrested T cell differentiation
|
J:117105
|
| decreased B cell number
|
J:117105
|
\Gfi1tm1Tmo/\Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:75143
|
| decreased B cell number
|
J:75143
|
| decreased lymphocyte cell number
|
J:75143
|
| decreased T cell number
|
J:75143
|
| decreased thymocyte number
|
J:75143
|
\Gfi1tm1Tmo/\Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:192927
|
| decreased thymocyte number
|
J:192927
|
\Gfi1tm1Wep/\Gfi1tm1Wep
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:117105
|
\Gfi1tm2Tmo/\Gfi1tm2Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:93337
|
| decreased thymocyte number
|
J:93337
|
\Gfi1tm4Tmo/\Gfi1tm4Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:116870
|
| abnormal T cell differentiation
|
J:116870
|
| decreased double-negative T cell number
|
J:116870
|
| decreased lymphocyte cell number
|
J:116870
|
| decreased thymocyte number
|
J:116870
|
\Gfi1btm1b(EUCOMM)Hmgu/\Gfi1b+
(C57BL/6N-Gfi1btm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Ggta1tm1Jbl/\Ggta1+
\Ightm1Jiac/\Igh+
\Igktm1Jiac/\Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased mature B cell number
|
J:133032
|
\Ggta1tm1Jbl/\Ggta1+
\Ightm1Jiac/\Ightm1Jiac
\Igktm1Jiac/\Igk+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased mature B cell number
|
J:133032
|
\Ggta1tm1Jbl/\Ggta1+
\Ightm1Jiac/\Ightm1Jiac
\Igktm1Jiac/\Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal B cell selection
|
J:133032
|
| decreased mature B cell number
|
J:133032
|
\Gimap1m1Btlr/\Gimap1m1Btlr
(C57BL/6J-Gimap1m1Btlr)
|
decreased B cell number
|
J:267546
|
| decreased B-1 B cell number
|
J:267546
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267546
|
| increased CD4-positive, alpha-beta T cell number
|
J:267546
|
\Gimap1tm1.1Gwb/\Gimap1tm1.1Gwb
\Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:160782
|
| decreased B-1a cell number
|
J:160782
|
| decreased B-1b cell number
|
J:160782
|
| decreased B-2 B cell number
|
J:160782
|
| decreased CD4-positive, alpha-beta T cell number
|
J:160782
|
| decreased CD8-positive, alpha-beta T cell number
|
J:160782
|
| decreased follicular B cell number
|
J:160782
|
| decreased lymphocyte cell number
|
J:160782
|
| decreased marginal zone B cell number
|
J:160782
|
| decreased T cell number
|
J:160782
|
| decreased thymocyte number
|
J:160782
|
| decreased transitional stage T2 B cell number
|
J:160782
|
\Gimap3tm1.1Yout/\Gimap3tm1.1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased T cell number
|
J:209926
|
| decreased thymocyte number
|
J:209926
|
\Gimap5m1Btlr/\Gimap5m1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:160090
|
| decreased B-1 B cell number
|
J:160090
|
| decreased CD8-positive, alpha-beta T cell number
|
J:160090
|
| decreased lymphocyte cell number
|
J:160090
|
| decreased mature B cell number
|
J:160090
|
| decreased NK cell number
|
J:160090
|
| decreased NK T cell number
|
J:160090
|
\Gimap5m1Btlr/\Gimap5m1Btlr
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:160090
|
| decreased thymocyte number
|
J:160090
|
\Gimap5tm1Wlr/\Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:143620
|
| abnormal lymphocyte cell number
|
J:143620
|
| decreased B cell number
|
J:143620
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143620
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143620
|
| decreased NK cell number
|
J:143620
|
| decreased NK T cell number
|
J:143620
|
| decreased T cell number
|
J:143620
|
\Gimap5tm1Yout/\Gimap5tm1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased T cell number
|
J:209926
|
\Gimap6tm1.1Gwb/\Gimap6tm1.1Gwb
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:262059
|
| decreased T cell number
|
J:262059
|
| increased B cell number
|
J:262059
|
\Gimap6tm1a(KOMP)Wtsi/\Gimap6tm1a(KOMP)Wtsi
(C57BL/6N-Gimap6tm1a(KOMP)Wtsi/Wtsi)
|
decreased CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
\Git2Gt(XG510)Byg/\Git2Gt(XG510)Byg
(B6.129P2-Git2Gt(XG510)Byg)
|
decreased marginal zone B cell number
|
J:160613
|
\Git2Gt(XG510)Byg/\Git2Gt(XG510)Byg
(C.129P2-Git2Gt(XG510)Byg)
|
decreased marginal zone B cell number
|
J:160613
|
\Git2Gt(XG510)Byg/\Git2Gt(XG510)Byg
\Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:160613
|
\Git2Gt(XG510)Byg/\Git2Gt(XG510)Byg
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:160613
|
| decreased CD8-positive, alpha-beta T cell number
|
J:160613
|
\Git2Gt(XG510)Byg/\Git2Gt(XG510)Byg
\Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:160613
|
\Gk5m5Btlr/\Gk5m5Btlr
(C57BL/6J-Gk5m5Btlr)
|
increased alpha-beta T cell number
|
J:265118
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265118
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265118
|
\Glb1tm1Jmat/\Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR)
|
abnormal lymphopoiesis
|
J:43534
|
\Glb1l2tm1Lex/\Glb1l2tm1Lex
(B6;129S5-Glb1l2tm1Lex/Mmucd)
|
decreased lymphocyte cell number
|
J:171883
|
| decreased NK cell number
|
J:171883
|
\Glra2tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra2tm1b(KOMP)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Gm5148em1(IMPC)Ccpcz/\Gm5148+
(C57BL/6NCrl-Gm5148em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Gm5544tm1a(KOMP)Wtsi/\Gm5544+
(C57BL/6N-Gm5544tm1a(KOMP)Wtsi/Wtsi)
|
decreased marginal zone B cell number
|
J:211773
|
\Gm26330em1Liuq/\Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq)
|
decreased NK cell number
|
J:341056
|
\Gm36723em1Flv/\Gm36723em1Flv
(C57BL/6-Gm36723em1Flv)
|
abnormal lymphopoiesis
|
J:258967
|
| decreased lymphocyte cell number
|
J:258967
|
| decreased mature NK cell number
|
J:258967
|
| decreased NK cell number
|
J:258967
|
| increased immature NK cell number
|
J:258967
|
\Gm36723em3Flv/\Gm36723em3Flv
(C57BL/6-Gm36723em3Flv)
|
decreased mature NK cell number
|
J:258967
|
\Gm40600em1Cya/\Gm40600em1Cya
(C57BL/6-Gm40600em1Cya)
|
abnormal plasmablast number
|
J:311878
|
| decreased B cell number
|
J:311878
|
| decreased plasma cell number
|
J:311878
|
| increased B cell number
|
J:311878
|
| increased plasma cell number
|
J:311878
|
\Gmdstm1a(KOMP)Wtsi/\Gmdstm1a(KOMP)Wtsi
(C57BL/6N-Gmdstm1a(KOMP)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased mature NK cell number
|
J:211773
|
| decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased gamma-delta T cell number
|
J:211773
|
| increased immature NK cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
\Gmnntm1.1Kio/\Gmnntm1.2Kio
\Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased CD4-positive, alpha-beta T cell number
|
J:159657
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:159657
|
| decreased CD8-positive, alpha-beta T cell number
|
J:159657
|
| decreased DN1 thymic pro-T cell number
|
J:159657
|
| decreased DN4 thymocyte number
|
J:159657
|
| decreased double-positive T cell number
|
J:159657
|
| decreased memory T cell number
|
J:159657
|
| decreased thymocyte number
|
J:159657
|
\Gmpsem1(IMPC)Tcp/\Gmps+
(C57BL/6NCrl-Gmpsem1(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Gna12tm1.1Cgh/\Gna12tm1.1Cgh
\Gna13tm2Cgh/\Gna13tm2Cgh
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal germinal center B cell morphology
|
J:174313
|
| increased germinal center B cell number
|
J:174313
|
\Gna12tm1Citb/\Gna12tm1Citb
\Gna13tm2.1Soff/\Gna13tm2.1Soff
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased CD4-positive, alpha-beta T cell number
|
J:149560
|
| increased CD8-positive, alpha-beta T cell number
|
J:149560
|
\Gnai2tm1Lbi/\Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
increased single-positive T cell number
|
J:30507
|
| increased T cell number
|
J:30507
|
\Gnai2tm1Lbi/\Gnai2tm1Lbi
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased thymocyte number
|
J:24434
|
\Gnai2tm1Lbi/\Gnai2tm1Lbi
(B6.129S7-Gnai2tm1Lbi)
|
increased lymphocyte cell number
|
J:120069
|
\Gnai2tm2.1Lbi/\Gnai2tm2.1Lbi
\Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)
|
decreased T-helper 17 cell number
|
J:194587
|
\Gnrh1hpg/\Gnrh1hpg
(HPG/BmJ)
|
increased B cell number
|
J:19436
|
| increased immature B cell number
|
J:19436
|
| increased mature B cell number
|
J:19436
|
\Gon4ljusty/\Gon4ljusty
(C3HeB/FeJ-Gon4ljusty)
|
absent B cells
|
J:163412
|
| arrested B cell differentiation
|
J:163412
|
| decreased B cell number
|
J:163412
|
| decreased immature B cell number
|
J:163412
|
| decreased pro-B cell number
|
J:163412
|
| decreased T cell number
|
J:163412
|
\Got1tm1b(EUCOMM)Hmgu/\Got1+
(C57BL/6N-Got1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Gp6tm2b(EUCOMM)Hmgu/\Gp6tm2b(EUCOMM)Hmgu
(C57BL/6N-Gp6tm2b(EUCOMM)Hmgu/Orl)
|
increased lymphocyte cell number
|
J:211773
|
\Gpatch2em1Boui/\Gpatch2em1Boui
(C57BL/6-Gpatch2em1Boui)
|
decreased B cell number
|
J:336774
|
\Gpatch4em1(IMPC)Ccpcz/\Gpatch4em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpatch4em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
\Gper1tm1Dgen/\Gper1tm1Dgen
(B6.129-Gper1tm1Dgen)
|
decreased CD4-positive, alpha-beta T cell number
|
J:151816
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151816
|
| decreased T cell number
|
J:151816
|
\Gpr15tm1.1Litt/\Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
decreased CD4-positive, alpha-beta T cell number
|
J:199126
|
| decreased double-negative T cell number
|
J:199126
|
| decreased regulatory T cell number
|
J:199126
|
| increased CD8-positive, alpha-beta T cell number
|
J:199126
|
\Gpr15tm1.1Litt/\Gpr15tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased regulatory T cell number
|
J:199126
|
\Gpr18tm1.1Cys/\Gpr18tm1.1Cys
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:219661
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:219661
|
\Gpr83em1(IMPC)Ccpcz/\Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
\Gpr83tm1.1Fpow/\Gpr83tm1.1Fpow
(C.129-Gpr83tm1.1Fpow)
|
decreased CD4-positive, alpha-beta T cell number
|
J:144445
|
\Gpr89ex/\Gpr89ex
(C57BL/6J-Gpr89ex)
|
abnormal T cell morphology
|
J:287198
|
| abnormal T cell number
|
J:287198
|
\Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
|
abnormal T-helper 1 cell differentiation
|
J:222307
|
| increased single-positive T cell number
|
J:222307
|
\Gpr183tm1.2Rbr/\Gpr183tm1.2Rbr
(involves: C57BL/6 * FVB/N * SJL)
|
decreased plasma cell number
|
J:151883
|
\Gpr183tm1.2Rbr/\Gpr183tm1.2Rbr
\Ightm1Rbr/\Ightm1Rbr
\Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased B cell number
|
J:151883
|
| decreased plasma cell number
|
J:151883
|
\Grap2tm1Amch/\Grap2tm1Amch
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:76696
|
| decreased CD4-positive, alpha-beta T cell number
|
J:76696
|
| decreased CD8-positive, alpha-beta T cell number
|
J:76696
|
| decreased thymocyte number
|
J:76696
|
| increased double-negative T cell number
|
J:76696
|
\Grap2tm1Amch/\Grap2tm1Amch
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:150304
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150304
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150304
|
| decreased double-positive T cell number
|
J:150304
|
| decreased single-positive T cell number
|
J:150304
|
\Grap2tm1Eac/\Grap2tm1Eac
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:92023
|
| abnormal double-negative T cell morphology
|
J:92023
|
| decreased T cell number
|
J:92023
|
| decreased thymocyte number
|
J:92023
|
| increased activated T cell number
|
J:92023
|
| increased memory T cell number
|
J:92023
|
\Graptm1Gsf/\Graptm1Gsf
(B6.129-Graptm1Gsf)
|
increased CD4-positive, alpha-beta T cell number
|
J:76243
|
\Grb2tm1.1Hua/\Grb2tm1.1Hua
\Tg(DO11.10)10Dlo/0
\Tg(Lck-cre)1Jtak/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161294
|
\Grb2tm1.1Hua/\Grb2tm1.1Hua
\Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161294
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161294
|
| decreased double-positive T cell number
|
J:161294
|
| decreased thymocyte number
|
J:161294
|
\Grb2tm1.1Hua/\Grb2tm1.1Hua
\Tg(Lck-cre)1Jtak/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:161294
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161294
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161294
|
| increased CD8-positive, alpha-beta T cell number
|
J:161294
|
| increased double-positive T cell number
|
J:161294
|
\Grb2tm1Lnit/\Grb2tm1Lnit
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * BALB/cJ)
|
abnormal B cell differentiation
|
J:171222
|
| decreased B cell number
|
J:171222
|
| decreased follicular B cell number
|
J:171222
|
| decreased mature B cell number
|
J:171222
|
| decreased transitional stage T1 B cell number
|
J:171222
|
| decreased transitional stage T2 B cell number
|
J:171222
|
| increased plasma cell number
|
J:171222
|
\Grk2tm1Gwd/\Grk2tm1Gwd
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129 * BALB/c * C57BL/6)
|
decreased B cell number
|
J:176118
|
| increased B cell number
|
J:176118
|
| increased CD4-positive, alpha-beta T cell number
|
J:176118
|
| increased CD8-positive, alpha-beta T cell number
|
J:176118
|
| increased follicular B cell number
|
J:176118
|
| increased marginal zone B cell number
|
J:176118
|
\Grk2tm1Gwd/\Grk2tm1Mca
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:176118
|
| decreased CD8-positive, alpha-beta T cell number
|
J:176118
|
| decreased T cell number
|
J:176118
|
| increased B cell number
|
J:176118
|
\Grk6tm1.1Mca/\Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca)
|
abnormal T cell subpopulation ratio
|
J:225063
|
| decreased CD8-positive, alpha-beta T cell number
|
J:225063
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:225063
|
| increased memory T cell number
|
J:225063
|
\Gsdma3tm1(KOMP)Vlcg/\Gsdma3tm1(KOMP)Vlcg
(C57BL/6N-Gsdma3tm1(KOMP)Vlcg/Nju)
|
increased lymphocyte cell number
|
J:211773
|
\Gsx1tm1Ssp/\Gsx1tm1Ssp
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:31764
|
\Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:208980
|
| abnormal B-2 B cell morphology
|
J:208980
|
| abnormal class switch recombination
|
J:208980
|
| abnormal follicular B cell morphology
|
J:208980
|
| abnormal transitional stage T3 B cell morphology
|
J:208980
|
| absent marginal zone B cells
|
J:208980
|
| decreased B-1 B cell number
|
J:208980
|
| decreased B-1a cell number
|
J:208980
|
| decreased immature B cell number
|
J:208980
|
| decreased marginal zone B cell number
|
J:208980
|
| decreased transitional stage T1 B cell number
|
J:208980
|
| increased lymphocyte cell number
|
J:208980
|
\Gt(ROSA)26Sortm1(CAG-Foxn1/ERT2,-GFP)Cbln/\Gt(ROSA)26Sor+
\Foxn1tm3(cre)Nrm/\Foxn1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T cell number
|
J:208852
|
\Gt(ROSA)26Sortm1(CAG-SETBP1*G870S,-EGFP)Ase/\Gt(ROSA)26Sor+
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
decreased lymphocyte cell number
|
J:363041
|
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sortm1(Tcfe2a/Tal1)Xhsu
(involves: 129/Sv * C57BL/6)
|
abnormal lymphopoiesis
|
J:144569
|
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
\Il1r2tm1.1Epi/\Il1r2tm1.1Epi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6NTac)
|
increased T follicular helper cell number
|
J:347877
|
\Gt(ROSA)26Sortm1(CTNNB1)Nerl/\Gt(ROSA)26Sortm1(CTNNB1)Nerl
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:112660
|
| decreased double-negative T cell number
|
J:112660
|
\Gt(ROSA)26Sortm1(DTA)Jpmb/\Gt(ROSA)26Sor+
\Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:234435
|
\Gt(ROSA)26Sortm1(DTA)Lky/\Gt(ROSA)26Sortm1(DTA)Lky
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:133382
|
| abnormal T cell receptor V(D)J recombination
|
J:133382
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133382
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133382
|
| decreased double-positive T cell number
|
J:133382
|
| decreased lymphocyte cell number
|
J:133382
|
| decreased NK T cell number
|
J:133382
|
| decreased regulatory T cell number
|
J:133382
|
\Gt(ROSA)26Sortm1(DTA)Riet/\Gt(ROSA)26Sortm1(DTA)Riet
\Tg(Rorc-cre)1Litt/?
(involves: 129P2/OlaHsd)
|
abnormal effector T cell morphology
|
J:137020
|
\Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/\Gt(ROSA)26Sor+
\Cd79atm3(cre/ERT2)Reth/\Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal plasma cell differentiation
|
J:208904
|
| increased B cell number
|
J:208904
|
\Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/\Gt(ROSA)26Sor+
\Cd79atm3(cre/ERT2)Reth/\Cd79a+
\Tg(BCL2)22Wehi/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)
|
abnormal plasma cell differentiation
|
J:208904
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
\Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal plasma cell differentiation
|
J:167612
|
| increased germinal center B cell number
|
J:167612
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:157757
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:157757
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157757
|
| decreased CD8-positive, alpha-beta T cell number
|
J:157757
|
| decreased single-positive T cell number
|
J:157757
|
| decreased T cell number
|
J:157757
|
| increased double-positive T cell number
|
J:157757
|
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
\Rev3ltm1.1Diaz/\Rev3ltm1.1Diaz
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:188723
|
| abnormal somatic hypermutation frequency
|
J:188723
|
\Gt(ROSA)26Sortm1(gp80)Eces/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
| decreased B cell number
|
J:172031
|
| decreased germinal center B cell number
|
J:172031
|
| decreased plasma cell number
|
J:172031
|
| increased B cell number
|
J:172031
|
| increased marginal zone B cell number
|
J:172031
|
| increased T cell number
|
J:172031
|
\Gt(ROSA)26Sortm1(gp80)Eces/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
| decreased B cell number
|
J:172031
|
| decreased follicular B cell number
|
J:172031
|
| decreased germinal center B cell number
|
J:172031
|
| decreased plasma cell number
|
J:172031
|
| increased B cell number
|
J:172031
|
| increased marginal zone B cell number
|
J:172031
|
\Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/\Gt(ROSA)26Sortm9(cre/ESR1)Arte
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:170965
|
| increased memory B cell number
|
J:170965
|
\Gt(ROSA)26Sortm1(HBEGF)Awai/\Gt(ROSA)26Sortm1(HBEGF)Awai
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymphocyte cell number
|
J:131076
|
| decreased single-positive T cell number
|
J:131076
|
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:160931
|
| decreased double-positive T cell number
|
J:160931
|
| decreased single-positive T cell number
|
J:160931
|
| decreased T cell number
|
J:160931
|
\Gt(ROSA)26Sortm1(Mirn155)Rsky/\Gt(ROSA)26Sortm1(Mirn155)Rsky
(involves: BALB/c * C57BL/6)
|
increased germinal center B cell number
|
J:121084
|
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Hes1tm1.1Frad/\Hes1tm1.1Frad
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased B cell number
|
J:167000
|
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased B cell number
|
J:167000
|
\Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/\Gt(ROSA)26Sor+
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased B cell number
|
J:260047
|
| decreased lymphocyte cell number
|
J:260047
|
| increased T cell number
|
J:260047
|
\Gt(ROSA)26Sortm1(Ptpn22*)Draw/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:201448
|
| increased germinal center B cell number
|
J:201448
|
\Gt(ROSA)26Sortm1(rtTA)Awu/\Gt(ROSA)26Sortm1(rtTA)Awu
\Xisttm1Awu/Y
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:112954
|
| abnormal T cell differentiation
|
J:112954
|
| absent pre-B cells
|
J:112954
|
| decreased double-positive T cell number
|
J:112954
|
| decreased immature B cell number
|
J:112954
|
| decreased pro-B cell number
|
J:112954
|
| decreased thymocyte number
|
J:112954
|
\Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/\Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:205858
|
\Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/\Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased regulatory T cell number
|
J:205858
|
| increased T-helper 1 cell number
|
J:205858
|
| increased T-helper 17 cell number
|
J:205858
|
\Gt(ROSA)26Sortm1.1(Ubc-BCL3)Sbn/\Gt(ROSA)26Sor+
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
decreased follicular B cell number
|
J:207111
|
| decreased marginal zone B cell number
|
J:207111
|
| increased follicular B cell number
|
J:207111
|
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+
\Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
arrested B cell differentiation
|
J:202090
|
| decreased B cell number
|
J:202090
|
| decreased double-positive T cell number
|
J:202090
|
| decreased mature B cell number
|
J:202090
|
| decreased pre-B cell number
|
J:202090
|
| decreased pro-B cell number
|
J:202090
|
| increased CD8-positive, alpha-beta T cell number
|
J:202090
|
| increased large unstained cell number
|
J:202090
|
| increased single-positive T cell number
|
J:202090
|
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
arrested B cell differentiation
|
J:202090
|
| decreased B cell number
|
J:202090
|
| decreased double-positive T cell number
|
J:202090
|
| decreased mature B cell number
|
J:202090
|
| decreased pre-B cell number
|
J:202090
|
| decreased pro-B cell number
|
J:202090
|
| increased CD8-positive, alpha-beta T cell number
|
J:202090
|
| increased large unstained cell number
|
J:202090
|
| increased single-positive T cell number
|
J:202090
|
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Id3tm2.1Zhu/\Id3tm2.1Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased T cell number
|
J:172701
|
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
| decreased B cell number
|
J:179036
|
| decreased B-1a cell number
|
J:179036
|
| decreased B-2 B cell number
|
J:179036
|
| decreased follicular B cell number
|
J:179036
|
| decreased transitional stage T2 B cell number
|
J:179036
|
| increased marginal zone B cell number
|
J:179036
|
| increased T cell number
|
J:179036
|
| increased transitional stage T1 B cell number
|
J:179036
|
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
| decreased follicular B cell number
|
J:179036
|
| decreased mature B cell number
|
J:179036
|
| decreased pre-B cell number
|
J:179036
|
| decreased transitional stage T2 B cell number
|
J:179036
|
| increased marginal zone B cell number
|
J:179036
|
| increased transitional stage T1 B cell number
|
J:179036
|
\Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/\Gt(ROSA)26Sor+
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6J)
|
arrested B cell differentiation
|
J:179036
|
| decreased B cell number
|
J:179036
|
| increased T cell number
|
J:179036
|
\Gt(ROSA)26Sortm2(ITK/Syk)Hjum/\Gt(ROSA)26Sor+
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:207306
|
| increased CD4-positive, alpha-beta T cell number
|
J:207306
|
| increased mature B cell number
|
J:207306
|
| increased plasma cell number
|
J:207306
|
\Gt(ROSA)26Sortm2(ITK/Syk)Hjum/\Gt(ROSA)26Sor+
\Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR)
|
increased activated T cell number
|
J:207306
|
| increased CD4-positive, alpha-beta T cell number
|
J:207306
|
| increased mature B cell number
|
J:207306
|
| increased plasma cell number
|
J:207306
|
\Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:137122
|
| increased B cell number
|
J:137122
|
| increased follicular B cell number
|
J:137122
|
| increased marginal zone B cell number
|
J:137122
|
| increased T cell number
|
J:137122
|
\Gt(ROSA)26Sortm2(Mirn150)Rsky/\Gt(ROSA)26Sor+
(involves: C57BL/6 * SJL/J)
|
decreased mature B cell number
|
J:127234
|
\Gt(ROSA)26Sortm2(Mirn150)Rsky/\Gt(ROSA)26Sortm2(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
decreased B-1 B cell number
|
J:127234
|
| decreased B-2 B cell number
|
J:127234
|
| decreased CD4-positive, alpha-beta T cell number
|
J:127234
|
| decreased CD8-positive, alpha-beta T cell number
|
J:127234
|
\Gt(ROSA)26Sortm2.1(Mirn150)Rsky/\Gt(ROSA)26Sor+
(involves: C57BL/6 * SJL/J)
|
decreased mature B cell number
|
J:127234
|
\Gt(ROSA)26Sortm2.1(Mirn150)Rsky/\Gt(ROSA)26Sortm2.1(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
arrested B cell differentiation
|
J:127234
|
| arrested T cell differentiation
|
J:127234
|
| decreased B-1 B cell number
|
J:127234
|
| decreased B-2 B cell number
|
J:127234
|
| decreased lymphocyte cell number
|
J:127234
|
\Gt(ROSA)26Sortm2Sho/\Gt(ROSA)26Sor+
\Lef1tm1Hhx/\Lef1tm1Hhx
\Tg(GZMB-cre)1Jcb/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:189838
|
\Gt(ROSA)26Sortm3(CAG-EYFP)Hze/\Gt(ROSA)26Sor+
\Stat5atm2Mam \Stat5btm1Mam/\Del(11Stat5a-Stat5b)1Mam
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/\Gt(ROSA)26Sor+
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased marginal zone B cell number
|
J:133215
|
| increased B-1a cell number
|
J:133215
|
\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/\Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal B cell morphology
|
J:133215
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:133215
|
| abnormal T cell differentiation
|
J:133215
|
| decreased marginal zone B cell number
|
J:133215
|
| increased B cell number
|
J:133215
|
| increased B-1a cell number
|
J:133215
|
| increased CD4-positive, alpha-beta T cell number
|
J:133215
|
| increased CD8-positive, alpha-beta T cell number
|
J:133215
|
| increased germinal center B cell number
|
J:133215
|
| increased lymphocyte cell number
|
J:133215
|
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Hnrnpltm1.1Tmo/\Hnrnpltm1.1Tmo
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:188749
|
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased germinal center B cell number
|
J:167612
|
| increased B cell number
|
J:167612
|
| increased plasma cell number
|
J:167612
|
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sor+
\Ighg1tm1(cre)Cgn/\Ighg1+
\Prdm1tm2Masu/\Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:167612
|
| increased germinal center B cell number
|
J:167612
|
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/\Gt(ROSA)26Sortm4(Ikbkb)Rsky
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:157297
|
\Gt(ROSA)26Sortm7(Pik3ca*,-EGFP)Rsky/\Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:191824
|
| increased germinal center B cell number
|
J:191824
|
\Gt(ROSA)26Sortm8(Map2k1*,-EGFP)Rsky/\Gt(ROSA)26Sortm8(Map2k1*,-EGFP)Rsky
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:157297
|
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
\Map3k14tm1.1Gne/\Map3k14tm1.1Gne
(B6(Cg)-Map3k14tm1.1Gne Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
decreased B cell number
|
J:240453
|
| decreased germinal center B cell number
|
J:240453
|
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
\Ripk3tm1Arte/\Ripk3tm1Arte
(involves: C57BL/6NTac)
|
abnormal lymphocyte morphology
|
J:209137
|
\Gt(ROSA)26Sortm9(Rac1*,-EGFP)Rsky/\Gt(ROSA)26Sortm9(Rac1*,-EGFP)Rsky
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:157297
|
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
(involves: BALB/cJ)
|
abnormal B cell morphology
|
J:181546
|
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal B cell differentiation
|
J:181546
|
| decreased B cell number
|
J:181546
|
| decreased mature B cell number
|
J:181546
|
| decreased pre-B cell number
|
J:181546
|
| increased B cell number
|
J:181546
|
| increased CD4-positive, alpha-beta T cell number
|
J:181546
|
| increased CD8-positive, alpha-beta T cell number
|
J:181546
|
| increased pro-B cell number
|
J:181546
|
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrb+
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)
|
increased B cell number
|
J:181546
|
\Gt(ROSA)26Sortm10(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)
|
increased B cell number
|
J:181546
|
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:181546
|
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:181546
|
| decreased B cell number
|
J:181546
|
| decreased mature B cell number
|
J:181546
|
| decreased pre-B cell number
|
J:181546
|
| increased B cell number
|
J:181546
|
| increased CD4-positive, alpha-beta T cell number
|
J:181546
|
| increased CD8-positive, alpha-beta T cell number
|
J:181546
|
| increased pro-B cell number
|
J:181546
|
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Cd19tm1(cre/ERT2)Rsky/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased activated T cell number
|
J:217520
|
| increased B cell number
|
J:217520
|
| increased CD4-positive, alpha-beta T cell number
|
J:217520
|
| increased CD8-positive, alpha-beta T cell number
|
J:217520
|
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrb+
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased B cell number
|
J:181546
|
\Gt(ROSA)26Sortm11(Lmp1)Rsky/\Gt(ROSA)26Sor+
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased B cell number
|
J:181546
|
\Gzmbtm1Ley/\Gzmbtm1Ley
\Serpinb9tm1Arp/\Serpinb9tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:113349
|
\H2-Aab-tm1Blt/\H2-Aab-tm1Blt
(C57BL/6-H2-Aab-tm1Blt)
|
abnormal T cell morphology
|
J:16372
|
| decreased CD4-positive, alpha-beta T cell number
|
J:16372
|
| increased CD8-positive, alpha-beta T cell number
|
J:16372
|
\H2-Ab1b-tm1.1Jssh/\H2-Ab1b-tm1.1Jssh
(C57BL/6-H2-Ab1b-tm1.1Jssh)
|
abnormal T cell differentiation
|
J:201198
|
| decreased regulatory T cell number
|
J:201198
|
\H2-Ab1b-tm1Doi/\H2-Ab1b-tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:65736
|
| decreased CD4-positive, alpha-beta T cell number
|
J:51885,
J:65736
|
| increased CD4-positive, alpha-beta T cell number
|
J:64283
|
| increased CD8-positive, alpha-beta T cell number
|
J:65736,
J:64283
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(involves: 129S2/SvPas * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:74418
|
| increased CD8-positive, alpha-beta T cell number
|
J:74418
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(B6.129S2-H2-Ab1b-tm1Gru)
|
decreased CD4-positive, alpha-beta T cell number
|
J:91341
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(involves: 129S2/SvPas * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:67941
|
| decreased single-positive T cell number
|
J:67941
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Runx1tm1Toku/\Runx1tm1Toku
\Runx3tm1Itan/\Runx3tm1Itan
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2)
|
increased CD4-positive, alpha-beta T cell number
|
J:131081
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tespa1tm1Smoc/\Tespa1tm1Smoc
(involves: 129 * 129S2/SvPas * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(Ab1TL)1Gru/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:91341
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DQA1,HLA-DQB1)1Dv/0
\Tg(HLA-DRB1)31Dmz/0
\Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68641
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:68641
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(HLA-DRB1)31Dmz/0
\Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68641
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:68641
|
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
\H2-Ab1b-tm1Koni/\H2-Ab1b-tm1.1Koni
\Tg(Tek-cre)12Flv/0
(involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:131774
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:131774
|
| increased CD4-positive, alpha-beta T cell number
|
J:131774
|
\H2-Ab1b-tm1Wug/\H2-Ab1b-tm1Wug
(involves: C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:204951
|
\H2-Ab1bm12/\H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12)
|
decreased CD8-positive, alpha-beta T cell number
|
J:4554
|
| increased B cell number
|
J:104189
|
| increased CD4-positive, alpha-beta T cell number
|
J:4554
|
| increased double-negative T cell number
|
J:4554
|
\H2-Ab1g7-em1Dvs/\H2-Ab1g7-em1Dvs
\H2-D1b-em5Dvs/\H2-D1b-em5Dvs
\H2-K1d-em1Dvs/\H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-Ab1g7-em1Dvs H2-D1em5Dvs/Dvs)
|
abnormal T cell subpopulation ratio
|
J:257229
|
| decreased alpha-beta T cell number
|
J:257229
|
| decreased CD4-positive, alpha-beta T cell number
|
J:257229
|
\H2-Ab1g7-em1Ygch/\H2-Ab1g7-em1Ygch
(NOD/ShiLtJ-H2-Ab1g7-em1Ygch)
|
decreased CD4-positive, alpha-beta T cell number
|
J:101977
|
\H2-D1b-em5Dvs/\H2-D1b-em5Dvs
\H2-K1d-em1Dvs/\H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs/Dvs)
|
abnormal T cell subpopulation ratio
|
J:257229
|
\H2-D1b-tm1Bpe/\H2-D1b-tm1Bpe
\H2-K1b-tm1Bpe/\H2-K1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:57703
|
| decreased CD8-positive, alpha-beta T cell number
|
J:54709
|
| increased CD4-positive, alpha-beta T cell number
|
J:54709
|
\H2-DMatm1Liz/\H2-DMatm1Liz
(involves: BALB/cJ)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113714
|
\H2-DMatm1Lkrl/\H2-DMatm1Lkrl
(involves: 129P2/OlaHsd)
|
abnormal positive T cell selection
|
J:31786
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31786
|
\H2-DMatm1Luc/\H2-DMatm1Luc
(involves: 129S4/SvJae)
|
abnormal positive T cell selection
|
J:125548
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31625,
J:45185
|
\H2-K1b-tm1Bpe/\H2-K1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:54709
|
| increased CD4-positive, alpha-beta T cell number
|
J:54709
|
\H2-Kbm1/\H2-Kbm1
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:92867
|
\H2-Kbm5/\H2-Kbm5
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:133645
|
\H2-M3tm1Crw/\H2-M3tm1Crw
(B6.129-H2-M3tm1Crw)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:118960
|
| decreased activated T cell number
|
J:118960
|
\H2-Oatm1Dma/\H2-Oatm1Dma
(involves: 129/Sv * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:65235
|
\H2-Q10tm1.1(KOMP)Mbp/\H2-Q10tm1.1(KOMP)Mbp
(involves: C57BL/6 * C57BL/6N)
|
decreased gamma-delta T cell number
|
J:294888
|
| decreased immature NK cell number
|
J:294888
|
| decreased mature NK cell number
|
J:294888
|
| decreased NK cell number
|
J:294888
|
| increased NK cell number
|
J:294888
|
\H2-T18b/\H2-T18b
\H2-T3tm1Luc/\H2-T3tm1Luc
(C57BL/6-H2-T3tm1Luc)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:142515
|
| abnormal CD8-positive, gamma-delta intraepithelial T cell morphology
|
J:142515
|
| abnormal intraepithelial T cell morphology
|
J:142515
|
\H2-T18b/\H2-T18b
\H2-T3tm1Luc/\H2-T3tm1Luc
\Tcratm1Mom/\Tcratm1Mom
(B6.Cg-Tcratm1Mom H2-T3tm1Luc)
|
abnormal intraepithelial T cell number
|
J:142515
|
\H2b/\H2b
\Itktm1Ljb/\Itktm1Ljb
\Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
\H2b/\H2b
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
\H2b/\H2b
\Ptcratm1Vbo/\Ptcratm1Vbo
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
\H2b/\H2b
\Ptcratm1Vbo/\Ptcratm1Vbo
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
\H2b/\H2b
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133112
|
| increased CD8-positive, alpha-beta T cell number
|
J:133112
|
\H2b/\H2b
\Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
\H2b/\H2b
\Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
\H2b/\H2b
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
| abnormal double-positive T cell morphology
|
J:81564
|
| abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
| decreased double-positive T cell number
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
\H2b/\H2d
((C57BL/6 x DBA/2)F1)
|
abnormal T cell differentiation
|
J:106141
|
\H2b/\H2d
\Tg(TcraTcrb)1100Mjb/?
(involves: BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:133645
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133645
|
\H2b/\H2d
\Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
\H2b/\H2k
\Itktm1Ljb/\Itktm1Ljb
\Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
\H2b/\H2k
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
|
abnormal negative T cell selection
|
J:133645
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133645
|
\H2b/\H2s
\Tg(TcraTcrb)1100Mjb/?
(involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)
|
abnormal negative T cell selection
|
J:133645
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133645
|
\H2d/\H2d
(DBA/2)
|
abnormal T cell differentiation
|
J:106141
|
\H2d/\H2d
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133112
|
| decreased CD8-positive, alpha-beta T cell number
|
J:133112
|
\H2d/\H2d
\Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
\H2d/\H2d
\Tg(TcraP1.5,TcrbP1.5)29Amsv/0
\Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2)
|
abnormal T cell clonal deletion
|
J:180807
|
\H2dlAb1-Ea/\H2dlAb1-Ea
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell number
|
J:57484
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57484
|
| increased CD8-positive, alpha-beta T cell number
|
J:57484
|
\H2dlAb1-Ea/\H2dlAb1-Ea
\Psmb11tm1(Psmb8)Khog/\Psmb11tm1(Psmb8)Khog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:196156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
\H2dlAb1-Ea/\H2dlAb1-Ea
\Rr381em2Kap/\Rr381em2Kap
(involves: 129S2/SvPas * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:333471
|
\H2dlAb1-Ea/\H2dlAb1-Ea
\Rr381em4Kap/\Rr381em4Kap
(involves: 129S2/SvPas * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
\H2dlAb1-Ea/\H2dlAb1-Ea
\Rr381em5Kap/\Rr381em5Kap
(involves: 129S2/SvPas * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
\H2dlAb1-Ea/\H2dlAb1-Ea
\Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
\Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:189816
|
| increased T-helper 1 cell number
|
J:189816
|
| increased T-helper 17 cell number
|
J:189816
|
\H2g7/\H2g7
\Tg(Ins2-Vtcn1)#Xxz/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: C57BL/6 * NOD * SJL)
|
decreased regulatory T cell number
|
J:177612
|
\H2k/\H2k
\Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL)
|
increased CD4-positive, alpha-beta T cell number
|
J:124701
|
\H2u/\H2u
\Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| decreased thymocyte number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
\H2u/\H2u
\Tg(TCRA)B1Jg/?
\Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
|
abnormal effector T cell morphology
|
J:92991
|
| decreased CD8-positive, alpha-beta T cell number
|
J:92991
|
| decreased double-positive T cell number
|
J:92991
|
| increased CD4-positive, alpha-beta T cell number
|
J:92991
|
\H2u/\H2u
\Tg(TCRA)B1Jg/0
\Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)
|
abnormal double-negative T cell morphology
|
J:92992
|
| abnormal double-positive T cell morphology
|
J:92992
|
| absent gamma-delta T cells
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| increased CD4-positive, alpha-beta T cell number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
\H2u/\H2u
\Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRB)C14Jg/J)
|
abnormal double-negative T cell morphology
|
J:92992
|
| abnormal double-positive T cell morphology
|
J:92992
|
| absent gamma-delta T cells
|
J:92992
|
\H2axtm1Fwa/\H2axtm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:84879
|
| decreased lymphocyte cell number
|
J:84879
|
\H2axtm1Nus/\H2axtm1Nus
(Not Specified)
|
abnormal class switch recombination
|
J:194603,
J:120658
|
| decreased B cell number
|
J:76360
|
| decreased T cell number
|
J:76360
|
\Havcr1tm1Kuch/\Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch)
|
abnormal T cell differentiation
|
J:186484
|
| increased activated T cell number
|
J:186484
|
| increased CD4-positive, alpha-beta T cell number
|
J:186484
|
| increased CD8-positive, alpha-beta T cell number
|
J:186484
|
| increased double-negative T cell number
|
J:186484
|
| increased T cell number
|
J:186484
|
\Havcr2tm1Vlcg/\Havcr2tm1Vlcg
(B6.129-Havcr2tm1Vlcg)
|
decreased T cell number
|
J:209885
|
\Havcr2tm1Vlcg/\Havcr2tm1Vlcg
\Tg(TcraTcrb)1100Mjb/?
(B6.Cg-Havcr2tm1Vlcg Tg(TcraTcrb)1100Mjb)
|
decreased T cell number
|
J:209885
|
\Hax1tm1.1Gach/\Hax1tm1.1Gach
(involves: BALB/c)
|
abnormal B cell number
|
J:174159
|
| abnormal lymphocyte morphology
|
J:174159
|
| abnormal T cell number
|
J:174159
|
| decreased B cell number
|
J:174159
|
| decreased B-1a cell number
|
J:174159
|
| decreased CD4-positive, alpha-beta T cell number
|
J:174159
|
| decreased CD8-positive, alpha-beta T cell number
|
J:174159
|
| decreased double-positive T cell number
|
J:174159
|
| decreased immature B cell number
|
J:174159
|
| decreased marginal zone B cell number
|
J:174159
|
| decreased mature B cell number
|
J:174159
|
| decreased pre-B cell number
|
J:174159
|
| decreased pro-B cell number
|
J:174159
|
| decreased thymocyte number
|
J:174159
|
| decreased transitional stage T1 B cell number
|
J:174159
|
| decreased transitional stage T2 B cell number
|
J:174159
|
| increased follicular B cell number
|
J:174159
|
\Hax1tm1Jni/\Hax1tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:132627
|
| decreased immature B cell number
|
J:132627
|
| decreased lymphocyte cell number
|
J:132627
|
| decreased single-positive T cell number
|
J:132627
|
| decreased T cell number
|
J:132627
|
\Hbs1ltm1a(KOMP)Wtsi/\Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi)
|
decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased mature B cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD5-positive gamma-delta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased regulatory T cell number
|
J:211773
|
\Hcar1em1(IMPC)Ccpcz/\Hcar1em1(IMPC)Ccpcz
(C57BL/6N-Hcar1em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
\Hcls1tm1Wtn/\Hcls1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:28146
|
\Hcls1tm1Wtn/\Hcls1tm1Wtn
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:28146
|
| decreased double-positive T cell number
|
J:28146
|
\Hcls1tm2Wtn/\Hcls1tm2Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:28146
|
\Hcn2m1Btlr/\Hcn2m1Btlr
(C57BL/6J-Hcn2m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255187
|
| increased CD4-positive, alpha-beta T cell number
|
J:255187
|
\Hcrttm1.1(KOMP)Vlcg/\Hcrttm1.1(KOMP)Vlcg
(C57BL/6N-Hcrttm1.1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Hcsttm1.1Cln/\Hcsttm1.1Cln
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:80426
|
\Hcsttm1.1Cln/\Hcsttm1.1Cln
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
\Hdac1tm1.1Pmt/\Hdac1tm1.1Pmt
\Hdac2tm1.1Pmt/\Hdac2tm1.1Pmt
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)
|
arrested B cell differentiation
|
J:157903
|
| decreased B cell number
|
J:157903
|
| decreased pre-B cell number
|
J:157903
|
| decreased pro-B cell number
|
J:157903
|
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc
\Hdac2tm1.1Shmc/\Hdac2+
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
| decreased CD4-positive, alpha-beta T cell number
|
J:194769
|
| decreased CD8-positive, alpha-beta T cell number
|
J:194769
|
| decreased double-positive T cell number
|
J:194769
|
| increased double-negative T cell number
|
J:194769
|
| increased double-positive T cell number
|
J:194769
|
| increased single-positive T cell number
|
J:194769
|
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc
\Hdac2tm1.1Shmc/\Hdac2tm1.1Shmc
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
| decreased double-positive T cell number
|
J:194769
|
| decreased thymocyte number
|
J:194769
|
| increased double-positive T cell number
|
J:194769
|
| increased single-positive T cell number
|
J:194769
|
| increased thymocyte number
|
J:194769
|
\Hdac4em1(IMPC)Ccpcz/\Hdac4+
(C57BL/6N-Hdac4em1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
\Hddc2em1(IMPC)H/\Hddc2em1(IMPC)H
(C57BL/6NTac-Hddc2em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Hellstm1Kmu/\Hellstm1Kmu
(involves: 129S1/Sv)
|
decreased B cell number
|
J:61948
|
| increased CD8-positive, alpha-beta T cell number
|
J:61948
|
| increased double-negative T cell number
|
J:61948
|
\Hes1tm1.1Frad/\Hes1tm1.1Frad
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167000
|
| decreased DN1 thymic pro-T cell number
|
J:167000
|
| decreased DN2 thymocyte number
|
J:167000
|
| decreased DN3 thymocyte number
|
J:167000
|
| decreased DN4 thymocyte number
|
J:167000
|
| decreased double-positive T cell number
|
J:167000
|
| decreased gamma-delta T cell number
|
J:167000
|
| increased DN1 thymic pro-T cell number
|
J:167000
|
| increased immature B cell number
|
J:167000
|
\Hfgi1C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
\Hfgi2C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
\Hhatem1(IMPC)Ccpcz/\Hhat+
(C57BL/6NCrl-Hhatem1(IMPC)Ccpcz/Ccpcz)
|
increased memory-marker CD4-positive NK T cell number
|
J:211773
|
\Hif1atm3Rsjo/\Hif1atm3Rsjo
\Tg(Tal1-cre/ERT)42-056Jrg/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:192126
|
| abnormal T cell differentiation
|
J:192126
|
\Hivep2tm1Sis/\Hivep2+
(involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased CD8-positive, alpha-beta T cell number
|
J:72249
|
| decreased single-positive T cell number
|
J:72249
|
\Hivep2tm1Sis/\Hivep2tm1Sis
(involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased single-positive T cell number
|
J:72249
|
\Hivep2tm1Sis/\Hivep2tm1Sis
(C.Cg-Hivep2tm1Sis)
|
abnormal T-helper 2 cell morphology
|
J:96024
|
\Hivep2tm1Sis/\Hivep2tm1Sis
\Tg(DO11.10)10Dlo/?
(involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal positive T cell selection
|
J:96024
|
| abnormal T-helper 2 cell morphology
|
J:96024
|
| decreased single-positive T cell number
|
J:72249
|
\Hivep3tm1Lcw/\Hivep3tm1Lcw
(chimera involves: 129S/SvEv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:79652
|
\Hmbox1em1(IMPC)Tcp/\Hmbox1em1(IMPC)Tcp
(C57BL/6N-Hmbox1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Hmgn5tm1.2Mbus/Y
(involves: 129S4/SvJae * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:199604
|
\Hmgn5tm1.2Mbus/\Hmgn5tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:199604
|
\Hmox1tm1.1Gkl/\Hmox1tm1.1Gkl
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased B cell number
|
J:148498
|
| increased CD4-positive, alpha-beta T cell number
|
J:148498
|
| increased CD8-positive, alpha-beta T cell number
|
J:148498
|
\Hnrnpdtm1b(KOMP)Wtsi/\Hnrnpd+
(C57BL/6N-Hnrnpdtm1b(KOMP)Wtsi/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
\Hnrnph1tm1b(KOMP)Wtsi/\Hnrnph1+
(C57BL/6N-Hnrnph1tm1b(KOMP)Wtsi/Nju)
|
increased lymphocyte cell number
|
J:211773
|
\Hnrnpltm1.1Tmo/\Hnrnpltm1.1Tmo
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
abnormal T cell differentiation
|
J:188749
|
| decreased CD4-positive, alpha-beta T cell number
|
J:188749
|
| decreased CD8-positive, alpha-beta T cell number
|
J:188749
|
| decreased double-positive T cell number
|
J:188749
|
| decreased T cell number
|
J:188749
|
| increased double-negative T cell number
|
J:188749
|
\Hnrnpllthdr/\Hnrnpllthdr
(C57BL/6JSfdAnu-Hnrnpllthdr/Anu)
|
abnormal memory T cell morphology
|
J:142641
|
| abnormal T cell differentiation
|
J:142641
|
| decreased CD4-positive, alpha-beta T cell number
|
J:142641
|
\Hoxc4tm2.1Mrc/\Hoxc4tm2.1Mrc
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:148278
|
| abnormal somatic hypermutation frequency
|
J:148278
|
\Hprt1b-m3/Y
\Impdh1tm1Bmi/\Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
\Hprt1b-m3/Y
\Impdh2tm1Bmi/\Impdh2+
(involves: 129P2/OlaHsd)
|
abnormal lymphocyte cell number
|
J:86045
|
\Hprt1tm1(CUX1)Anep/\Hprt1+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB))
|
decreased B cell number
|
J:113393
|
\Hrem1(IMPC)H/\Hrem1(IMPC)H
(C57BL/6NTac-Hrem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Hrhr/\Hrhr
(HRS/J)
|
decreased T cell number
|
J:6087
|
\Hrh1tm1Wtn/\Hrh1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell number
|
J:111704
|
\Hsd17b11Gt(OST237628)Lex/\Hsd17b11Gt(OST237628)Lex
(B6;129S5-Hsd17b11Gt(OST237628)Lex/Mmucd)
|
increased immature B cell number
|
J:171883
|
\Hspa9Gt(IST14901H6)Tigm/\Hspa9+
(involves: C57BL/6N)
|
decreased pre-B cell number
|
J:227164
|
\Hspa13tm1.1Smoc/\Hspa13tm1.1Smoc
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6)
|
abnormal class switch recombination
|
J:303927
|
| abnormal plasmablast number
|
J:303927
|
| abnormal somatic hypermutation frequency
|
J:303927
|
| decreased plasma cell number
|
J:303927
|
\Htr3atm1Ckn/\Htr3atm1Ckn
(involves: 129S1/Sv * C57BL/6J * DBA/2)
|
decreased lymphocyte cell number
|
J:90942
|
\Htra2mnd2/\Htra2mnd2
(involves: C57BL/6J)
|
decreased double-positive T cell number
|
J:132627
|
| decreased pre-B cell number
|
J:132627
|
| decreased pro-B cell number
|
J:132627
|
| decreased single-positive T cell number
|
J:132627
|
\Htra2tm1.2Hohj/\Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:225666
|
\Icam1tm1Bay/\Icam1tm1Bay
(B6.129S7-Icam1tm1Bay)
|
increased lymphocyte cell number
|
J:48271
|
\Icam1tm1Bay/\Icam1tm1Bay
\Selltm1Tft/\Selltm1Tft
(B6.129-Selltm1Tft Icam1tm1Bay)
|
increased lymphocyte cell number
|
J:48271
|
\Icam1tm1Jcgr/\Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased lymphocyte cell number
|
J:18743
|
\Icam1tm1Jcgr/\Icam1tm1Jcgr
\Ldlrtm1Her/\Ldlrtm1Her
\Vcam1tm1Dmil/\Vcam1tm1Dmil
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased lymphocyte cell number
|
J:69597
|
\Icostm1.1Wks/\Icostm1.1Wks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell number
|
J:155586
|
| abnormal B cell selection
|
J:155586
|
| abnormal class switch recombination
|
J:155586
|
| decreased CD4-positive, alpha-beta T cell number
|
J:155586
|
\Icostm1Dgry/\Icostm1Dgry
(B6.129P2-Icostm1Dgry)
|
abnormal memory B cell number
|
J:123477
|
| decreased germinal center B cell number
|
J:123477
|
| decreased plasma cell number
|
J:123477
|
| increased plasma cell number
|
J:123477
|
\Icostm1Flv/\Icostm1Flv
(NOD.129S1-Icostm1Flv)
|
decreased T cell number
|
J:131529
|
\Icostm1Mak/\Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:155586
|
| abnormal class switch recombination
|
J:66702
|
| decreased CD4-positive, alpha-beta T cell number
|
J:155586
|
\Icostm1Shr/\Icostm1Shr
(Not Specified)
|
abnormal T cell differentiation
|
J:87124
|
\Icosltm1Cdon/\Icosltm1Cdon
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:86697
|
\Icosltm1Mak/\Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:84668
|
| abnormal T-helper 2 cell differentiation
|
J:84668
|
\Id1tm1Zhu/\Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:119519
|
\Id1tm1Zhu/\Id1tm1Zhu
\Tcf3tm1Wein/\Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
absent B cells
|
J:44278
|
| arrested B cell differentiation
|
J:44278
|
| decreased lymphocyte cell number
|
J:44278
|
\Id2tm1Ago/\Id2tm1Ago
(B6.129-Id2tm1Ago)
|
absent NK cells
|
J:116119
|
| decreased CD8-positive, alpha-beta T cell number
|
J:116119
|
\Id2tm1Yyk/\Id2tm1Yyk
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased NK cell number
|
J:53267
|
\Id2tm1Yyk/\Id2tm1Yyk
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
decreased NK cell number
|
J:53267
|
\Id2tm1Yyk/\Id2tm1Yyk
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * FVB/NJ))
|
decreased NK T cell number
|
J:125739
|
\Id2tm1Yyk/\Id2tm1Yyk
\Tcf3tm1Cmu/\Tcf3+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased NK T cell number
|
J:125739
|
\Id2tm1Yyk/\Id2tm1Yyk
\Tcf3tm1Cmu/\Tcf3tm1Cmu
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:125739
|
| decreased NK T cell number
|
J:125739
|
\Id3tm1Cmu/\Id3tm1Cmu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal double-positive T cell morphology
|
J:59969
|
| abnormal T cell differentiation
|
J:59969
|
\Id3tm1Zhu/\Id3tm1Zhu
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal T cell differentiation
|
J:144696
|
\Id3tm2.1Cmu/\Id3tm2.1Cmu
(Not Specified)
|
decreased thymocyte number
|
J:176462
|
| increased B cell number
|
J:176462
|
| increased gamma-delta T cell number
|
J:176462
|
| increased T follicular helper cell number
|
J:176462
|
\Id3tm2.1Cmu/\Id3tm2.1Cmu
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:176462
|
\Id3tm2.1Zhu/\Id3tm2.1Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:172701
|
| decreased CD4-positive, alpha-beta T cell number
|
J:172701
|
| decreased CD8-positive, alpha-beta T cell number
|
J:172701
|
| decreased T cell number
|
J:172701
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:172701
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:172701
|
| increased gamma-delta T cell number
|
J:172701
|
\Idd1NOD/Uf/\Idd1NOD/Uf
(B6.NOD-(D17Mit164-D17Mit152))
|
increased CD4-positive, alpha-beta T cell number
|
J:92304
|
\Idd2NOD/Smrf/\Idd2NOD/Smrf
(involves: NON/Lt * NOD/Smrf)
|
increased CD4-positive, alpha-beta T cell number
|
J:30526
|
\Idd4NOD/\Idd4NOD
(B6.NOD-Idd4)
|
decreased NK T cell number
|
J:85823
|
\Idd6.2C3H/HeJ/\Idd6.2C3H/HeJ
(NOD.C3-Idd6.2C3H/HeJ)
|
decreased NK cell number
|
J:137837
|
\Idd6.2NOD/\Idd6.2NOD
(B6.NOD-(D6Mit259-D6Mit304))
|
abnormal T cell differentiation
|
J:120148
|
\Idd6C3H/HeJ/\Idd6C3H/HeJ
(NOD.C3-Idd6C3H/HeJ)
|
decreased NK cell number
|
J:137837
|
\Idd7NOD/ShiLt/\Idd7NOD/ShiLt
(involves: C57BL/6 * NOD/ShiLt)
|
abnormal T cell clonal deletion
|
J:131557
|
\Idd9.1C57BL/10SnJ/\Idd9.1C57BL/10SnJ
(NOD.B10-Idd9.1C57BL/10SnJ)
|
increased NK T cell number
|
J:85823
|
\Idh1tm1Mak/\Idh1tm1Mak
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:186700
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186700
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186700
|
| increased CD4-positive, alpha-beta T cell number
|
J:186700
|
\Idh1tm2Mak/\Idh1tm2Mak
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:186700
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186700
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186700
|
| increased CD4-positive, alpha-beta T cell number
|
J:186700
|
\Ier3tm1Mxw/\Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
decreased regulatory T cell number
|
J:157504
|
\Ier3tm1Mxw/\Ier3tm1Mxw
(involves: C57BL/6)
|
increased T-helper 17 cell number
|
J:194587
|
\Ifi44tm1b(KOMP)Wtsi/\Ifi44tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
increased CD8-positive, alpha-beta T cell number
|
J:297991
|
\Ifih1Rgsc422/\Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
increased plasma cell number
|
J:209917
|
\Ifitm1tm1.1Ieg/\Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg)
|
decreased T cell number
|
J:192287
|
\Ifnar1tm1Agt/\Ifnar1tm1Agt
(involves: 129S2/SvPas * BALB/c)
|
increased CD4-positive, alpha-beta T cell number
|
J:291874
|
| increased CD8-positive, alpha-beta T cell number
|
J:291874
|
\Ifnar1tm1Agt/\Ifnar1tm1Agt
\Slamf1tm1Oono/\Slamf1tm1Oono
(B6.129-Slamf1tm1Oono Ifnar1tm1Agt)
|
abnormal lymphopoiesis
|
J:117810
|
\Ifnar1tm1Pjh/\Ifnar1tm1Pjh
(B6.129S2-Ifnar1tm1Pjh)
|
decreased NK cell number
|
J:125812
|
\Ifnar2tm1Pjh/\Ifnar2tm1Pjh
(B6.Cg-Ifnar2tm1Pjh)
|
decreased NK cell number
|
J:125812
|
\Ifnb1tm1Acgp/\Ifnb1tm1Acgp
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:86527
|
| decreased pro-B cell number
|
J:86527
|
\Ifnetm1.2Pjh/\Ifnetm1.2Pjh
(involves: C57BL/6)
|
decreased NK cell number
|
J:197569
|
\Ifngtm1.1Hayg/\Ifngtm1.1Hayg
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell differentiation
|
J:220784
|
| decreased mature B cell number
|
J:220784
|
| decreased pre-B cell number
|
J:220784
|
| increased T cell number
|
J:220784
|
\Ifngtm1Ts/\Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
increased NK T cell number
|
J:122801
|
\Ifngtm1Ts/\Ifngtm1Ts
(B6.129S7-Ifngtm1Ts)
|
increased CD8-positive, alpha-beta T cell number
|
J:112048
|
\Ifngtm1Ts/\Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J)
|
abnormal uterine NK cell morphology
|
J:56503
|
| increased uterine NK cell number
|
J:56503
|
\Ifngtm1Ts/\Ifngtm1Ts
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129S7-Ldlrtm1Her Ifngtm1Ts)
|
increased T cell number
|
J:103072
|
\Ifngtm1Ts/\Ifngtm1Ts
\Pld4tm1.2Nemz/\Pld4tm1.2Nemz
(involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
decreased NK T cell number
|
J:281205
|
\Ifngtm1Ts/\Ifngtm1Ts
\Tnfrsf1atm1Blt/\Tnfrsf1atm1Blt
\Tnfrsf1btm1Mwm/\Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased lymphocyte cell number
|
J:119206
|
\Ifngr1m1Btlr/\Ifngr1m1Btlr
(C57BL/6J-Ifngr1m1Btlr)
|
increased B cell number
|
J:236694
|
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
abnormal uterine NK cell morphology
|
J:56503
|
| increased uterine NK cell number
|
J:56503
|
\Ifngr1tm1Agt/\Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
abnormal lymphopoiesis
|
J:138728
|
| decreased CD4-positive, alpha-beta T cell number
|
J:138728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:138728
|
| decreased lymphocyte cell number
|
J:138728
|
\Ifngr2tm1Pbro/\Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
abnormal class switch recombination
|
J:48016
|
| abnormal T-helper 1 cell differentiation
|
J:48016
|
\Igbp1tm1Cbt/Y
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:93221
|
\Igbp1tm1Cbt/\Igbp1+
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:93221
|
\Igbp1tm1Imku/Y
\Tg(Lck-cre)I57Jxm/?
(involves: 129P2/OlaHsd * ICR)
|
decreased double-negative T cell number
|
J:84395
|
| decreased T cell number
|
J:84395
|
| decreased thymocyte number
|
J:84395
|
\Igh-7tm1.1Lam/\Igh-7tm1.1Lam
(involves: BALB/c)
|
decreased mature B cell number
|
J:146733
|
\Igh-7tm1Gach/\Igh-7tm1Gach
(BALB/c-Igh-7tm1Gach)
|
abnormal B cell number
|
J:143266
|
| increased memory B cell number
|
J:143266
|
| increased plasma cell number
|
J:143266
|
\Igh-7tm1Lam/\Igh-7tm1Lam
(involves: BALB/c)
|
decreased mature B cell number
|
J:146733
|
\Igh-7tm1Lcwu/\Igh-7tm1Lcwu
(involves: C57BL/6)
|
decreased mature B cell number
|
J:161452
|
\Igh-7tm1Led/\Igh-7tm1Led
\Lyntm1Ard/\Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased B cell number
|
J:161523
|
\Igh-8tm1.1Aak/\Igh-8tm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
\Igh-8tm1Aak/\Igh-8tm1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:107063
|
\Igh-8tm2(Ighg1)Aak/\Igh-8tm2(Ighg1)Aak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:130574
|
\Igh-Jtm1(3H9-VDJ)Mwg/\Igh-Jtm1(3H9-VDJ)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
\Igh-Jtm1(CB20)Riho/\Igh-J+
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
| decreased pre-B cell number
|
J:179456
|
| increased immature B cell number
|
J:179456
|
| increased marginal zone B cell number
|
J:179456
|
| increased mature B cell number
|
J:179456
|
\Igh-Jtm1(CB20)Riho/\Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
| decreased pre-B cell number
|
J:179456
|
| increased immature B cell number
|
J:179456
|
| increased marginal zone B cell number
|
J:179456
|
| increased mature B cell number
|
J:179456
|
\Igh-Jtm1.1Lave/\Igh-J+
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
| decreased B cell number
|
J:155798
|
| decreased immature B cell number
|
J:155798
|
| decreased mature B cell number
|
J:155798
|
| decreased T cell number
|
J:155798
|
| decreased transitional stage B cell number
|
J:155798
|
| decreased transitional stage T1 B cell number
|
J:155798
|
| decreased transitional stage T2 B cell number
|
J:155798
|
| increased pre-B cell number
|
J:155798
|
| increased pro-B cell number
|
J:155798
|
\Igh-Jtm1.1Lave/\Igh-Jtm1.1Lave
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
| arrested B cell differentiation
|
J:179317
|
| decreased B cell number
|
J:155798,
J:179317
|
| decreased immature B cell number
|
J:155798
|
| decreased mature B cell number
|
J:155798
|
| decreased T cell number
|
J:155798
|
| decreased transitional stage B cell number
|
J:155798
|
| decreased transitional stage T1 B cell number
|
J:155798
|
| decreased transitional stage T2 B cell number
|
J:155798
|
| increased pre-B cell number
|
J:155798
|
| increased pro-B cell number
|
J:155798
|
\Igh-Jtm1.1Lave/\Igh-Jtm1.1Lave
\Igk-Jtm1.1Lave/\Igk-Jtm1.1Lave
(Not Specified)
|
abnormal B cell clonal deletion
|
J:179317
|
| abnormal B cell differentiation
|
J:205708
|
| arrested B cell differentiation
|
J:205708,
J:179317
|
| decreased B cell number
|
J:205708,
J:179317
|
| decreased immature B cell number
|
J:205708
|
| decreased mature B cell number
|
J:205708
|
\Igh-Jtm1.1Lave/\Igh-Jtm1.1Lave
\Igk-Jtm1.1Lave/\Igk-Jtm1.1Lave
\Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:179317
|
\Igh-Jtm1Aigl/\Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell morphology
|
J:111543
|
| decreased B cell number
|
J:111543
|
| decreased B-1 B cell number
|
J:111543
|
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
decreased B cell number
|
J:79299
|
| decreased follicular B cell number
|
J:79299
|
| decreased marginal zone B cell number
|
J:79299
|
\Igh-Jtm1Cgn/\Ightm4Cgn
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:157297
|
\Igh-Jtm1Cgn/\Ightm11.1Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113434
|
\Igh-Jtm1Cgn/\Igh-J+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:64285
|
\Igh-Jtm1Cgn/\Ightm1Leck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
\Igh-Jtm1Cgn/\Igh-Jtm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
absent mature B cells
|
J:64285
|
| arrested B cell differentiation
|
J:64285
|
\Igh-Jtm1Dhu/\Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
| decreased B cell number
|
J:102308
|
\Igh-Jtm1Dhu/\Ightm1Tim
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:88410
|
| abnormal B cell morphology
|
J:87624
|
\Igh-Jtm1Dhu/\Ightm2Tim
(involves: 129X1/SvJ * C57BL/6)
|
decreased marginal zone B cell number
|
J:87624
|
\Igh-Jtm1Dhu/\Igh-Jtm1(VDJ-17.2.25)Wabl
\Igktm1Dhu/\Igktm1Dhu
(Not Specified)
|
abnormal B cell differentiation
|
J:33628
|
| abnormal immature B cell morphology
|
J:89757
|
\Igh-Jtm1Dim/\Igh-J+
\Igk-Jtm1Dim/\Igk-J+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:107241
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell number
|
J:113083
|
| absent B cells
|
J:70038
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd)
|
absent mature B cells
|
J:137738
|
| arrested B cell differentiation
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
(involves: 129P2/OlaHsd)
|
absent B cells
|
J:23827
|
| absent mature B cells
|
J:137738,
J:70620
|
| arrested B cell differentiation
|
J:137738,
J:23827
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH1)2BJkbv/0
\Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| increased mature B cell number
|
J:23827
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH1)2BJkbv/0
\Tg(IGK@yK1)9.2CJkbv/\Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH1)2BJkbv/\Tg(IGH@yH1)2BJkbv
\Tg(IGK@yK1)9.2CJkbv/\Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH1)2BJkbv/\Tg(IGH@yH1)2BJkbv
\Tg(IGK@yK2)J23.1Jkbv/\Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH2)J9.2Jkbv/0
\Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell morphology
|
J:70620
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:70620
|
| abnormal immunoglobulin light chain V-J recombination
|
J:70620
|
| increased mature B cell number
|
J:70620
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH2)J9.2Jkbv/0
\Tg(IGK@yK2)J23.1Jkbv/\Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH2BM)7Amgn/0
\Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:139792
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGH@yH2CM)2Amgn/0
\Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:139792
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Tg(IGH@*)SALed/0
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Tg(IGH@yH1)2BJkbv/0
\Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| increased late pro-B cell number
|
J:23827
|
| increased mature B cell number
|
J:23827
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Tg(IGH@yH1)2BJkbv/\Tg(IGH@yH1)2BJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| decreased pre-B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
\Igh-Jtm1Jkbv/\Igh-Jtm1Jkbv
\Tg(IGH@yH2)J9.2Jkbv/0
(involves: 129P2/OlaHsd)
|
decreased mature B cell number
|
J:137738
|
\Igh-Jtm1Khyk/\Igh-J+
(CB17.129X1-Igh-Jtm1Khyk)
|
increased B-1 B cell number
|
J:109979
|
\Igh-Jtm1Mcdl/\Igh-Jtm1Mcdl
\Igk-Jtm1Mcdl/\Igk-Jtm1Mcdl
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(DO11.10)10Dlo/?
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:100072
|
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell receptor editing
|
J:131138
|
| abnormal marginal zone B cell morphology
|
J:131138
|
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(B6.129P2-Igh-Jtm2(3H9-VDJ*)Mwg)
|
decreased B cell number
|
J:142389
|
| increased marginal zone B cell number
|
J:142389
|
\Igh-Jtm2.1(4E10)Lave/\Igh-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:205708
|
| decreased B-1a cell number
|
J:205708
|
\Igh-Jtm2.1(4E10)Lave/\Igh-Jtm2.1(4E10)Lave
\Igk-Jtm2.1(4E10)Lave/\Igk-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:205708
|
| arrested B cell differentiation
|
J:205708
|
| decreased immature B cell number
|
J:205708
|
| decreased mature B cell number
|
J:205708
|
\Igh-Jtm3(3H9-VDJ*)Mwg/\Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
\Igh-Jtm3.1(48d)Lave/\Igh-Jtm3.1(48d)Lave
(involves: C57BL/6)
|
decreased B-1a cell number
|
J:205708
|
\IghdeltaD/\Igh+
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
| decreased B cell number
|
J:95981
|
\IghdeltaD/\IghdeltaD
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
| arrested B cell differentiation
|
J:95981
|
| decreased B cell number
|
J:95981
|
| decreased follicular B cell number
|
J:95981
|
| increased marginal zone B cell number
|
J:95981
|
\IghdeltaD/\Ightm11.1Cgn
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:113434
|
\Ightm1(PAX5)Mbu/\Igh+
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
| decreased double-negative T cell number
|
J:118111
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:118111
|
\Ightm1(PAX5)Mbu/\Igh+
\Pax5tm1Mbu/\Pax5tm1Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:118111
|
| decreased B cell number
|
J:118111
|
\Ightm1(PAX5)Mbu/\Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
| decreased double-negative T cell number
|
J:118111
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:118111
|
\Ightm1(VH558)Mss/\Igh+
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
\Ightm1(VH558)Mss/\Ightm1(VH558)Mss
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
\Ightm1.1(b12)Nemz/\Ightm1.1(b12)Nemz
(involves: C57BL/6N * FVB/N)
|
decreased immature B cell number
|
J:205766
|
| increased B cell number
|
J:205766
|
\Ightm1.1(b12)Nemz/\Ightm1.1(b12)Nemz
\Igktm1.1(b12)Nemz/\Igktm1.1(b12)Nemz
(involves: C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased immature B cell number
|
J:205766
|
| increased B cell number
|
J:205766
|
\Ightm1.1(Rr361-HBB)Aak/\Ightm1.1(Rr361-HBB)Aak
(129.129S2(Cg)-Ightm1.1(Rr361-HBB)Aak)
|
abnormal class switch recombination
|
J:333279
|
\Ightm1.1(Tag)Rwhe/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:150315
|
| increased B cell number
|
J:150315
|
\Ightm1.1Hmj/\Ightm1.1Hmj
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:140486
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:140486
|
| decreased mature B cell number
|
J:140486
|
\Ightm1.1Hws/\Ightm1.1Hws
(BALB/cJ-Ightm1.1Hws)
|
decreased immature B cell number
|
J:119391
|
| decreased pre-B cell number
|
J:119391
|
| increased late pro-B cell number
|
J:119391
|
\Ightm1.1Hws/\Ightm1.1Hws
(involves: BALB/c)
|
decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| increased early pro-B cell number
|
J:142069
|
\Ightm1.1Lnit/\Igh+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:119484
|
\Ightm1.1Rsky/\Ightm1.1Rsky
(BALB/c-Ightm1.1Rsky)
|
abnormal class switch recombination
|
J:125719
|
\Ightm1.1Twin/\Igh+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
decreased pre-B cell number
|
J:174233
|
| increased pro-B cell number
|
J:174233
|
\Ightm1.1Twin/\Ightm1.1Twin
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:174233
|
| abnormal B cell morphology
|
J:174233
|
| abnormal B cell number
|
J:174233
|
| abnormal marginal zone B cell morphology
|
J:174233
|
| absent plasma cells
|
J:174233
|
| decreased B cell number
|
J:174233
|
| decreased B-1a cell number
|
J:174233
|
| decreased follicular B cell number
|
J:174233
|
| decreased immature B cell number
|
J:174233
|
| decreased mature B cell number
|
J:174233
|
| decreased transitional stage T2 B cell number
|
J:174233
|
\Ightm1.1Twin/\Ightm1.1Twin
\Plcg2Ali5/\Plcg2+
(involves: 129 * 129S4/SvJae * C3HeB/FeJ * C57BL/6)
|
increased B-1a cell number
|
J:174233
|
\Ightm1.1Vmd/\Igh+
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
\Ightm1.1Vmd/\Ightm1.1Vmd
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
\Ightm1.2Rsky/\Igh+
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(involves: BALB/c * C57BL/6)
|
decreased mature B cell number
|
J:125719
|
\Ightm1.2Rsky/\Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky)
|
abnormal B cell morphology
|
J:125719
|
| abnormal mature B cell morphology
|
J:125719
|
| decreased B-1a cell number
|
J:125719
|
| decreased pre-B cell number
|
J:125719
|
| decreased transitional stage B cell number
|
J:125719
|
| increased marginal zone B cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
\Ightm1.2Rsky/\Ightm1.2Rsky
\Tg(CD19-cre/ERT2)1Cgn/?
(involves: BALB/c)
|
abnormal class switch recombination
|
J:125719
|
\Ightm1Aak/\Ightm1Aak
(Not Specified)
|
abnormal B cell differentiation
|
J:158402
|
| decreased B cell number
|
J:158402
|
| decreased pre-B cell number
|
J:158402
|
| increased pro-B cell number
|
J:158402
|
\Ightm1Cgn/\Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm1Cgn/\Ightm2Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm1Cog/\Ightm1Cog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:80654
|
| absent B cells
|
J:80654
|
| arrested B cell differentiation
|
J:80654
|
\Ightm1Kplm/\Igh+
(involves: A/WySnJ * BALB/c)
|
abnormal B-1 B cell morphology
|
J:115788
|
\Ightm1Kplm/\Igh+
(Not Specified)
|
abnormal B cell differentiation
|
J:115292
|
| increased B cell number
|
J:115292
|
\Ightm1Kplm/\Igh+
\Tg(Igk-V4CH27)1-2Shc/0
(involves: C57BL/6 * SJL)
|
increased B cell number
|
J:115292
|
\Ightm1Kplm/\Ightm3Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:115292
|
| abnormal B cell number
|
J:115292
|
\Ightm1Kplm/\Ightm4Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
| abnormal B cell number
|
J:115292
|
| abnormal B-1 B cell morphology
|
J:115292
|
\Ightm1Kplm/\Ightm4Cgn
\Tg(Igk-V4CH27)1-2Shc/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased B cell number
|
J:115292
|
\Ightm1Ktom/\Ightm1Ktom
(involves: ICR)
|
absent mature B cells
|
J:178635
|
\Ightm1Leck/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:144033
|
| abnormal B-1a B cell morphology
|
J:144033
|
| abnormal immature B cell morphology
|
J:144033
|
| abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
| abnormal mature B cell morphology
|
J:144033
|
\Ightm1Leck/\Ightm1Leck
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:144033
|
\Ightm1Mnz/\Ightm1Mnz
\Dis3tm1.1Uba/\Dis3tm1.1Uba
\Aicdatm1(cre)Uba/\Aicda+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:302856
|
\Ightm1Rbr/\Igh+
(C57BL/6-Ightm1Rbr)
|
abnormal B cell morphology
|
J:132538
|
\Ightm1Rbr/\Igh+
\Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:132538
|
| abnormal B-2 B cell morphology
|
J:132538
|
| increased immature B cell number
|
J:132538
|
\Ightm1Rbr/\Igh+
\Tg(IgkHyHEL10)1Rbr/0
\Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6 * C57BL/6JSfd)
|
abnormal B cell morphology
|
J:132538
|
| decreased follicular B cell number
|
J:132538
|
| decreased marginal zone B cell number
|
J:132538
|
| increased immature B cell number
|
J:132538
|
\Ightm2.1(4E10)Nemz/\Ightm2.1(4E10)Nemz
\Igktm2.1(4E10)Nemz/\Igktm2.1(4E10)Nemz
(involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased B cell number
|
J:101977
|
\Ightm2.1(Tag)Rwhe/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:150315
|
| increased B cell number
|
J:150315
|
\Ightm2.1Fwa/\Ightm2.1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:161437
|
| abnormal somatic hypermutation frequency
|
J:161437
|
| decreased mature B cell number
|
J:161437
|
\Ightm2.1Hws/\Ightm2.1Hws
(involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)
|
decreased B cell number
|
J:124421
|
| decreased B-1a cell number
|
J:124421
|
| decreased B-1b cell number
|
J:124421
|
| decreased follicular B cell number
|
J:124421
|
| decreased pre-B cell number
|
J:124421
|
| decreased transitional stage B cell number
|
J:124421
|
| increased early pro-B cell number
|
J:124421
|
| increased marginal zone B cell number
|
J:124421
|
\Ightm2.1Hws/\Ightm2.1Hws
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:142069
|
| decreased B-1a cell number
|
J:142069
|
| decreased follicular B cell number
|
J:142069
|
| decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| decreased mature B cell number
|
J:142069
|
| decreased transitional stage B cell number
|
J:142069
|
| increased early pro-B cell number
|
J:142069
|
| increased marginal zone B cell number
|
J:142069
|
\Ightm2Cgn/\Igh+
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm2Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
\Ightm2Cgn/\Igh+
\Igktm1Rsky/\Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
| absent pre-B cells
|
J:111431
|
\Ightm2Cgn/\Igh+
\Igktm2Rsky/\Igk+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:150435
|
\Ightm2Cgn/\Igh+
\Igktm2Rsky/\Igk+
\Prkdcscid/\Prkdcscid
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal class switch recombination
|
J:150435
|
\Ightm2Cgn/\Igh+
\Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:44361
|
\Ightm2Cgn/\Ightm2Cgn
\Igktm1Rsky/\Igktm1Rsky
\Lig4tm1Fwa/\Lig4tm1Fwa
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
\Ightm2Cgn/\Ightm2Cgn
\Igktm1Rsky/\Igktm1Rsky
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc4tm1Fwa/\Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
\Ightm2Cgn/\Ightm3Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
\Ightm2Cgn/\Ightm4.1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal immunoglobulin V(D)J recombination
|
J:176649
|
\Ightm2Emo/\Ightm2Emo
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:108098
|
| absent pre-B cells
|
J:108098
|
\Ightm2Rsky/\Igh+
\Igktm1Rsky/\Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
\Ightm2Rsky/\Igh+
\Igktm2Rsky/\Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
\Ightm3.1Tim/\Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
\Ightm3Cgn/\Igh+
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:79556,
J:115292
|
\Ightm3Cgn/\Ightm3Cgn
(involves: C57BL/6)
|
decreased immature B cell number
|
J:76117
|
\Ightm3Hws/\Ightm3Hws
(BALB/c-Ightm3Hws)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:142068
|
\Ightm3Hws/\Ightm3Hws
(involves: BALB/c)
|
decreased B cell number
|
J:142069
|
| decreased follicular B cell number
|
J:142069
|
| decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| decreased mature B cell number
|
J:142069
|
| decreased transitional stage B cell number
|
J:142069
|
\Ightm3Tim/\Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
\Ightm4.1Cog/\Ightm4.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:184094
|
\Ightm4.1Fwa/\Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| abnormal immunoglobulin V(D)J recombination
|
J:176649
|
\Ightm4.1Fwa/\Ightm4.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| abnormal immunoglobulin V(D)J recombination
|
J:176649
|
\Ightm4Cgn/\Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
\Ightm5.1Cgn/\Ightm5.1Cgn
(BALB/c-Ightm5.1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
| abnormal mature B cell morphology
|
J:88472
|
| absent B-1 B cells
|
J:88472
|
| absent B-1a cells
|
J:88472
|
| absent B-1b cells
|
J:88472
|
| decreased B cell number
|
J:88472
|
| decreased immature B cell number
|
J:88472
|
| decreased marginal zone B cell number
|
J:88472
|
| increased pro-B cell number
|
J:88472
|
\Ightm5.1Fwa/\Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| decreased pre-B cell number
|
J:176649
|
\Ightm5.1Fwa/\Ightm5.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| decreased pre-B cell number
|
J:176649
|
\Ightm5Cgn/\Ightm5Cgn
(involves: BALB/c)
|
absent B cells
|
J:88472
|
| arrested B cell differentiation
|
J:88472
|
\Ightm5Cgn/\Ightm5Cgn
\Tg(CD19-cre/ERT2)1Cgn/0
(C.Cg-Ightm5Cgn Tg(CD19-cre/ERT2)1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
| abnormal mature B cell morphology
|
J:88472
|
| absent follicular B cells
|
J:88472
|
| absent marginal zone B cells
|
J:88472
|
| increased B cell number
|
J:88472
|
| increased pro-B cell number
|
J:88472
|
\Ightm7(VHB1-8)Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
\Ightm8(VHB1-8)Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
\Ightm9(VHB1-8)Cgn/\Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
\Ightm11.1Cgn/\Ightm11.1Cgn
(Not Specified)
|
abnormal B cell differentiation
|
J:113434
|
| decreased B cell number
|
J:113434
|
| decreased immature B cell number
|
J:113434
|
| decreased mature B cell number
|
J:113434
|
| increased pro-B cell number
|
J:113434
|
\Ightm12Cgn/\Ightm12Cgn
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:66031
|
\Ighatm1(Myc)Janz/\Igha+
(involves: 129S1/Sv * C57BL/6)
|
increased plasma cell number
|
J:90901
|
\Ighatm1(Myc)Janz/\Igha+
\Tg(Igk-V21-Bax)1967Bvn/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal plasma cell morphology
|
J:90901
|
| increased plasma cell number
|
J:90901
|
\Ighatm1(Myc)Janz/\Igha+
\Tg(Tnfsf13b)1Fma/0
(involves: 129S1/Sv * C57BL/6 * DBA/2J)
|
increased B cell number
|
J:166158
|
| increased lymphocyte cell number
|
J:166158
|
| increased mature B cell number
|
J:166158
|
\Ighatm2Grh/\Ighatm2Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:72521
|
\IghdM1Btlr/\Ighd+
(C57BL/6J-IghdM1Btlr)
|
decreased B cell number
|
J:255202
|
\IghdM1Btlr/\IghdM1Btlr
(C57BL/6J-IghdM1Btlr)
|
decreased B cell number
|
J:255202
|
\Ighdm2Btlr/\Ighd+
(C57BL/6J-Ighdm2Btlr)
|
decreased B cell number
|
J:255203
|
\Ighdm2Btlr/\Ighdm2Btlr
(C57BL/6J-Ighdm2Btlr)
|
decreased B cell number
|
J:255203
|
\Ighdtm1Lam/\Ighd+
(involves: 129S2/SvPas * C57BL/6)
|
decreased B cell number
|
J:111020
|
\Ighg1em1Wliu/\Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu)
|
abnormal plasma cell differentiation
|
J:266937
|
| increased germinal center B cell number
|
J:266937
|
| increased plasma cell number
|
J:266937
|
\Ighg1tm1(cre)Cgn/0
\Mef2btm1.1Rdf/\Mef2b+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased germinal center B cell number
|
J:265465
|
\Ighg1tm1(cre)Cgn/0
\Mef2btm1.1Rdf/\Mef2btm1.1Rdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| decreased germinal center B cell number
|
J:265465
|
\Ighg1tm1(cre)Cgn/0
\Mef2btm1.1Rdf/\Mef2btm1.1Rdf
\Mef2ctm2Eno/\Mef2ctm2Eno
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased germinal center B cell number
|
J:265465
|
\Ighg1tm1(cre)Cgn/0
\Mef2btm2Rdf/\Mef2b+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| increased germinal center B cell number
|
J:265465
|
\Ighg1tm1(cre)Cgn/0
\Mef2btm2Rdf/\Mef2btm1.1Rdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| increased germinal center B cell number
|
J:265465
|
\Ighg1tm1(cre)Cgn/0
\Mef2ctm2Eno/\Mef2ctm2Eno
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
decreased germinal center B cell number
|
J:265465
|
\Ighg1tm1(cre)Cgn/\Ighg1+
\Irf4tm1Rdf/\Irf4tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal class switch recombination
|
J:112643
|
| abnormal memory B cell morphology
|
J:112643
|
| absent plasma cells
|
J:112643
|
\Ighg1tm1(cre)Cgn/\Ighg1+
\Myd88em1.1Rsky/\Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
abnormal somatic hypermutation frequency
|
J:308792
|
| increased germinal center B cell number
|
J:308792
|
| increased plasma cell number
|
J:308792
|
\Ighg1tm1(cre)Cgn/\Ighg1+
\Tbl1xr1tm1.1Meln/\Tbl1xr1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
\Ighg1tm1(cre)Cgn/\Ighg1+
\Tbl1xr1tm1c(EUCOMM)Hmgu/\Tbl1xr1tm1c(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
\Ighg1tm1Ksho/\Ighg1tm1Ksho
(involves: 129P2/OlaHsd * C57BL/6)
|
absent memory B cells
|
J:39568
|
\Ighg1tm2Cgn/\Ighg1+
((C57BL/6 x 129P2/OlaHsd)F1)
|
abnormal class switch recombination
|
J:146428
|
\Ighg1tm3Cgn/\Ighg1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:166887
|
\Ighg2cem1Wliu/\Ighg2cem1Wliu
(C57BL/6J-Ighg2cem1Wliu)
|
abnormal plasma cell differentiation
|
J:322180
|
| increased CD8-positive, alpha-beta T cell number
|
J:322180
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:322180
|
| increased germinal center B cell number
|
J:322180
|
| increased memory B cell number
|
J:322180
|
\Ighg2cem2Wliu/\Ighg2cem2Wliu
(C57BL/6J-Ighg2cem2Wliu)
|
abnormal plasma cell differentiation
|
J:322180
|
| decreased germinal center B cell number
|
J:322180
|
| decreased memory B cell number
|
J:322180
|
\Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6)
|
decreased plasma cell number
|
J:98937
|
\Ighmtm1.1(IGH-2)Cog/\Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:157575
|
| abnormal plasma cell differentiation
|
J:157575
|
| decreased B cell number
|
J:157575
|
| decreased B-1 B cell number
|
J:157575
|
| decreased follicular B cell number
|
J:157575
|
| decreased marginal zone B cell number
|
J:157575
|
| decreased mature B cell number
|
J:157575
|
| decreased pre-B cell number
|
J:157575
|
| decreased transitional stage B cell number
|
J:157575
|
| increased B cell number
|
J:157575
|
| increased plasma cell number
|
J:157575
|
| increased pro-B cell number
|
J:157575
|
\Ighmtm1.1Aak/\Ighmtm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
| decreased B cell number
|
J:171251
|
| decreased pre-B cell number
|
J:171251
|
| increased pro-B cell number
|
J:171251
|
\Ighmtm1Cgn/\Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
| decreased B cell number
|
J:102308
|
\Ighmtm1Cgn/\Ighm+
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:70398
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:64298,
J:70398
|
| absent immature B cells
|
J:64298
|
| absent mature B cells
|
J:64298
|
| arrested B cell differentiation
|
J:64298
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn/J)
|
arrested B cell differentiation
|
J:119584
|
| decreased CD4-positive, alpha-beta T cell number
|
J:73100,
J:118565
|
| decreased CD8-positive, alpha-beta T cell number
|
J:73100
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(involves: 129S2/SvPas)
|
absent mature B cells
|
J:118453
|
| arrested B cell differentiation
|
J:118453
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:126867
|
\Ighmtm1Cgn/\Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ)
|
abnormal T cell number
|
J:80859
|
| absent B cells
|
J:80859
|
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal mature B cell morphology
|
J:80859
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80859
|
\Ighmtm1Che/\Ighmtm1Che
(involves: 129S4/SvJae * C57BL/6)
|
increased B-1 B cell number
|
J:47425
|
\Ighmtm1Msn/\Ighmtm1Msn
(involves: 129S/SvEv)
|
abnormal B-1a B cell morphology
|
J:49405
|
| abnormal immature B cell morphology
|
J:49405
|
| abnormal mature B cell morphology
|
J:49405
|
\Ighmtm1Msn/\Ighmtm1Msn
(B6.129S-Ighmtm1Msn)
|
abnormal B-1a B cell morphology
|
J:80656
|
| decreased follicular B cell number
|
J:80656
|
| increased marginal zone B cell number
|
J:80656
|
\Ighmtm1Msn/\Ighmtm1Msn
\Tg(Igh-6)1Msn/?
(B6.129S-Ighmtm1Msn)
|
abnormal B-1a B cell morphology
|
J:80656
|
| decreased follicular B cell number
|
J:80656
|
| increased marginal zone B cell number
|
J:80656
|
\Ighmtm1Sls/\Ighmtm1Sls
(Not Specified)
|
abnormal class switch recombination
|
J:99465
|
\Ighmtm2.1Bgmn/\Ighmtm2.1Bgmn
(involves: 129/Sv * C57BL/6 * CBA)
|
absent mature B cells
|
J:118453
|
| arrested B cell differentiation
|
J:118453
|
\Ighmtm3Bgmn/\Ighmtm3Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
| decreased mature B cell number
|
J:131633
|
| increased B-1 B cell number
|
J:131633
|
\Ighmtm3Bgmn/\Ighmtm3Bgmn
\Igkctm1Bgmn/\Igkctm1Bgmn
\Igltm2.1Bgmn/\Igltm2.1Bgmn
(involves: 129P2/OlaHsd * 129/Sv)
|
abnormal B cell differentiation
|
J:130864
|
\Ighmtm4Bgmn/\Ighmtm4Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
| decreased mature B cell number
|
J:131633
|
| increased B-1 B cell number
|
J:131633
|
\Igk-Jtm1Cog/\Igk-Jtm1.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:110100
|
| abnormal plasma cell morphology
|
J:110100
|
| decreased B cell number
|
J:110100
|
| decreased naive B cell number
|
J:110100
|
| increased plasma cell number
|
J:110100
|
| increased pre-B cell number
|
J:110100
|
\Igk-Jtm1Cog/\Igk-Jtm1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:110100
|
\Igktm1Dhu/\Igktm1Dhu
\Iglc1tm1.1Ust/\Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
decreased B cell number
|
J:68144
|
\Igktm1Dhu/\Igktm1Dhu
\Iglc1tm1.1Ust/\Iglc1tm1.1Ust
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
decreased B cell number
|
J:68144
|
\Igktm1Dhu/\Igktm1Dhu
\Iglc1tm1Ust/\Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:68144
|
| increased B cell number
|
J:68144
|
\Igktm1Dhu/\Igktm1Dhu
\Iglc1tm1Ust/\Iglc1tm1Ust
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased B cell number
|
J:68144
|
\Igktm1Dhu/\Igktm1Dhu
\Iglc1tm2Ust/\Iglc1tm2Ust
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal B cell differentiation
|
J:74717
|
| decreased B cell number
|
J:74717
|
| decreased immature B cell number
|
J:74717
|
| decreased marginal zone B cell number
|
J:74717
|
| decreased mature B cell number
|
J:74717
|
| decreased transitional stage T1 B cell number
|
J:74717
|
| decreased transitional stage T2 B cell number
|
J:74717
|
\Igktm1Dhu/\Igktm1Dhu
\Iglc1tm2Ust/\Iglc1tm2Ust
(involves: 129S7/SvEvBrd)
|
increased B-1a cell number
|
J:113218
|
\Igktm1Dhu/\Igktm1Dhu
\Tg(H2-Ea-HA)HACIIAjca/0
\Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:209872
|
| absent B cells
|
J:209872
|
| increased CD4-positive, alpha-beta T cell number
|
J:209872
|
\Igktm1Rsky/\Igk+
\Igll1tm1Cgn/\Igll1tm1Cgn
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:35357
|
| decreased B cell number
|
J:35357
|
| decreased immature B cell number
|
J:35357
|
| decreased mature B cell number
|
J:35357
|
| decreased pre-B cell number
|
J:35357
|
\Igktm2Ybgn/\Igktm2Ybgn
(Not Specified)
|
decreased pre-B cell number
|
J:123344
|
| increased immature B cell number
|
J:123344
|
\Igkctm1(IGKC)Mnz/\Igkc+
\Igk-Jtm1(CD4*)Mss/\Igk-J+
(involves: 129S4/SvJae)
|
abnormal immunoglobulin light chain V-J recombination
|
J:143876
|
\Igkctm1(IGKC)Mnz/\Igkc+
\Rr158tm1(Igh)Xu/\Rr158+
(Not Specified)
|
decreased B cell number
|
J:124407
|
\Igkctm1Bgmn/\Igkctm1Bgmn
(involves: 129P2/OlaHsd)
|
abnormal B cell number
|
J:28868,
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn
\Igltm1.1Bgmn/\Igltm1.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
| absent B cells
|
J:118712
|
| absent B-1 B cells
|
J:118712
|
| absent B-2 B cells
|
J:118712
|
| decreased B cell number
|
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn
\Igltm1Bgmn/\Igltm1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
| absent B-1 B cells
|
J:118712
|
| absent B-2 B cells
|
J:118712
|
| absent mature B cells
|
J:118712
|
| decreased B cell number
|
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn
\Igltm2.1Bgmn/\Igltm2.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
absent B cells
|
J:118712
|
| arrested B cell differentiation
|
J:118712
|
\Igkctm1Bgmn/\Igkctm1Bgmn
\Igltm2.1Bgmn/\Igltm2.1Bgmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:130864
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:130864
|
| abnormal plasma cell morphology
|
J:130864
|
\Igkctm1Bgmn/\Igkctm1Bgmn
\Igltm2Bgmn/\Igltm2Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
absent B cells
|
J:118712
|
| arrested B cell differentiation
|
J:118712
|
\Igkctm1Cgn/\Igkc+
(involves: C57BL/6)
|
increased mature B cell number
|
J:64287
|
\Igkctm1Cgn/\Igkctm1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:64287
|
| decreased mature B cell number
|
J:64287
|
| increased immature B cell number
|
J:64287
|
| increased mature B cell number
|
J:64287
|
\Igkctm1Jkbv/\Igkctm1Jkbv
(Not Specified)
|
abnormal B cell differentiation
|
J:137738
|
| abnormal immunoglobulin light chain V-J recombination
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| increased pre-B cell number
|
J:137738
|
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| increased pre-B cell number
|
J:137738
|
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGK@yK1)9.2CJkbv/\Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| decreased mature B cell number
|
J:137738
|
| increased pre-B cell number
|
J:137738
|
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:137738
|
\Igkctm1Jkbv/\Igkctm1Jkbv
\Tg(IGK@yK2)J23.1Jkbv/\Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:137738
|
\Igkctm2(IGKC)Cgn/\Igkctm2(IGKC)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113008
|
\Igkrstm1Nemz/\Igkrstm1Nemz
(B6.129-Igkrstm1Nemz)
|
abnormal immunoglobulin light chain V-J recombination
|
J:132125
|
| decreased immature B cell number
|
J:132125
|
| decreased mature B cell number
|
J:132125
|
\Igkrstm1Nemz/\Igkrstm1Nemz
\Tg(UBC-scFv)2Nemz/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal B cell clonal deletion
|
J:132125
|
| decreased immature B cell number
|
J:132125
|
| decreased mature B cell number
|
J:132125
|
\Iglc1tm1Ust/\Iglc1tm1Ust
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell number
|
J:68144
|
| increased lymphocyte cell number
|
J:68144
|
\Iglc1tm2Ust/\Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal immunoglobulin light chain V-J recombination
|
J:74717
|
\Iglc1tm2Ust/\Iglc1tm2Ust
(involves: 129S7/SvEvBrd)
|
decreased B cell number
|
J:113218
|
\Iglc1tm2Ust/\Iglc1tm2Ust
\Ptpn6me-v/\Ptpn6me-v
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:113218
|
\Igll1tm1Cgn/\Igll1tm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell morphology
|
J:64284
|
| abnormal B-1 B cell number
|
J:64284
|
| abnormal lymphopoiesis
|
J:64284
|
| abnormal pre-B cell morphology
|
J:64284
|
| decreased B cell number
|
J:64284,
J:35357
|
| increased pro-B cell number
|
J:64284
|
\Igll1tm1Cgn/\Igll1tm1Cgn
\Tg(Igk-V4CH27)1-2Shc/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:35357
|
| decreased pre-B cell number
|
J:35357
|
\Igll1tm1Shim/\Igll1tm1Shim
\Vpreb1atm1Shim/\Vpreb1atm1Shim
\Vpreb1btm1Shim/\Vpreb1btm1Shim
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76947
|
| decreased B cell number
|
J:76947
|
| decreased B-1a cell number
|
J:76947
|
| decreased immature B cell number
|
J:76947
|
| decreased mature B cell number
|
J:76947
|
| decreased pre-B cell number
|
J:76947
|
| increased late pro-B cell number
|
J:76947
|
\Igs2em1(Alb-Golm1)Jdon/\Igs2+
(involves: C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:306528
|
\Ikbkbem1Macc/\Ikbkb+
(involves: C57BL/6NCrl)
|
abnormal effector T cell number
|
J:290616
|
| decreased B cell number
|
J:290616
|
| decreased CD4-positive, alpha-beta T cell number
|
J:290616
|
| decreased CD8-positive, alpha-beta T cell number
|
J:290616
|
| decreased memory B cell number
|
J:290616
|
| decreased T cell number
|
J:290616
|
| increased regulatory T cell number
|
J:290616
|
\Ikbkbem1Macc/\Ikbkbem1Macc
(involves: C57BL/6NCrl)
|
abnormal effector T cell number
|
J:290616
|
| decreased B cell number
|
J:290616
|
| decreased CD4-positive, alpha-beta T cell number
|
J:290616
|
| decreased CD8-positive, alpha-beta T cell number
|
J:290616
|
| decreased memory B cell number
|
J:290616
|
| decreased T cell number
|
J:290616
|
| increased regulatory T cell number
|
J:290616
|
\Ikbkbem1Smoc/\Ikbkbem1Smoc
(C57BL/6J-Ikbkbem1Smoc)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:309163
|
\IkbkbM1Btlr/\Ikbkb+
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
\IkbkbM1Btlr/\IkbkbM1Btlr
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
\IkbkbM2Btlr/\IkbkbM2Btlr
(C57BL/6J-IkbkbM2Btlr)
|
decreased central memory CD4-positive, alpha-beta T cell number
|
J:274802
|
\Ikbkbtm1Cgn/\Ikbkbtm1.1Cgn
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
| decreased single-positive T cell number
|
J:85810
|
| decreased T cell number
|
J:85810
|
\Ikbkbtm1Cgn/\Ikbkbtm1Cgn
\Tg(Lck-cre)I57Jxm/0
(involves: C57BL/6 * ICR)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
\Ikbkbtm2Cgn/\Ikbkbtm2.1Cgn
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
\Ikbkbtm2Cgn/\Ikbkbtm2Cgn
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased memory T cell number
|
J:85810
|
| decreased regulatory T cell number
|
J:85810
|
\Ikbkgm1Btlr/Y
(C57BL/6J-Ikbkgm1Btlr)
|
decreased regulatory T cell number
|
J:139558
|
\Ikbkgtm1.1Chtr/Y
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased NK cell number
|
J:151485
|
| decreased NK T cell number
|
J:151485
|
\Ikbkgtm1.1Chtr/\Ikbkgtm1.1Chtr
\Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased NK cell number
|
J:151485
|
| decreased NK T cell number
|
J:151485
|
\Ikbkgtm1.1Dwat/\Ikbkg+
(B6.Cg-Ikbkgtm1.1Dwat)
|
decreased B cell number
|
J:202106
|
\Ikbkgtm1.1Mpa/Y
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:85810
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85810
|
| decreased single-positive T cell number
|
J:85810
|
| decreased T cell number
|
J:85810
|
\Ikbkgtm1.1Mpa/\Ikbkgtm1.1Mpa
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113365
|
| decreased B cell number
|
J:113365
|
| decreased mature B cell number
|
J:113365
|
\Ikzf1m1Btlr/\Ikzf1m1Btlr
(C57BL/6J-Ikzf1m1Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265249
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265249
|
| increased B-1 B cell number
|
J:265249
|
| increased CD4-positive, alpha-beta T cell number
|
J:265249
|
| increased CD8-positive, alpha-beta T cell number
|
J:265249
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265249
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265249
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265249
|
| increased single-positive T cell number
|
J:265249
|
| increased T cell number
|
J:265249
|
\Ikzf1m2Btlr/\Ikzf1m2Btlr
(C57BL/6J-Ikzf1m2Btlr)
|
decreased B cell number
|
J:265250
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265250
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265250
|
| decreased single-positive T cell number
|
J:265250
|
| decreased T cell number
|
J:265250
|
| increased CD8-positive, alpha-beta T cell number
|
J:265250
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265250
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265250
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265250
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265250
|
| increased single-positive T cell number
|
J:265250
|
\Ikzf1m3Btlr/\Ikzf1m3Btlr
(C57BL/6J-Ikzf1m3Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265251
|
| increased B-1 B cell number
|
J:265251
|
| increased CD8-positive, alpha-beta T cell number
|
J:265251
|
| increased single-positive T cell number
|
J:265251
|
| increased T cell number
|
J:265251
|
\Ikzf1plstc/\Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal B cell differentiation
|
J:84569
|
| abnormal lymphopoiesis
|
J:84569
|
| abnormal T cell differentiation
|
J:84569
|
| decreased double-negative T cell number
|
J:84569
|
| decreased double-positive T cell number
|
J:84569
|
| decreased mature B cell number
|
J:84569
|
| decreased pre-B cell number
|
J:84569
|
| decreased thymocyte number
|
J:84569
|
| increased pro-B cell number
|
J:84569
|
\Ikzf1plstc/\Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal lymphopoiesis
|
J:84569
|
| absent pro-B cells
|
J:84569
|
| absent T cells
|
J:84569
|
| arrested B cell differentiation
|
J:84569
|
\Ikzf1tm1(Pax5)Mbu/\Ikzf1tm1(Pax5)Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:80815
|
| abnormal T cell differentiation
|
J:80815
|
\Ikzf1tm1(Pax5)Mbu/\Ikzf1tm1(Pax5)Mbu
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:80815
|
| arrested T cell differentiation
|
J:80815
|
| increased B cell number
|
J:80815
|
| increased early pro-B cell number
|
J:80815
|
\Ikzf1tm1.1(Pax5)Mbu/\Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:80815
|
| decreased double-positive T cell number
|
J:118111
|
| increased B cell number
|
J:80815
|
| increased pro-B cell number
|
J:80815
|
\Ikzf1tm1.1(Pax5)Mbu/\Ikzf1+
\Tcf3tm1Mbu/\Tcf3tm1Mbu
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:137719
|
\Ikzf1tm1.1Smale/\Ikzf1tm1.1Smale
(B6.Cg-Ikzf1tm1.1Smale)
|
decreased B cell number
|
J:208211
|
| decreased B-1a cell number
|
J:208211
|
| decreased B-1b cell number
|
J:208211
|
| decreased DN1 thymic pro-T cell number
|
J:208211
|
| decreased immature B cell number
|
J:208211
|
| decreased mature B cell number
|
J:208211
|
| decreased pre-B cell number
|
J:208211
|
\Ikzf1tm1Kast/\Ikzf1tm1Kast
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:82813
|
| decreased B cell number
|
J:82813
|
| decreased B-1a cell number
|
J:82813
|
| decreased B-1b cell number
|
J:82813
|
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:29355
|
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell differentiation
|
J:29355
|
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK cell morphology
|
J:20671
|
| absent B cells
|
J:20671
|
| absent pre-B cells
|
J:20671
|
| arrested T cell differentiation
|
J:20671
|
| decreased gamma-delta intraepithelial T cell number
|
J:20671
|
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
abnormal NK cell morphology
|
J:20671
|
| absent B cells
|
J:20671
|
| absent pre-B cells
|
J:20671
|
| arrested T cell differentiation
|
J:20671
|
| decreased gamma-delta intraepithelial T cell number
|
J:20671
|
\Ikzf1tm2.1Smale/\Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale)
|
abnormal lymphopoiesis
|
J:208211
|
| abnormal T cell differentiation
|
J:208211
|
| absent NK cells
|
J:208211
|
| decreased B cell number
|
J:208211
|
| decreased DN2 thymocyte number
|
J:208211
|
| decreased DN3 thymocyte number
|
J:208211
|
| decreased double-negative T cell number
|
J:208211
|
| decreased double-positive T cell number
|
J:208211
|
| decreased immature B cell number
|
J:208211
|
| decreased mature B cell number
|
J:208211
|
| decreased pre-pro B cell number
|
J:208211
|
| increased gamma-delta T cell number
|
J:208211
|
| increased pre-B cell number
|
J:208211
|
\Ikzf1tm2Kge/\Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:208211,
J:37317
|
| absent B cells
|
J:208211,
J:37317
|
| absent B-1a cells
|
J:37317
|
| absent NK cells
|
J:208211,
J:37317
|
| absent pre-B cells
|
J:37317
|
| absent pro-B cells
|
J:37317
|
| decreased double-positive T cell number
|
J:37317
|
| decreased gamma-delta intraepithelial T cell number
|
J:37317
|
| decreased mature gamma-delta T cell number
|
J:37317
|
\Ikzf1tm3.1Mbu/\Ikzf1tm3.1Mbu
\Cd79atm1(cre)Reth/\Cd79a+
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6 * SJL)
|
decreased pro-B cell number
|
J:209928
|
\Ikzf1tm3Kge/\Ikzf1tm3Kge
\Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
absent pre-B cells
|
J:209927
|
| decreased pre-B cell number
|
J:209927
|
\Ikzf3tm1(KOMP)Vlcg/\Ikzf3tm1(KOMP)Vlcg
(C57BL/6N-Ikzf3tm1(KOMP)Vlcg/Rbrc)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:50626
|
| decreased B cell number
|
J:81805
|
| decreased naive B cell number
|
J:81805
|
| increased pre-B cell number
|
J:50626
|
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129S4/SvJae)
|
decreased marginal zone B cell number
|
J:69477
|
| increased follicular B cell number
|
J:69477
|
\Ikzf5tm1(KOMP)Wtsi/\Ikzf5tm1(KOMP)Wtsi
(C57BL/6N-Ikzf5tm1(KOMP)Wtsi/Rbrc)
|
increased large unstained cell number
|
J:211773
|
\Il1r1tm1Imx/\Il1r1tm1Imx
\Vsig4tm1Gne/\Vsig4tm1Gne
(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne)
|
decreased T helper 1 cell number
|
J:281762
|
| decreased T-helper 17 cell number
|
J:281762
|
\Il1r1tm1Roml/\Il1r1tm1Roml
(C.Cg-Il1r1tm1Roml)
|
decreased T cell number
|
J:82863
|
\Il1r1tm1Roml/\Il1r1tm1Roml
\Nlrp1aNeut1/\Nlrp1aNeut1
(involves: 129S1/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:191055
|
\Il1r2tm1.2Epi/\Il1r2tm1.2Epi
(involves: BALB/cJ * C57BL/6J * C57BL/6NTac)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:347877
|
| increased CD4-positive, alpha-beta T cell number
|
J:347877
|
\Il1rl2tm1Hblu/\Il1rl2tm1Hblu
(involves: 129)
|
decreased gamma-delta T cell number
|
J:193548
|
| increased regulatory T cell number
|
J:256437
|
\Il1rntm1Sush/\Il1rntm1Sush
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:97684
|
| abnormal T-helper 1 cell morphology
|
J:97684
|
| abnormal T-helper 2 cell morphology
|
J:97684
|
\Il2tm1Hor/\Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:39981,
J:15223
|
| abnormal class switch recombination
|
J:15573
|
| abnormal gamma-delta intraepithelial T cell morphology
|
J:15223
|
| abnormal lymphocyte cell number
|
J:15223
|
| abnormal lymphocyte morphology
|
J:37220
|
| abnormal T-helper 1 cell differentiation
|
J:37220
|
| decreased double-negative T cell number
|
J:15223
|
| decreased double-positive T cell number
|
J:37220
|
| increased double-negative T cell number
|
J:37220
|
| increased pre-B cell number
|
J:16662
|
| increased pro-B cell number
|
J:16662
|
| increased single-positive T cell number
|
J:37220
|
\Il2tm1Hor/\Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
abnormal lymphocyte morphology
|
J:29799
|
| increased germinal center B cell number
|
J:29799
|
| increased plasma cell number
|
J:29799
|
\Il2tm1Hor/\Il2tm1Hor
(B6.129P2-Il2tm1Hor)
|
increased activated T cell number
|
J:28924
|
| increased CD4-positive, alpha-beta T cell number
|
J:28924
|
| increased CD8-positive, alpha-beta T cell number
|
J:28924
|
| increased T cell number
|
J:125748
|
\Il2tm1Hor/\Il2tm1Hor
(C3.129P2-Il2tm1Hor)
|
increased CD4-positive, alpha-beta T cell number
|
J:28924
|
| increased CD8-positive, alpha-beta T cell number
|
J:28924
|
\Il2tm1Hor/\Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:131774
|
| decreased regulatory T cell number
|
J:113547
|
| increased CD4-positive, alpha-beta T cell number
|
J:131774
|
\Il2tm1Hor/\Il2tm1Hor
(involves: 129P2/OlaHsd)
|
increased regulatory T cell number
|
J:208318
|
\Il2tm1Hor/\Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T-helper 17 cell number
|
J:120176
|
\Il2tm1Hor/\Il2tm1Hor
\Il4tm1Cgn/\Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pre-B cell number
|
J:16662
|
| increased pro-B cell number
|
J:16662
|
\Il2tm1Hor/\Il2tm1Hor
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: 129P2/OlaHsd * C57BL/10)
|
abnormal T cell number
|
J:120176
|
| increased T-helper 17 cell number
|
J:120176
|
\Il2tm1Hor/\Il2tm1Hor
\Tg(DO11.10)10Dlo/?
(C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo)
|
increased activated T cell number
|
J:88349
|
\Il2tm1Hor/\Il2tm1Hor
\Tg(Pgk1-HA)1.1Vbo/?
\Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Il2tm1Hor Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
decreased regulatory T cell number
|
J:112603
|
| increased regulatory T cell number
|
J:112603
|
\Il2ratm1b(EUCOMM)Wtsi/\Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Il2ratm1Dw/\Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell morphology
|
J:64279
|
| increased lymphocyte cell number
|
J:64279
|
| increased memory T cell number
|
J:64279
|
\Il2ratm1Dw/\Il2ratm1Dw
\Tg(CD2-Ccdc86)1Hfuj/?
(B6.Cg-Il2ratm1Dw Tg(CD2-Ccdc86)1Hfuj)
|
increased activated T cell number
|
J:151722
|
\Il2ratm1Dw/\Il2ratm1Dw
\Tg(Pgk1-HA)1.1Vbo/?
\Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Il2ratm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
decreased regulatory T cell number
|
J:112603
|
| increased regulatory T cell number
|
J:112603
|
\Il2rbm1Btlr/\Il2rbm1Btlr
(C57BL/6J-Il2rbm1Btlr)
|
decreased B cell number
|
J:267694
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267694
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:267694
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267694
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267694
|
\Il2rbM3Btlr/\Il2rbM3Btlr
(C57BL/6J-Il2rbM3Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272833
|
| abnormal T cell morphology
|
J:272833
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272833
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:272833
|
| decreased NK cell number
|
J:272833
|
| decreased NK T cell number
|
J:272833
|
| increased CD4-positive, alpha-beta T cell number
|
J:272833
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
decreased B cell number
|
J:25940
|
| decreased double-positive T cell number
|
J:25940
|
| decreased memory T cell number
|
J:25940
|
| increased activated T cell number
|
J:25940
|
| increased CD4-positive, alpha-beta T cell number
|
J:25940
|
| increased CD8-positive, alpha-beta T cell number
|
J:25940
|
| increased plasma cell number
|
J:25940
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(B6.129-Il2rbtm1Mak)
|
abnormal lymphocyte morphology
|
J:113547
|
| decreased regulatory T cell number
|
J:113547
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
abnormal lymphocyte morphology
|
J:113547
|
| abnormal marginal zone B cell morphology
|
J:113547
|
| abnormal T cell clonal deletion
|
J:113547
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113547
|
\Il2rbtm1Mak/\Il2rbtm1Mak
(D2.129-Il2rbtm1Mak)
|
abnormal T cell clonal deletion
|
J:113547
|
\Il2rbtm1Mak/\Il2rbtm1Mak
\Lcktm1Mak/\Lcktm1Mak
(involves: 129)
|
absent uterine NK cells
|
J:134589
|
\Il2rbtm1Mak/\Il2rbtm1Mak
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129 * 129S/SvEv)
|
decreased NK cell number
|
J:142654
|
\Il2rgtm1.1Asin/\Il2rgtm1Wjl
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:190889
|
| decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\Il2rgtm1.1Asin/\Il2rgtm1Wjl
\Tg(Cd8a*-cre)B8Asin/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:190889
|
| decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
| decreased NK T cell number
|
J:190889
|
| decreased regulatory T cell number
|
J:190889
|
\Il2rgtm1.1Asin/\Il2rgtm1Wjl
\Tg(Cd8a*-cre)B8Asin/0
\Tg(LCKprBCL2)36Sjk/0
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:190889
|
\Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:22521
|
| abnormal class switch recombination
|
J:22521
|
| abnormal gamma-delta T cell differentiation
|
J:111821
|
| absent gamma-delta intraepithelial T cell
|
J:111821
|
| absent gamma-delta T cells
|
J:111821
|
| absent NK cells
|
J:22521
|
| decreased mature B cell number
|
J:22521
|
| decreased plasma cell number
|
J:22521
|
| decreased pre-B cell number
|
J:22521
|
| decreased T cell number
|
J:22521
|
\Il2rgtm1Cgn/Y
\Rag2tm1Fwa/\Rag2tm1Fwa
(B6.129-Rag2tm1Fwa Il2rgtm1Cgn)
|
absent B cells
|
J:132257
|
| absent NK cells
|
J:132257
|
| absent T cells
|
J:132257
|
\Il2rgtm1Cgn/\Il2rgtm1Cgn
(involves: 129 * CB20)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:22521
|
| abnormal class switch recombination
|
J:22521
|
| absent NK cells
|
J:22521
|
| decreased mature B cell number
|
J:22521
|
| decreased plasma cell number
|
J:22521
|
| decreased pre-B cell number
|
J:22521
|
| decreased T cell number
|
J:22521
|
\Il2rgtm1Cgn/\Il2rgtm1Cgn
\Kittm1.1Bsm/\Kittm1.1Bsm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
arrested T cell differentiation
|
J:90485
|
\Il2rgtm1Cgn/\Il2rgtm1Cgn
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased NK cell number
|
J:142654
|
\Il2rgtm1Krf/\Il2rgtm1Krf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))
|
decreased thymocyte number
|
J:114561
|
\Il2rgtm1Krf/\Il2rgtm1Krf
\Tg(BCL2/IGH)1Tjd/0
(either: (involves: 129P2/OlaHsd * C3H/He * C57BL/6) or (involves: 129P2/OlaHsd * C3H/He * C57BL/6 * FVB/N))
|
decreased thymocyte number
|
J:114561
|
\Il2rgtm1Krf/\Il2rgtm1Krf
\Tg(Igh-Pim1)1Brn/0
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N))
|
decreased thymocyte number
|
J:114561
|
\Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))
|
absent NK cells
|
J:31167
|
| arrested B cell differentiation
|
J:31167
|
| decreased lymphocyte cell number
|
J:31167
|
| decreased T cell number
|
J:31167
|
| decreased thymocyte number
|
J:31167
|
\Il2rgtm1Sug/\Il2rgtm1Sug
(B6.129-Il2rgtm1Sug)
|
absent uterine NK cells
|
J:116952
|
\Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell number
|
J:108209
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:108209
|
| abnormal lymphocyte morphology
|
J:108209
|
| absent gamma-delta intraepithelial T cell
|
J:24117
|
| absent gamma-delta T cells
|
J:24117
|
| absent NK cells
|
J:24117
|
| decreased CD8-positive, alpha-beta T cell number
|
J:24117
|
| decreased double-negative T cell number
|
J:24117
|
| decreased double-positive T cell number
|
J:24117
|
| decreased immature B cell number
|
J:24117
|
| decreased single-positive T cell number
|
J:24117
|
\Il2rgtm1Wjl/Y
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109833
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109833
|
| decreased immature B cell number
|
J:109833
|
| decreased mature B cell number
|
J:109833
|
| decreased NK cell number
|
J:109833
|
\Il2rgtm1Wjl/Y
\Rag1tm1Mom/\Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ)
|
absent NK T cells
|
J:140388
|
\Il2rgtm1Wjl/\Il2rgtm1Wjl
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109833
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109833
|
| decreased immature B cell number
|
J:109833
|
| decreased mature B cell number
|
J:109833
|
| decreased NK cell number
|
J:109833
|
\Il2rgtm1Wjl/\Il2rgtm1Wjl
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * 129S4/SvJae)
|
absent NK cells
|
J:140483
|
| absent T cells
|
J:140483
|
\Il2rgtm1Wjl/\Il2rgtm1Wjl
\Tg(CD2-Ccdc86)1Hfuj/?
(B6.Cg-Il2rgtm1Wjl Tg(CD2-Ccdc86)1Hfuj)
|
decreased CD4-positive, alpha-beta T cell number
|
J:151722
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151722
|
| decreased regulatory T cell number
|
J:151722
|
\Il2rgtm2Cgn/Y
\Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased NK cell number
|
J:132257
|
\Il4tm1.1Wep/\Il4+
\Stat6tm1Gru/\Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
\Il4tm1.1Wep/\Il4tm1.1Wep
(C.129P2-Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
\Il4tm1.1Wep/\Il4tm1.1Wep
\Stat6tm1Gru/\Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
\Il4tm1Cgn/\Il4tm1Cgn
\Ndfip1Gt(RRD002)Byg/\Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
increased CD4-positive, alpha-beta T cell number
|
J:205692
|
| increased T cell number
|
J:205692
|
\Il4tm1Kopf/\Il4tm1Kopf
\Lyntm1Ard/\Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased B cell number
|
J:161523
|
\Il4ratm1Fbb/\Il4ratm1Fbb
(involves: BALB/cJ)
|
decreased T-helper 2 cell number
|
J:172134
|
\Il4ratm1Sz/\Il4ratm1Sz
\Il7rtm1.1Asin/\Il7rtm1Imx
\Tg(Cd8a*-cre)B8Asin/0
(involves: 129S7/SvEvBrd * BALB/cJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\Il4ratm1Tch/\Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c)
|
abnormal T-helper 2 cell morphology
|
J:86215
|
\Il5tm1Kopf/\Il5tm1Kopf
(C57BL/6-Il5tm1Kopf)
|
increased lymphocyte cell number
|
J:30641
|
\Il5tm1Ktk/\Il5tm1Ktk
(B6.129S4-Il5tm1Ktk)
|
abnormal B-1 B cell morphology
|
J:180790
|
\Il5ratm1Ktk/\Il5ratm1Ktk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:33140
|
| abnormal lymphopoiesis
|
J:33140
|
| abnormal T cell differentiation
|
J:33140
|
| decreased CD4-positive, alpha-beta T cell number
|
J:33140
|
\Il5ratm1Ktk/\Il5ratm1Ktk
(B6.129P2-Il5ratm1Ktk)
|
abnormal B-1 B cell morphology
|
J:89849
|
| decreased B-1 B cell number
|
J:89849
|
\Il5ratm1Ktk/\Il5ratm1Ktk
\Lyntm1Tya/\Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1 B cell number
|
J:91089
|
\Il6tm1Kopf/\Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:17360
|
| decreased T cell number
|
J:17360
|
\Il6tm1Kopf/\Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
decreased pro-B cell number
|
J:117320
|
\Il6tm1Kopf/\Il6tm1Kopf
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:117320
|
| decreased pro-B cell number
|
J:117320
|
\Il6tm1Kopf/\Il6tm1Kopf
\Tg(Rorc-EGFP)1Ebe/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
\Il6tm1Mur/\Il6tm1Mur
(involves: 129/Sv * C57BL/6)
|
abnormal lymphocyte cell number
|
J:40579
|
| absent NK cells
|
J:40579
|
\Il6tm1Poli/\Il6tm1Poli
(involves: 129S/SvEv * MF1)
|
abnormal T-helper 1 cell morphology
|
J:79314
|
\Il6ratm1.1(IL6R)Csk/\Il6ratm1.1(IL6R)Csk
\Tg(H2-L-IL6)40Csk/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased plasma cell number
|
J:207264
|
\Il6sttm1Thir/\Il6sttm1Thir
(Not Specified)
|
increased B cell number
|
J:59922
|
| increased CD4-positive, alpha-beta T cell number
|
J:59922
|
| increased CD8-positive, alpha-beta T cell number
|
J:59922
|
\Il6sttm1Thir/\Il6sttm1Thir
(involves: 129 * C57BL/6)
|
abnormal T cell clonal deletion
|
J:133059
|
| decreased double-positive T cell number
|
J:133059
|
| increased activated T cell number
|
J:133059
|
| increased double-negative T cell number
|
J:133059
|
| increased single-positive T cell number
|
J:133059
|
\Il6sttm1Thir/\Il6sttm1Thir
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal negative T cell selection
|
J:133059
|
\Il6sttm1Wme/\Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:67677
|
| decreased thymocyte number
|
J:67677
|
\Il6sttm2Thir/\Il6sttm2Thir
(Not Specified)
|
decreased B-1a cell number
|
J:59922
|
\Il7hlb368/\Il7hlb368
(C57BL/6J-Il7hlb368/J)
|
abnormal T cell subpopulation ratio
|
J:118450
|
| decreased T cell number
|
J:118450
|
\Il7m1Jyen/\Il7m1Jyen
(involves: C3H * C57BL/6)
|
decreased B cell number
|
J:136470
|
| decreased single-positive T cell number
|
J:136470
|
\Il7tm1.1Mysl/\Il7+
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
decreased T cell number
|
J:200544
|
\Il7tm1.1Mysl/\Il7tm1.1Mysl
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
arrested B cell differentiation
|
J:200544
|
| decreased T cell number
|
J:200544
|
| decreased thymocyte number
|
J:200544
|
\Il7tm1Dnax/\Il7tm1Dnax
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
| arrested B cell differentiation
|
J:24165
|
| decreased lymphocyte cell number
|
J:24165
|
\Il7tm1Dnax/\Il7tm1Dnax
(involves: 129P2/OlaHsd)
|
decreased thymocyte number
|
J:64861
|
\Il7tm1Dnax/\Il7tm1Dnax
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased NK cell number
|
J:132257
|
\Il7tm2.1Iku/\Il7tm2.1Iku
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal B cell differentiation
|
J:190615
|
| decreased B cell number
|
J:190615
|
| decreased double-negative T cell number
|
J:190615
|
| decreased lymphocyte cell number
|
J:190615
|
| decreased NK T cell number
|
J:190615
|
| decreased T cell number
|
J:190615
|
\Il7rtm1.1Asin/\Il7rtm1Imx
\Tg(Cd4-cre)1Cwi/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\Il7rtm1.1Asin/\Il7rtm1Imx
\Tg(Cd8a*-cre)B8Asin/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\Il7rtm1Abra/\Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
abnormal T cell differentiation
|
J:125360
|
| decreased B cell number
|
J:125360
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125360
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125360
|
| decreased memory T cell number
|
J:125360
|
| decreased thymocyte number
|
J:125360
|
| increased double-positive T cell number
|
J:125360
|
\Il7rtm1Iku/\Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:34658
|
| abnormal gamma-delta T cell differentiation
|
J:34658
|
| abnormal T cell subpopulation ratio
|
J:34658
|
| absent mature gamma-delta T cells
|
J:34658
|
| decreased B-1 B cell number
|
J:34658
|
| decreased double-positive T cell number
|
J:34658
|
| decreased immature B cell number
|
J:34658
|
| decreased lymphocyte cell number
|
J:34658
|
| decreased mature B cell number
|
J:34658
|
| decreased T cell number
|
J:34658
|
| increased double-negative T cell number
|
J:34658
|
\Il7rtm1Imx/\Il7rtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd)
|
arrested B cell differentiation
|
J:21135
|
| arrested T cell differentiation
|
J:21135
|
| decreased B cell number
|
J:21135
|
| decreased T cell number
|
J:21135
|
\Il7rtm1Imx/\Il7rtm1Imx
(B6.129S7-Il7rtm1Imx)
|
abnormal T cell differentiation
|
J:125360
|
| decreased double-positive T cell number
|
J:125360
|
| decreased thymocyte number
|
J:125360
|
\Il7rtm1Imx/\Il7rtm1Imx
(involves: 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:64861
|
\Il7rtm1Imx/\Il7rtm1Imx
\Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased thymocyte number
|
J:66400
|
\Il7rtm2Iku/\Il7rtm2Iku
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:193283
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:193283
|
| abnormal T cell morphology
|
J:193283
|
| decreased NK T cell number
|
J:193283
|
| increased B cell number
|
J:193283
|
| increased gamma-delta T cell number
|
J:193283
|
| increased thymocyte number
|
J:193283
|
\Il9rtm1Jcrd/\Il9rtm1Jcrd
(involves: C57BL/6)
|
increased T-helper 1 cell number
|
J:151907
|
\Il10tm1.1Roer/\Il10tm1.1Roer
(involves: 129P2/OlaHsd)
|
increased B cell number
|
J:151551
|
| increased plasma cell number
|
J:151551
|
| increased T cell number
|
J:151551
|
\Il10tm1Cgn/\Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:35020
|
| increased CD4-positive, alpha-beta T cell number
|
J:35020
|
\Il10tm1Cgn/\Il10tm1Cgn
\Il4tm1Cgn/\Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:111712
|
\Il10tm1Cgn/\Il10tm1Cgn
\Il12btm1Jm/\Il12btm1Jm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:111712
|
\Il10tm1Cgn/\Il10tm1Cgn
\Vdrtm1Mbd/\Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:107077
|
\Il10ratm1.1Tlg/\Il10ratm1.1Tlg
\Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg)
|
abnormal lymphocyte cell number
|
J:189797
|
| abnormal regulatory T cell number
|
J:189797
|
| decreased T cell number
|
J:189797
|
\Il10ratm1b(KOMP)Wtsi/\Il10ratm1b(KOMP)Wtsi
(C57BL/6N-Il10ratm1b(KOMP)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
\Il11ra1tm1Gos/\Il11ra1tm1Gos
(involves: 129S2/SvPas * C57BL/6J * CD-1)
|
abnormal NK cell differentiation
|
J:93811
|
| abnormal uterine NK cell morphology
|
J:93811
|
\Il12rb1tm1Jm/\Il12rb1tm1Jm
\Tg(Rorc-EGFP)1Ebe/?
(involves: 129S1/Sv * C57BL/6)
|
abnormal effector T cell morphology
|
J:137020
|
\Il13tm1.1Anjm/\Il13tm1.1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
| decreased T-helper 2 cell number
|
J:67965
|
\Il13tm2Anjm/\Il13tm2Anjm
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
| decreased T-helper 2 cell number
|
J:67965
|
\Il13ra1tm1Twy/Y
(C.Cg-Il13ra1tm1Twy)
|
increased CD4-positive, alpha-beta T cell number
|
J:130488
|
| increased T-helper 2 cell number
|
J:130488
|
\Il15m1Hwata/\Il15m1Hwata
(Not Specified)
|
abnormal NK T cell number
|
J:184570
|
| decreased NK cell number
|
J:184570
|
| decreased NK T cell number
|
J:184570
|
\Il15tm1Imx/\Il15+
\Myctm1Atp/\Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased memory T cell number
|
J:132730
|
\Il15tm1Imx/\Il15tm1Imx
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:60915
|
| absent uterine NK cells
|
J:84009
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113408,
J:60915
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:155298
|
| decreased memory T cell number
|
J:132730
|
| decreased NK cell number
|
J:132730,
J:142654,
J:60915
|
| decreased regulatory T cell number
|
J:208318
|
\Il15tm1Imx/\Il15tm1Imx
(C57BL/6-Il15tm1Imx/Tac)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111786
|
\Il15tm1Imx/\Il15tm1Imx
\Il7rtm1.1Asin/\Il7rtm1Imx
\Tg(Cd8a*-cre)B8Asin/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:190889
|
\Il15tm1Imx/\Il15tm1Imx
\Itktm1Ljb/\Itktm1Ljb
(involves: 129 * C57BL/6 * C57BL/10)
|
decreased CD8-positive, alpha-beta T cell number
|
J:113408
|
\Il15tm1Imx/\Il15tm1Imx
\Myctm1Atp/\Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased memory T cell number
|
J:132730
|
| decreased NK cell number
|
J:132730
|
\Il15tm1Imx/\Il15tm1Imx
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
decreased NK cell number
|
J:132257
|
\Il15ratm1.1Nsl/\Il15ratm1.1Nsl
(involves: 129X1/SvJ * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:73738
|
| decreased memory T cell number
|
J:73738
|
| decreased NK cell number
|
J:73738
|
| decreased NK T cell number
|
J:73738
|
| decreased single-positive T cell number
|
J:73738
|
| increased CD4-positive, alpha-beta T cell number
|
J:73738
|
\Il15ratm1Ama/\Il15ratm1Ama
(involves: 129X1/SvJ)
|
decreased CD8-positive, alpha-beta T cell number
|
J:142570
|
| decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:155298
|
| decreased memory T cell number
|
J:142570
|
| decreased NK cell number
|
J:119213,
J:142570
|
| decreased NK T cell number
|
J:142570
|
\Il15ratm1Ama/\Il15ratm2.1Ama
\Lyz2tm1(cre)Ifo/0
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:155298
|
| decreased memory T cell number
|
J:155298
|
| decreased NK cell number
|
J:155298
|
\Il15ratm1Ama/\Il15ratm2.1Ama
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal NK cell differentiation
|
J:155298
|
| decreased CD8-positive, alpha-beta T cell number
|
J:155298
|
| decreased memory T cell number
|
J:155298
|
| decreased NK cell number
|
J:155298
|
\Il15ratm1Ama/\Il15ratm2.1Ama
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129X1/SvJ * C57BL/6J * CBA)
|
abnormal NK cell differentiation
|
J:155298
|
| abnormal T cell subpopulation ratio
|
J:155298
|
| decreased CD8-positive, alpha-beta T cell number
|
J:155298
|
| decreased memory T cell number
|
J:155298
|
| decreased NK cell number
|
J:155298
|
\Il15ratm1Ama/\Il15ratm2.1Ama
\Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
decreased CD8-positive, gamma-delta intraepithelial T cell number
|
J:155298
|
\Il15ratm1Wjl/\Il15ratm1Wjl
(involves: 129 * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:142570
|
| decreased memory T cell number
|
J:142570
|
| decreased NK cell number
|
J:142570
|
| decreased NK T cell number
|
J:142570
|
\Il17a/Il17ftm1.1Impr/\Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:187400
|
| absent gamma-delta T cells
|
J:187400
|
| increased gamma-delta T cell number
|
J:187400
|
\Il17a/Il17ftm1.1Impr/\Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:187400
|
| absent gamma-delta T cells
|
J:187400
|
| increased gamma-delta T cell number
|
J:187400
|
\Il17atm1Cdon/\Il17atm1Cdon
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:136279
|
\Il17atm1Yiw/\Il17atm1Yiw
(involves: 129P2/OlaHsd)
|
increased gamma-delta T cell number
|
J:193548
|
\Il17bGt(371C12)Cmhd/\Il17bGt(371C12)Cmhd
(B6.129-Il17bGt(371C12)Cmhd)
|
increased T-helper 2 cell number
|
J:229778
|
\Il17ctm1.1Cdon/\Il17ctm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:177650
|
\Il17ratm1.2Kurs/\Il17ratm1.2Kurs
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)
|
increased CD4-positive, alpha-beta T cell number
|
J:196483
|
| increased gamma-delta T cell number
|
J:196483
|
| increased T-helper 17 cell number
|
J:196483
|
\Il17ratm1Koll/\Il17ratm1Koll
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:158594
|
\Il17rbtm1Tgi/\Il17rbtm1Tgi
(B6.Cg-Il17rbtm1Tgi)
|
decreased NK T cell number
|
J:184570
|
\Il18tm1Khe/\Il18tm1Khe
(involves: 129P2/OlaHsd)
|
abnormal T cell morphology
|
J:62263
|
\Il18tm1Khe/\Il18tm1Khe
(B6.129P2-Il18tm1Khe)
|
increased NK cell number
|
J:138759
|
\Il18bptm1(KOMP)Vlcg/\Il18bptm1(KOMP)Vlcg
(C57BL/6-Il18bptm1(KOMP)Vlcg)
|
abnormal NK cell differentiation
|
J:255309
|
| decreased KLRG1-positive NK cell number
|
J:255309
|
| decreased mature NK cell number
|
J:255309
|
| decreased NK cell number
|
J:255309
|
| increased immature NK cell number
|
J:255309
|
\Il18bptm1.1(KOMP)Vlcg/\Il18bptm1.1(KOMP)Vlcg
(involves: C57BL/6N)
|
increased B cell number
|
J:261967
|
\Il20rbtm1Uwe/\Il20rbtm1Uwe
(B6.129P2-Il20rbtm1Uwe)
|
increased memory T cell number
|
J:143497
|
\Il21tm1Lex/\Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal gamma-delta T cell morphology
|
J:123351
|
| abnormal T cell differentiation
|
J:123351
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123351
|
\Il21tm1Lex/\Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:137867
|
| decreased germinal center B cell number
|
J:137867
|
\Il21tm1Llit/\Il21tm1Llit
(involves: 129 * C57BL/6J)
|
abnormal class switch recombination
|
J:114783
|
\Il21rtm1Day/\Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955,
J:123352
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123352
|
\Il21rtm1Wjl/\Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
|
abnormal CD4-positive T cell differentiation
|
J:139075
|
\Il23atm1Dnax/\Il23atm1Dnax
(Not Specified)
|
decreased gamma-delta T cell number
|
J:193548
|
| decreased T cell number
|
J:193548
|
\Il23atm1Ngh/\Il23atm1Ngh
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:88235
|
\Il23atm1Ngh/\Il23atm1Ngh
(involves: 129 * C57BL/6)
|
decreased activated T cell number
|
J:120806
|
\Il23rtm1Kuch/\Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch)
|
abnormal CD4-positive T cell differentiation
|
J:148248
|
\Il25tm1.1Cdon/\Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased T-helper 2 cell number
|
J:229778
|
\Il25tm1Dart/\Il25tm1Dart
(involves: C57BL/6)
|
increased T cell number
|
J:125296
|
\Il27tm1b(EUCOMM)Wtsi/\Il27tm1b(EUCOMM)Wtsi
(C57BL/6N-Il27tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Il27tm1Cua/\Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
abnormal CD4-positive T cell differentiation
|
J:147706
|
\Il27ratm1Fjs/\Il27ratm1Fjs
(B6.Cg-Il27ratm1Fjs)
|
increased lymphocyte cell number
|
J:94856
|
\Il33tm1Amgn/\Il33tm1Amgn
(B6.129-Il33tm1Amgn)
|
decreased lymphocyte cell number
|
J:192531
|
\Il36gtm1Lex/\Il36gtm1Lex
(involves: 129S5/SvEvBrd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:256437
|
| increased CD4-positive, alpha-beta T cell number
|
J:256437
|
| increased regulatory T cell number
|
J:256437
|
\Immp2lTg(HLA-A/H2-D)2Enge/?
((C57BL/6 x CBA)F1)
|
abnormal negative T cell selection
|
J:31937
|
| abnormal positive T cell selection
|
J:31937
|
\Impdh1tm1Bmi/\Impdh1tm1Bmi
\Impdh2tm1Bmi/\Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
\Impdh2tm1Bmi/\Impdh2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte cell number
|
J:86045
|
\Ing1Gt(OST206270)Lex/\Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased thymocyte number
|
J:118602
|
\Inpp5del20/\Inpp5del20
(B6.129-Inpp5del20)
|
abnormal lymphocyte cell number
|
J:173266
|
| decreased lymphocyte cell number
|
J:173266
|
| decreased pre-B cell number
|
J:173266
|
| decreased thymocyte number
|
J:173266
|
\Inpp5dm1Btlr/\Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr)
|
abnormal B cell differentiation
|
J:140987
|
\Inpp5dm2Btlr/\Inpp5dm2Btlr
(C57BL/6J-Inpp5dm2Btlr)
|
decreased B cell number
|
J:216053
|
\Inpp5dM3Btlr/\Inpp5d+
(C57BL/6J-Inpp5dM3Btlr)
|
decreased NK cell number
|
J:254907
|
\Inpp5dm5Btlr/\Inpp5dm5Btlr
(C57BL/6J-Inpp5dm5Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272856
|
| abnormal lymphocyte morphology
|
J:272856
|
| abnormal T cell differentiation
|
J:272856
|
| decreased alpha-beta T cell number
|
J:272856
|
| decreased B cell number
|
J:272856
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272856
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272856
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272856
|
| decreased NK cell number
|
J:272856
|
| increased B-1 B cell number
|
J:272856
|
| increased CD8-positive, alpha-beta T cell number
|
J:272856
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272856
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272856
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272856
|
\Inpp5dtm1.1Wgk/\Inpp5dtm1.1Wgk
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal NK cell morphology
|
J:95215
|
| increased NK cell number
|
J:95215
|
\Inpp5dtm1Dmt/\Inpp5dtm1Dmt
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:77739
|
\Inpp5dtm1Dmt/\Inpp5dtm1Dmt
(B6.129P2/OlaHsd-Inpp5dtm1Dmt)
|
decreased lymphocyte cell number
|
J:173266
|
| decreased pre-B cell number
|
J:173266
|
\Inpp5dtm1Rav/\Inpp5dtm1.1Rav
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
absent marginal zone B cells
|
J:119256
|
\Inpp5dtm1Rav/\Inpp5dtm1Rav
\Cd79atm1(cre)Reth/\Cd79a+
\Tg(IghAb36-65)1Wys/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
abnormal B cell negative selection
|
J:178833
|
| decreased B cell number
|
J:178833
|
| increased plasma cell number
|
J:178833
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal lymphopoiesis
|
J:48193
|
| decreased lymphocyte cell number
|
J:48193
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased pro-B cell number
|
J:117320
|
\Inpp5dtm1Rkh/\Inpp5dtm1Rkh
\Rag1tm1(GFP)Imku/\Rag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:117320
|
\Ins2Akita/\Ins2+
\Prf1tm1Sdz/\Prf1tm1Sdz
\Rag1tm1Mom/\Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz)
|
absent mature B cells
|
J:138005
|
| absent T cells
|
J:138005
|
\Iqcetm1b(EUCOMM)Hmgu/\Iqcetm1b(EUCOMM)Hmgu
(C57BL/6N-Iqcetm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Iqgap1tm1b(EUCOMM)Wtsi/\Iqgap1tm1b(EUCOMM)Wtsi
(C57BL/6N-Iqgap1tm1b(EUCOMM)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Irag1em1(IMPC)Ccpcz/\Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Irak3tm1Flv/\Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
abnormal T cell differentiation
|
J:229884
|
| increased effector memory T-helper cell number
|
J:229884
|
\Irf1M1Btlr/\Irf1+
(C57BL/6J-Irf1M1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:162995
|
| decreased NK cell number
|
J:162995
|
\Irf1M1Btlr/\Irf1M1Btlr
(C57BL/6J-Irf1M1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:162995
|
| decreased NK cell number
|
J:162995
|
\Irf1m2Btlr/\Irf1m2Btlr
(C57BL/6J-Irf1m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:267675
|
| decreased NK cell number
|
J:267675
|
| increased B-1 B cell number
|
J:267675
|
| increased CD4-positive, alpha-beta T cell number
|
J:267675
|
\Irf1M3Btlr/\Irf1M3Btlr
(C57BL/6J-Irf1M3Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:267677
|
| increased CD4-positive, alpha-beta T cell number
|
J:267677
|
\Irf1tm1Cwe/\Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:21235,
J:36025
|
| decreased CD8-positive, alpha-beta T cell number
|
J:21235
|
| increased T-helper 2 cell number
|
J:110672
|
\Irf1tm1Mak/\Irf1tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
abnormal T cell number
|
J:64286
|
| decreased CD8-positive, alpha-beta T cell number
|
J:64286
|
| increased CD4-positive, alpha-beta T cell number
|
J:64286
|
| increased double-positive T cell number
|
J:64286
|
\Irf2tm1Mak/\Irf2tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
decreased mature B cell number
|
J:64286
|
| decreased T cell number
|
J:64286
|
\Irf2tm1Mak/\Irf2tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
increased memory T cell number
|
J:66034
|
\Irf3tm1Ttg/\Irf3tm1Ttg
\Sting1em1Jmin/\Sting1em1Jmin
(involves: 129S/SvEv * C57BL/6N)
|
decreased single-positive T cell number
|
J:251372
|
\Irf4em1(IMPC)Mbp/\Irf4em1(IMPC)Mbp
(C57BL/6N-Irf4em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Irf4m1Btlr/\Irf4m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
\Irf4tm1.1Rdf/\Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:112643
|
\Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:42683
|
| absent plasma cells
|
J:42683
|
| arrested B cell differentiation
|
J:42683
|
| increased lymphocyte cell number
|
J:42683
|
\Irf4tm1Mak/\Irf4tm1Mak
(B6.129P2-Irf4tm1Mak)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78909
|
| abnormal T-helper 1 cell differentiation
|
J:78909
|
\Irf5tm1e(EUCOMM)Wtsi/\Irf5tm1e(EUCOMM)Wtsi
(C57BL/6N-Irf5tm1e(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta memory T cell number
|
J:211773
|
\Irf8m2Btlr/\Irf8m2Btlr
(C57BL/6J-Irf8m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:274937
|
| increased CD4-positive, alpha-beta T cell number
|
J:274937
|
\Irf8myls/\Irf8+
(involves: BXH2/TyJ * C57BL/6)
|
increased B cell number
|
J:168923
|
| increased B-1b cell number
|
J:168923
|
| increased follicular B cell number
|
J:168923
|
| increased transitional stage B cell number
|
J:168923
|
\Irf8tm1Hor/\Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal plasma cell number
|
J:36038
|
| decreased B cell number
|
J:36038
|
| decreased lymphocyte cell number
|
J:36038
|
| decreased T cell number
|
J:36038
|
| increased B cell number
|
J:36038
|
| increased lymphocyte cell number
|
J:36038
|
| increased mature B cell number
|
J:36038
|
\Irf8tm1Hor/\Irf8tm1Hor
(B6.129P2-Irf8tm1Hor)
|
decreased follicular B cell number
|
J:168923
|
| increased B-1b cell number
|
J:168923
|
| increased marginal zone B cell number
|
J:168923
|
\Irf8tm1Hor/\Irf8tm1Hor
\Irf4tm1Mak/\Irf4tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84577
|
| abnormal pre-B cell morphology
|
J:84577
|
| absent B cells
|
J:84577
|
| arrested B cell differentiation
|
J:84577
|
| decreased lymphocyte cell number
|
J:84577
|
| decreased T cell number
|
J:84577
|
| increased pre-B cell number
|
J:84577
|
\Is(14)1Rdf \Is(14)2Rdf/\Del(14Trim13-Dleu2)4Rdf
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
\Is(14)1Rdf \Is(14)5Rdf/\Del(14Trim13-Rnaseh2b)6Rdf
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
| increased B cell number
|
J:179879
|
\Is(14)1Rdf/\Is(14)1Rdf
\Is(14)5Rdf/\Is(14)5Rdf
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
| increased B cell number
|
J:179879
|
\Itchtm1.1Alta/\Itchtm1.1Alta
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:204685
|
| abnormal T-helper 2 cell differentiation
|
J:204685
|
| decreased CD4-positive, alpha-beta T cell number
|
J:204685
|
| increased CD4-positive, alpha-beta T cell number
|
J:204685
|
| increased CD8-positive, alpha-beta T cell number
|
J:204685
|
| increased regulatory T cell number
|
J:204685
|
\Itchtm1b(EUCOMM)Hmgu/\Itchtm1b(EUCOMM)Hmgu
(C57BL/6N-Itchtm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Itfg2Gt(OST215121)Lex/\Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:205951
|
| decreased lymphocyte cell number
|
J:205951
|
| decreased T follicular helper cell number
|
J:205951
|
| increased B cell number
|
J:205951
|
\Itga4tm1Mshi/\Itga4tm1Mshi
(C57BL/6-Itga4tm1Mshi)
|
decreased B cell number
|
J:144092
|
| decreased lymphocyte cell number
|
J:144092
|
| decreased T cell number
|
J:144092
|
\Itga4tm1Tpa/\Itga4tm1Tpa
\Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:86861
|
| decreased CD4-positive, alpha-beta T cell number
|
J:86861
|
\Itga6tm1Son/\Itga6tm1Son
(involves: 129P2/OlaHsd * FVB)
|
decreased T cell number
|
J:50235
|
\Itgadtm1Bll/\Itgadtm1Bll
(B6.129S7-Itgadtm1Bll)
|
abnormal lymphocyte cell number
|
J:90954
|
| abnormal T cell subpopulation ratio
|
J:90954
|
| decreased CD4-positive, alpha-beta T cell number
|
J:90954
|
| increased CD8-positive, alpha-beta T cell number
|
J:90954
|
\Itgaetm1b(EUCOMM)Wtsi/\Itgaetm1b(EUCOMM)Wtsi
(C57BL/6N-Itgaetm1b(EUCOMM)Wtsi/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Itgaetm1Cmp/\Itgaetm1Cmp
(involves: 129S2/SvPas * BALB/c)
|
decreased lymphocyte cell number
|
J:55333
|
| decreased T cell number
|
J:55333
|
\Itgaltm1.1Mshi/\Itgaltm1.1Mshi
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:168533
|
\Itgaltm1Hlz/\Itgaltm1Hlz
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:99286
|
\Itgaltm1Hogg/\Itgaltm1Hogg
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:82587
|
| decreased CD4-positive, alpha-beta T cell number
|
J:82587
|
| decreased CD8-positive, alpha-beta T cell number
|
J:82587
|
| decreased lymphocyte cell number
|
J:82587
|
| increased CD4-positive, alpha-beta T cell number
|
J:82587
|
| increased CD8-positive, alpha-beta T cell number
|
J:82587
|
\Itgamtm1Bll/\Itgamtm1Bll
(B6.129S7-Itgamtm1Bll)
|
abnormal lymphocyte cell number
|
J:90954
|
| abnormal T cell subpopulation ratio
|
J:90954
|
| decreased CD4-positive, alpha-beta T cell number
|
J:90954
|
| increased CD8-positive, alpha-beta T cell number
|
J:90954
|
\Itgavtm2Hyn/\Itgavtm2.1Hyn
\Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
|
decreased regulatory T cell number
|
J:125508
|
| increased regulatory T cell number
|
J:125508
|
\Itgb2M1Btlr/\Itgb2M1Btlr
(C57BL/6J-Itgb2M1Btlr)
|
abnormal NK cell differentiation
|
J:139559
|
\Itgb2m3Btlr/\Itgb2m3Btlr
(C57BL/6J-Itgb2m3Btlr)
|
decreased B cell number
|
J:265126
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265126
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265126
|
| decreased single-positive T cell number
|
J:265126
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265126
|
| increased NK T cell number
|
J:265126
|
\Itgb2M4Btlr/\Itgb2M4Btlr
(C57BL/6J-Itgb2M4Btlr)
|
abnormal T cell differentiation
|
J:272843
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272843
|
\Itgb2m5Btlr/\Itgb2m5Btlr
(C57BL/6J-Itgb2m5Btlr)
|
increased B-1b cell number
|
J:272844
|
\Itgb2tm1.1Arte/\Itgb2tm1.1Arte
(involves: C57BL/6NTac)
|
increased B cell number
|
J:202261
|
| increased T cell number
|
J:202261
|
\Itgb2tm1Bay/\Itgb2tm1Bay
(involves: 129S7/SvEvBrd)
|
increased lymphocyte cell number
|
J:13599
|
\Itgb2tm1Bay/\Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J)
|
increased lymphocyte cell number
|
J:32126
|
| increased T cell number
|
J:109598
|
| increased T-helper 1 cell number
|
J:109598
|
\Itgb2tm2Bay/\Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased lymphocyte cell number
|
J:48542
|
\Itgb2tm2Bay/\Itgb2tm2Bay
(B6.129S7-Itgb2tm2Bay)
|
increased lymphocyte cell number
|
J:83226
|
\Itgb7tm1Cgn/\Itgb7tm1Cgn
(involves: C57BL/6)
|
abnormal uterine NK cell morphology
|
J:44813
|
| decreased B cell number
|
J:34306
|
| decreased CD4-positive, alpha-beta T cell number
|
J:34306
|
| increased uterine NK cell number
|
J:44813
|
\Itkm2Btlr/\Itkm2Btlr
(C57BL/6J-Itkm2Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254826
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:254826
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254826
|
| increased B cell number
|
J:254826
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254826
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254826
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254826
|
\Itktm1Lex/\Itktm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:103485
|
| decreased CD8-positive, alpha-beta T cell number
|
J:103485
|
| increased B cell number
|
J:103485
|
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
decreased B cell number
|
J:31230
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31230
|
| decreased T cell number
|
J:31230
|
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111786
|
\Itktm1Litt/\Itktm1Litt
(B6.129S4-Itktm1Litt)
|
abnormal positive T cell selection
|
J:141390
|
| abnormal T cell morphology
|
J:141390
|
| decreased T cell number
|
J:141390
|
| increased double-negative T cell number
|
J:141390
|
\Itktm1Litt/\Itktm1Litt
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:31230
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31230
|
| increased double-positive T cell number
|
J:31230
|
\Itktm1Litt/\Itktm1Litt
\Tg(TcrAND)53Hed/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal lymphocyte morphology
|
J:31230
|
| decreased CD4-positive, alpha-beta T cell number
|
J:31230
|
| increased double-negative T cell number
|
J:31230
|
\Itktm1Litt/\Itktm1Litt
\Txktm1Pls/\Txktm1Pls
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:54449
|
| decreased single-positive T cell number
|
J:54449
|
\Itktm1Litt/\Itktm1Litt
\Vav1tm2Bbd/\Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141390
|
| abnormal positive T cell selection
|
J:141390
|
| abnormal T cell morphology
|
J:141390
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141390
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141390
|
| decreased double-positive T cell number
|
J:141390
|
| decreased T cell number
|
J:141390
|
| decreased thymocyte number
|
J:141390
|
| increased B cell number
|
J:141390
|
\Itktm1Ljb/\Itktm1Ljb
(B6.129-Itktm1Ljb)
|
abnormal NK T cell morphology
|
J:120689
|
| decreased NK T cell number
|
J:120689
|
\Itktm1Ljb/\Itktm1Ljb
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:48231
|
\Itktm1Ljb/\Itktm1Ljb
(B10.129-Itktm1Ljb)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:113408
|
| abnormal gamma-delta T cell morphology
|
J:148531
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
| increased CD8-positive, alpha-beta T cell number
|
J:113408,
J:123795
|
| increased germinal center B cell number
|
J:148531
|
| increased mature gamma-delta T cell number
|
J:148531
|
| increased memory T cell number
|
J:113408
|
\Itktm1Ljb/\Itktm1Ljb
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Tcra5CC7,Tcrb5CC7)IWep/?
(involves: 129 * C57BL/10)
|
abnormal CD4-positive T cell differentiation
|
J:93606
|
\Itktm1Ljb/\Itktm1Ljb
\Tg(Tcra2B4)1Mmd/?
\Tg(Tcrb2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
\Itktm1Ljb/\Itktm1Ljb
\Tg(Tcra5CC7,Tcrb5CC7)IWep/?
(involves: 129 * C57BL/10)
|
decreased CD4-positive, alpha-beta T cell number
|
J:123795
|
\Itktm1Ljb/\Itktm1Ljb
\Txktm1Pls/\Txktm1Pls
(B6.129-Txktm1Pls Itktm1Ljb)
|
increased CD8-positive, alpha-beta T cell number
|
J:113408
|
| increased memory T cell number
|
J:113408
|
\ItpkbT-less/\ItpkbT-less
(C57BL/6-ItpkbT-less)
|
arrested T cell differentiation
|
J:89286
|
\Itpkbtm1Ssch/\Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent CD4-positive, alpha-beta T cells
|
J:86257
|
| absent CD8-positive, alpha-beta T cells
|
J:86257
|
| absent T cells
|
J:86257
|
| arrested T cell differentiation
|
J:86257
|
| increased double-positive T cell number
|
J:86257
|
\Itpkbtm1Ssch/\Itpkbtm1Ssch
\Itpkctm1Ssch/\Itpkctm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
absent CD4-positive, alpha-beta T cells
|
J:86257
|
| absent CD8-positive, alpha-beta T cells
|
J:86257
|
| arrested T cell differentiation
|
J:86257
|
\Jag2tm1Grid/\Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal gamma-delta T cell differentiation
|
J:46930
|
| decreased gamma-delta T cell number
|
J:46930
|
\Jak1M1Mhda/\Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
abnormal plasma cell morphology
|
J:199153
|
| increased plasma cell number
|
J:199153
|
\Jak1tm1Rds/\Jak1tm1Rds
(involves: 129)
|
abnormal B cell differentiation
|
J:47300
|
| abnormal lymphopoiesis
|
J:47300
|
| abnormal T cell differentiation
|
J:47300
|
| arrested B cell differentiation
|
J:47300
|
| decreased B cell number
|
J:47300
|
| decreased thymocyte number
|
J:47300
|
| increased double-negative T cell number
|
J:47300
|
\Jak2tm1.1Jlvl/\Jak2tm1.1Jlvl
(involves: 129S2/SvPas * C57BL/6)
|
increased lymphocyte cell number
|
J:163497
|
\Jak2tm1.2Ble/\Jak2+
\Picalmtm1.1Tmae/\Picalmtm1.1Tmae
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:220728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:220728
|
\Jak2tm1Mohi/\Jak2+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:183821
|
\Jak2tm1Mohi/\Jak2tm1Mohi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:183821
|
\Jak2tm2.1Jlvl/\Jak2+
\Tg(Vav1-cre)#Cgp/0
(involves: 129S2/SvPas * C57BL/6NTac)
|
decreased B cell number
|
J:202234
|
\Jak3bfy/\Jak3bfy
(C57BL/6JSfdAnu-Jak3bfy/AnuApb)
|
abnormal lymphopoiesis
|
J:104190
|
| abnormal T cell subpopulation ratio
|
J:104190
|
| decreased B cell number
|
J:104190
|
| decreased lymphocyte cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
| decreased thymocyte number
|
J:104190
|
\Jak3m1Btlr/\Jak3m1Btlr
(C57BL/6J-Jak3m1Btlr)
|
abnormal T cell subpopulation ratio
|
J:217795
|
| decreased NK cell number
|
J:217795
|
| decreased single-positive T cell number
|
J:217795
|
| decreased T cell number
|
J:217795
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:217795
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:217795
|
| increased single-positive T cell number
|
J:217795
|
\Jak3M1Pgrs/\Jak3M1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
absent B cells
|
J:185217
|
| decreased B cell number
|
J:185217
|
| decreased NK cell number
|
J:185217
|
| increased CD4-positive, alpha-beta T cell number
|
J:185217
|
| increased CD8-positive, alpha-beta T cell number
|
J:185217
|
\Jak3m2Btlr/\Jak3m2Btlr
(C57BL/6J-Jak3m2Btlr)
|
increased B cell number
|
J:217796
|
| increased memory B cell number
|
J:217796
|
\Jak3m3Btlr/\Jak3m3Btlr
(C57BL/6J-Jak3m3Btlr)
|
abnormal T cell subpopulation ratio
|
J:225935
|
| decreased B cell number
|
J:225935
|
| decreased B-1 B cell number
|
J:225935
|
| decreased immature B cell number
|
J:225935
|
| decreased mature B cell number
|
J:225935
|
| decreased memory B cell number
|
J:225935
|
| decreased NK cell number
|
J:225935
|
| decreased single-positive T cell number
|
J:225935
|
| decreased T cell number
|
J:225935
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:225935
|
\Jak3m4Btlr/\Jak3m4Btlr
(C57BL/6J-Jak3m4Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:272398
|
\Jak3M5Btlr/\Jak3M5Btlr
(C57BL/6J-Jak3M5Btlr)
|
decreased NK T cell number
|
J:272399
|
\Jak3m6Btlr/\Jak3m6Btlr
(C57BL/6J-Jak3m6Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272400
|
| increased CD4-positive, alpha-beta T cell number
|
J:272400
|
\Jak3M7Btlr/\Jak3M7Btlr
(C57BL/6J-Jak3M7Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272401
|
\Jak3m8Btlr/\Jak3m8Btlr
(C57BL/6J-Jak3m8Btlr)
|
decreased B cell number
|
J:274939
|
| decreased B-1 B cell number
|
J:274939
|
| decreased B-2 B cell number
|
J:274939
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274939
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274939
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274939
|
| decreased T cell number
|
J:274939
|
| increased B-1b cell number
|
J:274939
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274939
|
\Jak3tm1Flv/\Jak3tm1Flv
(involves: 129S1/Sv)
|
arrested B cell differentiation
|
J:95794
|
| decreased CD8-positive, alpha-beta T cell number
|
J:95794
|
| increased CD4-positive, alpha-beta T cell number
|
J:95794
|
\Jak3tm1Jni/\Jak3tm1Jni
\Crlf2tm1Jni/\Crlf2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:89031
|
| decreased B cell number
|
J:89031
|
\Jak3tm1Ljb/\Jak3+
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:56629
|
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell morphology
|
J:29722
|
| arrested B cell differentiation
|
J:29722
|
| decreased immature B cell number
|
J:29722
|
| decreased mature B cell number
|
J:29722
|
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:64861
|
| absent B cells
|
J:128694
|
| decreased lymphocyte cell number
|
J:56629
|
| decreased thymocyte number
|
J:64861
|
\Jak3tm1Ljb/\Jak3tm1Ljb
(B6;129S4-Jak3tm1Ljb/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:123902
|
| decreased CD8-positive, alpha-beta T cell number
|
J:123902
|
\Jak3tm1Ljb/\Jak3tm1Ljb
\Tg(Lck-Jak3)1Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
absent B cells
|
J:128694
|
\Jak3tm1Ljb/\Jak3tm1Ljb
\Tg(Lck-Jak3)2Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
absent B cells
|
J:128694
|
\Jak3tm1Tks/\Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:31231
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:31231
|
| abnormal lymphopoiesis
|
J:31231
|
| abnormal T cell morphology
|
J:31231
|
| abnormal T cell number
|
J:31231
|
| absent NK cells
|
J:31231
|
| decreased B cell number
|
J:31231
|
| decreased pre-B cell number
|
J:31231
|
| decreased thymocyte number
|
J:31231
|
\Jak3wil/\Jak3wil
(C57BL/6JSfdAnu-Jak3wil/Anu)
|
arrested B cell differentiation
|
J:104190
|
| decreased CD8-positive, alpha-beta T cell number
|
J:104190
|
\Jak3X887Y/\Jak3X887Y
(Not Specified)
|
abnormal lymphocyte morphology
|
J:112658
|
\Jchaintm3Tl/\Jchain+
(involves: 129P2/OlaHsd)
|
decreased plasma cell number
|
J:49168
|
\Jchaintm3Tl/\Jchaintm3Tl
(involves: 129P2/OlaHsd)
|
decreased plasma cell number
|
J:49168,
J:56158
|
\Junbtm3Wag/\Junbtm3Wag
\Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
increased plasma cell number
|
J:155575
|
\Kat6atm1.1Glac/\Kat6atm1.1Glac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:148955
|
| decreased immature B cell number
|
J:148955
|
| decreased pre-B cell number
|
J:148955
|
| decreased pro-B cell number
|
J:148955
|
\Kat6atm1Avo/\Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N)
|
decreased double-negative T cell number
|
J:108453
|
\Kat6atm1Iki/\Kat6atm1Iki
(Not Specified)
|
decreased B cell number
|
J:108699
|
\Kcne1tm1b(EUCOMM)Hmgu/\Kcne1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcne1tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Kctd9em1Beij/\Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
abnormal immature NK cell morphology
|
J:281803
|
| abnormal NK cell differentiation
|
J:281803
|
| decreased mature NK cell number
|
J:281803
|
| increased immature NK cell number
|
J:281803
|
| increased NK cell number
|
J:281803
|
\Kdelr1em1Btlr/\Kdelr1em1Btlr
(involves: C57BL/6J * C57BL/6JJcl)
|
decreased lymphocyte cell number
|
J:224970
|
\Kdelr1em1Btlr/\Kdelr1em1Btlr
\Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr/0
(C57BL/6J-Kdelr1em1Btlr Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr)
|
abnormal lymphocyte morphology
|
J:224970
|
\Kdelr1m1Btlr/\Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr)
|
abnormal lymphocyte morphology
|
J:224970
|
| abnormal T cell differentiation
|
J:224970
|
| absent NK T cells
|
J:224970
|
| decreased B cell number
|
J:224970
|
| decreased CD4-positive, alpha-beta T cell number
|
J:224970,
J:158794
|
| decreased CD8-positive, alpha-beta T cell number
|
J:224970,
J:158794
|
| decreased follicular B cell number
|
J:224970
|
| decreased lymphocyte cell number
|
J:224970
|
| decreased transitional stage T1 B cell number
|
J:224970
|
| decreased transitional stage T2 B cell number
|
J:224970
|
| increased marginal zone B cell number
|
J:224970
|
\Kdm4ctm1a(KOMP)Wtsi/\Kdm4c+
(C57BL/6N-Kdm4ctm1a(KOMP)Wtsi/Wtsi)
|
increased B cell number
|
J:165965
|
\Kdm6atm1.1Afst/\Kdm6atm1.1Afst
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac)
|
increased B cell number
|
J:196401
|
\Kdm8tm1a(EUCOMM)Wtsi/\Kdm8+
(C57BL/6N-Kdm8tm1a(EUCOMM)Wtsi/Ics)
|
increased B cell number
|
J:165965
|
\Kif5ctm1dIcs/\Kif5c+
(C57BL/6N-Kif5ctm1dIcs/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Kif15em1Lium/\Kif15em1Lium
(C57BL/6-Kif15em1Lium)
|
increased CD8-positive, alpha-beta T cell number
|
J:336767
|
\Kiss1rtm1.1Lex/\Kiss1r+
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:181650
|
\Kiss1rtm1.1Lex/\Kiss1rtm1.1Lex
(involves: 129S4/SvJae)
|
decreased lymphocyte cell number
|
J:181650
|
\Kittm3.1Bsm/\Kittm3.1Bsm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:90485
|
| abnormal T cell differentiation
|
J:90485
|
| decreased B cell number
|
J:90485
|
\Kittm3Ber/\Kittm3Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested B cell differentiation
|
J:89602
|
| increased B cell number
|
J:89602
|
\KitW-sh/\KitW-sh
\Lyntm1Ard/\Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH)
|
decreased B cell number
|
J:161523
|
\KitW-vkd/\KitW-vkd
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)
|
abnormal B cell differentiation
|
J:79128
|
| abnormal T cell differentiation
|
J:79128
|
| decreased B cell number
|
J:79128
|
| decreased thymocyte number
|
J:79128
|
\KitW/\KitW
\Tg(PDGFB-EPO)321Zbz/?
(involves: C3H * C57BL/6)
|
abnormal B cell differentiation
|
J:79128
|
| abnormal T cell differentiation
|
J:79128
|
| decreased B cell number
|
J:79128
|
| decreased thymocyte number
|
J:79128
|
\Kitltm3.1Pbes/\Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased double-negative T cell number
|
J:157170
|
| decreased double-positive T cell number
|
J:157170
|
| decreased T cell number
|
J:157170
|
| decreased thymocyte number
|
J:157170
|
\Klkl/\Klkl
(involves: C3H/HeJ * C57BL/6J)
|
decreased B cell number
|
J:80503
|
\Klkl/\Klkl
\Tnfrsf11btm1Khs/\Tnfrsf11b+
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
decreased B cell number
|
J:80503
|
\Klf2tm1Mlkn/\Klf2tm1Mlkn
\Tg(VAV1-cre)1Graf/0
(Not Specified)
|
absent T cells
|
J:127228
|
\Klf2tm2Ling/\Klf2tm2Ling
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:151604
|
| decreased T cell number
|
J:151604
|
| increased single-positive T cell number
|
J:151604
|
\Klf13tm1Coll/\Klf13tm1Coll
(involves: 129S/SvEv)
|
decreased lymphocyte cell number
|
J:136545
|
\Klf13tm1Kren/\Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
abnormal T cell number
|
J:145839
|
| decreased thymocyte number
|
J:145839
|
| increased double-positive T cell number
|
J:145839
|
| increased thymocyte number
|
J:145839
|
\Klhdc2tm1b(EUCOMM)Hmgu/\Klhdc2+
(C57BL/6N-Klhdc2tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Klhdc7bem1(IMPC)H/\Klhdc7bem1(IMPC)H
(C57BL/6N-Klhdc7bem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Klhl6em1(IMPC)Ccpcz/\Klhl6em1(IMPC)Ccpcz
(C57BL/6NCrl-Klhl6em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Klhl6m1Anu/\Klhl6m1Anu
(C57BL/6JAnu-Klhl6m1Anu)
|
decreased B cell number
|
J:104190
|
| decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
\Klhl6m1Btlr/\Klhl6m1Btlr
(C57BL/6J-Klhl6m1Btlr)
|
decreased B cell number
|
J:265167
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:265167
|
| increased B-1b cell number
|
J:265167
|
| increased CD4-positive, alpha-beta T cell number
|
J:265167
|
| increased single-positive T cell number
|
J:265167
|
| increased T cell number
|
J:265167
|
\Klhl6m2Btlr/\Klhl6m2Btlr
(C57BL/6J-Klhl6m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265168
|
| increased CD4-positive, alpha-beta T cell number
|
J:265168
|
| increased single-positive T cell number
|
J:265168
|
| increased T cell number
|
J:265168
|
\Klhl6M3Btlr/\Klhl6M3Btlr
(C57BL/6J-Klhl6M3Btlr)
|
increased alpha-beta T cell number
|
J:267699
|
| increased B-1a cell number
|
J:267699
|
| increased CD4-positive, alpha-beta T cell number
|
J:267699
|
| increased CD8-positive, alpha-beta T cell number
|
J:267699
|
\Klhl6m4Btlr/\Klhl6m4Btlr
(C57BL/6J-Klhl6m4Btlr)
|
increased B-1 B cell number
|
J:272394
|
\Klhl6M5Btlr/\Klhl6M5Btlr
(C57BL/6J-Klhl6M5Btlr)
|
increased B-1 B cell number
|
J:272395
|
\Klhl6m6Btlr/\Klhl6m6Btlr
(C57BL/6J-Klhl6m6Btlr)
|
increased alpha-beta T cell number
|
J:272396
|
| increased CD4-positive, alpha-beta T cell number
|
J:272396
|
\Klhl6M7Btlr/\Klhl6M7Btlr
(C57BL/6J-Klhl6M7Btlr)
|
abnormal B cell differentiation
|
J:272397
|
\Klhl6M8Btlr/\Klhl6M8Btlr
(C57BL/6J-Klhl6M8Btlr)
|
decreased B cell number
|
J:274963
|
| increased CD4-positive, alpha-beta T cell number
|
J:274963
|
| increased T cell number
|
J:274963
|
\Klhl6tm1Sato/\Klhl6tm1Sato
(either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))
|
abnormal B cell differentiation
|
J:101363
|
| decreased B cell number
|
J:101363
|
| decreased follicular B cell number
|
J:101363
|
\Klhl14tm1.1Jyw/\Klhl14+
(involves: C57BL/6)
|
decreased B-1a cell number
|
J:263511
|
| increased B-1b cell number
|
J:263511
|
\Klhl29tm1b(EUCOMM)Hmgu/\Klhl29+
(C57BL/6N-Klhl29tm1b(EUCOMM)Hmgu/Ics)
|
increased large unstained cell number
|
J:211773
|
\Klk8em1(IMPC)Ccpcz/\Klk8em1(IMPC)Ccpcz
(C57BL/6N-Klk8em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Klk10em1(IMPC)Ccpcz/\Klk10em1(IMPC)Ccpcz
(C57BL/6NCrl-Klk10em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Klrb1tm1b(EUCOMM)Wtsi/\Klrb1tm1b(EUCOMM)Wtsi
(C57BL/6N-Klrb1tm1b(EUCOMM)Wtsi/Ieg)
|
increased follicular B cell number
|
J:211773
|
\Klrc1tm1Mmka/\Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka)
|
decreased CD8-positive, alpha-beta T cell number
|
J:222503
|
\Klrk1tm1.1Bpol/\Klrk1tm1.1Bpol
(C57BL/6-Klrk1tm1.1Bpol)
|
abnormal NK cell differentiation
|
J:151878
|
| decreased B cell number
|
J:151878
|
| decreased T cell number
|
J:151878
|
\Klrk1tm2.1Bpol/\Klrk1tm2.1Bpol
(Not Specified)
|
abnormal NK cell differentiation
|
J:215590
|
\Kmt2atm1(AFF1)Ksy/\Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB)
|
abnormal lymphocyte morphology
|
J:110241
|
| increased pro-B cell number
|
J:110241
|
\Kmt2atm1Brad/\Kmt2atm1Brad
\Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased pre-B cell number
|
J:149811
|
\Kmt2atm1Sjk/\Kmt2a+
(involves: 129S2/SvPas * C3H * C57BL/6)
|
decreased B cell number
|
J:29958
|
\Kmt2atm2(MLLT3)Thr/\Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased pro-B cell number
|
J:110241
|
\Kmt2dtm1.1Kaig/\Kmt2d+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased germinal center B cell number
|
J:228913
|
\Kmt2dtm1.1Kaig/\Kmt2dtm1.1Kaig
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:228913
|
| decreased B cell number
|
J:228913
|
| decreased follicular B cell number
|
J:228913
|
| decreased mature B cell number
|
J:228913
|
| increased germinal center B cell number
|
J:228913
|
\Kmt2etm1.1Hjf/\Kmt2e+
(B6.129P2-Kmtetm1.1Hjf)
|
decreased thymocyte number
|
J:145579
|
\Kmt2etm1.1Hjf/\Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf)
|
abnormal lymphopoiesis
|
J:145579
|
| decreased B cell number
|
J:145579
|
| decreased double-negative T cell number
|
J:145579
|
| decreased double-positive T cell number
|
J:145579
|
| decreased pre-B cell number
|
J:145579
|
| decreased pro-B cell number
|
J:145579
|
| decreased T cell number
|
J:145579
|
| decreased thymocyte number
|
J:145579
|
\Kmt2etm1Nik/\Kmt2etm1Nik
(B6.Cg-Kmtetm1Nik)
|
decreased NK cell number
|
J:145449
|
| decreased NK T cell number
|
J:145449
|
\Kmt5btm1Jnw/\Kmt5btm1Jnw
\Kmt5ctm1.1Jnw/\Kmt5ctm1.1Jnw
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal class switch recombination
|
J:139510
|
| abnormal lymphopoiesis
|
J:139510
|
| decreased B cell number
|
J:139510
|
| decreased double-positive T cell number
|
J:139510
|
\Krastm4.1Bbd/\Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:223433
|
\Krastm4Tyj/\Kras+
(involves: 129S4/SvJae)
|
increased regulatory T cell number
|
J:154046
|
\Krastm4Tyj/\Kras+
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:247853
|
| decreased double-negative T cell number
|
J:247853
|
| decreased double-positive T cell number
|
J:247853
|
| decreased T cell number
|
J:247853
|
\Krastm4Tyj/\Kras+
\Pggt1btm1Mbrg/\Pggt1b+
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased lymphocyte cell number
|
J:122107
|
\Krastm4Tyj/\Kras+
\Tg(MUC1)79.24Gend/0
(involves: 129S4/SvJae * C57BL/6)
|
increased regulatory T cell number
|
J:154046
|
\Krastm4Tyj/\Kras+
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
(B6.129-Krastm4Tyj Tgfbr2tm1.2Hlm)
|
increased B cell number
|
J:177379
|
| increased T cell number
|
J:177379
|
\Krt1em1(IMPC)Ccpcz/\Krt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt1em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Krtap8-1em1(IMPC)Ccpcz/\Krtap8-1em1(IMPC)Ccpcz
(C57BL/6N-Krtap8-1em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
\Ksr1tm1Shaw/\Ksr1tm1Shaw
\Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75739
|
\Lag3tm1Daav/\Lag3tm1Daav
\Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)
|
abnormal effector T cell number
|
J:260063
|
\Lag3tm1Doi/\Lag3tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:89653
|
| increased CD8-positive, alpha-beta T cell number
|
J:89653
|
| increased single-positive T cell number
|
J:89653
|
\Lair1tm1.1Jco/\Lair1tm1.1Jco
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:180203
|
| decreased CD8-positive, alpha-beta T cell number
|
J:180203
|
| decreased thymocyte number
|
J:180203
|
| increased activated T cell number
|
J:180203
|
| increased B cell number
|
J:180203
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:180203
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:180203
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:180203
|
| increased marginal zone B cell number
|
J:180203
|
\Lama2tm1Stk/\Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c)
|
decreased double-positive T cell number
|
J:61802
|
| decreased T cell number
|
J:61802
|
\Lama5tm1Lsor/\Lama5tm1Lsor
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased marginal zone B cell number
|
J:198783
|
| decreased transitional stage T2 B cell number
|
J:198783
|
| increased B cell number
|
J:198783
|
| increased transitional stage T1 B cell number
|
J:198783
|
\Lamp1em1(IMPC)Mbp/\Lamp1em1(IMPC)Mbp
(C57BL/6N-Lamp1em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Lancl2tm2a(KOMP)Wtsi/\Lancl2tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased regulatory T cell number
|
J:250673
|
\Lancl2tm2c(KOMP)Wtsi/\Lancl2tm2c(KOMP)Wtsi
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: C57BL/6N)
|
decreased regulatory T cell number
|
J:250673
|
\Lat2tm2Wz/\Lat2tm2Wz
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6)
|
increased activated T cell number
|
J:116157
|
\Lat2tm3.1Wz/\Lat2tm3.1Wz
(B6.Cg-Lat2tm3.1Wz)
|
increased memory T cell number
|
J:181866
|
\Lattm1.1Lov/\Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116157,
J:77099
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:77099
|
| abnormal double-negative T cell morphology
|
J:77099
|
| abnormal T cell differentiation
|
J:77099
|
| decreased double-positive T cell number
|
J:77099
|
| decreased thymocyte number
|
J:77099
|
| increased activated T cell number
|
J:77099
|
\Lattm1.1Lov/\Lattm1.1Lov
\Lat2tm1Wz/\Lat2tm1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116157
|
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:77098
|
| abnormal lymphocyte morphology
|
J:77098
|
| abnormal T cell selection
|
J:77098
|
| abnormal T cell subpopulation ratio
|
J:77098
|
| decreased double-positive T cell number
|
J:77098
|
| increased B cell number
|
J:77098
|
| increased CD4-positive, alpha-beta T cell number
|
J:125722,
J:77098
|
| increased memory T cell number
|
J:77098
|
| increased plasma cell number
|
J:125722
|
| increased T-helper 2 cell number
|
J:77098
|
\Lattm1Bpay/\Lattm1Bpay
(involves: 129S2/SvPas)
|
abnormal T cell differentiation
|
J:103904
|
| arrested T cell differentiation
|
J:103904
|
| decreased double-negative T cell number
|
J:103904
|
| decreased T cell number
|
J:103904
|
| decreased thymocyte number
|
J:103904
|
\Lattm1Les/\Lattm1.1Wz
(involves: C57BL/6)
|
abnormal effector T cell morphology
|
J:147946
|
\Lattm1Les/\Lattm1.1Wz
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal effector T cell morphology
|
J:147946
|
| abnormal T cell differentiation
|
J:147946
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147946
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147946
|
| decreased regulatory T cell number
|
J:147946
|
| decreased thymocyte number
|
J:147946
|
| increased double-positive T cell number
|
J:147946
|
| increased gamma-delta T cell number
|
J:147946
|
\Lattm1Les/\Lattm1.2Wz
(involves: C57BL/6 * FVB/N)
|
absent T cells
|
J:147946
|
| arrested T cell differentiation
|
J:147946
|
\Lattm1Les/\Lattm1Les
(Not Specified)
|
abnormal T cell morphology
|
J:54059
|
| arrested T cell differentiation
|
J:116964,
J:54059
|
| decreased double-negative T cell number
|
J:54059
|
| decreased T cell number
|
J:54059
|
| decreased thymocyte number
|
J:54059
|
\Lattm1Les/\Lattm1Les
\Lcp2tm5(Lat/Lcp2)Gak/\Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
| decreased double-positive T cell number
|
J:147721
|
\Lattm1Les/\Lattm1Les
\Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
abnormal single-positive T cell number
|
J:116964
|
| abnormal T cell differentiation
|
J:116964
|
| decreased double-positive T cell number
|
J:116964
|
\Lattm2.1Lov/\Lattm2.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:77695
|
| decreased T cell number
|
J:77695
|
\Lattm2.1Mal/\Lattm2.1Mal
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:94074
|
| abnormal gamma-delta T cell differentiation
|
J:94074
|
| abnormal lymphocyte morphology
|
J:94074
|
| abnormal lymphopoiesis
|
J:94074
|
| abnormal mature gamma-delta T cell morphology
|
J:94074
|
| abnormal plasma cell morphology
|
J:94074
|
| abnormal T-helper 2 cell morphology
|
J:94074
|
| absent CD4-positive, alpha-beta T cells
|
J:94074
|
| absent CD8-positive, alpha-beta T cells
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
| increased B cell number
|
J:94074
|
| increased mature gamma-delta T cell number
|
J:94074
|
\Lattm3.1Mal/\Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
| absent CD4-positive, alpha-beta T cells
|
J:94074
|
| absent CD8-positive, alpha-beta T cells
|
J:94074
|
| absent mature gamma-delta T cells
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
| decreased T cell number
|
J:94074
|
| increased T cell number
|
J:94074
|
\Lattm4.1Mal/\Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
| abnormal lymphocyte morphology
|
J:94074
|
| absent CD4-positive, alpha-beta T cells
|
J:94074
|
| absent CD8-positive, alpha-beta T cells
|
J:94074
|
| absent mature gamma-delta T cells
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
| decreased T cell number
|
J:94074
|
\Lattm4.1Mal/\Lattm4.1Mal
\Tg(Lck*F505)3073Rmp/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased CD4-positive, alpha-beta T cell number
|
J:151840
|
\Lattm4.1Mal/\Lattm4.1Mal
\Trdctm1Mal/\Trdctm1Mal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
\Lattm5.1Mal/\Lattm5.1Mal
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:152363
|
\Lattm8.1(CD2,-ECFP)Mal/\Lattm8.1(CD2,-ECFP)Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal lymphocyte morphology
|
J:152149
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:152149
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:152149
|
| arrested T cell differentiation
|
J:152149
|
| increased double-negative T cell number
|
J:152149
|
\Lattm9Mal/\Lattm9Mal
(involves: C57BL/6)
|
abnormal B cell number
|
J:205441
|
| abnormal lymphopoiesis
|
J:205441
|
| increased T-helper 2 cell number
|
J:205441
|
\Lbrem1(IMPC)Tcp/\Lbrem1(IMPC)Tcp
(C57BL/6N-Lbrem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\LbrGt(XE569)Byg/\LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
abnormal lymphocyte morphology
|
J:138854
|
\Lbric-J/\Lbric-J
(C57BL/6J-Lbric-J)
|
abnormal lymphocyte morphology
|
J:80915
|
\Lbric-J/\Lbrlym3
(C57BL/6-Lbric-J/Lbrlym3)
|
decreased lymphocyte cell number
|
J:180355
|
\Lbrlym3/\Lbrlym3
(C57BL/6-Lbrlym3)
|
abnormal lymphocyte cell number
|
J:180355
|
| abnormal lymphocyte morphology
|
J:180355
|
| decreased B cell number
|
J:180355
|
| decreased CD4-positive, alpha-beta T cell number
|
J:180355
|
| decreased CD8-positive, alpha-beta T cell number
|
J:180355
|
| decreased lymphocyte cell number
|
J:180355
|
| decreased T cell number
|
J:180355
|
\Lckm1Btlr/\Lckm1Btlr
(C57BL/6J-Lckm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:144695
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:144695
|
| decreased CD4-positive, alpha-beta T cell number
|
J:144695
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144695
|
\Lckm2Btlr/\Lckm2Btlr
(C57BL/6J-Lckm2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203759
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203759
|
\Lckm3Btlr/\Lckm3Btlr
(C57BL/6J-Lckm3Btlr)
|
abnormal T cell subpopulation ratio
|
J:217863
|
| decreased single-positive T cell number
|
J:217863
|
| increased activated T cell number
|
J:217863
|
| increased single-positive T cell number
|
J:217863
|
\Lcktm1.1Litt/\Lcktm1.1Litt
(Not Specified)
|
abnormal lymphocyte morphology
|
J:152472
|
\Lcktm1Dbs/\Lcktm1Dbs
(involves: C3H * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:114660
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:114660
|
| abnormal double-negative T cell morphology
|
J:114660
|
| abnormal T cell differentiation
|
J:114660
|
| decreased T cell number
|
J:114660
|
| decreased thymocyte number
|
J:114660
|
\Lcktm1Dbs/\Lcktm1Dbs
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C3H * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:114660
|
| abnormal T cell differentiation
|
J:114660
|
| arrested T cell differentiation
|
J:114660
|
\Lcktm1Dbs/\Lcktm1Dbs
\Tg(TcraTcrb)425Cbn/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
| arrested T cell differentiation
|
J:114660
|
\Lcktm1Dbs/\Lcktm1Dbs
\Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
\Lcktm1Litt/\Lcktm1.1Litt
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ)
|
decreased regulatory T cell number
|
J:152472
|
| increased regulatory T cell number
|
J:152472
|
| increased T cell number
|
J:152472
|
\Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:112977
|
| abnormal double-negative T cell morphology
|
J:110847
|
| abnormal lymphocyte morphology
|
J:1119
|
| abnormal single-positive T cell number
|
J:37062
|
| abnormal T cell morphology
|
J:110847
|
| decreased CD4-positive, alpha-beta T cell number
|
J:37940
|
| decreased CD8-positive, alpha-beta T cell number
|
J:37940
|
| decreased double-positive T cell number
|
J:1119,
J:110847
|
| decreased gamma-delta intraepithelial T cell number
|
J:112977,
J:37940
|
| decreased gamma-delta T cell number
|
J:37062
|
| decreased T cell number
|
J:1119,
J:37062
|
| decreased thymocyte number
|
J:1119
|
\Lcktm1Mak/\Lcktm1Mak
(B6.129S2-Lcktm1Mak)
|
abnormal intraepithelial T cell morphology
|
J:111646
|
| abnormal intraepithelial T cell number
|
J:111646
|
| abnormal T cell differentiation
|
J:111646
|
| decreased gamma-delta intraepithelial T cell number
|
J:111646
|
\Lcktm1Mak/\Lcktm1Mak
\Rag1tm1Mom/\Rag1+
\Tg(Lck-Fyn*Y528F)5525Cjg/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:37062
|
| decreased T cell number
|
J:37062
|
\Lcmt1em1(IMPC)Rbrc/\Lcmt1+
(C57BL/6NJcl-Lcmt1em1(IMPC)Rbrc/Rbrc)
|
increased large unstained cell number
|
J:211773
|
\Lcn2tm1Mrgr/\Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
increased B cell number
|
J:173490
|
| increased lymphocyte cell number
|
J:173490
|
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
abnormal effector T cell morphology
|
J:150304
|
| abnormal T cell differentiation
|
J:150304
|
| abnormal T cell subpopulation ratio
|
J:150304
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150304
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150304
|
| decreased double-negative T cell number
|
J:150304
|
| decreased T cell number
|
J:150304
|
| decreased thymocyte number
|
J:150304
|
| increased double-negative T cell number
|
J:150304
|
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:150304
|
\Lcp2tm1Geha/\Lcp2tm1Geha
(involves: 129S4/SvJae)
|
increased NK cell number
|
J:131621
|
\Lcp2tm2Gak/\Lcp2tm2Gak
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:107467
|
| increased CD8-positive, alpha-beta T cell number
|
J:107467
|
| increased gamma-delta T cell number
|
J:107467
|
\Lcp2tm3Gak/\Lcp2tm3Gak
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:132995
|
| abnormal negative T cell selection
|
J:132995
|
| abnormal T cell subpopulation ratio
|
J:132995
|
| decreased NK T cell number
|
J:132995
|
\Lcp2tm3Gak/\Lcp2tm3Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
\Lcp2tm3Gak/\Lcp2tm3Gak
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2J)
|
abnormal negative T cell selection
|
J:132995
|
| increased CD8-positive, alpha-beta T cell number
|
J:132995
|
| increased double-positive T cell number
|
J:132995
|
\Lcp2tm3Gak/\Lcp2tm3Gak
\Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal double-negative T cell morphology
|
J:132995
|
| abnormal negative T cell selection
|
J:132995
|
| abnormal T cell subpopulation ratio
|
J:132995
|
| decreased NK T cell number
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
abnormal negative T cell selection
|
J:132995
|
| increased double-positive T cell number
|
J:132995
|
\Lcp2tm4Gak/\Lcp2tm4Gak
\Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
\Lcp2tm5(Lat/Lcp2)Gak/\Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
| decreased double-positive T cell number
|
J:147721
|
| decreased single-positive T cell number
|
J:147721
|
\Lcp2twm/\Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
|
abnormal double-positive T cell morphology
|
J:104190
|
| abnormal negative T cell selection
|
J:104190
|
| abnormal positive T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased T cell number
|
J:104190
|
| decreased thymocyte number
|
J:104190
|
\Lctlp1DBA/1J/\Lctlp1DBA/1J
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
\Lctlp1DBA/1J/\Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
\Lctlp2DBA/1J/\Lctlp2DBA/1J
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
\Lctlp2DBA/1J/\Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
increased CD8-positive, alpha-beta T cell number
|
J:122919
|
\Ldb3tm2b(EUCOMM)Hmgu/\Ldb3+
(C57BL/6N-Ldb3tm2b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
\Lect2tm1Ymg/\Lect2tm1Ymg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T cell number
|
J:90961
|
\Lef1tm1Hhx/\Lef1tm1Hhx
\Tcf7tm1Cle/\Tcf7tm1Cle
\Gt(ROSA)26Sortm2Sho/\Gt(ROSA)26Sor+
\Tg(GZMB-cre)1Jcb/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:189838
|
\Lepob/\Lepob
(B6.Cg-Lepob/J)
|
decreased NK cell number
|
J:117826
|
\Lepob/\Lepob
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:164339
|
\Leprdb-5J/\Leprdb-5J
(NOD/ShiLt-Leprdb-5J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:118304
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:118304
|
\Leprm8Btlr/\Leprm8Btlr
(C57BL/6J-Leprm8Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:267679
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267679
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267679
|
\Leprtm1b(EUCOMM)Wtsi/\Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Leprtm4Mgmj/\Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj)
|
decreased CD4-positive, alpha-beta T cell number
|
J:164339
|
\Lgals2tm1.1Cfg/\Lgals2tm1.1Cfg
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:217719
|
| increased CD8-positive, alpha-beta T cell number
|
J:217719
|
| increased lymphocyte cell number
|
J:217719
|
| increased T cell number
|
J:217719
|
\Lgals3tm1Ftl/\Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:109126
|
\Lgals3tm1Ftl/\Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6)
|
decreased lymphocyte cell number
|
J:60741
|
\Lgals9tm1.1Cfg/\Lgals9tm1.1Cfg
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:217719
|
\Lgals9tm1Glp/\Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp)
|
decreased regulatory T cell number
|
J:132889
|
| increased T-helper 1 cell number
|
J:132889
|
\Lgmntm1Ihn/\Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:143886
|
\Lgr5em1(IMPC)Kmpc/\Lgr5+
(C57BL/6NTac-Lgr5em1(IMPC)Kmpc/Kmpc)
|
increased CD8-positive, CD25-positive alpha-beta T cell number
|
J:211773
|
\Lgr6em1(IMPC)Ccpcz/\Lgr6em1(IMPC)Ccpcz
(C57BL/6NCrl-Lgr6em1(IMPC)Ccpcz/Ccpcz)
|
increased lymphocyte cell number
|
J:211773
|
\Lhcgrtm1(KOMP)Vlcg/\Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju)
|
increased lymphocyte cell number
|
J:211773
|
\Liftm1Cgre/\Liftm1Cgre
(involves: MF1)
|
increased uterine NK cell number
|
J:96965
|
\Lig4m1Btlr/\Lig4m1Btlr
(C57BL/6J-Lig4m1Btlr)
|
decreased B cell number
|
J:267684
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267684
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:267684
|
| increased CD8-positive, alpha-beta T cell number
|
J:267684
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:267684
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267684
|
| increased NK cell number
|
J:267684
|
\Lig4m2Btlr/\Lig4m2Btlr
(C57BL/6J-Lig4m2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:267692
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267692
|
\Lig4tiny/\Lig4tiny
(C57BL/6-Lig4tiny)
|
absent CD8-positive, alpha-beta T cells
|
J:104190
|
| decreased B cell number
|
J:122725
|
| decreased lymphocyte cell number
|
J:122725
|
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:50865
|
| abnormal lymphopoiesis
|
J:50865
|
| abnormal T cell differentiation
|
J:63078
|
| arrested B cell differentiation
|
J:63078
|
| arrested T cell differentiation
|
J:50865
|
| decreased thymocyte number
|
J:63078
|
\Lig4tm1Fwa/\Lig4tm1Fwa
\Tg(Cr2-cre)3Cgn/0
\Xrcc4tm2Fwa/\Xrcc4tm2Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
\Lig4tm1Fwa/\Lig4tm1Fwa
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased thymocyte number
|
J:63078
|
| increased B cell number
|
J:63078
|
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:157574
|
| abnormal lymphocyte cell number
|
J:157574
|
| abnormal regulatory T cell morphology
|
J:157574
|
| abnormal T cell differentiation
|
J:157574
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:157574
|
| abnormal T cell receptor V(D)J recombination
|
J:157574
|
| decreased B cell number
|
J:157574
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157574
|
| decreased CD8-positive, alpha-beta T cell number
|
J:157574
|
| decreased double-negative T cell number
|
J:157574
|
| decreased double-positive T cell number
|
J:157574
|
| decreased thymocyte number
|
J:157574
|
\Lig4tm3.1Fwa/\Lig4tm3.1Fwa
\Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
abnormal class switch recombination
|
J:157537
|
\Lilrb4atm1Eol/\Lilrb4atm1Eol
(B6.129P2-Lilrb4atm1Eol)
|
increased plasma cell number
|
J:129969
|
\Lime1tm1.1Mal/\Lime1tm1.1Mal
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)1Pas/?
(B6.Cg-Rag2tm1Fwa Lime1tm1.1Mal Tg(TcraH-Y,TcrbH-Y)1Pas)
|
abnormal CD4-positive T cell differentiation
|
J:126321
|
| increased CD4-positive, alpha-beta T cell number
|
J:126321
|
\ll/\ll
X/\Yaa
(BXSB/MpJScr-ll)
|
decreased CD4-positive, alpha-beta T cell number
|
J:10973
|
\Lmb1C57BL/6Scr/\Lmb1C57BL/6Scr
(MRL.Cg-Lmb1C57BL/6Scr Faslpr)
|
increased CD8-positive, alpha-beta T cell number
|
J:125557
|
| increased double-negative T cell number
|
J:125557
|
\Lmb2MRL/MpScr/\Lmb2MRL/MpScr
(B6.MRL-Lmb2MRL/MpScr Faslpr)
|
decreased double-negative T cell number
|
J:125557
|
\Lmbr1lem1Btlr/\Lmbr1lem1Btlr
(C57BL/6J-Lmbr1lem1Btlr)
|
abnormal alpha-beta T cell morphology
|
J:274568
|
| abnormal B cell differentiation
|
J:274568
|
| abnormal lymphocyte morphology
|
J:274568
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274568
|
| decreased lymphocyte cell number
|
J:274568
|
| decreased T cell number
|
J:274568
|
\Lmbr1lm1Btlr/\Lmbr1lm1Btlr
(C57BL/6J-Lmbr1lm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274568
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274568
|
| abnormal T cell differentiation
|
J:274568
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274568
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274568
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274568
|
| decreased NK cell number
|
J:274568
|
| decreased NK T cell number
|
J:274568
|
| decreased T cell number
|
J:274568
|
| increased B-1 B cell number
|
J:274568
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274568
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274568
|
\Lmbr1lm2Btlr/\Lmbr1lm2Btlr
(C57BL/6J-Lmbr1lm2Btlr)
|
increased central memory CD4-positive, alpha-beta T cell number
|
J:274857
|
\Lmo4tm1Slp/\Lmo4tm1Slp
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
\Lmo4tm1Slp/\Lmo4tm1Slp
\Yeats4em1Zfa/\Yeats4em1Zfa
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
\Lmod3em1(IMPC)Mbp/\Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Lnx1tm1Lex/\Lnx1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased B-1b cell number
|
J:171883
|
\Loxtm1.1Khki/\Loxtm1.1Khki
(involves: C57BL/6)
|
increased lymphocyte cell number
|
J:264295
|
\Lpin3tm1b(KOMP)Wtsi/\Lpin3tm1b(KOMP)Wtsi
(C57BL/6N-Lpin3tm1b(KOMP)Wtsi/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Lpxntm1b(EUCOMM)Hmgu/\Lpxntm1b(EUCOMM)Hmgu
(C57BL/6N-Lpxntm1b(EUCOMM)Hmgu/Wtsi)
|
abnormal plasma cell differentiation
|
J:305662
|
\Lratd2em1(IMPC)Ccpcz/\Lratd2em1(IMPC)Ccpcz
(C57BL/6N-Lratd2em1(IMPC)Ccpcz/Ccpcz)
|
increased B-2 B cell number
|
J:211773
|
\LrbaGt(OST69142)Lex/\LrbaGt(OST69142)Lex
(involves: 129 * 129S5/SvEvBrd)
|
increased regulatory T cell number
|
J:237187
|
\Lrfn2Tg(CD2-Myb/en)5Kmw/\Lrfn2+
(involves: C57BL/10 * CBA)
|
decreased T cell number
|
J:126456
|
\Lrfn2Tg(CD2-Myb/en)5Kmw/\Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126456
|
| decreased double-negative T cell number
|
J:126456
|
| decreased T cell number
|
J:126456
|
\Lrfn2tm1.1Jaru/\Lrfn2tm1.1Jaru
(B6.129P2(Cg)-Lrfn2tm1.1Jaru)
|
decreased lymphocyte cell number
|
J:301285
|
\Lrp12em1Gpt/\Lrp12em1Gpt
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JGpt * DBA/2)
|
increased T cell number
|
J:338432
|
\Lrrc3tm1b(EUCOMM)Hmgu/\Lrrc3tm1b(EUCOMM)Hmgu
(C57BL/6N-Lrrc3tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Lrrc8atm1.1Geha/\Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal B cell differentiation
|
J:211308
|
| abnormal T cell differentiation
|
J:211308
|
| abnormal T cell selection
|
J:211308
|
| decreased B cell number
|
J:211308
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211308
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211308
|
| decreased DN2 thymocyte number
|
J:211308
|
| decreased DN3 thymocyte number
|
J:211308
|
| decreased DN4 thymocyte number
|
J:211308
|
| decreased double-negative T cell number
|
J:211308
|
| decreased double-positive T cell number
|
J:211308
|
| decreased immature B cell number
|
J:211308
|
| decreased marginal zone B cell number
|
J:211308
|
| decreased pre-B cell number
|
J:211308
|
| decreased T cell number
|
J:211308
|
| decreased thymocyte number
|
J:211308
|
| decreased transitional stage B cell number
|
J:211308
|
| increased pro-B cell number
|
J:211308
|
| increased regulatory T cell number
|
J:211308
|
\Lrrk1tm1b(KOMP)Wtsi/\Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Lsp1tm1Jejb/\Lsp1tm1Jejb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:64219
|
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(involves: 129)
|
decreased T cell number
|
J:31129
|
| increased B cell number
|
J:31129
|
\Lta/Tnftm1Eug/\Lta/Tnftm1Eug
(involves: 129)
|
decreased T cell number
|
J:31129
|
| increased B cell number
|
J:31129
|
\Lta/Tnftm1Jods/\Lta/Tnftm1Jods
(involves: C57BL/6)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Lta/Tnftm1Jods/\Lta/Tnftm1Jods
(involves: C57BL/6)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Ltahlb382/\Ltahlb382
(C57BL/6J-Ltahlb382/J)
|
absent marginal zone B cells
|
J:134498
|
| decreased NK cell number
|
J:134498
|
| decreased transitional stage B cell number
|
J:134498
|
| increased B-1b cell number
|
J:134498
|
\Ltatm1.1(KOMP)Vlcg/\Ltatm1.1(KOMP)Vlcg
(C57BL/6N-Ltatm1.1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Ltatm1.1Sned/\Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
abnormal class switch recombination
|
J:109621
|
| abnormal lymphopoiesis
|
J:109621
|
\Ltatm1Dch/\Ltatm1Dch
(B6.129S2-Ltatm1Dch)
|
abnormal class switch recombination
|
J:80616
|
\Ltatm1Dch/\Ltatm1Dch
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:109621
|
| decreased T cell number
|
J:17976
|
| increased B cell number
|
J:17976
|
\Ltatm1Dch/\Ltatm1Dch
(involves: 129S2/SvPas)
|
abnormal lymphocyte morphology
|
J:173115
|
\Ltatm1Dch/\Ltatm1Dch
\Tnfsf14tm1Lpc/\Tnfsf14tm1Lpc
(involves: 129S2/SvPas * 129X1/SvJ)
|
abnormal lymphocyte morphology
|
J:173115
|
\Ltatm1Jods/\Ltatm1Jods
(C57BL/6-Ltatm1Jods)
|
increased lymphocyte cell number
|
J:47428
|
\Ltb/Tnf/Ltatm1Dvk/\Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
\Ltb/Tnf/Ltatm1Dvk/\Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
\Ltb/Tnf/Ltatm1Dvk/\Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
\Ltb/Tnftm1.1Dvk/\Ltb/Tnftm1.1Dvk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
absent germinal center B cells
|
J:58981
|
\Ltb/Tnftm1.1Dvk/\Ltb/Tnftm1.1Dvk
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
absent germinal center B cells
|
J:58981
|
\Ltbtm1Kpf/\Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
abnormal class switch recombination
|
J:80616
|
\Ltbtm1Kpf/\Ltbtm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:42508
|
\Ltbrm3Btlr/\Ltbrm3Btlr
(C57BL/6J-Ltbrm3Btlr)
|
increased NK T cell number
|
J:264642
|
\Ltbrm4Btlr/\Ltbrm4Btlr
(C57BL/6J-Ltbrm4Btlr)
|
decreased alpha-beta T cell number
|
J:264820
|
| decreased CD4-positive, alpha-beta T cell number
|
J:264820
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264820
|
| decreased NK cell number
|
J:264820
|
| decreased single-positive T cell number
|
J:264820
|
| increased B cell number
|
J:264820
|
| increased B-1 B cell number
|
J:264820
|
\Ltbrtm1Kpf/\Ltbrtm1Kpf
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
| absent marginal zone B cells
|
J:48837
|
| increased B cell number
|
J:48837
|
| increased lymphocyte cell number
|
J:48837
|
| increased T cell number
|
J:48837
|
\Ltbrtm1Mmat/\Ltbrtm1Mmat
(involves: C57BL/6 * CBA)
|
abnormal lymphocyte morphology
|
J:173115
|
\Ltn1tm1b(EUCOMM)Hmgu/\Ltn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ltn1tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Ly6atm1Pmf/\Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf)
|
increased lymphocyte cell number
|
J:81387
|
\Ly6etm1c(EUCOMM)Hmgu/\Ly6etm1c(EUCOMM)Hmgu
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio)
|
decreased B cell number
|
J:291868
|
| decreased CD4-positive, alpha-beta T cell number
|
J:291868
|
| decreased NK cell number
|
J:291868
|
\Ly9tm1Mckn/\Ly9tm1Mckn
(involves: 129/Sv * C57BL/6)
|
abnormal T-helper 2 cell morphology
|
J:105482
|
\Ly75tm1Mnz/\Ly75tm1Mnz
(Not Specified)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:97290
|
\Ly86tm1a(KOMP)Wtsi/\Ly86+
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Ly86tm1a(KOMP)Wtsi/\Ly86tm1a(KOMP)Wtsi
(C57BL/6N-Ly86tm1a(KOMP)Wtsi/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Lyg1tm1(KOMP)Vlcg/\Lyg1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:256594
|
| decreased CD8-positive, alpha-beta T cell number
|
J:256594
|
\Lyl1tm1Fsky/\Lyl1tm1Fsky
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:116300
|
| arrested B cell differentiation
|
J:116300
|
| decreased B cell number
|
J:116300
|
| decreased pro-B cell number
|
J:116300
|
\Lynm1Anu/\Lynm1Anu
(C57BL/6JAnu-Lynm1Anu)
|
decreased B cell number
|
J:195155
|
\LynM1Btlr/\Lyn+
(C57BL/6J-LynM1Btlr)
|
decreased B cell number
|
J:214511
|
\LynM1Btlr/\LynM1Btlr
(C57BL/6J-LynM1Btlr)
|
decreased B cell number
|
J:214511
|
\Lynm2Anu/\Lynm2Anu
(C57B/6JAnu-Lynm2Anu/AnuApb)
|
decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
\LynM3Btlr/\Lyn+
(C57BL/6J-LynM3Btlr)
|
decreased T cell number
|
J:236679
|
| increased B-1 B cell number
|
J:236679
|
\LynM3Btlr/\LynM3Btlr
(C57BL/6J-LynM3Btlr)
|
decreased T cell number
|
J:236679
|
| increased B-1 B cell number
|
J:236679
|
\Lynmld4/\Lynmld4
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:144799
|
| decreased follicular B cell number
|
J:144799
|
| decreased marginal zone B cell number
|
J:144799
|
| decreased transitional stage B cell number
|
J:144799
|
| increased T cell number
|
J:144799
|
\Lyntm1.1Calo/\Lyntm1.1Calo
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased activated T cell number
|
J:200745
|
| increased plasma cell number
|
J:200745
|
| increased T cell number
|
J:200745
|
\Lyntm1Ard/\Lyn+
\Ptpn6me-v/\Ptpn6+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
\Lyntm1Ard/\Lyn+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
\Lyntm1Ard/\Lyntm1Ard
(B6.129P2-Lyntm1Ard)
|
abnormal B cell morphology
|
J:144799
|
| decreased follicular B cell number
|
J:144799
|
| decreased marginal zone B cell number
|
J:144799
|
| decreased transitional stage B cell number
|
J:144799
|
| increased T cell number
|
J:144799
|
\Lyntm1Ard/\Lyntm1Ard
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
| abnormal mature B cell morphology
|
J:110531
|
| absent B-1 B cells
|
J:110531
|
\Lyntm1b(EUCOMM)Hmgu/\Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:42037
|
| decreased mature B cell number
|
J:42037
|
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
decreased B cell number
|
J:200745
|
| decreased follicular B cell number
|
J:146161
|
| decreased marginal zone B cell number
|
J:146161
|
| decreased mature B cell number
|
J:146161
|
| decreased transitional stage B cell number
|
J:146161
|
| increased plasma cell number
|
J:200745
|
\Lyntm1Sor/\Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell number
|
J:71174
|
| decreased B-1 B cell number
|
J:71174
|
| decreased mature B cell number
|
J:71174
|
\Lyntm1Tya/\Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:29751
|
| decreased B cell number
|
J:29751
|
| decreased lymphocyte cell number
|
J:29751
|
\Lynweeb/\Lynweeb
(C57BL/6-Lynweeb)
|
decreased follicular B cell number
|
J:146161
|
| decreased marginal zone B cell number
|
J:146161
|
| decreased mature B cell number
|
J:146161
|
| decreased transitional stage B cell number
|
J:146161
|
\Lystbg-J/\Lystbg-J
\Prkdcscid/\Prkdcscid
(B6.Cg-Lystbg-J Prkdcscid/Sz)
|
decreased B cell number
|
J:34814
|
| decreased CD4-positive, alpha-beta T cell number
|
J:34814
|
| decreased CD8-positive, alpha-beta T cell number
|
J:34814
|
| decreased lymphocyte cell number
|
J:34814
|
| decreased pre-B cell number
|
J:34814
|
| decreased T cell number
|
J:34814
|
| increased NK cell number
|
J:34814
|
\Lystbg-Lac/\Lystbg-Lac
(CBA/CaLac-Lystbg-Lac)
|
absent NK T cells
|
J:29745
|
\Lystbg/\Lystbg
(B6.C3Rl-Lystbg)
|
abnormal lymphocyte morphology
|
J:5078
|
\Lyve1tm1.1(EGFP/cre)Cys/\Lyve1+
\Sphk1tm2Cgh/\Sphk1tm2Cgh
\Sphk2tm1.1Cgh/\Sphk2tm1.1Cgh
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal lymphocyte cell number
|
J:156826
|
| decreased B cell number
|
J:156826
|
| decreased T cell number
|
J:156826
|
\Lyz2tm1(cre)Ifo/\Lyz2+
\Pikfyvetm1b(EUCOMM)Hmgu/\Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N)
|
decreased regulatory T cell number
|
J:244776
|
\m1Hefl/\m1Hefl
(C3HeB/FeJ-m1Hefl)
|
decreased B cell number
|
J:137446
|
X/\m1Nish
(involves: BALB/c * C57BL/6N)
|
absent B cells
|
J:204833
|
| decreased NK cell number
|
J:204833
|
X/\m1Nish
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:204833
|
| abnormal NK cell differentiation
|
J:204833
|
| absent B cells
|
J:204833
|
| absent B-1 B cells
|
J:204833
|
| absent B-2 B cells
|
J:204833
|
| decreased B cell number
|
J:204833
|
| decreased B-1 B cell number
|
J:204833
|
| decreased immature B cell number
|
J:204833
|
| decreased NK cell number
|
J:204833
|
\m2Hefl/\m2Hefl
(C3HeB/FeJ-m2Hefl)
|
absent B cells
|
J:137446
|
| absent T cells
|
J:137446
|
\m3Hefl/\m3Hefl
(C3HeB/FeJ-m3Hefl)
|
decreased CD8-positive, alpha-beta T cell number
|
J:137446
|
| decreased NK cell number
|
J:137446
|
\m4Hefl/\m4Hefl
(C3HeB/FeJ-m4Hefl)
|
decreased T cell number
|
J:137446
|
\m5Hefl/\m5Hefl
(C3HeB/FeJ-m5Hefl)
|
decreased T cell number
|
J:137446
|
\Macroh2a1tm1.1Oxbo/\Macroh2a1tm1.1Oxbo
(B6.Cg-Macroh2a1tm1.1Oxbo)
|
decreased B cell number
|
J:293382
|
| increased lymphocyte cell number
|
J:293382
|
\Madcam1tm1.2Nwag/\Madcam1tm1.2Nwag
(B6.129P2-Madcam1tm1.2Nwag)
|
decreased B cell number
|
J:169739
|
| decreased plasma cell number
|
J:169739
|
| increased plasma cell number
|
J:169739
|
\Magt1Gt(IST13422E1)Tigm/Y
(involves: C57BL/6N)
|
abnormal B cell morphology
|
J:260923
|
| decreased plasma cell number
|
J:260923
|
| decreased T cell number
|
J:260923
|
| increased B cell number
|
J:260923
|
| increased marginal zone B cell number
|
J:260923
|
\Malt1tm1Vmd/\Malt1tm1Vmd
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:86770
|
| abnormal double-negative T cell morphology
|
J:86770
|
| abnormal T cell differentiation
|
J:86770
|
| absent B-1a cells
|
J:86770
|
\Maml1tm1Mkit/\Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased marginal zone B cell number
|
J:122286
|
| decreased thymocyte number
|
J:122286
|
| increased double-negative T cell number
|
J:122286
|
\Mamld1tm1.1(NCOM)Mfgc/Y
(C57BL/6N-Mamld1tm1.1(NCOM)Mfgc/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Man2a1tm1Jxm/\Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased memory T cell number
|
J:74579
|
\Man2b2tm1b(KOMP)Wtsi/\Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Map3k3tm1Bisu/\Map3k3tm2Bisu
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:145923
|
| decreased CD8-positive, alpha-beta T cell number
|
J:145923
|
\Map3k3tm1Kuro/\Map3k3tm1Kuro
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:147103
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147103
|
| decreased double-positive T cell number
|
J:147103
|
| decreased single-positive T cell number
|
J:147103
|
| decreased thymocyte number
|
J:147103
|
| increased double-negative T cell number
|
J:147103
|
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
absent regulatory T cells
|
J:112837
|
| decreased CD4-positive, alpha-beta T cell number
|
J:112837
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112837
|
| decreased single-positive T cell number
|
J:112837
|
| decreased T cell number
|
J:112837
|
| increased memory T cell number
|
J:112837
|
\Map3k7tm1Aki/\Map3k7tm1Aki
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:238318
|
| abnormal intraepithelial T cell number
|
J:238318
|
| abnormal regulatory T cell number
|
J:238318
|
| abnormal T cell morphology
|
J:238318
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:238318
|
| decreased NK T cell number
|
J:238318
|
| increased CD4-positive, alpha-beta T cell number
|
J:238318
|
| increased gamma-delta intraepithelial T cell number
|
J:238318
|
\Map3k7tm1Zjc/\Map3k7tm1Zjc
\Tg(Lck-cre)548Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:111794
|
| decreased CD8-positive, alpha-beta T cell number
|
J:111794
|
| decreased T cell number
|
J:111794
|
\Map3k8tm1Pnt/\Map3k8tm1Pnt
\Tnftm2Gkl/\Tnf+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:108572
|
| increased single-positive T cell number
|
J:108572
|
\Map3k14aly/\Map3k14+
\RelbTg(H2-K1/GH1)106Bri/\Relb+
(involves: C57BL/6 * C57BL/6J)
|
decreased NK T cell number
|
J:120659
|
\Map3k14aly/\Map3k14aly
(involves: C57BL/6J)
|
abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:87993,
J:128211
|
| abnormal NK T cell morphology
|
J:120659
|
| decreased NK T cell number
|
J:120659
|
| decreased regulatory T cell number
|
J:128211
|
\Map3k14aly/\Map3k14aly
(involves: AEJ/GnRk * C57BL/6J)
|
abnormal lymphocyte morphology
|
J:16865
|
| abnormal lymphopoiesis
|
J:16865
|
| decreased B cell number
|
J:54529
|
\Map3k14m1Btlr/\Map3k14m1Btlr
(C57BL/6J-Map3k14m1Btlr)
|
arrested B cell differentiation
|
J:152065
|
| decreased B cell number
|
J:152065
|
\Map3k14m1Btlr/\Map3k14m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| arrested B cell differentiation
|
J:185495
|
\Map3k14tm1.1Gne/\Map3k14tm1.1Gne
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)
|
decreased B cell number
|
J:280549
|
\Map3k14tm1.2Gne/\Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne)
|
decreased B cell number
|
J:240453
|
| decreased B-2 B cell number
|
J:240453
|
| decreased follicular B cell number
|
J:240453
|
| decreased germinal center B cell number
|
J:240453
|
| decreased marginal zone B cell number
|
J:240453
|
| decreased transitional stage T1 B cell number
|
J:240453
|
| decreased transitional stage T2 B cell number
|
J:240453
|
\Map3k14tm1Rds/\Map3k14tm1Rds
(involves: 129)
|
abnormal class switch recombination
|
J:188560
|
\Map4k3Gt(RRO270)Byg/\Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
|
abnormal T-helper 1 cell differentiation
|
J:177642
|
| abnormal T-helper 2 cell differentiation
|
J:177642
|
| abnormal T-helper 17 cell differentiation
|
J:177642
|
\Map4k5Gt(OST218153)Lex/\Map4k5Gt(OST218153)Lex
(B6;129S5-Map4k5Gt(OST218153)Lex/Ieg)
|
increased CD4-positive, alpha-beta T cell number
|
J:82809
|
\Mapk1tm1.1Hed/\Mapk1tm1.1Hed
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:113280
|
| decreased CD4-positive, alpha-beta T cell number
|
J:113280
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(Cd4-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(Cd4-cre)1Cwi/0
\Tg(TcrAND)53Hed/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
| abnormal T cell subpopulation ratio
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:113280
|
| increased double-positive T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6)
|
decreased thymocyte number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
| decreased CD4-positive, alpha-beta T cell number
|
J:113280
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113280
|
| increased double-positive T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:113280
|
| decreased double-positive T cell number
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(Lck-cre)1Cwi/0
\Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
| abnormal T cell subpopulation ratio
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal double-positive T cell morphology
|
J:113280
|
| abnormal positive T cell selection
|
J:113280
|
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
decreased thymocyte number
|
J:113280
|
\Mapk1tm2Moga/\Mapk1tm2Moga
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(Mx1-cre)1Cgn/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pro-B cell differentiation
|
J:134528
|
| abnormal pro-B cell morphology
|
J:134528
|
| decreased pre-B cell number
|
J:134528
|
\Mapk3tm1Gpg/\Mapk3tm1Gpg
(involves: 129)
|
decreased T cell number
|
J:58468
|
\Mapk8tm1Flv/\Mapk8tm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:51510
|
\Mapk9tm1Flv/\Mapk9tm1Flv
(involves: 129S2/SvPas)
|
abnormal T-helper 1 cell differentiation
|
J:50628
|
\Mapk11tm1Jda/\Mapk11tm1Jda
\Mapk14tm1Jda/\Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:165966
|
| abnormal T-helper 2 cell differentiation
|
J:165966
|
| abnormal T-helper 17 cell differentiation
|
J:165966
|
\Mapk14tm1Jda/\Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda)
|
increased double-negative T cell number
|
J:146088
|
\Mapkapk2tm1b(EUCOMM)Hmgu/\Mapkapk2tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkapk2tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
\Mar1tm1Wtg/\Mar1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
\Mar1tm1Wtg/\Mar1tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
\Marchf1tm1.1Sish/\Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:201198
|
| decreased regulatory T cell number
|
J:201198
|
\Marchf6tm1b(EUCOMM)Hmgu/\Marchf6tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf6tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
\Marchf9tm1a(EUCOMM)Wtsi/\Marchf9tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased B cell number
|
J:165965
|
\Mark2tm1Hpw/\Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:68830
|
| increased B cell number
|
J:68830
|
\Matn1tm1Ref/\Matn1tm1Ref
\Matn2tm1Asz/\Matn2tm1Asz
\Matn3tm1Asz/\Matn3tm1Asz
\Matn4tm1.1Asz/\Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-positive T cell number
|
J:237230
|
\Mavstm1Aki/\Mavstm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:130954
|
\Mavstm1Aki/\Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:162888
|
| decreased CD8-positive, alpha-beta T cell number
|
J:162888
|
\Mavstm1Aki/\Mavstm1Aki
\Ticam1tm1Aki/\Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:130954
|
\Mbd2tm1Bh/\Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:323838
|
| abnormal effector T cell morphology
|
J:323838
|
| increased T-helper 1 cell number
|
J:323838
|
| increased T-helper 2 cell number
|
J:323838
|
\Mbd5tm1b(EUCOMM)Wtsi/\Mbd5+
(C57BL/6N-Mbd5tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Mbl1tm1Kata/\Mbl1tm1Kata
\Mbl2tm1Kata/\Mbl2tm1Kata
(involves: 129 * C57BL/6)
|
abnormal B cell number
|
J:97686
|
| decreased germinal center B cell number
|
J:97686
|
| increased B-1 B cell number
|
J:97686
|
\Mboat7tm1b(KOMP)Wtsi/\Mboat7+
(C57BL/6N-Mboat7tm1b(KOMP)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Mcattm1.1Ssmi/\Mcattm1.1Ssmi
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
decreased lymphocyte cell number
|
J:192213
|
\Mcl1tm1Dmta/\Mcl1+
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(B6.Cg-Mcl1tm1Dmta Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
decreased germinal center B cell number
|
J:166069
|
| decreased memory B cell number
|
J:166069
|
\Mcl1tm1Dmta/\Mcl1+
\Tg(Aicda-cre)9Mbu/0
(B6.Cg-Mcl1tm1Dmta Tg(Aicda-cre)9Mbu)
|
decreased germinal center B cell number
|
J:166069
|
| decreased memory B cell number
|
J:166069
|
\Mcl1tm1Dmta/\Mcl1tm1Dmta
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(B6.Cg-Mcl1tm1Dmta Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
abnormal B cell differentiation
|
J:166069
|
| absent germinal center B cells
|
J:166069
|
| absent memory B cells
|
J:166069
|
| decreased naive B cell number
|
J:166069
|
\Mcl1tm1Dmta/\Mcl1tm1Dmta
\Tg(Aicda-cre)9Mbu/0
(B6.Cg-Mcl1tm1Dmta Tg(Aicda-cre)9Mbu)
|
absent germinal center B cells
|
J:166069
|
| absent memory B cells
|
J:166069
|
\Mcl1tm1Yen/\Mcl1tm1Yen
(B6.129-Mcl1tm1Yen)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146246
|
| decreased double-negative T cell number
|
J:146246
|
| decreased single-positive T cell number
|
J:146246
|
\Mcl1tm1Yen/\Mcl1tm1Yen
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146246
|
\Mcl1tm1Yen/\Mcl1tm1Yen
\Tg(TcraTcrb)425Cbn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased CD4-positive, alpha-beta T cell number
|
J:146246
|
\Mcl1tm1Ywh/\Mcl1tm1Ywh
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:137400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137400
|
| decreased T cell number
|
J:137400
|
| increased double-positive T cell number
|
J:137400
|
\Mcl1tm1Ywh/\Mcl1tm1Ywh
\Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137400
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137400
|
| decreased double-negative T cell number
|
J:137400
|
| decreased double-positive T cell number
|
J:137400
|
| decreased T cell number
|
J:137400
|
\Mcl1tm2Sjk/\Mcl1tm3Sjk
\Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:86906
|
| decreased double-negative T cell number
|
J:86906
|
| decreased double-positive T cell number
|
J:86906
|
| decreased T cell number
|
J:86906
|
| decreased thymocyte number
|
J:86906
|
\Mcl1tm2Sjk/\Mcl1tm3Sjk
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased B cell number
|
J:86906
|
| decreased T cell number
|
J:86906
|
\Mcm3aptm1Imku/\Mcm3aptm1Imku
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal memory B cell number
|
J:88276
|
| decreased B cell number
|
J:88276
|
| decreased germinal center B cell number
|
J:88276
|
\Mcm4Sdla/\Mcm4+
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:194117
|
\Mcph1tm1a(EUCOMM)Wtsi/\Mcph1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased B cell number
|
J:213427
|
\Mdc1Gt(OST441263)Lex/\Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:137341
|
\Mdm2tm1Bay/\Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:81065
|
| decreased double-negative T cell number
|
J:81065
|
| decreased double-positive T cell number
|
J:81065
|
| decreased immature B cell number
|
J:81065
|
| decreased lymphocyte cell number
|
J:81065
|
| decreased T cell number
|
J:81065
|
| decreased thymocyte number
|
J:81065
|
\Mdm4m1Btlr/\Mdm4m1Btlr
(C57BL/6J-Mdm4m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265262
|
| decreased single-positive T cell number
|
J:265262
|
| increased CD4-positive, alpha-beta T cell number
|
J:265262
|
| increased single-positive T cell number
|
J:265262
|
\Mdm4m2Btlr/\Mdm4m2Btlr
(C57BL/6J-Mdm4m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272830
|
| increased CD4-positive, alpha-beta T cell number
|
J:272830
|
\Mecomtm2.2Aspe/\Mecomtm2.2Aspe
(involves: 129 * C57BL/6J * FVB/N)
|
decreased B cell number
|
J:213829
|
\Mef2btm2Rdf/\Mef2b+
\Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6)
|
abnormal mature B cell morphology
|
J:265465
|
| increased germinal center B cell number
|
J:265465
|
\Mefvtm5.1(MEFV)Chae/\Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae)
|
decreased B cell number
|
J:172117
|
| decreased lymphocyte cell number
|
J:172117
|
| decreased T cell number
|
J:172117
|
\Men1tm1.2Zqw/\Men1tm1.2Zqw
\Pgrtm2(cre)Lyd/\Pgr+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased uterine NK cell number
|
J:322043
|
\Mertktm1Gkm/\Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm)
|
decreased T cell number
|
J:147153
|
\Mertktm1Gkm/\Mertktm1Gkm
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Mertktm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
decreased double-positive T cell number
|
J:147153
|
| increased CD8-positive, alpha-beta T cell number
|
J:147153
|
\Mfap2tm1a(KOMP)Wtsi/\Mfap2tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased B cell number
|
J:236092
|
| increased B cell number
|
J:236092
|
\Mfngem1(IMPC)Ccpcz/\Mfngem1(IMPC)Ccpcz
(C57BL/6NCrl-Mfngem1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
\Mfngtm1.1Cfg/\Mfngtm1.1Cfg
(involves: C57BL/6)
|
decreased mature B cell number
|
J:217719
|
| increased B cell number
|
J:217719
|
| increased lymphocyte cell number
|
J:217719
|
\Mfngtm1Cjg/\Mfngtm1Cjg
(B6.Cg-Mfngtm1Cjg)
|
abnormal marginal zone B cell morphology
|
J:146621
|
\Mfsd1em1(IMPC)Tcp/\Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Mfsd2btm1a(KOMP)Wtsi/\Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi)
|
decreased B cell number
|
J:250123
|
| decreased T cell number
|
J:250123
|
\Mgat2tm1.1Jxm/\Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal B cell differentiation
|
J:80661
|
| decreased T cell number
|
J:80661
|
\Mgat5btm1.1Cfg/\Mgat5btm1.1Cfg
(involves: 129S6/SvEvTac)
|
decreased pre-B cell number
|
J:217719
|
\Mgl2tm1.1(HBEGF/EGFP)Aiwsk/\Mgl2+
(involves: C57BL/6 * FVB/N)
|
abnormal T-helper 2 cell morphology
|
J:201044
|
| decreased B cell number
|
J:201044
|
| decreased CD4-positive, alpha-beta T cell number
|
J:201044
|
| decreased CD8-positive, alpha-beta T cell number
|
J:201044
|
\Mgrn1em1(IMPC)Tcp/\Mgrn1+
(C57BL/6NCrl-Mgrn1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Micu1em#Fink/\Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
decreased B cell number
|
J:238984
|
| decreased follicular B cell number
|
J:238984
|
\Micu1em#Fink/\Micu1em#Fink
\Smdt1em1Fink/\Smdt1+
(involves: C57BL/6J * C57BL/6N * CBA)
|
decreased B cell number
|
J:238984
|
\Miga2tm1a(KOMP)Wtsi/\Miga2tm1a(KOMP)Wtsi
(C57BL/6N-Miga2tm1a(KOMP)Wtsi/Mmucd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:339075
|
\Mipeptm1.1Yhig/\Mipeptm1.1Yhig
\Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6J * C57BL/6N * FVB/NJ)
|
decreased T cell number
|
J:365489
|
\Mir34atm1.2Arte/\Mir34atm1.2Arte
(involves: C57BL/6N)
|
increased B cell number
|
J:221990
|
\Mir125atm1Smoc/\Mir125atm1Smoc
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:224880
|
\Mir126atm2.1Smoc/\Mir126atm2.1Smoc
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6J * C57BL/6N * DBA/2)
|
decreased T-helper 2 cell number
|
J:355195
|
| increased T-helper 1 cell number
|
J:355195
|
| increased T-helper 17 cell number
|
J:355195
|
\Mir142tm1.1Sbel/\Mir142tm1.1Sbel
(involves: C57BL/6N)
|
decreased lymphocyte cell number
|
J:227228
|
\Mir146tm1.1Bal/\Mir146tm1.1Bal
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:167922
|
| decreased lymphocyte cell number
|
J:173230
|
| increased regulatory T cell number
|
J:167922
|
\Mir146tm1.1Bal/\Mir146tm1.1Bal
\Tifabtm1.1Dsta/\Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:229024
|
\Mir146tm1.1Lfl/\Mir146tm1.1Lfl
\Ighg1tm1(cre)Cgn/\Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased germinal center B cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
\Mir146tm1.1Lfl/\Mir146tm1.1Lfl
\Mir146btm1.1Lfl/\Mir146btm1.1Lfl
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased germinal center B cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
\Mir146tm1.1Lfl/\Mir146tm1.1Lfl
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
increased germinal center B cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
\Mir146tm1.1Lfl/\Mir146tm1.1Lfl
\Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6)
|
increased germinal center B cell number
|
J:266124
|
| increased plasma cell number
|
J:266124
|
| increased T follicular helper cell number
|
J:266124
|
\Mir146tm2.1Bal/\Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
decreased lymphocyte cell number
|
J:173671
|
\Mir148atm2942.1Arte/\Mir148atm2942.1Arte
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasmablast number
|
J:307366
|
| decreased plasma cell number
|
J:307366
|
| increased memory B cell number
|
J:307366
|
\Mir148atm2942.1Arte/\Mir148atm2942.1Arte
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal plasmablast number
|
J:307366
|
| decreased plasma cell number
|
J:307366
|
| increased plasma cell number
|
J:307366
|
\Mir148atm2942.2Arte/\Mir148atm2942.2Arte
(involves: C57BL/6 * FVB/N)
|
decreased plasma cell number
|
J:307366
|
\Mir150tm1Rsky/\Mir150tm1Rsky
(involves: C57BL/6)
|
decreased B-2 B cell number
|
J:127234
|
| increased B-1 B cell number
|
J:127234
|
\Mir155tm1.1Brd/\Mir155tm1.1Brd
(B6.Cg-Mir155tm1.1Brd Tyrc-Brd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:121095
|
| abnormal T-helper 1 cell morphology
|
J:121095
|
| increased T-helper 2 cell number
|
J:121095
|
\Mir155tm1.1Brd/\Mir155tm1.1Brd
(B6.129S7-Mir155tm1.1Brd)
|
decreased regulatory T cell number
|
J:146268
|
\Mir155tm1.1Rsky/\Mir155tm1.1Rsky
(involves: 129 * C57BL/6)
|
decreased germinal center B cell number
|
J:121084
|
\Mir155tm1.1Rsky/\Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J)
|
abnormal T-helper 17 cell differentiation
|
J:226678
|
| decreased effector memory T-helper cell number
|
J:226678
|
| decreased regulatory T cell number
|
J:226678
|
| decreased T-helper 17 cell number
|
J:226678
|
\Mir155tm1Brd/\Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:121095
|
\Mir155tm1Rsky/\Mir155tm1Rsky
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:136224
|
\Mir181dtm1.1Oers/\Mir181dtm1.1Oers
(involves: C57BL/6)
|
increased T cell number
|
J:212571
|
\Mir210tm1.1Wtsi/\Mir210tm1.1Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased germinal center B cell number
|
J:205868
|
\Mirc1tm1.1Aven/\Mirc1tm1.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased alpha-beta T cell number
|
J:223213
|
| decreased B cell number
|
J:223213
|
| decreased pre-B cell number
|
J:223213
|
| decreased pro-B cell number
|
J:223213
|
\Mirc1tm1.2Tyj/\Mirc1tm1.2Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)
|
abnormal B cell differentiation
|
J:134861
|
| decreased pre-B cell number
|
J:134861
|
\Mirc1tm1.3Tyj/\Mirc1tm1.3Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:134861
|
| decreased pre-B cell number
|
J:134861
|
\Mirc1tm1Tyj/\Mirc1tm1Tyj
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:134861
|
| decreased pre-B cell number
|
J:134861
|
\Mirc1tm2.1Aven/\Mirc1tm2.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased B cell number
|
J:223213
|
\Mirc1tm2.1Aven/\Mirc1tm2.1Aven
\Tg(IghMyc)22Bri/?
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
abnormal pre-B cell morphology
|
J:223213
|
\Mirc1tm3.1Aven/\Mirc1tm3.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased alpha-beta T cell number
|
J:223213
|
| decreased B cell number
|
J:223213
|
| decreased pre-B cell number
|
J:223213
|
| decreased pro-B cell number
|
J:223213
|
\Mirc11tm1Rdhl/\Mirc11tm1Rdhl
(B6.129-Mirc11tm1Rdhl)
|
abnormal B cell differentiation
|
J:243248
|
| increased B cell number
|
J:243248
|
| increased follicular B cell number
|
J:243248
|
| increased immature B cell number
|
J:243248
|
| increased mature B cell number
|
J:243248
|
| increased plasma cell number
|
J:243248
|
| increased pre-pro B cell number
|
J:243248
|
| increased pro-B cell number
|
J:243248
|
| increased transitional stage T1 B cell number
|
J:243248
|
\Mirc14tm1.1Ankr/\Mirc14tm1.1Ankr
(involves: C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:196134
|
| abnormal NK T cell morphology
|
J:196134
|
| abnormal T cell differentiation
|
J:196134
|
| decreased double-positive T cell number
|
J:196134
|
| decreased NK T cell number
|
J:196134
|
| increased CD4-positive, alpha-beta T cell number
|
J:196134
|
\Mirc14tm1.1Czc/\Mirc14tm1.1Czc
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))
|
decreased double-positive T cell number
|
J:188125
|
\Mirc14tm1.1Flv/\Mirc14tm1.1Flv
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2 * SJL)
|
decreased NK T cell number
|
J:203157
|
\Mirc14tm1.2Czc/\Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
decreased B cell number
|
J:188125
|
| decreased DN3 thymocyte number
|
J:188125
|
| decreased double-positive T cell number
|
J:188125
|
| decreased germinal center B cell number
|
J:188125
|
| decreased thymocyte number
|
J:188125
|
| increased CD4-positive, alpha-beta T cell number
|
J:188125
|
| increased marginal zone B cell number
|
J:188125
|
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal T cell differentiation
|
J:203157
|
| abnormal T cell receptor V(D)J recombination
|
J:203157
|
| decreased B cell number
|
J:203157
|
| decreased CD4-positive, alpha-beta T cell number
|
J:203157
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203157
|
| decreased DN1 thymic pro-T cell number
|
J:203157
|
| decreased double-positive T cell number
|
J:203157
|
| decreased NK T cell number
|
J:203157
|
| decreased thymocyte number
|
J:203157
|
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
\Mirc15tm1.2Flv/\Mirc15tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased B cell number
|
J:203157
|
| decreased immature B cell number
|
J:203157
|
| decreased pre-B cell number
|
J:203157
|
| increased pro-B cell number
|
J:203157
|
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
\Tg(Cd4-TcraDN32D3)1Aben/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased NK T cell number
|
J:203157
|
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
\Tg(LCKprBCL2L1)12Sjk/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased NK T cell number
|
J:203157
|
\Mirc16tm1.2Czc/\Mirc16tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
increased CD8-positive, alpha-beta T cell number
|
J:188125
|
\Mirc30em1Hhzg/\Mirc30em1Hhzg
\Tg(Vav1-cre)#Cgp/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)
|
abnormal NK cell morphology
|
J:320883
|
| increased B cell number
|
J:320883
|
| increased pre-B cell number
|
J:320883
|
| increased pro-B cell number
|
J:320883
|
\Mirc30tm1.2Rdf/\Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
increased B cell number
|
J:156946
|
| increased B-1a cell number
|
J:156946
|
\Mirc33tm1.1Cwh/\Mirc33tm1.1Cwh
(involves: 129X1/SvJ)
|
abnormal T cell morphology
|
J:189763
|
| increased T-helper 1 cell number
|
J:189763
|
\Mki67em1(IMPC)Mbp/\Mki67em1(IMPC)Mbp
(C57BL/6NCrl-Mki67em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Mkrn2tm1b(KOMP)Wtsi/\Mkrn2tm1b(KOMP)Wtsi
(C57BL/6N-Mkrn2tm1b(KOMP)Wtsi/Wtsi)
|
decreased dendritic epidermal T cell number
|
J:211773
|
\Mlf1tm1Swm/\Mlf1tm1Swm
(involves: 129 * C57BL/6)
|
increased B cell number
|
J:266833
|
\Mllt6em1(IMPC)Tcp/\Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Mllt10em1(IMPC)Mbp/\Mllt10+
(C57BL/6N-Mllt10em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Mmgt2tm1b(EUCOMM)Wtsi/\Mmgt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Mmgt2tm1b(EUCOMM)Wtsi/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
\Mmp9tm1Tvu/\Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased lymphocyte cell number
|
J:88065
|
| increased T-helper 2 cell number
|
J:88065
|
\Mmp19tm1Rase/\Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
abnormal T cell differentiation
|
J:137128
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137128
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137128
|
| increased double-positive T cell number
|
J:137128
|
\Mmp20em1(IMPC)Ccpcz/\Mmp20em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp20em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Mmrn1tm1b(EUCOMM)Hmgu/\Mmrn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mmrn1tm1b(EUCOMM)Hmgu/Cnrm)
|
increased large unstained cell number
|
J:211773
|
\Morc3tm1b(EUCOMM)Hmgu/\Morc3+
(C57BL/6N-Morc3tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Mpgtm1Rhe/\Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased CD4-positive, alpha-beta T cell number
|
J:70603
|
\Mpltm1Wsa/\Mpltm1Wsa
\MybPlt3/\MybPlt3
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:89601
|
\Mpltm1Wsa/\Mpltm1Wsa
\Suz12Gt(Betageo)1Khe/\Suz12+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased lymphocyte cell number
|
J:136262
|
\Mpltm1Wsa/\Mpltm1Wsa
\Suz12Plt8/\Suz12+
(B6.Cg-Mpltm1Wsa Suz12Plt8)
|
increased lymphocyte cell number
|
J:136262
|
\Mpp1em1(IMPC)Ccpcz/\Mpp1em1(IMPC)Ccpcz
(C57BL/6NCrl-Mpp1em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Mpztm1Msch/\Mpz+
\Rag1tm1Mom/\Rag1tm1Mom
(B6.129S7-Mpztm1Msch Rag1tm1Mom)
|
absent CD4-positive, alpha-beta T cells
|
J:59319
|
| absent CD8-positive, alpha-beta T cells
|
J:59319
|
\Mpztm1Msch/\Mpz+
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * BALB/c * C57BL/6)
|
decreased T cell number
|
J:59319
|
\Mpzl2tm1Lex/\Mpzl2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:171883
|
| increased CD8-positive, alpha-beta T cell number
|
J:171883
|
\Mr1tm1Gfn/\Mr1tm1Gfn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal T cell number
|
J:113083
|
\MrasGt(OST108223)Lex/\MrasGt(OST108223)Lex
(B6;129S5-MrasGt(OST108223)Lex/Ieg)
|
decreased B cell number
|
J:82809
|
\Mrc1tm1Mnz/\Mrc1tm1Mnz
(B6.129P2-Mrc1tm1Mnz)
|
decreased T cell number
|
J:194065
|
\Mre11atm1.1Rchd/\Mre11atm1.1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:184053
|
\Ms4a1tm1Tft/\Ms4a1tm1Tft
(involves: 129 * C57BL/6)
|
abnormal B cell number
|
J:88933
|
| decreased B-1 B cell number
|
J:88933
|
| increased transitional stage B cell number
|
J:88933
|
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:80893
|
| abnormal somatic hypermutation frequency
|
J:155454
|
\Msh2tm1Htr/\Msh2tm1Htr
\Pcnatm1Jcbs/\Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
\Msh2tm1Mak/\Msh2tm1Mak
(C57BL/6NTac-Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
\Msh2tm1Rak/\Msh2tm1Rak
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:56764
|
| decreased mature B cell number
|
J:56764
|
\Msh2tm1Wed/\Msh2tm1Wed
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:86278
|
\Msi2em1(IMPC)Mbp/\Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Msi2Gt(E035H03)Wrst/\Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst)
|
decreased B cell number
|
J:174870
|
| decreased CD4-positive, alpha-beta T cell number
|
J:174870
|
| decreased CD8-positive, alpha-beta T cell number
|
J:174870
|
| decreased DN2 thymocyte number
|
J:174870
|
| decreased DN3 thymocyte number
|
J:174870
|
| decreased double-negative T cell number
|
J:174870
|
| decreased double-positive T cell number
|
J:174870
|
| decreased immature B cell number
|
J:174870
|
| decreased mature B cell number
|
J:174870
|
| decreased pre-B cell number
|
J:174870
|
\Msntm1Sts/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:189837
|
| decreased CD4-positive, alpha-beta T cell number
|
J:189837
|
| decreased lymphocyte cell number
|
J:189837
|
\Mt1tm1Bri/\Mt1tm1Bri
\Mt2tm1Bri/\Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
decreased B cell number
|
J:110643
|
| decreased T cell number
|
J:110643
|
| increased CD4-positive, alpha-beta T cell number
|
J:110643
|
| increased CD8-positive, alpha-beta T cell number
|
J:110643
|
| increased lymphocyte cell number
|
J:110643
|
| increased plasma cell number
|
J:110643
|
\Mta1em1(IMPC)Ccpcz/\Mta1+
(C57BL/6NCrl-Mta1em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Mtf1tm1Wsc/\Mtf1tm1Wsc
\Tg(Mx1-cre)1Cgn/0
\Tg(UBC-Mtf1)1Wsc/0
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:91119
|
\Mtorchino/\Mtorchino
(involves: C57BL/6JAnu)
|
decreased CD4-positive, alpha-beta T cell number
|
J:207898
|
\Mtortm1.2Koz/\Mtortm1.2Koz
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:150108
|
| abnormal T cell subpopulation ratio
|
J:150108
|
| increased regulatory T cell number
|
J:150108
|
\Mtortm1Lgm/\Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:168600
|
| decreased B cell number
|
J:168600
|
| decreased double-positive T cell number
|
J:168600
|
| decreased follicular B cell number
|
J:168600
|
| decreased marginal zone B cell number
|
J:168600
|
| decreased plasma cell number
|
J:168600
|
| decreased thymocyte number
|
J:168600
|
| decreased transitional stage T1 B cell number
|
J:168600
|
| increased CD4-positive, alpha-beta T cell number
|
J:168600
|
| increased CD8-positive, alpha-beta T cell number
|
J:168600
|
\Mtss1Gt(CSC156)Byg/\Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg)
|
abnormal B cell differentiation
|
J:186118
|
| abnormal B cell number
|
J:186118
|
| decreased immature B cell number
|
J:186118
|
| increased pre-B cell number
|
J:186118
|
\Mtus1Gt(RRA048)Byg/\Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:212144
|
\Muc2wnn/\Muc2wnn
(C57BL/6-Muc2wnn)
|
increased lymphocyte cell number
|
J:194148
|
\Mug1tm2Vln/\Mug1tm2Vln
\Pzptm1Vln/\Pzptm1Vln
(B.129P2-Pzptm1Vln Mug1tm2Vln)
|
abnormal uterine NK cell morphology
|
J:117841
|
\Mxi1tm1Rdp/\Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal lymphocyte morphology
|
J:48236
|
\Mybboo/\Mybboo
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:167270
|
\MybM303V/\MybM303V
(involves: 129S1/SvlmJ * C57BL/6)
|
arrested B cell differentiation
|
J:96507
|
| arrested T cell differentiation
|
J:96507
|
| decreased B cell number
|
J:96507
|
| decreased single-positive T cell number
|
J:96507
|
| decreased thymocyte number
|
J:96507
|
\Mybtm1.1Cgn/\Myb+
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:127234
|
| decreased B-1 B cell number
|
J:127234
|
| decreased mature B cell number
|
J:127234
|
| decreased pre-B cell number
|
J:127234
|
\Mybtm1Cgn/\Mybtm1.1Cgn
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
\Mybtm1Cgn/\Mybtm1Cgn
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:91122
|
| decreased CD4-positive, alpha-beta T cell number
|
J:91122
|
| decreased CD8-positive, alpha-beta T cell number
|
J:91122
|
| decreased double-negative T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
| decreased gamma-delta T cell number
|
J:91122
|
\Mybtm1Cgn/\Mybtm1Cgn
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
\Mybtm1Epr/\Mybtm1Epr
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:93481
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93481
|
| decreased double-positive T cell number
|
J:93481
|
| increased CD8-positive, alpha-beta T cell number
|
J:93481
|
\Mybtm1Epr/\Mybtm1Epr
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal double-negative T cell morphology
|
J:93481
|
| abnormal T cell differentiation
|
J:93481
|
| decreased double-positive T cell number
|
J:93481
|
\Mybtm1Jof/\Mybtm1Jof
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:85344
|
| abnormal double-negative T cell morphology
|
J:85344
|
| abnormal T cell differentiation
|
J:85344
|
| decreased thymocyte number
|
J:85344
|
\Mybtm1Jof/\Mybtm1Ssp
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:85344
|
| decreased thymocyte number
|
J:85344
|
\Mybl1tm1Epr/\Mybl1tm1Epr
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:67604
|
\Mybl2tm1.1Epr/\Mybl2tm1.1Epr
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased B cell number
|
J:206816
|
| decreased lymphocyte cell number
|
J:206816
|
| decreased T cell number
|
J:206816
|
\Myctm1Atp/\Myc+
(B6.129P2-Myctm1Atp)
|
decreased memory T cell number
|
J:132730
|
\Myctm1Lbox/\Myc+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell number
|
J:97900
|
\Myctm1Lbox/\Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased T cell number
|
J:97900
|
| increased B cell number
|
J:97900
|
\Myctm3(Tcrb)Fwa/\Myc+
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
\Myct1em1Choi/\Myct1em1Choi
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:303692
|
| increased CD8-positive, alpha-beta T cell number
|
J:303692
|
\Myd88tm1.1Defr/\Myd88tm1.1Defr
(B6.129P2(SJL)-Myd88tm1.1Defr)
|
decreased effector memory CD4-positive, alpha-beta T cell number
|
J:224849
|
\Myd88tm1Aki/\Myd88tm1Aki
\Tg(IghelMD4)4Ccg/0
\Tg(KLK4mHEL)6Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:115059
|
| increased B-1 B cell number
|
J:115059
|
\Myd88tm1Defr/\Myd88tm1Defr
\Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Myd88tm1Defr Tg(Itgax-cre)1-1Reiz)
|
abnormal T-helper 1 cell differentiation
|
J:139001
|
\Myh9tm5Rsad/\Myh9tm5Rsad
\Tg(Lck-cre)#Nik/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:164684
|
\Myo1gtm1.2Mfk/\Myo1gtm1.2Mfk
(Not Specified)
|
decreased B cell number
|
J:209304
|
| increased B cell number
|
J:209304
|
\Myoz1tm1b(EUCOMM)Hmgu/\Myoz1tm1b(EUCOMM)Hmgu
(C57BL/6N-Myoz1tm1b(EUCOMM)Hmgu/Ieg)
|
increased marginal zone B cell number
|
J:211773
|
\Mysm1tm1a(KOMP)Wtsi/\Mysm1tm1a(KOMP)Wtsi
(Not Specified)
|
decreased B cell number
|
J:165965
|
| decreased mature B cell number
|
J:165965
|
| increased T cell number
|
J:165965
|
\Mysm1tm1b(KOMP)Wtsi/\Mysm1tm1b(KOMP)Wtsi
\Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal T cell differentiation
|
J:179287
|
| arrested B cell differentiation
|
J:179287
|
| decreased B cell number
|
J:179287
|
| decreased immature B cell number
|
J:179287
|
| decreased pre-B cell number
|
J:179287
|
| decreased pro-B cell number
|
J:179287
|
\Mzb1tm1.2Rug/\Mzb1tm1.2Rug
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)
|
decreased pre-B cell number
|
J:211639
|
| increased pro-B cell number
|
J:211639
|
\N4bp1tm1.2Vmd/\N4bp1tm1.2Vmd
(involves: C57BL/6)
|
increased activated T cell number
|
J:297419
|
| increased germinal center B cell number
|
J:297419
|
\Nampttm1Oleo/\Nampttm1Oleo
\Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:141448
|
| decreased double-negative T cell number
|
J:141448
|
| decreased T cell number
|
J:141448
|
\Nba10NZB/\Nba10NZB
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB)
|
increased B cell number
|
J:134128
|
| increased marginal zone B cell number
|
J:134128
|
\Nbnem7Jpt/\Nbntm2Zqw
\Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
abnormal T cell morphology
|
J:277750
|
| absent mature B cells
|
J:277750
|
| decreased B cell number
|
J:277750
|
| decreased T cell number
|
J:277750
|
| decreased thymocyte number
|
J:277750
|
| increased CD8-positive, alpha-beta T cell number
|
J:277750
|
| increased pro-B cell number
|
J:277750
|
\Nbntm1Xu/\Nbntm1Xu
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:75272
|
| decreased mature B cell number
|
J:75272
|
| decreased pre-B cell number
|
J:75272
|
| decreased T cell number
|
J:75272
|
\Nbr1tm1.1Jmos/\Nbr1tm1.1Jmos
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:165438
|
| abnormal T-helper 2 cell differentiation
|
J:165438
|
\Ncaph2nes/\Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu)
|
abnormal double-negative T cell morphology
|
J:123300
|
| abnormal T cell morphology
|
J:123300
|
| decreased CD8-positive, alpha-beta T cell number
|
J:123300
|
| decreased double-negative T cell number
|
J:123300
|
| decreased double-positive T cell number
|
J:123300
|
| decreased T cell number
|
J:123300
|
| decreased thymocyte number
|
J:123300
|
\Ncaph2nes/\Ncaph2nes
\Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd)
|
abnormal double-negative T cell morphology
|
J:123300
|
| decreased double-positive T cell number
|
J:123300
|
\Ncf2tm1a(EUCOMM)Wtsi/\Ncf2tm1a(EUCOMM)Wtsi
(C57BL/6N-Ncf2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
\Ncf2tm1b(EUCOMM)Wtsi/\Ncf2+
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased activated T cell number
|
J:260777
|
| increased B cell number
|
J:260777
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:260777
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:260777
|
| increased CD8-positive, alpha-beta T cell number
|
J:260777
|
| increased follicular B cell number
|
J:260777
|
| increased germinal center B cell number
|
J:260777
|
| increased T cell number
|
J:260777
|
\Ncf2tm1b(EUCOMM)Wtsi/\Ncf2tm1b(EUCOMM)Wtsi
(B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:260777
|
\Ncf2tm1b(EUCOMM)Wtsi/\Ncf2tm1b(EUCOMM)Wtsi
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased activated T cell number
|
J:260777
|
| increased B cell number
|
J:260777
|
| increased follicular B cell number
|
J:260777
|
| increased germinal center B cell number
|
J:260777
|
| increased T cell number
|
J:260777
|
\Nckap1lm1Btlr/\Nckap1lm1Btlr
(C57BL/6J-Nckap1lm1Btlr)
|
decreased alpha-beta T cell number
|
J:272079
|
| decreased B cell number
|
J:272079
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272079
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272079
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272079
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:272079
|
| decreased NK cell number
|
J:272079
|
| increased alpha-beta T cell number
|
J:272079
|
| increased CD8-positive, alpha-beta T cell number
|
J:272079
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272079
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272079
|
\Nckap1lm1Iri/\Nckap1lm1Iri
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:141377
|
| abnormal lymphopoiesis
|
J:141377
|
| abnormal regulatory T cell number
|
J:141377
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141377
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141377
|
| decreased double-positive T cell number
|
J:141377
|
| decreased lymphocyte cell number
|
J:141377
|
| decreased mature B cell number
|
J:141377
|
| decreased mature gamma-delta T cell number
|
J:141377
|
| increased double-negative T cell number
|
J:141377
|
\Ncoa3tm1Jxu/\Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell morphology
|
J:109522
|
| abnormal lymphopoiesis
|
J:109522
|
| increased B cell number
|
J:109522
|
| increased CD4-positive, alpha-beta T cell number
|
J:109522
|
| increased CD8-positive, alpha-beta T cell number
|
J:109522
|
| increased lymphocyte cell number
|
J:109522
|
\Ncor1tm1Rsd/\Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested T cell differentiation
|
J:65417
|
\Ncr1noe/\Ncr1noe
(involves: C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:179728
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:179728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:179728
|
| increased NK cell number
|
J:179728
|
\Ncr1tm1Oman/\Ncr1tm1Oman
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased NK cell number
|
J:112394
|
\Ndfip1Gt(RRD002)Byg/\Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased activated T cell number
|
J:116617
|
\Ndfip1Gt(RRD002)Byg/\Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
increased activated T cell number
|
J:205692
|
\Ndfip1kru/\Ndfip1kru
(involves: C57BL/6JSfdAnu)
|
increased T-helper 2 cell number
|
J:188722
|
\Ndfip1tm1.1Pmo/\Ndfip1tm1.1Pmo
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:205692
|
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Rnpc3tm1c(EUCOMM)Wtsi/\Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:267519
|
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Rragatm2Dmsa/\Rragatm2Dmsa
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
decreased B cell number
|
J:213516
|
\Ndst3tm1.1Grob/\Ndst3tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:138557
|
| decreased lymphocyte cell number
|
J:138557
|
\Nedd4Gt(XA209)Byg/\Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:143560
|
| increased CD4-positive, alpha-beta T cell number
|
J:143560
|
| increased CD8-positive, alpha-beta T cell number
|
J:143560
|
| increased T cell number
|
J:143560
|
\Nedd4Gt(XB398)Byg/\Nedd4Gt(XB398)Byg
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:143560
|
| increased CD4-positive, alpha-beta T cell number
|
J:143560
|
| increased CD8-positive, alpha-beta T cell number
|
J:143560
|
| increased T cell number
|
J:143560
|
\Nedd4tm2b(EUCOMM)Hmgu/\Nedd4+
(C57BL/6N-Nedd4tm2b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Nedd9m1Btlr/\Nedd9m1Btlr
(C57BL/6J-Nedd9m1Btlr)
|
decreased B-1a cell number
|
J:267702
|
| decreased B-1b cell number
|
J:267702
|
\Nedd9tm1Miku/\Nedd9tm1Miku
(B6.CBA-Nedd9tm1Miku)
|
abnormal B cell number
|
J:116716
|
| decreased lymphocyte cell number
|
J:116716
|
| decreased marginal zone B cell number
|
J:116716
|
| increased follicular B cell number
|
J:116716
|
\Nek8m1Btlr/\Nek8m1Btlr
(C57BL/6J-Nek8m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:267544
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:267544
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:267544
|
| increased CD4-positive, alpha-beta T cell number
|
J:267544
|
\Nf1tm1Fcr/\Nf1+
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Nf1tm1Fcr Ptentm1Hwu)
|
decreased B cell number
|
J:232645
|
| decreased lymphocyte cell number
|
J:232645
|
| decreased T cell number
|
J:232645
|
\Nf1tm1Par/\Nf1tm1Par
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:90973
|
\Nfatc1tm1.1Fbs/\Nfatc1tm1.1Fbs
(C57BL/6-Nfatc1tm1.1Fbs)
|
increased regulatory T cell number
|
J:305649
|
\Nfatc1tm1Glm/\Nfatc1tm2Glm
(chimera involves: 129S2/SvPas)
|
abnormal lymphocyte cell number
|
J:78376
|
| decreased double-positive T cell number
|
J:78376
|
| decreased lymphocyte cell number
|
J:78376
|
| increased double-negative T cell number
|
J:78376
|
\Nfatc1tm1Rao/\Nfatc1tm1Rao
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c)
|
abnormal class switch recombination
|
J:177319
|
| decreased B cell number
|
J:177319
|
| decreased B-1a cell number
|
J:177319
|
\Nfatc1tm1Rao/\Nfatc1tm1Rao
\Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:177319
|
\Nfatc2tm1Glm/\Nfatc2tm1Glm
\Nfatc3tm1Glm/\Nfatc3tm1Glm
(involves: 129S2/SvPas)
|
abnormal lymphocyte cell number
|
J:51339
|
| decreased T cell number
|
J:51339
|
| increased B cell number
|
J:51339
|
| increased T cell number
|
J:51339
|
\Nfatc2tm1Rao/\Nfatc2tm1Rao
\Nfatc3tm1Grc/\Nfatc3tm1Grc
\Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal double-negative T cell morphology
|
J:141917
|
| abnormal T cell differentiation
|
J:141917
|
\Nfatc2tm1Srf/\Nfatc2tm1Srf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell number
|
J:110686
|
| increased activated T cell number
|
J:110686
|
\Nfatc2tm1Srf/\Nfatc2tm1Srf
(involves: 129P2/OlaHsd)
|
increased B cell number
|
J:45252
|
| increased lymphocyte cell number
|
J:45252
|
| increased T cell number
|
J:45252
|
\Nfatc2iptm1.1Glm/\Nfatc2iptm1.1Glm
(either: B6.129-Nfatc2iptm1.1Glm or C.129-Nfatc2iptm1.1Glm)
|
decreased T-helper 2 cell number
|
J:157559
|
\Nfatc3tm1Glm/\Nfatc3tm1Glm
\Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)
|
decreased double-positive T cell number
|
J:50124
|
| increased double-negative T cell number
|
J:50124
|
\Nfatc3tm1Grc/\Nfatc3tm1Grc
\Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal T cell differentiation
|
J:141917
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141917
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141917
|
| decreased thymocyte number
|
J:141917
|
| increased double-negative T cell number
|
J:141917
|
\Nfe2l2tm1Mym/\Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
|
decreased CD4-positive, alpha-beta T cell number
|
J:104016
|
| decreased T cell number
|
J:104016
|
\Nficem1(IMPC)Ccpcz/\Nficem1(IMPC)Ccpcz
(C57BL/6NCrl-Nficem1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
\Nfil3tm1.1Brad/\Nfil3+
(B6.Cg-Nfil3tm1.1Brad)
|
decreased NK cell number
|
J:152774
|
\Nfil3tm1.1Brad/\Nfil3tm1.1Brad
(B6.Cg-Nfil3tm1.1Brad)
|
abnormal NK cell differentiation
|
J:152774
|
| decreased NK cell number
|
J:152774
|
| increased memory T cell number
|
J:152774
|
| increased NK T cell number
|
J:152774
|
\Nfil3tm1Look/\Nfil3tm1Look
(B6.129X1-Nfil3tm1Look)
|
abnormal NK cell differentiation
|
J:155677
|
| decreased NK cell number
|
J:155677
|
\Nfil3tm1Pbro/\Nfil3tm1Pbro
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:156521
|
\Nfil3tm1Pbro/\Nfil3tm1Pbro
(B6.129S6-Nfil3tm1Pbro)
|
abnormal plasma cell morphology
|
J:209365
|
| decreased NK cell number
|
J:209365
|
| increased T-helper 17 cell number
|
J:209365
|
\Nfkb1m2Btlr/\Nfkb1+
(C57BL/6J-Nfkb1m2Btlr)
|
decreased central memory CD4-positive, alpha-beta T cell number
|
J:254822
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:254822
|
\Nfkb1m2Btlr/\Nfkb1m2Btlr
(C57BL/6J-Nfkb1m2Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:254822
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:254822
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:254822
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254822
|
\Nfkb1M3Btlr/\Nfkb1+
(C57BL/6J-Nfkb1M3Btlr)
|
increased central memory CD8 positive, alpha-beta T cell number
|
J:254821
|
\Nfkb1M3Btlr/\Nfkb1M3Btlr
(C57BL/6J-Nfkb1M3Btlr)
|
increased central memory CD8 positive, alpha-beta T cell number
|
J:254821
|
\Nfkb1M4Btlr/\Nfkb1M4Btlr
(C57BL/6J-Nfkb1M4Btlr)
|
decreased B-1 B cell number
|
J:265169
|
\Nfkb1M5Btlr/\Nfkb1M5Btlr
(C57BL/6J-Nfkb1M5Btlr)
|
decreased B-1a cell number
|
J:272117
|
\Nfkb1tm1a(KOMP)Wtsi/\Nfkb1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased NK cell number
|
J:213427
|
| decreased regulatory T cell number
|
J:213427
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:30268
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal
(involves: 129P2/OlaHsd)
|
decreased marginal zone B cell number
|
J:65246
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal
\Nfkb2tm1Sbn/\Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
arrested B cell differentiation
|
J:45119
|
| decreased B cell number
|
J:45119
|
| decreased CD4-positive, alpha-beta T cell number
|
J:45119
|
| decreased CD8-positive, alpha-beta T cell number
|
J:45119
|
| decreased double-positive T cell number
|
J:45119
|
| decreased mature B cell number
|
J:45119
|
| decreased single-positive T cell number
|
J:45119
|
| decreased T cell number
|
J:45119
|
\Nfkb1tm1Bal/\Nfkb1tm1Bal
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb1tm1Bal Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
| decreased marginal zone B cell number
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
\Nfkb1tm1Brv/\Nfkb1tm1Brv
(involves: 129S1/Sv)
|
decreased single-positive T cell number
|
J:46912
|
\Nfkb1tm1Sley/\Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased memory T cell number
|
J:142340
|
| decreased regulatory T cell number
|
J:142340
|
\Nfkb1tm1Sley/\Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)
|
decreased memory T cell number
|
J:142340
|
| decreased NK T cell number
|
J:142340
|
| decreased regulatory T cell number
|
J:142340
|
\Nfkb2Lym1/\Nfkb2+
(BALB/c-Nfkb2Lym1)
|
increased lymphocyte cell number
|
J:154812
|
\Nfkb2Lym1/\Nfkb2+
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:188560
|
\Nfkb2Lym1/\Nfkb2Lym1
(involves: BALB/c)
|
abnormal class switch recombination
|
J:154812
|
| abnormal plasma cell differentiation
|
J:154812
|
| abnormal T cell differentiation
|
J:154812
|
| decreased follicular B cell number
|
J:154812
|
| decreased marginal zone B cell number
|
J:154812
|
| decreased mature B cell number
|
J:154812
|
| decreased transitional stage B cell number
|
J:154812
|
| increased CD4-positive, alpha-beta T cell number
|
J:154812
|
| increased CD8-positive, alpha-beta T cell number
|
J:154812
|
| increased double-negative T cell number
|
J:154812
|
| increased double-positive T cell number
|
J:154812
|
| increased transitional stage B cell number
|
J:154812
|
\Nfkb2m2Btlr/\Nfkb2m2Btlr
(C57BL/6J-Nfkb2m2Btlr)
|
increased B-1a cell number
|
J:221493
|
\Nfkb2m3Btlr/\Nfkb2m3Btlr
(C57BL/6J-Nfkb2m3Btlr)
|
abnormal B cell differentiation
|
J:274960
|
| abnormal CD4-positive T cell differentiation
|
J:274960
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274960
|
| abnormal T cell differentiation
|
J:274960
|
| decreased B cell number
|
J:274960
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274960
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:274960
|
| decreased NK cell number
|
J:274960
|
| increased B-1 B cell number
|
J:274960
|
| increased CD4-positive, alpha-beta T cell number
|
J:274960
|
| increased CD8-positive, alpha-beta T cell number
|
J:274960
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:274960
|
| increased T cell number
|
J:274960
|
\Nfkb2M4Btlr/\Nfkb2M4Btlr
(C57BL/6J-Nfkb2M4Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:274961
|
| increased CD8-positive, alpha-beta T cell number
|
J:274961
|
| increased T cell number
|
J:274961
|
\Nfkb2m5Btlr/\Nfkb2m5Btlr
(C57BL/6J-Nfkb2m5Btlr)
|
increased B-1 B cell number
|
J:274962
|
\Nfkb2tm1Brv/\Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
abnormal lymphocyte cell number
|
J:43469
|
| abnormal T cell number
|
J:43469
|
| abnormal T cell subpopulation ratio
|
J:43469
|
| decreased double-positive T cell number
|
J:43469
|
\Nfkb2tm1Rsch/\Nfkb2tm1Rsch
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:77049
|
\Nfkb2tm1Sbn/\Nfkb2tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:45437
|
| abnormal lymphocyte cell number
|
J:45437
|
| decreased B cell number
|
J:45437
|
| increased T cell number
|
J:45437
|
\Nfkb2tm2Brv/\Nfkb2tm2Brv
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:76380
|
| increased CD4-positive, alpha-beta T cell number
|
J:76380
|
| increased CD8-positive, alpha-beta T cell number
|
J:76380
|
\Nfkb2tm2Brv/\Nfkb2tm2Brv
(involves: 129S1/Sv)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
| decreased gamma-delta T cell number
|
J:169863
|
\Nfkb2tm2Brv/\Nfkb2tm2Brv
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb2tm2Brv Tg(Tnfsf13b)1Fma)
|
decreased marginal zone B cell number
|
J:113556
|
\Nfkb2xdr/\Nfkb2xdr
(C57BL/6JSfdAnu-Nfkb2xdr/Anu)
|
decreased B-2 B cell number
|
J:79725
|
| decreased follicular B cell number
|
J:79725
|
| decreased marginal zone B cell number
|
J:79725
|
| decreased mature B cell number
|
J:79725
|
| decreased transitional stage T2 B cell number
|
J:79725
|
| increased B-1 B cell number
|
J:79725
|
\Nfkb2xdr/\Nfkb2xdr
(involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd * NOD)
|
decreased B cell number
|
J:79725
|
\Nfkbiatm1.1Pjc/\Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
abnormal T cell number
|
J:163686
|
| decreased CD4-positive, alpha-beta T cell number
|
J:163686
|
| decreased CD8-positive, alpha-beta T cell number
|
J:163686
|
| increased activated T cell number
|
J:163686
|
| increased double-positive T cell number
|
J:163686
|
| increased memory T cell number
|
J:163686
|
| increased thymocyte number
|
J:163686
|
\Nfkbiatm1.1Smiy/\Nfkbia+
(B6.129-Nfkbiatm1.1Smiy)
|
decreased B cell number
|
J:168977
|
| decreased follicular B cell number
|
J:168977
|
| decreased marginal zone B cell number
|
J:168977
|
| decreased transitional stage T2 B cell number
|
J:168977
|
| increased pro-B cell number
|
J:168977
|
\Nfkbiatm1.1Smiy/\Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy)
|
abnormal B cell differentiation
|
J:168977
|
| abnormal marginal zone B cell morphology
|
J:168977
|
| decreased B cell number
|
J:168977
|
| decreased B-2 B cell number
|
J:168977
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:168977
|
| decreased follicular B cell number
|
J:168977
|
| decreased marginal zone B cell number
|
J:168977
|
| decreased mature B cell number
|
J:168977
|
| decreased regulatory T cell number
|
J:168977
|
| decreased transitional stage T2 B cell number
|
J:168977
|
| increased immature B cell number
|
J:168977
|
| increased pre-B cell number
|
J:168977
|
| increased pro-B cell number
|
J:168977
|
\Nfkbiatm1Bal/\Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
decreased double-positive T cell number
|
J:30058
|
\Nfkbiatm1Bal/\Nfkbiatm1Bal
\Nfkbietm1Syme/\Nfkbietm1Syme
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:88142
|
| abnormal T cell differentiation
|
J:88142
|
| decreased immature B cell number
|
J:88142
|
| decreased pre-B cell number
|
J:88142
|
\Nfkbiatm1Fey/\Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:110817
|
| decreased double-negative T cell number
|
J:110817
|
| decreased thymocyte number
|
J:110817
|
| increased single-positive T cell number
|
J:110817
|
\Nfkbibtm1.2Rsch/\Nfkbibtm1.2Rsch
(B6.129P2-Nfkbibtm1.2Rsch)
|
decreased B cell number
|
J:176877
|
| increased marginal zone B cell number
|
J:176877
|
| increased memory T cell number
|
J:176877
|
\Nfkbidm1Btlr/\Nfkbidm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| absent marginal zone B cells
|
J:185495
|
| decreased B-1 B cell number
|
J:185495
|
| decreased B-1a cell number
|
J:185495
|
\Nfkbidtm1a(EUCOMM)Wtsi/\Nfkbid+
(C57BL/6N-Nfkbidtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased B cell number
|
J:165965
|
\Nfkbidtm1a(EUCOMM)Wtsi/\Nfkbidtm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:185495
|
\Nfkbietm1Syme/\Nfkbietm1Syme
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal double-negative T cell morphology
|
J:88538
|
\Nfkbiztm1Aki/\Nfkbiztm1Aki
(involves: 129P2/OlaHsd)
|
abnormal lymphocyte morphology
|
J:194832
|
| abnormal T-helper 1 cell morphology
|
J:194832
|
\Nhej1tm1.1Ics/\Nhej1+
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:194422
|
\Nhej1tm1.1Ics/\Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
| decreased lymphocyte cell number
|
J:194422
|
| decreased NK T cell number
|
J:194422
|
| decreased thymocyte number
|
J:194422
|
\Nhej1tm1.1Ics/\Nhej1tm1.1Ics
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
| decreased NK T cell number
|
J:194422
|
\Nhej1tm1Fwa/\Nhej1tm1Fwa
(involves: 129)
|
abnormal class switch recombination
|
J:138774
|
\Niban3tm1Jyw/\Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw)
|
abnormal B cell differentiation
|
J:282961
|
| abnormal class switch recombination
|
J:282961
|
| abnormal transitional stage B cell morphology
|
J:282961
|
| decreased B-1a cell number
|
J:282961
|
| increased B cell number
|
J:282961
|
| increased follicular B cell number
|
J:282961
|
| increased transitional stage T2 B cell number
|
J:282961
|
\Nipal3tm1Pbfd/\Nipal3tm1Pbfd
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased NK cell number
|
J:152829
|
\Nipsnap3atm1b(KOMP)Wtsi/\Nipsnap3atm1b(KOMP)Wtsi
(C57BL/6N-Nipsnap3atm1b(KOMP)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
\Nkaptm1.1Viss/Y
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:165961
|
| decreased CD4-positive, alpha-beta T cell number
|
J:165961
|
| decreased CD8-positive, alpha-beta T cell number
|
J:165961
|
| decreased DN4 thymocyte number
|
J:165961
|
| decreased double-positive T cell number
|
J:165961
|
| decreased thymocyte number
|
J:165961
|
| increased DN3 thymocyte number
|
J:165961
|
\Nkapd1tm1.1Tak/\Nkapd1tm1.1Tak
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal B cell differentiation
|
J:350073
|
\Nkapd1tm1.1Tak/\Nkapd1tm1.1Tak
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:350073
|
\Nkg7tm1.1(KOMP)Vlcg/\Nkg7tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:301637
|
| decreased CD4-positive, alpha-beta T cell number
|
J:301637
|
| decreased T helper 1 cell number
|
J:301637
|
\Nktcn1C57BL/6J/\Nktcn1C57BL/6J
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
\Nktcn1C57BL/6J/\Nktcn1C57BL/6J
(NOD.B6-(D1Mit369-D1Mit155)(D6Mit105-D6Mit135))
|
abnormal T cell differentiation
|
J:137521
|
| increased NK T cell number
|
J:137521
|
\Nktcn1C57BL/6J/\Nktcn1NOD/ShiLt
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
\Nktcn2C57BL/6J/\Nktcn2C57BL/6J
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
\Nktcn2C57BL/6J/\Nktcn2NOD/ShiLt
(involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))
|
increased NK T cell number
|
J:85376
|
\Nkx2-3tm1Hha/\Nkx2-3tm1Hha
(involves: 129S4/SvJae)
|
abnormal marginal zone B cell morphology
|
J:62129
|
| absent marginal zone B cells
|
J:62129
|
| decreased B cell number
|
J:62129
|
| decreased lymphocyte cell number
|
J:62129
|
| decreased T cell number
|
J:62129
|
\Nkx2-3tm1Rph/\Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:64018
|
| decreased plasma cell number
|
J:64018
|
\Nle1tm1Cba/\Nle1tm1.1Cota
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased NK cell number
|
J:204063
|
| decreased T cell number
|
J:204063
|
\Nlktm1Tbo/\Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo)
|
decreased double-positive T cell number
|
J:73353
|
| decreased gamma-delta T cell number
|
J:73353
|
| decreased lymphocyte cell number
|
J:73353
|
| decreased NK cell number
|
J:73353
|
| decreased pro-B cell number
|
J:73353
|
| decreased thymocyte number
|
J:73353
|
\Nlrc5tm1.1Ggaur/\Nlrc5tm1.1Ggaur
(involves: BALB/cJ)
|
decreased CD8-positive, alpha-beta T cell number
|
J:184076
|
\Nlrp1am1Btlr/\Nlrp1am1Btlr
(C57BL/6J-Nlrp1am1Btlr)
|
decreased B cell number
|
J:265173
|
| decreased B-1 B cell number
|
J:265173
|
| decreased B-1b cell number
|
J:265173
|
| decreased B-2 B cell number
|
J:265173
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265173
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:265173
|
| decreased NK cell number
|
J:265173
|
| decreased single-positive T cell number
|
J:265173
|
| decreased T cell number
|
J:265173
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265173
|
\Nlrp1am2Btlr/\Nlrp1am2Btlr
(C57BL/6J-Nlrp1am2Btlr)
|
decreased B cell number
|
J:265174
|
| decreased NK cell number
|
J:265174
|
\Nlrp1aNeut1/\Nlrp1aNeut1
(C.B6-Nlrp1aNeut1)
|
decreased lymphocyte cell number
|
J:191055
|
\Nlrp3tm1Hhf/\Nlrp3+
\Rag1tm1Mom/\Rag1tm1Mom
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
absent B cells
|
J:150054
|
| absent T cells
|
J:150054
|
\Nlrp3tm1Wstr/\Nlrp3+
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:150053
|
| increased activated T cell number
|
J:150053
|
| increased T-helper 1 cell number
|
J:150053
|
\Nlrp3tm3.1Hhf/\Nlrp3+
(involves: 129)
|
decreased lymphocyte cell number
|
J:202147
|
| increased lymphocyte cell number
|
J:202147
|
\Nlrp6tm1Flv/\Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
increased B cell number
|
J:173245
|
\Nmt1tm1.1Poru/\Nmt1tm1.1Poru
\Nmt2tm1.1Poru/\Nmt2tm1.1Poru
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:226234
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:226234
|
| decreased DN4 thymocyte number
|
J:226234
|
| decreased double-positive T cell number
|
J:226234
|
| decreased single-positive T cell number
|
J:226234
|
| decreased T cell number
|
J:226234
|
| increased double-negative T cell number
|
J:226234
|
| increased gamma-delta T cell number
|
J:226234
|
\Nmt1tm1.1Poru/\Nmt1tm1.1Poru
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:226234
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:226234
|
| decreased double-positive T cell number
|
J:226234
|
| decreased single-positive T cell number
|
J:226234
|
| decreased T cell number
|
J:226234
|
\Nmt2tm1.1Poru/\Nmt2tm1.1Poru
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased double-positive T cell number
|
J:226234
|
| decreased single-positive T cell number
|
J:226234
|
| decreased T cell number
|
J:226234
|
\Noc2ltm1.1Arte/\Noc2ltm1.1Arte
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal B cell morphology
|
J:216490
|
| abnormal T cell morphology
|
J:216490
|
| absent T cells
|
J:216490
|
| arrested T cell differentiation
|
J:216490
|
| decreased alpha-beta T cell number
|
J:216490
|
| decreased DN3 thymocyte number
|
J:216490
|
| decreased DN4 thymocyte number
|
J:216490
|
| decreased double-positive T cell number
|
J:216490
|
| decreased immature B cell number
|
J:216490
|
| decreased mature B cell number
|
J:216490
|
| decreased pre-B cell number
|
J:216490
|
| decreased pro-B cell number
|
J:216490
|
| decreased single-positive T cell number
|
J:216490
|
\Noc2ltm1.1Arte/\Noc2ltm1.1Arte
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased pre-B cell number
|
J:216490
|
\Nod2tm1Jhgt/\Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt)
|
increased CD4-positive, alpha-beta T cell number
|
J:124575
|
| increased double-negative T cell number
|
J:124575
|
\Nop53tm2.1Asuz/\Nop53tm2.1Asuz
\Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
\Nop53tm2.1Asuz/\Nop53tm2.1Asuz
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte number
|
J:241062
|
\Nos2tm1Lau/\Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
increased single-positive T cell number
|
J:90903
|
\Nos3em1(IMPC)Mbp/\Nos3em1(IMPC)Mbp
(C57BL/6N-Nos3em1(IMPC)Mbp/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Notch1tm1Agt/\Notch1tm1Agt
\Notch2tm1Frad/\Notch2tm1Frad
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:125373
|
| arrested T cell differentiation
|
J:125373
|
\Notch1tm1Agt/\Notch1tm1Agt
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
| abnormal T cell differentiation
|
J:125373,
J:55400
|
| decreased CD4-positive, alpha-beta T cell number
|
J:55400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:55400
|
| decreased double-negative T cell number
|
J:55400
|
| decreased double-positive T cell number
|
J:55400
|
| decreased single-positive T cell number
|
J:55400
|
| decreased thymocyte number
|
J:55400
|
| increased immature B cell number
|
J:143472
|
\Notch1tm2Pst/\Notch1tm2Pst
(B6.Cg-Notch1tm2Pst)
|
abnormal T cell differentiation
|
J:131563
|
| decreased double-negative T cell number
|
J:131563
|
| decreased T cell number
|
J:131563
|
| decreased thymocyte number
|
J:131563
|
\Notch2Gt(betageo)1Byg/\Notch2+
(B6.129P2-Notch2Gt(betageo)1Byg)
|
decreased marginal zone B cell number
|
J:146621
|
\Notch2tm1Frad/\Notch2tm1Frad
\Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
| absent marginal zone B cells
|
J:125373
|
\Notch2tm1Yha/\Notch2+
(B6.129-Notch2tm1Yha)
|
decreased B-1 B cell number
|
J:85379
|
| decreased marginal zone B cell number
|
J:85379
|
\Notch2tm2Hhi/\Notch2tm1.1Hhi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased marginal zone B cell number
|
J:83476
|
\Notch3tm1Khan/\Notch3tm1Khan
(involves: C57BL/6 * CBA)
|
decreased thymocyte number
|
J:98284
|
\Npas2em1(IMPC)Mbp/\Npas2em1(IMPC)Mbp
(C57BL/6N-Npas2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Npc2tm1Plob/\Npc2tm1Plob
(involves: 129S1/Sv * C57BL/6)
|
decreased NK cell number
|
J:125609
|
\Npc2tm1Plob/\Npc2tm1Plob
(C.129S1-Npc2tm1Plob)
|
decreased NK cell number
|
J:125609
|
\Npm1tm1Gsva/\Npm1+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:172071
|
\Npy1rtm1.1Wpg/\Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T cell number
|
J:118850
|
| decreased B cell number
|
J:118850
|
| decreased CD8-positive, alpha-beta T cell number
|
J:118850
|
| decreased marginal zone B cell number
|
J:118850
|
| decreased mature B cell number
|
J:118850
|
| decreased transitional stage B cell number
|
J:118850
|
| increased CD4-positive, alpha-beta T cell number
|
J:118850
|
| increased CD8-positive, alpha-beta T cell number
|
J:118850
|
| increased single-positive T cell number
|
J:118850
|
\Nqo2tm1Akj/\Nqo2tm1Akj
(Not Specified)
|
abnormal lymphopoiesis
|
J:80549
|
\Nr1d1tm1(KOMP)Vlcg/\Nr1d1tm1(KOMP)Vlcg
(C57BL/6N-Nr1d1tm1(KOMP)Vlcg/Bay)
|
decreased NK cell number
|
J:211773
|
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda
\Rag2tm1.1Cgn/\Rag2tm1.1Cgn
\Tg(Lck-cre)548Jxm/0
\Tg(TcrAND)53Hed/0
(B6.Cg-Rag2tm1.1Cgn Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed)
|
decreased double-positive T cell number
|
J:189951
|
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda
\Tcratm1Mom/\Tcratm1Mom
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Tcratm1Mom Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased double-positive T cell number
|
J:189951
|
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased CD4-positive, alpha-beta T cell number
|
J:189951
|
| decreased CD8-positive, alpha-beta T cell number
|
J:189951
|
| decreased double-positive T cell number
|
J:189951
|
| decreased single-positive T cell number
|
J:189951
|
\Nr3c1tm1Dage/\Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:147914
|
\Nr3c1tm1Dage/\Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:147914
|
| decreased CD4-positive, alpha-beta T cell number
|
J:147914
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147914
|
\Nr4a1tm1Jmi/\Nr4a1tm1Jmi
\Nr4a3tm1Omc/\Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
decreased lymphocyte cell number
|
J:121903
|
\Nr4a2tm1.1Pcn/\Nr4a2+
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal regulatory T cell morphology
|
J:205658
|
\Nr4a2tm1.1Pcn/\Nr4a2tm1.1Pcn
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal regulatory T cell morphology
|
J:205658
|
| abnormal T-helper 1 cell differentiation
|
J:205658
|
| abnormal T-helper 17 cell differentiation
|
J:205658
|
\Nr4a2tm1.1Pcn/\Nr4a2tm1.1Pcn
\Tg(Lck-cre)1Jtak/0
(Not Specified)
|
abnormal regulatory T cell morphology
|
J:205658
|
| abnormal T-helper 1 cell differentiation
|
J:205658
|
| abnormal T-helper 17 cell differentiation
|
J:205658
|
| decreased regulatory T cell number
|
J:205658
|
| increased CD4-positive, alpha-beta T cell number
|
J:205658
|
| increased T-helper 1 cell number
|
J:205658
|
\Nrastm1.1Emfu/\Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N)
|
increased T cell number
|
J:189834
|
\Nrbp1tm3b(EUCOMM)Wtsi/\Nrbp1+
(C57BL/6N-Nrbp1tm3b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
\Nrxn1tm1b(KOMP)Wtsi/\Nrxn1tm1b(KOMP)Wtsi
(C57BL/6N-Nrxn1tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Nsg1tm1.1(KOMP)Vlcg/\Nsg1tm1.1(KOMP)Vlcg
(C57BL/6N-Nsg1tm1.1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Nsrp1tm1.1Cdj/\Nsrp1tm1.1Cdj
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell number
|
J:306261
|
| decreased CD4-positive, alpha-beta T cell number
|
J:306261
|
| decreased CD8-positive, alpha-beta T cell number
|
J:306261
|
| increased memory T cell number
|
J:306261
|
\Nsun5tm2b(EUCOMM)Wtsi/\Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6N-Nsun5tm2b(EUCOMM)Wtsi/J)
|
decreased lymphocyte cell number
|
J:211773
|
\Ntrk1tm1Tes/\Ntrk1tm1Tes
\Tg(Tuba1-cre)1Tes/0
(involves: 129S1/Sv)
|
increased B-1 B cell number
|
J:93578
|
\Nub1tm1b(EUCOMM)Hmgu/\Nub1tm1b(EUCOMM)Hmgu
(C57BL/6N-Nub1tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD5-positive Ly6C-positive T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive NK T cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
\Nudcd3em1(IMPC)Wtsi/\Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi)
|
abnormal immunoglobulin light chain V-J recombination
|
J:351330
|
| abnormal T cell differentiation
|
J:351330
|
| abnormal T cell receptor V(D)J recombination
|
J:351330
|
| decreased NK T cell number
|
J:351330
|
| increased DN3 thymocyte number
|
J:351330
|
| increased double-negative T cell number
|
J:351330
|
| increased double-positive T cell number
|
J:351330
|
| increased memory T cell number
|
J:351330
|
| increased pre-B cell number
|
J:351330
|
\Nuggctm1Diaz/\Nuggctm1Diaz
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal somatic hypermutation frequency
|
J:190402
|
\Nup98tm1Bmaf/\Nup98+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased B cell number
|
J:110907
|
| decreased CD4-positive, alpha-beta T cell number
|
J:110907
|
\Nup210enuI476T/\Nup210enuI476T
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal alpha-beta T cell morphology
|
J:266693
|
| decreased CD4-positive, alpha-beta T cell number
|
J:266693
|
\Nup210enuI476T/\Nup210tm1a(EUCOMM)Hmgu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:266693
|
\Nup210tm1.1Mdan/\Nup210tm1.1Mdan
(B6.Cg-Nup210tm1.1Mdan)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:282451
|
| abnormal lymphocyte morphology
|
J:282451
|
| decreased CD4-positive, alpha-beta T cell number
|
J:282451
|
| increased effector memory T-helper cell number
|
J:282451
|
\Nup210tm1b(EUCOMM)Hmgu/\Nup210tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
decreased alpha-beta T cell number
|
J:266693
|
| decreased CD4-positive, alpha-beta T cell number
|
J:266693
|
| decreased CD8-positive, alpha-beta T cell number
|
J:266693
|
| decreased T cell number
|
J:266693
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:266693
|
| increased CD8-positive, alpha-beta T cell number
|
J:266693
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:266693
|
| increased T-helper 1 cell number
|
J:266693
|
\Nwd2em1(IMPC)Ccpcz/\Nwd2em1(IMPC)Ccpcz
(C57BL/6N-Nwd2em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Nxntm1b(EUCOMM)Wtsi/\Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Ociad1tm1.1Msin/\Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased B cell number
|
J:279239
|
| decreased T cell number
|
J:279239
|
\Ogttm1Gwh/Y
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:93112
|
| decreased CD8-positive, alpha-beta T cell number
|
J:93112
|
| decreased double-positive T cell number
|
J:93112
|
| decreased T cell number
|
J:93112
|
| decreased thymocyte number
|
J:93112
|
\Orai1tm1.1Hjm/\Orai1tm1.1Hjm
\Orai2tm1.1(KOMP)Vlcg/\Orai2tm1.1(KOMP)Vlcg
\Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Orai1tm1.1Hjm Orai2tm1.1(KOMP)Vlcg)
|
abnormal CD4-positive helper T cell morphology
|
J:241365
|
| decreased germinal center B cell number
|
J:241365
|
| decreased regulatory T cell number
|
J:241365
|
| decreased single-positive T cell number
|
J:241365
|
\Otub1tm1c(EUCOMM)Hmgu/\Otub1tm1c(EUCOMM)Hmgu
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal follicular B cell morphology
|
J:280549
|
| decreased B-1 B cell number
|
J:280549
|
| decreased immature B cell number
|
J:280549
|
| decreased T cell number
|
J:280549
|
| increased B cell number
|
J:280549
|
| increased B-2 B cell number
|
J:280549
|
| increased marginal zone B cell number
|
J:280549
|
| increased mature B cell number
|
J:280549
|
\Otud5tm1Vmd/\Otud5tm1Vmd
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
| decreased regulatory T cell number
|
J:219495
|
| decreased thymocyte number
|
J:219495
|
\Otud5tm1Vmd/\Otud5tm1Vmd
\Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
\Otud7btm1Dgen/\Otud7btm1Dgen
(involves: 129 * C57BL/6)
|
increased B cell number
|
J:194553
|
\P2rx5tm1Lex/\P2rx5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:82809
|
| increased NK cell number
|
J:82809
|
\Pag1tm1Kplm/\Pag1tm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte number
|
J:101365
|
\Pank2em1(IMPC)Ccpcz/\Pank2em1(IMPC)Ccpcz
(C57BL/6NCrl-Pank2em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Pank3tm1b(KOMP)Mbp/\Pank3tm1b(KOMP)Mbp
(C57BL/6N-Pank3tm1b(KOMP)Mbp/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
\Parltm1.1Bdes/\Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell morphology
|
J:116017
|
| decreased B cell number
|
J:116017
|
| decreased double-positive T cell number
|
J:116017
|
| decreased lymphocyte cell number
|
J:116017
|
\Parp1tm1b(EUCOMM)Hmgu/\Parp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Parp1tm1b(EUCOMM)Hmgu/Ics)
|
decreased NK cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Parp14Gt(OST415485)Lex/\Parp14Gt(OST415485)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased marginal zone B cell number
|
J:146533
|
| increased follicular B cell number
|
J:146533
|
\Parvbtm1a(EUCOMM)Wtsi/\Parvbtm1a(EUCOMM)Wtsi
(C57BL/6N-Parvbtm1a(EUCOMM)Wtsi/Cnrm)
|
decreased mature B cell number
|
J:165965
|
| decreased NK cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
\Patz1tm1.1Welm/\Patz1tm1.1Welm
(involves: 129P2/OlaHsd)
|
abnormal T cell subpopulation ratio
|
J:158947
|
| decreased thymocyte number
|
J:158947
|
\Patz1tm1.1Welm/\Patz1tm1.1Welm
\Tg(TcraTcrb)425Cbn/0
(involves: C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:158947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158947
|
| increased CD4-positive, alpha-beta T cell number
|
J:158947
|
\Patz1tm1.1Welm/\Patz1tm1.1Welm
\Tg(TcraTcrb)1100Mjb/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:158947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158947
|
| increased CD4-positive, alpha-beta T cell number
|
J:158947
|
\Pawrtm1Jmos/\Pawrtm1Jmos
(involves: 129/Sv * CD-1)
|
increased lymphocyte cell number
|
J:85495
|
\Pax1un-i/\Pax1+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased CD4-positive, alpha-beta T cell number
|
J:100951
|
| decreased CD8-positive, alpha-beta T cell number
|
J:100951
|
| decreased thymocyte number
|
J:100951
|
\Pax1un-i/\Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased CD4-positive, alpha-beta T cell number
|
J:100951
|
| decreased CD8-positive, alpha-beta T cell number
|
J:100951
|
| decreased double-negative T cell number
|
J:100951
|
| decreased double-positive T cell number
|
J:100951
|
| decreased thymocyte number
|
J:100951
|
| increased double-negative T cell number
|
J:100951
|
\Pax1un/\Pax1+
\Tcf3tm1Cmu/\Tcf3tm1Cmu
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:103567
|
| abnormal T cell subpopulation ratio
|
J:103567
|
\Pax5m1Btlr/\Pax5m1Btlr
(C57BL/6J-Pax5m1Btlr)
|
decreased B cell number
|
J:220072
|
| increased single-positive T cell number
|
J:220072
|
| increased T cell number
|
J:220072
|
\Pax5m2Btlr/\Pax5+
(C57BL/6J-Pax5m2Btlr)
|
decreased B-1b cell number
|
J:254824
|
\Pax5m2Btlr/\Pax5m2Btlr
(C57BL/6J-Pax5m2Btlr)
|
decreased B-1b cell number
|
J:254824
|
| increased B-1 B cell number
|
J:254824
|
\Pax5m3Btlr/\Pax5+
(C57BL/6J-Pax5m3Btlr)
|
decreased B cell number
|
J:254825
|
\Pax5m3Btlr/\Pax5m3Btlr
(C57BL/6J-Pax5m3Btlr)
|
decreased B cell number
|
J:254825
|
| decreased B-1 B cell number
|
J:254825
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254825
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254825
|
\Pax5tm1b(EUCOMM)Wtsi/\Pax5+
(C57BL/6N-Pax5tm1b(EUCOMM)Wtsi/Ieg)
|
increased CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
\Pax5tm1Mbu/\Pax5tm1Mbu
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:38813
|
| abnormal lymphopoiesis
|
J:38813
|
| absent B-2 B cells
|
J:113076
|
| absent mature B cells
|
J:113076
|
| arrested B cell differentiation
|
J:113076
|
| decreased B cell number
|
J:113076
|
| decreased B-1 B cell number
|
J:113076
|
| decreased immature B cell number
|
J:113076
|
| increased T cell number
|
J:113076
|
\Pax5tm1Mbu/\Pax5tm1Mbu
(involves: 129S2/SvPas)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:139510
|
| arrested B cell differentiation
|
J:75504
|
\Pax5tm1Mbu/\Pax5tm1Mbu
(either: 129 or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal late pro-B cell
|
J:21935
|
| abnormal lymphopoiesis
|
J:21935
|
| absent late pro-B cells
|
J:21935
|
| arrested B cell differentiation
|
J:21935
|
\Pax5tm1Mbu/\Pax5tm3Mbu
\Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
decreased mature B cell number
|
J:75504
|
\Pax5tm3.1Mbu/\Pax5tm3.1Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:75504
|
\Pax5tm3Mbu/\Pax5+
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:226241
|
| arrested B cell differentiation
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
\Paxxem1Spj/\Paxxem1Spj
(C57BL/6NTac-Paxxem1Spj)
|
decreased B cell number
|
J:236776
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236776
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236776
|
| decreased follicular B cell number
|
J:236776
|
| decreased T cell number
|
J:236776
|
| decreased transitional stage B cell number
|
J:236776
|
| increased mature B cell number
|
J:236776
|
\Paxxem1Spj/\Paxxem1Spj
\Nhej1tm1Fwa/\Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
absent lymphocyte
|
J:236776
|
\Pbbcp1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased B cell number
|
J:74270
|
\Pbrm1tm1Zhwa/\Pbrm1tm1Zhwa
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:236906
|
\Pbx1tm1Mlc/\Pbx1tm2.1Mlc
(involves: 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:132963
|
| decreased CD8-positive, alpha-beta T cell number
|
J:132963
|
| decreased mature B cell number
|
J:132963
|
\Pbx1tm1Mlc/\Pbx1tm3.1Mlc
\Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased B cell number
|
J:149799
|
| decreased double-negative T cell number
|
J:149799
|
| decreased pre-B cell number
|
J:149799
|
| decreased pro-B cell number
|
J:149799
|
| decreased T cell number
|
J:149799
|
\Pbx4em2Hncs/\Pbx4em2Hncs
(involves: C57BL/6J * DBA * ICR)
|
decreased lymphocyte cell number
|
J:349843
|
\Pcd4ts1DBA/2/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Pcd4ts2BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Pcd4ts3BALB/c/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83220
|
\Pcd8ts1C57BL/6/?
(involves: BALB/c * C3H * C57BL/6 * DBA/2)
|
increased CD8-positive, alpha-beta T cell number
|
J:83220
|
\Pcgf2tm1Hko/\Pcgf2tm1Hko
(involves: BALB/c * C57BL/6)
|
decreased lymphocyte cell number
|
J:71268
|
| decreased thymocyte number
|
J:71268
|
\Pcid2tm1Imku/\Pcid2tm1Imku
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased follicular B cell number
|
J:166080
|
| decreased marginal zone B cell number
|
J:166080
|
| decreased mature B cell number
|
J:166080
|
\Pclaftm1a(EUCOMM)Wtsi/\Pclaftm1a(EUCOMM)Wtsi
(C57BL/6N-Pclaftm1a(EUCOMM)Wtsi/Wtsi)
|
decreased immature NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| increased mature NK cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased pro-B cell number
|
J:211773
|
\Pcnatm1.1Mdsc/\Pcnatm1.1Mdsc
\Tg(Pcna*K164R)1Mdsc/0
(involves: FVB/N)
|
abnormal class switch recombination
|
J:141098
|
| abnormal somatic hypermutation frequency
|
J:141098
|
\Pcnatm1Jcbs/\Pcnatm1Jcbs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:125916
|
\Pcnatm1Jcbs/\Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454,
J:177630
|
\Pcnatm1Jcbs/\Pcnatm1Jcbs
\Ungtm1Tld/\Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
\Pcsk1tm1Dfs/\Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:184882
|
| decreased NK T cell number
|
J:184882
|
| decreased T cell number
|
J:184882
|
| increased lymphocyte cell number
|
J:184882
|
\Pcsk9em1(IMPC)Ccpcz/\Pcsk9em1(IMPC)Ccpcz
(C57BL/6NCrl-Pcsk9em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Pdap1em1Rkuhn/\Pdap1em1Rkuhn
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal class switch recombination
|
J:298705
|
| abnormal somatic hypermutation frequency
|
J:298705
|
| decreased germinal center B cell number
|
J:298705
|
| decreased mature B cell number
|
J:298705
|
\Pdcd1tm1.1Liux/\Pdcd1tm1.1Liux
(involves: C57BL/6)
|
decreased regulatory T cell number
|
J:190150
|
| increased T-helper 1 cell number
|
J:190150
|
\Pdcd1tm1.1Liux/\Pdcd1tm1.1Liux
\Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N)
|
decreased regulatory T cell number
|
J:190150
|
| decreased T-helper 2 cell number
|
J:190150
|
| decreased T-helper 17 cell number
|
J:190150
|
| increased T-helper 1 cell number
|
J:190150
|
\Pdcd1tm1.1Shr/\Pdcd1tm1.1Shr
(involves: C57BL/6)
|
decreased B-1 B cell number
|
J:153040
|
| increased regulatory T cell number
|
J:153040
|
\Pdcd1tm1Hon/\Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6)
|
increased B cell number
|
J:50688
|
| increased B-1 B cell number
|
J:50688
|
| increased lymphocyte cell number
|
J:50688
|
\Pdcd1tm1Llc/\Pdcd1tm1Llc
(involves: 129S5/SvEvBrd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126829
|
\Pdcd1lg2tm1.1Lex/\Pdcd1lg2tm1.1Lex
(involves: 129S5/SvEvBrd)
|
decreased CD8-positive, alpha-beta T cell number
|
J:126829
|
\Pdcd1lg2tm3Shr/\Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
|
increased CD4-positive, alpha-beta T cell number
|
J:123785
|
| increased CD8-positive, alpha-beta T cell number
|
J:123785
|
\Pdgfctm1b(EUCOMM)Hmgu/\Pdgfc+
(C57BL/6N-Pdgfctm1b(EUCOMM)Hmgu/Ieg)
|
increased CD4-negative, CD25-positive NK T cell number
|
J:211773
|
\Pdgfraem1(IMPC)Ccpcz/\Pdgfra+
(C57BL/6NCrl-Pdgfraem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
\Pdia6em1Btlr/\Pdia6m1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:288824
|
| decreased double-negative T cell number
|
J:288824
|
| decreased double-positive T cell number
|
J:288824
|
| decreased follicular B cell number
|
J:288824
|
| decreased lymphocyte cell number
|
J:288824
|
| decreased NK T cell number
|
J:288824
|
| decreased pre-B cell number
|
J:288824
|
| decreased transitional stage B cell number
|
J:288824
|
| increased marginal zone B cell number
|
J:288824
|
| increased marginal zone precursor B cell number
|
J:288824
|
| increased mature B cell number
|
J:288824
|
\Pdia6tm1b(EUCOMM)Hmgu/\Pdia6+
(C57BL/6N-Pdia6tm1b(EUCOMM)Hmgu/Ieg)
|
decreased CD4-positive NK T cell number
|
J:211773
|
\Pdlim7Gt(OST445990)Lex/\Pdlim7Gt(OST445990)Lex
(B6.129S5-Pdlim7Gt(OST445990)Lex)
|
increased lymphocyte cell number
|
J:209780
|
\Pdpk1tm1.1Mlw/\Pdpk1tm1.1Mlw
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell number
|
J:226194
|
\Pdpk1tm1Mlw/\Pdpk1tm1.1Daca
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:165626
|
| decreased NK T cell number
|
J:165626
|
| decreased T cell number
|
J:165626
|
\Pdpk1tm1Mlw/\Pdpk1tm1Mlw
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:165626
|
| abnormal NK T cell morphology
|
J:165626
|
| abnormal T cell differentiation
|
J:165626
|
| absent NK T cells
|
J:165626
|
| decreased NK T cell number
|
J:165626
|
| decreased T cell number
|
J:165626
|
\Pdpntm2.1Mlkn/\Pdpntm2.1Mlkn
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Pdgfrb-cre)9Rha/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
absent lymphocyte
|
J:205423
|
\Pdprtm1b(EUCOMM)Wtsi/\Pdprtm1b(EUCOMM)Wtsi
(C57BL/6N-Pdprtm1b(EUCOMM)Wtsi/Ics)
|
decreased large unstained cell number
|
J:211773
|
\Pdzd8tm1b(EUCOMM)Wtsi/\Pdzd8+
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased large unstained cell number
|
J:211773
|
\Penk-rstm1Pig/\Penk-rstm1Pig
(B6.129-Penk-rstm1Pig)
|
decreased T-helper 2 cell number
|
J:62435
|
\Pepdtm1a(KOMP)Wtsi/\Pepdtm1a(KOMP)Wtsi
(C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd)
|
decreased immature B cell number
|
J:211773
|
| decreased Ly6C-positive NK T cell number
|
J:211773
|
| decreased transitional stage T1 B cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
\Pepdtm1b(KOMP)Wtsi/\Pepdtm1b(KOMP)Wtsi
(C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg)
|
decreased B-1a cell number
|
J:211773
|
| decreased CD5-positive Ly6C-positive T cell number
|
J:211773
|
| decreased follicular B cell number
|
J:211773
|
\PfasSofa-2J/\Pfas+
(B6(Cg)-PfasSofa-2J/GrsrJ)
|
abnormal transitional stage B cell morphology
|
J:223062
|
\Pfdn1Gt(GTR1.3)1Rul/\Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
abnormal B cell differentiation
|
J:137415
|
| abnormal B cell morphology
|
J:137415
|
| decreased B-1 B cell number
|
J:137415
|
| decreased B-2 B cell number
|
J:137415
|
| decreased pre-B cell number
|
J:137415
|
\Pfkfb2tm1b(KOMP)Wtsi/\Pfkfb2tm1b(KOMP)Wtsi
(C57BL/6N-Pfkfb2tm1b(KOMP)Wtsi/Nju)
|
increased lymphocyte cell number
|
J:211773
|
\Pgam1tm1.1Hiko/\Pgam1tm1.1Hiko
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:293746
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:293746
|
| abnormal effector T cell number
|
J:293746
|
| decreased CD4-positive, alpha-beta T cell number
|
J:293746
|
| decreased CD8-positive, alpha-beta T cell number
|
J:293746
|
| decreased NK T cell number
|
J:293746
|
| decreased T-helper 2 cell number
|
J:293746
|
| decreased T-helper 17 cell number
|
J:293746
|
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(involves: 129 * C57BL/6)
|
abnormal T cell morphology
|
J:181221
|
\Pgap3tm1.1Ymra/\Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
|
abnormal T-helper 2 cell differentiation
|
J:203443
|
\Pgap4em1Osbir/\Pgap4em1Osbir
(involves: C57BL/6NSlc)
|
increased Ly6C-positive immature NK cell number
|
J:333707
|
\Pgdtm1.1Pse/\Pgdtm1.1Pse
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal CD4-positive helper T cell morphology
|
J:313817
|
| increased T cell number
|
J:313817
|
\Pgdtm1.1Pse/\Pgdtm1.1Pse
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal alpha-beta T cell morphology
|
J:306553
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:306553
|
| abnormal T cell differentiation
|
J:306553
|
| decreased CD4-positive, alpha-beta T cell number
|
J:306553
|
| decreased CD8-positive, alpha-beta T cell number
|
J:306553
|
\Pgfem1(IMPC)Ccpcz/\Pgfem1(IMPC)Ccpcz
(C57BL/6NCrl-Pgfem1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
\Pgm3Gt(W037B08)Wrst/\Pgm3mld1
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:125094
|
| absent follicular B cells
|
J:125094
|
| decreased B cell number
|
J:125094
|
| decreased T cell number
|
J:125094
|
| increased pro-B cell number
|
J:125094
|
\Pgm3mld1/\Pgm3mld1
(C57BL/6-Pgm3mld1)
|
absent follicular B cells
|
J:125094
|
| decreased B cell number
|
J:125094
|
| increased pro-B cell number
|
J:125094
|
\Pgrmc2tm1.1Jjp/\Pgrmc2tm1.1Jjp
\Pgrtm2(cre)Lyd/\Pgr+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased uterine NK cell number
|
J:247103
|
\Phb1em1(IMPC)H/\Phb1+
(C57BL/6NTac-Phb1em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
\Phc1tm1Os/\Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:75707
|
\Phf6em1Wencc/Y
\Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
abnormal effector T cell number
|
J:278804
|
| decreased CD4-positive, alpha-beta T cell number
|
J:278804
|
| decreased CD8-positive, alpha-beta T cell number
|
J:278804
|
| decreased double-negative T cell number
|
J:278804
|
| decreased lymphocyte cell number
|
J:278804
|
| increased B cell number
|
J:278804
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:278804
|
| increased pro-B cell number
|
J:278804
|
\Phf6em1Wencc/\Phf6em1Wencc
\Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
abnormal effector T cell number
|
J:278804
|
| decreased CD4-positive, alpha-beta T cell number
|
J:278804
|
| decreased CD8-positive, alpha-beta T cell number
|
J:278804
|
| decreased double-negative T cell number
|
J:278804
|
| decreased lymphocyte cell number
|
J:278804
|
| increased B cell number
|
J:278804
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:278804
|
| increased pro-B cell number
|
J:278804
|
\Phf6tm1.1Avo/Y
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:276228
|
| decreased DN2 thymocyte number
|
J:276228
|
\Phf8tm1dIcs/\Phf8tm1dIcs
(C57BL/6N-Phf8tm1dIcs/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Phf20Gt(XN131)Byg/\Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:228714
|
| decreased double-positive T cell number
|
J:228714
|
| decreased thymocyte number
|
J:228714
|
| increased double-negative T cell number
|
J:228714
|
\Phf20l1em1(IMPC)Tcp/\Phf20l1em1(IMPC)Tcp
(C57BL/6N-Phf20l1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Phyhtm1b(EUCOMM)Wtsi/\Phyhtm1b(EUCOMM)Wtsi
(C57BL/6N-Phyhtm1b(EUCOMM)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Pi4kam2Btlr/\Pi4kam2Btlr
(C57BL/6J-Pi4kam2Btlr)
|
increased alpha-beta T cell number
|
J:272852
|
| increased CD4-positive, alpha-beta T cell number
|
J:272852
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272852
|
\Pi16Gt(OST292194)Lex/\Pi16Gt(OST292194)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased regulatory T cell number
|
J:94077
|
\Picalmtm1.1Tmae/\Picalmtm1.1Tmae
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:220728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:220728
|
\Picalmtm1.1Tmae/\Picalmtm1.1Tmae
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:220728
|
| decreased CD8-positive, alpha-beta T cell number
|
J:220728
|
\Picalmtm1Towa/\Picalmtm1Towa
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B cell differentiation
|
J:185312
|
\Pigatm1Tak/\Pigatm1Tak
\Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca)
|
abnormal T cell morphology
|
J:162065
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:162065
|
\Pigrtm1Ohw/\Pigrtm1Ohw
(B6.129X1-Pigrtm1Ohw)
|
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:97824
|
| abnormal intraepithelial T cell number
|
J:97824
|
\Pigrtm1Ohw/\Pigrtm1Ohw
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
decreased lymphocyte cell number
|
J:97824
|
\Pik3ap1m1Btlr/\Pik3ap1m1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
\Pik3ap1m2Btlr/\Pik3ap1m2Btlr
(C57BL/6J-Pik3ap1m2Btlr)
|
decreased B-1a cell number
|
J:255271
|
| increased B-1b cell number
|
J:255271
|
\Pik3ap1M3Btlr/\Pik3ap1M3Btlr
(C57BL/6J-Pik3ap1M3Btlr)
|
decreased B-1 B cell number
|
J:272019
|
\Pik3ap1tm1b(KOMP)Wtsi/\Pik3ap1tm1b(KOMP)Wtsi
(C57BL/6N-Pik3ap1tm1b(KOMP)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
\Pik3ap1tm1Kuro/\Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:75075
|
| absent B-1a cells
|
J:84669
|
| decreased B cell number
|
J:84669
|
| decreased follicular B cell number
|
J:84669
|
| decreased pre-B cell number
|
J:75075
|
\Pik3c2aGt(OST288105)Lex/\Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased B cell number
|
J:169710
|
| increased CD4-positive, alpha-beta T cell number
|
J:169710
|
| increased CD8-positive, alpha-beta T cell number
|
J:169710
|
\Pik3c2atm1b(EUCOMM)Hmgu/\Pik3c2a+
(C57BL/6N-Pik3c2atm1b(EUCOMM)Hmgu/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Pik3c3tm1.1Flv/\Pik3c3tm1.1Flv
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal T cell number
|
J:184753
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184753
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184753
|
\Pik3c3tm1.1Flv/\Pik3c3tm1.1Flv
\Tg(Cd8a-cre)1Itan/0
(involves: C57BL/6 * C57BL/6N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:184753
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:184753
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184753
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184753
|
| decreased lymphocyte cell number
|
J:184753
|
\Pik3cdem1.1Pls/\Pik3cd+
(Not Specified)
|
abnormal B cell differentiation
|
J:282486
|
| abnormal class switch recombination
|
J:282486
|
| abnormal plasmablast number
|
J:282486
|
| decreased CD4-positive, alpha-beta T cell number
|
J:282486
|
| decreased follicular B cell number
|
J:282486
|
| decreased naive B cell number
|
J:282486
|
| increased activated T cell number
|
J:282486
|
| increased B-1a cell number
|
J:282486
|
| increased germinal center B cell number
|
J:282486
|
| increased lymphocyte cell number
|
J:282486
|
| increased marginal zone B cell number
|
J:282486
|
| increased plasma cell number
|
J:282486
|
| increased T follicular helper cell number
|
J:282486
|
| increased transitional stage B cell number
|
J:282486
|
| increased transitional stage T1 B cell number
|
J:282486
|
\Pik3cdGt(OST451938)Lex/\Pik3cdGt(OST451938)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased lymphocyte cell number
|
J:103485
|
\Pik3cdm2Btlr/\Pik3cd+
(C57BL/6J-Pik3cdm2Btlr)
|
decreased B-1 B cell number
|
J:236693
|
\Pik3cdm2Btlr/\Pik3cdm2Btlr
(C57BL/6J-Pik3cdm2Btlr)
|
decreased B-1 B cell number
|
J:236693
|
| decreased B-1a cell number
|
J:236693
|
\Pik3cdtm1.1Bvan/\Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell differentiation
|
J:78412
|
| decreased B-1 B cell number
|
J:78412
|
\Pik3cdtm1Jni/\Pik3cdtm1Jni
(involves: 129P2/OlaHsd)
|
absent B-1 B cells
|
J:80614
|
| decreased B cell number
|
J:80614
|
| decreased mature B cell number
|
J:80614
|
\Pik3cdtm1Jni/\Pik3cdtm1Jni
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
| decreased NK cell number
|
J:124330
|
| decreased T cell number
|
J:124330
|
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:79133
|
| decreased B-1 B cell number
|
J:79133
|
| decreased B-2 B cell number
|
J:79133
|
| decreased marginal zone B cell number
|
J:79133
|
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:125791
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125791
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125791
|
| decreased double-positive T cell number
|
J:125791
|
| decreased lymphocyte cell number
|
J:125791
|
| decreased T cell number
|
J:125791
|
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:130950
|
| increased marginal zone B cell number
|
J:130950
|
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
\Tg(BCL2)36Wehi/0
(involves: 129S4/SvJae * C57BL/6JWehi * SJL/JWehi)
|
decreased follicular B cell number
|
J:130950
|
\Pik3cdtm2.1Tnr/\Pik3cdtm2.1Tnr
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:164283
|
| decreased CD8-positive, alpha-beta T cell number
|
J:164283
|
| decreased germinal center B cell number
|
J:164283
|
| decreased T cell number
|
J:164283
|
| decreased T follicular helper cell number
|
J:164283
|
\Pik3cdtm2.1Tnr/\Pik3cdtm2.1Tnr
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
decreased germinal center B cell number
|
J:164283
|
| decreased T follicular helper cell number
|
J:164283
|
\Pik3cgtm1Dwu/\Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131923
|
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
| abnormal T cell differentiation
|
J:60347
|
| decreased CD4-positive, alpha-beta T cell number
|
J:60347
|
| decreased thymocyte number
|
J:60347
|
\Pik3r1m1Btlr/\Pik3r1m1Btlr
(C57BL/6J-Pik3r1m1Btlr)
|
decreased B cell number
|
J:254890
|
| decreased B-1a cell number
|
J:254890
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254890
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254890
|
\Pik3r1M2Btlr/\Pik3r1+
(C57BL/6J-Pik3r1M2Btlr)
|
decreased B-1 B cell number
|
J:254892
|
| decreased B-1a cell number
|
J:254892
|
| decreased B-1b cell number
|
J:254892
|
| decreased B-2 B cell number
|
J:254892
|
| decreased NK T cell number
|
J:254892
|
| increased B-1b cell number
|
J:254892
|
\Pik3r1m3Btlr/\Pik3r1m3Btlr
(C57BL/6J-Pik3r1m3Btlr)
|
increased B-1b cell number
|
J:272853
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:52229
|
| decreased mature B cell number
|
J:52229
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
| decreased immature B cell number
|
J:104166
|
| decreased mature B cell number
|
J:104166
|
| decreased pre-B cell number
|
J:104166
|
| increased pro-B cell number
|
J:104166
|
\Pik3r1tm1Dfr/\Pik3r1tm1Dfr
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
| arrested B cell differentiation
|
J:104166
|
| decreased immature B cell number
|
J:104166
|
| decreased mature B cell number
|
J:104166
|
| decreased pre-B cell number
|
J:104166
|
\Pik3r1tm1Tka/\Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:52228
|
| decreased mature B cell number
|
J:52228
|
| decreased pre-B cell number
|
J:52228
|
| decreased pro-B cell number
|
J:52228
|
\Pik3r1tm2Dfr/\Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
abnormal B cell differentiation
|
J:94077
|
\Pik3r6tm1.1Lste/\Pik3r6tm1.1Lste
(Not Specified)
|
decreased lymphocyte cell number
|
J:238900
|
\Pim1tm1Pwl/\Pim1tm1Pwl
\Pim2tm1Brn/\Pim2tm1Brn
\Pim3tm1Brn/\Pim3tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased B cell number
|
J:91592
|
| decreased pre-B cell number
|
J:91592
|
| decreased pro-B cell number
|
J:91592
|
| increased early pro-B cell number
|
J:91592
|
\Pip4k2ctm1b(KOMP)Wtsi/\Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased regulatory T cell number
|
J:234283
|
| increased CD4-positive, alpha-beta T cell number
|
J:234283
|
| increased CD8-positive, alpha-beta T cell number
|
J:234283
|
| increased T-helper cell number
|
J:234283
|
\Pip4p1em1(IMPC)Ccpcz/\Pip4p1em1(IMPC)Ccpcz
(C57BL/6N-Pip4p1em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-negative, CD25-positive NK T cell number
|
J:211773
|
\Pip5k1ctm1.2Ref/\Pip5k1ctm1.2Ref
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
decreased B cell number
|
J:164732
|
\Pirbtm1Ttk/\Pirbtm1Ttk
(involves: 129X1/SvJ)
|
increased B-1 B cell number
|
J:76770
|
\Pitx3eyl/\Pitx3eyl
(involves: C3H/He * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:156878
|
| increased CD8-positive, alpha-beta T cell number
|
J:156878
|
\Pkhd1l1em1(IMPC)H/\Pkhd1l1em1(IMPC)H
(C57BL/6N-Pkhd1l1em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Pkn1tm1b(KOMP)Wtsi/\Pkn1tm1b(KOMP)Wtsi
(C57BL/6N-Pkn1tm1b(KOMP)Wtsi/H)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Pkn1tm1Kik/\Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
abnormal somatic hypermutation frequency
|
J:193187
|
| increased germinal center B cell number
|
J:193187
|
\Pknox1Gt(OST71835)Lex/\Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased single-positive T cell number
|
J:103769
|
| increased double-negative T cell number
|
J:103769
|
\Pknox1tm2.1Fbla/\Pknox1tm2.1Fbla
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
decreased pre-B cell number
|
J:192251
|
| increased pro-B cell number
|
J:192251
|
\Pla1aem1Appsc/\Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc)
|
increased lymphocyte cell number
|
J:333902
|
\Pla2g2dtm1.1Mhg/\Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg)
|
abnormal effector T cell morphology
|
J:201008
|
| increased CD4-positive, alpha-beta T cell number
|
J:229035,
J:201008
|
| increased CD8-positive, alpha-beta T cell number
|
J:229035
|
\Pla2g6m1Sein/\Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
decreased double-positive T cell number
|
J:155328
|
\Pla2g10Gt712Lex/\Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:125607
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125607
|
| decreased T cell number
|
J:125607
|
\Plag1em1(IMPC)Hmgu/\Plag1em1(IMPC)Hmgu
(C57BL/6N-Plag1em1(IMPC)Hmgu/Ieg)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Plautm1Mlg/\Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased lymphocyte cell number
|
J:63134
|
\Plcd1tm1.1Kfu/\Plcd1tm1.1Kfu
\Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA)
|
decreased B cell number
|
J:205633
|
| increased NK T cell number
|
J:205633
|
\Plcd1tm1Tta/\Plcd1tm1Tta
(involves: 129P2/OlaHsd)
|
decreased B cell number
|
J:205633
|
\Plce1em1(IMPC)Mbp/\Plce1em1(IMPC)Mbp
(C57BL/6N-Plce1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
decreased regulatory T cell number
|
J:157757
|
| decreased T cell number
|
J:157757
|
| increased CD4-positive, alpha-beta T cell number
|
J:157757
|
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:157757
|
| decreased double-negative T cell number
|
J:157757
|
| increased CD8-positive, alpha-beta T cell number
|
J:157757
|
| increased double-positive T cell number
|
J:157757
|
\Plcg2Ali5/\Plcg2+
(C3HeB/FeJ-Plcg2Ali5)
|
decreased B-2 B cell number
|
J:97930
|
\Plcg2Ali5/\Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
decreased mature B cell number
|
J:97930
|
| decreased transitional stage B cell number
|
J:97930
|
\Plcg2m1Btlr/\Plcg2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
\Plcg2M3Btlr/\Plcg2M3Btlr
(C57BL/6J-Plcg2M3Btlr)
|
decreased B-1a cell number
|
J:265101
|
\Plcg2m4Btlr/\Plcg2m4Btlr
(C57BL/6J-Plcg2m4Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:272862
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272862
|
\Plcg2tm1.1Kuro/\Plcg2tm1.1Kuro
(Not Specified)
|
abnormal B cell differentiation
|
J:131161
|
| increased pro-B cell number
|
J:131161
|
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:86373
|
| decreased follicular B cell number
|
J:86373
|
| decreased mature B cell number
|
J:104166
|
| increased pro-B cell number
|
J:104166
|
| increased transitional stage T2 B cell number
|
J:86373
|
\Plcg2tm1Jni/\Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:117023
|
| increased pre-B cell number
|
J:117023
|
\Plcg2tm1Kuro/\Plcg2tm1Kuro
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased mature B cell number
|
J:63744
|
| decreased pre-B cell number
|
J:63744
|
| increased B-1a cell number
|
J:63744
|
| increased immature B cell number
|
J:63744
|
| increased pro-B cell number
|
J:63744
|
\Plcl2tm1Tta/\Plcl2tm1Tta
(involves: 129P2/OlaHsd)
|
decreased B-1a cell number
|
J:85960
|
| decreased mature B cell number
|
J:85960
|
\Pld4em1(IMPC)Mbp/\Pld4em1(IMPC)Mbp
(C57BL/6N-Pld4em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Pld4thss/\Pld4thss
(BALB/cJ-Pld4thss/GrsrJ)
|
abnormal alpha-beta T cell morphology
|
J:278304
|
| increased marginal zone B cell number
|
J:278304
|
| increased plasma cell number
|
J:278304
|
\Pld4tm1.2Nemz/\Pld4tm1.2Nemz
(B6.129(Cg)-Pld4tm1.1Nemz)
|
decreased B-1 B cell number
|
J:281205
|
| decreased NK T cell number
|
J:281205
|
| increased marginal zone B cell number
|
J:281205
|
\Pld4tm1.2Nemz/\Pld4tm1.2Nemz
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
decreased NK T cell number
|
J:281205
|
\Plp1tm1c(EUCOMM)Wtsi/Y
\Cnptm1(cre)Kan/\Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
increased T cell number
|
J:245100
|
\Plp1tm1Kan/Y
\Cnptm1(cre)Kan/\Cnp+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased T cell number
|
J:245100
|
\plt/\plt
(involves: DDD/1)
|
decreased single-positive T cell number
|
J:15290
|
| decreased T cell number
|
J:47819
|
| increased memory T cell number
|
J:47460
|
| increased T cell number
|
J:47819
|
\plt/\plt
(C.DDD-plt)
|
decreased single-positive T cell number
|
J:119345
|
\Pmaip1tm1Ast/\Pmaip1tm1Ast
(C57BL/6-Pmaip1tm1Ast)
|
abnormal NK cell morphology
|
J:123409
|
\Pms2tm1.1Wed/\Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal class switch recombination
|
J:162378
|
\Pms2tm1Lisk/\Pms2tm1Lisk
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:162378
|
\Pnma8bem1(IMPC)Tcp/\Pnma8bem1(IMPC)Tcp
(C57BL/6NCrl-Pnma8bem1(IMPC)Tcp/Cmmr)
|
increased lymphocyte cell number
|
J:211773
|
\Pnpbata/\Pnpbata
(C57BL/6JSfdAnu-Pnpbata)
|
decreased marginal zone B cell number
|
J:104190
|
| increased T follicular helper cell number
|
J:104190
|
\Pnpf/\Pnpf
(involves: C3H/HeHa * C57BL/6J)
|
increased double-negative T cell number
|
J:522
|
\Pnpf/\Pnpf
(C57BL/6J-Pnpf)
|
decreased CD8-positive, alpha-beta T cell number
|
J:39328
|
| decreased double-positive T cell number
|
J:39328
|
\Pnpg/\Pnpg
(involves: C57BL/6 * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:39328
|
| decreased double-positive T cell number
|
J:39328
|
| increased double-negative T cell number
|
J:39328
|
\Pnpm2Btlr/\Pnpm2Btlr
(C57BL/6J-Pnpm2Btlr)
|
decreased B-1a cell number
|
J:265150
|
| decreased B-2 B cell number
|
J:265150
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265150
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265150
|
| decreased T cell number
|
J:265150
|
| increased B-1b cell number
|
J:265150
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265150
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265150
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265150
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265150
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265150
|
\Pnptm1Cmr/\Pnptm1Cmr
(involves: 129)
|
decreased CD4-positive, alpha-beta T cell number
|
J:62870
|
| decreased CD8-positive, alpha-beta T cell number
|
J:62870
|
| decreased double-positive T cell number
|
J:62870
|
| decreased single-positive T cell number
|
J:62870
|
| increased double-negative T cell number
|
J:62870
|
| increased pre-B cell number
|
J:62870
|
\Polbtm1.1Jbsw/\Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:206872
|
| abnormal somatic hypermutation frequency
|
J:206872
|
| increased germinal center B cell number
|
J:206872
|
| increased T-helper 2 cell number
|
J:206872
|
\Pole3em1Tbo/\Pole3em1Tbo
(FVB-Pole3em1Tbo)
|
decreased B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
\Pole3em2Tbo/\Pole3em2Tbo
(FVB-Pole3em2Tbo)
|
decreased B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
\Pole3em3Tbo/\Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
decreased B cell number
|
J:298827
|
| decreased DN4 thymocyte number
|
J:298827
|
| decreased double-positive T cell number
|
J:298827
|
| decreased gamma-delta T cell number
|
J:298827
|
| decreased immature B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased pre-B cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
\Pole3em4Tbo/\Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
decreased B cell number
|
J:298827
|
| decreased DN4 thymocyte number
|
J:298827
|
| decreased immature B cell number
|
J:298827
|
| decreased lymphocyte cell number
|
J:298827
|
| decreased pre-B cell number
|
J:298827
|
| decreased thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
\Pole3tm1(KOMP)Vlcg/\Pole3tm1(KOMP)Vlcg
(involves: C57BL/6NTac * FVB)
|
decreased DN4 thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
abnormal B cell differentiation
|
J:261973
|
| abnormal T cell differentiation
|
J:261973
|
| arrested B cell differentiation
|
J:261973
|
| decreased B cell number
|
J:261973
|
| decreased lymphocyte cell number
|
J:261973
|
| decreased single-positive T cell number
|
J:261973
|
| increased double-negative T cell number
|
J:261973
|
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
\Trp53tm1Brd/\Trp53+
(involves: C57BL/6J * C57BL/6NTac)
|
decreased lymphocyte cell number
|
J:261973
|
\Polgtm1Prol/\Polgtm1Prol
(B6J.129S7-Polgtm1Prol)
|
abnormal lymphopoiesis
|
J:154187
|
| decreased double-positive T cell number
|
J:154187
|
| decreased immature B cell number
|
J:154187
|
| decreased lymphocyte cell number
|
J:154187
|
| decreased mature B cell number
|
J:154187
|
| decreased pre-B cell number
|
J:154187
|
| decreased pro-B cell number
|
J:154187
|
| decreased thymocyte number
|
J:154187
|
\Polltm1Crey/\Polltm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
\Polltm1Crey/\Polltm1Crey
\Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113406
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
| abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
| decreased B cell number
|
J:113406
|
\Polmm1Btlr/\Polmm1Btlr
(C57BL/6J-Polmm1Btlr)
|
decreased B cell number
|
J:272866
|
\Polmm2Btlr/\Polmm2Btlr
(C57BL/6J-Polmm2Btlr)
|
abnormal lymphocyte morphology
|
J:272867
|
| decreased B cell number
|
J:272867
|
\Polmtm1Abnd/\Polmtm1Abnd
(involves: 129/Sv * BALB/c)
|
abnormal B cell number
|
J:97782
|
\Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:75927,
J:85190
|
\Polmtm1Crey/\Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
\Polqtm1Jcs/\Polqtm1Jcs
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal somatic hypermutation frequency
|
J:103365
|
\Polqtm1Jow/\Polqtm1Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal somatic hypermutation frequency
|
J:101409
|
\Polqtm2Jow/\Polqtm2Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:115989
|
\Polr2atm1(cre/ERT2)Bbd/\Polr2a+
\Rnf2tm1Mvi/\Rnf2tm1Mvi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * SJL)
|
decreased B cell number
|
J:130397
|
\Pou1f1dw/\Pou1f1dw
(DW/J Pou1f1dw)
|
decreased B cell number
|
J:110683
|
\Pou2af1tm1b(KOMP)Wtsi/\Pou2af1tm1b(KOMP)Wtsi
(C57BL/6N-Pou2af1tm1b(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Pou2af1tm1Pjln/\Pou2af1tm1Pjln
(C57BL/6-Pou2af1tm1Pjln)
|
decreased B cell number
|
J:37085
|
\Pou2af1tm1Pjln/\Pou2af1tm1Pjln
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:67362
|
| decreased B cell number
|
J:123039,
J:67362
|
| decreased immature B cell number
|
J:67362
|
| decreased mature B cell number
|
J:67362
|
| decreased T cell number
|
J:123039
|
\Pou2af1tm1Pjln/\Pou2af1tm1Pjln
\Tg(tetO-Pou2af1)1Pjln/0
\Tg(tTA)1Pjln/0
(involves: C57BL/6)
|
decreased B cell number
|
J:67362
|
| decreased mature B cell number
|
J:67362
|
\Pou2af1tm1Pmt/\Pou2af1tm1Pmt
\Ikzf3tm1Kge/\Ikzf3tm1Kge
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:81805
|
\Pou2af1tm1Rgr/\Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))
|
abnormal B cell differentiation
|
J:114816,
J:35785
|
| abnormal pre-B cell morphology
|
J:114816
|
| arrested B cell differentiation
|
J:114816
|
| decreased B cell number
|
J:114816
|
\Pou2af3tm1b(NCOM)Mfgc/\Pou2af3tm1b(NCOM)Mfgc
(C57BL/6N-Pou2af3tm1b(NCOM)Mfgc/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Pou2f2tm1Bal/\Pou2f2+
(involves: 129S2/SvPas)
|
decreased mature B cell number
|
J:4555
|
\Pou2f2tm1Bal/\Pou2f2tm1Bal
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
| decreased B cell number
|
J:88240
|
\Pou2f2tm1Bal/\Pou2f2tm1Bal
(involves: 129S2/SvPas)
|
decreased mature B cell number
|
J:4555
|
\Pou2f2tm1Lmc/\Pou2f2tm1Lmc
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
| decreased B cell number
|
J:88240
|
| decreased B-1 B cell number
|
J:88240
|
\Ppargtm2Rev/\Ppargtm2Rev
\Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:153358
|
\Ppbptm1.1(KOMP)Vlcg/\Ppbptm1.1(KOMP)Vlcg
(C57BL/6N-Ppbptm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Ppiatm1Lubn/\Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn)
|
increased T cell number
|
J:93591
|
\Ppicem1Igc/\Ppicem1Igc
(C57BL/6-Ppicem1Igc)
|
decreased NK cell number
|
J:321155
|
| increased transitional stage T1 B cell number
|
J:321155
|
| increased transitional stage T2 B cell number
|
J:321155
|
\Ppm1dtm1Lad/\Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:74284
|
| increased CD4-positive, alpha-beta T cell number
|
J:74284
|
\Ppm1mtm2b(EUCOMM)Hmgu/\Ppm1mtm2b(EUCOMM)Hmgu
(C57BL/6N-Ppm1mtm2b(EUCOMM)Hmgu/Bay)
|
decreased large unstained cell number
|
J:211773
|
\Ppp1r18em1Mgin/\Ppp1r18em1Mgin
(B6J.B6N-Ppp1r18em1Mgin)
|
decreased B cell number
|
J:331428
|
| decreased T cell number
|
J:331428
|
\Ppp1r18em3Mgin/\Ppp1r18em3Mgin
(B6J.B6N-Ppp1r18em3Mgin)
|
decreased B cell number
|
J:331428
|
| decreased T cell number
|
J:331428
|
\Ppp2r3ctm1Imku/\Ppp2r3ctm1Imku
\Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6)
|
decreased B cell number
|
J:100706
|
| decreased B-1a cell number
|
J:100706
|
| decreased follicular B cell number
|
J:100706
|
| decreased immature B cell number
|
J:100706
|
| decreased mature B cell number
|
J:100706
|
| decreased pre-B cell number
|
J:100706
|
| decreased transitional stage B cell number
|
J:100706
|
| increased pro-B cell number
|
J:100706
|
| increased T cell number
|
J:100706
|
| increased transitional stage B cell number
|
J:100706
|
\Ppp3cbem1(IMPC)Ccpcz/\Ppp3cbem1(IMPC)Ccpcz
(C57BL/6NCrl-Ppp3cbem1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Ppp3cbM3Btlr/\Ppp3cb+
(C57BL/6J-Ppp3cbM3Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254889
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254889
|
\Ppp3cbM3Btlr/\Ppp3cbM3Btlr
(C57BL/6J-Ppp3cbM3Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254889
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254889
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254889
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254889
|
\Ppp3cbM4Btlr/\Ppp3cb+
(C57BL/6J-Ppp3cbM4Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254905
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254905
|
\Ppp3cbM4Btlr/\Ppp3cbM4Btlr
(C57BL/6J-Ppp3cbM4Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254905
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254905
|
\Ppp3cbm5Btlr/\Ppp3cbm5Btlr
(C57BL/6J-Ppp3cbm5Btlr)
|
abnormal T cell morphology
|
J:272839
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272839
|
\Ppp3cbM6Btlr/\Ppp3cbM6Btlr
(C57BL/6J-Ppp3cbM6Btlr)
|
abnormal lymphocyte morphology
|
J:272840
|
| decreased alpha-beta T cell number
|
J:272840
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272840
|
| decreased CD8-positive, alpha-beta T cell number
|
J:272840
|
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell differentiation
|
J:77729
|
| decreased single-positive T cell number
|
J:77729
|
| decreased T cell number
|
J:77729
|
\Ppp3r1tm2Grc/\Ppp3r1tm2.1Grc
\Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:89771
|
\Ppp3r1tm2Grc/\Ppp3r1tm2Grc
\Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:89771
|
\Ppp4ctm1Tht/\Ppp4ctm1Tht
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
| abnormal T cell differentiation
|
J:117684
|
| decreased CD4-positive, alpha-beta T cell number
|
J:117684
|
| decreased CD8-positive, alpha-beta T cell number
|
J:117684
|
| decreased double-positive T cell number
|
J:117684
|
| decreased single-positive T cell number
|
J:117684
|
| increased double-negative T cell number
|
J:117684
|
\Ppp4ctm1Tht/\Ppp4ctm1Tht
\Tg(Lck-cre)548Jxm/0
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
| decreased double-positive T cell number
|
J:117684
|
| decreased single-positive T cell number
|
J:117684
|
\Ppp5ctm1a(EUCOMM)Wtsi/\Ppp5ctm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased CD8-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
\Prdm1tm1.1Liz/\Prdm1tm1.1Liz
(involves: 129S/SvEv)
|
absent plasma cells
|
J:196531
|
\Prdm1tm1Clme/\Prdm1tm1Clme
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T follicular helper cell differentiation
|
J:178876
|
| increased germinal center B cell number
|
J:178876
|
| increased T follicular helper cell number
|
J:178876
|
\Prdm11tm1.1Ahl/\Prdm11tm1.1Ahl
(B6.129(C)-Prdm11tm1.1Ahl)
|
decreased CD4-positive, alpha-beta T cell number
|
J:233986
|
| increased B cell number
|
J:233986
|
\Prdm14tm1a(EUCOMM)Wtsi/\Prdm14tm1a(EUCOMM)Wtsi
(C57BL/6N-Prdm14tm1a(EUCOMM)Wtsi/Bay)
|
increased effector memory T-helper cell number
|
J:211773
|
\Prdx1flro/\Prdx1flro
(C57BL/10JAnu-Prdx1flro/AnuApb)
|
abnormal lymphocyte morphology
|
J:104190
|
\Prdx1tm1Rave/\Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal NK T cell number
|
J:84677
|
\Prf1tm1Clrk/\Prf1tm1Clrk
(C.129S7(B6)-Prf1tm1Clrk)
|
increased activated T cell number
|
J:71576
|
\Primpolem1Nki/\Primpolem1Nki
(C57BL/6-Primpolem1Nki)
|
abnormal somatic hypermutation frequency
|
J:242620
|
\Prkab1tm1b(KOMP)Wtsi/\Prkab1+
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ccpcz)
|
decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Prkab1tm1b(KOMP)Wtsi/\Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Wtsi)
|
increased memory-marker CD4-negative NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
\Prkab1tm1b(KOMP)Wtsi/\Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Prkar1atm2Gsm/\Prkar1atm2Gsm
\Tg(Cr2-cre)3Cgn/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147785
|
\PrkcbM4Btlr/\PrkcbM4Btlr
(C57BL/6J-PrkcbM4Btlr)
|
decreased B-1 B cell number
|
J:274860
|
| increased CD4-positive, alpha-beta T cell number
|
J:274860
|
| increased CD8-positive, alpha-beta T cell number
|
J:274860
|
| increased T cell number
|
J:274860
|
\PrkcbM6Btlr/\PrkcbM6Btlr
(C57BL/6J-PrkcbM6Btlr)
|
decreased B-1 B cell number
|
J:274862
|
\Prkcbtilc/\Prkcbtilc
(involves: C57BL/6JSfdAnu)
|
decreased B-1a cell number
|
J:221236
|
\Prkcbtm1Tara/\Prkcbtm1Tara
(involves: 129)
|
decreased B cell number
|
J:34818
|
| decreased B-1 B cell number
|
J:34818
|
| decreased B-1a cell number
|
J:34818
|
\Prkcdm2Btlr/\Prkcdm2Btlr
(C57BL/6J-Prkcdm2Btlr)
|
increased NK cell number
|
J:265146
|
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:143854
|
| increased B cell number
|
J:76135
|
| increased follicular B cell number
|
J:143854
|
| increased marginal zone B cell number
|
J:143854
|
| increased transitional stage B cell number
|
J:143854
|
\Prkcdtm1Qxu/\Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:76134
|
\Prkcdtm1Qxu/\Prkcdtm1Qxu
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:76134
|
\Prkcem1Btlr/\Prkcem1Btlr
(C57BL/6J-Prkcem1Btlr)
|
decreased NK cell number
|
J:267703
|
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal effector T cell morphology
|
J:186080
|
| decreased B cell number
|
J:186080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186080
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased DN4 thymocyte number
|
J:186080
|
| decreased double-positive T cell number
|
J:186080
|
| decreased lymphocyte cell number
|
J:186080
|
| decreased T cell number
|
J:186080
|
| increased B cell number
|
J:186080
|
| increased CD4-positive, alpha-beta T cell number
|
J:186080
|
| increased CD8-positive, alpha-beta T cell number
|
J:186080
|
| increased memory T cell number
|
J:186080
|
| increased T cell number
|
J:186080
|
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal positive T cell selection
|
J:186080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186080
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased DN4 thymocyte number
|
J:186080
|
| decreased double-negative T cell number
|
J:186080
|
| decreased double-positive T cell number
|
J:186080
|
\Prkcqtm1Litt/\Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
abnormal T-helper 1 cell differentiation
|
J:94285
|
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal effector T cell morphology
|
J:186080
|
| abnormal positive T cell selection
|
J:186080
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186080
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased NK T cell number
|
J:141128
|
\Prkcqtm1Litt/\Prkcqtm1Litt
\Tg(LCKprBCL2L1)12Sjk/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased NK T cell number
|
J:141128
|
\Prkcztm1Jmos/\Prkcztm1Jmos
(involves: 129P2/OlaHsd * 129/Sv)
|
decreased B cell number
|
J:72720
|
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(BCL2)25Wehi/0
\Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
decreased thymocyte number
|
J:236298
|
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte number
|
J:236298
|
| increased double-positive T cell number
|
J:236298
|
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
\Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6)
|
decreased thymocyte number
|
J:236298
|
\Prkdcberty/\Prkdcberty
(C57BL/6JAnu-Prkdcberty)
|
absent B cells
|
J:104190
|
| absent T cells
|
J:104190
|
\Prkdcem2(IMPC)Ics/\Prkdcem2(IMPC)Ics
(C57BL/6N-Prkdcem2(IMPC)Ics/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Prkdchanky/\Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))
|
decreased lymphocyte cell number
|
J:104190
|
| increased plasma cell number
|
J:104190
|
\Prkdcm1Anu/\Prkdcm1Anu
(C57BL/6JAnu-Prkdcm1Anu)
|
abnormal lymphocyte morphology
|
J:104190
|
\Prkdcm1Btlr/\Prkdcm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
\Prkdcm2Btlr/\Prkdcm2Btlr
(C57BL/6J-Prkdcm2Btlr)
|
decreased B cell number
|
J:204502
|
| decreased CD4-positive, alpha-beta T cell number
|
J:204502
|
| decreased CD8-positive, alpha-beta T cell number
|
J:204502
|
\Prkdcm4Btlr/\Prkdcm4Btlr
(C57BL/6J-Prkdcm4Btlr)
|
decreased B cell number
|
J:255217
|
| increased B-1b cell number
|
J:255217
|
\Prkdcm5Btlr/\Prkdcm5Btlr
(C57BL/6J-Prkdcm5Btlr)
|
increased alpha-beta T cell number
|
J:255220
|
| increased CD4-positive, alpha-beta T cell number
|
J:255220
|
\Prkdcm6Btlr/\Prkdcm6Btlr
(C57BL/6J-Prkdcm6Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:255221
|
| increased alpha-beta T cell number
|
J:255221
|
| increased CD4-positive, alpha-beta T cell number
|
J:255221
|
| increased CD8-positive, alpha-beta T cell number
|
J:255221
|
\Prkdcm7Btlr/\Prkdcm7Btlr
(C57BL/6J-Prkdcm7Btlr)
|
increased effector memory CD4-positive, alpha-beta T cell number
|
J:255223
|
\PrkdcM8Btlr/\Prkdc+
(C57BL/6J-PrkdcM8Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255224
|
\PrkdcM8Btlr/\PrkdcM8Btlr
(C57BL/6J-PrkdcM8Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255224
|
| increased CD4-positive, alpha-beta T cell number
|
J:255224
|
\PrkdcM9Btlr/\Prkdc+
(C57BL/6J-PrkdcM9Btlr)
|
decreased B-1a cell number
|
J:255268
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:255268
|
| increased B cell number
|
J:255268
|
| increased B-1b cell number
|
J:255268
|
\PrkdcM9Btlr/\PrkdcM9Btlr
(C57BL/6J-PrkdcM9Btlr)
|
decreased B-1a cell number
|
J:255268
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:255268
|
| increased B cell number
|
J:255268
|
| increased B-1b cell number
|
J:255268
|
\PrkdcM10Btlr/\Prkdc+
(C57BL/6J-PrkdcM10Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255269
|
\PrkdcM10Btlr/\PrkdcM10Btlr
(C57BL/6J-PrkdcM10Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:255269
|
\Prkdcm12Btlr/\Prkdcm12Btlr
(C57BL/6J-Prkdcm12Btlr)
|
decreased B cell number
|
J:264708
|
| decreased B-1 B cell number
|
J:264708
|
| decreased CD4-positive, alpha-beta T cell number
|
J:264708
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264708
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:264708
|
| decreased NK T cell number
|
J:264708
|
| decreased single-positive T cell number
|
J:264708
|
| decreased T cell number
|
J:264708
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:264708
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:264708
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:264708
|
| increased NK cell number
|
J:264708
|
\Prkdcm13Btlr/\Prkdcm13Btlr
(C57BL/6J-Prkdcm13Btlr)
|
increased effector memory CD4-positive, alpha-beta T cell number
|
J:272441
|
\Prkdcm14Btlr/\Prkdcm14Btlr
(C57BL/6J-Prkdcm14Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272442
|
\PrkdcM15Btlr/\PrkdcM15Btlr
(C57BL/6J-PrkdcM15Btlr)
|
decreased B-1 B cell number
|
J:272445
|
\PrkdcM16Btlr/\PrkdcM16Btlr
(C57BL/6J-PrkdcM16Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272520
|
\Prkdcm18Btlr/\Prkdcm18Btlr
(C57BL/6J-Prkdcm18Btlr)
|
abnormal B cell differentiation
|
J:274730
|
| abnormal CD4-positive T cell differentiation
|
J:274730
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274730
|
| abnormal T cell differentiation
|
J:274730
|
| decreased alpha-beta T cell number
|
J:274730
|
| decreased B cell number
|
J:274730
|
| decreased B-1 B cell number
|
J:274730
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274730
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274730
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274730
|
| increased CD4-positive, alpha-beta T cell number
|
J:274730
|
| increased CD8-positive, alpha-beta T cell number
|
J:274730
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274730
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274730
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274730
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274730
|
| increased T cell number
|
J:274730
|
\Prkdcm19Btlr/\Prkdcm19Btlr
(C57BL/6J-Prkdcm19Btlr)
|
abnormal B cell differentiation
|
J:274763
|
| abnormal CD4-positive T cell differentiation
|
J:274763
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274763
|
| abnormal T cell differentiation
|
J:274763
|
| decreased B cell number
|
J:274763
|
| decreased B-1 B cell number
|
J:274763
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274763
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274763
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274763
|
| decreased T cell number
|
J:274763
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274763
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274763
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274763
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274763
|
| increased NK cell number
|
J:274763
|
\Prkdcscid/\Prkdcscid
(C.BKa-Prkdcscid)
|
absent B cells
|
J:6958
|
| absent pre-B cells
|
J:6958
|
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid)
|
decreased B cell number
|
J:22026
|
| decreased CD4-positive, alpha-beta T cell number
|
J:109833,
J:22026
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109833,
J:22026
|
| decreased lymphocyte cell number
|
J:22026
|
| decreased mature B cell number
|
J:109833
|
| decreased NK cell number
|
J:22026
|
| decreased pre-B cell number
|
J:22026
|
| decreased T cell number
|
J:22026
|
\Prkdcscid/\Prkdcscid
(B6.Cg-Prkdcscid/Sz)
|
decreased B cell number
|
J:34814
|
| decreased CD4-positive, alpha-beta T cell number
|
J:34814
|
| decreased CD8-positive, alpha-beta T cell number
|
J:34814
|
| decreased lymphocyte cell number
|
J:34814
|
| decreased pre-B cell number
|
J:34814
|
| decreased T cell number
|
J:34814
|
| increased NK cell number
|
J:34814
|
\Prkdcscid/\Prkdcscid
\Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/\Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(NOD.Cg-Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz Prkdcscid/Gck)
|
absent T cells
|
J:126700
|
\Prkdcscid/\Prkdcscid
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Prkdcscid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
\Prkdcscid/\Prkdcscid
\Tg(Tcrb)93Vbo/0
(involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:111476
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:111476
|
| abnormal double-positive T cell morphology
|
J:111476
|
| abnormal single-positive T cell number
|
J:111476
|
| abnormal T cell differentiation
|
J:111476
|
\Prkdctm1.1Bpcc/\Prkdctm1.1Bpcc
(involves: 129 * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:171351
|
| arrested B cell differentiation
|
J:171351
|
| decreased CD4-positive, alpha-beta T cell number
|
J:171351
|
| decreased CD8-positive, alpha-beta T cell number
|
J:171351
|
| decreased double-negative T cell number
|
J:171351
|
| decreased double-positive T cell number
|
J:171351
|
| decreased gamma-delta T cell number
|
J:171351
|
| decreased lymphocyte cell number
|
J:171351
|
| decreased mature B cell number
|
J:171351
|
| decreased T cell number
|
J:171351
|
\Prkdctm1Fwa/\Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:50221
|
| abnormal T cell receptor V(D)J recombination
|
J:50221
|
| absent pre-B cells
|
J:50221
|
| arrested B cell differentiation
|
J:50221
|
| arrested T cell differentiation
|
J:50221
|
| decreased double-positive T cell number
|
J:50221
|
| decreased thymocyte number
|
J:50221
|
\Prkdctm1Gcl/\Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:53765
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:53765
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:53765
|
| absent mature B cells
|
J:53765
|
| arrested B cell differentiation
|
J:53765
|
\Prkdctm1Get/\Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss)
|
abnormal B cell differentiation
|
J:50222
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:50222
|
| abnormal immunoglobulin light chain V-J recombination
|
J:50222
|
| abnormal T cell differentiation
|
J:50222
|
| abnormal T cell number
|
J:50222
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:50222
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:50222
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:50222
|
| arrested B cell differentiation
|
J:50222
|
| arrested T cell differentiation
|
J:50222
|
| decreased single-positive T cell number
|
J:50222
|
| increased double-negative T cell number
|
J:50222
|
| increased double-positive T cell number
|
J:50222
|
| increased NK cell number
|
J:50222
|
\Prl7d1em1Liga/\Prl7d1em1Liga
(involves: C57BL/6)
|
increased uterine NK cell number
|
J:288761
|
\Prmt3tm1a(EUCOMM)Wtsi/\Prmt3tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased CD8-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Lck-Prnp)33Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:129512
|
| increased gamma-delta T cell number
|
J:129512
|
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell morphology
|
J:129512
|
| abnormal T cell differentiation
|
J:129512
|
| decreased CD4-positive, alpha-beta T cell number
|
J:129512
|
| decreased CD8-positive, alpha-beta T cell number
|
J:129512
|
| decreased DN2 thymocyte number
|
J:129512
|
| decreased DN4 thymocyte number
|
J:129512
|
| decreased double-positive T cell number
|
J:129512
|
| decreased thymocyte number
|
J:129512
|
| increased DN3 thymocyte number
|
J:129512
|
| increased double-negative T cell number
|
J:129512
|
| increased gamma-delta T cell number
|
J:129512
|
\Prps1tm1b(EUCOMM)Wtsi/\Prps1+
(C57BL/6N-Prps1tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Prr7tm1(KOMP)Vlcg/\Prr7tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:237776
|
\Prss16tm1.1Mal/\Prss16+
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148034
|
| decreased single-positive T cell number
|
J:148034
|
\Prss16tm1.1Mal/\Prss16tm1.1Mal
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
| decreased CD4-positive, alpha-beta T cell number
|
J:148034
|
| decreased double-positive T cell number
|
J:148034
|
| decreased single-positive T cell number
|
J:148034
|
\Prss50tm1a(EUCOMM)Hmgu/\Prss50tm1a(EUCOMM)Hmgu
(C57BL/6N-Prss50tm1a(EUCOMM)Hmgu/H)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
\Prss54em1(IMPC)Ccpcz/\Prss54em1(IMPC)Ccpcz
(C57BL/6N-Prss54em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
\Prss57em1(IMPC)Ccpcz/\Prss57em1(IMPC)Ccpcz
(C57BL/6N-Prss57em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK T cell number
|
J:211773
|
\Psen1tm1Bdes/\Psen1+
\Psen2tm1Bdes/\Psen2tm1Bdes
(involves: 129P2/OlaHsd)
|
abnormal T cell subpopulation ratio
|
J:91235
|
\Psmb8tm1Hjf/\Psmb8tm1Hjf
\Tg(TcraTcrb)1100Mjb/?
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:107657
|
\Psmb9tm1Stl/\Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:21549
|
| decreased CD8-positive, alpha-beta T cell number
|
J:21549
|
\Psmb10tm1Mgro/\Psmb10tm1Mgro
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:125058
|
| decreased CD8-positive, alpha-beta T cell number
|
J:125058
|
\Psmb10tm1Mgro/\Psmb10tm1Mgro
\Psmb9/Psmb8tm1Klr/\Psmb9/Psmb8tm1Klr
(B6.129-Psmb10tm1Mgro Psmb9/Psmb8tm1Klr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:180765
|
\Psmb10tm1Mgro/\Psmb10tm1Mgro
\Psmb9/Psmb8tm1Klr/\Psmb9/Psmb8tm1Klr
(B6.129-Psmb10tm1Mgro Psmb9/Psmb8tm1Klr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:180765
|
\Psmb10tm1Mgro/\Psmb10Tub6
(involves: 129S2/SvPas * C3HeB/FeJ)
|
decreased NK cell number
|
J:261081
|
| decreased T cell number
|
J:261081
|
\Psmb10Tub6/\Psmb10+
(C3HeB/FeJ-Psmb10Tub6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:261081
|
| decreased CD8-positive, alpha-beta T cell number
|
J:261081
|
| decreased T cell number
|
J:261081
|
\Psmb10Tub6/\Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
decreased B cell number
|
J:261081
|
| decreased NK cell number
|
J:261081
|
| decreased T cell number
|
J:261081
|
\Psmb11em1(IMPC)Ccpcz/\Psmb11em1(IMPC)Ccpcz
(C57BL/6NCrl-Psmb11em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| increased CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Psmb11tm1(Psmb8)Khog/\Psmb11+
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
\Psmb11tm1(Psmb8)Khog/\Psmb11tm1(Psmb8)Khog
(involves: C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:196156
|
| abnormal T cell differentiation
|
J:196156
|
| abnormal T cell receptor V(D)J recombination
|
J:196156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
| decreased memory T cell number
|
J:196156
|
\Psmb11tm1(Psmb8)Khog/\Psmb11tm1(Psmb8)Khog
\Psmb8tm1Hjf/\Psmb8tm1Hjf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
\Psmb11tm1.1(Psmb8)Khog/\Psmb11tm1.1(Psmb8)Khog
\Psmb8tm1Hjf/\Psmb8tm1Hjf
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)
|
abnormal T cell receptor V(D)J recombination
|
J:196156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196156
|
\Psmb11tm1Smta/\Psmb11tm1Smta
(involves: C57BL/6 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:121869
|
\Psme3tm1Jjm/\Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm)
|
decreased double-positive T cell number
|
J:88626
|
\Pstpip1em1(IMPC)Ccpcz/\Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased T-helper cell number
|
J:211773
|
\Ptch1tm1Hahn/\Ptch1tm1Hahn
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:127207
|
| decreased B cell number
|
J:127207
|
| decreased double-positive T cell number
|
J:127207
|
| decreased immature B cell number
|
J:127207
|
| decreased lymphocyte cell number
|
J:127207
|
| decreased pre-B cell number
|
J:127207
|
| decreased transitional stage B cell number
|
J:127207
|
| increased B cell number
|
J:127207
|
| increased double-negative T cell number
|
J:127207
|
| increased mature B cell number
|
J:127207
|
| increased single-positive T cell number
|
J:127207
|
\Ptch2tm3b(EUCOMM)Hmgu/\Ptch2tm3b(EUCOMM)Hmgu
(C57BL/6N-Ptch2tm3b(EUCOMM)Hmgu/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
\Ptcratm1(icre)Hjf/\Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf)
|
decreased DN4 thymocyte number
|
J:197923
|
| decreased double-positive T cell number
|
J:197923
|
| decreased thymocyte number
|
J:197923
|
\Ptcratm1.1Shoy/\Ptcratm1.1Shoy
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:166147
|
| decreased T cell number
|
J:166147
|
| decreased thymocyte number
|
J:166147
|
| increased DN3 thymocyte number
|
J:166147
|
| increased gamma-delta T cell number
|
J:166147
|
| increased T cell number
|
J:166147
|
\Ptcratm1Bjf/\Ptcra+
(involves: 129X1/SvJ)
|
abnormal T cell differentiation
|
J:94338
|
| decreased double-negative T cell number
|
J:94338
|
| decreased single-positive T cell number
|
J:94338
|
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:91542
|
| increased double-negative T cell number
|
J:91542
|
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
abnormal double-positive T cell morphology
|
J:123569
|
| decreased DN4 thymocyte number
|
J:123569
|
| increased DN3 thymocyte number
|
J:123569
|
\Ptdss1tm1b(EUCOMM)Hmgu/\Ptdss1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ptdss1tm1b(EUCOMM)Hmgu/Ics)
|
decreased large unstained cell number
|
J:211773
|
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
decreased B cell number
|
J:232645
|
| decreased lymphocyte cell number
|
J:232645
|
| decreased T cell number
|
J:232645
|
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tnfrsf4tm2(cre)Nik/\Tnfrsf4+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased germinal center B cell number
|
J:164283
|
| increased T follicular helper cell number
|
J:164283
|
\Ptgdrtm1Sna/\Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:243958
|
| increased regulatory T cell number
|
J:243958
|
\Ptger1tm1Sna/\Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:128435
|
| abnormal T-helper 1 cell differentiation
|
J:128435
|
\Ptgs2tm1Unc/\Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal class switch recombination
|
J:140698
|
| abnormal memory B cell differentiation
|
J:140698
|
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c)
|
abnormal B cell number
|
J:42595
|
| decreased B cell number
|
J:42595
|
| decreased double-positive T cell number
|
J:42595
|
| increased B cell number
|
J:42595
|
| increased mature B cell number
|
J:42595
|
| increased pre-B cell number
|
J:42595
|
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr)
|
abnormal negative T cell selection
|
J:186843
|
| abnormal positive T cell selection
|
J:186843
|
| abnormal T cell differentiation
|
J:186843
|
| abnormal T cell subpopulation ratio
|
J:186843
|
| decreased B cell number
|
J:186843
|
| decreased B-1 B cell number
|
J:186843
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased follicular B cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
| decreased marginal zone B cell number
|
J:186843
|
| decreased mature B cell number
|
J:186843
|
| decreased single-positive T cell number
|
J:186843
|
| decreased T cell number
|
J:186843
|
| decreased thymocyte number
|
J:186843
|
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr)
|
decreased B cell number
|
J:186843
|
| decreased B-1 B cell number
|
J:186843
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased follicular B cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
| decreased marginal zone B cell number
|
J:186843
|
| decreased mature B cell number
|
J:186843
|
| decreased single-positive T cell number
|
J:186843
|
| decreased T cell number
|
J:186843
|
| decreased thymocyte number
|
J:186843
|
\Ptpn2tm2.1Ttig/\Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig)
|
abnormal negative T cell selection
|
J:186843
|
| abnormal positive T cell selection
|
J:186843
|
| abnormal T cell differentiation
|
J:186843
|
| abnormal T cell subpopulation ratio
|
J:186843
|
| decreased B cell number
|
J:186843
|
| decreased B-1 B cell number
|
J:186843
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased follicular B cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
| decreased marginal zone B cell number
|
J:186843
|
| decreased mature B cell number
|
J:186843
|
| decreased single-positive T cell number
|
J:186843
|
| decreased thymocyte number
|
J:186843
|
\Ptpn6em1.1Shoy/\Ptpn6em1.1Shoy
(involves: C57BL/6)
|
decreased thymocyte number
|
J:236298
|
\Ptpn6m1Btlr/\Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
|
decreased mature B cell number
|
J:142845
|
\Ptpn6m3Btlr/\Ptpn6+
(C57BL/6J-Ptpn6m3Btlr)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:234259
|
| decreased B cell number
|
J:234259
|
| decreased B-2 B cell number
|
J:234259
|
| decreased immature B cell number
|
J:234259
|
| decreased mature B cell number
|
J:234259
|
| increased B-1 B cell number
|
J:234259
|
| increased B-1a cell number
|
J:234259
|
\Ptpn6m3Btlr/\Ptpn6m3Btlr
(C57BL/6J-Ptpn6m3Btlr)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:234259
|
| decreased B cell number
|
J:234259
|
| decreased B-2 B cell number
|
J:234259
|
| decreased immature B cell number
|
J:234259
|
| decreased mature B cell number
|
J:234259
|
| increased B-1 B cell number
|
J:234259
|
| increased B-1b cell number
|
J:234259
|
\Ptpn6m4Btlr/\Ptpn6m4Btlr
(C57BL/6J-Ptpn6m4Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:264807
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:264807
|
| increased B-1 B cell number
|
J:264807
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:264807
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:264807
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:264807
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:264807
|
\Ptpn6M5Btlr/\Ptpn6M5Btlr
(C57BL/6J-Ptpn6M5Btlr)
|
decreased B cell number
|
J:265075
|
| decreased B-1 B cell number
|
J:265075
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265075
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265075
|
\Ptpn6m6Btlr/\Ptpn6m6Btlr
(C57BL/6J-Ptpn6m6Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272439
|
| abnormal T cell differentiation
|
J:272439
|
\Ptpn6m7Btlr/\Ptpn6m7Btlr
(C57BL/6J-Ptpn6m7Btlr)
|
abnormal T cell differentiation
|
J:272440
|
\Ptpn6me-v/\Ptpn6+
\Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mature B cell morphology
|
J:110531
|
\Ptpn6me-v/\Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
|
abnormal plasma cell morphology
|
J:14936
|
| decreased B cell number
|
J:113218
|
| decreased mature B cell number
|
J:7905
|
| increased plasma cell number
|
J:7905
|
\Ptpn9tm1Dny/\Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
abnormal T cell differentiation
|
J:118880
|
\Ptpn11tm1Bgn/\Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
increased lymphocyte cell number
|
J:91609
|
\Ptpn11tm1Ckq/\Ptpn11+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
arrested B cell differentiation
|
J:177285
|
\Ptpn13tm1Wjh/\Ptpn13tm1Wjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased T-helper 2 cell number
|
J:144351
|
\Ptpn22tm1.1Draw/\Ptpn22+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
| abnormal B cell morphology
|
J:201448
|
| abnormal B cell number
|
J:201448
|
| abnormal T cell morphology
|
J:201448
|
| abnormal T cell number
|
J:201448
|
| decreased follicular B cell number
|
J:201448
|
| decreased mature B cell number
|
J:201448
|
| increased B cell number
|
J:201448
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:201448
|
| increased double-positive T cell number
|
J:201448
|
| increased germinal center B cell number
|
J:201448
|
| increased regulatory T cell number
|
J:201448
|
| increased transitional stage T1 B cell number
|
J:201448
|
\Ptpn22tm1.1Draw/\Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
| abnormal B cell morphology
|
J:201448
|
| abnormal T cell differentiation
|
J:201448
|
| abnormal T cell morphology
|
J:201448
|
| decreased follicular B cell number
|
J:201448
|
| decreased mature B cell number
|
J:201448
|
| increased B cell number
|
J:201448
|
| increased double-positive T cell number
|
J:201448
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:201448
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:201448
|
| increased germinal center B cell number
|
J:201448
|
| increased regulatory T cell number
|
J:201448
|
| increased transitional stage T1 B cell number
|
J:201448
|
\Ptpn22tm1.1Kas/\Ptpn22tm1.1Kas
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:176519
|
| increased CD8-positive, alpha-beta T cell number
|
J:176519
|
| increased T cell number
|
J:176519
|
\Ptpn22tm1.1Kas/\Ptpn22tm1.1Kas
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:176519
|
\Ptpn22tm1Achn/\Ptpn22tm1Achn
(involves: C57BL/6)
|
increased B cell number
|
J:90029
|
| increased follicular B cell number
|
J:90029
|
\Ptpn22tm2Achn/\Ptpn22tm2Achn
(involves: C57BL/6)
|
increased B cell number
|
J:90029
|
| increased follicular B cell number
|
J:90029
|
\Ptpn22tm2Achn/\Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
| abnormal T cell subpopulation ratio
|
J:147129
|
| increased memory T cell number
|
J:147129
|
\Ptpn22tm2Achn/\Ptpn22tm2Achn
\Ptprctm1Weis/\Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
| abnormal lymphocyte cell number
|
J:147129
|
| abnormal T cell subpopulation ratio
|
J:147129
|
| decreased follicular B cell number
|
J:147129
|
| increased memory T cell number
|
J:147129
|
| increased plasma cell number
|
J:147129
|
| increased transitional stage B cell number
|
J:147129
|
\Ptprcloc/\Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb)
|
abnormal B cell number
|
J:104190
|
| abnormal double-positive T cell morphology
|
J:104190
|
| abnormal memory T cell number
|
J:104190
|
| abnormal T cell morphology
|
J:104190
|
| abnormal T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
| decreased CD8-positive, alpha-beta T cell number
|
J:104190
|
| decreased double-positive T cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Ptprcltng/\Ptprcltng
(C57BL/6-Ptprcltng)
|
abnormal T cell differentiation
|
J:158876
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
| decreased double-positive T cell number
|
J:158876
|
\Ptprcltng/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
| decreased double-positive T cell number
|
J:158876
|
\Ptprcltng/\Ptprctm1Mak
\Tg(TcraTcrb)425Cbn/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
\Ptprcm1Btlr/\Ptprcm1Btlr
(involves: C57BL/6J)
|
absent T cells
|
J:152064
|
\Ptprcm1Smv/\Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
abnormal CD4-positive T cell differentiation
|
J:214487
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214487
|
| decreased DN4 thymocyte number
|
J:214487
|
| increased DN3 thymocyte number
|
J:214487
|
| increased double-negative T cell number
|
J:214487
|
\Ptprcm2Btlr/\Ptprcm2Btlr
(C57BL/6J-Ptprcm2Btlr)
|
decreased B-1a cell number
|
J:216796
|
| decreased B-2 B cell number
|
J:216796
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:216796
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:216796
|
| decreased mature B cell number
|
J:216796
|
| decreased memory B cell number
|
J:216796
|
| decreased memory T cell number
|
J:216796
|
| decreased single-positive T cell number
|
J:216796
|
| increased B-1 B cell number
|
J:216796
|
| increased B-1b cell number
|
J:216796
|
| increased single-positive T cell number
|
J:216796
|
\Ptprcm3Btlr/\Ptprcm3Btlr
(C57BL/6J-Ptprcm3Btlr)
|
decreased B cell number
|
J:254899
|
| decreased B-1a cell number
|
J:254899
|
| decreased B-2 B cell number
|
J:254899
|
| decreased CD8-positive, alpha-beta T cell number
|
J:254899
|
| increased B-1b cell number
|
J:254899
|
\Ptprcm4Btlr/\Ptprcm4Btlr
(C57BL/6J-Ptprcm4Btlr)
|
decreased B cell number
|
J:264808
|
| decreased CD4-positive, alpha-beta T cell number
|
J:264808
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264808
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:264808
|
| decreased single-positive T cell number
|
J:264808
|
| decreased T cell number
|
J:264808
|
| increased B-1 B cell number
|
J:264808
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:264808
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:264808
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:264808
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:264808
|
\PtprcM5Btlr/\PtprcM5Btlr
(C57BL/6J-PtprcM5Btlr)
|
increased alpha-beta T cell number
|
J:265143
|
\PtprcM6Btlr/\PtprcM6Btlr
(C57BL/6J-PtprcM6Btlr)
|
decreased B-1a cell number
|
J:265186
|
| decreased B-1b cell number
|
J:265186
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265186
|
| increased B-1 B cell number
|
J:265186
|
\Ptprcm7Btlr/\Ptprcm7Btlr
(C57BL/6J-Ptprcm7Btlr)
|
decreased alpha-beta T cell number
|
J:267486
|
| decreased B cell number
|
J:267486
|
| decreased CD4-positive, alpha-beta T cell number
|
J:267486
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267486
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:267486
|
| decreased NK T cell number
|
J:267486
|
| increased B-1 B cell number
|
J:267486
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:267486
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:267486
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267486
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267486
|
\PtprcM8Btlr/\PtprcM8Btlr
(C57BL/6J-PtprcM8Btlr)
|
increased B-1 B cell number
|
J:267487
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:267487
|
\PtprcM9Btlr/\PtprcM9Btlr
(C57BL/6J-PtprcM9Btlr)
|
abnormal B cell differentiation
|
J:272745
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:272745
|
| abnormal lymphocyte morphology
|
J:272745
|
| decreased B cell number
|
J:272745
|
| decreased NK cell number
|
J:272745
|
| increased CD8-positive, alpha-beta T cell number
|
J:272745
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272745
|
\PtprcM10Btlr/\PtprcM10Btlr
(C57BL/6J-PtprcM10Btlr)
|
decreased B-1b cell number
|
J:272777
|
\PtprcM11Btlr/\PtprcM11Btlr
(C57BL/6J-PtprcM11Btlr)
|
abnormal B cell differentiation
|
J:274863
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274863
|
| increased B-1 B cell number
|
J:274863
|
\Ptprcm12Btlr/\Ptprcm12Btlr
(C57BL/6J-Ptprcm12Btlr)
|
decreased B cell number
|
J:274972
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274972
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274972
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274972
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:274972
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:274972
|
| decreased T cell number
|
J:274972
|
| increased B-1 B cell number
|
J:274972
|
\Ptprcnim/\Ptprcnim
(C57BL/6JAnu-Ptprcnim)
|
decreased B cell number
|
J:225105
|
| decreased T cell number
|
J:225105
|
\Ptprcstrm/\Ptprcstrm
(C57BL/6JAnu-Ptprcstrm/AnuApb)
|
decreased B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Ptprctm1Holm/\Ptprctm1Holm
(involves: 129/Sv * C57BL/6)
|
abnormal B cell number
|
J:33466
|
| abnormal lymphopoiesis
|
J:33466
|
| abnormal T cell differentiation
|
J:33466
|
| decreased CD4-positive, alpha-beta T cell number
|
J:33466
|
| decreased CD8-positive, alpha-beta T cell number
|
J:33466
|
| decreased double-positive T cell number
|
J:33466
|
| decreased T cell number
|
J:33466
|
| decreased thymocyte number
|
J:33466
|
| increased double-negative T cell number
|
J:33466
|
\Ptprctm1Mak/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:13163
|
| arrested T cell differentiation
|
J:158876
|
| decreased CD4-positive, alpha-beta T cell number
|
J:13163
|
| decreased CD8-positive, alpha-beta T cell number
|
J:13163
|
| decreased T cell number
|
J:13163
|
| decreased thymocyte number
|
J:13163
|
| increased double-negative T cell number
|
J:13163
|
\Ptprctm1Mak/\Ptprctm1Mak
(B6.Cg-Ptprctm1Mak)
|
abnormal CD4-positive, alpha-beta intraepithelial T cell morphology
|
J:111646
|
| abnormal intraepithelial T cell morphology
|
J:111646
|
| abnormal intraepithelial T cell number
|
J:111646
|
| abnormal T cell differentiation
|
J:111646
|
| decreased gamma-delta intraepithelial T cell number
|
J:111646
|
\Ptprctm1Mak/\Ptprctm1Mak
\Ptprjtm1.2Weis/\Ptprjtm1.2Weis
(involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal follicular B cell morphology
|
J:131736
|
| decreased B cell number
|
J:131736
|
\Ptprctm1Mak/\Ptprctm1Mak
\Ptprjtm1.2Weis/\Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis)
|
abnormal B cell differentiation
|
J:131736
|
| abnormal follicular B cell morphology
|
J:131736
|
| abnormal transitional stage B cell morphology
|
J:131736
|
| decreased B cell number
|
J:131736
|
| decreased immature B cell number
|
J:131736
|
| decreased mature B cell number
|
J:131736
|
\Ptprctm1Mak/\Ptprctm1Mak
\Tg(TcraTcrb)425Cbn/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:158876
|
\Ptprctm1Tyb/\Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb)
|
abnormal positive T cell selection
|
J:57681
|
| abnormal T cell differentiation
|
J:57681
|
| decreased CD4-positive, alpha-beta T cell number
|
J:57681
|
| decreased CD8-positive, alpha-beta T cell number
|
J:57681
|
| decreased double-positive T cell number
|
J:57681
|
| increased double-negative T cell number
|
J:57681
|
\Ptprctm1Tyb/\Ptprctm1Tyb
(B6.129S2-Ptprctm1Tyb)
|
increased NK cell number
|
J:98190
|
\Ptprctm1Weis/\Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell number
|
J:66501
|
| increased T cell number
|
J:66501
|
\Ptprctm1Weis/\Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
abnormal double-positive T cell morphology
|
J:147129
|
| abnormal T cell subpopulation ratio
|
J:147129
|
| decreased follicular B cell number
|
J:147129
|
| increased memory T cell number
|
J:147129
|
| increased plasma cell number
|
J:147129
|
| increased transitional stage B cell number
|
J:147129
|
\Ptprjtm1.2Weis/\Ptprjtm1.2Weis
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal B cell differentiation
|
J:131736
|
| increased B-2 B cell number
|
J:131736
|
| increased marginal zone B cell number
|
J:131736
|
\Ptstm1b(EUCOMM)Wtsi/\Pts+
(C57BL/6N-Ptstm1b(EUCOMM)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
\Pttg1tm1Sme/\Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell number
|
J:72267
|
\Pycardtm1Flv/\Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased NK cell number
|
J:158969
|
\Pycr2m1J/\Pycr2m1J
(involves: C3H/HeJ * C57BL/6J)
|
decreased lymphocyte cell number
|
J:308336
|
\Rab7tm1.1Ale/\Rab7tm1.1Ale
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell morphology
|
J:211733
|
| abnormal T cell subpopulation ratio
|
J:211733
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211733
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211733
|
| decreased T cell number
|
J:211733
|
\Rab13tm1.1Ktg/\Rab13tm1.1Ktg
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:259093
|
\Rab19tm1b(EUCOMM)Hmgu/\Rab19tm1b(EUCOMM)Hmgu
(C57BL/6N-Rab19tm1b(EUCOMM)Hmgu/Ics)
|
decreased large unstained cell number
|
J:211773
|
\Rabgap1tm1b(EUCOMM)Hmgu/\Rabgap1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rabgap1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased effector memory T-helper cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Rabl3xm/\Rabl3em1Btlr
(C57BL/6J-Rabl3xm Rabl3em1Btlr)
|
decreased lymphocyte cell number
|
J:287198
|
\Rabl3xm/\Rabl3xm
(C57BL/6J-Rabl3xm)
|
abnormal T cell morphology
|
J:287198
|
| abnormal T cell number
|
J:287198
|
\Rac2em1Shl/\Rac2+
(involves: C57BL/6)
|
decreased alpha-beta T cell number
|
J:276213
|
| decreased CD4-positive, alpha-beta T cell number
|
J:276213
|
| decreased CD8-positive, alpha-beta T cell number
|
J:276213
|
| decreased lymphocyte cell number
|
J:276213
|
| decreased T cell number
|
J:276213
|
\Rac2M2Btlr/\Rac2+
(C57BL/6J-Rac2M2Btlr)
|
decreased B-1 B cell number
|
J:231801
|
| decreased B-1a cell number
|
J:231801
|
| increased B-1b cell number
|
J:231801
|
\Rac2M2Btlr/\Rac2M2Btlr
(C57BL/6J-Rac2M2Btlr)
|
decreased B-1 B cell number
|
J:231801
|
| decreased B-1a cell number
|
J:231801
|
| increased B-1b cell number
|
J:231801
|
\Rac2m3Btlr/\Rac2+
(C57BL/6J-Rac2m3Btlr)
|
decreased B-1a cell number
|
J:236680
|
| increased B-1 B cell number
|
J:236680
|
\Rac2m3Btlr/\Rac2m3Btlr
(C57BL/6J-Rac2m3Btlr)
|
decreased B cell number
|
J:236680
|
| decreased B-1a cell number
|
J:236680
|
| increased B-1b cell number
|
J:236680
|
\Rac2M4Btlr/\Rac2+
(C57BL/6J-Rac2M4Btlr)
|
decreased alpha-beta T cell number
|
J:255273
|
| decreased CD4-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:255273
|
| increased alpha-beta T cell number
|
J:255273
|
| increased CD8-positive, alpha-beta T cell number
|
J:255273
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:255273
|
\Rac2M4Btlr/\Rac2M4Btlr
(C57BL/6J-Rac2M4Btlr)
|
decreased alpha-beta T cell number
|
J:255273
|
| decreased CD4-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, alpha-beta T cell number
|
J:255273
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:255273
|
| increased alpha-beta T cell number
|
J:255273
|
| increased CD8-positive, alpha-beta T cell number
|
J:255273
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:255273
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:255273
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:255273
|
\Rac2M5Btlr/\Rac2+
(C57BL/6J-Rac2M5Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:255283
|
\Rac2M5Btlr/\Rac2M5Btlr
(C57BL/6J-Rac2M5Btlr)
|
decreased B-1a cell number
|
J:255283
|
| increased B-1b cell number
|
J:255283
|
| increased CD8-positive, alpha-beta T cell number
|
J:255283
|
\Racgap1tm1Mahi/\Racgap1tm1Mahi
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:137760
|
| decreased pro-B cell number
|
J:137760
|
| decreased transitional stage B cell number
|
J:137760
|
\Rad21tm1.1Mmk/\Rad21tm1.1Mmk
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:175827
|
| abnormal T cell differentiation
|
J:175827
|
| decreased CD4-positive, alpha-beta T cell number
|
J:175827
|
| decreased CD8-positive, alpha-beta T cell number
|
J:175827
|
| decreased double-positive T cell number
|
J:175827
|
\Rad50tm2.1Flv/\Rad50tm2.2Flv
\Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:165055
|
\Rad50tm2Jpt/\Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased B cell number
|
J:78820
|
| decreased immature B cell number
|
J:78820
|
| decreased pre-B cell number
|
J:78820
|
| decreased T cell number
|
J:78820
|
| increased late pro-B cell number
|
J:78820
|
\Rad50tm2Jpt/\Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-negative T cell number
|
J:103922
|
| decreased pro-B cell number
|
J:103922
|
\Rad50tm2Jpt/\Rad50tm2Jpt
\Smc1atm1Mbk/\Smc1atm1Mbk
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
| decreased double-negative T cell number
|
J:103922
|
\Rag1/Rag2tm1Mnz/\Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
| abnormal double-positive T cell morphology
|
J:90487
|
| abnormal T cell morphology
|
J:90487
|
| decreased T cell number
|
J:90487
|
\Rag1/Rag2tm1Mnz/\Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
| abnormal double-positive T cell morphology
|
J:90487
|
| abnormal T cell morphology
|
J:90487
|
| decreased T cell number
|
J:90487
|
\Rag1coln/\Rag1coln
(C57BL/6JAnu-Rag1coln/AnuApb)
|
absent B cells
|
J:104190
|
| absent T cells
|
J:104190
|
\Rag1em2Mvw/\Rag1em2Mvw
(A/J-Rag1em2Mvw/MvwJ)
|
absent B cells
|
J:332675
|
| absent T cells
|
J:332675
|
| arrested B cell differentiation
|
J:332675
|
| arrested T cell differentiation
|
J:332675
|
\Rag1em3Mvw/\Rag1em3Mvw
(129S1/SvImJ-Rag1em3Mvw/MvwJ)
|
absent B cells
|
J:332675
|
| absent T cells
|
J:332675
|
| arrested B cell differentiation
|
J:332675
|
| arrested T cell differentiation
|
J:332675
|
\Rag1m1Anu/\Rag1m1Anu
(C57BL/6NCrlAnu-Rag1m1Anu)
|
decreased lymphocyte cell number
|
J:104190
|
\Rag1m1Btlr/\Rag1m1Btlr
(C57BL/6J-Rag1m1Btlr)
|
absent late pro-B cells
|
J:150635
|
| decreased CD4-positive, alpha-beta T cell number
|
J:150635
|
| decreased CD8-positive, alpha-beta T cell number
|
J:150635
|
\Rag1m2Btlr/\Rag1m2Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
\Rag1m3Btlr/\Rag1m3Btlr
(C57BL/6J-Rag1m3Btlr)
|
increased central memory CD8 positive, alpha-beta T cell number
|
J:272858
|
\Rag1m4Btlr/\Rag1m4Btlr
(C57BL/6J-Rag1m4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272094
|
| abnormal T cell differentiation
|
J:272094
|
| decreased B cell number
|
J:272094
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272094
|
| increased alpha-beta T cell number
|
J:272094
|
| increased CD8-positive, alpha-beta T cell number
|
J:272094
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272094
|
\Rag1tm1(cre)Thr/\Rag1tm1(cre)Thr
(Not Specified)
|
abnormal lymphopoiesis
|
J:86869
|
| absent lymphocyte
|
J:86869
|
\Rag1tm1(GFP)Imku/?
\Zfp335blt/\Zfp335blt
(involves: C57BL/6 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
\Rag1tm1(GFP)Imku/\Rag1tm1(GFP)Imku
(involves: C57BL/6 * CBA)
|
abnormal immunoglobulin V(D)J recombination
|
J:79416
|
\Rag1tm1.1Sadu/\Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
\Rag1tm1.1Sadu/\Rag1tm1.1Sadu
\Trdctm1Mal/\Trdctm1Mal
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
absent gamma-delta T cells
|
J:187400
|
| decreased gamma-delta T cell number
|
J:187400
|
| increased gamma-delta T cell number
|
J:187400
|
\Rag1tm1Bal/\Rag1tm1Bal
\Tg(TcraTcrb)1100Mjb/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:133645
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133645
|
| increased CD8-positive, alpha-beta T cell number
|
J:133645
|
\Rag1tm1Bal/\Rag1tm1Bal
\Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
arrested T cell differentiation
|
J:113270
|
\Rag1tm1Bal/\Rag1tm1Bal
\Vav1tm2Tyb/\Vav1tm2Tyb
\Tg(TcrAND)53Hed/0
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113270
|
\Rag1tm1Fwa/\Rag1tm1Fwa
(involves: 129)
|
abnormal B cell differentiation
|
J:86464
|
| abnormal T cell differentiation
|
J:86464
|
| decreased B cell number
|
J:86464
|
| increased double-negative T cell number
|
J:86464
|
\Rag1tm1Jsek/\Rag1+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:146912
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
| abnormal T cell differentiation
|
J:146912
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
| decreased double-positive T cell number
|
J:146912
|
\Rag1tm1Jsek/\Rag1tm1Jsek
(involves: 129S6/SvEvTac)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
| abnormal lymphopoiesis
|
J:146912
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
| abnormal T cell receptor V(D)J recombination
|
J:146912
|
| absent immature B cells
|
J:146912
|
| absent mature B cells
|
J:146912
|
| arrested B cell differentiation
|
J:146912
|
| arrested T cell differentiation
|
J:146912
|
| decreased CD4-positive, alpha-beta T cell number
|
J:146912
|
| decreased CD8-positive, alpha-beta T cell number
|
J:146912
|
| decreased double-positive T cell number
|
J:146912
|
| decreased gamma-delta T cell number
|
J:146912
|
| increased double-negative T cell number
|
J:146912
|
| increased pro-B cell number
|
J:146912
|
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal B cell differentiation
|
J:1934
|
| abnormal immunoglobulin V(D)J recombination
|
J:1934
|
| abnormal T cell differentiation
|
J:1934
|
| abnormal T cell morphology
|
J:1934
|
| abnormal T cell receptor V(D)J recombination
|
J:1934
|
| absent mature B cells
|
J:1934
|
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
decreased lymphocyte cell number
|
J:111874
|
\Rag1tm1Mom/\Rag1tm1Mom
(NOD.129S7(B6)-Rag1tm1Mom)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109843
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109843
|
| decreased mature B cell number
|
J:109843
|
| increased immature B cell number
|
J:109843
|
| increased NK cell number
|
J:109843
|
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal double-negative T cell morphology
|
J:112990
|
\Rag1tm1Mom/\Rag1tm1Mom
\Prf1tm1Sdz/\Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz)
|
decreased CD4-positive, alpha-beta T cell number
|
J:109843
|
| decreased CD8-positive, alpha-beta T cell number
|
J:109843
|
| decreased mature B cell number
|
J:109843
|
| increased immature B cell number
|
J:109843
|
| increased NK cell number
|
J:109843
|
\Rag1tm1Mom/\Rag1tm1Mom
\Slc46a2tm1Moki/\Slc46a2+
\Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:140121
|
| decreased double-positive T cell number
|
J:140121
|
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6)
|
increased double-positive T cell number
|
J:135903
|
| increased thymocyte number
|
J:135903
|
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell receptor V(D)J recombination
|
J:47667
|
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Rag1tm1Mom Tg(Tcra,Tcrb)HRCAll)
|
abnormal T cell differentiation
|
J:131347
|
| abnormal T cell subpopulation ratio
|
J:131347
|
| absent CD4-positive, alpha-beta T cells
|
J:131347
|
| increased CD8-positive, alpha-beta T cell number
|
J:131347
|
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
decreased CD4-positive, alpha-beta T cell number
|
J:111874
|
| decreased lymphocyte cell number
|
J:111874
|
| increased double-positive T cell number
|
J:111874
|
\Rag1tm1Mom/\Rag1tm1Mom
\Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:84536
|
\Rag2m1Btlr/\Rag2m1Btlr
(C57BL/6J-Rag2m1Btlr)
|
decreased B cell number
|
J:203045
|
| decreased CD4-positive, alpha-beta T cell number
|
J:203045
|
\Rag2tm1.1Cgn/\Rag2tm1.1Cgn
(C57BL/6-Rag2tm1.1Cgn)
|
arrested B cell differentiation
|
J:72214
|
| arrested T cell differentiation
|
J:72214
|
\Rag2tm1.1Desi/\Rag2tm1.1Desi
(involves: 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
\Rag2tm1.1Mss/\Rag2tm1.1Mss
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:171970
|
| abnormal pre-B cell morphology
|
J:171970
|
| decreased pre-B cell number
|
J:171970
|
| increased DN3 thymocyte number
|
J:171970
|
\Rag2tm1Avla/\Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:122108
|
| arrested T cell differentiation
|
J:122108
|
| decreased double-positive T cell number
|
J:122108
|
| decreased lymphocyte cell number
|
J:122108
|
| decreased NK T cell number
|
J:122108
|
\Rag2tm1Cgn/\Rag2tm1.1Cgn
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
absent immature B cells
|
J:72214
|
| absent pre-B cells
|
J:72214
|
| arrested B cell differentiation
|
J:72214
|
| arrested T cell differentiation
|
J:72214
|
| decreased follicular B cell number
|
J:72214
|
| decreased marginal zone B cell number
|
J:72214
|
| decreased mature B cell number
|
J:72214
|
| increased plasma cell number
|
J:72214
|
\Rag2tm1Cgn/\Rag2tm1Cgn
\Xrcc4tm1Fwa/\Xrcc4tm2Fwa
\Tg(Cr2-cre)3Cgn/?
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:150339
|
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
abnormal effector T cell morphology
|
J:1935
|
| abnormal immunoglobulin V(D)J recombination
|
J:1935
|
| abnormal T cell receptor V(D)J recombination
|
J:1935
|
| absent mature B cells
|
J:1935
|
| arrested B cell differentiation
|
J:1935
|
| arrested T cell differentiation
|
J:1935
|
| decreased CD4-positive, alpha-beta T cell number
|
J:1935
|
| decreased CD8-positive, alpha-beta T cell number
|
J:1935
|
| decreased double-positive T cell number
|
J:1935
|
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv)
|
decreased thymocyte number
|
J:114561
|
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell morphology
|
J:81133
|
| arrested T cell differentiation
|
J:91542
|
| decreased double-negative T cell number
|
J:81133,
J:91542
|
| increased double-negative T cell number
|
J:91542
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Cd47tm1Fpl/\Cd47tm1Fpl
\Il2rgtm1Cgn/Y
(involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203904
|
| decreased lymphocyte cell number
|
J:203904
|
| increased activated T cell number
|
J:203904
|
| increased CD8-positive, alpha-beta T cell number
|
J:203904
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Rr299391tm1.1Fwa/\Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:149413
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Sos1tm1.1Les/\Sos1tm1.1Les
\Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:174536
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tbatatm1Faf/\Tbatatm1Faf
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:166065
|
| increased thymocyte number
|
J:166065
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\TcraLn3Jae/\Tcra+
\TcrbLn3Jae/\Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| increased CD8-positive, alpha-beta T cell number
|
J:143006
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\TcrbLn3Jae/\Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| increased double-positive T cell number
|
J:143006
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
|
increased DN3 thymocyte number
|
J:235890
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(EmuSR-tTa)83Bop/0
\Tg(tetO-Nfatct1*)1Grc/0
(involves: 129S/SvEv * C57BL/6J * CBA/J * FVB/N)
|
abnormal double-positive T cell morphology
|
J:141917
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Igh-Pim1)1Brn/0
(involves: 129S/SvEv * C57BL/6LiA * CBA)
|
decreased thymocyte number
|
J:114561
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Lck-Akt1*)M-1Pnt/0
(involves: 129S/SvEv * C3H/He * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:135903
|
| absent CD8-positive, alpha-beta T cells
|
J:135903
|
| increased double-positive T cell number
|
J:135903
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Tcra5CC7,Tcrb5CC7)IWep/?
\Themis5AT161/\Themis5AT161
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:151076
|
| increased double-positive T cell number
|
J:151076
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125548
|
| abnormal positive T cell selection
|
J:125548
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125548
|
| increased double-positive T cell number
|
J:125548
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
\Themis5AT161/\Themis5AT161
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased single-positive T cell number
|
J:151076
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| abnormal double-positive T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcrHEL3A9)1Mmd/0
\Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
\Rag2tm1Fwa/\Rag2tm1Mao
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell number
|
J:81837
|
| abnormal gamma-delta T cell differentiation
|
J:81837
|
| arrested B cell differentiation
|
J:81837
|
| arrested T cell differentiation
|
J:81837
|
| decreased double-negative T cell number
|
J:81837
|
| decreased immature B cell number
|
J:81837
|
| decreased mature B cell number
|
J:81837
|
| decreased pre-B cell number
|
J:81837
|
| increased immature B cell number
|
J:81837
|
\Rag2tm1Libo/\Rag2tm1Libo
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:84563
|
| decreased B cell number
|
J:84563
|
| decreased pre-B cell number
|
J:84563
|
\Rag2tm1Mao/\Rag2tm1Mao
(involves: 129 * C57BL/6)
|
abnormal B cell number
|
J:81837
|
| abnormal gamma-delta T cell differentiation
|
J:81837
|
| arrested B cell differentiation
|
J:81837
|
| arrested T cell differentiation
|
J:81837
|
| decreased double-negative T cell number
|
J:81837
|
| decreased immature B cell number
|
J:81837
|
| decreased mature B cell number
|
J:81837
|
| decreased pre-B cell number
|
J:81837
|
| increased immature B cell number
|
J:81837
|
\Rag2tm1Tgi/\Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:113641
|
| arrested T cell differentiation
|
J:113641
|
| decreased B cell number
|
J:113641
|
| decreased double-positive T cell number
|
J:113641
|
| decreased thymocyte number
|
J:113641
|
\Rap1gapem1(IMPC)H/\Rap1gapem1(IMPC)H
(C57BL/6NTac-Rap1gapem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Rap1gds1tm1Ytk/\Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased thymocyte number
|
J:62244
|
\Raratm1.1Ybe/\Raratm1.1Ybe
(involves: C57BL/6N)
|
abnormal lymphopoiesis
|
J:207485
|
\Rarres1tm1.2Mhl/\Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)
|
abnormal B cell differentiation
|
J:324270
|
| abnormal plasma cell differentiation
|
J:324270
|
\Rasa3scat/\Rasa3scat
(involves: BALB/cBy)
|
decreased B cell number
|
J:186485
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186485
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186485
|
| decreased T cell number
|
J:186485
|
\Rasal3tm1.1Fuj/\Rasal3tm1.1Fuj
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased NK T cell number
|
J:229641
|
\Rasal3tm1b(EUCOMM)Hmgu/\Rasal3tm1b(EUCOMM)Hmgu
(C57BL/6N-Rasal3tm1b(EUCOMM)Hmgu/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
\Rasgrp1lag/\Rasgrp1lag
(involves: 129 * C57BL/6)
|
abnormal positive T cell selection
|
J:85189
|
| increased B cell number
|
J:85189
|
| increased T cell number
|
J:85189
|
\Rasgrp1m1Anu/\Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu)
|
abnormal T cell differentiation
|
J:104190
|
\Rasgrp1m1Anu/\Rasgrp1m1Anu
(involves: C57BL/6JSfdAnu * CBA/J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:207898
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:207898
|
\Rasgrp1m1Btlr/\Rasgrp1m1Btlr
(C57BL/6J-Rasgrp1m1Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265163
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265163
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:265163
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265163
|
| increased NK cell number
|
J:265163
|
\Rasgrp1m2Btlr/\Rasgrp1m2Btlr
(C57BL/6J-Rasgrp1m2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265163
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265163
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265163
|
| decreased single-positive T cell number
|
J:265163
|
| decreased T cell number
|
J:265163
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265163
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265163
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265163
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265163
|
| increased NK cell number
|
J:265163
|
\Rasgrp1m3Btlr/\Rasgrp1m3Btlr
(C57BL/6J-Rasgrp1m3Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265255
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265255
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265255
|
| decreased single-positive T cell number
|
J:265255
|
| decreased T cell number
|
J:265255
|
| increased B cell number
|
J:265255
|
| increased B-1b cell number
|
J:265255
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265255
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265255
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265255
|
| increased NK cell number
|
J:265255
|
\Rasgrp1M4Btlr/\Rasgrp1M4Btlr
(C57BL/6J-Rasgrp1M4Btlr)
|
abnormal T cell morphology
|
J:267490
|
\Rasgrp1m5Btlr/\Rasgrp1m5Btlr
(C57BL/6J-Rasgrp1m5Btlr)
|
increased NK cell number
|
J:272846
|
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225109
|
| abnormal T cell differentiation
|
J:225109
|
| decreased single-positive T cell number
|
J:225109
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:225109
|
| increased single-positive T cell number
|
J:225109
|
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * DBA/2J)
|
decreased single-positive T cell number
|
J:225109
|
| increased double-positive T cell number
|
J:225109
|
\Rasgrp1tm1.1Wz/\Rasgrp1tm1.1Wz
\Tg(TcraTcrb)425Cbn/?
(involves: C57BL/6 * BALB/c)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
\Rasgrp1tm1Jstn/\Rasgrp1tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased B cell number
|
J:108677
|
| decreased thymocyte number
|
J:108677
|
| increased plasma cell number
|
J:108677
|
\Rasgrp1tm1Jstn/\Rasgrp1tm1Jstn
(involves: 129P3/J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:207898
|
| abnormal double-positive T cell morphology
|
J:207898
|
| decreased CD4-positive, alpha-beta T cell number
|
J:207898
|
| decreased CD8-positive, alpha-beta T cell number
|
J:207898
|
\Rasgrp1tm1Jstn/\Rasgrp1tm1Jstn
\Rasgrp3tm1Jstn/\Rasgrp3tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased B cell number
|
J:108677
|
| decreased plasma cell number
|
J:108677
|
\Rasgrp3em1(IMPC)Wtsi/\Rasgrp3em1(IMPC)Wtsi
(C57BL/6N-Rasgrp3em1(IMPC)Wtsi/Wtsi)
|
increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Rasgrp3tm1Jstn/\Rasgrp3tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased B cell number
|
J:108677
|
\Rassf2tm1Dlim/\Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim)
|
decreased B cell number
|
J:181952
|
| decreased CD4-positive, alpha-beta T cell number
|
J:181952
|
| decreased CD8-positive, alpha-beta T cell number
|
J:181952
|
| decreased T cell number
|
J:181952
|
\Rassf5tm1Kina/\Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR)
|
abnormal B cell differentiation
|
J:92670
|
| decreased thymocyte number
|
J:92670
|
\Rassf5tm1Kina/\Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
|
increased B cell number
|
J:168749
|
| increased memory T cell number
|
J:168749
|
| increased plasma cell number
|
J:168749
|
| increased T cell number
|
J:168749
|
\Rbm15tm1Dgg/\Rbm15tm1.1Dgg
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA * FVB/N)
|
abnormal B cell differentiation
|
J:120321
|
| decreased B cell number
|
J:120321
|
| decreased pre-B cell number
|
J:120321
|
\Rbm15tm1Swm/\Rbm15tm1Swm
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:152262
|
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal T-helper 2 cell differentiation
|
J:90018
|
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Lck-cre)19Hhan/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal CD4-positive helper T cell morphology
|
J:168475
|
| increased single-positive T cell number
|
J:168475
|
| increased T cell number
|
J:168475
|
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:99747
|
| abnormal lymphopoiesis
|
J:99747
|
| arrested T cell differentiation
|
J:125869,
J:99747
|
| decreased double-positive T cell number
|
J:99747
|
| decreased marginal zone B cell number
|
J:76240,
J:99747
|
| decreased single-positive T cell number
|
J:99747
|
| decreased thymocyte number
|
J:99747
|
| increased B cell number
|
J:125869,
J:99747
|
| increased double-negative T cell number
|
J:99747
|
| increased follicular B cell number
|
J:99747
|
\Rc3h1san/\Rc3h1+
(involves: C57BL/6JSfdAnu)
|
increased T follicular helper cell number
|
J:189087
|
\Rc3h1san/\Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))
|
abnormal T cell differentiation
|
J:98938
|
\Rc3h1san/\Rc3h1san
(involves: C57BL/6JSfdAnu)
|
abnormal effector T cell morphology
|
J:199407
|
| abnormal intraepithelial T cell number
|
J:199407
|
| increased activated T cell number
|
J:199407
|
| increased CD4-positive, alpha-beta T cell number
|
J:199407
|
\Rc3h1san/\Rc3h1san
\Rc3h2tm1.2Cgv/\Rc3h2tm1.2Cgv
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased T follicular helper cell number
|
J:196137
|
\Rc3h1tm1.1Mass/\Rc3h1tm1.1Mass
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * NZB * SJL)
|
abnormal effector T cell morphology
|
J:177784
|
| increased B cell number
|
J:177784
|
| increased regulatory T cell number
|
J:177784
|
\Rc3h1tm1.1Mass/\Rc3h1tm1.1Mass
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)
|
abnormal B cell differentiation
|
J:177784
|
| abnormal effector T cell morphology
|
J:177784
|
| decreased B cell number
|
J:177784
|
| decreased immature B cell number
|
J:177784
|
| increased regulatory T cell number
|
J:177784
|
\Rc3h1tm1.1Mass/\Rc3h1tm1.1Mass
\Rc3h2tm1c(KOMP)Wtsi/\Rc3h2tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6N * DBA/2)
|
abnormal B cell number
|
J:196136
|
| decreased CD4-positive, alpha-beta T cell number
|
J:196136
|
| decreased CD8-positive, alpha-beta T cell number
|
J:196136
|
| decreased T cell number
|
J:196136
|
| increased germinal center B cell number
|
J:196136
|
| increased T follicular helper cell number
|
J:196136
|
\Rc3h1tm1.1Mass/\Rc3h1tm1.1Mass
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * NZB * SJL)
|
increased CD8-positive, alpha-beta T cell number
|
J:177784
|
\Rc3h1tm1.2Cgv/\Rc3h1san
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased CD4-positive, alpha-beta T cell number
|
J:196137
|
| increased T follicular helper cell number
|
J:196137
|
\Rc3h1tm1.2Mass/\Rc3h1tm1.2Mass
(involves: C57BL/6 * CBA * CD-1 * NZB * SJL)
|
abnormal effector T cell morphology
|
J:177784
|
\Rcan1tm1Jmol/\Rcan1tm1Jmol
\Rcan2tm1Jmol/\Rcan2tm1Jmol
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:109586
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:109586
|
\Rdh7tm1c(KOMP)Wtsi/\Rdh7tm1c(KOMP)Wtsi
\Tg(RARE-Hspa1b/lacZ)12Jrt/0
\Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * C57BL/6N * CD-1 * SJL)
|
decreased lymphocyte cell number
|
J:279231
|
\Reep3em1(IMPC)Tcp/\Reep3em1(IMPC)Tcp
(C57BL/6NCrl-Reep3em1(IMPC)Tcp/Cmmr)
|
decreased lymphocyte cell number
|
J:211773
|
\Reg3gtm1.1Lvh/\Reg3gtm1.1Lvh
(B6.129-Reg3gtm1.1Lvh)
|
increased T-helper 1 cell number
|
J:177506
|
\RelM1Btlr/\Rel+
(C57BL/6J-RelM1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:236682
|
| increased T cell number
|
J:236682
|
\RelM1Btlr/\RelM1Btlr
(C57BL/6J-RelM1Btlr)
|
decreased B-1 B cell number
|
J:236682
|
| decreased CD4-positive, alpha-beta T cell number
|
J:236682
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236682
|
| increased CD4-positive, alpha-beta T cell number
|
J:236682
|
| increased CD8-positive, alpha-beta T cell number
|
J:236682
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:236682
|
| increased T cell number
|
J:236682
|
\RelM2Btlr/\RelM2Btlr
(C57BL/6J-RelM2Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272778
|
| abnormal T cell differentiation
|
J:272778
|
| decreased alpha-beta T cell number
|
J:272778
|
| decreased B-1 B cell number
|
J:272778
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272778
|
| decreased central memory CD4-positive, alpha-beta T cell number
|
J:272778
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:272778
|
\Reltm1Hcl/\Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal memory B cell number
|
J:75621
|
| abnormal T-helper 1 cell differentiation
|
J:79107
|
\Relatm1Bal/\Relatm1Bal
(involves: 129S4/SvJae)
|
decreased marginal zone B cell number
|
J:65246
|
\Relatm1Rsch/\Relatm1Rsch
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Relatm1Rsch/\Relatm1Rsch
\Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Relatm1Yuo/\Relatm1Yuo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:63099
|
\RelbTg(H2-K1/GH1)106Bri/\Relb+
(involves: C57BL/6)
|
decreased NK T cell number
|
J:120659
|
\RelbTg(H2-K1/GH1)106Bri/\RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
decreased B cell number
|
J:76450
|
| decreased pre-B cell number
|
J:76450
|
| decreased T cell number
|
J:76450
|
\RelbTg(H2-K1/GH1)106Bri/\RelbTg(H2-K1/GH1)106Bri
(involves: C57BL/6)
|
decreased NK T cell number
|
J:120659
|
\Relbtm1.1Fwei/\Relbtm1.1Fwei
\Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased T cell number
|
J:22675
|
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Relttm1Hlee/\Relttm1Hlee
(Not Specified)
|
abnormal T cell morphology
|
J:266480
|
\Retreg2em2(IMPC)Ccpcz/\Retreg2em2(IMPC)Ccpcz
(C57BL/6N-Retreg2em2(IMPC)Ccpcz/Ccpcz)
|
increased lymphocyte cell number
|
J:211773
|
\Rev1tm1.1Jow/\Rev1tm1.1Jow
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:151700
|
\Rev1tm1Ndew/\Rev1tm1Ndew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:119176
|
\Rev3ltm1.1Kunk/\Rev3ltm1.1Kunk
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:188723
|
\Rev3ltm1Rsky/\Rev3ltm1.1Rsky
\Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:146453
|
| abnormal somatic hypermutation frequency
|
J:146453
|
| decreased germinal center B cell number
|
J:146453
|
\Rexo2tm1b(EUCOMM)Wtsi/\Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Rft1tm1b(KOMP)Wtsi/\Rft1+
(C57BL/6N-Rft1tm1b(KOMP)Wtsi/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
\Rftn1tm1Ayos/\Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos)
|
abnormal CD4-positive T cell differentiation
|
J:150299
|
\Rfx5tm1.1Ifo/\Rfx5tm1.1Ifo
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:67941
|
| decreased single-positive T cell number
|
J:67941
|
\Rfx7tm1.1Ggaur/\Rfx7tm1.1Ggaur
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal NK cell morphology
|
J:282535
|
| decreased NK cell number
|
J:282535
|
\Rfx7tm1.1Ggaur/\Rfx7tm1.1Ggaur
\Ncr1tm1.1(icre)Viv/\Ncr1+
(involves: C57BL/6)
|
decreased NK cell number
|
J:282535
|
\Rfx7tm1.1Ggaur/\Rfx7tm1.1Ggaur
\Rptortm1.1Dmsa/\Rptor+
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S/SvEv * C57BL/10 * CBA/Ca)
|
abnormal NK cell morphology
|
J:282535
|
| decreased NK cell number
|
J:282535
|
\Rgs1tm1Jhk/\Rgs1tm1Jhk
(B6.129P2-Rgs1tm1Jhk)
|
decreased plasma cell number
|
J:90780
|
| increased marginal zone B cell number
|
J:90780
|
\Rgs3tm1Ndul/\Rgs3tm1Ndul
(B6.129-Rgs3tm1Ndul)
|
increased B cell number
|
J:210195
|
| increased CD4-positive, alpha-beta T cell number
|
J:210195
|
| increased CD8-positive, alpha-beta T cell number
|
J:210195
|
\Rgs4em1(IMPC)H/\Rgs4em1(IMPC)H
(C57BL/6N-Rgs4em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Rgs5tm1Jhk/\Rgs5tm1Jhk
(involves: 129S/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:133897
|
\Rgs9em1(IMPC)Ccpcz/\Rgs9em1(IMPC)Ccpcz
(C57BL/6NCrl-Rgs9em1(IMPC)Ccpcz/Ccpcz)
|
increased lymphocyte cell number
|
J:211773
|
\Rgs13tm1.1Jhk/\Rgs13tm1.1Jhk
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:199530
|
| decreased B cell number
|
J:199530
|
| increased B cell number
|
J:199530
|
| increased germinal center B cell number
|
J:199530
|
\Rgsc14/\Rgsc14+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased lymphocyte cell number
|
J:133634
|
\Rgsc15/\Rgsc15+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased lymphocyte cell number
|
J:133634
|
\Rgsc17/\Rgsc17+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased lymphocyte cell number
|
J:133634
|
\Rhbdd3tm1Caox/\Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox)
|
increased NK cell number
|
J:197348
|
\Rhoatm1.1Tpal/\Rhoa+
\Tg(Cd4-cre/ERT2)11Gnri/0
(involves: C57BL/6)
|
increased regulatory T cell number
|
J:257764
|
| increased T follicular helper cell number
|
J:257764
|
\Rhobtb1em2(IMPC)Ccpcz/\Rhobtb1em2(IMPC)Ccpcz
(C57BL/6N-Rhobtb1em2(IMPC)Ccpcz/Ccpcz)
|
increased Ly6C-positive NK T cell number
|
J:211773
|
\Rhoftm1.2Dash/\Rhoftm1.2Dash
(involves: 129)
|
decreased marginal zone B cell number
|
J:303076
|
\Rhohtm1Brak/\Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143161
|
| abnormal lymphocyte cell number
|
J:143161
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143161
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143161
|
| decreased double-positive T cell number
|
J:143161
|
| decreased single-positive T cell number
|
J:143161
|
| decreased T cell number
|
J:143161
|
| increased double-negative T cell number
|
J:143161
|
| increased gamma-delta T cell number
|
J:143161
|
| increased NK cell number
|
J:143161
|
| increased NK T cell number
|
J:143161
|
| increased T cell number
|
J:143161
|
\Rhohtm1Brak/\Rhohtm1Brak
\Itgb2tm2Bay/\Itgb2tm2Bay
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:143161
|
| decreased CD8-positive, alpha-beta T cell number
|
J:143161
|
| decreased double-positive T cell number
|
J:143161
|
| decreased single-positive T cell number
|
J:143161
|
| increased double-negative T cell number
|
J:143161
|
\Rhohtm1Brak/\Rhohtm1Brak
\Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:143161
|
\Rhohtm1Daw/\Rhohtm1Daw
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:113565
|
| decreased double-positive T cell number
|
J:113565
|
| decreased T cell number
|
J:113565
|
\Ric1tm1a(EUCOMM)Hmgu/\Ric1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ric1tm1a(EUCOMM)Hmgu/H)
|
decreased B cell number
|
J:165965
|
| decreased mature B cell number
|
J:165965
|
\Ric8btm1b(EUCOMM)Hmgu/\Ric8b+
(C57BL/6N-Ric8btm1b(EUCOMM)Hmgu/Cnrm)
|
increased lymphocyte cell number
|
J:211773
|
\Rictortm1.1Klg/\Rictortm1.1Klg
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
abnormal double-negative T cell morphology
|
J:189736
|
| decreased DN1 thymic pro-T cell number
|
J:189736
|
| decreased DN2 thymocyte number
|
J:189736
|
| decreased DN3 thymocyte number
|
J:189736
|
| decreased DN4 thymocyte number
|
J:189736
|
| decreased double-positive T cell number
|
J:189736
|
| decreased single-positive T cell number
|
J:189736
|
| increased double-negative T cell number
|
J:189736
|
\Rif1Gt(XT0278)Wtsi/\Rif1Gt(XT0278)Wtsi
(involves: 129P2/OlaHsd * CD-1 * MF1)
|
abnormal class switch recombination
|
J:195061
|
\Rigitm1Zgwg/\Rigitm1Zgwg
(involves: 129S1/Sv)
|
abnormal B cell differentiation
|
J:139016
|
| decreased T cell number
|
J:139868
|
| increased activated T cell number
|
J:139868
|
| increased memory T cell number
|
J:139868
|
\Rinltm1.1Boun/\Rinltm1.1Boun
(B6.Cg-Rinltm1.1Boun)
|
increased B cell number
|
J:346452
|
| increased CD4-positive, alpha-beta T cell number
|
J:346452
|
| increased germinal center B cell number
|
J:346452
|
| increased T follicular helper cell number
|
J:346452
|
\Rinltm1.1Boun/\Rinltm1.1Boun
\Tg(TcraTcrb)425Cbn/0
(involves: C57BL/6)
|
abnormal T follicular helper cell differentiation
|
J:346452
|
| increased CD4-positive, alpha-beta T cell number
|
J:346452
|
| increased T follicular helper cell number
|
J:346452
|
\Riok2tm1c(KOMP)Wtsi/\Riok2+
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:305794
|
| increased NK T cell number
|
J:305794
|
\Ripk1tm1Led/\Ripk1tm1Led
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:46522
|
\Rnase11em1(IMPC)Mbp/\Rnase11em1(IMPC)Mbp
(C57BL/6N-Rnase11em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Rnaseh2bem1Anu/\Rnaseh2b+
\Tlr7em2Anu/\Tlr7+
(C57BL/6NCrl-Rnaseh2bem1Anu Tlr7em2Anu)
|
abnormal mature B cell morphology
|
J:324448
|
| increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased germinal center B cell number
|
J:324448
|
| increased plasma cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
\Rnd3tm1b(EUCOMM)Hmgu/\Rnd3+
(C57BL/6N-Rnd3tm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
\Rnf2tm1Mvi/\Rnf2tm1Mvi
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * CBA)
|
abnormal B cell differentiation
|
J:130397
|
| decreased B cell number
|
J:130397
|
\Rnf8Gt(AS0574)Wtsi/\Rnf8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
\Rnf8Gt(AS0574)Wtsi/\Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased B cell number
|
J:161240
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161240
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161240
|
| decreased double-negative T cell number
|
J:161240
|
| decreased double-positive T cell number
|
J:161240
|
| decreased immature B cell number
|
J:161240
|
| decreased pre-B cell number
|
J:161240
|
| decreased pro-B cell number
|
J:161240
|
| decreased T cell number
|
J:161240
|
| decreased thymocyte number
|
J:161240
|
\Rnf8Gt(RRR260)Byg/\Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased B cell number
|
J:161240
|
| decreased CD4-positive, alpha-beta T cell number
|
J:161240
|
| decreased CD8-positive, alpha-beta T cell number
|
J:161240
|
| decreased double-negative T cell number
|
J:161240
|
| decreased double-positive T cell number
|
J:161240
|
| decreased immature B cell number
|
J:161240
|
| decreased pre-B cell number
|
J:161240
|
| decreased pro-B cell number
|
J:161240
|
| decreased T cell number
|
J:161240
|
| decreased thymocyte number
|
J:161240
|
\Rnf10tm1b(KOMP)Wtsi/\Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Rnf10tm1b(KOMP)Wtsi/\Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
\Rnf31tm1.1Kiwa/\Rnf31tm1.1Kiwa
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B-1 B cell morphology
|
J:201885
|
| decreased B-1a cell number
|
J:201885
|
| decreased B-1b cell number
|
J:201885
|
\Rnf128tm1.1(KOMP)Vlcg/Y
(C57BL/6N-Rnf128tm1.1(KOMP)Vlcg/Ccpcz)
|
increased effector memory T-helper cell number
|
J:211773
|
\Rnf149em1Staa/\Rnf149em1Staa
(involves: BALB/c * C57BL/6)
|
increased lymphocyte cell number
|
J:335358
|
\Rnf168Gt(156B6)Cmhd/\Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
| decreased gamma-delta T cell number
|
J:198260
|
| increased DN3 thymocyte number
|
J:198260
|
| increased double-negative T cell number
|
J:198260
|
\Rnf168Gt(405F11)Cmhd/\Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
| decreased gamma-delta T cell number
|
J:198260
|
| increased DN3 thymocyte number
|
J:198260
|
| increased double-negative T cell number
|
J:198260
|
\Rnf216tm1b(EUCOMM)Wtsi/\Rnf216tm1b(EUCOMM)Wtsi
(C57BL/6N-Rnf216tm1b(EUCOMM)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Rorcm1Btlr/\Rorcm1Btlr
(C57BL/6J-Rorcm1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:203039
|
| decreased CD8-positive, alpha-beta T cell number
|
J:203039
|
\Rorcm3Btlr/\Rorcm3Btlr
(C57BL/6J-Rorcm3Btlr)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:234257
|
| decreased B-2 B cell number
|
J:234257
|
| decreased CD4-positive, alpha-beta T cell number
|
J:234257
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:234257
|
| increased B-1a cell number
|
J:234257
|
| increased B-1b cell number
|
J:234257
|
| increased CD8-positive, alpha-beta T cell number
|
J:234257
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:234257
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:234257
|
\Rorctm1.1Zsun/\Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun)
|
abnormal T-helper 17 cell differentiation
|
J:248565
|
\Rorctm1Amj/\Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))
|
decreased CD4-positive, alpha-beta T cell number
|
J:64381
|
| decreased CD8-positive, alpha-beta T cell number
|
J:64381
|
| decreased double-positive T cell number
|
J:64381
|
| decreased T cell number
|
J:64381
|
| increased double-negative T cell number
|
J:64381
|
\Rorctm1Litt/\Rorctm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:248565
|
| abnormal T cell differentiation
|
J:128344,
J:248565
|
| abnormal T cell morphology
|
J:248565
|
| abnormal T-helper 17 cell differentiation
|
J:248565
|
| decreased CD4-positive, alpha-beta T cell number
|
J:248565
|
| decreased double-positive T cell number
|
J:248565
|
| decreased thymocyte number
|
J:248565
|
\Rorctm1Litt/\Rorctm1Litt
\Tcra-Jtm3.1Krg/\Tcra-Jtm3.1Krg
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
\Rorctm2Litt/\Rorctm2Litt
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive, alpha-beta intraepithelial T cell morphology
|
J:91566
|
| abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
|
J:91566
|
| decreased double-negative T cell number
|
J:91566
|
| decreased double-positive T cell number
|
J:87395
|
| decreased NK cell number
|
J:142654
|
\Rpa1tm1Wed/\Rpa1+
(involves: 129/Sv * C57BL/6J * SJL)
|
increased lymphocyte cell number
|
J:99303
|
\Rpl22Gt(GST000137)Lex/\Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:123569
|
| abnormal T cell number
|
J:123569
|
| arrested T cell differentiation
|
J:123569
|
| decreased CD4-positive, alpha-beta T cell number
|
J:123569
|
| decreased CD8-positive, alpha-beta T cell number
|
J:123569
|
| decreased double-negative T cell number
|
J:123569
|
| decreased T cell number
|
J:123569
|
\Rpl22Gt(YHB332)Byg/\Rpl22Gt(YHB332)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:201164
|
| decreased T cell number
|
J:201164
|
\Rr7tm1.1Kio/\Rr7tm1.1Kio
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326,
J:164573
|
\Rr7tm2.1Kio/\Rr7tm2.1Kio
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:164573
|
\Rr7tm3.1Kio/\Rr7+
(B6.129S4-Rr7tm3.1Kio)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326
|
\Rr7tm3.1Kio/\Rr7+
\Tg(Lck-cre)#Nik/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326
|
\Rr7tm4.1Kio/\Rr7tm4.1Kio
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:179326
|
\Rr38tm1.2Aafo/\Rr38+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased thymocyte number
|
J:227747
|
\Rr38tm1.2Aafo/\Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:227747
|
| decreased CD8-positive, alpha-beta T cell number
|
J:227747
|
| decreased double-positive T cell number
|
J:227747
|
| decreased single-positive T cell number
|
J:227747
|
| decreased thymocyte number
|
J:227747
|
| increased DN3 thymocyte number
|
J:227747
|
\Rr79em2Rtew/\Rr79em2Rtew
(C57BL/6J-Rr79em2Rtew/J)
|
abnormal T cell subpopulation ratio
|
J:332957
|
\Rr94tm3.1Litt/\Rr94+
\Tg(Cd4-cre)1Cwi/0
\Rr112tm4.1Litt/\Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
\Rr94tm3.1Litt/\Rr94tm3.1Litt
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
\Rr94tm3.2Litt/\Rr94+
\Rr112tm4.1Litt/\Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
\Rr94tm3.2Litt/\Rr94tm3.2Litt
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:158962
|
| abnormal double-positive T cell morphology
|
J:158962
|
| abnormal T cell differentiation
|
J:158962
|
| abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
\Rr94tm3.2Litt/\Rr94tm3.2Litt
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
abnormal T cell subpopulation ratio
|
J:158962
|
| decreased CD4-positive, alpha-beta T cell number
|
J:158962
|
| increased CD8-positive, alpha-beta T cell number
|
J:158962
|
\Rr96tm1.1Tich/\Rr96+
\Gt(ROSA)26Sortm1(cre/ERT2)Thl/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
\Rr96tm1.1Tich/\Rr96+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:191711
|
\Rr96tm1.1Tich/\Rr96tm1.1Tich
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
\Rr96tm1.1Tich/\Rr96tm1.1Tich
\Tg(ACTB-tTS)1Mllo/?
(involves: 129 * C57BL/6)
|
decreased double-positive T cell number
|
J:191711
|
\Rr96tm1.1Yzo/\Rr96tm1.1Yzo
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:130559
|
| increased CD4-positive, alpha-beta T cell number
|
J:130559
|
| increased double-positive T cell number
|
J:130559
|
\Rr96tm1.1Yzo/\Rr96tm1.1Yzo
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
\Rr96tm1Yzo/\Rr96tm1Yzo
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:130559
|
| increased double-positive T cell number
|
J:130559
|
\Rr96tm1Yzo/\Rr96tm1Yzo
\Tg(Cd8a-cre,-GFP)1Yzo/?
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:130559
|
\Rr96tm2Litt/\Rr96+
\Zbtb7btm1.1Tani/\Zbtb7btm1.1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
\Rr96tm2Litt/\Rr96+
\Zbtb7btm1Itan/\Zbtb7btm1.1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:141142
|
| decreased CD8-positive, alpha-beta T cell number
|
J:141142
|
\Rr96tm2Litt/\Rr96tm2Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:80690
|
\Rr96tm2Litt/\Rr96tm2Litt
\Tfap4tm1.1Litt/\Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
\Rr97tm3Welm/\Rr97tm3Welm
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:126027
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:126027
|
| abnormal double-positive T cell morphology
|
J:126027
|
| abnormal gamma-delta intraepithelial T cell morphology
|
J:126027
|
| abnormal T cell differentiation
|
J:126027
|
\Rr99tm1Litt/\Rr99tm1Litt
(either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:50624
|
\Rr100tm2.1Welm/\Rr100+
(involves: 129P2/OlaHsd * AKR.1 * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
\Rr100tm2.1Welm/\Rr100tm2.1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
| abnormal T cell subpopulation ratio
|
J:113136
|
| decreased CD8-positive, alpha-beta T cell number
|
J:113136
|
| decreased double-positive T cell number
|
J:113136
|
| increased CD4-positive, alpha-beta T cell number
|
J:113136
|
\Rr100tm2.1Welm/\Rr100tm2.1Welm
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:158947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158947
|
| decreased double-positive T cell number
|
J:158947
|
| increased CD4-positive, alpha-beta T cell number
|
J:158947
|
\Rr100tm2.1Welm/\Rr100tm2.1Welm
\Tcratm1Mom/\Tcratm1Mom
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal T cell morphology
|
J:113136
|
\Rr123tm1.1Vbo/\Rr123tm1.1Vbo
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal regulatory T cell morphology
|
J:191815
|
| increased regulatory T cell number
|
J:191815
|
\Rr148tm1.1Fwa/\Rr148tm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
| arrested B cell differentiation
|
J:101400
|
| decreased immature B cell number
|
J:101400
|
\Rr148tm1.1Fwa/\Rr148tm1.1Fwa
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
\Rr148tm1Anbo/\Rr148tm1Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
| decreased immature B cell number
|
J:136307
|
| decreased mature B cell number
|
J:136307
|
| decreased pre-B cell number
|
J:136307
|
\Rr148tm1Fwa/\Rr148tm1Fwa
(129S6/SvEvTac-Rr148tm1Fwa)
|
abnormal immature B cell morphology
|
J:101400
|
| absent B cells
|
J:101400
|
| arrested B cell differentiation
|
J:101400
|
\Rr148tm1Fwa/\Rr148tm1Fwa
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
\Rr148tm2Anbo/\Rr148tm2Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
| decreased immature B cell number
|
J:136307
|
| decreased mature B cell number
|
J:136307
|
| decreased pre-B cell number
|
J:136307
|
\Rr152tm2Cog/\Rr152tm2Cog
(involves: 129S2/SvPas * C57BL/6)
|
increased pre-B cell number
|
J:90548
|
\Rr152tm3.1Cog/\Rr152tm3.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:71300
|
\Rr152tm3Cog/\Rr152tm3Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:71300
|
| abnormal class switch recombination
|
J:71300
|
\Rr152tm5.1Cog/\Rr152tm5.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:164513
|
| abnormal somatic hypermutation frequency
|
J:164513,
J:333348
|
\Rr156tm6.1Cog/\Rr156tm6.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:165617
|
\Rr156tm6Cog/\Rr156tm6Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:165617
|
\Rr158tm1(Igh)Xu/\Rr158tm1(Igh)Xu
(Not Specified)
|
decreased B cell number
|
J:124407
|
| decreased immature B cell number
|
J:124407
|
| increased pre-B cell number
|
J:124407
|
\Rr158tm1Cgn/\Rr158tm1Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574,
J:64287
|
| decreased mature B cell number
|
J:64287
|
| increased mature B cell number
|
J:64287
|
\Rr158tm2Cgn/\Rr158tm2Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574
|
\Rr158tm2Xu/\Rr158tm2Xu
(Not Specified)
|
decreased B cell number
|
J:124407
|
\Rr159tm1.1Fwa/\Rr159+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
\Rr159tm1.1Fwa/\Rr159tm1.1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
| decreased B cell number
|
J:113715
|
\Rr159tm1Fwa/\Rr159+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell number
|
J:113715
|
\Rr159tm1Fwa/\Rr159tm1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
| decreased B cell number
|
J:113715
|
\Rr160tm1Wtg/\Rr160tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal mature B cell morphology
|
J:134885
|
| abnormal somatic hypermutation frequency
|
J:134885
|
| decreased follicular B cell number
|
J:134885
|
| increased transitional stage B cell number
|
J:134885
|
\Rr161tm2.2Wtg/\Rr161tm2.2Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:167472
|
| abnormal immunoglobulin V(D)J recombination
|
J:167472
|
| decreased B cell number
|
J:167472
|
| decreased pro-B cell number
|
J:167472
|
| increased pre-B cell number
|
J:167472
|
\Rr162tm3.1Wtg/\Rr162tm3.1Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:172855
|
\Rr166tm4.1Wtg/\Rr166tm4.1Wtg
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:193015
|
| abnormal immunoglobulin light chain V-J recombination
|
J:193015
|
| abnormal pre-B cell morphology
|
J:193015
|
\Rr169tm2Rao/\Rr169+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
\Rr169tm2Rao/\Rr169tm2Rao
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
\Rr170tm1.1Iku/\Rr170tm1.1Iku
(B6.Cg-Rr170tm1.1Iku)
|
decreased T cell number
|
J:333539
|
\Rr253em1Kmm/\Rr253em1Kmm
(C57BL/6-Rr253em1Kmm)
|
abnormal class switch recombination
|
J:316113
|
| abnormal effector T cell number
|
J:316113
|
| decreased B cell number
|
J:316113
|
| decreased mature NK cell number
|
J:316113
|
| increased lymphocyte cell number
|
J:316113
|
| increased NK cell number
|
J:316113
|
| increased T cell number
|
J:316113
|
\Rr308tm1.1Fwa/\Rr308tm1.1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616,
J:82395
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
\Rr308tm1Fwa/\Rr308tm1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
\Rr308tm2Fwa/\Rr308tm2Fwa
(Not Specified)
|
abnormal T cell differentiation
|
J:82395
|
\Rr338em1Jeng/\Rr338em1Jeng
(Not Specified)
|
abnormal T cell differentiation
|
J:232438
|
| abnormal T cell number
|
J:232438
|
| decreased CD4-positive, alpha-beta T cell number
|
J:232438
|
\Rr364tm1.1Aak/\Rr364tm1.1Aak
(129.129S2(Cg)-Rr364tm1.1Aak)
|
abnormal class switch recombination
|
J:242276
|
\Rr381em1Kap/\Rr381em1Kap
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
\Rr381em4Kap/\Rr381em4Kap
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
\Rr381em5Kap/\Rr381em5Kap
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:333471
|
\Rr381tm1.1Tani/\Rr381+
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
\Rr394em1Bhao/\Rr394em1Bhao
(Not Specified)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:333961
|
| decreased thymocyte number
|
J:333961
|
| increased DN3 thymocyte number
|
J:333961
|
\Rr395em1Bhao/\Rr395em1Bhao
(Not Specified)
|
decreased double-positive T cell number
|
J:333961
|
| decreased thymocyte number
|
J:333961
|
| increased DN4 thymocyte number
|
J:333961
|
\Rr149356tm1.1Pf/\Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal T cell differentiation
|
J:34311
|
| arrested T cell differentiation
|
J:34311
|
| decreased double-positive T cell number
|
J:34311
|
| decreased single-positive T cell number
|
J:34311
|
| decreased T cell number
|
J:34311
|
| decreased thymocyte number
|
J:34311
|
| increased double-negative T cell number
|
J:34311
|
| increased gamma-delta T cell number
|
J:34311
|
\Rr149356tm1Abnd/\Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:137580
|
| arrested T cell differentiation
|
J:137580
|
| decreased double-positive T cell number
|
J:137580
|
| decreased single-positive T cell number
|
J:137580
|
| decreased T cell number
|
J:137580
|
| increased double-negative T cell number
|
J:137580
|
| increased gamma-delta T cell number
|
J:137580
|
\Rr149356tm1Che/\Rr149356tm1Che
(involves: 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246,
J:107306
|
| abnormal double-positive T cell morphology
|
J:106246,
J:107306
|
\Rr149356tm1Che/\Rr149356tm1Che
\Tcrdtm1Mom/\Tcrdtm1Mom
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
\Rr149356tm1Che/\Rr149356tm1Che
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
| abnormal double-positive T cell morphology
|
J:106246
|
\Rr275254tm2.1Dhr/\Rr275254tm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Rr275254tm2Dhr/\Rr275254tm2Dhr
(involves: 129S4/SvJae)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Rr282726tm1Dhr/\Rr282726tm1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Rr282729tm1.1Iku/\Rr282729tm1.1Iku
(C57BL/6J-Rr316tm1.1Iku)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:288442
|
| decreased gamma-delta T cell number
|
J:288442
|
\Rr299391tm1.1Fwa/\Rr299391+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell number
|
J:55401
|
| decreased thymocyte number
|
J:55401
|
\Rr299391tm1.1Fwa/\Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell number
|
J:55401
|
| decreased thymocyte number
|
J:55401
|
\Rragcem1Efe/\Rragc+
(Not Specified)
|
abnormal class switch recombination
|
J:320567
|
| decreased germinal center B cell number
|
J:320567
|
| decreased plasma cell number
|
J:320567
|
\Rragcem1Efe/\Rragc+
\Tg(Vav-BCL2)69Jad/0
(Not Specified)
|
decreased germinal center B cell number
|
J:320567
|
\Rras2em1(IMPC)Ccpcz/\Rras2em1(IMPC)Ccpcz
(C57BL/6NCrl-Rras2em1(IMPC)Ccpcz/Ccpcz)
|
increased NK cell number
|
J:211773
|
\Rras2Gt(OST361011)Lex/\Rras2+
(involves: 129S5/SvEvBrd)
|
decreased B cell number
|
J:151653
|
| decreased follicular B cell number
|
J:151653
|
| decreased marginal zone B cell number
|
J:151653
|
| decreased memory T cell number
|
J:151653
|
| decreased T cell number
|
J:151653
|
\Rras2Gt(OST361011)Lex/\Rras2Gt(OST361011)Lex
(involves: 129S5/SvEvBrd)
|
decreased B cell number
|
J:151653
|
| decreased follicular B cell number
|
J:151653
|
| decreased marginal zone B cell number
|
J:151653
|
| decreased memory T cell number
|
J:151653
|
| decreased T cell number
|
J:151653
|
\Rras2Gt(OST361011)Lex/\Rras2Gt(OST361011)Lex
(B6.129S5-Rras2Gt(OST361011)Lex)
|
decreased B cell number
|
J:151653
|
| decreased memory T cell number
|
J:151653
|
| decreased T cell number
|
J:151653
|
\RrasGt(OST24882)Lex/\RrasGt(OST24882)Lex
(B6;129S5-RrasGt(OST24882)Lex/Ieg)
|
decreased B cell number
|
J:82809
|
| increased CD4-positive, alpha-beta T cell number
|
J:82809
|
| increased CD8-positive, alpha-beta T cell number
|
J:82809
|
\Rsad2tm1Kchc/\Rsad2tm1Kchc
(B6.129-Rsad2tm1Kchc)
|
abnormal T-helper 2 cell differentiation
|
J:148305
|
\Rspo1tm2b(KOMP)Wtsi/\Rspo1tm2b(KOMP)Wtsi
(C57BL/6N-Rspo1tm2b(KOMP)Wtsi/Ics)
|
increased lymphocyte cell number
|
J:211773
|
\Rtcbtm1c(KOMP)Wtsi/\Rtcbtm1c(KOMP)Wtsi
\Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA * SJL)
|
abnormal B cell number
|
J:216740
|
| abnormal plasma cell morphology
|
J:216740
|
\Rthyd1NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rthyd2B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rthyd3B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rthyd5NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
\Rubcnem1Dgre/\Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
increased CD8-positive, alpha-beta T cell number
|
J:235399
|
| increased lymphocyte cell number
|
J:235399
|
\Runx1tm1(RUNX1)Gcg/\Runx1tm1(RUNX1)Gcg
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:106800
|
| decreased CD4-positive, alpha-beta T cell number
|
J:106800
|
| decreased double-positive T cell number
|
J:106800
|
| increased CD8-positive, alpha-beta T cell number
|
J:106800
|
\Runx1tm1Soga/\Runx1tm1.1Soga
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:88511
|
| abnormal T cell differentiation
|
J:88511
|
\Runx1tm1Spe/\Runx1+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
\Runx1tm1Tani/\Runx1tm1Tani
\Runx3tm1Itan/\Runx3tm1Itan
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:125959
|
\Runx1tm1Tani/\Runx1tm1Tani
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125959
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125959
|
| abnormal double-positive T cell morphology
|
J:125959
|
| decreased CD4-positive, alpha-beta T cell number
|
J:125959
|
\Runx1tm1Tani/\Runx1tm1Tani
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:125959
|
| decreased double-positive T cell number
|
J:125959
|
| decreased thymocyte number
|
J:125959
|
| increased double-negative T cell number
|
J:125959
|
\Runx1tm1Toku/\Runx1+
\Runx3tm1Itan/\Runx3tm1Itan
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
\Runx1tm1Toku/\Runx1tm1Toku
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:87697
|
| increased CD4-positive, alpha-beta T cell number
|
J:87697
|
\Runx1tm1Toku/\Runx1tm1Toku
\Runx3tm1Itan/\Runx3+
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:131081
|
| decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
\Runx1tm1Toku/\Runx1tm1Toku
\Runx3tm1Itan/\Runx3tm1Itan
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:131081
|
| decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
\Runx1tm1Toku/\Runx1tm1Toku
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
\Runx1tm1Yg/\Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal T cell differentiation
|
J:125830
|
| decreased single-positive T cell number
|
J:125830
|
| decreased thymocyte number
|
J:125830
|
| increased double-positive T cell number
|
J:125830
|
\Runx1tm1Yg/\Runx1tm1Yg
\Tg(Lck-cre)1Jtak/?
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
decreased T cell number
|
J:125830
|
\Runx1tm2(Runx1)Toku/\Runx1tm2(Runx1)Toku
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:87697
|
\Runx1tm2.1Gss/\Runx1tm2.1Gss
(involves: 129S4/SvJae * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:214025
|
| decreased immature B cell number
|
J:214025
|
| decreased pre-pro B cell number
|
J:214025
|
| increased mature B cell number
|
J:214025
|
| increased pro-B cell number
|
J:214025
|
\Runx1tm2Buch/\Runx1tm2Buch
\Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:105709
|
| decreased CD8-positive, alpha-beta T cell number
|
J:105709
|
| decreased double-positive T cell number
|
J:105709
|
| decreased lymphocyte cell number
|
J:105709
|
| decreased mature B cell number
|
J:105709
|
| decreased T cell number
|
J:105709
|
\Runx1tm3(Runx3)Toku/\Runx1tm3(Runx3)Toku
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:98965
|
| decreased thymocyte number
|
J:98965
|
\Runx1tm3Itan/\Runx1tm3Itan
(involves: 129P2/OlaHsd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:168918
|
| decreased thymocyte number
|
J:168918
|
\Runx1tm3Spe/\Runx1tm3Spe
\Spi1tm2.1Dgt/\Spi1tm2.1Dgt
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased B cell number
|
J:131217
|
\Runx1tm3Spe/\Runx1tm3Spe
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:131217
|
| decreased B cell number
|
J:151639
|
| decreased double-negative T cell number
|
J:131217
|
| increased double-negative T cell number
|
J:131217
|
\Runx1tm3Spe/\Runx1tm3Spe
\Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae)
|
decreased B cell number
|
J:145700
|
| decreased double-positive T cell number
|
J:145700
|
| decreased lymphocyte cell number
|
J:145700
|
| decreased thymocyte number
|
J:145700
|
\Runx1tm4Spe/\Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
\Runx1tm4Spe/\Runx1tm4Spe
(involves: 129/Sv * C57BL/6)
|
decreased lymphocyte cell number
|
J:120100
|
\Runx1tm5Spe/\Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
\Runx1tm6Spe/\Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
\Runx1tm7Spe/\Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
\Runx1tm8Spe/\Runx1+
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:120100
|
\Runx2tm1Kish/\Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:53069
|
| decreased thymocyte number
|
J:40783
|
\Runx3tm1Itan/\Runx3tm1Itan
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125953
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
| decreased CD8-positive, alpha-beta T cell number
|
J:131081
|
\Runx3tm1Litt/\Runx3tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
| abnormal double-positive T cell morphology
|
J:141144
|
\Runx3tm1Yg/\Runx3tm1Yg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:109584
|
\Runx3tm2Yg/\Runx3tm2Yg
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * ICR)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:109584
|
\Ruvbl2M1Btlr/\Ruvbl2+
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased CD4-positive, alpha-beta T cell number
|
J:185495
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185495
|
| decreased double-positive T cell number
|
J:185495
|
| decreased T cell number
|
J:185495
|
| increased thymocyte number
|
J:185495
|
\Rwdd1tm1b(KOMP)Wtsi/\Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
\Rxrapke/\Rxrapke
(C57BL/6J-Rxrapke)
|
abnormal T-helper 2 cell morphology
|
J:103186
|
\Rykem1(IMPC)Mbp/\Ryk+
(C57BL/6NCrl-Rykem1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\S1pr1tm1.1Cys/\S1pr1tm1.1Cys
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
decreased B cell number
|
J:176118
|
\S1pr1tm1.1Thla/\S1pr1tm1.1Thla
(B6.Cg-S1pr1tm1.1Thla)
|
increased CD4-positive, alpha-beta T cell number
|
J:163389
|
| increased CD8-positive, alpha-beta T cell number
|
J:163389
|
\S1pr1tm1Cys/\S1pr1tm1Cys
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell number
|
J:176118
|
\S1pr1tm1Rlp/\S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
abnormal NK cell differentiation
|
J:154069
|
| decreased NK cell number
|
J:154069
|
\S1pr2tm1Ajml/\S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased germinal center B cell number
|
J:154439
|
| increased T cell number
|
J:154439
|
\S1pr2tm1Rlp/\S1pr2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased B cell number
|
J:174313
|
| increased germinal center B cell number
|
J:174313
|
| increased T cell number
|
J:174313
|
\S1pr5tm1Club/\S1pr5tm1Club
(B6.129P2-S1pr5tm1Club)
|
abnormal NK cell morphology
|
J:178789
|
| decreased NK cell number
|
J:178789
|
\S1pr5tm1Jch/\S1pr5tm1Jch
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:154069
|
\Samd3tm1.1(HBEGF)Wfkr/\Samd3+
(C57BL/6J-Samd3tm1.1(HBEGF)Wfkr)
|
abnormal NK cell differentiation
|
J:322359
|
| decreased memory T cell number
|
J:322359
|
| decreased NK cell number
|
J:322359
|
\Samd3tm1.1(HBEGF)Wfkr/\Samd3tm1.1(HBEGF)Wfkr
(C57BL/6J-Samd3tm1.1(HBEGF)Wfkr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:322359
|
\Samsn1tm1Xyw/\Samsn1tm1Xyw
(B6.129P2-Samsn1tm1Xyw)
|
increased B-1a cell number
|
J:158032
|
\Sash3tm1Hlz/\Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz)
|
abnormal B cell morphology
|
J:102171
|
| abnormal CD4-positive T cell differentiation
|
J:102171
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:102171
|
| abnormal T cell morphology
|
J:102171
|
| decreased double-positive T cell number
|
J:102171
|
| decreased marginal zone B cell number
|
J:102171
|
\Satb1m1Anu/\Satb1+
(C57L/6JAnu-Satb1m1Anu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:104190
|
\Satb1m1Anu/\Satb1m1Anu
(C57L/6JAnu-Satb1m1Anu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:104190
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:104190
|
\Satb1tm1Kos/\Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:61085
|
| arrested T cell differentiation
|
J:61085
|
| decreased thymocyte number
|
J:61085
|
\Satb1tm2Kos/\Satb1tm2Kos
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
absent regulatory T cells
|
J:252606
|
\Saxo1tm1b(EUCOMM)Hmgu/\Saxo1tm1b(EUCOMM)Hmgu
(C57BL/6N-Saxo1tm1b(EUCOMM)Hmgu/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Sbdstm1Dats/\Sbdstm1Dats
\Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6 * CD-1)
|
decreased B cell number
|
J:158901
|
| decreased lymphocyte cell number
|
J:158901
|
\Sbf1em1(IMPC)Mbp/\Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Scarb2em2(IMPC)Tcp/\Scarb2em2(IMPC)Tcp
(C57BL/6NCrl-Scarb2em2(IMPC)Tcp/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Scarf1tm1Tkms/\Scarf1tm1Tkms
(involves: C57BL/6)
|
increased B cell number
|
J:208237
|
| increased CD4-positive, alpha-beta T cell number
|
J:208237
|
| increased lymphocyte cell number
|
J:208237
|
| increased T follicular helper cell number
|
J:208237
|
\Scmh1tm1Yota/\Scmh1tm1Yota
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:194424
|
| decreased T cell number
|
J:194424
|
\Sdc4tm2b(KOMP)Wtsi/\Sdc4tm2b(KOMP)Wtsi
(C57BL/6N-Sdc4tm2b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Sec63tm1b(EUCOMM)Hmgu/\Sec63+
(C57BL/6N-Sec63tm1b(EUCOMM)Hmgu/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
\Secisbp2tm1a(EUCOMM)Wtsi/\Secisbp2+
(Not Specified)
|
increased NK cell number
|
J:165965
|
\Seletm1Hyn/\Seletm1Hyn
\Selptm1Hyn/\Selptm1Hyn
(involves: 129S2/SvPas)
|
increased lymphocyte cell number
|
J:31626
|
\Sellm1Btlr/\Sellm1Btlr
(C57BL/6J-Sellm1Btlr)
|
decreased single-positive T cell number
|
J:217794
|
\Sellm2Btlr/\Sellm2Btlr
(C57BL/6J-Sellm2Btlr)
|
decreased single-positive T cell number
|
J:231806
|
\Selltm1Flv/\Selltm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
decreased activated T cell number
|
J:89253
|
\Selltm1Tft/\Selltm1Tft
(B6.129P2-Selltm1Tft)
|
abnormal regulatory T cell number
|
J:141931
|
\Selltm2Tft/\Selltm2.1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell number
|
J:141931
|
\Selplgtm1Rpmc/\Selplgtm1Rpmc
(involves: 129S1/Sv * C57BL/6J)
|
increased lymphocyte cell number
|
J:75829
|
\Sema4atm1Kik/\Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik)
|
abnormal T-helper 1 cell differentiation
|
J:97027
|
\Sema4dtm1Kik/\Sema4dtm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B-1 B cell morphology
|
J:66033
|
| decreased B-1a cell number
|
J:66033
|
| decreased CD4-positive, alpha-beta T cell number
|
J:66033
|
| decreased T cell number
|
J:66033
|
| increased B cell number
|
J:66033
|
\Sema5btm1a(EUCOMM)Wtsi/\Sema5btm1a(EUCOMM)Wtsi
(C57BL/6N-Sema5btm1a(EUCOMM)Wtsi/Cnrm)
|
decreased T cell number
|
J:165965
|
\Septin9tm2.1Emfu/\Septin9tm2.1Emfu
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:205027
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:205027
|
| decreased CD4-positive, alpha-beta T cell number
|
J:205027
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:205027
|
| decreased CD8-positive, alpha-beta T cell number
|
J:205027
|
| decreased DN4 thymocyte number
|
J:205027
|
| decreased regulatory T cell number
|
J:205027
|
| decreased single-positive T cell number
|
J:205027
|
| decreased T cell number
|
J:205027
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:205027
|
| increased DN3 thymocyte number
|
J:205027
|
| increased double-negative T cell number
|
J:205027
|
\Septin9tm2.1Emfu/\Septin9tm2.1Emfu
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased CD8-positive, alpha-beta T cell number
|
J:205027
|
\Serf1tm1a(EUCOMM)Hmgu/\Serf1tm1a(EUCOMM)Hmgu
(C57BL/6N-Serf1tm1a(EUCOMM)Hmgu/H)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
\Serpina3gtm1.1Arp/\Serpina3gtm1.1Arp
(involves: C57BL/6)
|
abnormal memory T cell morphology
|
J:189782
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:189782
|
\Serpinb2tm1Dgi/\Serpinb2tm1Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
decreased lymphocyte cell number
|
J:52283
|
\Serpinb2tm2Dgi/\Serpinb2tm2Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
decreased lymphocyte cell number
|
J:52283
|
\Serpinb9em1(IMPC)Ccpcz/\Serpinb9em1(IMPC)Ccpcz
(C57BL/6NCrl-Serpinb9em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
\Serpinb9tm1Arp/\Serpinb9tm1Arp
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:113349
|
\Serpini2pq/\Serpini2pq
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:115744
|
| abnormal pre-B cell morphology
|
J:115744
|
| abnormal pro-B cell morphology
|
J:115744
|
| decreased B cell number
|
J:115744
|
| decreased immature B cell number
|
J:115744
|
| decreased lymphocyte cell number
|
J:115744
|
| decreased pre-B cell number
|
J:115744
|
| decreased pro-B cell number
|
J:115744
|
| decreased T cell number
|
J:115744
|
| decreased thymocyte number
|
J:115744
|
\Sesn1tm1a(EUCOMM)Wtsi/\Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:240602
|
| abnormal effector T cell number
|
J:240602
|
| decreased B cell number
|
J:240602
|
| increased NK T cell number
|
J:240602
|
| increased single-positive T cell number
|
J:240602
|
\Setd2tm1c(NCOM)Mfgc/\Setd2tm1c(NCOM)Mfgc
\Tg(Lck-cre)#Zhu/0
(involves: C57BL/6 * SJL/J)
|
increased gamma-delta T cell number
|
J:243973
|
\Setd3tm1.1(NCOM)Mfgc/\Setd3tm1.1(NCOM)Mfgc
(C57BL/6N-Setd3tm1.1(NCOM)Mfgc/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Setd5tm1a(EUCOMM)Wtsi/\Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi)
|
increased regulatory T cell number
|
J:211773
|
\Setxtm1b(EUCOMM)Wtsi/\Setxtm1b(EUCOMM)Wtsi
(C57BL/6N-Setxtm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Sf3b1tm1.1Mdf/\Sf3b1+
\Tet2tm1.1Iaai/\Tet2tm1.1Iaai
\Tg(Mx1-cre)1Cgn/?
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA/J)
|
decreased B cell number
|
J:234976
|
\Sfntm1Mak/\Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:168328
|
| decreased B cell number
|
J:168328
|
| decreased B-1a cell number
|
J:168328
|
| decreased follicular B cell number
|
J:168328
|
| decreased marginal zone B cell number
|
J:168328
|
\Sfrp1tm1Bsk/\Sfrp1tm1Bsk
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased lymphocyte cell number
|
J:89547
|
\Sgpl1Gt(OST58278)Lex/\Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal lymphopoiesis
|
J:145159
|
| decreased B cell number
|
J:145159
|
| decreased double-positive T cell number
|
J:145159
|
| decreased lymphocyte cell number
|
J:145159
|
| decreased pre-B cell number
|
J:145159
|
| decreased T cell number
|
J:145159
|
| increased CD4-positive, alpha-beta T cell number
|
J:145159
|
| increased CD8-positive, alpha-beta T cell number
|
J:145159
|
\Sgpl1Gt(OST58278)Lex/\Sgpl1tm1(SGPL1)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased T cell number
|
J:145159
|
\Sgpl1Gt(ROSA)78Sor/\Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased lymphocyte cell number
|
J:187619
|
\Sgpl1tm1(SGPL1)Lex/\Sgpl1tm1(SGPL1)Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:145159
|
| decreased CD4-positive, alpha-beta T cell number
|
J:145159
|
| decreased CD8-positive, alpha-beta T cell number
|
J:145159
|
| decreased lymphocyte cell number
|
J:145159
|
| decreased T cell number
|
J:145159
|
| increased single-positive T cell number
|
J:145159
|
\Sgsm1tm1b(EUCOMM)Wtsi/\Sgsm1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sgsm1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
\Sh2b2tm1Yeb/\Sh2b2tm1Yeb
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:88527
|
| increased B-1 B cell number
|
J:88527
|
\Sh2b3tm1Paw/\Sh2b3tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased B cell number
|
J:77248
|
\Sh2b3tm1Paw/\Sh2b3tm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:161643
|
| increased lymphocyte cell number
|
J:161643
|
\Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:189126
|
\Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * BALB/c)
|
abnormal germinal center B cell morphology
|
J:189126
|
| decreased germinal center B cell number
|
J:189126
|
| decreased NK T cell number
|
J:189126
|
\Sh2d1atm1Cpt/Y
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
decreased germinal center B cell number
|
J:189126
|
\Sh2d1atm1Cpt/\Sh2d1atm1Cpt
(B6.129S4-Sh2d1atm1Cpt)
|
absent NK T cells
|
J:97690
|
| decreased NK T cell number
|
J:97690
|
| decreased transitional stage B cell number
|
J:97690
|
| increased B cell number
|
J:97388
|
\Sh2d1atm1Cpt/\Sh2d1atm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
decreased NK T cell number
|
J:189126
|
\Sh2d1atm1Cpt/\Sh2d1atm1Cpt
(involves: 129S4/SvJae * BALB/c)
|
abnormal germinal center B cell morphology
|
J:189126
|
| decreased germinal center B cell number
|
J:189126
|
| decreased NK T cell number
|
J:189126
|
\Sh2d1atm1Cpt/\Sh2d1atm1Cpt
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
decreased germinal center B cell number
|
J:189126
|
\Sh2d1atm1Lyin/Y
(involves: 129S2/SvPas * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:97346
|
\Sh2d1atm1Lyin/\Sh2d1atm1Lyin
(involves: 129S2/SvPas * C57BL/6)
|
increased CD8-positive, alpha-beta T cell number
|
J:97346
|
\Sh2d1atm1Pls/Y
(involves: 129S6/SvEvTac)
|
abnormal long lived plasma cell morphology
|
J:157915
|
| abnormal NK T cell morphology
|
J:196692
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157915
|
\Sh2d1atm1Pls/\Sh2d1atm1Pls
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal lymphocyte cell number
|
J:70032
|
| abnormal T-helper 1 cell morphology
|
J:70032
|
| abnormal T-helper 2 cell morphology
|
J:70032
|
\Sh2d1atm1Pls/\Sh2d1atm1Pls
(involves: 129S6/SvEvTac)
|
abnormal long lived plasma cell morphology
|
J:157915
|
| abnormal NK T cell morphology
|
J:196692
|
| decreased CD4-positive, alpha-beta T cell number
|
J:157915
|
\Sh2d1atm2.1Vei/\Sh2d1atm2.1Vei
(involves: C57BL/6)
|
decreased germinal center B cell number
|
J:131618
|
| decreased NK T cell number
|
J:131618
|
\Sh2d1atm2Vei/\Sh2d1atm2Vei
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased germinal center B cell number
|
J:131618
|
| decreased NK T cell number
|
J:131618
|
\Sh2d1atm2Vei/\Sh2d1atm2Vei
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
decreased germinal center B cell number
|
J:131618
|
| decreased NK T cell number
|
J:131618
|
\Sh2d3ctm1Lex/\Sh2d3ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased marginal zone B cell number
|
J:161448
|
\Sh3bp2tm1Bjro/\Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
abnormal B cell number
|
J:117880
|
\Sh3bp2tm1Geha/\Sh3bp2tm1Geha
(Not Specified)
|
abnormal B cell number
|
J:110319
|
| increased pre-B cell number
|
J:110319
|
\Sh3bp2tm1Rtpl/\Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl)
|
abnormal B cell number
|
J:121380
|
| decreased B-1 B cell number
|
J:121380
|
| decreased pro-B cell number
|
J:121380
|
| decreased transitional stage B cell number
|
J:121380
|
| increased marginal zone B cell number
|
J:121380
|
\Sh3kbp1tm1Kuro/\Sh3kbp1tm1Kuro
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6 * NZB)
|
abnormal lymphocyte cell number
|
J:176805
|
| decreased B cell number
|
J:176805
|
| decreased B-1a cell number
|
J:176805
|
| decreased follicular B cell number
|
J:176805
|
| decreased immature B cell number
|
J:176805
|
| decreased transitional stage T2 B cell number
|
J:176805
|
| decreased transitional stage T3 B cell number
|
J:176805
|
\Sh3kbp1tm1Kuro/\Sh3kbp1tm1Kuro
\Cd79atm1(cre)Reth/\Cd79a+
\Gt(ROSA)26Sortm4(Ikbkb)Rsky/?
(involves: BALB/c * C57BL/6 * NZB)
|
decreased B-1a cell number
|
J:176805
|
\Sharpincpdm/\Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm)
|
decreased B cell number
|
J:53575
|
| decreased CD4-positive, alpha-beta T cell number
|
J:53575
|
| decreased T cell number
|
J:53575
|
\Shc1tm1Ravi/\Shc1tm1Ravi
\Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
| decreased double-positive T cell number
|
J:78180
|
| decreased single-positive T cell number
|
J:78180
|
\Shcbp1tm1d(EUCOMM)Wtsi/\Shcbp1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * FVB/N)
|
decreased B cell number
|
J:212898
|
| decreased CD4-positive, alpha-beta T cell number
|
J:212898
|
| decreased T cell number
|
J:212898
|
\Shisa6em1(IMPC)Tcp/\Shisa6em1(IMPC)Tcp
(C57BL/6N-Shisa6em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Shld1em1Nus/\Shld1em1Nus
(involves: C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
\Siglec1tm1Croc/\Siglec1tm1Croc
(B6.129-Siglec1tm1Croc)
|
abnormal B cell number
|
J:105546
|
| abnormal T cell subpopulation ratio
|
J:105546
|
| decreased follicular B cell number
|
J:105546
|
| increased CD8-positive, alpha-beta T cell number
|
J:105546
|
| increased marginal zone B cell number
|
J:105546
|
\SiglecgM1Btlr/\SiglecgM1Btlr
(C57BL/6J-SiglecgM1Btlr)
|
increased B-1 B cell number
|
J:265179
|
\Siglecgm2Btlr/\Siglecgm2Btlr
(C57BL/6J-Siglecgm2Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:265183
|
| increased B-1 B cell number
|
J:265183
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:265183
|
\SiglecgM3Btlr/\SiglecgM3Btlr
(C57BL/6J-SiglecgM3Btlr)
|
decreased B-2 B cell number
|
J:265185
|
| increased B-1 B cell number
|
J:265185
|
| increased B-1a cell number
|
J:265185
|
\SiglecgM4Btlr/\SiglecgM4Btlr
(C57BL/6J-SiglecgM4Btlr)
|
increased B-1 B cell number
|
J:272021
|
\SiglecgM5Btlr/\SiglecgM5Btlr
(C57BL/6J-SiglecgM5Btlr)
|
increased B-1a cell number
|
J:272022
|
\Siglecgtm1Lnit/\Siglecgtm1Lnit
(involves: BALB/c)
|
abnormal plasma cell differentiation
|
J:123353
|
| increased B-1 B cell number
|
J:123353
|
| increased B-1a cell number
|
J:123353
|
| increased B-1b cell number
|
J:123353
|
\Siglecgtm1Yliu/\Siglecgtm1Yliu
(C57BL/6-Siglecgtm1Yliu)
|
increased B-1a cell number
|
J:130017
|
| increased pre-B cell number
|
J:130017
|
\Siglechtm1.1Ksat/\Siglechtm1.1Ksat
(B6.Cg-Siglechtm1.1Ksat)
|
abnormal regulatory T cell morphology
|
J:179283
|
| decreased T-helper 17 cell number
|
J:179283
|
| increased T-helper 17 cell number
|
J:179283
|
\Sik3tm1a(EUCOMM)Hmgu/\Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD5-positive gamma-delta T cell number
|
J:211773
|
| decreased early germinal center B cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased gamma-delta T cell number
|
J:211773
|
| decreased germinal center B cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased KLRG1-positive T-helper cell number
|
J:211773
|
| decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased memory-marker CD4-negative NK T cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased regulatory T cell number
|
J:211773
|
| decreased T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased CD4-negative NK T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased follicular B cell number
|
J:211773
|
| increased KLRG1+ CD8 alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive CD4-negative NK T cell number
|
J:211773
|
| increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased KLRG1-positive T-helper cell number
|
J:211773
|
| increased Ly6C-positive NK T cell number
|
J:211773
|
| increased memory-marker gamma-delta T cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Sirpatm1Nog/\Sirpatm1Nog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell number
|
J:79592
|
\Sirt1tm1Mcby/\Sirt1tm1Mcby
(involves: 129)
|
decreased CD8-positive, alpha-beta T cell number
|
J:81010
|
\Sirt1tm1Mcby/\Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased CD8-positive, alpha-beta T cell number
|
J:81010
|
\Sirt6tm1Fwa/\Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112817
|
| abnormal lymphopoiesis
|
J:112817
|
| decreased double-positive T cell number
|
J:112817
|
\Sit1tm1Lsmn/\Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
abnormal lymphocyte cell number
|
J:100408
|
| abnormal T cell differentiation
|
J:100408
|
| abnormal T-helper 1 cell differentiation
|
J:100408
|
| decreased CD4-positive, alpha-beta T cell number
|
J:100408
|
| decreased CD8-positive, alpha-beta T cell number
|
J:100408
|
| increased double-positive T cell number
|
J:100408
|
| increased mature gamma-delta T cell number
|
J:100408
|
\Sit1tm1Lsmn/\Sit1tm1Lsmn
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:100408
|
| abnormal positive T cell selection
|
J:100408
|
| abnormal T cell differentiation
|
J:100408
|
\Sit1tm1Lsmn/\Sit1tm1Lsmn
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:100408
|
| abnormal T cell selection
|
J:100408
|
\Skint1m1Tac/\Skint1m1Tac
(FVB/NTac)
|
abnormal T cell differentiation
|
J:139711
|
| abnormal T cell morphology
|
J:139711
|
\Skint2em2Htaka/\Skint2em2Htaka
(C57BL/6-Skint2em2Htaka)
|
decreased dendritic epidermal T cell number
|
J:291989
|
\Skp2tm1Kin/\Skp2tm1Kin
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
\Sla2em1(IMPC)Ccpcz/\Sla2em1(IMPC)Ccpcz
(C57BL/6N-Sla2em1(IMPC)Ccpcz/Ccpcz)
|
decreased NK cell number
|
J:211773
|
\Slatm1Weis/\Slatm1Weis
(involves: 129 * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:71804
|
\Slatm1Weis/\Slatm1Weis
\Tg(DO11.10)10Dlo/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:71804
|
| abnormal T cell differentiation
|
J:71804
|
\Slatm1Weis/\Slatm1Weis
\Zap70tm1Weis/\Zap70tm1Weis
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:71804
|
| decreased CD4-positive, alpha-beta T cell number
|
J:71804
|
\Slc1a5tm1Tac/\Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:254980
|
| abnormal T-helper 2 cell differentiation
|
J:254980
|
| abnormal T-helper 17 cell differentiation
|
J:254980
|
| decreased B cell number
|
J:254980
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:254980
|
| decreased T helper 1 cell number
|
J:254980
|
| decreased T-helper 17 cell number
|
J:254980
|
| increased CD4-positive, alpha-beta T cell number
|
J:254980
|
\Slc4a4tm1Ges/\Slc4a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased lymphocyte cell number
|
J:120867
|
\Slc7a7em1Lbu/\Slc7a7em1Lbu
(involves: 129/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:293773
|
\Slc11a1em1(IMPC)Mbp/\Slc11a1em1(IMPC)Mbp
(C57BL/6N-Slc11a1em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Slc12a2em1Dlp/\Slc12a2em1Dlp
(involves: C57BL/6J * DBA/2J)
|
increased lymphocyte cell number
|
J:285398
|
\Slc13a3tm1b(KOMP)Wtsi/\Slc13a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc13a3tm1b(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Slc19a1tm1Gold/\Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:68666
|
| decreased lymphocyte cell number
|
J:68666
|
\Slc25a37tm1.1Kapl/\Slc25a37tm1.2Kapl
\Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA)
|
abnormal B cell morphology
|
J:173284
|
| abnormal lymphocyte morphology
|
J:173284
|
| abnormal T cell morphology
|
J:173284
|
\Slc28a3em1(IMPC)H/\Slc28a3em1(IMPC)H
(C57BL/6N-Slc28a3em1(IMPC)H/H)
|
increased large unstained cell number
|
J:211773
|
\Slc33a1tm1.1Lpu/\Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased B cell number
|
J:211266
|
| increased B cell number
|
J:211266
|
\Slc35c1tm1Cknr/\Slc35c1tm1Cknr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased lymphocyte cell number
|
J:121151
|
\Slc37a4tm1Jyc/\Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
decreased lymphocyte cell number
|
J:86005
|
\Slc39a3tm1Gka/\Slc39a3tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:99161
|
| decreased double-positive T cell number
|
J:99161
|
| increased CD4-positive, alpha-beta T cell number
|
J:99161
|
\Slco1a5tm1Lex/\Slco1a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:103485
|
| increased B cell number
|
J:103485
|
\Slco4c1em1(IMPC)Ccpcz/\Slco4c1em1(IMPC)Ccpcz
(C57BL/6NCrl-Slco4c1em1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Sle1NZM2410/Aeg/\Sle1NZM2410/Aeg
\Sle3NZM2410/Aeg/\Sle3NZM2410/Aeg
(B6;NZM-Sle1NZM2410/Aeg Sle2NZM2410/Aeg Sle3NZM2410/Aeg/LmoJ)
|
increased marginal zone B cell number
|
J:138314
|
\Sle1NZW/\Sle1NZW
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW)
|
increased B cell number
|
J:134128
|
| increased marginal zone B cell number
|
J:134128
|
\Slfn2m1Btlr/\Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:158985
|
| decreased CD8-positive, alpha-beta T cell number
|
J:158985
|
\Slfn4tm1c(EUCOMM)Wtsi/\Slfn4tm1c(EUCOMM)Wtsi
\Gli1tm3(cre/ERT2)Alj/\Gli1+
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:337060
|
\Slx4tm1a(EUCOMM)Wtsi/\Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi)
|
abnormal lymphopoiesis
|
J:168567
|
\Smad3em1(IMPC)H/\Smad3+
(C57BL/6NTac-Smad3em1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Smad3tm1Cxd/\Smad3tm1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955
|
\Smad7tm1.1Ink/\Smad7tm1.1Ink
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
| decreased activated T cell number
|
J:184670
|
\Smad7tm1Rheu/\Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal class switch recombination
|
J:120714
|
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn
\Tg(Lck-cre)1Cwi/0
(Not Specified)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-negative T cell number
|
J:144072
|
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn
\Tg(Lck-cre)1Cwi/0
\Tg(LCKprBCL2L1)12Sjk/0
(Not Specified)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
| increased double-negative T cell number
|
J:144072
|
| increased thymocyte number
|
J:144072
|
\Smarca4tm1.2Pcn/\Smarca4tm1Mag
\Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:85191
|
| absent CD8-positive, alpha-beta T cells
|
J:85191
|
| arrested T cell differentiation
|
J:85191
|
| decreased CD4-positive, alpha-beta T cell number
|
J:85191
|
| decreased double-negative T cell number
|
J:85191
|
| decreased double-positive T cell number
|
J:85191
|
\Smarca4tm1.2Pcn/\Smarca4tm1Mag
\Tg(Lck-cre)1Cwi/?
\Tg(LCKprBCL2)36Sjk/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:85191
|
\Smarca4tm1.2Pcn/\Smarca4tm1Tich
\Tg(Lck-cre)1Cwi/0
(involves: 129)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-negative T cell number
|
J:144072
|
| decreased thymocyte number
|
J:144072
|
\Smarca4tm1.2Pcn/\Smarca4tm1Tich
\Tg(Lck-cre)1Cwi/0
\Tg(LCKprBCL2L1)12Sjk/0
(involves: 129)
|
abnormal T cell morphology
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
| increased double-negative T cell number
|
J:144072
|
| increased thymocyte number
|
J:144072
|
\Smarca4tm1Tich/\Smarca4+
\Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased double-negative T cell number
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
| decreased single-positive T cell number
|
J:144072
|
| decreased thymocyte number
|
J:144072
|
\Smarcal1tm1.1Cfbo/\Smarcal1tm1.1Cfbo
(either: B6.129-Smarcal1tm1.1Cfbo or (involves: 129 * C57BL/6))
|
decreased B cell number
|
J:183899
|
\Smarcc1tm2.1Rhs/\Smarcc1tm2.1Rhs
\Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:184060
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:184060
|
| abnormal pre-B cell morphology
|
J:184060
|
| abnormal pro-B cell morphology
|
J:184060
|
| arrested B cell differentiation
|
J:184060
|
| decreased B cell number
|
J:184060
|
| decreased early pro-B cell number
|
J:184060
|
| decreased follicular B cell number
|
J:184060
|
| decreased late pro-B cell number
|
J:184060
|
| decreased pro-B cell number
|
J:184060
|
\Smc3tm1a(EUCOMM)Wtsi/\Smc3+
(involves: C57BL/6N)
|
increased T cell number
|
J:200082
|
\Smc5tm1b(KOMP)Wtsi/\Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Smcr8em1Btlr/\Smcr8em1Btlr
(C57BL/6J-Smcr8em1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
\Smcr8em2Btlr/\Smcr8em2Btlr
(C57BL/6J-Smcr8em2Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
\Smoc1tm1b(EUCOMM)Wtsi/\Smoc1+
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Smoc1tm1b(EUCOMM)Wtsi/\Smoc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Smstm1a(EUCOMM)Wtsi/Y
(involves: C57BL/6 * C57BL/6N)
|
increased NK cell number
|
J:213427
|
| increased NK T cell number
|
J:213427
|
\Snai2tm2Grid/\Snai2+
\Snai3tm1.2Jhws/\Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:204710
|
\Snai2tm2Grid/\Snai2tm2Grid
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:78323
|
\Snai2tm2Grid/\Snai2tm2Grid
\Snai3tm1.2Jhws/\Snai3+
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:204710
|
\Snai2tm2Grid/\Snai2tm2Grid
\Snai3tm1.2Jhws/\Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased B cell number
|
J:204710
|
| decreased double-positive T cell number
|
J:204710
|
| increased single-positive T cell number
|
J:204710
|
\Snd1em1(IMPC)Tcp/\Snd1+
(C57BL/6NCrl-Snd1em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Snrnp40em1Btlr/\Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
decreased B cell number
|
J:282417
|
| decreased CD4-positive, alpha-beta T cell number
|
J:282417
|
| decreased CD8-positive, alpha-beta T cell number
|
J:282417
|
| decreased DN1 thymic pro-T cell number
|
J:282417
|
| decreased DN4 thymocyte number
|
J:282417
|
| decreased lymphocyte cell number
|
J:282417
|
| decreased NK cell number
|
J:282417
|
| decreased T cell number
|
J:282417
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:282417
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:282417
|
\Socs1tm1.1Ayr/\Socs1tm1.1Ayr
(involves: C57BL/6)
|
decreased effector memory T-helper cell number
|
J:226678
|
\Socs1tm1Ayos/\Socs1tm1Ayos
\Foxp3tm4(YFP/icre)Ayr/\Foxp3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased regulatory T cell number
|
J:167922
|
\Socs1tm1Ayos/\Socs1tm1Ayos
\Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
\Socs1tm1Ayos/\Socs1tm1Ayos
\Tg(Tek-cre)1Ywa/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:132905
|
| increased CD8-positive, alpha-beta T cell number
|
J:132905
|
\Socs1tm1Jni/\Socs1tm1Jni
(Not Specified)
|
abnormal T cell differentiation
|
J:57475
|
| decreased B cell number
|
J:57475
|
| decreased thymocyte number
|
J:57475
|
\Socs1tm1Kish/\Socs1tm1Kish
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased lymphocyte cell number
|
J:51685
|
\Socs1tm1Kish/\Socs1tm1Kish
(B6.129P2-Socs1tm1Kish)
|
increased activated T cell number
|
J:69472
|
| increased NK T cell number
|
J:69472
|
\Socs1tm1Kish/\Socs1tm1Kish
\Stat1tm1Rds/\Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased activated T cell number
|
J:69472
|
\Socs1tm1Kish/\Socs1tm1Kish
\Stat6tm1Aki/\Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
increased activated T cell number
|
J:69472
|
\Socs1tm1Wehi/\Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
abnormal follicular B cell morphology
|
J:51281
|
| abnormal mature B cell morphology
|
J:51281
|
| decreased B cell number
|
J:51281
|
| decreased lymphocyte cell number
|
J:51281
|
| decreased pre-B cell number
|
J:51281
|
\Socs1tm1Wehi/\Socs1tm3Wehi
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83009
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:83009
|
| abnormal T cell differentiation
|
J:83009
|
| abnormal T cell subpopulation ratio
|
J:83009
|
| decreased B cell number
|
J:83009
|
| increased CD4-positive, alpha-beta T cell number
|
J:83009
|
| increased CD8-positive, alpha-beta T cell number
|
J:83009
|
\Socs4m1Nch/\Socs4m1Nch
(C.C3Fe-Socs4m1Nch)
|
decreased T cell number
|
J:241977
|
| increased T cell number
|
J:241977
|
\Sonem1.1Bcgen/\Son+
(B6(Cg)-Sonem1.1Bcgen)
|
abnormal B cell differentiation
|
J:347709
|
| abnormal naive B cell morphology
|
J:347709
|
| abnormal transitional stage B cell morphology
|
J:347709
|
| decreased follicular B cell number
|
J:347709
|
| decreased lymphocyte cell number
|
J:347709
|
| decreased transitional stage T2 B cell number
|
J:347709
|
| increased marginal zone B cell number
|
J:347709
|
| increased pre-B cell number
|
J:347709
|
| increased transitional stage T1 B cell number
|
J:347709
|
\Sorbs1tm1Krc/\Sorbs1tm1Krc
(B6.129-Sorbs1tm1Krc)
|
decreased lymphocyte cell number
|
J:121762
|
\Sos1tm1.1Les/\Sos1tm1.1Les
\Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:174536
|
| decreased CD8-positive, alpha-beta T cell number
|
J:174536
|
| decreased DN4 thymocyte number
|
J:174536
|
| decreased double-negative T cell number
|
J:174536
|
| decreased double-positive T cell number
|
J:174536
|
| decreased gamma-delta T cell number
|
J:174536
|
| decreased thymocyte number
|
J:174536
|
\Sox4tm1Cle/\Sox4tm1Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
| absent pre-B cells
|
J:32741
|
| decreased pro-B cell number
|
J:32741
|
\Sox4tm2Cle/\Sox4tm2Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
| absent pre-B cells
|
J:32741
|
| decreased pro-B cell number
|
J:32741
|
\Sox9em1(cre/ERT2)Smoc/\Sox9+
\Tnfsf18em1Pwan/\Tnfsf18em1Pwan
(involves: C57BL/6J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:346395
|
\Sox13tm1Jskg/\Sox13+
(involves: C57BL/6)
|
decreased gamma-delta T cell number
|
J:117301
|
\Sox13tm1Jskg/\Sox13tm1Jskg
(involves: C57BL/6)
|
decreased gamma-delta T cell number
|
J:117301
|
\Sox21em1(IMPC)Mbp/\Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Sp3tm1Sus/\Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84837
|
| decreased CD4-positive, alpha-beta T cell number
|
J:84837
|
\Spata2tm1.1(KOMP)Vlcg/\Spata2tm1.1(KOMP)Vlcg
(C57BL/6N-Spata2tm1.1(KOMP)Vlcg/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Spata31f3em1(IMPC)Ccpcz/\Spata31f3em1(IMPC)Ccpcz
(C57BL/6NCrl-Spata31f3em1(IMPC)Ccpcz/Ccpcz)
|
increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Spentm1Hon/\Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:82332
|
\Sphk1tm1.1Cgh/\Sphk1tm2Cgh
\Sphk2tm1.1Cgh/\Sphk2tm1.1Cgh
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal NK cell differentiation
|
J:154069
|
| abnormal T cell differentiation
|
J:120783
|
| decreased B cell number
|
J:120783
|
| decreased NK cell number
|
J:154069
|
| decreased T cell number
|
J:120783
|
| increased NK cell number
|
J:154069
|
\Sphk1tm1Npa/\Sphk1tm1Npa
(BALB/c-Sphk1tm1Npa)
|
increased B cell number
|
J:129314
|
\Sphk2tm1Npa/\Sphk2tm1Npa
(BALB/c-Sphk2tm1Npa)
|
increased B cell number
|
J:129314
|
\Spi1tm1.1Dgt/\Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell number
|
J:90331
|
\Spi1tm1.2Nutt/\Spi1tm1.2Nutt
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:98188
|
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106040
|
| abnormal T cell subpopulation ratio
|
J:106040
|
| arrested B cell differentiation
|
J:106040
|
| decreased B-1a cell number
|
J:106040
|
| decreased mature B cell number
|
J:106040
|
| decreased pre-B cell number
|
J:106040
|
| decreased pro-B cell number
|
J:106040
|
| decreased T cell number
|
J:106040
|
| decreased thymocyte number
|
J:106040
|
| increased B-1 B cell number
|
J:106040
|
| increased B-1b cell number
|
J:106040
|
| increased lymphocyte cell number
|
J:106040
|
| increased T cell number
|
J:106040
|
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6)
|
decreased B cell number
|
J:90331
|
\Spi1tm1Kast/\Spi1tm1Kast
(B6.129S2-Spi1tm1Kast)
|
absent B cells
|
J:90543
|
\Spi1tm1Ram/\Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell number
|
J:36473
|
| abnormal T cell differentiation
|
J:36473
|
| abnormal T cell number
|
J:36473
|
| absent mature B cells
|
J:36473
|
| decreased CD4-positive, alpha-beta T cell number
|
J:36473
|
| decreased CD8-positive, alpha-beta T cell number
|
J:36473
|
| decreased double-positive T cell number
|
J:36473
|
| decreased thymocyte number
|
J:36473
|
\Spi1tm1Rpd/\Spi1tm1Rpd
(involves: 129/Sv * C57BL/6 * Black Swiss)
|
arrested B cell differentiation
|
J:123079
|
\Spi1tm1Sing/\Spi1+
\Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:88257
|
| abnormal immature B cell morphology
|
J:88257
|
| decreased B cell number
|
J:88257
|
\Spi1tm1Sing/\Spi1tm1Sing
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:20348
|
| abnormal T cell differentiation
|
J:20348
|
\Spi1tm3Dgt/\Spi1tm3Dgt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:131217
|
| decreased double-negative T cell number
|
J:131217
|
| increased double-negative T cell number
|
J:131217
|
\Spibtm1Mcs/\Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immature B cell morphology
|
J:88257
|
\Spink5tm2.1Hov/\Spink5tm2.1Hov
\Tg(KRT5-cre/ERT2)2Ipc/0
(involves: C57BL/6 * C57BL/6JRj * SJL)
|
arrested T cell differentiation
|
J:357366
|
| decreased double-positive T cell number
|
J:357366
|
\Spink6em1(IMPC)Ccpcz/\Spink6em1(IMPC)Ccpcz
(C57BL/6N-Spink6em1(IMPC)Ccpcz/Ccpcz)
|
decreased Ly6C-positive immature NK cell number
|
J:211773
|
| increased Ly6C-positive mature NK cell number
|
J:211773
|
\Spink14tm1e(KOMP)Wtsi/\Spink14tm1e(KOMP)Wtsi
(C57BL/6N-Spink14tm1e(KOMP)Wtsi/Wtsi)
|
decreased immature NK cell number
|
J:211773
|
| decreased mature NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
\Spns2tm1.1Nmoc/\Spns2tm1.1Nmoc
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)
|
abnormal effector T cell morphology
|
J:184558
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184558
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184558
|
| decreased mature B cell number
|
J:184558
|
| increased CD4-positive, alpha-beta T cell number
|
J:184558
|
| increased CD8-positive, alpha-beta T cell number
|
J:184558
|
\Spns2tm1.2Nmoc/\Spns2tm1.2Nmoc
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased B-1 B cell number
|
J:184558
|
| decreased CD4-positive, alpha-beta T cell number
|
J:184558
|
| decreased CD8-positive, alpha-beta T cell number
|
J:184558
|
| decreased follicular B cell number
|
J:184558
|
| decreased immature B cell number
|
J:184558
|
| decreased mature B cell number
|
J:184558
|
| decreased transitional stage T1 B cell number
|
J:184558
|
| increased CD4-positive, alpha-beta T cell number
|
J:184558
|
| increased CD8-positive, alpha-beta T cell number
|
J:184558
|
| increased single-positive T cell number
|
J:184558
|
\Spns2tm1a(KOMP)Wtsi/\Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased B cell number
|
J:188933,
J:213427
|
| decreased B-1 B cell number
|
J:188933
|
| decreased CD4-positive, alpha-beta T cell number
|
J:188933,
J:213427
|
| decreased CD8-positive, alpha-beta T cell number
|
J:188933,
J:213427
|
| decreased follicular B cell number
|
J:188933
|
| decreased mature B cell number
|
J:213427
|
| decreased T cell number
|
J:213427
|
| increased CD4-positive, alpha-beta T cell number
|
J:188933
|
| increased CD8-positive, alpha-beta T cell number
|
J:188933
|
| increased NK cell number
|
J:213427
|
| increased NK T cell number
|
J:213427
|
\Spns2tm1b(KOMP)Wtsi/\Spns2tm1b(KOMP)Wtsi
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N)
|
decreased B cell number
|
J:188933
|
| decreased CD4-positive, alpha-beta T cell number
|
J:188933
|
| decreased CD8-positive, alpha-beta T cell number
|
J:188933
|
| increased CD4-positive, alpha-beta T cell number
|
J:188933
|
| increased CD8-positive, alpha-beta T cell number
|
J:188933
|
\Spns2tm1Tni/\Spns2tm1Tni
(B6.Cg-Spns2tm1Tni)
|
abnormal mature B cell number
|
J:225108
|
| decreased lymphocyte cell number
|
J:225108
|
| decreased single-positive T cell number
|
J:225108
|
| decreased thymocyte number
|
J:225108
|
\Spp1tm1Blh/\Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
increased lymphocyte cell number
|
J:103050
|
\Sppl2achompB/\Sppl2achompB
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:194595
|
| decreased follicular B cell number
|
J:194595
|
| decreased marginal zone B cell number
|
J:194595
|
| decreased mature B cell number
|
J:194595
|
| decreased transitional stage T2 B cell number
|
J:194595
|
\Sppl2am1Anu/\Sppl2am1Anu
(involves: C57BL/6JAnu)
|
abnormal mature B cell morphology
|
J:194663
|
| abnormal transitional stage B cell morphology
|
J:194663
|
| decreased marginal zone B cell number
|
J:194663
|
| decreased transitional stage T2 B cell number
|
J:194663
|
| decreased transitional stage T3 B cell number
|
J:194663
|
\Sppl2am1Anu/\Sppl2am1Anu
\Tg(Vav-BCL2)69Jad/?
(involves: C57BL/6JAnu)
|
abnormal T cell number
|
J:194663
|
| decreased CD4-positive, alpha-beta T cell number
|
J:194663
|
| decreased double-negative T cell number
|
J:194663
|
| increased mature B cell number
|
J:194663
|
\Sppl2atm1Basc/\Sppl2atm1Basc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
arrested B cell differentiation
|
J:194664
|
| decreased B cell number
|
J:194664
|
| decreased B-1 B cell number
|
J:194664
|
| decreased B-2 B cell number
|
J:194664
|
| decreased follicular B cell number
|
J:194664
|
| decreased marginal zone B cell number
|
J:194664
|
| decreased mature B cell number
|
J:194664
|
| decreased T cell number
|
J:194664
|
| decreased transitional stage T2 B cell number
|
J:194664
|
\Sppl2atm1Basc/\Sppl2atm1Basc
\Sppl2bGt(Ayu21-T160)Imeg/\Sppl2bGt(Ayu21-T160)Imeg
(B6N.Cg-Sppl2atm1Basc Sppl2bGt(Ayu21-T160)Imeg)
|
abnormal mature B cell morphology
|
J:213519
|
| decreased B cell number
|
J:213519
|
\Sppl2atm1Dgen/\Sppl2atm1Dgen
(B6.129P2-Sppl2atm1Dgen)
|
decreased B cell number
|
J:194595
|
| decreased B-1 B cell number
|
J:194595
|
| decreased follicular B cell number
|
J:194595
|
| decreased transitional stage T2 B cell number
|
J:194595
|
\Sppl3tm1Itl/\Sppl3em1Pomz
\Ncr1tm1.1(icre)Viv/\Ncr1+
(involves: 129S/SvEv * C57BL/6 * C57BL/6J)
|
abnormal NK cell differentiation
|
J:280182
|
| decreased mature NK cell number
|
J:280182
|
| decreased NK cell number
|
J:280182
|
| increased immature NK cell number
|
J:280182
|
\Sppl3tm1Itl/\Sppl3tm1Itl
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal NK cell differentiation
|
J:280182
|
| decreased mature NK cell number
|
J:280182
|
| decreased NK cell number
|
J:280182
|
| increased immature NK cell number
|
J:280182
|
\Sppl3tm1Itl/\Sppl3tm1Itl
\Ncr1tm1.1(icre)Viv/\Ncr1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal NK cell differentiation
|
J:280182
|
| decreased mature NK cell number
|
J:280182
|
| decreased NK cell number
|
J:280182
|
| increased immature NK cell number
|
J:280182
|
\Spred1em1(IMPC)Ccpcz/\Spred1em1(IMPC)Ccpcz
(C57BL/6N-Spred1em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
| increased CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
\Sprol1STS/A/?
(involves: B10.O20/Dem * O20/A)
|
increased lymphocyte cell number
|
J:56029
|
\Spta1sph-ha/\Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
increased B cell number
|
J:1967
|
| increased CD4-positive, alpha-beta T cell number
|
J:1967
|
| increased CD8-positive, alpha-beta T cell number
|
J:1967
|
| increased lymphocyte cell number
|
J:12830,
J:1967
|
| increased T cell number
|
J:1967
|
\Sptlc2tm1Yhir/\Sptlc2tm1Yhir
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
decreased lymphocyte cell number
|
J:202954
|
\Sptlc2tm1Yhir/\Sptlc2tm1Yhir
\Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6)
|
abnormal dendritic epidermal T cell morphology
|
J:202388
|
| increased gamma-delta T cell number
|
J:202388
|
| increased T-helper 17 cell number
|
J:202388
|
\Srftm2Nor/\Srftm2Nor
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd)
|
abnormal mature B cell morphology
|
J:124767
|
| absent marginal zone B cells
|
J:124767
|
| decreased B cell number
|
J:124767
|
| decreased B-1 B cell number
|
J:124767
|
\Srftm2Nor/\Srftm2Nor
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased CD4-positive, alpha-beta T cell number
|
J:124767
|
| decreased CD8-positive, alpha-beta T cell number
|
J:124767
|
| decreased T cell number
|
J:124767
|
| decreased thymocyte number
|
J:124767
|
\Srpxtm1Hzi/\Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphocyte morphology
|
J:119999
|
\Srsf2tm1.1Oaw/\Srsf2+
\Tg(Mx1-cre)1Cgn/?
(B6.Cg-Tg(Mx1-cre)1Cgn Srsf2tm1.1Oaw)
|
decreased B cell number
|
J:221404
|
\Srsf2tm1Xdfu/\Srsf2+
\Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
decreased thymocyte number
|
J:88668
|
\Srsf2tm1Xdfu/\Srsf2tm1Xdfu
\Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
abnormal T cell differentiation
|
J:88668
|
| decreased double-positive T cell number
|
J:88668
|
| decreased T cell number
|
J:88668
|
| decreased thymocyte number
|
J:88668
|
| increased double-negative T cell number
|
J:88668
|
\Srsf3tm1Pjln/\Srsf3tm1Pjln
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129P2/OlaHsd * BALB/c)
|
decreased B cell number
|
J:113645
|
| decreased pre-B cell number
|
J:113645
|
| decreased pro-B cell number
|
J:113645
|
\Ssbtm1Rjma/\Ssbtm2.1Rjma
\Cd79atm1(cre)Reth/\Cd79a+
(involves: 129S/SvEv * BALB/c)
|
arrested B cell differentiation
|
J:207687
|
| decreased B cell number
|
J:207687
|
\Ssbp2tm1Lana/\Ssbp2tm1Lana
(involves: 129S/SvEv * C57BL/6)
|
decreased lymphocyte cell number
|
J:162035
|
| increased pre-B cell number
|
J:162035
|
\St3gal2tm1Jxm/\St3gal2tm1Jxm
(Not Specified)
|
increased T cell number
|
J:217719
|
\St3gal4tm1.1Jxm/\St3gal4tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased lymphocyte cell number
|
J:189086
|
\St3gal4tm1.1Jxm/\St3gal4tm1.1Jxm
\St3gal6tm1.1Jxm/\St3gal6tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased lymphocyte cell number
|
J:189086
|
\St6gal1tm1Jxm/\St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased marginal zone B cell number
|
J:132991
|
| decreased transitional stage B cell number
|
J:132991
|
\St6galnac2tm1.1Cfg/\St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ)
|
increased pre-B cell number
|
J:217719
|
\St8sia1tm1Kfk/\St8sia1tm1Kfk
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:73818
|
\St14tm1Bug/\St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased double-positive T cell number
|
J:87125
|
\St14tm2Bug/\St14tm3Bug
\Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)
|
decreased CD4-positive, alpha-beta T cell number
|
J:213072
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:213072
|
| decreased CD8-positive, alpha-beta T cell number
|
J:213072
|
| decreased regulatory T cell number
|
J:213072
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:213072
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:213072
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:213072
|
\Stag2tm1.1Soga/Y
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased B cell number
|
J:289000
|
\Stamtm2Sug/\Stamtm2Sug
\Stam2tm1Sug/\Stam2tm1Sug
\Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
decreased T cell number
|
J:80617
|
\Stat1m4Btlr/\Stat1m4Btlr
(C57BL/6J-Stat1m4Btlr)
|
abnormal CD8-positive, naive alpha-beta T cell number
|
J:264800
|
| decreased B cell number
|
J:264800
|
| decreased B-1 B cell number
|
J:264800
|
| decreased CD8-positive, alpha-beta T cell number
|
J:264800
|
| decreased NK cell number
|
J:264800
|
| decreased single-positive T cell number
|
J:264800
|
| increased CD4-positive, alpha-beta T cell number
|
J:264800
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:264800
|
| increased NK T cell number
|
J:264800
|
\Stat1m5Btlr/\Stat1m5Btlr
(C57BL/6J-Stat1m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274938
|
| abnormal T cell differentiation
|
J:274938
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274938
|
| increased CD4-positive, alpha-beta T cell number
|
J:274938
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274938
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274938
|
| increased T cell number
|
J:274938
|
\Stat1tm1Rds/\Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
increased NK T cell number
|
J:122801
|
\Stat1tm1Rds/\Stat1tm1Rds
\Stat3tm2Aki/\Stat3tm2Aki
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:83280
|
\Stat1tm2b(EUCOMM)Wtsi/\Stat1tm2b(EUCOMM)Wtsi
(C57BL/6N-Stat1tm2b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Stat2m1Btlr/\Stat2m1Btlr
(C57BL/6J-Stat2m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265265
|
| decreased central memory CD8 positive, alpha-beta T cell number
|
J:265265
|
| decreased single-positive T cell number
|
J:265265
|
\Stat2tm1Shnd/\Stat2tm1Shnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:66564
|
\Stat3tm1Dlv/\Stat3tm1Dlv
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:124293
|
\Stat3tm1Dlv/\Stat3tm1Dlv
\Tg(Csf1r-icre)1Jwp/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased T cell number
|
J:156593
|
\Stat3tm1Dlv/\Stat3tm1Dlv
\Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB)
|
decreased T-helper 17 cell number
|
J:120176
|
\Stat3tm1Dnl/\Stat3tm1Dlv
(involves: C57BL/6)
|
decreased thymocyte number
|
J:87599
|
\Stat3tm2Aki/\Stat3tm2Aki
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:83280
|
\Stat4tm1Gru/\Stat4tm1Gru
(C.129S2-Stat4tm1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
\Stat5atm1.1Wjl/\Stat5atm1.1Wjl
\Stat5btm2.1Wjl/\Stat5btm2.1Wjl
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal T cell subpopulation ratio
|
J:187325
|
| decreased CD8-positive, alpha-beta T cell number
|
J:187325
|
| decreased NK cell number
|
J:187325
|
\Stat5atm1Jni/\Stat5atm1Jni
\Stat5btm2Jni/\Stat5btm2Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))
|
decreased T cell number
|
J:77412
|
\Stat5atm1Jni/\Stat5atm1Jni
\Stat5btm2Jni/\Stat5btm2Jni
(involves: 129 * C57BL/6)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:122463
|
\Stat5atm1Mam/\Stat5atm1Mam
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased NK cell number
|
J:112035
|
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5b+
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:258967
|
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Lck-cre)I57Jxm/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)
|
abnormal T cell subpopulation ratio
|
J:122463
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122463
|
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:155489
|
\Stat5btm1Hwd/\Stat5btm1Hwd
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112035
|
| abnormal lymphocyte cell number
|
J:112035
|
| abnormal lymphocyte morphology
|
J:112035
|
| decreased CD8-positive, alpha-beta T cell number
|
J:112035
|
| decreased NK cell number
|
J:112035
|
| decreased thymocyte number
|
J:112035
|
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Lck-cre)I57Jxm/0
(involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)
|
abnormal T cell subpopulation ratio
|
J:122463
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122463
|
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:155489
|
\Stat6tm1Aki/\Stat6tm1Aki
(involves: 129P2/OlaHsd)
|
decreased T-helper 2 cell number
|
J:172134
|
\Stat6tm1Gru/\Stat6tm1Gru
(C.129S2-Stat6tm1Gru/J)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
\Stat6tm1Gru/\Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru)
|
abnormal T-helper 2 cell differentiation
|
J:31932
|
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129S/SvEv)
|
abnormal class switch recombination
|
J:32607
|
| abnormal T-helper 1 cell differentiation
|
J:32607
|
| abnormal T-helper 2 cell differentiation
|
J:32607
|
\Stat6tm1Jni/\Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:51096
|
\Stim1em1(IMPC)Mbp/\Stim1+
(C57BL/6N-Stim1em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Stim1tm1.1Pg/\Stim1+
(involves: C57BL/6)
|
decreased NK cell number
|
J:285187
|
\Stim1tm1Kuro/\Stim1tm1Kuro
\Stim2tm1.1Kuro/\Stim2tm1.1Kuro
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:172608
|
| increased CD8-positive, alpha-beta T cell number
|
J:172608
|
| increased regulatory T cell number
|
J:172608
|
\Stim1tm1Rao/\Stim1tm1Rao
\Stim2tm1Rao/\Stim2tm1Rao
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal B cell differentiation
|
J:133262
|
| abnormal T cell differentiation
|
J:133262
|
| decreased regulatory T cell number
|
J:133262
|
| increased germinal center B cell number
|
J:133262
|
| increased lymphocyte cell number
|
J:133262
|
\Stim1tm1Rao/\Stim1tm1Rao
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
increased lymphocyte cell number
|
J:133262
|
\Stim1tm3Ics/\Stim1+
(involves: C57BL/6N)
|
decreased lymphocyte cell number
|
J:277842
|
| decreased NK T cell number
|
J:277842
|
| decreased regulatory T cell number
|
J:277842
|
\Sting1em1Jmin/\Sting1+
(involves: C57BL/6N)
|
decreased single-positive T cell number
|
J:251372
|
\Stk4Gt(AJ0315)Wtsi/\Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi)
|
abnormal memory T cell number
|
J:142674
|
| abnormal T cell differentiation
|
J:142674
|
| decreased CD4-positive, alpha-beta T cell number
|
J:142674
|
| decreased CD8-positive, alpha-beta T cell number
|
J:142674
|
\Stk4m1Btlr/\Stk4m1Btlr
(C57BL/6J-Stk4m1Btlr)
|
decreased B cell number
|
J:265233
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265233
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265233
|
| decreased single-positive T cell number
|
J:265233
|
| decreased T cell number
|
J:265233
|
| increased NK cell number
|
J:265233
|
\Stk4m2Btlr/\Stk4m2Btlr
(C57BL/6J-Stk4m2Btlr)
|
decreased B-1 B cell number
|
J:265237
|
| decreased B-2 B cell number
|
J:265237
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265237
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265237
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265237
|
| decreased single-positive T cell number
|
J:265237
|
| decreased T cell number
|
J:265237
|
| increased B-1b cell number
|
J:265237
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265237
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265237
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265237
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265237
|
| increased NK cell number
|
J:265237
|
\Stk4m3Btlr/\Stk4m3Btlr
(C57BL/6J-Stk4m3Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:265245
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265245
|
| decreased single-positive T cell number
|
J:265245
|
| decreased T cell number
|
J:265245
|
\Stk4m4Btlr/\Stk4m4Btlr
(C57BL/6J-Stk4m4Btlr)
|
increased B-1b cell number
|
J:272536
|
\Stk4m5Btlr/\Stk4m5Btlr
(C57BL/6J-Stk4m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272743
|
| abnormal T cell differentiation
|
J:272743
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272743
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272743
|
\Stk4tm1.1Kina/\Stk4tm1.1Kina
(involves: C57BL/6)
|
abnormal marginal zone B cell morphology
|
J:148791
|
| decreased B cell number
|
J:148791
|
| decreased lymphocyte cell number
|
J:148791
|
| decreased marginal zone B cell number
|
J:148791
|
| decreased T cell number
|
J:148791
|
| increased single-positive T cell number
|
J:148791
|
\Stk4tm1.1Wtao/\Stk4tm1.2Wtao
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL/J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152323
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152323
|
| decreased T cell number
|
J:152323
|
| increased single-positive T cell number
|
J:152323
|
| increased thymocyte number
|
J:152323
|
\Stk4tm1.2Wtao/\Stk4tm1.2Wtao
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
decreased B cell number
|
J:152323
|
| decreased CD4-positive, alpha-beta T cell number
|
J:152323
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152323
|
| decreased lymphocyte cell number
|
J:152323
|
| increased single-positive T cell number
|
J:152323
|
| increased thymocyte number
|
J:152323
|
\Stk4tm1Dlim/\Stk4tm1Dlim
(Not Specified)
|
decreased T cell number
|
J:155001
|
\Stk10em1(IMPC)Ccpcz/\Stk10em1(IMPC)Ccpcz
(C57BL/6NCrl-Stk10em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Stk17btm1Hed/\Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
|
decreased double-positive T cell number
|
J:94685
|
| increased CD4-positive, alpha-beta T cell number
|
J:94685
|
| increased memory T cell number
|
J:94685
|
\Stk26tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased NK T cell number
|
J:211773
|
\Stra6ltm1b(KOMP)Wtsi/\Stra6ltm1b(KOMP)Wtsi
(C57BL/6N-Stra6ltm1b(KOMP)Wtsi/Ucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Stx7em1(IMPC)Rbrc/\Stx7em1(IMPC)Rbrc
(C57BL/6NJcl-Stx7em1(IMPC)Rbrc/Rbrc)
|
decreased large unstained cell number
|
J:211773
|
\Stx11em1(IMPC)Mbp/\Stx11em1(IMPC)Mbp
(C57BL/6N-Stx11em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Sun1tm1b(EUCOMM)Wtsi/\Sun1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sun1tm1b(EUCOMM)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Sun2tm1b(EUCOMM)Hmgu/\Sun2tm1b(EUCOMM)Hmgu
(C57BL/6N-Sun2tm1b(EUCOMM)Hmgu/Bay)
|
increased large unstained cell number
|
J:211773
|
\Supv3l1tm2.1Jkl/\Supv3l1tm2.2Jkl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:144991
|
| decreased CD4-positive, alpha-beta T cell number
|
J:144991
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144991
|
| decreased double-negative T cell number
|
J:144991
|
| decreased double-positive T cell number
|
J:144991
|
\Supv3l1tm2Jkl/\Supv3l1tm2Jkl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:144991
|
| decreased CD4-positive, alpha-beta T cell number
|
J:144991
|
| decreased CD8-positive, alpha-beta T cell number
|
J:144991
|
| decreased double-negative T cell number
|
J:144991
|
| decreased double-positive T cell number
|
J:144991
|
\Supv3l1tm2Jkl/\Supv3l1tm2Jkl
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased plasma cell number
|
J:144991
|
\Susd6tm1b(KOMP)Wtsi/\Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay)
|
increased lymphocyte cell number
|
J:211773
|
\Suz12Plt8/\Suz12+
(involves: 129 * C57BL/6)
|
increased lymphocyte cell number
|
J:136262
|
\Swap70tm1Jess/\Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ)
|
abnormal class switch recombination
|
J:71160
|
\Sykm1Btlr/\Sykm1Btlr
(involves: C57BL/6J)
|
decreased B cell number
|
J:199281
|
\SykM2Btlr/\Syk+
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
\SykM2Btlr/\SykM2Btlr
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
\Syktm1.1Tara/\Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:115080
|
\Syktm1.2Tara/\Syktm1.2Tara
\Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:208904
|
\Syktm1Kuro/\Syktm1Kuro
\Zap70tm1Dlo/\Zap70tm1Dlo
\Cd79atm1(cre)Reth/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:134528
|
\Syktm1Paw/\Syktm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:29797
|
| absent pre-B cells
|
J:29797
|
| decreased late pro-B cell number
|
J:29797
|
\Syktm1Tyb/\Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal T cell number
|
J:29796
|
| arrested B cell differentiation
|
J:29796
|
\Syktm2.1(ZAP70)Fkfr/\Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
arrested B cell differentiation
|
J:188422
|
| decreased B cell number
|
J:188422
|
| decreased DN1 thymic pro-T cell number
|
J:188422
|
| decreased marginal zone B cell number
|
J:188422
|
| decreased mature B cell number
|
J:188422
|
| decreased transitional stage B cell number
|
J:188422
|
| decreased transitional stage T1 B cell number
|
J:188422
|
| decreased transitional stage T2 B cell number
|
J:188422
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:188422
|
| increased CD4-positive, alpha-beta T cell number
|
J:188422
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:188422
|
| increased CD8-positive, alpha-beta T cell number
|
J:188422
|
| increased DN3 thymocyte number
|
J:188422
|
\Synj1tm1b(EUCOMM)Wtsi/\Synj1+
(C57BL/6N-Synj1tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Synpo2tm1b(EUCOMM)Wtsi/\Synpo2+
(C57BL/6N-Synpo2tm1b(EUCOMM)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Sytl1tm1a(KOMP)Wtsi/\Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:213427
|
| decreased mature B cell number
|
J:213427
|
| decreased T cell number
|
J:213427
|
| increased regulatory T cell number
|
J:213427
|
\Tab2tm2.1Aki/\Tab2tm2.1Aki
\Tab3tm1Aki/\Tab3tm1Aki
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B-1a cell number
|
J:195289
|
| decreased mature B cell number
|
J:195289
|
| decreased plasma cell number
|
J:195289
|
\Tac4tm1Albe/\Tac4tm1Albe
(B6.129P2-Tac4tm1Albe)
|
increased pro-B cell number
|
J:166471
|
\Tacc3tm1Jni/\Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased thymocyte number
|
J:74762
|
\Taf7tm1.1Dss/\Taf7tm1.2Dss
\Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
| decreased CD4-positive, alpha-beta T cell number
|
J:185745
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185745
|
| decreased double-positive T cell number
|
J:185745
|
| decreased single-positive T cell number
|
J:185745
|
| decreased T cell number
|
J:185745
|
| decreased thymocyte number
|
J:185745
|
\Taf7tm1.1Dss/\Taf7tm1.2Dss
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
| decreased CD4-positive, alpha-beta T cell number
|
J:185745
|
| decreased CD8-positive, alpha-beta T cell number
|
J:185745
|
| decreased double-positive T cell number
|
J:185745
|
| decreased thymocyte number
|
J:185745
|
| increased double-negative T cell number
|
J:185745
|
\Taf15em1(IMPC)Mbp/\Taf15em1(IMPC)Mbp
(C57BL/6NCrl-Taf15em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Tagln2em1(IMPC)Tcp/\Tagln2em1(IMPC)Tcp
(C57BL/6N-Tagln2em1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Tanktm1Aki/\Tanktm1Aki
(involves: 129/Sv * C57BL/6)
|
increased mature B cell number
|
J:151757
|
| increased plasma cell number
|
J:151757
|
\Tap1m1Btlr/\Tap1m1Btlr
(C57BL/6J-Tap1m1Btlr)
|
decreased CD8-positive, alpha-beta memory T cell number
|
J:254888
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254888
|
\Tap1m2Btlr/\Tap1m2Btlr
(C57BL/6J-Tap1m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:236697
|
\Tap1rose/\Tap1rose
(C57BL/6JAnu-Tap1rose/AnuApb)
|
decreased CD8-positive, alpha-beta T cell number
|
J:166104
|
\Tap1tm1Arp/\Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:3524
|
| decreased double-negative T cell number
|
J:3524
|
\Tap1tm1Arp/\Tap1tm1Arp
(involves: 129S2/SvPas)
|
decreased CD8-positive, alpha-beta T cell number
|
J:64177,
J:64349
|
\Tap1tm1Arp/\Tap1tm1Arp
(B6.129S2-Tap1tm1Arp/J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:123934
|
| increased T-helper 1 cell number
|
J:123934
|
\Tap2jas/\Tap2jas
(C57BL/6JSfdAnu-Tap2jas/AnuApb)
|
absent CD8-positive, alpha-beta T cells
|
J:104190
|
| decreased CD8-positive, alpha-beta T cell number
|
J:166104
|
\Tap2m1Btlr/\Tap2m1Btlr
(C57BL/6J-Tap2m1Btlr)
|
absent CD8-positive, alpha-beta T cells
|
J:159355
|
\Tap2m2Btlr/\Tap2m2Btlr
(C57BL/6J-Tap2m2Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:217145
|
| increased CD4-positive, alpha-beta T cell number
|
J:217145
|
\Tap2m3Btlr/\Tap2m3Btlr
(C57BL/6J-Tap2m3Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:254929
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254929
|
| decreased effector memory CD4-positive, alpha-beta T cell number
|
J:254929
|
| decreased NK T cell number
|
J:254929
|
| increased CD4-positive, alpha-beta T cell number
|
J:254929
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254929
|
\Tap2M4Btlr/\Tap2M4Btlr
(C57BL/6J-Tap2M4Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:272847
|
\Tapbptm1Gjh/\Tapbptm1Gjh
(involves: 129S2/SvPas)
|
decreased T cell number
|
J:64349
|
\Tapbptm1Luc/\Tapbptm1Luc
(involves: 129S6/SvEvTac)
|
decreased CD8-positive, alpha-beta T cell number
|
J:64177
|
\Tapbptm1Luc/\Tapbptm1Luc
\Tg(TcraTcrb)1100Mjb/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:64177
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:64177
|
| abnormal negative T cell selection
|
J:64177
|
| abnormal positive T cell selection
|
J:64177
|
\Tarm1tm1Yiw/\Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
decreased B cell number
|
J:301164
|
| decreased CD4-positive, alpha-beta T cell number
|
J:301164
|
\Tasp1tm1Jjdh/\Tasp1tm1Jjdh
\Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:112159
|
| decreased thymocyte number
|
J:112159
|
\Tbatatm1Faf/\Tbatatm1Faf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:166065
|
| increased thymocyte number
|
J:166065
|
\Tbk1tm1.1Lex/\Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
decreased NK T cell number
|
J:166476
|
| increased NK T cell number
|
J:166476
|
\Tbk1tm1Arte/\Tbk1tm1Arte
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:188560
|
| increased mature B cell number
|
J:188560
|
\Tbk1tm1Arte/\Tbk1tm1Arte
\Map3k14tm1Rds/\Map3k14tm1Rds
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:188560
|
\Tbkbp1tm1b(EUCOMM)Wtsi/\Tbkbp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Tbkbp1tm1b(EUCOMM)Wtsi/H)
|
increased lymphocyte cell number
|
J:211773
|
\Tbrg1tm1a(KOMP)Wtsi/\Tbrg1tm1a(KOMP)Wtsi
(C57BL/6N-Tbrg1tm1a(KOMP)Wtsi)
|
increased marginal zone B cell number
|
J:225146
|
\Tbx21duane/\Tbx21duane
(C57BL/6-Tbx21duane)
|
abnormal NK cell differentiation
|
J:154069
|
| absent NK T cells
|
J:154069
|
| decreased NK cell number
|
J:154069
|
| increased NK cell number
|
J:154069
|
\Tbx21m1Btlr/\Tbx21m1Btlr
(C57BL/6J-Tbx21m1Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:267478
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:267478
|
\Tbx21tm1Glm/\Tbx21+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T helper 1 cell number
|
J:73833
|
\Tbx21tm1Glm/\Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:73833
|
| abnormal T-helper 1 cell differentiation
|
J:73833
|
| decreased T helper 1 cell number
|
J:73833
|
| increased T-helper 2 cell number
|
J:73833
|
\Tbx21tm1Glm/\Tbx21tm1Glm
(B6.129S6-Tbx21tm1Glm)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
\Tbx21tm1Glm/\Tbx21tm1Glm
(involves: 129S6/SvEvTac)
|
decreased CD4-positive, alpha-beta T cell number
|
J:163822
|
| decreased memory T cell number
|
J:163822
|
\Tbx21tm1Srnr/\Tbx21+
(involves: C57BL/6)
|
absent NK T cells
|
J:112679
|
| decreased NK cell number
|
J:112679
|
\Tbx21tm1Srnr/\Tbx21tm1Srnr
(involves: C57BL/6)
|
abnormal T-helper 1 cell morphology
|
J:112679
|
| decreased NK T cell number
|
J:112679
|
\Tbx21tm2Srnr/\Tbx21+
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:174315
|
\Tbx21tm2Srnr/\Tbx21tm2Srnr
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:174315
|
\Tcaimtm1b(EUCOMM)Wtsi/\Tcaimtm1b(EUCOMM)Wtsi
(C57BL/6N-Tcaimtm1b(EUCOMM)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Tcdel1C57BL/6/\Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
\Tcdel1NOD/ShiLtDoi/\Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
\Tcdel2C57BL/6/\Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
\Tcdel2NOD/ShiLtDoi/\Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:226241
|
| abnormal pro-B cell morphology
|
J:226241
|
| arrested B cell differentiation
|
J:226241
|
| decreased B cell number
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Cd79atm1(cre)Reth/\Cd79a+
(involves: BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:226241
|
| decreased B cell number
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
\Tcf3tm1(PBX1)Mlc/\Tcf3+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J)
|
arrested B cell differentiation
|
J:226241
|
| decreased B cell number
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
\Tcf3tm1(TCF3/HLF)Homy/\Tcf3+
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:160392
|
| increased B cell number
|
J:160392
|
\Tcf3tm1.1Mbu/\Tcf3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:137719
|
\Tcf3tm1Cmu/\Tcf3+
(either: 129P2/OlaHsd-Tcf3tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))
|
decreased B cell number
|
J:67011
|
\Tcf3tm1Cmu/\Tcf3tm1Cmu
(either: 129P2/OlaHsd-Tcf3tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:67011
|
| abnormal immunoglobulin V(D)J recombination
|
J:67011
|
| abnormal T cell subpopulation ratio
|
J:67011
|
| decreased B cell number
|
J:67011
|
| decreased lymphocyte cell number
|
J:67011
|
\Tcf3tm1Mbu/\Tcf3tm1.2Mbu
\Tg(Aicda-cre)9Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)
|
abnormal germinal center B cell morphology
|
J:137719
|
| decreased B cell number
|
J:137719
|
| decreased germinal center B cell number
|
J:137719
|
\Tcf3tm1Mbu/\Tcf3tm1.2Mbu
\Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)
|
abnormal germinal center B cell morphology
|
J:137719
|
| decreased B cell number
|
J:137719
|
| decreased germinal center B cell number
|
J:137719
|
| increased marginal zone B cell number
|
J:137719
|
\Tcf3tm1Mbu/\Tcf3tm1Mbu
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
decreased pro-B cell number
|
J:137719
|
\Tcf3tm1Wein/\Tcf3+
(either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))
|
decreased B cell number
|
J:22134
|
\Tcf3tm1Wein/\Tcf3+
(involves: 129S4/SvJaeSor)
|
abnormal B cell number
|
J:91042
|
| decreased pre-B cell number
|
J:91042
|
\Tcf3tm1Wein/\Tcf3tm1Wein
(either: (involves: 129 * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal B cell number
|
J:22134
|
| abnormal lymphocyte cell number
|
J:22134
|
\Tcf3tm1Wein/\Tcf3tm3Zhu
(involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)
|
decreased pro-B cell number
|
J:47671
|
\Tcf3tm1Xhsu/\Tcf3tm1Xhsu
(B6.129X1-Tcf3tm1Xhsu)
|
increased B cell number
|
J:132669
|
\Tcf3tm1Zhu/\Tcf3tm1Zhu
(involves: 129)
|
decreased B cell number
|
J:47671
|
\Tcf3tm1Zhu/\Tcf3tm1Zhu
(involves: 129 * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
| increased single-positive T cell number
|
J:136143
|
\Tcf3tm1Zhu/\Tcf3tm2Zhu
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:47671
|
\Tcf3tm2Cmu/\Tcf3tm2Cmu
(involves: 129P2/OlaHsd)
|
abnormal lymphopoiesis
|
J:118827
|
| absent pre-B cells
|
J:118827
|
| absent pro-B cells
|
J:118827
|
| decreased NK cell number
|
J:118827
|
\Tcf3tm2Zhu/\Tcf3tm2Zhu
(involves: 129 * C57BL/6)
|
decreased pre-B cell number
|
J:47671
|
| decreased pro-B cell number
|
J:47671
|
\Tcf3tm3.1Cmu/\Tcf3tm3.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal B cell differentiation
|
J:153423
|
| abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
| decreased pre-B cell number
|
J:153423
|
\Tcf3tm3Zhu/\Tcf3tm3Zhu
(involves: 129/Sv * C57BL/6)
|
decreased B cell number
|
J:47671
|
\Tcf3tm4.1Cmu/\Tcf3tm4.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
| absent B cells
|
J:153423
|
| arrested B cell differentiation
|
J:153423
|
| decreased pro-B cell number
|
J:153423
|
\Tcf3tm6(Esr1*)Zhu/\Tcf3tm6(Esr1*)Zhu
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:154788
|
| arrested B cell differentiation
|
J:154788
|
\Tcf4tm1.1Hmb/\Tcf4+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased double-negative T cell number
|
J:136143
|
\Tcf4tm1.1Hmb/\Tcf4tm1.1Hmb
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell differentiation
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
\Tcf4tm1Hmb/\Tcf4tm1Zhu
\Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:65236
|
| decreased double-positive T cell number
|
J:65236
|
| decreased thymocyte number
|
J:65236
|
\Tcf4tm1Zhu/\Tcf4+
\Tcf3tm1Wein/\Tcf3+
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:43324
|
\Tcf4tm1Zhu/\Tcf4tm1Zhu
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
\Tcf7tm1a(EUCOMM)Wtsi/\Tcf7tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7tm1a(EUCOMM)Wtsi/Ics)
|
decreased CD4-positive, alpha-beta T cell number
|
J:165965
|
| decreased T cell number
|
J:165965
|
| increased B cell number
|
J:165965
|
\Tcf7tm1Cle/\Tcf7tm1Cle
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:23255
|
| decreased CD8-positive, alpha-beta T cell number
|
J:189838
|
| decreased double-positive T cell number
|
J:23255
|
| decreased single-positive T cell number
|
J:23255
|
| decreased T cell number
|
J:23255
|
\Tcf7tm2Cle/\Tcf7tm2Cle
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:23255
|
| decreased single-positive T cell number
|
J:23255
|
\Tcf12m1Btlr/\Tcf12m1Btlr
(C57BL/6J-Tcf12M1Btlr)
|
increased CD8-positive, alpha-beta T cell number
|
J:267564
|
\Tcf12M2Btlr/\Tcf12M2Btlr
(C57BL/6J-Tcf12M2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:267666
|
| increased CD8-positive, alpha-beta T cell number
|
J:267666
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:267666
|
\Tcf12M3Btlr/\Tcf12M3Btlr
(C57BL/6J-Tcf12M3Btlr)
|
decreased B cell number
|
J:271971
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271971
|
| increased CD8-positive, alpha-beta T cell number
|
J:271971
|
\Tcf12m4Btlr/\Tcf12m4Btlr
(C57BL/6J-Tcf12m4Btlr)
|
abnormal B cell morphology
|
J:271972
|
| abnormal T cell morphology
|
J:271972
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271972
|
| increased CD8-positive, alpha-beta T cell number
|
J:271972
|
\Tcf12tm1Zhu/\Tcf12+
\Tcf3tm1Wein/\Tcf3+
(involves: 129S4/SvJaeSor)
|
decreased pro-B cell number
|
J:43324
|
\Tcf12tm1Zhu/\Tcf12+
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:75746
|
| increased double-negative T cell number
|
J:75746
|
| increased single-positive T cell number
|
J:75746
|
\Tcf12tm1Zhu/\Tcf12+
\Tcf4tm1Zhu/\Tcf4+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased pro-B cell number
|
J:43324
|
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129/Sv * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
| decreased thymocyte number
|
J:120411
|
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
| increased CD8-positive, alpha-beta T cell number
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
\Tcf12tm1Zhu/\Tcf12tm2Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
\Tcf12tm2Zhu/\Tcf12tm2Zhu
(Not Specified)
|
abnormal B cell differentiation
|
J:120411
|
| abnormal T cell differentiation
|
J:120411
|
| absent T cells
|
J:120411
|
| arrested T cell differentiation
|
J:120411
|
| decreased double-positive T cell number
|
J:120411
|
| decreased immature B cell number
|
J:120411
|
| decreased pre-B cell number
|
J:120411
|
| decreased pro-B cell number
|
J:120411
|
| decreased thymocyte number
|
J:120411
|
| increased double-negative T cell number
|
J:120411
|
\Tcf12tm2Zhu/\Tcf12tm2Zhu
\Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:120411
|
| abnormal T cell subpopulation ratio
|
J:120411
|
| arrested T cell differentiation
|
J:120411
|
| increased T cell number
|
J:120411
|
\Tcf12tm3Zhu/\Tcf12tm3Zhu
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:129171
|
| abnormal T cell differentiation
|
J:129171
|
| decreased CD4-positive, alpha-beta T cell number
|
J:129171
|
| increased CD8-positive, alpha-beta T cell number
|
J:129171
|
\Tcf12tm3Zhu/\Tcf12tm3Zhu
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased double-positive T cell number
|
J:129570
|
| decreased T cell number
|
J:129570
|
| increased double-negative T cell number
|
J:129570
|
\Tcf12tm3Zhu/\Tcf12tm3Zhu
\Tg(Lck-cre)#Zhu/0
(involves: C57BL/6 * SJL/J)
|
decreased thymocyte number
|
J:129570
|
| increased CD8-positive, alpha-beta T cell number
|
J:129570
|
\Tcimtm1Icle/\Tcimtm1Icle
(B6.129-Tcimtm1Icle)
|
increased lymphocyte cell number
|
J:217318
|
\Tcirg1tm1Utku/\Tcirg1tm1Utku
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell number
|
J:92730
|
| decreased lymphocyte cell number
|
J:92730
|
| decreased T cell number
|
J:92730
|
\Tcpm1BALB/c/\Tcpm1BALB/c
(involves: BALB/c * C57BL/10)
|
abnormal effector T cell morphology
|
J:36255
|
\Tcpm1BALB/c/\Tcpm1C57BL/10Sn
(involves: BALB/c * C57BL/10)
|
abnormal effector T cell morphology
|
J:36255
|
\Tcra-Jtm1Jpdv/\Tcra-Jtm1Jpdv
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77518
|
\Tcra-Jtm1Kgwa/\Tcra-Jtm1Kgwa
\Tg(Tcrb2B4)1Mmd/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:50143
|
| increased double-positive T cell number
|
J:50143
|
\Tcra-Jtm1Slek/\Tcra-Jtm1Slek
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:101398
|
| decreased double-positive T cell number
|
J:101398
|
| decreased single-positive T cell number
|
J:101398
|
| increased double-negative T cell number
|
J:101398
|
| increased thymocyte number
|
J:101398
|
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
|
decreased activated T cell number
|
J:99107
|
| decreased B cell number
|
J:99107
|
\Tcra-Jtm1Tgi/\Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased NK T cell number
|
J:89695
|
\Tcra-Jtm2.3Krg/\Tcra-Jtm2.3Krg
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
\Tcra-Jtm3.1Krg/\Tcra-Jtm3.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
\Tcra-Jtm4.1Krg/\Tcra-Jtm4.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
\Tcra-Jtm5Krg/\Tcra-Jtm5Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
\TcraLn1Ogu/\Tcra+
(involves: 129/Sv * C57BL/6)
|
abnormal NK T cell morphology
|
J:152041
|
| abnormal T cell subpopulation ratio
|
J:152041
|
| decreased thymocyte number
|
J:152041
|
| increased NK T cell number
|
J:152041
|
\TcraLn1Ogu/\Tcra+
\TcrbLn1Ogu/\Tcrb+
(involves: 129/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:152069
|
\TcraLn2Ogu/\Tcra+
\TcrbLn2Ogu/\Tcrb+
(involves: 129/Sv * C57BL/6)
|
abnormal T cell morphology
|
J:152069
|
\TcraLn3Jae/\Tcra+
(B6.Cg-TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| decreased double-positive T cell number
|
J:143006
|
| increased CD8-positive, alpha-beta T cell number
|
J:143006
|
\TcraLn3Jae/\Tcra+
\TcrbLn3Jae/\Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| abnormal T cell differentiation
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
| decreased CD4-positive, alpha-beta T cell number
|
J:143006
|
| decreased double-positive T cell number
|
J:143006
|
| increased CD8-positive, alpha-beta T cell number
|
J:143006
|
\Tcratm1Cgn/\Tcratm1Cgn
\Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:79298
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:79298
|
| abnormal memory T cell morphology
|
J:79298
|
| abnormal T cell morphology
|
J:79298
|
\Tcratm1Cgn/\Tcratm1Mass
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased T cell number
|
J:201417
|
\Tcratm1Mass/\Tcra+
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal NK T cell morphology
|
J:201417
|
| decreased NK cell number
|
J:201417
|
| increased NK T cell number
|
J:201417
|
\Tcratm1Mass/\Tcra+
\Tg(Nes-cre)Wme/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:201417
|
| decreased NK T cell number
|
J:201417
|
| decreased thymocyte number
|
J:201417
|
| increased double-negative T cell number
|
J:201417
|
\Tcratm1Mass/\Tcratm1Mass
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:201417
|
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal T cell morphology
|
J:1292
|
| increased activated T cell number
|
J:111129
|
| increased B cell number
|
J:111129
|
\Tcratm1Mjo/\Tcratm1Mjo
(NOD.129P2-Tcratm1Mjo)
|
increased activated T cell number
|
J:52940
|
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd)
|
increased activated T cell number
|
J:110898
|
| increased gamma-delta T cell number
|
J:110898
|
| increased T cell number
|
J:110898
|
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\H2b/\H2b
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
| abnormal double-positive T cell morphology
|
J:81564
|
| abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
| decreased double-positive T cell number
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\H2d/\H2d
\Ptcratm1Vbo/\Ptcratm1Vbo
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
| decreased thymocyte number
|
J:131357
|
\Tcratm1Mom/\Tcratm1Mom
(involves: 129S2/SvPas)
|
absent T cells
|
J:88620
|
\Tcratm1Mom/\Tcratm1Mom
(B6.129S2-Tcratm1Mom)
|
increased mature gamma-delta T cell number
|
J:135597
|
\Tcratm1Mom/\Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
| decreased CD4-positive, alpha-beta T cell number
|
J:3206
|
| decreased CD8-positive, alpha-beta T cell number
|
J:3206
|
| increased gamma-delta intraepithelial T cell number
|
J:15221
|
\Tcratm1Mom/\Tcratm1Mom
\Tcra-Jtm1Kgwa/\Tcra-Jtm1Kgwa
(involves: 129P2/OlaHsd * 129S2/SvPas * C3H/HeJ * C57BL/6J)
|
increased double-negative T cell number
|
J:50143
|
\Tcratm1Mom/\Tcratm1Mom
\Tcrbtm1Mom/\Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
\Tcratm1Mom/\Tcratm1Mom
\Tcrgtm1.1Hish/\Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
absent gamma-delta T cells
|
J:135597
|
\Tcratm1Mom/\Tcratm1Mom
\Tg(CD19-Tnfsf7)#Rvl/0
(involves: 129P2/OlaHsd * C57BL/6)
|
absent T cells
|
J:88620
|
\Tcratm1Mom/\Tcratm1Mom
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
arrested T cell differentiation
|
J:135903
|
\Tcratm1Mom/\Tcratm1Mom
\Tg(TcraAV19AJ33)1Shima/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal NK T cell morphology
|
J:140924
|
\TcrbLn3Jae/\Tcrb+
(B6.Cg-TcrbLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| absent gamma-delta T cells
|
J:143006
|
\Tcrbtm1(Tcrb)Chb/\Tcrbtm1(Tcrb)Chb
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
| abnormal T cell morphology
|
J:147947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147947
|
| increased single-positive T cell number
|
J:147947
|
\Tcrbtm1(Tcrb)Chb/\Tcrbtm1Slek
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
| abnormal T cell morphology
|
J:147947
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:147947
|
| decreased CD8-positive, alpha-beta T cell number
|
J:147947
|
| increased single-positive T cell number
|
J:147947
|
\Tcrbtm1(Tcrb)Fwa/\Tcrbtm1(Tcrb)Fwa
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
\Tcrbtm1Mom/\Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:3206
|
| decreased CD4-positive, alpha-beta T cell number
|
J:3206
|
| decreased CD8-positive, alpha-beta T cell number
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| decreased plasma cell number
|
J:187766
|
| decreased T cell number
|
J:187766
|
| increased B cell number
|
J:187766
|
| increased follicular B cell number
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased marginal zone B cell number
|
J:187766
|
| increased mature B cell number
|
J:187766
|
| increased transitional stage T2 B cell number
|
J:187766
|
| increased transitional stage T3 B cell number
|
J:187766
|
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
absent CD4-positive, alpha-beta T cells
|
J:3206
|
| absent CD8-positive, alpha-beta T cells
|
J:3206
|
| arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
(involves: 129P2/OlaHsd)
|
decreased lymphocyte cell number
|
J:97824
|
| increased T cell number
|
J:97824
|
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Igh-Jtm2(3H9-VDJ*)Mwg/\Igh-J+
(B6.129P2-Tcrbtm1Mom Igh-Jtm2(3H9-VDJ*)Mwg Tcrdtm1Mom)
|
increased marginal zone B cell number
|
J:142389
|
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| decreased T cell number
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased marginal zone B cell number
|
J:187766
|
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tg(H2-K-Cd86)7All/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:112475
|
| abnormal B cell morphology
|
J:112475
|
| decreased B cell number
|
J:112475
|
\Tcrbtm1Slek/\Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm1Slek/\Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm2(Tcrb)Fwa/\Tcrbtm3Slek
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:132446
|
\Tcrbtm2Slek/\Tcrbtm2Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
| decreased T cell number
|
J:119552
|
\Tcrbtm2Slek/\Tcrbtm2Slek
\Trbv13-2tm1(CD2)Zhu/\Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
\Tcrbtm3Slek/\Tcrbtm3Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
| decreased T cell number
|
J:119552
|
\Tcrbtm5Slek/\Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm6Slek/\Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrbtm7Slek/\Tcrbtm7Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
\Tcrd-V1tm1Kjk/\Tcrd-V1tm1Kjk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:64863
|
| abnormal mature gamma-delta T cell morphology
|
J:64863
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:64863
|
| decreased gamma-delta intraepithelial T cell number
|
J:64863
|
\Tcrd-V1tm1Kjk/\Tcrd-V1tm1Kjk
(B6.129P2-Tcrd-V1tm1Kjk)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:128525
|
| decreased gamma-delta intraepithelial T cell number
|
J:128525
|
\Tcrdtm1Mom/\Tcrdtm1Mom
(either: (involves: 129P2/OlaHsd * BALB/cJ) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal gamma-delta T cell differentiation
|
J:3865
|
| absent gamma-delta T cells
|
J:3865
|
\Tcrdtm1Mom/\Tcrdtm1Mom
\Tcrgtm2.1Dhr/\Tcrgtm2.1Dhr
(involves: 129 * C57BL/6)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Tcrgtm1.1Dhr/\Tcrgtm1.1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
\Tcrgtm1.1Hish/\Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * C57BL/6)
|
absent gamma-delta T cells
|
J:135597
|
\Tcrgtm1Dhr/\Tcrgtm1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
\Tcrgtm1Scar/\Tcrgtm1Scar
(B6.Cg-Tcrgtm1Scar)
|
increased T cell number
|
J:105477
|
\Tcrgtm2.1Dhr/\Tcrgtm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
\Tdp2tm1.1Huy/\Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1)
|
abnormal immature B cell morphology
|
J:195301
|
| abnormal lymphopoiesis
|
J:195301
|
| decreased double-positive T cell number
|
J:195301
|
\Tdrd3Gt(RRK474)Byg/\Tdrd3Gt(RRK474)Byg
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:210647
|
\Tent5aem1(IMPC)Ccpcz/\Tent5aem1(IMPC)Ccpcz
(C57BL/6N-Tent5aem1(IMPC)Ccpcz/Ccpcz)
|
decreased Ly6C-positive mature NK cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
abnormal T cell differentiation
|
J:186446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
| decreased regulatory T cell number
|
J:186446
|
| decreased T cell number
|
J:186446
|
| increased memory T cell number
|
J:186446
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * DBA/2J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc
\Tg(TcraTcrb)425Cbn/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)425Cbn)
|
abnormal T cell differentiation
|
J:186446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
\Tespa1tm1Smoc/\Tespa1tm1Smoc
\Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)1100Mjb)
|
abnormal T cell differentiation
|
J:186446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:186446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:186446
|
\Tet1tm1.2Jae/\Tet1tm1.2Jae
\Tet2tm1.1Iaai/\Tet2+
\Tet3tm1.1Yzhg/\Tet3tm1.1Yzhg
\Tg(Rorc-cre)1Litt/0
(involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)
|
decreased effector memory T-helper cell number
|
J:333574
|
\Tet2Gt(AN0709)Wtsi/\Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
increased B cell number
|
J:174052
|
\Tet2Gt(AN0709)Wtsi/\Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
decreased pre-B cell number
|
J:174052
|
| decreased pro-B cell number
|
J:174052
|
| increased B cell number
|
J:174052
|
| increased DN1 thymic pro-T cell number
|
J:174052
|
| increased double-negative T cell number
|
J:174052
|
\Tet2tm1.1Iaai/\Tet2tm1.1Iaai
\Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
decreased B cell number
|
J:234976
|
\Tet2tm1Ics/\Tet2tm1Ics
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased pre-B cell number
|
J:174052
|
| decreased pro-B cell number
|
J:174052
|
| increased B cell number
|
J:174052
|
| increased DN1 thymic pro-T cell number
|
J:174052
|
| increased double-negative T cell number
|
J:174052
|
\Tfap4tm1.1Litt/\Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
\Tg(ACTB-Mgat3)2Nta/0
(involves: C57BL/6 * DBA/2)
|
decreased lymphocyte cell number
|
J:80227
|
\Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:148162
|
| increased B-1a cell number
|
J:148162
|
\Tg(Alb1-GP33/H2-Kb)1Hpi/0
\Tg(TcrLCMV)318Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:162605
|
\Tg(Alb1-Myc)#Sst/0
\Tg(MtTGFA)Lmb/0
(involves: C57BL/6 * CBA * CD-1)
|
decreased NK cell number
|
J:176432
|
| increased NK T cell number
|
J:176432
|
\Tg(B19-RNAi:Il3)241Ckn/?
(involves: BALB/cJ * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:107618
|
| increased pre-B cell number
|
J:107618
|
\Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:93111
|
| increased B cell number
|
J:93111
|
\Tg(BCL2)22Wehi/0
(involves: C57BL/6J * C57BL/6JWehi)
|
increased B cell number
|
J:88565
|
\Tg(BCL2)22Wehi/0
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi)
|
abnormal B cell morphology
|
J:69571
|
| abnormal pre-B cell morphology
|
J:69571
|
| increased B cell number
|
J:69571
|
| increased pre-B cell number
|
J:69571
|
\Tg(BCL2)25Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:131912
|
| abnormal plasma cell differentiation
|
J:131912
|
| increased T cell number
|
J:93111
|
\Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
increased B cell number
|
J:93111
|
| increased T cell number
|
J:93111
|
\Tg(BCL2/IGH)1Tjd/?
(involves: C3H/He * C57BL/6)
|
increased B cell number
|
J:81147
|
\Tg(BCL2/IGH)#Jcre/0
\Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)
|
increased B cell number
|
J:94116
|
| increased B-1a cell number
|
J:94116
|
| increased B-1b cell number
|
J:94116
|
| increased marginal zone B cell number
|
J:94116
|
\Tg(BCL2/IGH)M23Tjd/?
(involves: C3H/He * C57BL/6)
|
increased B cell number
|
J:81147
|
\Tg(CD2-Ccdc86)1Hfuj/?
(B6.FVB-Tg(CD2-Ccdc86)1Hfuj)
|
abnormal T cell morphology
|
J:151722
|
\Tg(CD2-Ceacam1*4L)1Rsb/0
(involves: C57BL/6)
|
decreased T cell number
|
J:116136
|
\Tg(CD2-Foxj1)#Stlp/0
(C57BL/6-Tg(CD2-Foxj1)#Stlp)
|
decreased CD4-positive, alpha-beta T cell number
|
J:122222
|
| decreased CD8-positive, alpha-beta T cell number
|
J:122222
|
| increased single-positive T cell number
|
J:122222
|
\Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
\Tg(CD2-Ifngr2)2Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)2Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
\Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:212571
|
| decreased double-positive T cell number
|
J:212571
|
| decreased T cell number
|
J:212571
|
\Tg(CD2-Mir181d)38Oers/0
\Tg(TcraTcrb)425Cbn/0
(involves: C3H * C57BL/6)
|
decreased T cell number
|
J:212571
|
\Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA)
|
abnormal single-positive T cell number
|
J:126456
|
| decreased T cell number
|
J:126456
|
| increased double-negative T cell number
|
J:126456
|
\Tg(CD2-Myb/en)2Kmw/\Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
decreased double-positive T cell number
|
J:126456
|
| decreased T cell number
|
J:126456
|
| increased double-negative T cell number
|
J:126456
|
\Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:80066
|
| decreased CD4-positive, alpha-beta T cell number
|
J:80066
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80066
|
| decreased T cell number
|
J:80066
|
\Tg(CD2-Ppp2ca)#Gct/0
(involves: C57BL/6J)
|
abnormal T cell subpopulation ratio
|
J:184067
|
| increased germinal center B cell number
|
J:184067
|
\Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:236222
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:230700
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236222
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:230700
|
\Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2)
|
decreased activated T cell number
|
J:96558
|
| increased activated T cell number
|
J:96558
|
| increased T cell number
|
J:96558
|
\Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: C57BL/10)
|
abnormal positive T cell selection
|
J:113713
|
| increased CD8-positive, alpha-beta T cell number
|
J:113713
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: C57BL/10 * CBA/Ca)
|
decreased CD8-positive, alpha-beta T cell number
|
J:113713
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: BALB/c * C57BL/10)
|
decreased CD8-positive, alpha-beta T cell number
|
J:113713
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
| decreased CD4-positive, alpha-beta T cell number
|
J:126026
|
| increased CD8-positive, alpha-beta T cell number
|
J:126026
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
| increased T cell number
|
J:217939
|
\Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
\Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:93665
|
\Tg(CD2-Zbtb7b)C8Rbo/?
(involves: C57BL/6)
|
absent CD8-positive, alpha-beta T cells
|
J:97610
|
| increased CD4-positive, alpha-beta T cell number
|
J:97610
|
\Tg(CD2-Zbtb7b)C8Rbo/?
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(CD2-Zbtb7b)C8Rbo/?
\Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(CD2-Zbtb7b)C8Rbo/?
\Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal T cell differentiation
|
J:151075
|
\Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J)
|
abnormal T cell number
|
J:123440
|
| increased mature B cell number
|
J:123440
|
\Tg(CD3E)26Cpt/\Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J)
|
absent NK cells
|
J:81711
|
| arrested T cell differentiation
|
J:81711
|
| decreased double-positive T cell number
|
J:54756
|
| decreased T cell number
|
J:54756
|
| decreased thymocyte number
|
J:81711
|
| decreased uterine NK cell number
|
J:134589
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:217939
|
| abnormal T cell clonal deletion
|
J:217939
|
| abnormal T cell subpopulation ratio
|
J:217939
|
| decreased double-positive T cell number
|
J:217939
|
| increased activated T cell number
|
J:217939
|
| increased B cell number
|
J:217939
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:217939
|
| increased regulatory T cell number
|
J:217939
|
| increased single-positive T cell number
|
J:217939
|
| increased T cell number
|
J:217939
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
\Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Cd4-cre)1Cwi/0
\Trmt6em1Hbgl/\Trmt6em1Hbgl
(involves: C57BL/6 * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:336736
|
\Tg(Cd4-cre)1Cwi/0
\Trmt61aem1Hbgl/\Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
abnormal CD4-positive T cell differentiation
|
J:336736
|
| decreased CD4-positive, alpha-beta T cell number
|
J:336736
|
| decreased CD8-positive, alpha-beta T cell number
|
J:336736
|
| increased CD4-positive, alpha-beta T cell number
|
J:336736
|
| increased CD8-positive, alpha-beta T cell number
|
J:336736
|
\Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:158594
|
\Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal T cell differentiation
|
J:235890
|
| abnormal T cell morphology
|
J:235890
|
| increased DN3 thymocyte number
|
J:235890
|
\Tg(Cd4-NPM/ALK)N1Ingh/0
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal double-negative T cell morphology
|
J:235890
|
\Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased B cell number
|
J:97554
|
| increased memory T cell number
|
J:97554
|
\Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6)
|
abnormal CD8-positive, alpha-beta regulatory T cell morphology
|
J:134473
|
\Tg(Cd4-Zbtb16)1797Aben/?
(C57BL/6-Tg(Cd4-Zbtb16)1797Aben)
|
decreased CD4-positive, alpha-beta T cell number
|
J:139690
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:139690
|
| increased T-helper 2 cell number
|
J:139690
|
\Tg(Cd8aCd8b)3Erob/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
| abnormal double-positive T cell morphology
|
J:93004
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93004
|
| decreased double-negative T cell number
|
J:93004
|
| increased CD8-positive, alpha-beta T cell number
|
J:93004
|
\Tg(Cd8aCd8b)3Erob/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93004
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
| increased CD8-positive, alpha-beta T cell number
|
J:93004
|
\Tg(CD8aCD8b)57Scr/?
(B6;SJL-Tg(CD8aCD8b)57Scr/J)
|
abnormal effector T cell morphology
|
J:92994
|
\Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell subpopulation ratio
|
J:110916
|
| decreased T cell number
|
J:110916
|
| decreased thymocyte number
|
J:110916
|
\Tg(CD19)1Tft/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:27236
|
\Tg(CD19)1Tft/\Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased B cell number
|
J:27236
|
| decreased immature B cell number
|
J:27236
|
\Tg(CD19-Tnfsf7)#Rvl/0
(involves: C57BL/6)
|
decreased B cell number
|
J:88620
|
| decreased mature B cell number
|
J:88620
|
| decreased transitional stage B cell number
|
J:88620
|
\Tg(Cd74-Nlrc4*)1Kyas/0
(involves: C57BL/6N)
|
increased T cell number
|
J:219652
|
\Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6)
|
increased lymphocyte cell number
|
J:79703
|
\Tg(CLEC4C-HBEGF)956Cln/0
(C57BL/6-Tg(CLEC4C-HBEGF)956Cln)
|
decreased CD8-positive, alpha-beta T cell number
|
J:166504
|
\Tg(Cr2-cre)3Cgn/?
\Xrcc4tm1Fwa/\Xrcc4tm2Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150339
|
\Tg(DO11.10)10Dlo/?
(involves: BALB/c * C3H * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:70572
|
| decreased double-positive T cell number
|
J:70572
|
\Tg(DO11.10)10Dlo/?
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:131287
|
| decreased T cell number
|
J:131287
|
\Tg(EEF1A1-SHC1*)1Ravi/?
\Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
| decreased double-positive T cell number
|
J:78180
|
| decreased single-positive T cell number
|
J:78180
|
\Tg(EIF1AX-Il31ra)1Jagr/0
(involves: C3H * C57BL/6)
|
decreased T cell number
|
J:91124
|
| increased activated T cell number
|
J:91124
|
| increased B cell number
|
J:91124
|
| increased memory T cell number
|
J:91124
|
\Tg(Ela-KRAS*G12D)9Eps/0
(involves: C57BL/6 * FVB)
|
increased regulatory T cell number
|
J:231759
|
\Tg(Ela-KRAS*G12D)9Eps/0
\Tg(Mt1-TGFBR2*)AM3Epb/0
(involves: C57BL/6 * FVB)
|
increased regulatory T cell number
|
J:231759
|
\Tg(Ela-KRAS*G12D)9Eps/0
\Tgfbr1tm1Bopa/\Tgfbr1+
(involves: 129S1/SvImJ * C57BL/6 * FVB)
|
increased CD8-positive, alpha-beta T cell number
|
J:231759
|
\Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr)
|
increased B cell number
|
J:117018
|
| increased B-1 B cell number
|
J:117018
|
| increased B-2 B cell number
|
J:117018
|
| increased germinal center B cell number
|
J:117018
|
| increased marginal zone B cell number
|
J:117018
|
| increased plasma cell number
|
J:117018
|
\Tg(Emu-Zfp521)1Homy/0
(Not Specified)
|
abnormal B cell differentiation
|
J:160392
|
| increased B cell number
|
J:160392
|
\Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA)
|
increased B cell number
|
J:237420
|
\Tg(Fabp2-Arg1)1Wla/\Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
abnormal B cell differentiation
|
J:80204
|
| decreased B cell number
|
J:80204
|
| decreased pre-B cell number
|
J:80204
|
| decreased transitional stage B cell number
|
J:80204
|
\Tg(Fabp4-Phb*Y114F)#Smis/0
(Not Specified)
|
increased lymphocyte cell number
|
J:227976
|
\Tg(Fli1)1Ber/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased thymocyte number
|
J:33052
|
\Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
decreased lymphocyte cell number
|
J:288386
|
\Tg(Foxp3-HBEGF/EGFP)23.2Spar/0
(involves: C57BL/6NCrl)
|
decreased regulatory T cell number
|
J:125295
|
\Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0
(either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB))
|
decreased thymocyte number
|
J:67796
|
\Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr)
|
abnormal T cell morphology
|
J:67478
|
| abnormal T cell subpopulation ratio
|
J:67478
|
| increased lymphocyte cell number
|
J:67478
|
| increased memory T cell number
|
J:67478
|
| increased NK cell number
|
J:67478
|
\Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:117352
|
\Tg(H2-Ea-HA)HACIIAjca/0
\Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:209872
|
\Tg(H2-Ea-HA)HACIIAjca/0
\Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:209872
|
\Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:81133
|
| abnormal double-negative T cell morphology
|
J:81133
|
\Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6 * DBA/2)
|
increased pre-B cell number
|
J:171924
|
| increased pro-B cell number
|
J:171924
|
\Tg(H2-Ea-Ins2)1Wehi/\Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:117352
|
\Tg(H2-Ea-LACK)1Ngkh/0
(C.Cg-Tg(H2-Ea-LACK)1Ngkh)
|
decreased T-helper 2 cell number
|
J:181384
|
| increased T-helper 1 cell number
|
J:181384
|
\Tg(H2-Ea-Tnfsf9)16Lpc/0
(involves: C57BL/6)
|
decreased B cell number
|
J:132372
|
| increased lymphocyte cell number
|
J:132372
|
| increased memory T cell number
|
J:145439
|
| increased NK cell number
|
J:132372
|
\Tg(H2-K-Cd86)7All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
| decreased B cell number
|
J:112475
|
| increased CD4-positive, alpha-beta T cell number
|
J:112475
|
| increased CD8-positive, alpha-beta T cell number
|
J:112475
|
\Tg(H2-K-Cd86)7All/0
(B6.Cg-Tg(H2-K-Cd86)7All)
|
decreased B cell number
|
J:112266
|
| decreased CD4-positive, alpha-beta T cell number
|
J:112266
|
| increased CD8-positive, alpha-beta T cell number
|
J:112266
|
| increased T cell number
|
J:112266
|
\Tg(H2-K-Cd86)27All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
| decreased B cell number
|
J:112475
|
\Tg(H2-K-Cd86)31All/0
(involves: C57BL/6J * CBA)
|
increased CD4-positive, alpha-beta T cell number
|
J:112475
|
| increased CD8-positive, alpha-beta T cell number
|
J:112475
|
\Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
abnormal T cell number
|
J:138077
|
| decreased single-positive T cell number
|
J:138077
|
| increased CD4-positive, alpha-beta T cell number
|
J:138077
|
| increased CD8-positive, alpha-beta T cell number
|
J:138077
|
| increased double-positive T cell number
|
J:138077
|
| increased plasma cell number
|
J:138077
|
| increased single-positive T cell number
|
J:138077
|
\Tg(H2-K-IL6)2Srj/0
(B6.Cg-Tg(H2-K-IL6)2Srj)
|
increased plasma cell number
|
J:185153
|
\Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:138050
|
| increased follicular B cell number
|
J:138050
|
\Tg(H2-K-MC159/EGFP)13Fkmc/\Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6)
|
increased double-negative T cell number
|
J:138050
|
| increased T cell number
|
J:138050
|
\Tg(H2-K-TcrbP14)128Mak/?
(involves: C57BL/6 * C57L * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111265
|
| abnormal T cell clonal deletion
|
J:111265
|
| abnormal T cell differentiation
|
J:111265
|
| increased CD8-positive, alpha-beta T cell number
|
J:111265
|
\Tg(H2-Kb-IL21)5Wjl/0
(involves: 129)
|
abnormal B cell differentiation
|
J:93740
|
| abnormal class switch recombination
|
J:93740
|
| decreased follicular B cell number
|
J:93740
|
| decreased marginal zone B cell number
|
J:93740
|
| decreased mature B cell number
|
J:93740
|
| decreased transitional stage T2 B cell number
|
J:93740
|
| increased immature B cell number
|
J:93740
|
| increased transitional stage T1 B cell number
|
J:93740
|
\Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs)
|
increased T-helper 1 cell number
|
J:149511
|
| increased T-helper 17 cell number
|
J:149511
|
\Tg(H2-L-IL6)1Kish/\Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
increased plasma cell number
|
J:128016,
J:138762
|
\Tg(H2-L-IL6)46Kish/\Tg(H2-L-IL6)46Kish
(C57BL/6-Tg(H2-L-IL6)46Kish)
|
increased plasma cell number
|
J:40405
|
\Tg(H2KePCC)2403Stoe/?
\Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92997
|
\Tg(H2KmPCC)2939Stoe/0
\Tg(Tcra2B4)1Mmd/0
\Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:50143
|
| decreased thymocyte number
|
J:50143
|
\Tg(H2KmPCC)2939Stoe/?
\Tg(TcrAND)53Hed/?
(involves: C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92997
|
\Tg(H2KmPCC)2939Stoe/?
\Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92997
|
\Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:119625
|
\Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified)
|
increased B cell number
|
J:178816
|
\Tg(Igh-3/Igh-6VD93)1241Ust/?
(C57BL/6-Tg(Igh-3/Igh-6VD93)1241Ust)
|
abnormal B cell morphology
|
J:135209
|
| decreased pre-B cell number
|
J:135209
|
\Tg(Igh-3VD93)343Ust/?
(involves: C57BL/6 * SJL)
|
abnormal B cell morphology
|
J:135209
|
| decreased pre-B cell number
|
J:135209
|
\Tg(Igh-6-Cd80)1Gjf/0
(involves: FVB)
|
decreased B cell number
|
J:44271
|
\Tg(Igh-6-Cd80)1Gjf/0
(B6.Cg-Tg(Igh-6-Cd80)1Gjf)
|
abnormal T cell number
|
J:112266
|
\Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)
|
decreased B cell number
|
J:131077
|
| decreased B-2 B cell number
|
J:131077
|
| decreased follicular B cell number
|
J:131077
|
| decreased immature B cell number
|
J:131077
|
| decreased mature B cell number
|
J:131077
|
\Tg(Igh-6-Cd86)1Akab/0
(involves: FVB)
|
decreased B cell number
|
J:44271
|
\Tg(Igh-6/Igh-V125)2Jwt/0
\Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
|
abnormal B cell number
|
J:91865
|
\Tg(Igh-HMGA2)#Cro/0
(FVB/N-Tg(Igh-HMGA2)#Cro)
|
decreased B cell number
|
J:233225
|
| decreased T cell number
|
J:233225
|
| increased T cell number
|
J:233225
|
\Tg(Igh-HOX11)11Idd/0
(CD-1)
|
abnormal immunoglobulin V(D)J recombination
|
J:52782
|
\Tg(Igh-Lmp2a)ERlon/0
(involves: C57BL/6 * SJL)
|
decreased B cell number
|
J:129571
|
\Tg(Igh-Maf)68Staka/0
(C57BL/6-Tg(Igh-Maf)68Staka)
|
increased plasma cell number
|
J:168074
|
\Tg(Igh-Maf)524Staka/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
increased plasma cell number
|
J:168074
|
\Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
abnormal lymphopoiesis
|
J:162077
|
| increased B-1a cell number
|
J:162077
|
\Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
\Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased B-1a cell number
|
J:162077
|
\Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
abnormal lymphopoiesis
|
J:109591
|
| increased B cell number
|
J:109591
|
| increased pre-B cell number
|
J:109591
|
\Tg(Igh-Mir210)#aKgcs/\Tg(Igh-Mir210)#aKgcs
(B6.Cg-Tg(Igh-Mir210)#aKgcs)
|
abnormal class switch recombination
|
J:205868
|
| decreased marginal zone B cell number
|
J:205868
|
| decreased mature B cell number
|
J:205868
|
| decreased pre-B cell number
|
J:205868
|
| decreased pro-B cell number
|
J:205868
|
| increased B-1a cell number
|
J:205868
|
\Tg(Igh-ROR1)1Kip/0
(C57BL/6-Tg(Igh-ROR1)1Kip)
|
increased lymphocyte cell number
|
J:206368
|
| increased mature B cell number
|
J:206368
|
\Tg(Igh-ROR1)1Kip/0
\Tg(Igh-V186.2-TCL1A)3Cro/0
(B6.Cg-Tg(Igh-ROR1)1Kip Tg(Igh-V186.2-TCL1A)3Cro)
|
increased lymphocyte cell number
|
J:206368
|
| increased mature B cell number
|
J:206368
|
\Tg(Igh-V186.2-TCL1A)3Cro/0
(involves: C3H * C57BL/6)
|
abnormal B cell morphology
|
J:76574
|
| increased marginal zone B cell number
|
J:76574
|
\Tg(IGH@*)SALed/0
(involves: C57BL/6 * CD-1)
|
abnormal mature B cell morphology
|
J:131938
|
\Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:23827
|
\Tg(IGH@yH1)2BJkbv/0
\Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
\Tg(IghelMD4)4Ccg/0
(involves: C3H/HeJ * C57BL/6)
|
decreased pre-B cell number
|
J:115059
|
| decreased pro-B cell number
|
J:115059
|
\Tg(IghelMD4)4Ccg/0
(involves: C57BL/6)
|
decreased pre-B cell number
|
J:115059
|
| decreased pro-B cell number
|
J:115059
|
\Tg(IghelMD4)4Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg)
|
abnormal B cell morphology
|
J:78308,
J:109923,
J:132538
|
| abnormal B-2 B cell morphology
|
J:132538
|
| abnormal germinal center B cell morphology
|
J:109923
|
| abnormal immature B cell morphology
|
J:109923
|
| abnormal mature B cell morphology
|
J:89156,
J:109923
|
| abnormal plasma cell morphology
|
J:109923
|
| abnormal pro-B cell morphology
|
J:109923
|
| increased immature B cell number
|
J:78308,
J:132538
|
\Tg(IghelMD4)4Ccg/0
\Tg(KLK4mHEL)6Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg/Dvs)
|
decreased B cell number
|
J:89156
|
\Tg(IghelMD4)4Ccg/0
\Tg(KLK4mHEL)6Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg)
|
decreased B cell number
|
J:89156
|
\Tg(IghelMD4)4Ccg/?
\Tg(KLK4mHEL)6Ccg/?
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:78307
|
| decreased mature B cell number
|
J:78307
|
| increased immature B cell number
|
J:78307
|
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)
|
abnormal B cell clonal deletion
|
J:89156
|
| abnormal B cell morphology
|
J:89156
|
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)
|
abnormal germinal center B cell morphology
|
J:109923
|
| abnormal immature B cell morphology
|
J:109923
|
| abnormal mature B cell morphology
|
J:109923
|
| abnormal plasma cell morphology
|
J:109923
|
| abnormal pro-B cell morphology
|
J:109923
|
| decreased B cell number
|
J:89156
|
\Tg(IghelMD4)4Ccg/0
\Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6)
|
decreased B cell number
|
J:76134
|
| decreased marginal zone B cell number
|
J:132538
|
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal mature B cell morphology
|
J:80859,
J:89156
|
| decreased CD8-positive, alpha-beta T cell number
|
J:80859
|
\Tg(IghelMD4)4Ccg/\Tg(IghelMD4)4Ccg
(involves: C57BL/6)
|
decreased pre-B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
\Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
increased lymphocyte cell number
|
J:121564
|
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:78177
|
| increased pre-B cell number
|
J:223213
|
\Tg(IghMyc)22Bri/0
\Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N)
|
increased transitional stage B cell number
|
J:89049
|
\Tg(Igk-Lta/Ltb)4Cys/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell morphology
|
J:73100
|
\Tg(Igk-Lta/Ltb)10Cys/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell morphology
|
J:73100
|
\Tg(Igk-V21-Bax)1967Bvn/0
(involves: FVB/N)
|
abnormal plasma cell morphology
|
J:89049
|
| increased transitional stage B cell number
|
J:89049
|
\Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell morphology
|
J:23827
|
| abnormal immunoglobulin light chain V-J recombination
|
J:23827
|
\Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh)
|
abnormal plasma cell differentiation
|
J:131912
|
| increased plasma cell number
|
J:131912
|
\Tg(Igl-2MOPC315)1275Ust/?
(C57BL/6-Tg(Igl-2MOPC315)1275Ust)
|
abnormal B cell morphology
|
J:134666
|
| decreased immature B cell number
|
J:134666
|
\Tg(ILK3mHEL)3Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
\Tg(Ins2-GP)#Psoh/0
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell selection
|
J:81285
|
\Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:98589
|
\Tg(Ins2-TFRC/OVA)296Wehi/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:135154
|
| increased double-positive T cell number
|
J:135154
|
\Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:93555
|
| increased CD4-positive, alpha-beta T cell number
|
J:93555
|
\Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
| decreased double-positive T cell number
|
J:80777
|
| decreased lymphocyte cell number
|
J:80777
|
| decreased T cell number
|
J:80777
|
| increased CD8-positive, alpha-beta T cell number
|
J:80777
|
\Tg(ITGAL-Ptprca)FRasch/\Tg(ITGAL-Ptprca)FRasch
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
\Tg(Itgax-TGFBR2)1Flv/0
(C.Cg-Tg(Itgax-TGFBR2)1Flv)
|
abnormal NK cell differentiation
|
J:98953
|
| increased NK cell number
|
J:98953
|
\Tg(IVL-KLK5)#Hov/0
(involves: C57BL/6 * CBA)
|
increased activated T cell number
|
J:210758
|
\Tg(JAK2*V617F)FF1Rsko/0
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased B cell number
|
J:134364
|
| decreased T cell number
|
J:134364
|
\Tg(JAK2*V617F)FF1Rsko/0
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell number
|
J:134364
|
| decreased T cell number
|
J:134364
|
\Tg(JAK2*V617F)FF1Rsko/0
\Tg(Tek-cre)1Arnd/0
(involves: C57BL/6 * CBA * DBA/2)
|
decreased T cell number
|
J:206659
|
\Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
increased lymphocyte cell number
|
J:302313
|
| increased T cell number
|
J:300960
|
\Tg(KLK4mHEL)6Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
\Tg(KRT5-rtTA)1Glk/0
\Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased CD4-positive, alpha-beta T cell number
|
J:100506
|
\Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
decreased T cell number
|
J:78602
|
\Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak)
|
decreased T cell number
|
J:78602
|
\Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:258435
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:258435
|
| increased effector memory T-helper cell number
|
J:258435
|
| increased gamma-delta T cell number
|
J:258435
|
\Tg(KRT18-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J)
|
increased lymphocyte cell number
|
J:286231
|
\Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:196403
|
| abnormal marginal zone B cell morphology
|
J:196403
|
| increased germinal center B cell number
|
J:196403
|
| increased marginal zone B cell number
|
J:196403
|
| increased mature B cell number
|
J:196403
|
| increased plasma cell number
|
J:196403
|
\Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6)
|
decreased thymocyte number
|
J:73487
|
| increased double-negative T cell number
|
J:135903
|
| increased single-positive T cell number
|
J:135903
|
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: C3H/He * C57BL/6)
|
decreased thymocyte number
|
J:73487
|
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified)
|
abnormal T cell differentiation
|
J:144975
|
\Tg(Lck-Bcl2l1)1Cant/?
(B6.Cg-Tg(Lck-Bcl2l1)1Cant)
|
increased memory T cell number
|
J:77507
|
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:226234
|
\Tg(Lck-cre)548Jxm/?
\Tgfb1tm2.1Doe/\Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)
|
abnormal T cell subpopulation ratio
|
J:150024
|
\Tg(Lck-cre)548Jxm/?
\Upf2tm1Btp/\Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:134765
|
| decreased CD4-positive, alpha-beta T cell number
|
J:134765
|
| decreased CD8-positive, alpha-beta T cell number
|
J:134765
|
| decreased double-positive T cell number
|
J:134765
|
\Tg(Lck-cre)I57Jxm/?
\Traf2tm1Rbr/\Traf2tm1Rbr
(involves: C57BL/6 * ICR)
|
absent follicular B cells
|
J:132877
|
| absent marginal zone B cells
|
J:132877
|
| decreased mature B cell number
|
J:132877
|
\Tg(Lck-cre)I57Jxm/?
\Traf3tm1Rbr/\Traf3tm1Rbr
(involves: C57BL/6 * ICR * SJL)
|
decreased CD4-positive, alpha-beta T cell number
|
J:132877
|
| decreased CD8-positive, alpha-beta T cell number
|
J:132877
|
\Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:100451
|
| decreased T cell number
|
J:100451
|
| decreased thymocyte number
|
J:100451
|
\Tg(Lck-FADD)1Hed/\Tg(Lck-FADD)1Hed
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:100451
|
| decreased T cell number
|
J:100451
|
| decreased thymocyte number
|
J:100451
|
\Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
| decreased double-positive T cell number
|
J:80777
|
| decreased lymphocyte cell number
|
J:80777
|
| decreased T cell number
|
J:80777
|
| increased CD8-positive, alpha-beta T cell number
|
J:80777
|
\Tg(Lck-Il31)1Jagr/0
(involves: C3H * C57BL/6)
|
decreased T cell number
|
J:91124
|
| increased activated T cell number
|
J:91124
|
| increased B cell number
|
J:91124
|
| increased memory T cell number
|
J:91124
|
\Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93003
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93003
|
| decreased CD8-positive, alpha-beta T cell number
|
J:93003
|
\Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:63300
|
| increased double-negative T cell number
|
J:63300
|
| increased thymocyte number
|
J:63300
|
\Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
| decreased T cell number
|
J:128797
|
| decreased thymocyte number
|
J:128797
|
\Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:117301
|
| decreased thymocyte number
|
J:117301
|
\Tg(Lck-Stat5b*)1Mafa/0
(Not Specified)
|
decreased mature B cell number
|
J:132669
|
\Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
decreased CD4-positive, alpha-beta T cell number
|
J:149973
|
| decreased CD8-positive, alpha-beta T cell number
|
J:149973
|
| decreased single-positive T cell number
|
J:149973
|
| decreased thymocyte number
|
J:149973
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:149973
|
| increased double-positive T cell number
|
J:149973
|
\Tg(Lck-Stk17b)26.1Wals/?
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell differentiation
|
J:149973
|
| decreased CD8-positive, alpha-beta T cell number
|
J:149973
|
| decreased thymocyte number
|
J:149973
|
| increased CD8-positive, alpha-beta T cell number
|
J:149973
|
\Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
abnormal T cell subpopulation ratio
|
J:194882
|
| increased CD4-positive, alpha-beta T cell number
|
J:194882
|
| increased regulatory T cell number
|
J:194882
|
\Tg(Lck-Tnfsf4)1Nish/0
(C.Cg-Tg(Lck-Tnfsf4)1Nish)
|
increased CD4-positive, alpha-beta T cell number
|
J:194882
|
| increased regulatory T cell number
|
J:194882
|
\Tg(Lck-TNFSF13)3919Mhah/0
(B6.Cg-Tg(Lck-TNFSF13)3919Mhah)
|
increased B cell number
|
J:94628
|
| increased B-1 B cell number
|
J:94628
|
| increased CD4-positive, alpha-beta T cell number
|
J:94628
|
| increased CD8-positive, alpha-beta T cell number
|
J:94628
|
\Tg(Lck-Tnfsf15,-EGFP)#Targ/0
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta memory T cell number
|
J:169462
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:169462
|
\Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:92453
|
| abnormal T cell number
|
J:92453
|
| absent CD8-positive, alpha-beta T cells
|
J:92453
|
| decreased CD4-positive, alpha-beta T cell number
|
J:92453
|
| decreased double-positive T cell number
|
J:92453
|
| increased CD4-positive, alpha-beta T cell number
|
J:92453
|
| increased CD8-positive, alpha-beta T cell number
|
J:92453
|
| increased double-negative T cell number
|
J:92453
|
\Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93005
|
| decreased CD4-positive, alpha-beta T cell number
|
J:93005
|
| increased CD8-positive, alpha-beta T cell number
|
J:93005
|
\Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6)
|
abnormal T cell number
|
J:28635
|
| abnormal T cell subpopulation ratio
|
J:11548
|
| increased CD8-positive, alpha-beta T cell number
|
J:11548
|
| increased T cell number
|
J:11548
|
\Tg(LCKprBCL2)36Sjk/0
(B6.Cg-Tg(LCKprBCL2)36Sjk)
|
abnormal CD4-positive, alpha-beta T cell number
|
J:217939
|
| abnormal T cell subpopulation ratio
|
J:217939
|
| increased regulatory T cell number
|
J:217939
|
\Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(LCKprBCL2)36Sjk/0
\Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(LCKprBCL2)36Sjk/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
\Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA)
|
decreased B-1 B cell number
|
J:221238
|
| increased B-1 B cell number
|
J:221238
|
\Tg(Ly6a-SET/NUP214)2969Gcg/0
(involves: FVB/NJ)
|
abnormal B cell differentiation
|
J:142938
|
| decreased lymphocyte cell number
|
J:142938
|
| decreased pre-B cell number
|
J:142938
|
| decreased pro-B cell number
|
J:142938
|
\Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA)
|
increased mature B cell number
|
J:185590
|
| increased pre-B cell number
|
J:185590
|
| increased pro-B cell number
|
J:185590
|
\Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
abnormal immature B cell morphology
|
J:50604
|
| increased thymocyte number
|
J:50604
|
\Tg(ML5sHEL)5Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
\Tg(ML5sHEL)5Ccg/0
\Tg(TcrHEL3A9)1Mmd/0
\Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
\Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul)
|
increased regulatory T cell number
|
J:147923
|
\Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
increased T cell number
|
J:182703
|
\Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2)
|
increased plasma cell number
|
J:177825,
J:18424
|
\Tg(Mx1-cre)1Cgn/0
\Thoc5tm1Tate/\Thoc5tm1Tate
(involves: C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:169944
|
\Tg(Mx1-cre)1Cgn/0
\Tnfrsf13ctm2.1Mass/\Tnfrsf13ctm2.1Mass
(involves: C57BL/6 * CBA)
|
increased immature B cell number
|
J:170519
|
| increased pre-B cell number
|
J:170519
|
| increased pro-B cell number
|
J:170519
|
\Tg(Mx1-cre)1Cgn/0
\Traf2tm1Rbr/\Traf2tm1Rbr
(involves: C57BL/6 * CBA)
|
increased B cell number
|
J:93890
|
| increased marginal zone B cell number
|
J:93890
|
\Tg(Mx1-cre)1Cgn/0
\Zmiz1tm1c(EUCOMM)Hmgu/\Zmiz1tm1c(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J)
|
decreased B cell number
|
J:234445
|
| decreased NK cell number
|
J:234445
|
| decreased T cell number
|
J:234445
|
\Tg(Pgk1-HA)1.1Vbo/?
\Tg(Tcra/Tcrb)1Vbo/?
(involves: 129 * BALB/c * C57BL/6J * DBA/2J)
|
decreased CD4-positive, alpha-beta T cell number
|
J:125750
|
| increased double-positive T cell number
|
J:125750
|
| increased regulatory T cell number
|
J:125750
|
\Tg(Pgk1-HA)1.1Vbo/?
\Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
increased regulatory T cell number
|
J:112603
|
\Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tg(Pklr-Myc)73Ak)
|
decreased NK T cell number
|
J:184496
|
\Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6)
|
increased marginal zone B cell number
|
J:141378
|
\Tg(Rr158-H2-Ead)1Flv/0
\Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL)
|
decreased double-positive T cell number
|
J:124574
|
\Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0
(Not Specified)
|
increased T-helper 2 cell number
|
J:148490
|
\Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: C57BL/6 * CBA)
|
increased lymphocyte cell number
|
J:100854
|
\Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * CBA)
|
increased T-helper 2 cell number
|
J:148490
|
\Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: C57BL/6 * SJL)
|
abnormal B cell morphology
|
J:97297
|
| abnormal CD4-positive, alpha beta T cell morphology
|
J:97297
|
| abnormal T cell morphology
|
J:97297
|
| increased CD8-positive, alpha-beta T cell number
|
J:97297
|
| increased lymphocyte cell number
|
J:97297
|
\Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
abnormal lymphocyte morphology
|
J:129215
|
| decreased lymphocyte cell number
|
J:129215
|
\Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:210877
|
\Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA)
|
absent B-1a cells
|
J:82428
|
| decreased B-1 B cell number
|
J:82428
|
| increased B-2 B cell number
|
J:82428
|
| increased mature B cell number
|
J:82428
|
| increased pre-B cell number
|
J:82428
|
| increased pro-B cell number
|
J:82428
|
\Tg(SV40-Igh-64C8)H3Hon/0
\Tg(SV40-Igk4C8)L1Hon/0
(involves: C57BL/6)
|
abnormal B cell clonal deletion
|
J:139864
|
| abnormal B cell number
|
J:139864
|
\Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:55022
|
| arrested T cell differentiation
|
J:55022
|
| decreased CD4-positive, alpha-beta T cell number
|
J:55022
|
| decreased CD8-positive, alpha-beta T cell number
|
J:55022
|
| decreased double-positive T cell number
|
J:55022
|
| decreased T cell number
|
J:55022
|
| decreased thymocyte number
|
J:55022
|
\Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| decreased thymocyte number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
\Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57BL/6 * SJL)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:125259
|
\Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL)
|
decreased lymphocyte cell number
|
J:95380
|
| decreased thymocyte number
|
J:95380
|
| increased CD4-positive, alpha-beta T cell number
|
J:95380
|
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:83278
|
\Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell number
|
J:189919
|
| decreased T-helper 2 cell number
|
J:189919
|
| decreased T-helper 17 cell number
|
J:189919
|
\Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
\Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
\Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
abnormal T cell differentiation
|
J:104243
|
| increased memory T cell number
|
J:104243
|
\Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Tg(Tcra,Tcrb)HRCAll)
|
abnormal T cell subpopulation ratio
|
J:131347
|
| decreased CD4-positive, alpha-beta T cell number
|
J:131347
|
| increased CD8-positive, alpha-beta T cell number
|
J:131347
|
\Tg(Tcra,Tcrb)HRVAll/0
(B6.Cg-Tg(Tcra,Tcrb)HRVAll)
|
abnormal T cell subpopulation ratio
|
J:131347
|
| decreased CD4-positive, alpha-beta T cell number
|
J:131347
|
| increased CD8-positive, alpha-beta T cell number
|
J:131347
|
\Tg(TcraAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
\Tg(TcraAI4)1Dvs/0
\Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:94192
|
\Tg(TcraAV19AJ33)1Shima/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK T cell morphology
|
J:112657
|
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
increased activated T cell number
|
J:52940
|
\Tg(TcraCl1,TcrbCl1)1Shrm/0
(B10.Cg-Thy1a H2d Tg(TcraCl1,TcrbCl1)1Shrm)
|
abnormal T cell subpopulation ratio
|
J:97745
|
\Tg(TcraCl4,TcrbCl4)1Shrm/?
(B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:99756
|
| abnormal T cell subpopulation ratio
|
J:99756
|
\Tg(TcraDN32D3)#Alhn/0
(involves: NOD)
|
decreased NK cell number
|
J:201417
|
| decreased thymocyte number
|
J:201417
|
| increased double-negative T cell number
|
J:201417
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * C57L/J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:79738
|
| abnormal T cell differentiation
|
J:79738,
J:90776
|
| decreased thymocyte number
|
J:79738
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
\Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
| abnormal positive T cell selection
|
J:151074
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
\Themistm1Lov/\Themistm1Lov
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151075
|
| abnormal positive T cell selection
|
J:151075
|
| decreased single-positive T cell number
|
J:151075
|
| increased double-positive T cell number
|
J:151075
|
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
\Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:84536
|
| increased thymocyte number
|
J:84536
|
\Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal positive T cell selection
|
J:85777
|
| abnormal T cell differentiation
|
J:85777
|
| abnormal T cell subpopulation ratio
|
J:85777
|
| decreased CD8-positive, alpha-beta T cell number
|
J:85777
|
| decreased double-positive T cell number
|
J:85777
|
| increased CD4-positive, alpha-beta T cell number
|
J:85777
|
\Tg(TcrAND)53Hed/?
(involves: C57BL/6 * SJL)
|
increased CD4-positive, alpha-beta T cell number
|
J:124701
|
\Tg(TcrAND)53Hed/?
\Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151074
|
| decreased CD4-positive, alpha-beta T cell number
|
J:151074
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
\Tg(TcrAND)53Hed/?
\Themistm1Lov/\Themistm1Lov
(involves: 129 * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151075
|
| decreased single-positive T cell number
|
J:151075
|
| increased double-positive T cell number
|
J:151075
|
\Tg(TcrAND)53Hed/?
\Zbtb7btm1.1Rbo/\Zbtb7btm1.1Rbo
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:141145
|
\Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
abnormal lymphocyte cell number
|
J:36815
|
| abnormal T cell clonal deletion
|
J:36815
|
| decreased CD4-positive, alpha-beta T cell number
|
J:36815
|
| decreased CD8-positive, alpha-beta T cell number
|
J:36815
|
| increased B cell number
|
J:36815
|
\Tg(TcraTcrb)8Rest/?
(C57BL/6-Tg(TcraTcrb)8Rest)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:85058
|
\Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:125548
|
\Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:87876
|
| increased CD4-positive, alpha-beta T cell number
|
J:87876
|
\Tg(TcraTcrb)425Cbn/0
\Trip10tm1.1Geha/\Trip10tm1.1Geha
(B6.Cg-Trip10tm1.1Geha Tg(TcraTcrb)425Cbn)
|
abnormal effector T cell morphology
|
J:164363
|
| decreased CD4-positive, alpha-beta T cell number
|
J:164363
|
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:92867
|
| abnormal positive T cell selection
|
J:92867,
J:133645
|
| abnormal T cell clonal deletion
|
J:92867
|
| abnormal T cell subpopulation ratio
|
J:92867,
J:133645
|
| decreased CD4-positive, alpha-beta T cell number
|
J:133645
|
| increased CD8-positive, alpha-beta T cell number
|
J:92867,
J:133645
|
\Tg(TcraTcrb)1100Mjb/?
\Themistm1Gasc/\Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:151074
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
\Tg(Tcrb)93Vbo/0
(involves: C57BL/LiA * CBA/BrA)
|
abnormal T cell morphology
|
J:93247
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:93247
|
\Tg(Tcrb)93Vbo/0
(involves: C57BL/6 * C57BL/LiA * CBA/BrA)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:66565
|
| abnormal T cell clonal deletion
|
J:66565
|
\Tg(Tcrb-TCF3/PBX1)19Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased thymocyte number
|
J:95693
|
\Tg(Tcrb-TCF3/PBX1)23Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased thymocyte number
|
J:95693
|
\Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcrbAI4)1Dvs)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:93553
|
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:73608
|
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| abnormal double-positive T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
\Tg(TcrHEL3A9)1Mmd/0
\Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:78309
|
| decreased CD4-positive, alpha-beta T cell number
|
J:78309
|
| decreased double-positive T cell number
|
J:78309
|
\Tg(TcrLCMV)1Aox/?
(C57BL/6-Tg(TcrLCMV)1Aox)
|
decreased CD8-positive, alpha-beta T cell number
|
J:92228
|
| decreased double-positive T cell number
|
J:92228
|
| increased CD4-positive, alpha-beta T cell number
|
J:92228
|
| increased double-negative T cell number
|
J:92228
|
\Tg(TcrLCMV)2Aox/?
(C57BL/6-Tg(TcrLCMV)2Aox)
|
decreased CD8-positive, alpha-beta T cell number
|
J:92228
|
| decreased double-positive T cell number
|
J:92228
|
| increased CD4-positive, alpha-beta T cell number
|
J:92228
|
| increased double-negative T cell number
|
J:92228
|
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:77696
|
| decreased double-positive T cell number
|
J:77696
|
\Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
| decreased CD4-positive, alpha-beta T cell number
|
J:97610
|
\Tg(Tek-tTA)1Dmt/0
\Tg(tetO-Tek)1Dmt/0
(involves: CD-1)
|
increased T cell number
|
J:137745
|
\Tg(tetO-BCR/ABL1)2Dgt/0
\Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal lymphopoiesis
|
J:96511
|
X/\Tg(Tlr7)6Boll
(involves: C57BL/6)
|
abnormal B cell morphology
|
J:127600
|
| decreased marginal zone B cell number
|
J:127600
|
| increased mature B cell number
|
J:127600
|
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J)
|
abnormal B cell morphology
|
J:58798
|
| abnormal T cell number
|
J:58798
|
| abnormal T cell subpopulation ratio
|
J:58798
|
| increased B cell number
|
J:58798
|
| increased lymphocyte cell number
|
J:58798
|
| increased marginal zone B cell number
|
J:58798
|
| increased mature B cell number
|
J:58798
|
| increased plasma cell number
|
J:58798
|
| increased T cell number
|
J:58798
|
\Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
abnormal B cell differentiation
|
J:73711
|
| abnormal B-1 B cell morphology
|
J:114782
|
| increased B cell number
|
J:114782
|
| increased B-1a cell number
|
J:114782
|
| increased B-1b cell number
|
J:114782
|
| increased plasma cell number
|
J:114782
|
\Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell differentiation
|
J:115788
|
| abnormal B-1 B cell morphology
|
J:115788
|
\Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
increased B cell number
|
J:113556
|
| increased marginal zone B cell number
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
\Tg(Tnfsf13b)1Fma/?
\Tnfrsf13btm1Rjb/\Tnfrsf13btm1Rjb
(B6.Cg-Tnfrsf13btm1Rjb Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
\Tg(Tnfsf13b)1Fma/?
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(B6.Cg-Tnfrsf13ctm1Mass Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
\Tg(Tnfsf13b)1Fma/0
\Tnfsf14tm1Kpf/\Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
|
increased B cell number
|
J:114782
|
| increased plasma cell number
|
J:114782
|
\Tg(Tnfsf13b)1Fma/\Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2)
|
increased B cell number
|
J:178227
|
| increased marginal zone B cell number
|
J:178227
|
| increased transitional stage T2 B cell number
|
J:178227
|
\Tg(Tox)1Kay/?
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell number
|
J:131287
|
\Tg(UBC-scFv)2Nemz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:96759
|
| abnormal B cell morphology
|
J:96759
|
| abnormal B cell receptor editing
|
J:96759
|
| abnormal B-1 B cell morphology
|
J:96759
|
| abnormal mature B cell morphology
|
J:96759
|
| decreased mature B cell number
|
J:96759
|
\Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy)
|
decreased lymphocyte cell number
|
J:257690
|
\Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:189197
|
| decreased CD4-positive, alpha-beta T cell number
|
J:189197
|
| decreased CD8-positive, alpha-beta T cell number
|
J:189197
|
| decreased double-positive T cell number
|
J:189197
|
| decreased lymphocyte cell number
|
J:189197
|
| decreased thymocyte number
|
J:189197
|
| increased CD8-positive, alpha-beta T cell number
|
J:189197
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:189197
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:189197
|
\Tg(Vav1-NUP98/HOXD13)G2Apla/0
(C57BL/6-Tg(Vav1-NUP98/HOXD13)G2Apla)
|
decreased lymphocyte cell number
|
J:107446
|
\Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat)
|
abnormal effector T cell number
|
J:257519
|
| increased CD4-positive, alpha-beta T cell number
|
J:257519
|
| increased CD8-positive, alpha-beta T cell number
|
J:257519
|
\Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:88565
|
| abnormal lymphocyte cell number
|
J:88565
|
| abnormal somatic hypermutation frequency
|
J:88565
|
| increased B cell number
|
J:88565
|
| increased CD4-positive, alpha-beta T cell number
|
J:88565
|
| increased CD8-positive, alpha-beta T cell number
|
J:88565
|
| increased T cell number
|
J:88565
|
\Tg(Vil1-cre)997Gum/0
\Tnfrsf11atm1.1Irw/\Tnfrsf11atm1.1Irw
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * SJL)
|
decreased plasma cell number
|
J:226603
|
\Tg(VIM-Tag)3Pau/0
(involves: C57BL/6 * SJL/J)
|
increased double-negative T cell number
|
J:91542
|
\Tgm3Btlr/\Tgm3Btlr
(C57BL/6J-Tgm3Btlr)
|
decreased B cell number
|
J:265197
|
\Tgm4Btlr/\Tgm4Btlr
(C57BL/6J-Tgm4Btlr)
|
decreased B cell number
|
J:272522
|
| decreased B-2 B cell number
|
J:272522
|
| increased alpha-beta T cell number
|
J:272522
|
| increased B-1a cell number
|
J:272522
|
| increased CD4-positive, alpha-beta T cell number
|
J:272522
|
| increased CD8-positive, alpha-beta T cell number
|
J:272522
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272522
|
\TgM5Btlr/\TgM5Btlr
(C57BL/6J-TgM5Btlr)
|
increased central memory CD4-positive, alpha-beta T cell number
|
J:272523
|
\Tgm6Btlr/\Tgm6Btlr
(C57BL/6J-Tgm6Btlr)
|
increased alpha-beta T cell number
|
J:272525
|
\Tgfb1tm1(Tgfb3)Kul/\Tgfb1tm1(Tgfb3)Kul
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell morphology
|
J:204892
|
| increased regulatory T cell number
|
J:204892
|
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(C.129S2-Tgfb1tm1Doe)
|
decreased CD4-positive, alpha-beta T cell number
|
J:69346
|
| increased CD4-positive, alpha-beta T cell number
|
J:69346
|
| increased T-helper 1 cell number
|
J:69346
|
\Tgfb1tm3.1Flv/\Tgfb1tm3.1Flv
\Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD)
|
increased regulatory T cell number
|
J:196160
|
| increased T-helper 1 cell number
|
J:196160
|
\Tgfb1tm3.1Flv/\Tgfb1tm3.1Flv
\Tg(Cd4-cre)1Cwi/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
increased regulatory T cell number
|
J:196160
|
| increased T-helper 1 cell number
|
J:196160
|
\Tgfbitm1Zhao/\Tgfbitm1Zhao
(involves: 129 * C57BL/6J)
|
increased B cell number
|
J:143036
|
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Tg(Cd4-cre)1Cwi/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)
|
decreased regulatory T cell number
|
J:196160
|
| increased regulatory T cell number
|
J:196160
|
\Tgfbr2tm1.2Hlm/\Tgfbr2tm1.2Hlm
\Tg(Foxp3-EGFP/cre)1cJbs/0
\Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129S6/SvEvTac * C57BL/6 * NOD * SJL)
|
increased regulatory T cell number
|
J:196160
|
\TgTn(pb-CAG-Gm40600)#Rew/0
(C57BL/6-TgTn(pb-CAG-Gm40600)#Rew)
|
abnormal plasmablast number
|
J:311878
|
| decreased B cell number
|
J:311878
|
| decreased plasma cell number
|
J:311878
|
| increased B cell number
|
J:311878
|
| increased plasma cell number
|
J:311878
|
\Thbs1tm1Hyn/\Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
increased lymphocyte cell number
|
J:46182
|
\Thbs1tm1Hyn/\Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
decreased regulatory T cell number
|
J:153126
|
| increased CD4-positive, alpha-beta T cell number
|
J:153126
|
\Themis5AT161/\Themis5AT161
(involves: C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:151076
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151076
|
| decreased regulatory T cell number
|
J:151076
|
| decreased single-positive T cell number
|
J:151076
|
\Themism1Btlr/\Themism1Btlr
(C57BL/6J-Themism1Btlr)
|
abnormal lymphocyte morphology
|
J:211400
|
| decreased B-1a cell number
|
J:211400
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211400
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211400
|
\Themism2Btlr/\Themism2Btlr
(C57BL/6J-Themism2Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236691
|
| decreased T cell number
|
J:236691
|
| increased CD8-positive, alpha-beta T cell number
|
J:236691
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:236691
|
\Themism3Btlr/\Themism3Btlr
(C57BL/6J-Themism3Btlr)
|
abnormal CD8-positive, alpha-beta cytotoxic T cell morphology
|
J:254834
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254834
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:254834
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254834
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254834
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:254834
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254834
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254834
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254834
|
\ThemisM4Btlr/\ThemisM4Btlr
(C57BL/6J-ThemisM4Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:272849
|
\Themism5Btlr/\Themism5Btlr
(C57BL/6J-Themism5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274716
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274716
|
| abnormal T cell differentiation
|
J:274716
|
| decreased alpha-beta T cell number
|
J:274716
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274716
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274716
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274716
|
| increased CD8-positive, alpha-beta memory T cell number
|
J:274716
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:274716
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:274716
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274716
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274716
|
| increased NK T cell number
|
J:274716
|
\ThemisSpotr/\Themis+
(C57BL/6-ThemisSpotr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
\ThemisSpotr/\ThemisSpotr
(C57BL/6-ThemisSpotr)
|
abnormal T cell differentiation
|
J:152601
|
| decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
\Themistm1.1Hko/\Themis+
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
\Themistm1.1Hko/\Themistm1.1Hko
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:152601
|
| decreased CD8-positive, alpha-beta T cell number
|
J:152601
|
| decreased single-positive T cell number
|
J:152601
|
\Themistm1Gasc/\Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
abnormal memory T cell morphology
|
J:151074
|
| abnormal positive T cell selection
|
J:151074
|
| abnormal regulatory T cell morphology
|
J:151074
|
| decreased CD4-positive, alpha-beta T cell number
|
J:151074
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151074
|
| decreased thymocyte number
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
\Themistm1Hasu/\Themis+
(involves: C57BL/6 * CBA)
|
decreased CD4-positive, alpha-beta T cell number
|
J:153235
|
| decreased CD8-positive, alpha-beta T cell number
|
J:153235
|
\Themistm1Hasu/\Themistm1Hasu
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:153235
|
| decreased CD4-positive, alpha-beta T cell number
|
J:153235
|
| decreased CD8-positive, alpha-beta T cell number
|
J:153235
|
| decreased thymocyte number
|
J:153235
|
| increased memory T cell number
|
J:153235
|
\Themistm1Lov/\Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
| abnormal T cell differentiation
|
J:151075
|
| decreased CD4-positive, alpha-beta T cell number
|
J:151075
|
| decreased CD8-positive, alpha-beta T cell number
|
J:151075
|
| decreased regulatory T cell number
|
J:151075
|
| decreased single-positive T cell number
|
J:151075
|
| increased memory T cell number
|
J:151075
|
\Thop1Gt(CSG163)Byg/\Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
decreased lymphocyte cell number
|
J:290567
|
\Ticam1Lps2/\Ticam1Lps2
(C57BL/6J-Ticam1Lps2/J)
|
decreased CD8-positive, alpha-beta T cell number
|
J:288471
|
\Ticam1tm1Aki/\Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:130954
|
\Tifabtm1.1Dsta/\Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:229024
|
\Timd2tm1(GAL4)Pdre/\Timd2tm1(GAL4)Pdre
(C.129S4-Timd2tm1(GAL4)Pdre)
|
increased lymphocyte cell number
|
J:125054
|
\Timd4tm1Wouy/\Timd4tm1Wouy
(involves: 129)
|
increased lymphocyte cell number
|
J:160304
|
\Timd6tm1b(KOMP)Wtsi/\Timd6+
(C57BL/6N-Timd6tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Timmdc1Gt(OST407011)Lex/\Timmdc1+
(B6;129S5-Timmdc1Gt(OST407011)Lex/Mmucd)
|
increased CD4-positive, alpha-beta T cell number
|
J:171883
|
\Timp2em1(IMPC)Hmgu/\Timp2em1(IMPC)Hmgu
(C57BL/6N-Timp2em1(IMPC)Hmgu/Ieg)
|
increased follicular B cell number
|
J:211773
|
\Tle4tm1.2Dasw/\Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
abnormal lymphopoiesis
|
J:219243
|
| decreased B cell number
|
J:219243
|
| decreased DN2 thymocyte number
|
J:219243
|
| decreased double-positive T cell number
|
J:219243
|
| decreased follicular B cell number
|
J:219243
|
| decreased lymphocyte cell number
|
J:219243
|
| decreased pre-pro B cell number
|
J:219243
|
| increased NK T cell number
|
J:219243
|
\Tlf2NOD/Smrf/?
(involves: NOD/Smrf * NON/Lt)
|
increased CD8-positive, alpha-beta T cell number
|
J:49676
|
\TlfNOD/Smrf/?
(involves: NOD/Smrf * NON/Lt)
|
increased CD4-positive, alpha-beta T cell number
|
J:49676
|
\Tlr2tm1Aki/\Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
increased T cell number
|
J:118954
|
\Tlr4lps-5Btlr/\Tlr4lps-5Btlr
(C57BL/6J-Tlr4lps-5Btlr)
|
decreased B cell number
|
J:224666
|
| decreased memory B cell number
|
J:224666
|
\Tlr4Lps-d/\Tlr4Lps-d
\Tg(IghelMD4)4Ccg/0
\Tg(KLK4mHEL)6Ccg/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6)
|
decreased B cell number
|
J:115059
|
| increased B-1 B cell number
|
J:115059
|
\Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
\Tlr7em2Anu/\Tlr7+
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal mature B cell morphology
|
J:324448
|
| decreased marginal zone B cell number
|
J:324448
|
| increased B cell number
|
J:324448
|
| increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased germinal center B cell number
|
J:324448
|
| increased plasma cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
\Tlr7em2Anu/\Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal mature B cell morphology
|
J:324448
|
| decreased marginal zone B cell number
|
J:324448
|
| increased B cell number
|
J:324448
|
| increased CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:324448
|
| increased germinal center B cell number
|
J:324448
|
| increased plasma cell number
|
J:324448
|
| increased T follicular helper cell number
|
J:324448
|
\Tlr7tm1Flv/Y
(B6.129S1-Tlr7tm1Flv)
|
increased marginal zone B cell number
|
J:127600
|
\Tlr8/Tlr7tm1Vlcg/\Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg)
|
decreased follicular B cell number
|
J:165267
|
| increased marginal zone B cell number
|
J:165267
|
\Tlr8/Tlr7tm1Vlcg/\Tlr7+
\Tlr8/Tlr7tm1Vlcg/\Tlr8tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg)
|
decreased marginal zone B cell number
|
J:165267
|
| increased marginal zone B cell number
|
J:165267
|
\Tlr8/Tlr7tm1Vlcg/\Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg)
|
decreased follicular B cell number
|
J:165267
|
| increased marginal zone B cell number
|
J:165267
|
\Tlr8tm1Vlcg/\Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg)
|
decreased B-1a cell number
|
J:165267
|
| decreased B-1b cell number
|
J:165267
|
| decreased marginal zone B cell number
|
J:165267
|
| increased B-2 B cell number
|
J:165267
|
\Tlr9tm1Aki/\Tlr9tm1Aki
\Tg(IghelMD4)4Ccg/0
\Tg(KLK4mHEL)6Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:115059
|
| increased B-1 B cell number
|
J:115059
|
\Tlx1tm1Sjk/\Tlx1tm1Sjk
(involves: 129S2/SvPas)
|
increased lymphocyte cell number
|
J:17695
|
\Tm7sf2tm1b(KOMP)Wtsi/\Tm7sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm7sf2tm1b(KOMP)Wtsi/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
\Tmc6tm1.1Les/\Tmc6tm1.1Les
(B6.129S6(Cg)-Tmc6tm1.1Les)
|
decreased CD4-positive, alpha-beta T cell number
|
J:300461
|
| decreased CD8-positive, alpha-beta T cell number
|
J:300461
|
\Tmc8tm1.1Les/\Tmc8tm1.1Les
(B6.129S6(Cg)-Tmc8tm1.1Les)
|
decreased CD4-positive, alpha-beta T cell number
|
J:300461
|
| decreased CD8-positive, alpha-beta T cell number
|
J:300461
|
\Tmem60em1(IMPC)Ccpcz/\Tmem60em1(IMPC)Ccpcz
(C57BL/6N-Tmem60em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
\Tmem100tm1e.1(KOMP)Wtsi/\Tmem100+
(C57BL/6N-Tmem100tm1e.1(KOMP)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Tmem121bem1(IMPC)Tcp/\Tmem121bem1(IMPC)Tcp
(C57BL/6NCrl-Tmem121bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Tmem126atm1a(EUCOMM)Wtsi/\Tmem126atm1a(EUCOMM)Wtsi
(C57BL/6N-Tmem126atm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
\Tmem127tm1(KOMP)Wtsi/\Tmem127tm1(KOMP)Wtsi
(C57BL/6N-Tmem127tm1(KOMP)Wtsi/Wtsi)
|
decreased B cell number
|
J:211773
|
| decreased B-2 B cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
| decreased KLRG1-positive T-helper cell number
|
J:211773
|
| decreased memory-marker NK cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased alpha-beta T cell number
|
J:211773
|
| increased CD4-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| increased KLRG1-positive NK cell number
|
J:211773
|
| increased memory-marker NK cell number
|
J:211773
|
| increased T cell number
|
J:211773
|
\Tmem150bem1(IMPC)Ccpcz/\Tmem150bem1(IMPC)Ccpcz
(C57BL/6N-Tmem150bem1(IMPC)Ccpcz/Ccpcz)
|
decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
\Tmprss6tm1b(EUCOMM)Wtsi/\Tmprss6tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics)
|
decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased Ly6C-positive mature NK cell number
|
J:211773
|
\Tmub2tm1b(KOMP)Wtsi/\Tmub2tm1b(KOMP)Wtsi
(C57BL/6N-Tmub2tm1b(KOMP)Wtsi/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Tnftm1Gkl/\Tnftm1Gkl
(either: B6.129-Tnftm1Gkl or (involves: 129 * C57BL/6))
|
increased lymphocyte cell number
|
J:97783
|
\Tnftm1Ljo/\Tnftm1Ljo
(either: B6.129-Tnftm1Ljo or (involves: 129 * C57BL/6))
|
increased lymphocyte cell number
|
J:97783
|
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * C57BL/6)
|
abnormal alpha-beta intraepithelial T cell morphology
|
J:136667
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:136667
|
| abnormal T cell subpopulation ratio
|
J:136667
|
\Tnftm2Gkl/\Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
increased CD8-positive, alpha-beta T cell number
|
J:108572
|
\Tnftm2Gkl/\Tnf+
(B6.129S-Tnftm2Gkl/Jarn)
|
abnormal CD8-positive, alpha beta T cell morphology
|
J:131978
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:145626
|
| increased CD4-positive, alpha-beta T cell number
|
J:145626
|
\Tnfaip3m1Apb/\Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb)
|
increased effector memory T-helper cell number
|
J:324062
|
\Tnfaip3tm1Ama/\Tnfaip3tm1Ama
(Not Specified)
|
increased lymphocyte cell number
|
J:92931
|
\Tnfaip3tm1Homy/\Tnfaip3tm1Homy
\Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal B cell number
|
J:212681
|
\Tnfaip3tm2Ama/\Tnfaip3tm2Ama
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell morphology
|
J:163917
|
| abnormal B-1a B cell morphology
|
J:163917
|
| decreased B cell number
|
J:163917
|
| increased B cell number
|
J:163917
|
| increased germinal center B cell number
|
J:163917
|
| increased immature B cell number
|
J:163917
|
| increased plasma cell number
|
J:163917
|
| increased T cell number
|
J:163917
|
\Tnfaip3tm3.1Ama/\Tnfaip3tm3.1Ama
(C57BL/6J-Tnfaip3tm3.1Ama)
|
increased B cell number
|
J:203160
|
| increased CD4-positive, alpha-beta T cell number
|
J:203160
|
| increased CD8-positive, alpha-beta T cell number
|
J:203160
|
\Tnfaip3tm4.1Ama/\Tnfaip3tm4.1Ama
(C57BL/6J-Tnfaip3tm4.1Ama)
|
increased B cell number
|
J:203160
|
| increased CD4-positive, alpha-beta T cell number
|
J:203160
|
| increased CD8-positive, alpha-beta T cell number
|
J:203160
|
\Tnfaip8Gt(IST13629C1)Tigm/\Tnfaip8Gt(IST13629C1)Tigm
\Tnfaip8l1em1Huwa/\Tnfaip8l1em1Huwa
(involves: C57BL/6 * C57BL/6N)
|
increased T-helper 17 cell number
|
J:342074
|
\Tnfaip8l2tm1Yhcn/\Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn)
|
increased B cell number
|
J:139785
|
| increased T cell number
|
J:139785
|
\Tnfrsf1aem1(IMPC)Ccpcz/\Tnfrsf1aem1(IMPC)Ccpcz
(C57BL/6NCrl-Tnfrsf1aem1(IMPC)Ccpcz/Ccpcz)
|
increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Tnfrsf1atm2b(EUCOMM)Wtsi/\Tnfrsf1atm2b(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1atm2b(EUCOMM)Wtsi/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Tnfrsf1btm1a(EUCOMM)Wtsi/\Tnfrsf1btm1a(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1btm1a(EUCOMM)Wtsi/Ics)
|
decreased T cell number
|
J:165965
|
\Tnfrsf8tm1Mak/\Tnfrsf8tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte number
|
J:62854
|
\Tnfrsf9m1Btlr/\Tnfrsf9m1Btlr
(C57BL/6J-Tnfrsf9m1Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:265260
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265260
|
| decreased single-positive T cell number
|
J:265260
|
| increased B cell number
|
J:265260
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265260
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:265260
|
\Tnfrsf10btm1Wnt/\Tnfrsf10btm1Wnt
(involves: 129S6/SvEvTac * C57BL/6)
|
increased NK cell number
|
J:94681
|
\Tnfrsf11atm1Imx/\Tnfrsf11atm1Imx
(involves: 129 * C57BL/6)
|
decreased B cell number
|
J:57899
|
| decreased mature B cell number
|
J:57899
|
\Tnfrsf11atm1Imx/\Tnfrsf11atm1Imx
(involves: 129)
|
abnormal negative T cell selection
|
J:125864
|
\Tnfrsf11btm1Eac/\Tnfrsf11btm1Eac
(involves: 129S4/SvJaeSor)
|
abnormal pro-B cell differentiation
|
J:67105
|
| increased B cell number
|
J:67105
|
| increased immature B cell number
|
J:67105
|
| increased pro-B cell number
|
J:67105
|
\Tnfrsf13btm1Cmac/\Tnfrsf13btm1Cmac
(Not Specified)
|
increased B cell number
|
J:91914
|
\Tnfrsf13btm1Rjb/\Tnfrsf13btm1Rjb
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell number
|
J:69474
|
\Tnfrsf13btm1Rjb/\Tnfrsf13btm1Rjb
(involves: 129X1/SvJ)
|
abnormal class switch recombination
|
J:95288
|
\Tnfrsf13btm1Vmd/\Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
increased B cell number
|
J:70172,
J:82331
|
| increased follicular B cell number
|
J:70172
|
| increased marginal zone B cell number
|
J:70172
|
| increased mature B cell number
|
J:70172
|
| increased transitional stage B cell number
|
J:70172
|
\Tnfrsf13cm1Btlr/\Tnfrsf13cm1Btlr
(C57BL/6J-Tnfrsf13cm1Btlr)
|
decreased B cell number
|
J:265247
|
\Tnfrsf13cM2Btlr/\Tnfrsf13cM2Btlr
(C57BL/6J-Tnfrsf13cM2Btlr)
|
decreased B cell number
|
J:265247
|
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(C57BL/6-Tnfrsf13ctm1Mass)
|
absent marginal zone B cells
|
J:92732
|
| arrested B cell differentiation
|
J:92732
|
| decreased B-2 B cell number
|
J:92732
|
| decreased mature B cell number
|
J:92732
|
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
(involves: C57BL/6)
|
decreased lymphocyte cell number
|
J:139293
|
| decreased mature B cell number
|
J:139293
|
\Tnfrsf13ctm1Mass/\Tnfrsf13ctm1Mass
\Traf2tm1Rbr/\Traf2tm1Rbr
(involves: C57BL/6)
|
decreased germinal center B cell number
|
J:172843
|
\Tnfrsf13ctm1Msc/\Tnfrsf13ctm1Msc
(involves: 129P2/OlaHsd * C57BL/6)
|
absent marginal zone B cells
|
J:92676
|
| absent transitional stage B cells
|
J:92676
|
| decreased B cell number
|
J:92676
|
| decreased B-2 B cell number
|
J:92676
|
\Tnfrsf17tm1Kplm/\Tnfrsf17tm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased plasma cell number
|
J:124543
|
\Tnfrsf21tm1Vmd/\Tnfrsf21tm1Vmd
(involves: C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:72761
|
| increased CD8-positive, alpha-beta T cell number
|
J:72761
|
| increased T cell number
|
J:72761
|
\Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd)
|
abnormal negative T cell selection
|
J:84536
|
| increased thymocyte number
|
J:84536
|
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
\Tnfsf11tm1Pngr/\Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:52369
|
| arrested T cell differentiation
|
J:52369
|
| decreased immature B cell number
|
J:52369
|
| decreased mature B cell number
|
J:52369
|
\Tnfsf12tm1Ash/\Tnfsf12tm1Ash
(B6.129-Tnfsf12tm1Ash)
|
increased double-positive T cell number
|
J:104801
|
| increased memory T cell number
|
J:104801
|
| increased NK cell number
|
J:104801
|
| increased T-helper 1 cell number
|
J:104801
|
\Tnfsf13tm1Geha/\Tnfsf13tm1Geha
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:88910
|
| increased memory T cell number
|
J:88910
|
\Tnfsf13bm1Anu/\Tnfsf13bm1Anu
(C57BL/6JAnu-Tnfsf13bm1Anu/AnuApb)
|
abnormal B cell differentiation
|
J:104190
|
| decreased mature B cell number
|
J:104190
|
| increased immature B cell number
|
J:104190
|
\Tnfsf13bM1Btlr/\Tnfsf13b+
(C57BL/6J-Tnfsf13bM1Btlr)
|
decreased B cell number
|
J:220069
|
| increased single-positive T cell number
|
J:220069
|
| increased T cell number
|
J:220069
|
\Tnfsf13bM1Btlr/\Tnfsf13bM1Btlr
(C57BL/6J-Tnfsf13bM1Btlr)
|
decreased B cell number
|
J:220069
|
| increased single-positive T cell number
|
J:220069
|
| increased T cell number
|
J:220069
|
\Tnfsf13bm2Btlr/\Tnfsf13bm2Btlr
(C57BL/6J-Tnfsf13bm2Btlr)
|
decreased B cell number
|
J:220070
|
\Tnfsf13bm3Btlr/\Tnfsf13bm3Btlr
(C57BL/6J-Tnfsf13bm3Btlr)
|
abnormal lymphocyte morphology
|
J:272850
|
| decreased B cell number
|
J:272850
|
\Tnfsf13btm1Cleg/\Tnfsf13btm1Cleg
(involves: 129S5/SvEvBrd)
|
abnormal B cell differentiation
|
J:71301
|
| decreased follicular B cell number
|
J:71301
|
| decreased mature B cell number
|
J:71301
|
| decreased memory T cell number
|
J:71301
|
| increased T cell number
|
J:71301
|
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:71681
|
| arrested B cell differentiation
|
J:71681
|
| decreased B cell number
|
J:71681
|
| decreased follicular B cell number
|
J:71681
|
| decreased marginal zone B cell number
|
J:71681
|
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129S2/SvPas)
|
decreased B cell number
|
J:138560
|
| decreased follicular B cell number
|
J:138560
|
| decreased transitional stage B cell number
|
J:138560
|
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
\Traf2tm1Rbr/\Traf2tm1Rbr
(involves: 129S2/SvPas * C57BL/6)
|
absent follicular B cells
|
J:132877
|
| absent marginal zone B cells
|
J:132877
|
| decreased mature B cell number
|
J:132877
|
\Tnfsf14tm1Kpf/\Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell subpopulation ratio
|
J:77250
|
\Tnfsf14tm1Kpf/\Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell morphology
|
J:169863
|
\Tnfsf15tm1Hluo/\Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo)
|
decreased B cell number
|
J:207029
|
| decreased germinal center B cell number
|
J:207029
|
| decreased plasma cell number
|
J:207029
|
| decreased T cell number
|
J:207029
|
| decreased T follicular helper cell number
|
J:207029
|
\Tnfsf15tm1Lex/\Tnfsf15tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased NK cell number
|
J:82809
|
\Tnip1m1Btlr/\Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr)
|
decreased B cell number
|
J:265175
|
| decreased B-2 B cell number
|
J:265175
|
| increased B-1a cell number
|
J:265175
|
| increased B-1b cell number
|
J:265175
|
\Tnip1tm1.1Pcoh/\Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal effector T cell morphology
|
J:176826
|
| abnormal plasma cell morphology
|
J:176826
|
| increased B cell number
|
J:176826
|
| increased germinal center B cell number
|
J:176826
|
| increased plasma cell number
|
J:176826
|
| increased T follicular helper cell number
|
J:176826
|
\Tnip1tm1.2Ama/\Tnip1tm1.2Ama
\Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
increased memory T cell number
|
J:205446
|
\Tnip1tm1b(EUCOMM)Hmgu/\Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
| increased large unstained cell number
|
J:211773
|
\Tnk2tm1.2Npma/\Tnk2tm1.2Npma
(B6(Cg)-Tnk2tm1.2Npma)
|
abnormal regulatory T cell number
|
J:341740
|
| increased activated T cell number
|
J:341740
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:341740
|
\Tom1l2Gt(XG909)Byg/\Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased B cell number
|
J:133892
|
| increased CD4-positive, alpha-beta T cell number
|
J:133892
|
| increased CD8-positive, alpha-beta T cell number
|
J:133892
|
| increased T cell number
|
J:133892
|
\Tox2em1Cdon/\Tox2em1Cdon
(C57BL/6J-Tox2em1Cdon)
|
abnormal T follicular helper cell differentiation
|
J:290926
|
| decreased germinal center B cell number
|
J:290926
|
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:131287
|
| abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
|
J:131287
|
| abnormal CD8-positive, alpha beta T cell morphology
|
J:131287
|
| decreased CD4-positive, alpha-beta T cell number
|
J:131287
|
| decreased NK T cell number
|
J:131287
|
\Toxtm1.1Kay/\Toxtm1.1Kay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:164687
|
| decreased NK cell number
|
J:164687
|
\Toxtm1Kay/\Toxtm1Kay
\Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:164687
|
\Tpm4Plt53/\Tpm4Plt53
(BALB/c-Tpm4Plt53)
|
increased lymphocyte cell number
|
J:242938
|
\Tpp2tm1.1Gnie/\Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased CD8-positive, alpha-beta T cell number
|
J:133572
|
| decreased double-positive T cell number
|
J:133572
|
| decreased T cell number
|
J:133572
|
| increased double-negative T cell number
|
J:133572
|
| increased single-positive T cell number
|
J:133572
|
| increased T cell number
|
J:133572
|
\Tpp2tm1.1Gnie/\Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:221205
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221205
|
| increased B cell number
|
J:221205
|
| increased memory T cell number
|
J:221205
|
\Tppp3em1(IMPC)Ccpcz/\Tppp3+
(C57BL/6NCrl-Tppp3em1(IMPC)Ccpcz/Ccpcz)
|
increased CD4-positive NK T cell number
|
J:211773
|
| increased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased NK T cell number
|
J:211773
|
\Traf1tm1Tsi/\Traf1tm1Tsi
(involves: 129S4/SvJae * C57BL/6)
|
increased lymphocyte cell number
|
J:72327
|
\Traf2tm1a(EUCOMM)Wtsi/\Traf2+
(C57BL/6N-Traf2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
\Traf2tm1Mak/\Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased double-positive T cell number
|
J:44360
|
| decreased immature B cell number
|
J:44360
|
| decreased lymphocyte cell number
|
J:44360
|
| decreased thymocyte number
|
J:44360
|
\Traf3m1Btlr/\Traf3m1Btlr
(C57BL/6J-Traf3m1Btlr)
|
decreased mature B cell number
|
J:212064
|
\Traf3tm1Bal/\Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell differentiation
|
J:37065
|
| decreased double-positive T cell number
|
J:37065
|
| decreased thymocyte number
|
J:37065
|
\Traf3tm1Bshp/\Traf3tm1Bshp
\Cd19tm1(cre)Cgn/\Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased T cell number
|
J:124329
|
| increased B cell number
|
J:124329
|
| increased follicular B cell number
|
J:124329
|
| increased marginal zone B cell number
|
J:124329
|
| increased transitional stage B cell number
|
J:124329
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c)
|
increased B cell number
|
J:93923
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix)
|
increased follicular B cell number
|
J:138560
|
| increased marginal zone B cell number
|
J:138560
|
| increased transitional stage B cell number
|
J:138560
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| increased B cell number
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased marginal zone B cell number
|
J:187766
|
\Traf3ip2tm1.1Lix/\Traf3ip2tm1.1Lix
\Tnfsf13btm1Msc/\Tnfsf13btm1Msc
(involves: 129 * 129S2/SvPas * BALB/c)
|
decreased B cell number
|
J:138560
|
| decreased follicular B cell number
|
J:138560
|
| decreased mature B cell number
|
J:138560
|
| decreased transitional stage B cell number
|
J:138560
|
\Traf3ip2tm1Lix/\Traf3ip2tm1.1Lix
\Tg(CD19-cre/ERT2)1Cgn/0
(involves: 129/Sv * BALB/c)
|
increased B cell number
|
J:93923
|
\Traf3ip3tm1b(KOMP)Wtsi/\Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
abnormal T cell differentiation
|
J:226431
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:226431
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:226431
|
| decreased regulatory T cell number
|
J:226431
|
| decreased T cell number
|
J:226431
|
| decreased thymocyte number
|
J:226431
|
| increased double-positive T cell number
|
J:226431
|
| increased gamma-delta T cell number
|
J:226431
|
\Traf6tm1Jino/\Traf6tm1Jino
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:77453
|
\Traf6tm2Ywc/\Traf6tm2Ywc
\Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
increased activated T cell number
|
J:130882
|
| increased memory T cell number
|
J:130882
|
\Traj18em1Hwata/\Traj18em1Hwata
(C57BL/6-Traj18em1Hwata)
|
absent NK T cells
|
J:256533
|
\Traj18em1Hwata/\Traj18em1Hwata
(C.B6-Traj18em1Hwata)
|
absent NK T cells
|
J:256533
|
\Traj18tm1.1Kro/\Traj18tm1.1Kro
(involves: C57BL/6NTac)
|
absent NK T cells
|
J:232957
|
\Traj33em#Dig/\Traj33em#Dig
(involves: C57BL/6)
|
decreased T cell number
|
J:276912
|
\Trappc9tm1a(EUCOMM)Wtsi/\Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased gamma-delta T cell number
|
J:211773
|
| decreased KLRG1-positive NK cell number
|
J:211773
|
\Trbv13-2tm1(CD2)Zhu/\Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
\Trbv13-2tm1(CD2)Zhu/\Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:121608
|
\Trbv14tm1Che/\Trbv14tm1Che
(involves: 129S4/SvJae)
|
decreased T cell number
|
J:92288
|
\Trbv14tm2Che/\Trbv14tm2Che
(involves: 129S4/SvJae)
|
decreased T cell number
|
J:92288
|
\Trdmt1Gt(OST19279)Lex/\Trdmt1Gt(OST19279)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased NK cell number
|
J:103485
|
\Trex1em1(IMPC)Ccpcz/\Trex1em1(IMPC)Ccpcz
(C57BL/6NCrl-Trex1em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
| decreased NK cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Trex1tm1.1Fwpe/\Trex1+
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
increased CD4-positive, alpha-beta T cell number
|
J:220965
|
\Trex1tm1.1Fwpe/\Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
increased B cell number
|
J:220965
|
| increased CD4-positive, alpha-beta T cell number
|
J:220965
|
| increased plasma cell number
|
J:220965
|
| increased regulatory T cell number
|
J:220965
|
\Trfem1(IMPC)Rbrc/\Trf+
(C57BL/6NJcl-Trfem1(IMPC)Rbrc/Rbrc)
|
increased large unstained cell number
|
J:211773
|
\Trgc1tm1.2Dhr/\Trgc1tm1.2Dhr
(either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))
|
decreased gamma-delta T cell number
|
J:91304
|
\Trib2tm1Lex/\Trib2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased B cell number
|
J:82809
|
| increased CD8-positive, alpha-beta T cell number
|
J:82809
|
\Trim9em1(IMPC)Ccpcz/\Trim9em1(IMPC)Ccpcz
(C57BL/6N-Trim9em1(IMPC)Ccpcz/Ccpcz)
|
decreased effector memory T-helper cell number
|
J:211773
|
\Trim30atm1Yjk/\Trim30atm1Yjk
(B6.129P2-Trim30atm1Yjk)
|
abnormal T cell subpopulation ratio
|
J:215171
|
| increased CD4-positive, alpha-beta T cell number
|
J:215171
|
\Trim39tm1b(EUCOMM)Hmgu/\Trim39tm1b(EUCOMM)Hmgu
(C57BL/6N-Trim39tm1b(EUCOMM)Hmgu/H)
|
increased lymphocyte cell number
|
J:211773
|
\Trim56tm1a(EUCOMM)Wtsi/\Trim56tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim56tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased regulatory T cell number
|
J:211773
|
\Trmq1C57BL/6J/\Trmq1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
\Trmq1DBA/2J/\Trmq1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
\Trmq2C57BL/6J/\Trmq2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
\Trmq2C57BL/6J/\Trmq2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:77603
|
\Trmq3DBA/1J/\Trmq3FVB/N
(involves: DBA/1J * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116665
|
\Trmq3FVB/N/?
(involves: DBA/1J * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:94347
|
\Trmq3FVB/N/\Trmq3FVB/N
(involves: DBA/1J * FVB/N)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:116665
|
\Trmq4RIIIS/J/\Trmq4RIIIS/J
\Trmq5RIIIS/J/\Trmq5RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:95848
|
\Trp53tm1.1Awbr/\Trp53tm1.1Awbr
(involves: C57BL/6)
|
increased pro-B cell number
|
J:169434
|
\Trp53tm1.2Awbr/\Trp53+
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:173271
|
\Trp53tm1.2Awbr/\Trp53tm1.2Awbr
(involves: C57BL/6)
|
abnormal lymphocyte morphology
|
J:173271
|
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc4tm1Fwa/\Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:61973
|
\Trp53bp1Gt(OST94324)Lex/\Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:83164
|
| decreased mature B cell number
|
J:83164
|
| decreased T cell number
|
J:83164
|
\Trp53bp1m2Btlr/\Trp53bp1m2Btlr
(C57BL/6J-Trp53bp1m2Btlr)
|
decreased B cell number
|
J:254841
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254841
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254841
|
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:82512
|
| increased double-negative T cell number
|
J:82512
|
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129)
|
abnormal class switch recombination
|
J:194603,
J:231089,
J:307190
|
\Trpm7tm1Clph/\Trpm7tm1.1Clph
\Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:140630
|
| decreased T cell number
|
J:140630
|
| decreased thymocyte number
|
J:140630
|
\Tsc22d3tm1.2Efmd/Y
(Not Specified)
|
abnormal T cell subpopulation ratio
|
J:201728
|
\Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
decreased DN3 thymocyte number
|
J:223992
|
| increased DN4 thymocyte number
|
J:223992
|
\Tshrhyt/\Tshrhyt
(CBy.RF-Tshrhyt/J)
|
decreased B cell number
|
J:111014
|
| increased pro-B cell number
|
J:111014
|
\TsilTg(Myc)12ALvn/\TsilTg(Myc)12ALvn
(involves: C57BL/6 * SJL/J)
|
increased double-positive T cell number
|
J:33857
|
\Tslptm1(KOMP)Vlcg/\Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T-helper 2 cell differentiation
|
J:187770
|
\Tslptm1.1Pcn/\Tslptm1.1Pcn
\Tg(KRT14-cre)1Ipc/0
(involves: 129 * C57BL/6 * SJL)
|
decreased lymphocyte cell number
|
J:146511
|
\Tspotm1.1Guwu/\Tspotm1.1Guwu
(involves: C57BL/6)
|
increased NK cell number
|
J:219189
|
\Tsttm1(KOMP)Vlcg/\Tsttm1(KOMP)Vlcg
(C57BL/6N-Tsttm1(KOMP)Vlcg/Ucd)
|
increased lymphocyte cell number
|
J:211773
|
\Ttc7fsn/\Ttc7fsn
(involves: A/J * BALB/cByJ)
|
increased dendritic epidermal T cell number
|
J:14506
|
\Ttc28tm1b(EUCOMM)Hmgu/\Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Tti2tm1b(KOMP)Wtsi/\Tti2+
(C57BL/6N-Tti2tm1b(KOMP)Wtsi/Ics)
|
decreased lymphocyte cell number
|
J:211773
|
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
abnormal NK cell differentiation
|
J:119985
|
| decreased NK cell number
|
J:119985
|
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv)
|
decreased thymocyte number
|
J:309768
|
\Twsg1tm1Nosa/\Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:82738
|
| decreased double-positive T cell number
|
J:82738
|
| decreased immature B cell number
|
J:82738
|
| decreased lymphocyte cell number
|
J:82738
|
| decreased pre-B cell number
|
J:82738
|
| decreased pro-B cell number
|
J:82738
|
| decreased thymocyte number
|
J:82738
|
| increased single-positive T cell number
|
J:82738
|
\Txlnatm1b(EUCOMM)Hmgu/\Txlna+
(C57BL/6N-Txlnatm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
\Txlnatm1b(EUCOMM)Hmgu/\Txlnatm1b(EUCOMM)Hmgu
(C57BL/6N-Txlnatm1b(EUCOMM)Hmgu/H)
|
increased large unstained cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
\Txniptm1Yu/\Txniptm1Yu
(involves: 129)
|
abnormal NK cell morphology
|
J:96677
|
| decreased CD8-positive, alpha-beta T cell number
|
J:96677
|
| decreased NK cell number
|
J:96677
|
| decreased NK T cell number
|
J:96677
|
| increased lymphocyte cell number
|
J:96677
|
| increased regulatory T cell number
|
J:96677
|
\Tyk2tm1Shmd/\Tyk2tm1Shmd
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:65409
|
\Tyrobptm1.1Viv/\Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased uterine NK cell number
|
J:100668
|
\Tyrobptm1Ttk/\Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk)
|
increased germinal center B cell number
|
J:177613
|
\Ubash3btm1Jni/\Ubash3btm1Jni
\Ubash3atm1Jni/\Ubash3atm1Jni
(Not Specified)
|
increased mature B cell number
|
J:89761
|
\Ubdtm1b(EUCOMM)Wtsi/\Ubdtm1b(EUCOMM)Wtsi
(C57BL/6N-Ubdtm1b(EUCOMM)Wtsi/Ccpcz)
|
decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| increased CD4-positive, CD25-positive NK T cell number
|
J:211773
|
\Ube2btm1b(EUCOMM)Wtsi/\Ube2b+
(C57BL/6N-Ube2btm1b(EUCOMM)Wtsi/Ics)
|
increased lymphocyte cell number
|
J:211773
|
\Ube2j2em1(IMPC)Rbrc/\Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc)
|
decreased lymphocyte cell number
|
J:211773
|
\Ube3ctm1b(EUCOMM)Hmgu/\Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6N-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
increased lymphocyte cell number
|
J:211773
|
\Ube3ctm1b(EUCOMM)Hmgu/\Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
decreased CD4-negative NK T cell number
|
J:211773
|
| decreased CD5-positive Ly6C-positive T cell number
|
J:211773
|
| decreased Ly6C-positive immature NK cell number
|
J:211773
|
| decreased Ly6C-positive NK T cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
\Ufl1tm1c(EUCOMM)Wtsi/\Ufl1tm1c(EUCOMM)Wtsi
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)
|
decreased lymphocyte cell number
|
J:238253
|
\Ugcgem1(IMPC)H/\Ugcg+
(C57BL/6NTac-Ugcgem1(IMPC)H/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Uhrf1tm1a(EUCOMM)Wtsi/\Uhrf1+
(Not Specified)
|
increased NK cell number
|
J:165965
|
\Uhrf2tm1b(EUCOMM)Wtsi/\Uhrf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Uhrf2tm1b(EUCOMM)Wtsi/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Unc13dJinx/\Unc13dJinx
(C57BL/6J-Unc13dJinx/Mmucd)
|
increased CD8-positive, alpha-beta T cell number
|
J:119974
|
\Unc93b1tm1.1Kmiy/\Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:174308
|
| abnormal T-helper 17 cell differentiation
|
J:174308
|
| decreased marginal zone B cell number
|
J:174308
|
| increased B cell number
|
J:174308
|
| increased CD4-positive, alpha-beta memory T cell number
|
J:174308
|
| increased memory T cell number
|
J:174308
|
| increased T-helper 1 cell number
|
J:174308
|
| increased T-helper 17 cell number
|
J:174308
|
\Ungtm1Tld/\Ungtm1Tld
(Not Specified)
|
abnormal class switch recombination
|
J:79590
|
\Ungtm1Tld/\Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:306598
|
| abnormal somatic hypermutation frequency
|
J:155454
|
\Upf2tm1Btp/\Upf2tm1Btp
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell number
|
J:134765
|
\Upf3bem1(IMPC)Tcp/Y
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Upf3bem1(IMPC)Tcp/\Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Urahplt2/\Urahplt2
(C57BL/6-Urahplt2)
|
abnormal NK cell morphology
|
J:267227
|
| decreased CD8-positive, alpha-beta T cell number
|
J:267227
|
\Usp12tm1a(EUCOMM)Hmgu/\Usp12tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased CD8-positive, alpha-beta T cell number
|
J:165965
|
\Usp17lctm1Khb/\Usp17lc+
(either: 129-Usp17lctm1Khb or (involves: 129S/SvEv * C57BL/6J))
|
decreased regulatory T cell number
|
J:191761
|
| increased B cell number
|
J:191761
|
| increased CD4-positive, alpha-beta T cell number
|
J:191761
|
| increased CD8-positive, alpha-beta T cell number
|
J:191761
|
\Usp18ity9/\Usp18ity9
(involves: 129S1/SvImJ * C57BL/6)
|
abnormal lymphocyte morphology
|
J:163843
|
\Usp32em1(IMPC)Mhzh/\Usp32+
(C57BL/6N-Usp32em1(IMPC)Mhzh/Mhzh)
|
increased lymphocyte cell number
|
J:211773
|
\Usp42tm2a(EUCOMM)Wtsi/\Usp42tm2a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased CD4-positive, alpha-beta T cell number
|
J:213427
|
| increased T cell number
|
J:213427
|
\Usp54tm1b(KOMP)Wtsi/\Usp54tm1b(KOMP)Wtsi
(C57BL/6N-Usp54tm1b(KOMP)Wtsi/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Vav1m1Anu/\Vav1m1Anu
(C57BL/6JAnu-Vav1m1Anu)
|
increased T cell number
|
J:104190
|
\Vav1m1Btlr/\Vav1m1Btlr
(C57BL/6J-Vav1m1Btlr)
|
decreased B-1 B cell number
|
J:265128
|
| decreased CD4-positive, alpha-beta T cell number
|
J:265128
|
| decreased CD8-positive, alpha-beta T cell number
|
J:265128
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:265128
|
| decreased single-positive T cell number
|
J:265128
|
| decreased T cell number
|
J:265128
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:265128
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:265128
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:265128
|
\Vav1m2Btlr/\Vav1m2Btlr
(C57BL/6J-Vav1m2Btlr)
|
decreased B-1 B cell number
|
J:265130
|
\Vav1M4Btlr/\Vav1M4Btlr
(C57BL/6J-Vav1M4Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272528
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272528
|
| abnormal T cell differentiation
|
J:272528
|
| decreased B-1 B cell number
|
J:272528
|
| decreased CD4-positive, alpha-beta T cell number
|
J:272528
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:272528
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:272528
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272528
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:272528
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:272528
|
\Vav1M5Btlr/\Vav1M5Btlr
(C57BL/6J-Vav1M5Btlr)
|
decreased CD8-positive, alpha-beta T cell number
|
J:272529
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113270
|
| decreased double-negative T cell number
|
J:113270
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113270
|
| abnormal negative T cell selection
|
J:113270
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas)
|
abnormal double-negative T cell morphology
|
J:79323
|
| decreased double-positive T cell number
|
J:79323
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:79323
|
| decreased thymocyte number
|
J:86654
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(C.129S2-Vav1tm1Tyb)
|
abnormal negative T cell selection
|
J:79323
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:79323
|
\Vav1tm1Tyb/\Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
abnormal lymphocyte cell number
|
J:190087
|
| abnormal T cell number
|
J:190087
|
| decreased double-positive T cell number
|
J:190087
|
| increased DN2 thymocyte number
|
J:190087
|
| increased DN3 thymocyte number
|
J:190087
|
| increased double-negative T cell number
|
J:190087
|
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased double-negative T cell number
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:86654
|
| decreased T cell number
|
J:86654
|
| decreased thymocyte number
|
J:86654
|
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Kdf/\Vav2tm1Kdf
\Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:86654
|
| arrested T cell differentiation
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased follicular B cell number
|
J:86654
|
| decreased marginal zone B cell number
|
J:86654
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:86654
|
| decreased T cell number
|
J:86654
|
| decreased thymocyte number
|
J:86654
|
| decreased transitional stage T2 B cell number
|
J:86654
|
| increased immature B cell number
|
J:86654
|
| increased transitional stage T1 B cell number
|
J:86654
|
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased B cell number
|
J:69807
|
| decreased CD4-positive, alpha-beta T cell number
|
J:69807
|
| decreased CD8-positive, alpha-beta T cell number
|
J:69807
|
| decreased follicular B cell number
|
J:69807
|
| decreased immature B cell number
|
J:69807
|
| decreased mature B cell number
|
J:69807
|
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased double-negative T cell number
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased mature B cell number
|
J:86654
|
| decreased single-positive T cell number
|
J:86654
|
| decreased T cell number
|
J:86654
|
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal T cell differentiation
|
J:47596
|
| decreased B-1 B cell number
|
J:47596
|
| decreased CD4-positive, alpha-beta T cell number
|
J:47596
|
| decreased CD8-positive, alpha-beta T cell number
|
J:47596
|
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell number
|
J:55647
|
| abnormal T cell differentiation
|
J:47596
|
| abnormal T cell number
|
J:47596
|
| decreased B-1 B cell number
|
J:55647
|
| decreased CD4-positive, alpha-beta T cell number
|
J:47596
|
| decreased CD8-positive, alpha-beta T cell number
|
J:47596
|
| increased double-negative T cell number
|
J:47596
|
| increased transitional stage B cell number
|
J:69806
|
\Vav1tm2Bbd/\Vav1tm2Bbd
(B6.129-Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
| abnormal positive T cell selection
|
J:141390
|
| decreased double-positive T cell number
|
J:141390
|
| decreased NK T cell number
|
J:71161
|
| decreased T cell number
|
J:141390
|
\Vav1tm2Bbd/\Vav1tm2Bbd
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:69806
|
| abnormal T cell differentiation
|
J:69806
|
| decreased B cell number
|
J:69806
|
| decreased B-1 B cell number
|
J:69806
|
| decreased CD8-positive, alpha-beta T cell number
|
J:69806
|
| decreased mature B cell number
|
J:69806
|
| decreased T cell number
|
J:69806
|
\Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased CD4-positive, alpha-beta T cell number
|
J:113270
|
| decreased double-negative T cell number
|
J:113270
|
\Vav1tm2Tyb/\Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:113270
|
| abnormal negative T cell selection
|
J:113270
|
\Vav1tm4Tyb/\Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
abnormal lymphocyte cell number
|
J:190087
|
| abnormal T cell number
|
J:190087
|
| increased DN2 thymocyte number
|
J:190087
|
| increased DN3 thymocyte number
|
J:190087
|
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * C57BL/6)
|
decreased mature B cell number
|
J:69806
|
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:69807
|
| decreased B cell number
|
J:69807
|
\Vcam1tm1Dmil/\Vcam1tm1Dmil
(C.129S4-Vcam1tm1Dmil)
|
increased B cell number
|
J:69597
|
| increased T cell number
|
J:69597
|
\Vcam1tm2Flv/\Vcam1tm3Flv
\Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C3H * C57BL/6)
|
decreased B cell number
|
J:68147
|
| decreased CD4-positive, alpha-beta T cell number
|
J:68147
|
| decreased CD8-positive, alpha-beta T cell number
|
J:68147
|
| decreased immature B cell number
|
J:68147
|
| increased immature B cell number
|
J:68147
|
\Vcam1tm2Roml/\Vcam1tm2Roml
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased B cell number
|
J:68148
|
| decreased mature B cell number
|
J:68148
|
| decreased transitional stage B cell number
|
J:68148
|
| increased B cell number
|
J:68148
|
| increased immature B cell number
|
J:68148
|
| increased mature B cell number
|
J:68148
|
| increased transitional stage B cell number
|
J:68148
|
\Vdac2tm1.1Ehyc/\Vdac2tm1.1Ehyc
\Baxtm2Sjk/\Baxtm2Sjk
\Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:220951
|
\Vdac2tm1.1Ehyc/\Vdac2tm1.1Ehyc
\Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte number
|
J:220951
|
\Vdrtm1Ska/\Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ)
|
abnormal T cell number
|
J:127787
|
| decreased regulatory T cell number
|
J:127787
|
\Vegfatm1Pec/\Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased lymphocyte cell number
|
J:81698
|
\Vhltm1Jae/\Vhltm1Jae
\Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * CD-1)
|
decreased lymphocyte cell number
|
J:186085
|
\Vpreb1atm1Ilm/\Vpreb1atm1Ilm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pre-B cell morphology
|
J:53512
|
| arrested B cell differentiation
|
J:53512
|
\Vpreb1atm1Ilm/\Vpreb1atm1Ilm
(B6.129P2-Vpreb1atm1Ilm)
|
decreased pre-B cell number
|
J:104211
|
| increased pre-B cell number
|
J:104211
|
\Vpreb1atm1Ilm/\Vpreb1atm1Ilm
\Vpreb1btm1Ilm/\Vpreb1b+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased mature B cell number
|
J:104211
|
| decreased pre-B cell number
|
J:104211
|
| increased pre-B cell number
|
J:104211
|
\Vpreb1atm1Ilm/\Vpreb1atm1Ilm
\Vpreb1btm1Ilm/\Vpreb1btm1Ilm
(B6.129P2-Vpreb1atm1Ilm Vpreb1btm1Ilm)
|
abnormal B cell differentiation
|
J:67609
|
| abnormal immature B cell morphology
|
J:67609
|
| decreased B-1a cell number
|
J:67609
|
| decreased mature B cell number
|
J:67609
|
| decreased pre-B cell number
|
J:67609
|
| increased pre-B cell number
|
J:67609
|
\Vps13atm1b(EUCOMM)Wtsi/\Vps13atm1b(EUCOMM)Wtsi
(C57BL/6N-Vps13atm1b(EUCOMM)Wtsi/Wtsi)
|
decreased T-helper cell number
|
J:211773
|
\Vps13bem1(IMPC)Tcp/\Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Vps33aem2(IMPC)Tcp/\Vps33a+
(C57BL/6NCrl-Vps33aem2(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Vps33btm1.1Arte/\Vps33btm1.1Arte
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J)
|
decreased lymphocyte cell number
|
J:222766
|
\Vsig4tm1Gne/\Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
increased T-helper 1 cell number
|
J:281762
|
| increased T-helper 17 cell number
|
J:281762
|
\Vtcn1tm1Xxz/\Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased CD4-positive, alpha-beta T cell number
|
J:177612
|
| increased T-helper 1 cell number
|
J:177612
|
| increased T-helper 17 cell number
|
J:177612
|
\Wastm1Itl/Y
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
\Wastm1Itl/\Wastm1Itl
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
\Wastm1Kas/\Wastm1Kas
(involves: 129/Sv * C57BL/6)
|
decreased B cell number
|
J:87875
|
| decreased double-positive T cell number
|
J:87875
|
| decreased lymphocyte cell number
|
J:87875
|
| decreased T cell number
|
J:87875
|
\Wastm1Sbs/Y
(involves: 129S6/SvEvTac)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
\Wastm1Sbs/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
\Wastm1Sbs/\Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased B cell number
|
J:48836
|
| decreased lymphocyte cell number
|
J:48836
|
| decreased T cell number
|
J:48836
|
\Wastm1Sbs/\Wastm1Sbs
(involves: 129S6/SvEvTac)
|
abnormal double-negative T cell morphology
|
J:125309
|
| abnormal double-positive T cell morphology
|
J:125309
|
| abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
\Wastm1Sbs/\Wastm1Sbs
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased marginal zone B cell number
|
J:182528
|
| decreased mature B cell number
|
J:182528
|
| increased germinal center B cell number
|
J:182528
|
| increased plasma cell number
|
J:182528
|
\Wastm1Sbs/\Wastm1Sbs
\Wasltm2Sbs/\Wasltm2Sbs
\Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:125309
|
| abnormal double-positive T cell morphology
|
J:125309
|
| decreased regulatory T cell number
|
J:125309
|
| decreased single-positive T cell number
|
J:125309
|
| decreased T cell number
|
J:125309
|
| decreased thymocyte number
|
J:125309
|
| increased single-positive T cell number
|
J:125309
|
\Wastm2Itl/Y
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
\Wastm2Itl/\Wastm2Itl
(Not Specified)
|
abnormal lymphocyte morphology
|
J:153247
|
| decreased NK cell number
|
J:153247
|
| decreased T cell number
|
J:153247
|
| increased B cell number
|
J:153247
|
| increased follicular B cell number
|
J:153247
|
\Wbp1ltm2a(EUCOMM)Hmgu/\Wbp1ltm2a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal pre-B cell morphology
|
J:284781
|
| decreased B cell number
|
J:284781
|
| decreased B-1 B cell number
|
J:284781
|
| decreased pre-B cell number
|
J:284781
|
| decreased pro-B cell number
|
J:284781
|
| increased marginal zone B cell number
|
J:284781
|
\Wdr41m1Btlr/\Wdr41m1Btlr
(C57BL/6J-Wdr41m1Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
\Wdr41m2Btlr/\Wdr41m2Btlr
(C57BL/6J-Wdr41m2Btlr)
|
increased CD4-positive, alpha-beta T cell number
|
J:268243
|
| increased CD8-positive, alpha-beta T cell number
|
J:268243
|
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac)
|
decreased thymocyte number
|
J:74719
|
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal alpha-beta T cell morphology
|
J:116168
|
| abnormal lymphopoiesis
|
J:116168
|
| decreased B cell number
|
J:116168
|
| decreased follicular B cell number
|
J:116168
|
| decreased lymphocyte cell number
|
J:116168
|
| decreased marginal zone B cell number
|
J:116168
|
\Wlstm1.1Arte/\Wlstm1.1Arte
\Krt14tm1(cre)Wbm/\Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:202499
|
| abnormal T cell subpopulation ratio
|
J:202499
|
| decreased double-positive T cell number
|
J:202499
|
| decreased gamma-delta T cell number
|
J:202499
|
| decreased T cell number
|
J:202499
|
| increased double-negative T cell number
|
J:202499
|
\Wnt1tm1Brd/\Wnt1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte number
|
J:75999
|
\Wnt1tm1Brd/\Wnt1tm1Brd
\Wnt4tm1Amc/\Wnt4tm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte number
|
J:75999
|
\Wnt4em1(IMPC)Hmgu/\Wnt4+
(C57BL/6NCrl-Wnt4em1(IMPC)Hmgu/Ieg)
|
decreased lymphocyte cell number
|
J:211773
|
\Wnt4tm1Amc/\Wnt4tm1Amc
(involves: 129S1/Sv)
|
decreased thymocyte number
|
J:75999
|
\Wrnip1tm1a(EUCOMM)Wtsi/\Wrnip1tm1a(EUCOMM)Wtsi
(C57BL/6N-Wrnip1tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased T cell number
|
J:165965
|
\Xbp1tm1a(EUCOMM)Wtsi/\Xbp1+
(C57BL/6N-Xbp1tm1a(EUCOMM)Wtsi/Ics)
|
decreased T cell number
|
J:165965
|
\Xbp1tm1b(EUCOMM)Wtsi/\Xbp1+
(C57BL/6N-Xbp1tm1b(EUCOMM)Wtsi/Ics)
|
decreased large unstained cell number
|
J:211773
|
| decreased lymphocyte cell number
|
J:211773
|
\Xcl1tm1.1Dnax/\Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6))
|
decreased regulatory T cell number
|
J:176844
|
\Xcl1tm1Rakr/\Xcl1tm1Rakr
\Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6)
|
decreased T cell number
|
J:155297
|
\Xpatm1Tnka/\Xpatm1Tnka
(involves: C57BL/6 * CBA)
|
increased NK cell number
|
J:55739
|
\Xpnpep1tm1a(KOMP)Wtsi/\Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi)
|
increased gamma-delta T cell number
|
J:211773
|
| increased NK cell number
|
J:211773
|
\Xrcc5em1(IMPC)Ccpcz/\Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD4-positive NK T cell number
|
J:211773
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:211773
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211773
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
| decreased effector memory T-helper cell number
|
J:211773
|
| decreased memory-marker CD4-positive NK T cell number
|
J:211773
|
| decreased NK T cell number
|
J:211773
|
| decreased T-helper cell number
|
J:211773
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:211773
|
| increased effector memory T-helper cell number
|
J:211773
|
\Xrcc5m1Btlr/\Xrcc5m1Btlr
(C57BL/6J-Xrcc5m1Btlr)
|
abnormal B cell differentiation
|
J:274736
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274736
|
| abnormal T cell differentiation
|
J:274736
|
| decreased B-2 B cell number
|
J:274736
|
| decreased CD4-positive, alpha-beta T cell number
|
J:274736
|
| decreased CD8-positive, alpha-beta T cell number
|
J:274736
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:274736
|
| decreased T cell number
|
J:274736
|
| increased B-1a cell number
|
J:274736
|
| increased B-1b cell number
|
J:274736
|
| increased CD4-positive, alpha-beta T cell number
|
J:274736
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:274736
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:274736
|
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:34834
|
| absent T cells
|
J:34834
|
| arrested B cell differentiation
|
J:34834
|
| arrested T cell differentiation
|
J:34834
|
| increased double-negative T cell number
|
J:34834
|
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal lymphocyte morphology
|
J:80467
|
\Xrcc5tm1Nus/\Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal class switch recombination
|
J:120658
|
\Xrcc6avon/\Xrcc6avon
(involves: C57BL/6JAnu)
|
decreased B cell number
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:44361
|
| abnormal B cell morphology
|
J:44361
|
| abnormal T cell differentiation
|
J:44361
|
| abnormal T cell morphology
|
J:44361
|
| absent immature B cells
|
J:44361
|
| absent mature B cells
|
J:44361
|
| absent pre-B cells
|
J:44361
|
| arrested B cell differentiation
|
J:44361
|
| decreased single-positive T cell number
|
J:44361
|
| decreased thymocyte number
|
J:44361
|
| increased double-positive T cell number
|
J:44361
|
\Xrcc6tm1Gcl/\Xrcc6tm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:108657
|
| absent mature B cells
|
J:108657
|
X/\Yaa
(BXSB/MpJ)
|
abnormal B cell differentiation
|
J:108760
|
| abnormal T cell subpopulation ratio
|
J:179430
|
| increased plasma cell number
|
J:108760
|
X/\Yaa
(BXSB/MpJScr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:10973
|
X/\Yaa
(B6.SB-Yaa/J)
|
decreased marginal zone B cell number
|
J:127600
|
\Ydjctm1(KOMP)Wtsi/\Ydjctm1(KOMP)Wtsi
(C57BL/6N-Ydjctm1(KOMP)Wtsi/Wtsi)
|
increased effector memory T-helper cell number
|
J:211773
|
| increased germinal center B cell number
|
J:211773
|
\Yeats4em1Zfa/\Yeats4em1Zfa
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
| decreased lymphocyte cell number
|
J:282740
|
\Yod1tm1bNarl/\Yod1tm1bNarl
(C57BL/6N-Yod1tm1bNarl/Narl)
|
decreased lymphocyte cell number
|
J:211773
|
\Ywhaztm1b(EUCOMM)Hmgu/\Ywhaz+
(C57BL/6N-Ywhaztm1b(EUCOMM)Hmgu/Tcp)
|
increased lymphocyte cell number
|
J:211773
|
\Zap70m1Btlr/\Zap70m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| absent CD4-positive, alpha-beta T cells
|
J:167119
|
| absent CD8-positive, alpha-beta T cells
|
J:167119
|
| decreased T cell number
|
J:185495
|
\Zap70m1Saka/\Zap70m1Saka
(involves: BALB/c)
|
abnormal positive T cell selection
|
J:154166,
J:86607
|
| abnormal T cell clonal deletion
|
J:154166
|
| abnormal T cell differentiation
|
J:86607
|
| abnormal T cell selection
|
J:86607
|
| decreased CD4-positive, alpha-beta T cell number
|
J:154166,
J:86607
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154166,
J:86607
|
| decreased regulatory T cell number
|
J:154166
|
| increased activated T cell number
|
J:154166
|
| increased B cell number
|
J:86607
|
| increased memory T cell number
|
J:154166
|
\Zap70m1Saka/\Zap70m1Saka
\Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
decreased T cell number
|
J:86607
|
\Zap70m1Saka/\Zap70m1Saka
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: BALB/c * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:86607
|
\Zap70m1Saka/\Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell clonal deletion
|
J:154166
|
\Zap70m2Btlr/\Zap70m2Btlr
(involves: C57BL/6J)
|
decreased T cell number
|
J:174837
|
\Zap70m4Btlr/\Zap70m4Btlr
(C57BL/6J-Zap70m4Btlr)
|
decreased CD4-positive, alpha-beta T cell number
|
J:236698
|
| decreased CD8-positive, alpha-beta T cell number
|
J:236698
|
| decreased T cell number
|
J:236698
|
\Zap70m5Btlr/\Zap70m5Btlr
(C57BL/6J-Zap70m5Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254830
|
| decreased CD8-positive, alpha-beta T cell number
|
J:254830
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254830
|
| increased B cell number
|
J:254830
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254830
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254830
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254830
|
\Zap70m6Btlr/\Zap70m6Btlr
(C57BL/6J-Zap70m6Btlr)
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254831
|
| decreased CD8-positive, alpha-beta T cell number
|
J:254831
|
| decreased CD8-positive, naive alpha-beta T cell number
|
J:254831
|
| increased B cell number
|
J:254831
|
| increased central memory CD4-positive, alpha-beta T cell number
|
J:254831
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254831
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:254831
|
\Zap70m6Hefl/\Zap70m6Hefl
(C3HeB/FeJ-Zap70m6Hefl)
|
abnormal T cell differentiation
|
J:137446
|
| decreased CD4-positive, alpha-beta T cell number
|
J:137446
|
| decreased CD8-positive, alpha-beta T cell number
|
J:137446
|
| decreased T cell number
|
J:137446
|
\Zap70m6Hefl/\Zap70tm1Weis
(involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2)
|
decreased T cell number
|
J:137446
|
\Zap70m7Btlr/\Zap70m7Btlr
(C57BL/6J-Zap70m7Btlr)
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:254832
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:254832
|
\Zap70m8Btlr/\Zap70m8Btlr
(C57BL/6J-Zap70m8Btlr)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:272864
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272864
|
\Zap70mrtle/\Zap70mrtle
(C57BL/6JSfdAnu-Zap70mrtle/Apb)
|
abnormal positive T cell selection
|
J:104190
|
| abnormal T cell subpopulation ratio
|
J:104190
|
| absent T cells
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased T cell number
|
J:104190
|
\Zap70mrtle/\Zap70mrtle
(involves: C57BL/6JSfdAnu)
|
abnormal double-positive T cell morphology
|
J:211510
|
| abnormal regulatory T cell number
|
J:211510
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211510
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211510
|
| increased double-positive T cell number
|
J:211510
|
\Zap70mrtle/\Zap70rps
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:211510
|
| abnormal double-positive T cell morphology
|
J:211510
|
| abnormal regulatory T cell number
|
J:211510
|
| decreased CD4-positive, alpha-beta T cell number
|
J:211510
|
| decreased CD8-positive, alpha-beta T cell number
|
J:211510
|
| increased double-positive T cell number
|
J:211510
|
\Zap70mur/\Zap70mur
(C57BL/6Apb-Zap70mur/ApbH)
|
decreased T cell number
|
J:104190
|
\Zap70st/\Zap70st
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
| decreased T cell number
|
J:41170
|
\Zap70st/\Zap70tm1Dlo
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
\Zap70tm1Dlo/\Zap70tm1Dlo
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:97610
|
\Zap70tm1Weis/\Zap70tm1Weis
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:74974
|
| arrested T cell differentiation
|
J:74974
|
\Zap70tm2.1Mmal/\Zap70tm2.1Mmal
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * DBA/2J)
|
abnormal T cell morphology
|
J:71099
|
\Zap70tm2.1Mmal/\Zap70tm2.1Mmal
\Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)
|
abnormal T cell morphology
|
J:71099
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(B6.129S4-Zap70tm2.1Weis)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:154166
|
| decreased CD4-positive, alpha-beta T cell number
|
J:154166
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154166
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal positive T cell selection
|
J:154166
|
| abnormal T cell clonal deletion
|
J:154166
|
| decreased CD4-positive, alpha-beta T cell number
|
J:154166
|
| decreased CD8-positive, alpha-beta T cell number
|
J:154166
|
| decreased regulatory T cell number
|
J:154166
|
| increased activated T cell number
|
J:154166
|
| increased memory T cell number
|
J:154166
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis
\Tg(DO11.10)10Dlo/?
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:154166
|
\Zap70tm2.1Weis/\Zap70tm2.1Weis
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S4/SvJae * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:154166
|
| abnormal T cell clonal deletion
|
J:154166
|
\Zbtb1m1Btlr/\Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J)
|
abnormal B cell differentiation
|
J:178820
|
| abnormal T cell differentiation
|
J:178820
|
| decreased B cell number
|
J:178820
|
| decreased CD4-positive, alpha-beta T cell number
|
J:178820
|
| decreased CD8-positive, alpha-beta T cell number
|
J:178820
|
| decreased DN2 thymocyte number
|
J:178820
|
| decreased DN3 thymocyte number
|
J:178820
|
| decreased DN4 thymocyte number
|
J:178820
|
| decreased double-positive T cell number
|
J:178820
|
| decreased follicular B cell number
|
J:178820
|
| decreased NK cell number
|
J:178820
|
| decreased T cell number
|
J:178820
|
| decreased transitional stage B cell number
|
J:178820
|
| increased B cell number
|
J:178820
|
\Zbtb1m2Btlr/\Zbtb1m2Btlr
(C57BL/6J-Zbtb1m2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272845
|
| increased central memory CD8 positive, alpha-beta T cell number
|
J:272845
|
\Zbtb7atm1Ppp/\Zbtb7atm1Ppp
(B6.129S1-Zbtb7atm1Ppp)
|
abnormal lymphopoiesis
|
J:121576
|
| decreased B cell number
|
J:121576
|
| decreased pro-B cell number
|
J:121576
|
\Zbtb7atm1Ppp/\Zbtb7atm2Ppp
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:121576
|
| abnormal double-positive T cell morphology
|
J:121576
|
| decreased B cell number
|
J:121576
|
\Zbtb7bhd/\Zbtb7bhd
(involves: 129/Sv * BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:48734
|
| absent CD4-positive, alpha-beta T cells
|
J:48734
|
| increased CD8-positive, alpha-beta T cell number
|
J:48734
|
\Zbtb7bhpls/\Zbtb7bhpls
(involves: C57BL/6JAnu)
|
decreased CD4-positive, alpha-beta T cell number
|
J:104190
|
\Zbtb7btm1.1Rbo/\Zbtb7btm1.1Rbo
(Not Specified)
|
abnormal CD8-positive, alpha-beta T cell number
|
J:141145
|
| abnormal T cell differentiation
|
J:141145
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141145
|
\Zbtb7btm1.1Skok/\Zbtb7btm1.1Skok
(involves: 129/Sv * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:169841
|
\Zbtb7btm1.1Tani/\Zbtb7btm1.1Tani
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
\Zbtb7btm1Itan/\Zbtb7btm1.1Tani
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha beta T cell morphology
|
J:141142
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141142
|
| increased CD8-positive, alpha-beta T cell number
|
J:141142
|
| increased double-negative T cell number
|
J:141142
|
\Zbtb7btm1Itan/\Zbtb7btm2Itan
(involves: 129 * C57BL/6)
|
decreased CD4-positive, alpha-beta T cell number
|
J:141142
|
| increased CD8-positive, alpha-beta T cell number
|
J:141142
|
| increased double-negative T cell number
|
J:141142
|
\Zbtb7btm1Litt/\Zbtb7btm1.2Litt
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
| increased CD8-positive, alpha-beta T cell number
|
J:141144
|
\Zbtb7btm2Litt/\Zbtb7btm1.2Litt
(involves: 129P2/OlaHsd)
|
decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
\Zbtb7btm2Litt/\Zbtb7btm1.2Litt
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
| decreased CD4-positive, alpha-beta T cell number
|
J:141144
|
\Zbtb7btm2Litt/\Zbtb7btm2Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
absent CD4-positive, alpha-beta T cells
|
J:141519
|
\Zbtb7btm4.1Itan/\Zbtb7btm4.1Itan
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:193321
|
| increased CD8-positive, alpha-beta T cell number
|
J:193321
|
\Zbtb7btm6.1Itan/\Zbtb7btm6.1Itan
\Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
decreased CD8-positive, alpha-beta T cell number
|
J:195348
|
\Zbtb7btm7Itan/\Zbtb7btm7Itan
(Not Specified)
|
decreased CD4-positive, alpha-beta T cell number
|
J:195348
|
\Zbtb16lu/\Zbtb16lu
(B6.C3-Zbtb16lu/J)
|
decreased NK T cell number
|
J:139690
|
\Zbtb17tm1Cksn/\Zbtb17tm1Cksn
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
| decreased DN1 thymic pro-T cell number
|
J:170508
|
| decreased DN2 thymocyte number
|
J:170508
|
| decreased DN3 thymocyte number
|
J:170508
|
| decreased double-negative T cell number
|
J:170508
|
| decreased gamma-delta T cell number
|
J:170508
|
| decreased T cell number
|
J:170508
|
| decreased thymocyte number
|
J:170508
|
\Zc3h8em1(IMPC)Ccpcz/\Zc3h8+
(C57BL/6N-Zc3h8em1(IMPC)Ccpcz/Ccpcz)
|
decreased CD8-positive, naive alpha-beta T cell number
|
J:211773
|
\Zc3h12atm1Aki/\Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147868
|
| increased memory T cell number
|
J:147868
|
| increased plasma cell number
|
J:147868
|
\Zc3h12cem1(IMPC)Tcp/\Zc3h12cem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12cem1(IMPC)Tcp/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Zc3h12ctm2c(EUCOMM)Hmgu/\Zc3h12ctm2c(EUCOMM)Hmgu
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
increased B cell number
|
J:277714
|
| increased CD4-positive, alpha-beta T cell number
|
J:277714
|
| increased effector memory CD8-positive, alpha-beta T cell number
|
J:277714
|
| increased immature B cell number
|
J:277714
|
| increased marginal zone B cell number
|
J:277714
|
\Zc3h12ctm2d(EUCOMM)Hmgu/\Zc3h12ctm2d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
decreased CD8-positive, alpha-beta T cell number
|
J:277714
|
| decreased germinal center B cell number
|
J:277714
|
| increased B cell number
|
J:277714
|
| increased CD4-positive, alpha-beta T cell number
|
J:277714
|
| increased effector memory CD4-positive, alpha-beta T cell number
|
J:277714
|
| increased immature B cell number
|
J:277714
|
| increased marginal zone B cell number
|
J:277714
|
| increased T cell number
|
J:277714
|
\Zc3h12dtm1b(EUCOMM)Hmgu/\Zc3h12dtm1b(EUCOMM)Hmgu
(C57BL/6N-Zc3h12dtm1b(EUCOMM)Hmgu/Orl)
|
decreased lymphocyte cell number
|
J:211773
|
\Zc3h12dtm1Tom/\Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom)
|
increased T-helper 17 cell number
|
J:209383
|
\Zdhhc2em1Eko/\Zdhhc2em1Eko
(C57BL/6-Zdhhc2em1Eko)
|
decreased dendritic epidermal T cell number
|
J:303593
|
| increased alpha-beta T cell number
|
J:303593
|
| increased gamma-delta T cell number
|
J:303593
|
\Zeb1m1Btlr/\Zeb1m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
| abnormal class switch recombination
|
J:185495
|
| absent marginal zone B cells
|
J:185495
|
| decreased B-1 B cell number
|
J:185495
|
| decreased B-1a cell number
|
J:185495
|
| decreased B-1b cell number
|
J:185495
|
| decreased double-positive T cell number
|
J:185495
|
| decreased germinal center B cell number
|
J:185495
|
| decreased NK cell number
|
J:185495
|
| increased single-positive T cell number
|
J:185495
|
| increased thymocyte number
|
J:185495
|
\Zeb1tm1Yhi/\Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi)
|
abnormal T cell differentiation
|
J:39865
|
| abnormal T cell subpopulation ratio
|
J:39865
|
| decreased CD8-positive, alpha-beta T cell number
|
J:39865
|
| decreased double-positive T cell number
|
J:39865
|
| decreased lymphocyte cell number
|
J:39865
|
| decreased T cell number
|
J:39865
|
| decreased thymocyte number
|
J:39865
|
\Zeb1tm2Yhi/\Zeb1tm2Yhi
(B6.129-Zeb1tm2Yhi)
|
decreased thymocyte number
|
J:45575
|
\Zeb1Tw/\Zeb1+
(B6.Cg-Zeb1Tw)
|
decreased lymphocyte cell number
|
J:177274
|
\Zfand2btm1Otin/\Zfand2btm1Otin
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased lymphocyte cell number
|
J:233169
|
| increased lymphocyte cell number
|
J:233169
|
\Zfattm2.1Sawa/\Zfattm2.1Sawa
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:187164
|
| decreased CD4-positive, alpha-beta T cell number
|
J:187164
|
| decreased CD8-positive, alpha-beta T cell number
|
J:187164
|
\Zfp35tm1Naka/\Zfp35tm1Naka
(either: B6.Cg-Zfp35tm1Naka or C.Cg-Zfp35tm1Naka)
|
abnormal T-helper 2 cell differentiation
|
J:153828
|
\Zfp36tm1Pjb/\Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
decreased lymphocyte cell number
|
J:214114
|
\Zfp131tm1.1Mytk/\Zfp131tm1.1Mytk
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal T cell subpopulation ratio
|
J:271921
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271921
|
| decreased CD8-positive, alpha-beta T cell number
|
J:271921
|
| decreased T cell number
|
J:271921
|
\Zfp131tm1.1Mytk/\Zfp131tm1.2Mytk
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
abnormal double-negative T cell morphology
|
J:271921
|
| abnormal T cell differentiation
|
J:271921
|
| arrested T cell differentiation
|
J:271921
|
| decreased CD4-positive, alpha-beta T cell number
|
J:271921
|
| decreased CD8-positive, alpha-beta T cell number
|
J:271921
|
| decreased DN2 thymocyte number
|
J:271921
|
| decreased DN3 thymocyte number
|
J:271921
|
| decreased DN4 thymocyte number
|
J:271921
|
| decreased double-negative T cell number
|
J:271921
|
| decreased double-positive T cell number
|
J:271921
|
| decreased thymocyte number
|
J:271921
|
\Zfp207tm1b(EUCOMM)Hmgu/\Zfp207+
(C57BL/6N-Zfp207tm1b(EUCOMM)Hmgu/H)
|
decreased lymphocyte cell number
|
J:211773
|
\Zfp260tm1b(NCOM)Mfgc/\Zfp260+
(C57BL/6N-Zfp260tm1b(NCOM)Mfgc/Tcp)
|
decreased lymphocyte cell number
|
J:211773
|
\Zfp318m1Anu/\Zfp318m1Anu
(C57BL/6JAnu-Zfp318m1Anu)
|
abnormal B cell number
|
J:104190
|
| increased mature B cell number
|
J:207375
|
\Zfp318tm1.1Jhws/\Zfp318tm1.1Jhws
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zfp318tm1.1Jhws TgVav1-creA2Kio)
|
decreased transitional stage T2 B cell number
|
J:215815
|
\Zfp335blt/\Zfp335blt
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214793
|
| abnormal T cell differentiation
|
J:214793
|
| decreased B cell number
|
J:214793
|
| decreased CD4-positive, alpha-beta memory T cell number
|
J:214793
|
| decreased CD4-positive, alpha-beta T cell number
|
J:214793
|
| decreased CD8-positive, alpha-beta memory T cell number
|
J:214793
|
| decreased CD8-positive, alpha-beta T cell number
|
J:214793
|
| decreased NK T cell number
|
J:214793
|
| decreased regulatory T cell number
|
J:214793
|
| decreased single-positive T cell number
|
J:214793
|
\Zfp420tm1b(EUCOMM)Hmgu/\Zfp420tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp420tm1b(EUCOMM)Hmgu/Bay)
|
increased lymphocyte cell number
|
J:211773
|
\Zfp469em1(IMPC)Mbp/\Zfp469em1(IMPC)Mbp
(C57BL/6N-Zfp469em1(IMPC)Mbp/MbpMmucd)
|
increased lymphocyte cell number
|
J:211773
|
\Zfp474em1(IMPC)Ccpcz/\Zfp474em1(IMPC)Ccpcz
(C57BL/6N-Zfp474em1(IMPC)Ccpcz/Ccpcz)
|
decreased lymphocyte cell number
|
J:211773
|
\Zfp574em1Btlr/\Zfp574em1Btlr
(C57BL/6J-Zfp574em1Btlr)
|
abnormal class switch recombination
|
J:354285
|
| decreased B cell number
|
J:354285
|
| decreased B-1 B cell number
|
J:354285
|
| decreased lymphocyte cell number
|
J:354285
|
| decreased T cell number
|
J:354285
|
\Zfp574em1Btlr/\Zfp574em1Btlr
\Tg(IghMyc)22Bri/0
(B6.Cg-Zfp574em1Btlr Tg(IghMyc)22Bri)
|
decreased pre-B cell number
|
J:354285
|
\Zfp574em3Btlr/\Zfp574em3Btlr
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
(B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb Zfp574em3Btlr)
|
decreased B cell number
|
J:354285
|
\Zfp574em3Btlr/\Zfp574em3Btlr
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Tg(IghMyc)22Bri/0
(B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb Zfp574em3Btlr Tg(IghMyc)22Bri)
|
decreased B cell number
|
J:354285
|
\Zfp574m1Btlr/\Zfp574m1Btlr
(C57BL/6J-Zfp574m1Btlr)
|
decreased B cell number
|
J:354285
|
\Zfp595tm1b(KOMP)Wtsi/\Zfp595tm1b(KOMP)Wtsi
(C57BL/6N-Zfp595tm1b(KOMP)Wtsi/Bay)
|
decreased lymphocyte cell number
|
J:211773
|
\Zfp616tm1b(KOMP)Wtsi/\Zfp616tm1b(KOMP)Wtsi
(C57BL/6N-Zfp616tm1b(KOMP)Wtsi/Wtsi)
|
increased KLRG1-positive T-helper cell number
|
J:211773
|
\Zfp683Gt(OST314703)Lex/\Zfp683Gt(OST314703)Lex
(B6.129S5-Zfp683Gt(OST314703)Lex)
|
abnormal NK T cell morphology
|
J:187727
|
| decreased NK T cell number
|
J:187727
|
\Zfxtm1.1Reiz/Y
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased lymphocyte cell number
|
J:149654
|
\Zfxtm1.1Reiz/Y
\Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
decreased mature B cell number
|
J:149654
|
| decreased T cell number
|
J:149654
|
\Zfyve16tm2a(KOMP)Wtsi/\Zfyve16tm2a(KOMP)Wtsi
(C57BL/6N-Zfyve16tm2a(KOMP)Wtsi)
|
decreased B cell number
|
J:302014
|
| increased T cell number
|
J:302014
|
\Zranb1tm1c(EUCOMM)Hmgu/\Zranb1tm1c(EUCOMM)Hmgu
\Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA)
|
decreased T helper 1 cell number
|
J:235701
|
| decreased T-helper 17 cell number
|
J:235701
|
\Zranb1tm1d(EUCOMM)Hmgu/\Zranb1tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
decreased CD4-positive, alpha-beta T cell number
|
J:235701
|
| decreased T helper 1 cell number
|
J:235701
|
| decreased T-helper 17 cell number
|
J:235701
|
\Zrsr2em1(IMPC)Mbp/Y
(C57BL/6N-Zrsr2em1(IMPC)Mbp/MbpMmucd)
|
decreased lymphocyte cell number
|
J:211773
|
\Zscan10Gt(285B6)1.1Cmhd/\Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell subpopulation ratio
|
J:221010
|
| decreased T cell number
|
J:221010
|
| increased B cell number
|
J:221010
|
| increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
|
J:221010
|
| increased mature NK cell number
|
J:221010
|
\Zswim1tm1b(KOMP)Mbp/\Zswim1tm1b(KOMP)Mbp
(C57BL/6N-Zswim1tm1b(KOMP)Mbp/Nju)
|
decreased lymphocyte cell number
|
J:211773
|
| increased lymphocyte cell number
|
J:211773
|
Analysis Tools